{"title": "PDF", "author": "PDF", "url": "https://diposit.ub.edu/dspace/bitstream/2445/42412/2/JRM_TESIS.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "Detecci\u00f3n y caracterizaci\u00f3n de \nvirus pat\u00f3genos emergentes \nde inter\u00e9s general \nen seguridad alimentaria \nDetection and characterization \nof emerging viral pathogens \nof general interest \nin food safety \nJes\u00fas Rodr\u00edguez Manzano \nADVERTIMENT . La consulta d\u2019aquesta tesi queda condicionada a l\u2019acceptaci\u00f3 de les seg\u00fcents condicions d'\u00fas: La difusi\u00f3 \nd\u2019aquesta tesi per mitj\u00e0 del servei TDX ( www.tdx.cat ) ha estat autoritzada pels titulars dels drets de propietat intel\u00b7lectual \n\u00fanicament per a usos privats emmarcats en activitats d\u2019investigaci\u00f3 i doc\u00e8ncia. No s\u2019autoritza la seva reproducci\u00f3 amb \nfinalitats de lucre ni la seva difusi\u00f3 i posada a disposici\u00f3 des d\u2019un lloc ali\u00e8 al servei TDX. No s\u2019autoritza la presentaci\u00f3 de l\nseu contingut en una finestra o marc ali\u00e8 a TDX (framing). Aquesta reserva de drets afecta tant al resum de presentaci\u00f3 \nde la tesi com als seus continguts. En la utilitzaci\u00f3 o cita de parts de la tesi \u00e9s obligat indicar el nom de la persona autora .\nADVERTENCIA . La consulta de esta tesis queda condicionada a la aceptaci\u00f3n de las siguientes condiciones de uso: La \ndifusi\u00f3n de esta tesis por medio del servicio TDR ( www.tdx.cat ) ha sido autorizada por los titulares de los derechos de \npropiedad intelectual \u00fanicamente para usos privados enmarcados en actividades de investigaci\u00f3n y docencia. No se \nautoriza su reproducci\u00f3n con finalidades de lucro ni su difusi\u00f3n y puesta a disposici\u00f3n desde un sitio ajeno al servicio \nTDR. No se autoriza la presentaci\u00f3n de su contenido en una ventana o marco ajeno a TDR (framing). Esta reserva de \nderechos afecta tanto al resumen de presentaci\u00f3n de la tesis como a sus contenidos. En la utilizaci\u00f3n o cita de partes de \nla tesis es obligado indicar el nombre de la persona autora. \nWARNING . On having consulted this thesis you\u2019re accepting the following use conditions:  Spreading this thesis by the \nTDX ( www.tdx.cat ) service has been authorized by the titular of the intellectual property rights only for private uses placed \nin investigation and teaching activities. Reproduction with lucrative aims is not authorized neither its spreading and \navailability from a site foreign to the TDX service. Introducing its content in a window or frame foreign to the TDX service is\nnot authorized (framing). This rights affect to the presentation summary of the thesis as well as to its contents. In the using\nor citation of parts of the thesis it\u2019s obliged to indicate the name of the author.Jes\u00fas Rodr\u00edguez ManzanoDETECCI\u00d3N/g3Y/g3CARACTERIZACI\u00d3N/g3DE/g3\nVIRUS/g3PAT\u00d3GENOS/g3EMERGENTES/g3\nDE/g3INTER\u00c9S/g3GENERAL\nEN/g3SEGURIDAD/g3ALIMENTARIA\nTesis/g3Doctoral\nBarcelona,/g3Marzo/g32012  \n \nDetecci\u00f3n y caracterizaci\u00f3n de \nvirus pat\u00f3genos emergentes \nde inter\u00e9s general  \nen seguridad alimentaria \n  \nDetection and characterization \nof emerging viral pathogens \nof general interest \nin food safety \n \n \n \n \n \n  \nPor/ By Jes\u00fas Rodr\u00edguez Manzano \n \n  \n \n  \n \nMarzo 2012  Universidad de Barcelona \nFacultad de Biolog\u00eda  \nDepartamento de Microbiolog\u00eda \n \nPrograma de Doctorado: Microbiolog\u00eda \nAmbiental y Biotecnolog\u00eda \n \n  \nTESIS DOCTORAL/ THESIS  \n \nDETECCI\u00d3N Y CARACTERIZACI\u00d3N DE VIRUS PAT\u00d3GENOS EMERGENTES \nDE INTER\u00c9S GENERAL EN SEGURIDAD ALIMENTARIA \n \nDETECTION AND CHARACTERIZATION OF EMERGING VIRAL PATHOGENS \nOF GENERAL INTEREST IN FOOD SAFETY \n \n \nMemoria presentada por \nMemory presented by  \n \nJes\u00fas Rodr\u00edguez Manzano \n \npara optar al grado de \nto obtain the degree of \n \nDoctor en Biolog\u00eda \nDoctor in Biology \n \nTesis realizada bajo la direcci\u00f3n de la Dra. Rosi na Giron\u00e9s Llop (Catedr\u00e1tica en Microbiolog\u00eda) \nen el Departamento de Microbiolog\u00eda, Facultad de Biolog\u00eda, Universidad de Barcelona \n \nThesis developed under the supervision of PhD. Rosina Giron\u00e9s Llop (Professor in Microbiology)  \nin the Department of Microbiology, Faculty of Biology, University of Barcelona \n \n \nDirector, \nSupervisor, \n  \n \n  \nRosina Giron\u00e9s Llop Autor, \nAuthor, \n \n \n \n  \nJes\u00fas Rodr\u00edguez Manzano\n   \n \n   \nRosina Giron\u00e9s Llop, Professor of Microbiology in the University of Barcelona,   DECLARES:  That Jes\u00fas Rodr\u00edguez Manzano has perfor med the work entitled \u201cDetection and \ncharacterization of emerging viral pathogens of general interest in food safety\u201d under my \ndirection in order to obtain the degree of Doctor in Biology and that it fulfils the requirements \nto obtain the \u201cEuropea Doctor\u201d mention, and that  the work is ready to be presented from the \npresent day.    Signed: Rosina Giron\u00e9s Llop Barcelona, 20th March 2012   \n \n          \nA mi familia, en especial a mis padres, por el apoyo y amor \nincondicional que he recibido durante todos estos a\u00f1os de sacrificios \n        \n\u201cAll questions about life have the same answer: natural selection\u201d \nHenry Bennet-Clark \n   Agradecimientos/Acknowledgments \n iAGRADECIMIENTOS/ ACKNOWLEDGMENTS \n \nAntes de introducir el tema que aqu\u00ed se desarrolla, quisiera expresar mi m\u00e1s sincera \ngratitud a todas aquellas personas que han hecho posible este trabajo y que por supuesto, han sido una parte muy importante de mi vida durante los \u00faltimos a\u00f1os. De antemano pido perd\u00f3n por si alguien no se siente suficientemente reconocido en este apartado, pero afortunadamente me he cruzado con mucha gente interesante y como consecuencia no hay suficiente espacio para escribir unos agradecimientos que est\u00e9n a vuestra altura. Quiero que \nsep\u00e1is que cada uno de vosotros es una pieza esencial de lo que hoy considero que soy. \n \nEn primer lugar quisiera agradecer a la Dra. Rosina Giron\u00e9s  la oportunidad brindada \npara poder realizar la Tesis en su grupo de investigaci\u00f3n y permitir as\u00ed la realizaci\u00f3n de un objetivo personal muy importante, aunque parezca incre\u00edble desde bien peque\u00f1o he tenido la motivaci\u00f3n de realizar este proyecto y sin su ayuda no hubiera sido posible. Gracias Rosina  por \ntu confianza y por todas las facilidades y medios con los que has contribuido tanto a mi formaci\u00f3n profesional como personal.  \nEste apartado que sigue a continuaci\u00f3n est\u00e1 dedicado a los que han sido y son \nresponsables de que hoy me encuentre escribiendo estas l\u00edneas, la gente del Labo 8.  Todo \nempez\u00f3 durante mi tiempo como colaborador, hace ya siete a\u00f1os. En esa \u00e9poca el ala derecha del laboratorio estaba habitada por Ayalke , Carlitos , N\u00e9stor  (un t\u00edo listo donde los haya), \nPiluqui (mi mentora en el laboratorio) y S\u00edlvia  (gracias por creer que val\u00eda para esto y por toda \nla ayuda proporcionada), mientras que en el ala izquierda pod\u00edamos encontrar a Sari (la \nalegr\u00eda de la huerta) y Alejandra  (desde Bolivia con amor). Realmente, tengo que reconocer \nque fueron tiempos magn\u00edficos y que todos vosotros sois gente maravillosa de la que he aprendido un mont\u00f3n, aunque no quisiera dejar pasar la ocasi\u00f3n para recordaros que jam\u00e1s he apartado de mi mente una potencial venganza por la bromita de bienvenida y, ya que nunca es tarde si la dicha es buena, espero que sig\u00e1is esperando el d\u00eda en que Tip-boy /Rodman /Dennis  \nos la devuelva (porque ese d\u00eda llegar\u00e1\u2026). De este grupo mencionado debo destacar a los ahora Dr. Carlos (la rubia) y Dr. Ayalkibet  (mi hermano et\u00edope), creo que no hay p\u00e1ginas suficientes \npara describir las an\u00e9cdotas compartidas y lo mucho que hemos llegado a hablar de CIENCIA mientras nos tom\u00e1bamos unas birras. Gracias a vosotros dos, pack Benetton, he descubierto lo grande que es nuestra profesi\u00f3n y el poder que tiene la amistad. Seguidamente debo dar gracias al peque\u00f1o Byron  (moreno divino), hemos compartido muchas horas dentro y fuera del \nlaboratorio (especialmente en Sevilla y Floripa), y he aprendido mucho de ti. Sinceramente Agradecimientos/Acknowledgments \n ii espero que podamos continuar igual en proyectos futuros, colaborando por el mundo \nentero!!!! Acerc\u00e1ndonos un poco m\u00e1s al presente, me encuentro con Annita , ha sido todo un \nplacer tener una coet\u00e1nea de Tesis tan guapa y con un coraz\u00f3n tan grande, hemos tardado en conocernos pero he descubierto que eres una gran chica, espero que todo te vaya genial y que la Tesis que terminar\u00e1s en breve sea un \u00e9xito. M\u00e1s recientemente aparecieron; Cerver , siempre \ndispuesta a poner m\u00fasica, hablar de castells y echarse unas risas; Marta , sin duda alguna un \nfichaje de gran potencial y buenas cualidades, trabaja duro que el \u00e9xito te espera; Laura , \ninquieta por naturaleza y llena de buenas intenciones; Sandra , la compa\u00f1era que me vio \ndebutar en el mundo de impartir clases, paciente y bondadosa (\u00bfo no?); Persi , la \u00faltima \nincorporaci\u00f3n del grupo, un t\u00edo alegre, divertido e inteligente (nunca tendr\u00e1s mi poyata) y Tarik , no s\u00e9 que tiene este chico pero me tiene encantado (\u00a1Hala Madrid!). Todos vosotros sois \nel futuro inmediato del laboratorio y todav\u00eda nos queda mucho por hacer. Espero estar a \nvuestro lado para poder disfrutar de muchas otras historias divertidas. Ha sido un placer \ncompartir risas y pasar junto a vosotros el tiempo transcurrido en el laboratorio, las horas de la comida, caf\u00e9s de media tarde y alguna que otra fiesta. No quisiera olvidarme de la gente que nos ha visitado durante este tiempo ( Viviana , Rachel , Rabia , Juliana ,\u2026) y que ha dejado huella \nen el laboratorio; un placer haberos conocido! \n Tambi\u00e9n quiero agradecer a los profesores, especialmente a la Dra. Rosa Araujo  y al \nDr. Miquel Calvo , y a la secretaria del Departamento de Microbiolog\u00eda  por toda la ayuda \nprestada durante este tiempo, demostrando muy a menudo una paciencia infinita!!!  \nAunque no quiero convertir este apartado en un sopor\u00edfero listado de nombres, no \npuedo dejar de agradecer a los compa\u00f1eros del Departamento de Microbiolog\u00eda (\u00a1qu\u00e9 lugar!). Comenzando por los hist\u00f3ricos ( Bonjoch , \u00d3scar , Qu\u00edm , Unai , Pere , Markus , Mari , Cristina ,\u2026 \ntela marinera) y no tan hist\u00f3ricos ( Miriam , Arnau , Maruja , Aiora , Rachel , Eriel , M\u00e1rio , Arnau \nBassegoda, Sara ,\u2026) de Fase I y II, hasta llegar a los nuevos fichajes: \u00c1lex  (mi doble valenciano), \nAndr\u00e9s  (puro macho ecuatoriano), las chiquitas y chiquitos del labo 10 ( Marta G\u00f3mez , Marta \nColomer , Anna , Pablo , Andreu ,\u2026), Fran  (Oye loco, \u00bfte vienes a Albacete?), M\u00f3nica  (\u00a1vamos \ncanaria!),\u2026 Gracias a todos vosotros, por los buenos ratos que hemos pasado charlando y las risas compartidas en el laboratorio, en el pasillo y fuera del mundo acad\u00e9mico!  \nQuiero dar la gracias tambi\u00e9n a Nerea  (Beguristain,\u2026), mi pamplonica preferida, por \nlas historias y momentos compartidos, aguantar a Ayalke y a mi nos es tarea f\u00e1cil (te perdono \npor no recordarme durante los primeros cuatro a\u00f1os en el departamento). En este apartado Agradecimientos/Acknowledgments \n iiitambi\u00e9n quiero incluir de manera especial a Morata  (el que no juega en el Castilla) y Eli (-sonda \nde los elefantes), pienso que sois una pareja estupenda llena de buenas intenciones y energ\u00eda positiva (m\u00e1s o menos), me alegro mucho de haber tenido la oportunidad de conoceros mejor y poder consideraros como mis amigos. Aunque no he sido part\u00edcipe de la \u00e9poca dorada del departamento, quiero que sep\u00e1is que me parec\u00e9is de lo mejor que ha pasado por aqu\u00ed!  \nThank you very much (dank je wel!) to all the people in LZO of the RIVM, especially Dra. \nAna Maria de Roda  to supervise my work when I was there and to greatly contribute to my \nformation and English improvement (from zero to an understandable level). I don't want to forget the special time shared with Joost  (el ni\u00f1o prodigio), Harold  (my Dutch brother), Martijn  \n(THE SUPERVISOR), Manoij , Saskia , Willemijn ... It was a great time together, all of you are the \nbest!!! Gracias tambi\u00e9n a Irune (gemelos de bici) y Naike , mis amigas del Norte!! \n \nThank you very much to Dr. Purcell  and Dra. Emerson  from NIH in Washington DC to \nsupport me during the short stay and to allow me collaborate for a while with the HEV world. It was a pleasure to work with two great scientists of your level.   \nMuito obrigado ao grupo de brasileiros com o qual tive o prazer de conviver nos \n\u00faltimos anos!!! He tenido la suerte de presenciar el inicio de las colaboraciones con Fio Cruz y la UFSC, cuando mi querida Dra. Marize (siempre repleta de energ\u00eda y sonriente) lleg\u00f3 al \nlaboratorio temiendo ir sola por la Diagonal!!! Despu\u00e9s llegaron Adriana  (Nossa\u2026, esto eeesss \nver-dad!), Caroline  (Naxos, Barcelona, Utrecht, New York,\u2026) y la Dra. Celia  (gracias por \npermitirme conocer tu laboratorio y pasar unas semanas magn\u00edficas en Florian\u00f3polis). Gracias a Ana Paula , Vanessa , Izabella , Naira , Francielle , Heldom , Carmen ,\u2026 siempre llevar\u00e9 conmigo \nla hospitalidad y manera de vivir de la gente de Brasil. Saudade de voc\u00eas! \n \nGracias a todos los Can Rutianos ( Silvia , Irene , Alicia , Gemosa , Vero , Mini yo , \nElisabet ,\u2026 ) y especialmente a Carmen Ramil . Tengo que reconocer que el a\u00f1o que estuvimos \ntrabajando juntos fue divertido y productivo a la par. Aunque finalmente no pudimos ser compa\u00f1eros por m\u00e1s tiempo, siempre tendr\u00e9 un cari\u00f1o especial por el Servicio de Microbiolog\u00eda del Hospital Germans Trias i Pujol. Espero que sigamos en contacto por mucho tiempo!!  \nPara mis amigos del pueblo (PIERA TB EXISTE) y fuera de \u00e9l. Especialmente, Xavi  \n(arag\u00fc\u00eds, aragu\u00e0s,\u2026), Dani  (Rock & roll baby!), Miquel  (desde los 3 a\u00f1os!!), Meritxell  (la chica \nque sonr\u00ede y reparte por igual), Cris (llegaste un d\u00eda y te enamoramos), Vane  (gracias por traer Agradecimientos/Acknowledgments \n iv a tus amigas) y Mero  (\u00a1mucha qu\u00edmica!). Juntos hemos compartido la infancia, adolescencia y \nmadurez: f\u00fatbol, b\u00e1squet, atletismo, fiestas, bares cutres, noviazgos, penas, alegr\u00edas, secretos, ilusiones, viajes, aventuras, pisos,\u2026 en definitiva, el descubrir la vida. Sinceramente os digo que espero seguir compartiendo mucho m\u00e1s con vosotros!  \nQuiero agradecer muy especialmente a mi familia (los flowers). En primer lugar quiero \ndar las gracias a mis padres ( Jes\u00fas  y Lola ), que siempre han estado ah\u00ed cuando los he \nnecesitado, ofreci\u00e9ndome su apoyo y d\u00e1ndome aliento en los momentos dif\u00edciles. Ambos sois muy importantes en mi vida y me hab\u00e9is ense\u00f1ado los valores m\u00e1s fundamentales. Si consigo que est\u00e9is la mitad de orgullosos de mi, de lo que yo lo estoy de vosotros, ya me doy por satisfecho! A mi hermana ( Silvia ), siempre me he sentido querido y apreciado por tu parte, la \ngran confianza que siempre has depositado en mi me da fuerzas para seguir adelante. Me \nhaces sentir que soy alguien especial capaz de conseguir lo que quiera! Pase lo que pase, \nsiempre estar\u00e9 ah\u00ed para lo que necesites. A mi cu\u00f1ado ( Luis), una buena persona incapaz de \nhacer da\u00f1o a nadie. A pesar que a\u00fan tengo pendiente ganarte al ping-pong, estoy orgulloso de tenerte como parte de la familia! A mis sobrinos ( Hugo  y Berta ), tambi\u00e9n conocidos como los \nFarris, vuestro TITO os quiere un mont\u00f3n y espera que teng\u00e1is una vida plagada de \u00e9xitos. Aunque sois igual que un terremoto con patas, \u00a1no hay nada mejor que teneros cerca! A mi suegra ( Petri ), por acogerme dentro de la familia r\u00e1pidamente y hacerme sentir parte de ella. \n\u00a1Sin vuestra ayuda no hubiera sido posible alcanzar las diferentes metas propuestas, os quiero a todos! \n Finalmente quiero dar las gracias a mi Sarita , la persona m\u00e1s importante de mi vida. \nDesde el d\u00eda en que nos conocimos hemos conectado a la perfecci\u00f3n y siempre has estado a mi lado demostr\u00e1ndome que puedo contar contigo para todo.  Llevamos m\u00e1s de diez a\u00f1os juntos \ncompartiendo buenos y malos momentos, pasar contigo cada uno de ellos hace que la vida \ntenga sentido. \u00a1\u00a1\u00a1Espero que esta nueva etapa que empezaremos como doctores sea tan bonita como la que hemos vivido hasta el d\u00eda de hoy!!! \u00a1TQM guapa! \n Presentaci\u00f3n de la Tesis \n vPRESENTACI\u00d3N DE LA TESIS \n \nLa Tesis Doctoral aqu\u00ed presentada tiene co mo objetivo principal el estudio de virus \npat\u00f3genos emergentes de inter\u00e9s en seguridad alimentaria, mediante la evaluaci\u00f3n de su \nprevalencia y diseminaci\u00f3n ambiental, y la caracterizaci\u00f3n del riesgo asociado a la presencia de virus pat\u00f3genos en la reutilizaci\u00f3n de agua residual y en el consumo de moluscos bivalvos. \n \nPrincipalmente se ha estudiado la presencia de HEV, HAV, NoV, nuevos poliomavirus \n(KIPyV, WUPyV y MCPyV) y HAdV (como indicador de la contaminaci\u00f3n fecal). Para lograr \ndichos objetivos se han analizado muestras de ag ua residual y agua de r\u00edo, agua regenerada y \nmoluscos bivalvos, caracterizando as\u00ed las princi pales fuentes de contaminaci\u00f3n fecal ambiental \ny de alimentos, y constatando el riesgo microbiol\u00f3gico asociado al consumo de marisco. Durante el desarrollo de esta Tesis se ha tratad o de mejorar la metodolog\u00eda disponible para la \nconcentraci\u00f3n de part\u00edculas v\u00edricas en agua residua l, as\u00ed como aportar informaci\u00f3n acerca de la \neficiencia de eliminaci\u00f3n de pat\u00f3genos humanos  que tiene lugar al aplicar tratamientos de \ndepuraci\u00f3n en estaciones depuradoras de agua residual y en empresas productoras de marisco. Por \u00faltimo, debido a la creciente utilizaci\u00f3n de herramientas inform\u00e1ticas para establecer modelos matem\u00e1ticos que nos perm itan estimar los riesgos de infecci\u00f3n y \nenfermedad asociados al consumo de alimento s y aguas contaminadas, se decidi\u00f3 profundizar \nen este nuevo \u00e1mbito de la microbiolog\u00eda en el que se realizan an\u00e1lisis cuantitativos de riesgo microbiol\u00f3gico, estableciendo un modelo matem\u00e1tico para evaluar el riesgo microbiol\u00f3gico \nasociado al consumo de moluscos bivalvos contaminados por NoV. \n \nA grandes rasgos, el trabajo descrito se ha desarrollado en dos bloques. En la primera \nparte de la Tesis se ha trabajado principalmente con agua residual cruda y muestras recolectadas en distintos puntos del tratamiento que llevan a cabo las estaciones depuradoras \nde agua residual, mientras que en el segundo bloque se han evaluado muestras de moluscos \nbivalvos procedentes de mercado y empresas productoras de marisco. \n \nEl trabajo desarrollado se ha dividido en siete estudios comprendidos en cinco \ncap\u00edtulos: (I) evaluaci\u00f3n de los patrones de excreci\u00f3n y prevalencia de pat\u00f3genos v\u00edricos emergentes como potenciales contaminantes del agua mediante el est udio de agua residual, \n(II) evaluaci\u00f3n de la eficiencia de eliminaci\u00f3n de pat\u00f3genos e indicadores microbianos en estaciones depuradoras de agua residual donde se incluyen tratamientos terciarios, (III) \ndesarrollo e implementaci\u00f3n de un m\u00e9todo eficie nte de bajo coste para la concentraci\u00f3n de Presentaci\u00f3n de la Tesis \n \n vi part\u00edculas v\u00edricas en agua residual y detecci\u00f3n medi ante t\u00e9cnicas de PCR, (I V) seguimiento de la \npresencia de pat\u00f3genos v\u00edricos e indicadores virales en moluscos bivalvos de mercado y, (V) modelizaci\u00f3n matem\u00e1tica del riesgo de infecci \u00f3n y enfermedad por norovirus asociado al \nconsumo de marisco. Cada uno de los cinco cap\u00ed tulos incluidos en esta Tesis ha hado lugar a \ndiversos art\u00edculos cient\u00edficos publicados o sometidos para una publicaci\u00f3n cient\u00edfica.  \nDe acuerdo con los requisitos exigidos para  obtener la menci\u00f3n europea, los idiomas \nescogidos para realizar esta memoria han sido el castellano y el ingl\u00e9s. La base de esta Tesis \nson los art\u00edculos publicados y sometidos que han sido incluidos en la secci\u00f3n de resultados. \nTodos los art\u00edculos han sido escritos en ingl\u00e9s y van acompa\u00f1ados con un resumen en \ncastellano al inicio de cada apartado. Tamb i\u00e9n se ha incorporado un resumen general, unos \nobjetivos y conclusiones generales escritos en ambos idiomas. El resto de secciones se ha escrito \u00edntegramente en castellano. Presentation of the Thesis \n viiPRESENTATION OF THE THESIS \n \nThe Doctoral Thesis presented here has as main objective the study of emerging viral \npathogens of interest in food safety, by assessi ng its environmental prevalence and spread, \nand characterizing the risk associated with the presence of pathogenic viruses in the reuse of sewage and consumption of bivalve molluscan.  \nMainly, it was studied the presence of HEV, HAV, NoV, new polyomavirus (KIPyV, \nWUPyV and MCPyV) and HAdV (as an indicator of faecal contamination). To achieve these \nobjectives samples of sewage and river water, reclaimed water and bivalve molluscan were analyzed, characterizing the main sources of faecal contamination of the environment and \nfood, and noting the microbiological risk associated with consumption of seafood. During the development of this Thesis it was intended to improve the available methodology for concentrating viral particles from sewage, as well as provide information about the removal efficiency of human pathogens that occurs when applying depuration treatments in sewage treatment plants and seafood producers. Finally,  due to the increasing use of computational \ntools to establish mathematical models that allow us to estimate the risks of infection and disease associated with consumption of contamin ated food and water, we decided to go into \nthis new field in microbiology in which quantitative microbiological risk analyses are performed, establishing a mathematical model to assess the microbiological risk associated with consumption of bivalve mo lluscan contaminated by NoV. \n \nBroadly, the described work has been develope d in two blocks. In the first part of the \nThesis, raw sewage samples collected at different  sampling points of treatments performed by \nsewage treatment plants were the primary objects of study, while in the second block samples of bivalve molluscan from market and seafood producers were evaluated. \n \nThe work is divided into seven studies include d in five chapters: (I) evaluation of the \nexcretion patterns and prevalence of emerging  viral pathogens as potential water pollutants \nby studying sewage, (II) evaluation of removal e fficiency of pathogens and microbial indicators \nin sewage treatment plants which include tertiary treatment, (III) development and implementation of an efficient low cost procedure for the concentration of viral particles from sewage and detection by PCR technology, (IV) mo nitoring the presence of viral pathogens and \nviral indicators in market bivalve molluscan and (V) mathematical modeling of the risk of \nnorovirus infection and illness associated with consumption of shellfish. Each of the five Presentation of the Thesis \n \n viii chapters in this Thesis has given rise to va rious scientific articles already published or \nsubmitted for scientific publication.  \nIn accordance with the requirements for the European mention, the chosen languages  \nfor the development of this memory have been Spanish and English. The published and submitted articles that have been included in the results section are the basis of this Thesis. All articles were written in English and are accompanied with a summary in Spanish at the beginning of each section. It has also been included an overview, the objectives and the conclusions written in both languages. The rema ining sections have been written entirely in \nSpanish. Abreviaturas \n ix ABREVIATURAS \n \n\u00baC  Grados Cent\u00edgrados. \na. de C.   Antes de Cristo. \naa  Amino\u00e1cidos. \nAdV   Adenovirus. \nAgT  Ant\u00edgeno tumorales T. \nAgt  Ant\u00edgeno tumorales t. \nAgTm   Ant\u00edgeno tumoral T medio. \nAstV   Astrovirus. \nATP  Adenos\u00edn Trifosfato. \nBKPyV   Poliomavirus BK (del ingl\u00e9s BK Polyomavirus). \nBOE   Boletin Oficial del Estado. \nCCA  Comisi\u00f3n del Codex Alimentarius. \nCCFH   Comit\u00e9 del codex sobre higiene de los alimentos  \n(del ingl\u00e9s Codex Committee on Food Hygiene). \nCEE  Comunidad Economica Europea. \nCF  Coliformes Fecales. \ncm2  Cent\u00edmetro cuadrado. \nCRE  Elementos de replicaci\u00f3n en cis (del ingl\u00e9s Cis-acting Replication Element). \nDAF   Flotaci\u00f3n por aire disuelto (del ingl\u00e9s Disolved Air Flotation). \nDNA   \u00c1cido desoxirribonucleico (del ingl\u00e9s Desoxirribonucleic Acid). \nE. coli   Escherichia coli. \nECRM   Evaluaci\u00f3n Cuantitativa del Riesgo Microbiol\u00f3gico. \nEDAR  Estaci\u00f3n Depuradora de Agua Residual. \nEF  Estreptococos Fecales. \nERM   Evaluaci\u00f3n de Riesgos Microbiol\u00f3gicos. \net al.   Y colaboradores. \netc.  Etc\u00e9tera. \nEV  Enterovirus. \nF  Fertilidad. \nFAO   Organizaci\u00f3n de las Naciones Unidas para la agricultura y la alimentaci\u00f3n \n  (del ingl\u00e9s Food and Agriculture Organization of the United Nations). \nFCV  Calicivirus felino (del ingl\u00e9s Feline Calicivirus). \nFDA   Agencia de alimentos y medicamentos \n  (del ingl\u00e9s Food and Drug Administration). \ng  Gramos. \nGC  Copias gen\u00f3micas (del ingl\u00e9s Genomic Copies). \nh  Horas. \nHAdV   Adenovirus humano (del ingl\u00e9s Human Adenovirus). \nHAV   Virus de la hepatitis A (del ingl\u00e9s Hepatitis A Virus). \nHBV   Virus de la hepatitis B (del ingl\u00e9s Hepatitis B Virus). \nHEV   Virus de la hepatitis E (del ingl\u00e9s Hepatitis E Virus). \nHIV  Virus de la Inmunodeficiencia Humana \n  (del ingl\u00e9s Human Immunodeficiency Virus). Abreviaturas \n \n xHPyV   Poliomavirus humano (del ingl\u00e9s Human Polyomavirus). \nIgG  Immunoglobulina G. \nIRES   Punto de uni\u00f3n al ribosoma (del ingl\u00e9s Internal Ribosomal Entry Site). \nJ  Julios. \nJCPyV   Poliomavirus JC (del ingl\u00e9s JC Polyomavirus). \nKb  Kilobases. \nKDa  Kilodaltons. \nKg  Kilogramos. \nL  Litro. \nm3  Metro c\u00fabico. \nMCC   Carcinoma de c\u00e9lulas de Merkel (del ingl\u00e9s Merkel Cell Carcinoma). \nMCPyV   Poliomavirus de c\u00e9lulas Merkel (del ingl\u00e9s Merkel Cell Polyomavirus). \nmg  Miligramos. \nmin  Minutos. \nmJ  Milijulios. \nmL  Mililitros. \nmm  Mil\u00edmetros. \nMPa   Milipascales. \nMPN  N\u00famero m\u00e1s probable (del in gl\u00e9s Most Probable Number) \nMPyV   Poliomavirus murino (del ingl\u00e9s Murine Polyomavirus). \nmRNA   RNA mensajero (messenger RNA). \nNaOH  Hidr\u00f3xido de sodio. \nnm  Nan\u00f3metros. \nNoV   Norovirus. \nOMS   Organizaci\u00f3n Mundial de la Salud. \nORF   Pauta de lectura abierta (del ingl\u00e9s Open Reading Frame). \nORI  Origen de replicaci\u00f3n. \np.e.  Por ejemplo. \nPCR  Reacci\u00f3n en cadena de la polimerasa (del ingl\u00e9s Polymerase Chain Reaction). \nPCV1   Circovirus porcino tipo 1 (del ingl\u00e9s Porcine Circovirus type 1). \nPDU   Unidades de PCR (del ingl\u00e9s PCR Detectable Units). \npH  Potencial de Hidr\u00f3geno. \nPML   Leucoencefalopat\u00eda multifocal progresiva \n  (del ingl\u00e9s Progressive Multifocal Leukoencephalopathy). \nppm   Partes por mill\u00f3n. \npRb  Prote\u00edna del Retinoblastoma. \nPyV  Poliomavirus (del ingl\u00e9s Polyomavirus). \nRC  Complejo replicativo (del ingl\u00e9s Replication Complex). \nRNA   \u00c1cido ribonucleico (del ingl\u00e9s Ribonucleic Acid). \nRPA   Prote\u00edna de replicaci\u00f3n A (d e ingl\u00e9s Replication Protein A). \nRR  Regi\u00f3n Reguladora. \nRT-PCR   PCR con transcriptasa inversa (del ingl\u00e9s Reverse Transcription PCR). \nRV  Rotavirus. \nRVA   Rotavirus grupo A. \ns.  Siglo. Abreviaturas \n xi S  Coeficiente de Sedimentaci\u00f3n. \nSIDA   S\u00edndrome de Inmunodeficiencia Adquirida. \nspp.   Especie. \nSV40   Virus de simio 40 (del ingl\u00e9s Simian Virus 40). \nTCID 50  Dosis infectiva media de cultivo tisular (del ingl\u00e9s Median Tissue Culture \nInfective Dose). \nTCR  Regi\u00f3n del control transcripcional (del ingl\u00e9s Transcription Control Region). \nUFC  Unidades Formadoras de Colonia. \nUFP  Unidades Formadoras de Placa. \nUK  Reino Unido (del ingl\u00e9s United Kingdon). \nUSA   Estados Unidos (del ingl\u00e9s United States of America). \nUSEPA   Agencia de protecci\u00f3n ambiental de los Estados Unidos \n  (del ingl\u00e9s United States Environmental Protection Agency). \nUV  Ultravioleta. \nVLP  Pseudo-part\u00edculas virales (del ingl\u00e9s Virus-Like Particles). \nxg  Fuerza centr\u00edfuga relativa.  \n\u03bcm  Micr\u00f3metros. \n\u03bcW  Microvatios. \n  Contenido de la Tesis \n xiii CONTENIDO DE LA TESIS \n \nAgradecimientos/ Acknowledgments  i-iv \n \nPresentaci\u00f3n de la Tesis v-viii \n  \n\u2022 Castellano\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 v \u2022 English \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 vii \n \nAbreviaturas ix-xi \n \nContenido de la Tesis xiii-xvi \n 1. Introducci\u00f3n general 1-73 \n \n1.1. Contaminaci\u00f3n de agua y alimentos por microorganismos pat\u00f3genos\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 3-8 \n \n1.1.1.  Virus implicados en brotes epid\u00e9micos de origen ambiental\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 5 \n1.1.2.  Bacterias implicadas en brotes epid\u00e9micos de origen ambiental\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026 6 \n1.1.3.  Par\u00e1sitos implicados en brotes epid\u00e9micos de origen ambiental\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 8 \n \n1.2. El agua residual como agente transmisor de enfermedades infecciosas\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026. 9-17 \n \n1.2.1.  Etapas del tratamiento de aguas residuales\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026.. 11 \n1.2.2.  Usos ambientales de la reutilizaci\u00f3n de aguas residuales en Espa\u00f1a\u2026\u2026.\u2026\u2026\u2026\u2026\u2026.. 13 \n1.2.3.  Presencia de virus en agua residual\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 14 \n1.2.4.  M\u00e9todos de concentraci\u00f3n de virus en agua residual\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026. 15 \n \n1.3. Los moluscos bivalvos como agentes transmisores de enfermedades infecciosas\u2026\u2026\u2026\u2026\u2026 17-29 \n \n1.3.1.  Legislaci\u00f3n y zonas de producci\u00f3n de marisco\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 20 \n1.3.2.  Estrategias para eliminar la contaminaci\u00f3n microbiol\u00f3gica tras la recolecci\u00f3n\u2026\u2026. 22 \n1.3.3.  Microorganismos modelo\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 26 \n 1.4. Evaluaci\u00f3n de riesgos microbiol\u00f3gicos en alimentos\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 30-33 \n \n1.4.1.  Antecedentes\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 30 \n1.4.2.  Evaluaci\u00f3n cuantitativa de riesgos microbiol\u00f3gicos\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 31 \n1.4.3.  Virus en alimentos\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 33 \n 1.5. Virus de la hepatitis A\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 33-42 \n \n1.5.1.  Historia\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 33 \n1.5.2.  Caracter\u00edsticas moleculares\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 35 \n1.5.3.  Caracter\u00edsticas f\u00edsico-qu\u00edmicas y estabilidad\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 36 \n1.5.4.  Diversidad gen\u00e9tica\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 37 \n1.5.5.  Diversidad serot\u00edpica\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 38 \n1.5.6.  Replicaci\u00f3n del virus\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 38 \n1.5.7.  Epidemiolog\u00eda\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 38 \n1.5.8.  Zonas end\u00e9micas y no end\u00e9micas\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 39 \n1.5.9.  Seroprevalencia\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 40 \n1.5.10.  Profilaxis\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 41 \n 1.6. Virus de la Hepatitis E\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026... 42-51 \n \n1.6.1.  Historia\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 42 Contenido de la Tesis \n \n xiv 1.6.2.  Caracter\u00edsticas moleculares\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 44 \n1.6.3.  Caracter\u00edsticas f\u00edsico-qu\u00edmicas y estabilidad\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 46 \n1.6.4.  Diversidad gen\u00e9tica\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 46 \n1.6.5.  Diversidad serot\u00edpica\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 48 \n1.6.6.  Replicaci\u00f3n del virus\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 48 \n1.6.7.  Epidemiolog\u00eda\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 49 \n1.6.8.  Zonas end\u00e9micas y no end\u00e9micas\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 49 \n1.6.9.  Seroprevalencia\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 50 \n1.6.10.  Profilaxis\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 51 \n 1.7. Norovirus humanos\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 52-57 \n \n1.7.1.  Historia\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 52 \n1.7.2.  Caracter\u00edsticas moleculares\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 52 \n1.7.3.  Caracter\u00edsticas f\u00edsico-qu\u00edmicas y estabilidad\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 53 \n1.7.4.  Diversidad gen\u00e9tica\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 54 \n1.7.5.  Replicaci\u00f3n del virus\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 55 \n1.7.6.  Epidemiolog\u00eda\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 56 \n1.7.7.  Sintomatolog\u00eda cl\u00ednica\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 56 \n1.7.8.  Inmunidad\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 57 \n  \n1.8. Adenovirus humanos\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 57-62 \n \n1.8.1.  Historia\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 57 \n1.8.2.  Caracter\u00edsticas moleculares\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 58 \n1.8.3.  Caracter\u00edsticas f\u00edsico-qu\u00edmicas y estabilidad\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 59 \n1.8.4.  Diversidad gen\u00e9tica\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 59 \n1.8.5.  Diversidad serot\u00edpica\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 60 \n1.8.6.  Replicaci\u00f3n del virus\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 60 \n1.8.7.  Epidemiolog\u00eda\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 61 \n1.8.8.  Oncogenicidad\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 62 \n 1.9. Poliomavirus\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 62-71 \n \n1.9.1.  Historia\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 62 \n1.9.2.  Caracter\u00edsticas moleculares\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 63 \n1.9.3.  Caracter\u00edsticas f\u00edsico-qu\u00edmicas y estabilidad\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 65 \n1.9.4.  Replicaci\u00f3n del virus\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 66 \n1.9.5.\n Oncogenicidad\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 67 \n1.9.6.  V\u00edas de transmisi\u00f3n de poliomavirus humanos\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 69 \n1.9.7.  Poliomavirus de c\u00e9lulas de Merkel\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 69 \n1.9.8.  Epidemiolog\u00eda\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 70 \n  \n1.10. Otros virus presentes en la contaminaci\u00f3n ambiental\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026 71-73 \n \n1.10.1.  Enterovirus\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 71 \n1.10.2.  Astrovirus\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 72 \n1.10.3.  Rotavirus\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 72 \n \n2. Objetivos 75-80 \n  \n\u2022 Castellano\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 77 \n\u2022 English \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 79 \n   Contenido de la Tesis \n xv3. Publicaciones 81-88 \n  \n\u2022 Listado de publicaciones\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 83 \n\u2022 Informe de participaci\u00f3n en los art\u00edculos\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 85 \u2022 Informe del factor de impacto de los art\u00edculos \u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 87 \n \n4. Resultados 89-248 \n \nCap\u00edtulo I.   Infecciones por virus pat\u00f3genos en la poblaci\u00f3n, an\u00e1lisis de la prevalencia y \ndiseminaci\u00f3n ambiental ......\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026.....\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 91-126 \n \n\u2022  Resumen estudio 1\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026.   93 \n\u2022 Estudio 1: Analysis of the evolution in the circulation of HAV and HEV in \neastern Spain by testing urban sewage samples\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026  97 \n \u2022  Resumen estudio 2\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026.  107 \n\u2022 Estudio 2: Hepatitis E virus genotype 3 and sporadically also genotype 1 \ncirculate in the population of Catalonia, Spain \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.          109 \n \n\u2022  Resumen estudio 3\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026.  119 \n\u2022 Estudio 3: Newly described human polyomaviruses Merkel cell, KI and WU \nare present in urban sewage and may represent potential environmental contaminants\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026          121 \n Cap\u00edtulo II.   Estudio de la eficiencia de eliminaci\u00f3n de pat\u00f3genos virales en plantas \ndepuradoras de agua residual y control microbiol\u00f3gico del agua regenerada .\u2026 127-140 \n \u2022  Resumen estudio 4\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..  129 \n\u2022 Estudio 4: Standard and new faecal indicators and pathogens in sewage \ntreatment plants, microbiological parameters for improving the control of reclaimed water\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026.\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 133 \n \nCap\u00edtulo III.   Desarrollo de nuevos m\u00e9todos de concentraci\u00f3n de part\u00edculas v\u00edricas en agua \nresidual \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...\u2026\u2026\u2026\u2026 141-168 \n \n\u2022  Resumen estudio 5\u2026\u2026. \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 143 \n\u2022 Estudio 5: New methods for the concentration of viruses in urban sewage \nusing quantitative PCR\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 147 \n \nCap\u00edtulo IV.   Evaluaci\u00f3n de la contaminaci\u00f3n viral en moluscos bivalvos de mercado y \neficiencia de la eliminaci\u00f3n v\u00edrica en procesos de depuraci\u00f3n de moluscos .\u2026.\u2026 169-204 \n \n\u2022  Resumen estudio 6\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 171 \u2022 Estudio 6: Failure to control viral contamination in molluscan shellfish \napplying current depuration treatments\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 175 \n \nCap\u00edtulo V.   Desarrollo de un modelo matem\u00e1tico para la valoraci\u00f3n cuantitativa del \nriesgo de infecci\u00f3n y enfermedad por norovirus asociado al consumo de \nmarisco \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 205-230 \n \u2022 Resumen estudio 7\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026. 207  \u2022 Estudio 7: Quantitative risk assessment for human norovirus infection due to \noyster consumption\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026. 211 \n \n \n  Contenido de la Tesis \n \n xvi 5. RESUMEN GENERAL 231-264 \n  \n\u2022 Castellano\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 233 \u2022 English \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 249 \n   \n6. CONCLUSIONES 265-270 \n  \n\u2022 Castellano\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 267 \u2022 English \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 269 \n  \n7. REFERENCIAS 271-304 \n 8. ANEXOS 305-316 \n  \n\u2022 Otras publicaciones no incluidas en la Tesis\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 307  \n  \n \n    \n1. INTRODUCCI\u00d3N GENERAL \n  Introducci\u00f3n general \n 3 INTRODUCCI\u00d3N GENERAL \n \n1.1. Contaminaci\u00f3n de agua y alimentos por microorganismos pat\u00f3genos  \nA nivel mundial, las enfermedades transmitidas a trav\u00e9s de aguas y alimentos \ncontaminados constituyen un problema que en las \u00faltimas d\u00e9cadas se ha complicado \nconsiderablemente (Koopmans et al. , 2002). Entre los factores asociados a estos recientes \ncambios globales se pueden se\u00f1alar, entre otros, el  crecimiento de la poblaci\u00f3n, la pobreza, la \nurbanizaci\u00f3n en los pa\u00edses subdesarrollados y el comercio internacional de alimentos. Cada vez \nm\u00e1s se manifiesta un mayor inter\u00e9s por la contaminaci\u00f3n del agua y el suelo por microorganismos pat\u00f3genos, especialmente por virus. Este problema, como factor en la diseminaci\u00f3n de microorganismos pat\u00f3genos, tiene consecuencias considerables que a\u00fan no \nhan sido plenamente evaluadas. La mayor\u00eda de  los r\u00edos que sirven como fuentes de agua \npotable en nuestra regi\u00f3n transportan cantidades  variables de aguas de desecho, que se ven \nincrementadas en los periodos en que disminuye el caudal. La urbaniza ci\u00f3n r\u00e1pida, tanto de \nlos pa\u00edses desarrollados como de los pa\u00edses en v\u00edas de desarrollo, ha dado lugar a problemas cr\u00edticos en el suministro de agua y en la e liminaci\u00f3n de desechos. Las crecientes demandas de \nfuentes de agua utilizables debidas al aumento de la poblaci\u00f3n m undial y a la concurrente \nexpansi\u00f3n de la industria hacen inevitable el aprovechamiento de las aguas residuales dom\u00e9sticas. Al mismo tiempo, los adelantos tecnol \u00f3gicos dentro de la industria alimentaria y \nuna creciente conciencia de que la inocuidad de  los alimentos es un tema que debe abordarse \na lo largo de la cadena alimentaria, desde lo s inicios de producci\u00f3n hasta el momento del \nconsumo, est\u00e1 influyendo claramente en los sistemas alimentarios mundiales. \n \nSe ha estimado que aproximadamente 3.000 millones de personas en todo el mundo \ncarecen de sistemas de saneamiento y que el  95% de las aguas residuales dom\u00e9sticas son \nvertidas al medio sin ser tratadas. Como consecuencia de estas deficiencias sanitarias y de la falta de aguas de bebida limpias, se calcula que cada a\u00f1o 3.500 millones de personas contraen alguna enfermedad de transmisi\u00f3n h\u00eddrica, y 3,3 millones de personas mueren anualmente de enfermedades ent\u00e9ricas. La raz\u00f3n principal de es ta situaci\u00f3n es el alto coste que supone la \npuesta a punto de procesos de tratamiento y el mantenimient o de las infraestructuras \napropiadas que permitan el control sanitario, de los que solamente se benefician el 6% de la \npoblaci\u00f3n mundial (Niemczynowicz, 1997; Langford, 2005).  \n Introducci\u00f3n general \n 4 Las rutas de transmisi\u00f3n de los microorganismos pat\u00f3genos ent\u00e9ricos en el medio \nambiente son muy diversas (Figura 1). Se ha comprobado que la poblaci\u00f3n puede adquirir una infecci\u00f3n mediante difere ntes v\u00edas, incluyendo: \n \n\u2022 Ingesti\u00f3n de agua contaminada. \n\u2022 Ingesti\u00f3n de moluscos bivalvos vivos crudos o poco cocinados que hayan crecido en \naguas contaminadas. \n\u2022 Ingesti\u00f3n de vegetales irrigados con aguas contaminadas o abonados con bios\u00f3lidos \nprocedentes de estaciones depurad oras de agua residual (EDAR). \n\u2022 Contacto con aguas contaminadas destinadas a usos recreacionales. \n\u2022 Contacto con aerosoles generados a partir de aguas contaminadas. \n \n \nSER HU MANO  EXCRECIONES \nHUMANAS  \nAeros\u00f3les  Abonos con fangos de depuradora  Aguas residuales  Infiltraciones en suelos  \nMol\u00fascos \nbivalvos MAR  R\u00cdOS Y LAGOS  AGUAS SUBTERR\u00c1NEAS  AGUAS DE RIEGO  \nAguas de \nba\u00f1o Agua \npotable Verduras y \nfrutas \n \n \n \n \nLas toxo-infecciones de etiolog\u00eda diversa vinculadas a agua y alimentos que acaban \nafectando a la poblaci\u00f3n humana de todos los rincones del mundo comportan un importante \ntema de estudio a nivel de salud p\u00fablica, en el tema que aqu\u00ed nos ocupa nos centraremos en \nlas de origen microbiol\u00f3gico, m\u00e1s concretamente en virus.  Figura 1.  Ruta de transmisi\u00f3n fecal -oral de los microorganismos ent\u00e9ricos humanos en el \nmedio ambiente. Modificado de Melnick et al. , 1978  Introducci\u00f3n general \n 5 1.1.1. Virus implicados en brotes epid\u00e9micos de origen ambiental \n \nEl listado de virus potencialmente pat\u00f3geno s presentes en agua residual incluye virus \nde genoma DNA como los adenovirus (AdV) y poliomavirus (PyV), y virus de genoma RNA \ncomo el virus de la hepatitis A (HAV) y E (HEV ), norovirus (NoV), rota virus (RV), enterovirus \n(EV) y astrovirus (AstV), entre otros. Los aden ovirus humanos (HAdV) y poliomavirus humanos \nJC y BK (JCPyV y BKPyV) se encuentran en  una elevada prevalencia en todas las \u00e1reas \nestudiadas (Pina et al. , 1998a; Bofill-Mas et al. , 2000; Girones et al. , 2010). EV, NoV, RV y AstV \nhan sido ampliamente descritos mostrando prevalencias variables seg\u00fan el periodo del a\u00f1o y \nla presencia de brotes epid\u00e9micos entre la poblaci\u00f3n (Okoh et al. , 2010). La presencia de HAV \nvar\u00eda en funci\u00f3n del \u00e1rea geogr\u00e1fica estudiada,  aunque su detecci\u00f3n en agua residual urbana \nde zonas caracterizadas como end\u00e9micas es mu y elevada. HEV, al igual que HAV, es m\u00e1s \nabundante en pa\u00edses donde el saneamiento es pobr e. Se han descrito cepas de HEV propias del \nagua residual de muchos pa\u00edses industrializados,  as\u00ed como la existencia de casos espor\u00e1dicos \nde hepatitis agudas originadas por \u00e9stas cepas no importadas (Pina et al. , 2000; Clemente-\nCasares et al. , 2003; Purcell y Emerson, 2008). Adem\u00e1s, cepas de HEV tambi\u00e9n infectan cerdos, \njabal\u00edes y ciervos, y son frecuentemente detect adas en agua residual de mataderos y de zonas \nurbanas de Europa que actualmente se consideran no end\u00e9micas (Purdy y Khudyakov, 2011). \n \nMuchos de los virus considerados como contaminantes del agua son responsables de \ninfecciones subcl\u00ednicas, causando s\u00edntomas en un peque\u00f1a parte de la poblaci\u00f3n infectada. Los \nEV son un buen ejemplo de lo mencionado, aunque causan una amplia diversidad de s\u00edntomas \ncl\u00ednicos, incluyendo enfermedades que afectan al  sistema nervioso central. Las enfermedades \nproducidas por infecciones de origen v\u00edri co son muy variadas, desde enfermedades \nrespiratorias, frecuentemente asociadas con HAdV, hasta hepatitis agudas causadas por HAV y \nHEV. Otras infecciones com\u00fanmente relacionadas con RV, HAdV y NoV incluyen gastroenteritis \nseveras en ni\u00f1os y adolescentes (Hart et al. , 2009). La evoluci\u00f3n de la enfermedad depende de \nfactores como la ruta de infecci\u00f3n, la dosis infe cciosa del agente v\u00edrico, la edad, salud, estado \ninmunol\u00f3gico y estado nutricional del indivi duo infectado (embarazo, presencia de otras \ninfecciones o enfermedad), y el acceso a cuid ados sanitarios. Algunos virus, como JCPyV, \nBKPyV y determinados HAdV, producen infeccion es durante la infancia, estableciendo as\u00ed \ninfecciones persistentes \n \nLos virus que se transmiten v\u00eda alimen tos o aguas contaminadas son t\u00edpicamente \nestables en el medio ambiente debido a la ause ncia de envuelta lip\u00eddica y a la resistencia a Introducci\u00f3n general \n 6 condiciones adversas, como demuestra su capacidad de sobrevivir en el tracto digestivo. Como \nejemplo, entre las enfermedades asociadas con aguas para usos recreacionales, NoV tiene un \npapel muy importante ya que es uno de los principales responsables de brotes v\u00edricos \noriginados en este tipo de matriz, seguido por los HAdV (Sinclair et al. , 2009). \n 1.1.2. Bacterias implic adas en brotes epid\u00e9micos de origen ambiental \n \nLos principales agentes bacterianos responsables de gastroenteritis son Salmonella  y \nCampylobacter  (Westrell et al. , 2009). Salmonella suele encontrarse en menor n\u00famero en agua \nque indicadores bacterianos tales como los coliformes fecales (CF), estreptococos fecales (EF) o los enterococos, los cuales muestran una pr esencia de varios \u00f3rdenes de magnitud mayor \n(Sidhu y Toze, 2009). No obstante, se estipula que niveles bajos de Salmonella (15 \u2013 100 \nunidades formadoras de colonia [UFC]) en agua suponen un riesgo para la salud p\u00fablica (Jyoti \net al. , 2009). \n \nEspecies termotolerantes de Campylobacter  han sido descritas frecuentemente en \naguas superficiales y bios\u00f3lidos procedentes de  plantas depuradas de agua residual (Sahlstr\u00f6m \net al. , 2004). Otros pat\u00f3genos bacterianos frecuentemente detectados son Shigella , Yersinia  y \nVibrio cholera , siendo responsables de brotes infecciosos vinculados a agua o mariscos \ncontaminados (Sharma et al. , 2003). Legionella pneumophila  tiene un ciclo vital acu\u00e1tico muy \ncomplejo que afecta dr\u00e1sticamente a su estado de  actividad. Esta bacteria tiene la capacidad \nde sobrevivir en una amplia diversidad de entornos acu\u00e1ticos, como pueden ser ambientes \nhumanos controlados que contienen agua (p.e . sistemas de refrigeraci\u00f3n o tuber\u00edas que \nforman parte de las redes de distribuci\u00f3n de agua  potable). El recrecimiento en el interior de \nlos protozoos permite que estos pa t\u00f3genos sean capaces de sobrevivir a la cloraci\u00f3n y que la \ngeneraci\u00f3n de aerosoles en estos sistemas cont ribuya a su transmisi\u00f3n en humanos, a trav\u00e9s \nde la infecci\u00f3n de los macr\u00f3fagos alveolar es y finalmente generando una enfermedad \nrespiratoria (McDade et al. , 1977; Steinert et al. , 2002). \n \nAdem\u00e1s de estos pat\u00f3genos vinculados a enfermedades transmitidas por agua, existen \notros grupos de bacterias que tambi\u00e9n se transmit en por esta misma v\u00eda, algunos de los cuales \nse consideran pat\u00f3genos emergentes. Escherichia coli  (E. coli ) O157:H7 es un pat\u00f3geno de \norigen fecal que se detecta frecuentemente en agua (Bavaro, 2009). Ha sido detectado en el 2% de bios\u00f3lidos crudos procedentes de las ED AR, aunque se desconoce la cantidad presente \nen el agua residual cruda o su supervivencia a los tratamientos aplicados (Sidhu y Toze, 2009). Introducci\u00f3n general \n 7 Recientemente, en mayo de 2011 (Alemania), este pat\u00f3geno ha sido responsable de un brote \ninfeccioso que ha afectado a 3.842 personas. La elevada proporci\u00f3n de pacientes que desarrollaron un s\u00edndrome hemol\u00edtico-ur\u00e9mico co nvierte a este brote en el m\u00e1s relevante \ndesde que la E. coli  enterohemorr\u00e1gica fue identificada como pat\u00f3geno humano. \nInvestigaciones epidemiol\u00f3gicas han revelado que la soja fue el producto contaminado con agua residual que introdujo la infecci\u00f3n en la cadena alimentaria (Beutin y Martin, 2012).  \nListeria monocytogenes  es una bacteria ubicua aislada a partir de un amplio rango de \nfuentes ambientales, incluyendo suelos, agua, efluentes de las EDAR, alimentos, y heces de \nhumanos y animales (Barbuddhe y Chakraborty, 2009). Brotes recientes han demostrado que \nListeria monocytogenes  puede producir gastroenteritis en individuos sanos as\u00ed como una \nsintomatolog\u00eda m\u00e1s severa en pacientes in munocomprometidos (Barbuddhe y Chakraborty, \n2009; Wilkes et al. , 2009). Vibrio vulnificus  es un pat\u00f3geno oportunista capaz de causar \ngastroenteritis, necrosis severa de tejidos bl andos y/o septicemia primaria, con una tasa de \nmortalidad elevada. Dicha enferm edad se asocia con la ingesti\u00f3n de marisco o la exposici\u00f3n \ncon agua contaminada. Vibrio vulnificus  ha sido recuperado a partir de pescado, marisco, agua \ny sedimentos (Harwood et al. , 2004). Recientemente ha sido aislado en muestras de agua \nresidual urbana (Igbinosa et al. , 2009). \n \nHelicobacter pylori  es uno de los agentes etiol\u00f3gicos responsables de gastritis y \u00falcera \np\u00e9ptica y duodenal. Adem\u00e1s, la infecci\u00f3n es reconocida como un factor de riesgo en el \ndesarrollo de linfoma g\u00e1strico del tejido linfoide asociado a mucosa. Helicobacter pylori  est\u00e1 \npresente en aguas de superficie y agua residual (Queralt et al. , 2005), y los biofilms presentes \nen sistemas de distribuci\u00f3n de agua potable se consideran un potencial reservorio (Park et al. , \n2001). Hasta el momento no se ha conseguido cultivar Helicobacter pylori  a partir de muestras \nambientales de agua y su capacidad de sobrev ivir manteniendo su capacidad de infecci\u00f3n \nsigue siendo un tema controvertido. Debido a la dificultad intr\u00ednseca para ser cultivado junto \ncon la falta de m\u00e9todos de cultivo estandarizado s aplicables en muestras ambientales, existen \nmuy pocos estudios que hablen de su presencia en el medio ambiente (Percival y Thomas, 2009). En cambio, Arcobacter  spp., considerado un pat\u00f3geno emergente responsable de \nenfermedades en animales dom\u00e9sticos y diarre as en humanos, es frecuentemente estudiado y \ndetectado en alimentos de origen animal, en particular en aves de corral, as\u00ed como en diferentes tipos de agua: subterr\u00e1nea, superficial, residual cruda y de mar (Ho et al. , 2006). \nDiversos estudios concluyen que el agua repres enta una v\u00eda importante en la transmisi\u00f3n de \nArcobacter  spp., sugiriendo la ruta fecal-oral  para humanos y animales (Gonz\u00e1lez et al. , 2007). Introducci\u00f3n general \n 8 1.1.3. Par\u00e1sitos implicados en brotes epid\u00e9micos de origen ambiental \n \nEl parasitismo hace referencia a la relaci \u00f3n entre dos organismos, par\u00e1sito y hu\u00e9sped, \nen la cual el par\u00e1sito obtiene un benefici o en forma de crecimiento y reproducci\u00f3n \nproduciendo un da\u00f1o al hu\u00e9sped. Existen par\u00e1sitos de muchos tipos pero para el prop\u00f3sito del \ntrabajo aqu\u00ed desarrollado nos va mos a centrar en los protozoos. Existen una gran variedad de \npat\u00f3genos, como pueden ser Cryptosporidium , Entamoeba , Cyclospora , Toxoplasma , \nMicrosporidia  y Giardia , que representan un riesgo  real de infecci\u00f3n a trav\u00e9s del agua (Smith et \nal., 2004). Entre los protozoos se conoce que los g\u00e9neros Cryptosporidium  y Giardia  son muy \nresistentes en el ambiente (Cacci\u00f2, 2003). Cryptosporidium  ha sido detectado en diferentes \nfuentes de agua residual de bebida y es co nsiderado un importante contaminante (Xiao y \nRyan, 2008). La infecci\u00f3n ocurre tras la ingesti\u00f3n de alimentos, agua de bebida o agua para uso \nrecreacional contaminados con ooquistes ( fase esporulada). Existen 20 especies de \nCryptosporidium  y alrededor de 40 genotipos, entre \u00e9stos, Cryptosporidium parvum  y \nCryptosporidium hominis  son responsables de m\u00e1s del 95% de los casos de cryptosporidiosis \nreportadas humanos (Xiao y Ryan, 2008).  \nGiardia  se asocia frecuentemente a agua co ntaminada, aunque de las diferentes \nespecies definidas \u00fanicamente Giardia duodenalis , tambi\u00e9n conocida como Giardia intestinales  \no Giardia lamblia , se ha encontrado vinculada a humanos y otros mam\u00edferos (van der Giessen \net al. , 2006). Gran parte de las fuentes de agua superficial contaminadas con Giardia \nduodenalis  se contaminan a trav\u00e9s de agua residual tratada, agua residual sin tratar, lixiviados \nde abonos procedentes de zonas agr\u00edcola y, en el caso de aguas cristalinas, animales salvajes. \nSe han descrito concentraciones superiores a 10\n4 quistes/L de agua residual cruda y 102 \nquistes/L de agua superficial (Wallis et al. , 1996). Los quistes son estructuras de resistencia que \npueden sobrevivir en agua durante semanas, incluso meses. Cryptosporidium  spp. y Giardia \nduodenalis  se encuentran frecuentemente ligados a brotes infecciosos relacionados con aguas \ny alimentos, afectando a humanos y a un amplio rango de animales dom\u00e9sticos salvajes (Fayer, \n2004). Ambos par\u00e1sitos se sit\u00faan  entre las principales causas de diarrea en humanos y \nanimales en el mundo entero, y son potencia lmente responsables de la reducci\u00f3n de la \nesperanza de vida de los hu\u00e9sp edes inmunodeprimidos (Smith et al. , 2007; Reynolds et al. , \n2008). Los quistes y ooquistes de Giardia  spp. y Cryptosporidium  spp. son m\u00e1s resistentes al \ncloro que las bacterias ent\u00e9ricas. El n\u00famero de par\u00e1sitos necesario para inducir una infecci\u00f3n \nse estima alrededor de 10 ooquistes para Cryptosporidium  spp. (Fayer et al. , 2000) y 10 quistes \npara G. duodenalis  (Adam, 2001). Introducci\u00f3n general \n 9 1.2. El agua residual como agente transmisor de enfermedades infecciosas \n \nDebido al actual incremento masivo de poblaci\u00f3n mundial, se considera que el agua se \nconvertir\u00e1 en uno de los recursos m\u00e1s escaso s durante el transcurso del presente siglo, \nentendiendo la escasez de  agua como la situaci\u00f3n en la que un pa\u00eds o una regi\u00f3n no dispone de \nun m\u00ednimo de 1.000 m3/persona/a\u00f1o (Pereira et al. , 2009) (Figura 2). De hecho, desde hace \nm\u00e1s de diez a\u00f1os se asume que los niveles de  consumo de agua potable son insostenibles \ntanto para los pa\u00edses en v\u00edas desarrollo como para los pa\u00edses desarrollados y que, a nivel \nglobal, el consumo de agua ha incrementado tres veces m\u00e1s de lo esperado respecto el aumento de la poblaci\u00f3n. Como consecuencia di recta de este fen\u00f3meno  podemos observar el \ndeterioro de la salud de la pobl aci\u00f3n de determinadas regiones, la limitaci\u00f3n del desarrollo de \nla econom\u00eda y agricultura, y la vulnerabilidad de multitud de ecosistemas (UNCSD, 1997). Por \notro lado, la mayor\u00eda de desechos originados por la actividad humana acaban incorpor\u00e1ndose \na diferentes cuerpos de agua (lago, mar, oc\u00e9ano, etc.) a trav\u00e9s de aguas y vertidos residuales de origen urbano, agr\u00edcola e industrial y fuentes de contaminaci\u00f3n difusas. Aunque la recogida de aguas residuales data de tiempos remoto s, el tratamiento para su depuraci\u00f3n es \nrelativamente reciente, situ\u00e1ndose a finales del s. XIX y principios del s. XX (Cooper, 2001). El primer caso que constat\u00f3 la necesidad imperiosa de tratar el agua residual se remonta al 1855, cuando John Snow demostr\u00f3 la vinculaci\u00f3n de un brote de c\u00f3lera en Londres y la \ncontaminaci\u00f3n por agua residual del R\u00edo T\u00e1mesis (revisado en Cooper, 2001).  \n \n \n \n Figura 2.  Disponibilidad m undial de agua per c\u00e1pita (1.000 m3/a\u00f1o) y pa\u00eds (UNEP, 2002)  Introducci\u00f3n general \n 10 La necesidad de depurar los efluentes produc idos como consecuencia de la actividad \nhumana, en especial los de origen urbano, para  evitar la contaminaci\u00f3n ambiental es un hecho \nincuestionable. La reutilizaci\u00f3n de las aguas depuradas para usos diversos, como el regad\u00edo o la recarga artificial de acu\u00edferos, permite la re cuperaci\u00f3n parcial de los costes derivados del \nproceso de depuraci\u00f3n y, en las zonas \u00e1ridas y semi\u00e1ridas proporciona un recurso de agua alternativo. Si bien desde finales del s. XX el agua procedente de las EDAR ha sido utilizada para fines diversos, es durante la \u00faltima d\u00e9cada cuando se est\u00e1 registrando un incremento \nmayor en la utilizaci\u00f3n de este recurso (Levine y Asano, 2004, Hochstrat et al. , 2005). Los usos \nderivados de su aplicaci\u00f3n abarcan desde los meno s restrictivos (p.e. riego de bosques) hasta \nlos m\u00e1s exigentes (p.e. riego de productos agr\u00ed colas para su consumo en fresco), siempre y \ncuando se consigan unos criterios de calidad del agua m\u00ednimos para que su utilizaci\u00f3n sea segura. Posiblemente, el uso m\u00e1s extendido sea en la agricultura, por la existencia de \nnumerosas ventajas derivadas del enriquecimien to en nutrientes, implicaciones socio-\necon\u00f3micas, reducci\u00f3n de la dosis de aplicaci\u00f3n de abonos y posibilidad de gestionar los efluentes de una forma m\u00e1s efectiva (Candela et al. , 2007). \n \nLos tratamientos utilizados para depurar el agua residual var\u00edan en funci\u00f3n de la regi\u00f3n \ny pa\u00eds en la que nos fijemos, dependiendo de l n\u00famero de usuarios y del volumen de agua a \ntratar (Doorn et al. , 2006). A pesar de los adelantos tecnol\u00f3gicos y los conocimientos sobre el \ntratamiento de aguas de todo tipo (incluyendo al agua residual), siguen ocurriendo un n\u00famero \nelevado de infecciones y brotes infecciosos vinculados a esta matriz, suponiendo as\u00ed un gran reto para la salud p\u00fablica (Zhou y Smith, 2001). Gran parte de estas infecciones tienen lugar en los pa\u00edses en desarrollo, donde existe un li mitado nivel de saneamiento, unas condiciones \nsocioecon\u00f3micas inadecuadas y una conciencia sobre la salud menor a la existente en los \npa\u00edses desarrollados (Toze, 1997; Elimelech, 2006). Los riesgos de salud para la poblaci\u00f3n a \npartir de la exposici\u00f3n al ag ua residual pueden originarse prin cipalmente por el contacto con \npat\u00f3genos microbianos, t\u00f3xicos qu\u00edmicos y metales pesados.  \nLa relevancia del agua residual como vector  de brotes infecciosos queda claramente \nejemplificada con el brote de c\u00f3lera que azot\u00f3 Am \u00e9rica Latina a principios de los a\u00f1os noventa. \nEl uso de aguas residuales sin tratar para la fertilizaci\u00f3n de campos de hortalizas ocasion\u00f3 \nbrotes de c\u00f3lera en Chile y Per\u00fa. La epidemia se abati\u00f3 sobre Per\u00fa en 1991 y se extendi\u00f3 a \ngran parte de Latinoam\u00e9rica, afectando a m\u00e1s de un mill\u00f3n de personas y generando cerca de \n10.000 v\u00edctimas a finales de 1994. Este brote de c\u00f3lera tambi\u00e9n alert\u00f3 sobre el hecho de que la activaci\u00f3n de una ruta de transmisi\u00f3n da lugar a un impulso de otras v\u00edas alternativas, ya que Introducci\u00f3n general \n 11 el consumo de marisco contaminado y las infe cciones secundarias (contacto persona-persona) \nse convirtieron en el principal problema tras las infecciones iniciales a partir de las hortalizas contaminadas con agua residual (revisado en Tickner, 2005; PAHO, 2001).   \nAgrupando los conceptos desarrollados en los p\u00e1rrafos previos, podemos observar \ncomo la necesidad global de agua potable, el riesgo asociado al agua residual y la creciente reutilizaci\u00f3n de aguas depuradas generan una situaci\u00f3n que conlleva un riesgo para la salud p\u00fablica, representando as\u00ed un reto para los si stemas de saneamiento y regulaciones de aguas \nresiduales/tratadas.  1.2.1. Et apas del tratamiento de aguas residuales \n \nEl tratamiento de aguas residuales consiste en una serie de procesos f\u00edsicos, qu\u00edmicos \ny biol\u00f3gicos que tienen como fin eliminar los contaminantes presentes en el agua efluente destinada para el uso humano. El objetivo del tratamiento es producir agua limpia (efluente \ntratado) o reutilizable en el ambiente y un residuo s\u00f3lido o fango (tambi\u00e9n llamado bios\u00f3lido o lodo) convenientes para su disposici\u00f3n o reutilizaci\u00f3n. Es muy com\u00fan llamarlo depuraci\u00f3n de aguas residuales para distinguirlo del tratamie nto de aguas potables. En la Tabla 1 podemos \nobservar las principales funciones y tipo de proceso f\u00edsico de cada una de las etapas \ndiferenciadas en el tratamiento de aguas residuales. \nTabla 1.  Etapas del proceso de tratamiento de aguas residuales. \nEtapa  Funci\u00f3n  Tipo de procesos  \nPretratamiento  Eliminaci\u00f3n de s\u00f3lidos  F\u00edsico y/o qu\u00edmico  \nTratamiento primario  Eliminaci\u00f3n de materia en suspens i\u00f3n F\u00edsico  \nTratamiento secundario Eliminaci\u00f3n de materia org\u00e1nica \nbiodegradable Biol\u00f3gico \nTratamiento terciario Eliminaci\u00f3n de sales disueltas, \nnutrientes, pat\u00f3genos, materia org\u00e1nica \nrefractaria, reducci\u00f3n de s\u00f3lidos y demanda biol\u00f3gica de ox\u00edgeno F\u00edsico y/o qu\u00edmico \ny/o biol\u00f3gico \nTratamiento de bios\u00f3lidos Estabilizaci\u00f3n y reducci\u00f3n del volumen \nde los bios\u00f3lidos producidos en el tratamiento del agua F\u00edsico y/o qu\u00edmico \n \n- Pretratamiento:  Una vez el agua residual entra en la EDAR, \u00e9sta se somete a un \ntratamiento preeliminar, pretendi endo separar del agua residual tanto por operaciones f\u00edsicas \ncomo por operaciones mec\u00e1nicas, la mayor cant idad de materias que por su naturaleza o por \nsu tama\u00f1o crear\u00edan problemas en los tratamie ntos posteriores (obstr ucci\u00f3n de tuber\u00edas y \nbombas, dep\u00f3sitos de arenas, rotura de equipos,  etc.). Dentro del pret ratamiento y aplicados Introducci\u00f3n general \n 12 secuencialmente podemos diferenciar: el desbast e (eliminaci\u00f3n de grandes objetos flotantes, \ncomo trapos, latas, botellas y palos), desarenado (eliminaci\u00f3n de arenas, granos de caf\u00e9, etc.) y \ndesengrasado (eliminaci\u00f3n de los s\u00f3lidos y l\u00edqui dos no miscibles de menor densidad que el \nagua) (USEPA, 2004). \n - Tratamiento primario:  Es el segundo paso en el tratamiento del agua residual y \npermite la separaci\u00f3n de s\u00f3lidos en suspensi\u00f3n  de menor tama\u00f1o. Des pu\u00e9s de haber realizado \nel desbaste, desengrasado y desarenado, el agua  residual contin\u00faa presentando componentes \norg\u00e1nicos e inorg\u00e1nicos disueltos junto a s\u00f3lidos en suspensi\u00f3n. Los s\u00f3lidos en suspensi\u00f3n consisten en part\u00edculas diminutas que podr\u00e1n ser eliminadas tras la aplicaci\u00f3n de tratamientos \ntales como la sedimentaci\u00f3n (asentamiento por gravedad), tambi\u00e9n llamada decantaci\u00f3n \nprimaria, coagulaci\u00f3n qu\u00edmica o filtraci\u00f3n. A unque, los contaminantes que est\u00e1n disueltos o \nson excesivamente finos y perman ecen suspendidos en el agua residual no son eliminados \nefectivamente por sedimentaci\u00f3n. Cuando el agua residual entra en un tanque de \nsedimentaci\u00f3n se ralentiza, permitiendo que  los s\u00f3lidos en suspensi\u00f3n vayan cayendo \ngradualmente hacia el fondo del tanque, genera ndo los bios\u00f3lidos que ser\u00e1n posteriormente \ntratados.   \n- Tratamiento secundario: Tratamiento biol\u00f3gico que elimina la materia org\u00e1nica \ndisuelta en el agua residual. Hasta el 90% de la materia de origen org\u00e1nico presente en el agua \nresidual puede ser eliminada mediante el trat amiento secundario. Para ello se recurre \nconvencionalmente a bacterias que dentro de tanq ues grandes, en agitaci\u00f3n y con ayuda de la \noxigenaci\u00f3n del agua, se encargan de alimentars e de esta materia org\u00e1nica disuelta (USEPA, \n2004), separ\u00e1ndose posteriormente del agua mediante un nuevo proceso de decantaci\u00f3n, donde de nuevo se generar\u00e1n bi os\u00f3lidos. Los tres m\u00e9todos convencionales m\u00e1s utilizados en \nlos tratamientos secundarios son la biomasa bacteriana en lecho fijo, la biomasa bacteriana \nsuspendida y las lagunas de estabilizaci\u00f3n (Upadhyay et al. , 2007). Si la biomasa bacteriana \nest\u00e1 sobre superficies inertes tales como roca, escoria, material cer\u00e1mico o pl\u00e1stico, se habla de lecho fijo, si est\u00e1 suspendida en el agua sin tratar hablamos de biomasa suspendida. En cada una de estas situaciones, la concentraci\u00f3n de ox\u00edgeno en el agua determina la existencia \nde bacterias aer\u00f3bicas, facultativas o anaer\u00f3bicas. Una laguna de estabilizaci\u00f3n es una estructura simple para embalsar aguas residuales con el objeto de mejorar sus caracter\u00edsticas sanitarias. Las lagunas de estabilizaci\u00f3n se co nstruyen de poca profundidad (2 \u2013 4 m) y con \nper\u00edodos de retenci\u00f3n re lativamente grandes (por lo general de varios d\u00edas). Cuando las aguas \nresiduales son descargadas en lagunas de estabi lizaci\u00f3n se realiza en las mismas, de forma Introducci\u00f3n general \n 13 espont\u00e1nea, un proceso conocido como autodepuraci\u00f3n o estabilizaci\u00f3n natural, en el que \nocurren fen\u00f3menos de tipo f\u00edsico, qu\u00edmico, bio qu\u00edmico y biol\u00f3gico. La calidad del agua que \nabandona las lagunas de estabilizaci\u00f3n se considera equivalente al efluente procedente de un tratamiento secundario convencional. Las lagunas de estab ilizaci\u00f3n eliminan la materia \norg\u00e1nica biodegradable y parte del nitr\u00f3geno presente en el agua residual (Larsdotter et al. , \n2010).  \n- Tratamiento terciario:  Tratamiento adicional que se emplea para la eliminaci\u00f3n de \nsubstancias en suspensi\u00f3n y disueltas que permanecen tras la aplicaci\u00f3n del tratamiento secundario. Se realiza mediante la aplicaci\u00f3n de una gran variedad de procesos f\u00edsicos, \nqu\u00edmicos o biol\u00f3gicos. Los tratamientos terciarios incluyen la filtraci\u00f3n, la eliminaci\u00f3n de amonio y otros contaminantes espec\u00edficos y la desinfecci\u00f3n para elim inar pat\u00f3genos. La \neliminaci\u00f3n de pat\u00f3genos (higienizaci\u00f3n) suele ser el objetivo principal y los procesos que se \nutilizan se conocen como desinfecci\u00f3n. La cloraci\u00f3n, la ozonizaci\u00f3n y la irradiaci\u00f3n con ultravioletas (UV) son los mecanismos de desinfecci\u00f3n m\u00e1s utilizados con el agua residual (Hijnen et al. , 2006). \n \n- L\u00ednea de fangos:  Est\u00e1 formada por el conjunto de procesos utilizados para tratar a los \nbios\u00f3lidos producidos en la l\u00ednea de agua (pro cedentes del tratamiento primario y secundario). \nEstos bios\u00f3lidos son degradados en un digestor an aer\u00f3bico (o en otra forma similar), para ser \ndespu\u00e9s incinerados, usados como ab ono o depositados en un vertedero. \n 1.2.2. Usos ambientales de la reutilizaci\u00f3n de aguas resi duales en Espa\u00f1a \n \nEspa\u00f1a es el pa\u00eds europeo con mayor d\u00e9fici t h\u00eddrico y donde los recursos h\u00eddricos no \nconvencionales, como la desalaci\u00f3n o el agua procedente de las EDAR, constituyen una parte \nimportante de la gesti\u00f3n integrada de los recursos h\u00eddricos disponibles. Paralelamente, tambi\u00e9n es uno de los pa\u00edses que m\u00e1s agua re utiliza, aunque todav\u00eda en cantidades poco \nsignificativas ya que no se llega a reutilizar m\u00e1s del 5% del volumen total de las aguas residuales captadas. Seg\u00fan estudios recientes, el potencial de reutilizaci\u00f3n en Europa es unas 10 veces superior al nivel actual (Hochstrat et al. , 2005).  \n Recientemente, mediante la realizaci\u00f3n del Real Decreto 1620/2007 (An\u00f3nimo, 2007) \nse han concretado los potenciale s usos admitidos para el agua depurada y se han establecido \ncriterios de calidad. Este Real Decreto desarrolla la legislaci\u00f3n pendiente tras la publicaci\u00f3n del Introducci\u00f3n general \n 14 Plan Hidrol\u00f3gico Nacional 11/2005 (An\u00f3nimo, 2005) a la vez que da cumplimiento a las \nexigencias del Reglamento de Dominio P\u00fablico Hidr\u00e1ulico y transpone la Directiva Marco del Agua (An\u00f3nimo, 2000) e incorpora el concepto y la definici\u00f3n de \u2018agua regenerada\u2019, cuyo uso requerir\u00e1 una concesi\u00f3n administrativa que se conceder\u00e1 seg\u00fan la posterior utilizaci\u00f3n del \nagua. En este Real Decreto podemos distinguir lo s siguientes usos: urbano, agr\u00edcola, industrial, \nrecreativo y ambiental, y en su anexo I se recogen los criterios de calidad diferenciados seg\u00fan los usos, aportando l\u00edmites de obligado cumplimiento. Los criterios definidos tienen la consideraci\u00f3n de m\u00ednimos obligatorios exigibles, incluyendo par\u00e1metros f\u00edsico-qu\u00edmicos y sanitarios. Adem\u00e1s, para el resto de los par\u00e1metros es necesario que las aguas depuradas cumplan con las condiciones necesarias para el vertido de aguas residuales seg\u00fan se recoge en el Real Decreto 1315/1992 (An\u00f3nimo, 1992).  \n1.2.3. Presencia de virus en agua resi dual \n \nEl agua residual cruda representa una de l as fuentes m\u00e1s importantes de introducci\u00f3n \nde pat\u00f3genos en el medio ambiente, especialment e pat\u00f3genos como los virus (Tabla 2), ya que \n\u00e9stos muestran una gran estabilidad en condicion es ambientales adversas. Un estudio reciente \nha demostrado la presencia de m\u00e1s de 600.000 nuevas secuencias v\u00edricas, de las cuales 43.381 se relacionan con virus conocidos mientras que  el resto podr\u00edan representar nuevos virus \n(Cantalupo et al. , 2011). Aunque las aguas residuales procedentes de zonas urbanas, rurales, \nhospitales y mataderos son frecuentemente trat adas antes de ser vertidas al medio ambiente, \nexisten multitud de estudios que  demuestran la presencia de pat\u00f3genos v\u00edricos en ellas, \nrepresentando una fuente de cont aminaci\u00f3n importante (Gantzer et al. , 1998; Pusch et al. , \n2005; van den Berg et al. , 2005; Bofill-Mas et al. , 2006; Fumian et al. , 2010). \n \nTabla 2.  Detecci\u00f3n de pat\u00f3genos v\u00edricos humanos en aguas residuales crudas y tratadas. \nVirus  Tipo muestra  Procedencia  GC/mL  Positivas  \nHAdV  Agua residual cruda  Espa\u00f1a  102 \u2013 105 100%  \nEfluente secundario  Espa\u00f1a  101 \u2013 102 100%  \nAgua residual cruda  USA 102 \u2013 105  \nEfluente terciario  USA 101 \u2013 102  \nJCPyV  Agua residual cruda  Espa\u00f1a  103 \u2013 104 100%  \nAgua residual cruda  Brasil  102 \u2013 105 96%  \nEfluente secundario  Brasil  102 \u2013 103 39%  \nAstV  Agua residual cruda  Franci a 106 100%  \nEV Agua residual cruda  Francia  105  \nHEV Agua residual cruda  Espa\u00f1a  102  \nHAV  Agua residual cruda  Espa\u00f1a  101  \nNoV  Agua residual  UK 104  \nEfluente secundario  Brasil  105 \u2013 106  \nTabla modificada de la revisi\u00f3n realizada por Girones et al. , 2010; GC: copias gen\u00f3micas. Introducci\u00f3n general \n 15 Virus ent\u00e9ricos como los HAdV, RV, NoV, EV, HAV y HEV, y virus excretados por orina \ncomo los poliomavirus BK y JC, han sido descrito s en agua residual procedente de diferentes \n\u00e1reas geogr\u00e1ficas (Bofill-Mas et al. , 2000; Miagostovich et al. , 2008; Fumian et al. , 2010; \nVictoria et al. , 2010). Por otro lado, diversos estudios  han demostrado que los niveles de los \nindicadores bacterianos cl\u00e1sicos ( E. coli  y enterococos) no se correlacionan correctamente con \nla presencia de virus, especialmente cuando l as concentraciones del indicador bacteriano son \nbajas (Brownell et al. , 2007; Colford et al. , 2007; Calgua et al. , 2008; Wyn-Jones et al. , 2011). \n \nEl agua residual tratada y sin tratar termina principalmente contactando con el ser \nhumano a trav\u00e9s de fuentes de abastecimiento de agua (aguas potables), aguas para usos \nrecreacionales (playas, piscinas, etc.) o zonas de producci\u00f3n de marisco. Se han descrito brotes \ninfecciosos de origen v\u00edrico a partir de alimentos y aguas contaminadas con agua residual en \ndiversas \u00e1reas geogr\u00e1ficas (revisado en  Hedberg y Osterholm, 1993; Brugha et al. , 1999; \nH\u00e4fliger et al. , 2000; Breitenmoser et al. , 2008), hecho que constata el relevante papel que \njuega el agua residual en cuanto a la introdu cci\u00f3n de virus ent\u00e9ricos en el medio ambiente. \n 1.2.4. M\u00e9todos de concentraci\u00f3n de virus en agua resi dual \n \nLa ausencia de m\u00e9todos de concentraci\u00f3n de part\u00edculas v\u00edricas que sean f\u00e1cilmente \nimplementables en laboratorios de rutina, ec on\u00f3micos y con elevadas recuperaciones es una \nde las principales dificultades a la hora de an alizar y detectar virus en muestras ambientales. \nLos pasos b\u00e1sicos para el an\u00e1lisis de virus pr esentes en muestras de agua son los siguientes: \nmuestreo, concentraci\u00f3n, eliminaci\u00f3n de inhi bidores y detecci\u00f3n espec\u00edfica del virus que \nqueramos detectar. La concentraci\u00f3n es, con diferencia, el punto m\u00e1s cr\u00edtico entre los \nprocesos mencionados, debido a que las part\u00edculas v\u00edricas suelen presentarse en \nconcentraciones bajas y se requiere concentrar y reducir los vol\u00famenes finales hasta pocos \nmL.   \nDesde hace m\u00e1s de 70 a\u00f1os se han desa rrollado m\u00e9todos de concentraci\u00f3n para \ndetectar part\u00edculas v\u00edricas en aguas residuales (Gard, 1940). La mayor parte de m\u00e9todos de recuperaci\u00f3n de virus utilizan las propiedades de las part\u00edculas v\u00edricas como macromol\u00e9culas \nproteicas. Los virus se comportan en el medio como un coloide hidr\u00f3filo en el que la carga el\u00e9ctrica neta var\u00eda en funci\u00f3n del pH y de la fuerza i\u00f3nica del medio. Adem\u00e1s, tienen la capacidad de absorberse sobre part\u00edculas en su spensi\u00f3n o soportes de cualquier tipo. Seg\u00fan \nlos criterios establecidos por Wyn-Jones y Sellwood (2001), un m\u00e9todo de concentraci\u00f3n Introducci\u00f3n general \n 16 \u00f3ptimo deber\u00eda cumplir los siguientes criterios: f\u00e1cil de realizar en un tiempo relativamente \ncorto, eficiencia de recuperaci\u00f3n de part\u00edcul as v\u00edricas elevada, capacidad de concentrar un \namplio espectro de virus, permitir obtener un volumen final peque\u00f1o, econ\u00f3mico, tener la \ncapacidad de procesar un volumen de muestra adecuado a la concentraci\u00f3n de part\u00edculas \nv\u00edricas presentes, repetible y reproducible. Con el objetivo de lograr los criterios descritos, se han utilizado aproximaciones de diferente tipo, tales como t\u00e9cnicas de absorci\u00f3n-eluci\u00f3n (combinadas con floculaci\u00f3n), ultrafiltraci\u00f3n y ultracentrifugaci\u00f3n.    \n\u2022 Adsorci\u00f3n -eluci\u00f3n:  Hist\u00f3ricamente, los virus han sido recuperados mediante adsorci\u00f3n \ny eluci\u00f3n en microfiltros (0.1 \u2013 10 \u03bcm) combinado con la detecci\u00f3n por cultivos \ncelulares tradicionales. Sin embargo, debido  a que los virus se propagan lentamente \nen l\u00edneas celulares espec\u00edficas, frecuent emente se necesitan varias semanas para \ndetectar su presencia mediante ensayos en pl aca o la observaci\u00f3n de efecto citop\u00e1tico, \nconvirtiendo as\u00ed su detecci\u00f3n en un proces o largo y costoso. Obviando el hecho que \nalgunos virus ent\u00e9ricos, como NoV, RV o HAV,  son dif\u00edciles o imposibles de replicar por \ncultivo celular. Los virus contenidos en la muestra se ponen en contacto con una \nmatriz en la que ser\u00e1n adsorbidos en unas condiciones espec\u00edficas de pH y fuerza i\u00f3nica. Una vez adsorbidos, se descarta el agua en la que estaban suspendidos \noriginariamente, y a continuaci\u00f3n son elu\u00eddos de la matriz en un peque\u00f1o volumen. La \nelecci\u00f3n de la matriz adsorbente, l\u00edquido eluyente y condiciones del proceso depender\u00e1n de la natura leza de la muestra y de la experiencia, pero es muy frecuente \nutilizar soluciones que contienen extracto de carne o leche desnatada a pH elevado, que desplazan los virus de la matriz. Tamb i\u00e9n se usan soluciones de glicina/NaOH. \nOcasionalmente, la concentraci\u00f3n alcanzada  no es suficiente para su posterior \ndetecci\u00f3n, en cuyo caso se requiere una concentraci\u00f3n secundaria. \u00c9sta, se puede \nrealizar mediante coagulaci\u00f3n-floculaci\u00f3n, en la que el virus es adsorbido a los fl\u00f3culos, recuperado mediante centrifugaci \u00f3n y disueltos en peque\u00f1os vol\u00famenes de \nbuffer fosfato neutro. Numerosos protocolos utilizan la filtraci\u00f3n a trav\u00e9s de \nmembranas electronegativas y electropositivas con una posterior eluci\u00f3n con soluci\u00f3n de extracto de carne y/o precipitaci\u00f3n con polietilenglicol (Wallis y Melnick, 1967; Homma et al. , 1972; Gerba et al. , 1978; Landry et al. , 1978; Smith y Gerba, 1982; Rose, \n1984). \n \n\u2022 Ultrafiltraci\u00f3n:  Las muestras se hacen pasar a trav\u00e9s  de filtros con tama\u00f1o de poro \nmenor que los virus (0,001 \u2013 0,1 \u03bcm), por lo que son retenidos. Actualmente se utilizan Introducci\u00f3n general \n 17 membranas con un tama\u00f1o de poro que permite el paso del agua y los solutos de bajo \npeso molecular, pero excluye virus y ma cromol\u00e9culas que se concentran en la \nmembrana. En estos sistemas en que el agua pasa directamente a trav\u00e9s del filtro, los componentes no filtrables ocluyen la superficie del filtro, por lo que s\u00f3lo son \u00fatiles para peque\u00f1os vol\u00famenes de muestra, por lo  que se han desarrollado modificaciones \ntales como la filtraci\u00f3n con flujo tangencial o la ultrafiltraci\u00f3n-v\u00f3rtex. Las ventajas de la ultrafiltraci\u00f3n son que la muestra no requi ere preacondicionamiento (p.e. ajustar pH), \ny por lo tanto, una amplia variedad de virus pueden ser concentrados (Tsai et al. , 1993; \nGrassi et al. , 2010). \n \n\u2022 Ultracentrifugaci\u00f3n:  Es un m\u00e9todo poco selectivo, aunque capaz de concentrar todos \nlos virus aplicando suficiente fuerza de gravedad y tiempo (p.e. 100.000 xg durante \nuna hora). El volumen que puede ser proc esado es relativamente peque\u00f1o, por lo \ntanto es una metodolog\u00eda muy \u00fatil asociad a a muestras de peque\u00f1o volumen o como \nm\u00e9todo de concentraci\u00f3n secundario (Pina et al. , 1998a). El principal problema \nasociado a esta metodolog\u00eda reside en que es necesario disponer de una ultracentrifuga y debido a su elevado coste se dificulta la utilizaci\u00f3n en laboratorios de rutina y, por supuesto, en pa\u00edses  con bajo desarrollo econ\u00f3mico. \n \n1.3. Los moluscos bivalvos como agentes transmisores de enfermedades infecciosas  \nLa producci\u00f3n y el consumo de mariscos bivalvos a nivel mundial se ha visto \nincrementada significativamente en los \u00faltimos a\u00f1os. Recientemente se ha descrito que tanto \nla captura de individuos que crecen libres como la producci\u00f3n en zonas de cultivo controladas \nhan aumentado de aproximadamente 10,7 millones de toneladas en 1999 a 14 millones de toneladas en 2006 (Lee et al. , 2008b). Al mismo tiempo, el transporte de mercanc\u00edas por \ntransporte a\u00e9reo y mar\u00edtimo, junto con la impl ementaci\u00f3n de t\u00e9cnicas de preservaci\u00f3n, ha \npermitido que un mayor n\u00famero de consumidores  de diferentes part es del mundo puedan \nacceder a un producto producido en aguas de ma r lejanas. Este desarrollo en la distribuci\u00f3n y \nel comercio representa un nuevo reto a la hora  de garantizar unas condiciones microbiol\u00f3gicas \nadecuadas que garanticen la protecci\u00f3n del pote ncial consumidor, particularmente en relaci\u00f3n \na la seguridad en el consumo de los moluscos bivalvos respecto virus pat\u00f3genos. Muchas \nespecies de bivalvos suelen consumirse vivas, crudas o poco cocinadas, originando as\u00ed que los bivalvos se conviertan en un producto alimenticio de elevado riesgo para salud y provocando la necesidad de generar medidas exhaustivas de control para conseguir niveles aceptables de Introducci\u00f3n general \n 18 contaminantes biol\u00f3gicos o qu\u00edmicos. Por otro  lado, la distribuci\u00f3n de productos crudos \ncongelados ha extendido considerablemente el periodo de tiempo duran te el que lotes de \nmarisco contaminado son consumidos (Lee et al. , 2008b). \n \nLos productos extra\u00eddos del mar constituye n una proporci\u00f3n muy importante de los \nrecursos alimenticios a escala mundial. La acti vidad econ\u00f3mica relacionada con la explotaci\u00f3n \nde los criaderos naturales de moluscos bivalvos y su cultivo artificial tiene una gran importancia en la Comunidad Europea. En el Esta do Espa\u00f1ol, esta actividad econ\u00f3mica de gran \ntrascendencia se ha establecid o principalmente en las comunidades aut\u00f3nomas de Galicia y \nCatalu\u00f1a, en las que las r\u00edas gallegas y Delta del Ebro constituyen un ecosistema muy propicio para su desarrollo, respectivamente. Las especies explotadas comercialmente incluyen la ostra plana ( Ostrea edulis ), ostr\u00f3n ( Crassostrea gigas ), el mejill\u00f3n com\u00fan mediterr\u00e1neo ( Mytilus \ngalloprovincialis ) y atl\u00e1ntico ( Mytilus edulis ), varias especies de almeja ( Tapes  spp., Mercenaria \nmercenaria ), el berberecho ( Cerastoderma edule ), la navaja ( Ensis  spp.) y la vieira ( Pecten \nmaximus ) (Lees, 2000). Tambi\u00e9n existe una producci\u00f3n constante en el \u00e1rea del Delta del Ebro, \nd\u00f3nde se cultiva principalmente ostr\u00f3n y mejill\u00f3n.  \nLos moluscos bivalvos son animales de car\u00e1cter sedentario y de r\u00e9gimen alimentario \nexclusivamente filtrador. Las branquias, que se encuentran cubiertas de mucus y cilios vibr\u00e1tiles, adem\u00e1s de cumplir con la funci\u00f3n respiratoria, retienen las part\u00edculas en suspensi\u00f3n, entre ellas, bacterias, virus y protistas planct\u00f3nicos (Di Girolamo et al. , 1977). Las materias en \nsoluci\u00f3n contenidas en el agua tambi\u00e9n so n absorbidas e incorporadas a su organismo. \nAdem\u00e1s, el aumento de los aportes de aguas residua les al mar, debido al fuerte incremento de \nla poblaci\u00f3n y a la actividad industrial, han comprometido la calidad sanitaria de las zonas costeras. Esta situaci\u00f3n no solo conlleva camb ios importantes en las caracter\u00edsticas f\u00edsico-\nqu\u00edmicas y biol\u00f3gicas del ecosistema marino, sino  que constituye un riesgo potencial para la \nsalud p\u00fablica derivado del consumo directo de  organismos marinos y de las actividades \nrecreativas que se realizan en las aguas cost eras contaminadas por aguas residuales. Varios \npat\u00f3genos bacterianos est\u00e1n involucrados en to xi-infecciones alimentarias asociadas con el \nconsumo de mariscos, aunque son los virus la causa m\u00e1s frecuente (Potasman et al. , 2002) \n(Tabla 3). \n \n    Introducci\u00f3n general \n 19 Tabla 3.  Microorganismos pat\u00f3genos asociados al consumo de moluscos bivalvos. \nMicroorganismo  Periodo incubaci\u00f3n  Duraci\u00f3n  Origen  \nSalmonella typhi 1 \u2013 3 semanas > 4 semanas Heces humanas  \nAgua residual \nSalmonella paratyphi 1 \u2013 10 d\u00edas 2 \u2013 3 semanas Heces humanas  \nAgua residual \nOtras Salmonella 6 \u2013 72 horas 4 \u2013 7 d\u00edas Heces humanas  \nAgua residual \nHeces de aves \nYersinia enterocolitica  24 \u2013 48 horas 1 \u2013 21 d\u00edas Heces y orina  \nAgua residual \nCampylobacter 2 \u2013 7 d\u00edas 3 \u2013 6 d\u00edas Heces animals  \nHeces aves \nShigella 24 \u2013 72 horas 5 \u2013 7 d\u00edas Heces humanas  \nAgua residual \nVibrio parahaemolyticus  2 \u2013 48 horas  2 \u2013 14 d\u00edas  Ambiente marino  \nVibrio vulnificus  16 \u2013 24 horas  2 \u2013 3 d\u00edas  Ambiente marino  \nVibrio cholerae  (O1 y O139) 1 \u2013 5 d\u00edas 2 \u2013 5 d\u00edas Heces humanas  \nAgua residual \nVibrio cholerae  \n(no-O1/no-O139) 2 \u2013 3 d\u00edas > 1 semana Ambiente marino \nNorovirus 1 \u2013 3 d\u00edas 20 \u2013 72 horas Heces humanas  \nAgua residual \nHepatitis A virus 10 \u2013 50 d\u00edas 10 \u2013 30 d\u00edas2 Heces humanas  \nAgua residual \nAstrovirus1 1 \u2013 2 d\u00edas 48 \u2013 72 horas Heces humanas  \nAgua residual \n1Se han reportado muy pocas infe cciones asociadas a astrovirus. 2Aproximadamente un 10% \nde los infectados por hepatitis A mantienen los s\u00edntomas durante 6 \u2013 9 meses. (datos extra\u00eddos \nde Lee et al. , 2008b). \n \nComo se muestra en la Tabla 4, se han de scrito en todo el mundo numerosos brotes \nde HAV y NoV asociados al consumo de bivalvos, el m\u00e1s destacado entre ellos es el ocurrido en Shanghai (China) en 1988 donde se documentaron 300.000 casos de infectados por HAV tras la ingesti\u00f3n de almejas recogidas en una zona que recib\u00eda aportes de agua residual (Halliday et \nal., 1991). El consumo de bivalvos se ha relacionado con el 70% de las hepatitis de tipo A \ndiagnosticadas en Italia, 19% en Alemania, 25% en el Reino Unido o el 11% en Jap\u00f3n (Lees, 2000). Las gastroenteritis a menudo son tambi\u00e9n una consecuencia directa del consumo de \nmoluscos bivalvos contaminados con NoV. En el Reino Unido, entre 1965 y 1983, el 37% de los \nbrotes infecciosos declarados re lacionados con el consumo de bivalvos fueron causados por \nNoV, el 17% por HAV y en el 43% no se identific\u00f3 el agente (Lees, 2000). Los datos epidemiol\u00f3gicos recogidos han demostrado estacionalidad en la aparici\u00f3n de infecciones producidas por el consumo de moluscos bivalvos, siendo m\u00e1s predominantes en los meses fr\u00edos (Lees, 2000). Introducci\u00f3n general \n 20 Tabla 4.  Infecciones v\u00edricas atribuidas al consumo de moluscos bivalvosa. \nVirus  A\u00f1o Pa\u00eds Afectados  Origen  \nHAV 1955  Suecia  629 almejas  \n1961  USA 84 ostras  \n1973  USA 263 ostras  \n1978  UK 41 mejillones  \n1984  Italia  75 mejillones, almejas  \n1988  China  300.000  almejas  \n1994  Italia 620 mejillones  \n1996  Italia  271 diversas especies  \n1999  Espa\u00f1a  183 berberechos  \n2005  USA 39 ostras  \n2007  Francia  111 almejas, ostras  \n2008  Espa\u00f1a  29 berberechos  \nNoV 1976  \u2013 1977  UK 800 berberechos  \n1977  USA 83 almejas  \n1978  Australia  2.000  ostras \n1980  \u2013 1994  USA 126 almejas  \n1982  USA 1.472  almejas, ostras  \n1983  USA 2.000  almejas  \n1991  Canad\u00e1  200 ostras  \n2002  Francia  127 ostras  \n2002  Italia  200 ostras  \n2004  Canad\u00e1  53 ostras  \n2005  Espa\u00f1a  266 ostras, navajas  \n2007  Suecia  30 ostras  \naDatos recopilados en: Le Guayader et al. , 1996; Lipp y Rose, 1997; Wallace et al. , \n1999; Croci et al. , 2000; Lees, 2000; Bosch et al. , 2001; Le Guyader et al. , 2006; \nDavid et al. , 2007; Shieh et al. , 2007; AESAN, 2008; Guillois-B\u00e9cel et al. , 2009; \nNenonen et al. , 2009; Galm\u00e9s Truyols et al. , 2011. \n \n1.3.1. Legislaci\u00f3n y zonas de producci\u00f3n de marisco  \nTanto la normativa europea como la americ ana clasifican las zonas de producci\u00f3n de \nmoluscos bivalvos en funci\u00f3n del grado de co ntaminaci\u00f3n fecal estimada a partir de la \nmedici\u00f3n de indicadores bacterianos. Una de las principales diferencias radica en que en la Uni\u00f3n Europea la medici\u00f3n se realiza sobre la carne y el l\u00edquido intervalvar de los moluscos, mientras que en los Estados Unidos se hace sobre las aguas de producci\u00f3n. \n \nEl actual sistema de clasificaci\u00f3n para determinar la calidad de las zonas producci\u00f3n de \nmarisco emplea a E. coli  como organismo indicador de los niveles de contaminaci\u00f3n fecal y se \nbas\u00f3 originalmente en la legislaci\u00f3n francesa. Las negociaciones basadas en el modelo franc\u00e9s \ndieron lugar a la creaci\u00f3n de la Directiva 91/492/CEE del Consejo (An\u00f3nimo, 1991), del 15 de julio de 1991, por la que se fijan las normas sanitarias aplicables a la producci\u00f3n y puesta en el Introducci\u00f3n general \n 21 mercado de moluscos bivalvos vivos. Dicha directiva se mantuvo vigente hasta la aparici\u00f3n de \nlas nuevas regulaciones del Parlamento Europeo y del Consejo de 2004 y 2008, relativo a la higiene en alimentos de origen animal destinadas al consumo humano (An\u00f3nimo, 2004a, b, c, 2008). En el estado Espa\u00f1ol, la normativa de control de calidad sanitaria de los moluscos bivalvos se recoge dentro de los Reales Decretos 308/1993 y 571/1999 (An\u00f3nimo, 1993; An\u00f3nimo, 1999). \n \nActualmente, el sistema europeo de clasifi caci\u00f3n para las \u00e1reas de producci\u00f3n de \nmarisco se basa exclusivamente en el n\u00famero de E. Coli  presentes en la carne del animal. La \nclasificaci\u00f3n de las zonas de cultivo (A \u2013 C) se realiza anualmente por agencias propias de cada pa\u00eds estableciendo de esta mane ra la siguiente clasificaci\u00f3n: \n \n\u2022 Zonas clase A:  \u00c1reas de producci\u00f3n donde el cultivo del marisco es adecuado para que \nlos moluscos bivalvos obtenidos puedan se r destinados directamente al consumo \nhumano. Los moluscos bivalvos vivos de es tas zonas de producci\u00f3n deben presentar \nuna concentraci\u00f3n de E. coli  menor a 230 MPN por cada 100g de carne del molusco y \nl\u00edquido intervalvar. \n \n\u2022 Zonas clase B:  Los moluscos bivalvos obtenidos aqu\u00ed podr\u00e1n ser destinados al \nconsumo humano despu\u00e9s de aplicar un proces o de depuraci\u00f3n o de su reinstalaci\u00f3n \nen una zona de cultivo clase A. Los moluscos  bivalvos vivos en es ta zona de ben tener \nun n\u00famero de E. coli  igual o menor 4.600 MPN por 100g de carne en el 90% de las \nmuestras (esta \u00faltima puntualizaci\u00f3n se recoge dentro de An\u00f3nimo, 2006). \n \n\u2022 Zonas clase C:  El producto procedente de estas zo nas de cultivo podr\u00e1 ser destinado al \nconsumo humano \u00fanicamente despu\u00e9s de haber sido reinstalado en una zona clase A \ndurante un periodo m\u00ednimo de 2 meses, o tras una depuraci\u00f3n intensiva a fin de \ncumplir las condiciones mencionadas anteriormente. Los moluscos bivalvos vivos tendr\u00e1n que contener un n\u00famero de E. coli  inferior a 46.000 MPN por 100g de carne. \n \nDebido a la ausencia de metodolog\u00eda estanda rizada para la detecci\u00f3n de virus y de \nnormativa que regule la calidad virol\u00f3gica, tal y como se ha mencionado, el control sanitario se basa en el recuento de bacterias fecales. As\u00ed pues, los moluscos bivalvos destinados al consumo humano inmediato deben cumplir b\u00e1sicamente con niveles establecidos para una zona de categor\u00eda A, y no contener Salmonella  en 25g de carne. Adem\u00e1s, deben cumplir con Introducci\u00f3n general \n 22 las caracter\u00edsticas visuales propias de frescura y viabilidad y no contener compuestos t\u00f3xicos o \nnocivos (toxinas, metales pesados y/o pesticidas).   El Comit\u00e9 Europeo de Estandarizaci\u00f3n es t\u00e1 elaborando actual mente protocolos y \nt\u00e9cnicas est\u00e1ndar para la detecci \u00f3n de HAV y NoV en alimentos a trav\u00e9s del grupo de trabajo \nCEN/TC 275/WGG/TAG4.  1.3.2. Estrategias para eliminar la contaminaci\u00f3n microbiol\u00f3gica tras la recolecci\u00f3n  \nDebido a que no siempre se consiguen garantizar los niveles microbiol\u00f3gicos \npretendidos, ya sea porque la zona de cult ivo no cumple con la normativa establecida o \nporque se haya producido una contaminaci\u00f3n puntual en el proceso de producci\u00f3n o de \nrecolecta de los bivalvos. Existen diversas estrategias para reducir la presencia de \nmicroorganismos y poder as\u00ed garantizar un pro ducto competente frente las exigencias del \nmercado. Los sistemas m\u00e1s ampliamente util izados de describen a continuaci\u00f3n:  \n \n\u2022 Temperatura:  los tratamientos por calor o por cocci\u00f3n  se utilizan para reducir el nivel \nde contaminaci\u00f3n microbiol\u00f3gica cuando el marisco se comercializa como producto \nprocesado. Se aplican diversos tratamientos entre los cuales se encuentra la \npasteurizaci\u00f3n y la esterilizaci\u00f3n al enlatar. Los procesos de cocci\u00f3n se establecen bajo la decisi\u00f3n de la Comisi\u00f3n Europea del 30 de octubre de 2003 (An\u00f3nimo, 2003), donde se determina que la temperatura interna de la carne de los moluscos bivalvos deben \nalcanzar 90 \u00baC durante al menos noventa segundos. Tambi\u00e9n se considera la opci\u00f3n de someter al alimento de 3 a 5 minutos en un recipiente cerrado bajo una temperatura \nde 120 \u2013 160 \u00baC y una presi\u00f3n de 2 \u2013 5 Kg/cm\n2. El conjunto de estos y otros \npar\u00e1metros no mencionados aqu\u00ed est\u00e1n b asados en datos obteni dos de es tabilidad \npara HAV en almejas. Debido a que NoV no puede cultivarse in vitro , no se han podido \nrealizar estudios sobre su persistencia e inactivaci\u00f3n, aunque est udios realizados con \nfeline calicivirus (FCV), utilizado como microorganismo modelo para NoV, han demostrado que en moluscos bivalvos se inactivan por tratamientos t\u00e9rmicos m\u00e1s \nf\u00e1cilmente que HAV (Slomka y Appleton, 1998; Doultree et al. , 1999). De todos modos, \nla cocci\u00f3n ligera habitual que se realiza en hogares y restaurantes no es efectiva para \nlograr una reducci\u00f3n de la contaminaci\u00f3 n de origen fecal que sea totalmente \naceptable a nivel microbiol\u00f3gico. Se ha detectado la presencia de RV y HAV en Introducci\u00f3n general \n 23 mejillones cocinados al vapor minutos des pu\u00e9s de que se abrieran las valvas (Abad et \nal., 1997a). \n \n\u2022 Presi\u00f3n hidrost\u00e1tica:  El procesado mediante una elevada presi\u00f3n hidrost\u00e1tica se utiliza \nhabitualmente en la industria alimentaria con el objetivo de inactivar a los \nmicroorganismos no deseados, tales como Staphylococcus aureus , L. monocytogenes , \nVibrio  spp., Salmonella  spp., y E. coli  O157:H7 (revisado en Corbo et al. , 2009), tambi\u00e9n \nha sido propuesto para la inactivaci\u00f3n de Vibrio parahaemolyticus  (Kural et al. , 2008; \nMa y Su, 2011). Generalmente se utilizan presiones que oscilan entre 300 y 700 MPa, efectivas para inactivar la mayor\u00eda de bacterias en su forma vegetativa, aunque las esporas bacterianas pueden resistir a la aplicaci\u00f3n de estas presiones. Entre los beneficios de la utilizaci\u00f3n de este tipo de tr atamiento encontramos la rapidez y la \nuniformidad en la aplicaci\u00f3n, as\u00ed como el mantenimiento de las propiedades organol\u00e9pticas ya que se trata de un proces o isot\u00e9rmico. El principal inconveniente \nreside en el elevado coste econ\u00f3mico que representa. Este tipo de tratamiento suele utilizarse comercialmente para la eliminaci\u00f3n de Vibrio  spp. en ostras (L\u00f3pez-Caballero \net al. , 2000; Murchie et al. , 2005), adem\u00e1s, algunos estudios recientes han demostrado \nsu utilidad frente a ooqusites  de Cryptosporidium parvum  (Collins et al. , 2005), HAV y \nFCV en marisco crudo (Calci et al. , 2005; Kingsley et al. , 2007; Kingsley et al. , 2009; \nTerio et al. , 2010). \n \n\u2022 Depuraci\u00f3n:  Este tratamiento se aplica en la mayor\u00eda de especies de moluscos bivalvos \nque se comercializan vivas. Los procesos de depuraci\u00f3n se aplicaron por primera vez en la segunda d\u00e9cada del s. XX (citado en Lees, 2000), pensado como una manera de \naprovechar el proceso natural de purgaci\u00f3n de  contaminantes tras la filtraci\u00f3n de agua \nde mar limpia. Como se ha mencionado an teriormente, los bivalvos bioacumulan de \nforma pasiva diferentes part\u00edculas s\u00f3lidas y microorganismos pat\u00f3genos, y cuando se \naplica un tratamiento de depuraci\u00f3n con agua de mar con niveles muy bajos de nutrientes, los moluscos se van alimentando  del material retenido en su gl\u00e1ndula \ndigestiva, disminuyendo as\u00ed el tama\u00f1o y peso de la gl\u00e1ndula (Muniain-Mujika et al. , \n2002). Los diferentes procesos de depuraci\u00f3n existentes suelen aplicarse durante una semana, aunque 24 \u2013 48 horas es el period o aplicado m\u00e1s frecuentemente. Existe una \ngran variedad de sistemas de depuraci\u00f3n, al gunos de ellos mantienen el agua est\u00e1tica \nmientras que en otros se requiere que el agua est\u00e9 circulando continuamente, \nrecicl\u00e1ndola tras pasar por un proceso de esterilizaci\u00f3n. Las principales ventajas e Introducci\u00f3n general \n 24 inconvenientes de los tres principales sistemas de esterilizaci\u00f3n, irradiaci\u00f3n con luz \nUV, cloraci\u00f3n y ozonizaci\u00f3n (Lees, 2000) se  describen en la siguiente Tabla 5. \n \nTabla 5.  Comparaci\u00f3n de tres sistemas de desinfecci\u00f3n de agua. \nCondici\u00f3n valorada  Luz ultravioleta  Cloraci\u00f3n  Ozonizaci\u00f3n  \nCostos de capital  Bajo  Medio  Elevado  \nCostos operacionales  Muy bajo  Bajo  Elevado  \nInstalaci\u00f3n  Simple  Compleja  Compleja  \nMantenimiento  Sencillo  Moderado  Dif\u00edcil  \nCosto de mantenimiento  Bajo  Medio  Elevado  \nRendimiento  Excelente  Posible recrecimien to Poco fiable  \nClaridad de la fuente de agua  Elevada  Baja  Media  \nEfecto virucida  Bueno  Pobre  Bueno  \nRiesgos para el personal  Medio  Elevado  Medio  \nQu\u00edmicos t\u00f3xicos  No S\u00ed S\u00ed \nEfecto residual  No S\u00ed Ligeramente  \nEfecto sobre el agua  Ausente  Trihalometanos  Toxicidad  \nProblemas operacionales  Bajo  Medio  Elevado  \nContacto (tiempo o distancia)  1 \u2013 5 segundos  30 \u2013 60 mm  10 \u2013 20 mm  \nEfecto en el marisco  Ausente  Irritante  Oxidante  \nBasado Lee, 2008b. \n \nEn el pasado se hab\u00edan utilizado tambi\u00e9n si stemas que incorporaban yod\u00f3foros, con la \nintenci\u00f3n de desinfectar el agua de mar median te un efecto microbicida (incluyendo virus), \ndejando concentraciones residuales para una desi nfecci\u00f3n latente. Actu almente los yod\u00f3foros \nhan quedado relegados. De entre estos sistemas de  depuraci\u00f3n, la aplicaci\u00f3n de luz UV es la \nt\u00e9cnica m\u00e1s com\u00fanmente utilizada. El efecto germicida propio de la longitud de onda y los \nniveles de energ\u00eda son esenciales para una inactivaci\u00f3n efectiva de los microorganismos \npat\u00f3genos. Aunque est\u00e1 bastante aceptado que los actuales sistemas de depuraci\u00f3n tienen un \npoder limitado para eliminar pat\u00f3genos v\u00edricos,  existe un consenso general que estipula una \ndosis de UV de al menos 400 J/m2 (citado en SARF, 2010). \n \nLa cloraci\u00f3n es un sistema de depuraci\u00f3n ac eptado en todo el mundo por su poder \nbiocida y elevada efectividad para eliminar microorganismos, aunque existen algunos contratiempos en su aplicaci\u00f3n que contin\u00faan si endo tema de estudio y discusi\u00f3n. Debido a \nque el cloro es un poderoso agente oxidante , reacciona generando productos secundarios \ncomo el cloroformo y las cloraminas, productos no  deseados que se acumul an en el interior de \nlos tanques de depuraci\u00f3n. Estudios previos ha n comparado la reducci\u00f3n bacteriana entre un \nsistema de depuraci\u00f3n que utiliza agua de mar sin tratar y otro que utiliza agua de mar clorada, observando que la reducci\u00f3n del agua si n tratar es mayor que la tratada y sugiriendo Introducci\u00f3n general \n 25 as\u00ed que un exceso de cloraci\u00f3n podr\u00eda retrasar el proceso natural de depuraci\u00f3n (citado en \nSARF, 2010). Lee et al.  (2008b) sugiere que antes de ut ilizar este sistema de depuraci\u00f3n es \nnecesario reducir el cloro libre por debajo de 0,1 mg/L, permitiendo as\u00ed una depuraci\u00f3n \neficiente. En la industria francesa se recomienda  una dosis de cloro de 3 mg/L con 1 hora de \ncontacto (MPM, 2003), coincidiendo con la dosis recomendada por UK y el manual FAO (Lee et \nal., 2008b). \n \nLa ozonizaci\u00f3n como sistema de depuraci\u00f3n se ha implementado consistentemente en \nItalia y Espa\u00f1a, el manual de depuraci\u00f3n de la FAO (Lee et al. , 2008b) propone unas tasas de \nozonizaci\u00f3n que no excedan los 0,5 mg/L co n un tiempo de contacto de 10 minutos. La \nnormativa aplicada en industria francesa pro ductora de marisco (MPM, 2003) recomienda \nunas dosis de ozono de 0,5 \u2013 1,5 mg/L durante 6 minutos de tiempo de contacto. Debido a que \nel ozono residual puede tener un impacto letal respecto el marisco que est\u00e1 siendo \ndesinfectando, la mayor\u00eda de sistemas de ozonizaci\u00f3n utilizan generadores externos al ta nque \ndonde se depura el marisco, permitiendo una desinfecci\u00f3n efectiva y una ca\u00edda del ozono \nresidual hasta valores aceptables. Croci et al.  (1992) realiz\u00f3 estudios con moluscos bivalvos \ndopados con poliovirus y HAV, donde se realizar on depuraciones de 72 horas y se compar\u00f3 la \neliminaci\u00f3n de poliovirus con agua de mar sin tratar respecto agua de mar ozonizada (1 mg/L). Los resultados mostraron una ca\u00edda mayor de la carga viral en las muestras que recib\u00edan agua \nozonizada, aunque tambi\u00e9n se obse rv\u00f3 que la depuraci\u00f3n no fue to talmente efectiva (Tabla 6). \n \nTabla 6.  Depuraci\u00f3n de mejillones contaminados con poliovirus 1. \nTiempo (h) Poliovirus 1 (TCID 50/mL)  \nagua de mar sin tratar  agua de mar ozonizada  \n0 104.0  104.0 \n2 103.5 103.0 \n24 103.0 101.5 \n48 102.7 101.5 \n72 102.5 101.5 \nDatos extra\u00eddos de Croci et al.  (1992). \n \nAdem\u00e1s de los sistemas de depuraci\u00f3n aqu\u00ed descritos, tambi\u00e9n se utiliza otros \ntratamientos menos comunes o incluso la combin aci\u00f3n de los mencionados anteriormente. La \naplicaci\u00f3n del sistema de flotaci\u00f3n por aire disuelto (DAF) es un tratamiento muy efectivo tanto para la separaci\u00f3n de s\u00f3lidos en suspensi\u00f3n como para grasas y aceites. La separaci\u00f3n se consigue introduciendo finas burbujas de aire en la fase l\u00edquida. Las burbujas se adhieren a las part\u00edculas, y la fuerza ascendente que experime nta el conjunto part\u00edcula-burbuja de aire hace Introducci\u00f3n general \n 26 que suban hasta la superficie del l\u00edquido. De esta forma, es posible hacer ascender a la \nsuperficie part\u00edculas cuya densidad es mayor que la del l\u00edquido, adem\u00e1s de favorecer el ascenso de aquellas de densidad menor al l\u00edquido , como es el caso de los aceites en agua \n(citado en SARF, 2010). Debido a que los microorganismos contaminantes que se encuentran en suspensi\u00f3n tienden a adherirse a las part \u00edculas s\u00f3lidas, \u00e9stos acaban acumul\u00e1ndose \ntambi\u00e9n en la espuma superficial generada. De manera que, al eliminar la espuma estaremos \nreduciendo la carga microbiol\u00f3gica total. De forma habitual, los sistemas DAF utilizan bombas de alta presi\u00f3n y el sistema venturi (donde un fluido en movimiento dentro de un conducto \ncerrado disminuye su presi\u00f3n al aumentar la velocidad despu\u00e9s de pasar por una zona de \nsecci\u00f3n menor) para disolver el aire en la columna de agua. Este tipo de depuraci\u00f3n ha \nmostrado ser efectivo para la eliminaci\u00f3n de bacterias, aunque no ha mostrado buenos \nresultados respecto los virus (Boher et al. , 1992). \n \nLa reinstalaci\u00f3n es una de las posibilidades contempladas por la legislaci\u00f3n europea, la \ncual implica la transferencia de los animales recolectados a estuarios limpios para que se produzca una auto-depuraci\u00f3n en un ambiente na tural. Este proceso puede utilizarse como \nuna alternativa econ\u00f3mica y natural frente a la aplicaci\u00f3n de cualquiera de los tratamientos planteados anteriormente. La principal ventaja cons iste en que el marisco se puede dejar en su \nnuevo ambiente durante periodos  de tiempo m\u00e1s largos que en los tanques de depuraci\u00f3n, \naunque resulta dif\u00edcil poder controlar las condici ones del nuevo entorno as\u00ed como de encontrar \nde estuarios lo suficientemente limpios como para que la depuraci\u00f3n se realice a niveles \nsatisfactorios para los requisitos exigidos por el mercado.  1.3.3. Microorganismos modelo  \nLa detecci\u00f3n de microorganism os pat\u00f3genos transmitidos por la ruta fecal-oral a \nmenudo requiere de una metodolog\u00eda con un elevad o coste econ\u00f3mico. Por otro lado, no es \nfactible incluir t\u00e9cnicas moleculares para el an\u00e1lisis de todos y cada uno de los microorganismos pat\u00f3genos de inter\u00e9s. Po r estos motivos, es necesario utilizar \nmicroorganismos indicadores que podamos asociar a la calidad del agua y de los moluscos bivalvos. Hist\u00f3ricamente, se han utilizado los indicadores bacterianos (coliformes fecales, principalmente E. coli , y Salmonella ) para evaluar la contaminaci\u00f3n de origen fecal. No \nobstante, la descripci\u00f3n de brotes  infecciosos de etiolog\u00eda v\u00edrica en ausencia de las bacterias \nindicadoras ha puesto en entredicho su utilidad para garantizar la calidad sanitaria de los bivalvos (Christensen et al. , 1998). Por este motivo, se han propuesto otros microorganismos Introducci\u00f3n general \n 27 como modelo de virus ent\u00e9ricos humanos. Entre ellos encontramos, los colifagos som\u00e1ticos, \nlos fagos de RNA F-espec\u00edficos, los bacteri\u00f3fagos de Bacteriodes fragilis , los enterovirus \ninfecciosos y los adenovirus humanos.  Colifagos som\u00e1ticos.  Inician la infecci\u00f3n uni\u00e9ndose a receptores ubicados permanentemente \nen la pared celular de los hospedadores; suelen  replicarse en el aparato digestivo de los \nanimales de sangre caliente, pero tambi\u00e9n puede n hacerlo en medios acu\u00e1ticos. Los colifagos \nsom\u00e1ticos incluyen una gran variedad de  fagos (que pertenecen a las familias Myoviridae, \nSiphoviridae, Podoviridae y Microviridae ) con diferentes tipos morf ol\u00f3gicos. Se detectan en \nheces humanas y animales (granja, zool\u00f3gico y salvajes) a concentraciones que oscilan entre <10\n2 \u2013 108 unidades formadoras de placa (UFP)/mL (IAWPRC, 1991), mientras que en aguas \nresiduales se encuentran en valores de 105 \u2013 106 UFP/g. \u00c9stos, se propusieron como \nmicroorganismos indicadores de contaminaci\u00f3n fecal (Kott et al. , 1974; IAWPRC, 1991) y se \nhan realizado una gran variedad de estudios sobr e su eficiencia. No obstante, el hecho de que \ndeterminados colifagos sean capaces de replicarse en E. coli  sugiere que su capacidad de \nmultiplicarse en el medio ambiente imposibilite su utilizaci\u00f3n como microorganismos indicadores de la contaminaci\u00f3n fecal.  Fagos de RNA F-espec\u00edficos.  Los fagos F-espec\u00edficos (Havelaar y Hogemoon, 1984; Havelaar, \n1993; IAWPRC, 1991; ISO, 2000) son miembros de la familia Leviviridae  (fagos con genoma de \nRNA y cadena simple) y Inoviridae  (fagos DNA de cadena simple). Este grupo de fagos inicia la \ninfecci\u00f3n uni\u00e9ndose a las fimbrias de fertilidad (fimbrias F- o sexuales) de las E. coli  \nhospedadoras, que producen exclusivamente las bacterias portadoras del pl\u00e1smido F (de \nfertilidad). Dado que las fimbrias F se producen \u00fanicamente en la fase de crecimiento \nlogar\u00edtmico a temperaturas superiores a 30 \u00baC, no es probable que los colifagos de RNA F-\nespec\u00edficos sean capaces de replicarse en ambi entes diferentes del aparato digestivo de los \nanimales de sangre caliente. Los fagos F-espec\u00edficos son poco frecuentes en heces humanas y de animales (<10\n3 UFP/g), aunque en agua residuales ce han encontrado en rangos de entre \n103 \u2013 104 UFP/mL. La detecci\u00f3n se realiza prin cipalmente sobre el mutante WG49 de \nSalmonella cholerasuis  subsespecie cholerasuis serotipo Typhimurium  DTCC 700730/NCTC \n12484 (Havelaar y Hogeboom, 1984) que contiene un pl\u00e1smido que codifica para la formaci\u00f3n de los pilis sexuales. Tambi\u00e9n se utiliza la cepa mutante HS(pFamp)R de E. coli , esta cepa \nparece recuperar m\u00e1s fagos F-DNA que F-RNA. Se ha demostrado la multiplicaci\u00f3n del fago GA \n(fago F-RNA del serotipo II en agua residual pasteu rizada y en agua de mar y r\u00edo a 20 \u00b0C cuando \nla bacteria hu\u00e9sped hab\u00eda crecido previamente a 37 \u00baC (Havelaar y Hogeboom, 1988). De Introducci\u00f3n general \n 28 modo que su replicaci\u00f3n podr\u00eda estar restringid a a ambientes con una aportaci\u00f3n fecal directa, \nadem\u00e1s de necesitar una concentraci\u00f3n elevada de fago y de bacteria hu\u00e9sped. Estos requisitos hacen que la multiplicaci\u00f3n de los fagos RNA F-espec\u00edficos sean poco probables en ambientes distintos a los sistemas de aguas residuales.  Fagos de Bacteroides fragilis . El g\u00e9nero bacteriano Bacteroides  habita en el aparato digestivo \nhumano (10\n9 \u2013 1010 UFC/g) en cantidades mayores que E. coli  (106 \u2013 108 UFC/g). Las bacterias \ndel g\u00e9nero Bacteroides  se inactivan r\u00e1pidamente por la concentraci\u00f3n de ox\u00edgeno ambiental, \npero los bacteri\u00f3fagos de Bacteroides  son resistentes a las condiciones desfavorables. Hay dos \ngrupos de fagos de Bacteroides fragilis  que se utilizan como indicadores para la evaluaci\u00f3n de \nla calidad del agua. Uno es un grupo limitado  de fagos que utiliza espec\u00edficamente como \nhospedador la cepa HSP40 de Bacteroides fragilis . Este grupo de fagos tiene la propiedad \u00fanica \nde encontrarse exclusivamente en heces humanas y no en las de otros animales. Al parecer, \nlas concentraciones de estos fagos en aguas residuales son relativamente bajas y est\u00e1n pr\u00e1cticamente ausentes en algunas regiones geogr\u00e1ficas (Puig et al. , 1999). Los fagos de \nBacteroides fragilis  HSP40 forman parte de la familia Siphoviridae  y tienen colas flexibles sin \ncapacidad contr\u00e1ctil, DNA bicatenario y c\u00e1psides  de un di\u00e1metro de hasta 60 nm. El segundo \ngrupo de fagos de Bacteroides  utilizados como son hu\u00e9spedes de la cepa RYC2056 de \nBacteroides fragilis . Este grupo abarca una gama sustancialmente m\u00e1s amplia de fagos, los \ncuales est\u00e1n presentes en las heces del ser humano y de muchos otros animales. La concentraci\u00f3n de estos fagos en las aguas residua les es, por lo general, sustancialmente mayor \nque la de los fagos de Bacteroides fragilis  HSP40 (Puig et al. , 1999). Los requisitos nutricionales \ny el car\u00e1cter anaer\u00f3bico del hu\u00e9sped hacen que  la replicaci\u00f3n de estos fagos en el medio \nambiente sea poco probable. Un 10% de la pobl aci\u00f3n presenta niveles de excreci\u00f3n de hasta \n10\n8 UFP/g (Tartera y Jofre, 1987), y en aguas residuales se encuentran concentraciones de <100 \n\u2013 103 UFP/mL. El n\u00famero de UFP de fagos de Bacteroides fragilis  detectados en diferentes \nmuestras ambientales (agua, sedimentos, moluscos bivalvos) es superior al de enterovirus, tanto en valores num\u00e9ricos como en porcent aje de muestras positivas, y se correlaciona \nadecuadamente en muestras de agua residual y agua marina (Tartera et al. , 1988; Jofre et al. , \n1989; Lucena et al. , 1994; Pina et al. , 1998b). El principal inconveniente respecto otros \nmicroorganismos modelos propuestos consiste en que la detecci\u00f3n es baja, lo que supone la \nnecesidad de concentrar grandes vol\u00famenes de  agua para que su detecci\u00f3n sea posible \n(Lucena et al. , 1994). \n  Introducci\u00f3n general \n 29 Enterovirus infecciosos.  Los EV se han utilizado como par\u00e1metro de estudio de la \ncontaminaci\u00f3n v\u00edrica en el ambiente debido a que mayoritariamente pueden aislarse y cuantificarse mediante cultivo celular (Rao et al. , 1986). Su distribuci\u00f3n en el ambiente \ntambi\u00e9n se ha estudiado por t\u00e9cnicas basadas en la detecci\u00f3n del \u00e1cido nucleico, aunque diversos estudios han evidenciado la carencia de correlaci\u00f3n con importantes pat\u00f3genos como \nHAV (Puig et al. , 1994; Pina et al. , 1998b). Algunos autores sugieren la ut ilizaci\u00f3n de los \npoliovirus en la monitorizaci\u00f3n de la contaminaci\u00f3n v\u00edrica en el ambiente, aunque su prevalencia en el ambiente ha ido disminuyendo durante los \u00faltimos a\u00f1os (Pina et al. , 1998b). \nEn cualquier caso, la agencia de protecci\u00f3n am biental de los Estados Unidos (USEPA) describi\u00f3 \na los virus ent\u00e9ricos como el \u00edndice v\u00edrico m\u00e1s si gnificativo, seguro y efectivo en el ambiente \n(Karaganis et al. , 1983). En la directiva europea respecto los ambientes acu\u00e1ticos los \nenterovirus son el \u00fanico grupo de virus que ha sido contemplado en la normativa de aguas de \nba\u00f1os, aunque no ha sido incluido en las \u00faltimas revisiones. \n Adenovirus humanos.  Como se ha ido remarcando a lo la rgo de los diferentes apartados aqu\u00ed \ndiscutidos, los virus se encuentran potencialmen te en todos los ambientes acu\u00e1ticos naturales, \nllegando a concentraciones de 10\n7 \u2013 108 part\u00edculas v\u00edricas por mL, valores que son superiores a \nlos detectados para bacterias (Pina et al. , 1998b). La presencia de HAdV se ha descrito en \naguas de r\u00edo y superficiales (Pina et al. , 1998b; Albinana-Gimenez et al. , 2006; Bofill-Mas et al. , \n2011), agua de mar (Pina et al. , 1998b; Calgua et al. , 2008; Wyn-Jones et al. , 2011), agua de \npiscinas (Papapetropoulou y Vantarakis, 1998; van Heerden et al. , 2005), agua subterr\u00e1nea \n(Kukkula et al. , 1997; Ogorzaly et al. , 2010) y agua potable (van Heerden et al. , 2005; Albinana-\nGimenez et al. , 2006; Albinana-Gimenez et al. , 2009). Adem\u00e1s, est\u00e1 presente en cerca del \n100% de las muestras de agua residual (revisado en Girones et al. , 2010) y se detecta \nfrecuentemente en moluscos bivalvos, incluyendo las muestras que cumplen con la actual \nlegislaci\u00f3n respecto la calidad microbiol\u00f3gica (Formiga-Cruz et al. , 2002; Rigotto et al. , 2010). \nDiversos estudios realizados sugieren la apli caci\u00f3n de HAdV como nuevos indicadores de la \ncontaminaci\u00f3n fecal (Puig et al. , 1994; Pina et al. , 1998b) y recientemente la USEPA los ha \nincluido dentro del listado de contaminantes po tencialmente peligrosos, en base a su elevada \nprevalencia en agua residual, su capacidad de  producir enfermedades y su resistencia a \ntratamiento de depuraci\u00f3n de aguas, especial mente irradiaci\u00f3n por UV. Todos los estudios \nrealizados refuerzan la idea de utilizar los HAdV como indicador de la contaminaci\u00f3n v\u00edrica de origen humano.   Introducci\u00f3n general \n 30 1.4. Evaluaci\u00f3n de riesgos microbiol\u00f3gicos en alimentos \n 1.4.1. Antecedentes  \nLa evaluaci\u00f3n de riesgos microbiol\u00f3gico s (ERM) es un nuevo instrumento para el \nan\u00e1lisis de la seguridad de los suministros de  alimentos y de agua. La Organizaci\u00f3n de las \nNaciones Unidas para la Agricultura y la Alimentaci\u00f3n (FAO) y la Organizaci\u00f3n Mundial de la Salud (OMS) desempe\u00f1an una funci\u00f3n central en la elaboraci\u00f3n y normalizaci\u00f3n de la ERM a \nnivel internacional, a fin de informar acerca de la gesti\u00f3n de riesgos en los alimentos tanto en el \u00e1mbito nacional como internacional (FAO/OMS, 2003). La Comisi\u00f3n Mixta FAO/OMS de Expertos sobre la Aplicaci\u00f3n del An\u00e1lisis de Riesgos para las Normas Alimentarias en 1995 fue el primero en este \u00e1mbito. \u00c9ste perfilaba la terminolog\u00eda b\u00e1sica y los principios de la \nevaluaci\u00f3n de riesgo y concluy\u00f3 que el an\u00e1lisis de riesgo asociado con los peligros \nmicrobiol\u00f3gicos presenta un extraordinario reto. El an\u00e1lisis de riesgos es hoy considerado una parte integral de los procesos de decisi\u00f3n y elaboraci\u00f3n por parte de la Comisi\u00f3n del Codex \nAlimentarius (CCA). La CCA ha adoptado las de finiciones de los conceptos del an\u00e1lisis de \nriesgos relacionados con la inocuidad de los alim entos y la declaraci\u00f3n de principios respecto a \nla funci\u00f3n de la evaluaci\u00f3n de riesgos en materia de inocuidad de los alimentos. En 1999 se adoptaron los principios y directrices para la evaluaci\u00f3n de riesgos microbiol\u00f3gicos (CCA, 1999), elaborados por el Comit\u00e9 del Codex sobre Higiene de los Alimentos (CCFH), que actualmente est\u00e1 trabajando para establecer los principios y directrices de la gesti\u00f3n de riesgos microbiol\u00f3gicos.  \nDesde 1980, cuando se realizaron los primeros estudios del tema, se ha ut ilizado la \nevaluaci\u00f3n cuantitativa del riesgo microbiol\u00f3gico (ECRM) para cuantificar la seguridad \nmicrobiol\u00f3gica en agua de bebida (Haas, 1983; Gerba y Haas 1988; Regli et al. , 1991; Rose et \nal., 1991; Teunis et al. , 1994; Gibson et al. , 1999; Payment et al. , 2000). Estos estudios \ndemostraron que la evaluaci\u00f3n del riesgo, produc to de la contaminaci\u00f3n v\u00edrica tambi\u00e9n, pod\u00eda \nser analizada bajo el paradigma de la ERM. Existen varias razones por las que la ERM est\u00e1 \nemergiendo tambi\u00e9n dentro del \u00e1mbito de la  calidad y seguridad microbiolog\u00eda de los \nalimentos. En primer lugar, los adelantos inform\u00e1ticos est\u00e1n permitiendo desarrollar herramientas potentes para realiz ar los an\u00e1lisis de riesgos necesarios y, en segundo lugar, la \nproducci\u00f3n y distribuci\u00f3n de alimentos ha alcanzado un nivel de complejidad que hace \nextremadamente dif\u00edcil determinar de manera intuitiva los puntos cr\u00edticos de control para \ngarantizar niveles aceptables de carga microbiol\u00f3gica. Introducci\u00f3n general \n 31 Tratando de definir el t\u00e9rmino de manera amplia, podemos considerar que los an\u00e1lisis \nde riesgos son la ciencia del riesgo y de su evaluaci\u00f3n y probabilidad. A unque, el concepto del \nque hablamos es mucho m\u00e1s complejo que esto, ya que comprende los siguientes elementos interconectados (Figura 3): evaluaci\u00f3n de riesgos (evaluaci\u00f3n cient\u00edfica de los efectos adversos conocidos o potenciales en la salud), gesti\u00f3n de riesgos (evaluaci\u00f3n, selecci\u00f3n y aplicaci\u00f3n de alternativas de car\u00e1cter normativo) y comunicaci\u00f3n de riesgos (intercambio de informaci\u00f3n entre todas las partes interesadas). Aunque la  separaci\u00f3n funcional entre estos tres \ncomponentes es importante, hay un reconocimi ento cada vez mayor de la necesidad de \ninteracci\u00f3n entre ellos (FAO/OMS, 2003). \n \nCOMUNICACI\u00d3N DE \nRIESGOSEVALUACI\u00d3N DE \nRIESGOSGESTI\u00d3N DE \nRIESGOS\nCOMUNICACI\u00d3N DE \nRIESGOSEVALUACI\u00d3N DE \nRIESGOSGESTI\u00d3N DE \nRIESGOS\n \n \n \n1.4.2. Evaluaci\u00f3n c uantitativa de riesgos microbiol\u00f3gicos \n \nLa ECRM nos proporciona un marco de trabajo complementario a la epidemiolog\u00eda \npara identificar el riesgo potencial y definir la  ruta de acci\u00f3n sobre un pat\u00f3geno particular \ndesde la fuente al receptor. ECRM traduce la presencia ambiental de los pat\u00f3genos de inter\u00e9s \na una probabilidad de infecci\u00f3n (riesgo microbiol\u00f3gico) a trav\u00e9s del paradigma utilizado para los an\u00e1lisis de riesgos qu\u00edmicos (Haas et al. , 1999), no obstante, la ut ilidad de ECRM depende \nde la calidad, veracidad y uso apropiado de la informaci\u00f3n disponible sobre la frecuencia, \npersistencia y modelos de do sis-repuesta en humanos del mi croorganismo pat\u00f3geno objeto \ndel estudio en el ambiente.  \nLas t\u00e9cnicas utilizadas en los an\u00e1lisis cuantitativos de riesgos se desarrollaron \noriginalmente para la evaluaci\u00f3n del riesgo asociado a la exposici\u00f3n de agentes qu\u00edmicos (NAS, 1983). Cuando empez\u00f3 a utilizarse la ECRM, el marco conceptual de los an\u00e1lisis de riesgos Figura 3.  Interacci\u00f3n de los  componentes b\u00e1sicos de los an\u00e1lisis de riesgos  Introducci\u00f3n general \n 32 qu\u00edmicos fue absorvido y directamente aplicado pa ra evaluar el riesgo microbiol\u00f3gico. En el \ndocumento de la Comisi\u00f3n del Codex Alimentarius CAC/GL-30 (CCA, 1999) se definini\u00f3 la evaluaci\u00f3n de riesgos asociados a los peligros microbiol\u00f3gicos en los alimentos como un proceso con una base cient\u00edfica formado por cuat ro componentes (Figura 4): Identificaci\u00f3n de \npeligros, evaluaci\u00f3n de la exposici\u00f3n, caracteriz aci\u00f3n de peligros y caracterizaci\u00f3n de riesgos. \n \nCARACTERIZACI\u00d3N \nDE PELIGROSEVALUACI\u00d3N DE LA \nEXPOSICI\u00d3NIDENTIFICACI\u00d3N DE \nPELIGROS\nCARACTERIZACI\u00d3N \nDE RIESGOSCARACTERIZACI\u00d3N \nDE PELIGROSEVALUACI\u00d3N DE LA \nEXPOSICI\u00d3NIDENTIFICACI\u00d3N DE \nPELIGROS\nCARACTERIZACI\u00d3N \nDE RIESGOS \n \n \n\u2022 Identificaci\u00f3n de peligros:  En esta fase se debe describir la variedad de pat\u00f3genos que \ndebemos considerar en nuestro an\u00e1lisis  de riesgos. Identificando todas las \ncaracter\u00edsticas del microorganismo y recopilando toda la informaci\u00f3n existente. \n \n\u2022 Evaluaci\u00f3n de la exposici\u00f3n:  Se debe valorar la magnitud de la exposici\u00f3n, el n\u00famero \nde microorganismos consumidos, para ca da evento de riesgo identificado. \n \n\u2022 Caracterizaci\u00f3n de peligros:  En este punto de la evaluaci \u00f3n de riesgos se debe estimar \nla respuesta f\u00edsica (infecci\u00f3n/enfermedad)  de la poblaci\u00f3n estudiada frente a la \nexposici\u00f3n del microorganismo. Se realizar \u00e1 mediante modelos de dosis-respuesta. \n \n\u2022 Caracterizaci\u00f3n de riesgos:  Este apartado engloba los resultados y estudios obtenidos \nen las tres anteriores etapas. Llegados a este punto se calcular\u00e1 la probabilidad de \ninfecci\u00f3n y enfermedad de la poblaci\u00f3 n expuesta al microorganismo pat\u00f3geno \nestudiado. \n  Figura 4.  Componentes de una evaluaci\u00f3n de riesgos microbiol\u00f3gicos  Introducci\u00f3n general \n 33 El objetivo de una evaluaci\u00f3n de riesgos cons iste principalmente en estimar el nivel de \ninfecci\u00f3n y/o enfermedad provocado por un pat\u00f3geno concreto en una poblaci\u00f3n determinada, pero tambi\u00e9n se puede limitar a la evaluaci\u00f3n de una o varias etapas de un \nsistema de producci\u00f3n o elaboraci\u00f3n de alimen tos. Cuando se solicita una evaluaci\u00f3n de \nriesgos, el gestor de riesgos debe ser espec\u00ed fico con respecto al problema que tiene que \nafrontar y las cuestiones que se han de abordar en la evaluaci\u00f3n de riesgos e indicar las medidas que considera oportunas o de las que di spone para la reducci\u00f3n de la enfermedad. \n 1.4.3. Virus en alimentos  \nEn el \u00e1mbito de la alimentaci\u00f3n la ERM se  ha centrado principalmente en pat\u00f3genos \nbacterianos, debido a que los m\u00e9todos dispon ibles para cuantificar virus infecciosos (y \nprotozoos) en alimentos son generalmente m\u00e1s co mplejos o no se dispone de ellos de manera \nrutinaria. Debido a la limitaci\u00f3n de informaci\u00f3 n en este aspecto, en una reuni\u00f3n llevada a cabo \npor expertos del tema concluye ron que la ECRM sigue siendo un tema de estudio prematuro \n(citado en EFSA, 2011). Hasta el momento, se han publicado pocos trabajos basados en ECRM \nen alimentos y virus y los publicados se centran principalmente en NoV, HAV o virus ent\u00e9ricos, \nm\u00e1s ampliamente entendido, en moluscos bivalvos y productos cultivados (Petterson y Ashbolt, 2001; Petterson et al. , 2001; Stine et al. , 2005; Hamilton et al. , 2006; Bouwknegt et \nal., 2009; Mokhtari y Jaykus, 2009; Pinto et al. , 2009; Munoz et al. , 2010). \n  1.5. Virus de la hepatitis A  1.5.1. Historia \n \nLa hepatitis viral es una enfermedad conocida desde la antig\u00fcedad. Las primeras \ndescripciones de epidemias de ictericia se encuentran en la literatura china y en los trabajos de Hip\u00f3crates, que datan del s. V a. de C. La natu raleza infecciosa de la enfermedad tambi\u00e9n se \nreconoci\u00f3 en el s. VIII, cuando el Papa Zacar\u00edas alud\u00eda el car\u00e1cter aparentemente transmisible de la ictericia y la necesidad de mantener apartados a los enfermos.   Durante los s. XVII y XVIII fueron frecuentes las epidemias en Europa entre la poblaci\u00f3n civil y militar. En el s. XIX se especul\u00f3 con que la posible causa de la ictericia era la obstrucci\u00f3n biliar con un tap\u00f3n de moco, por lo que se la llam\u00f3 \u201cictericia catarral\u201d. A principios del s. XX Introducci\u00f3n general \n 34 algunos cient\u00edficos empezaron a sospechar que  el agente infeccioso responsable de la \nenfermedad podr\u00eda ser un virus. Durante esta  \u00e9poca aparecieron evidencias de una segunda \nforma de hepatitis transmitida aparentemente a trav\u00e9s del suero humano: la \u201chepatitis \ns\u00e9rica\u201d. El agente etiol\u00f3gico se denomin\u00f3 viru s de la hepatitis B (HBV). \u00c9sta enfermedad era \nclaramente diferente de la hepatitis infecciosa, llamada hepatitis A, y su agente etiol\u00f3gico se denomin\u00f3 virus de la hepatitis A (Melnick, 1995; S\u00e1nchez-T\u00e1pias, 1995; Ho llinger et al. , 2001). \nLas dos enfermedades se diferenc iaban claramente en el periodo de incubaci\u00f3n (2 \u2013 4 semanas \nen la hepatitis A frente a 1 \u2013 3 meses en la hepati tis B) y en la v\u00eda de transmisi\u00f3n (fecal-oral en \nla hepatitis A y transmisi\u00f3n parenteral /sexual en la hepatitis B), (Hunter et al. , 1997). \n  El virus de la hepatitis A se consigui\u00f3 propagar en primates no humanos en 1967. Estos estudios proporcionaron los primeros datos sobre alteraciones que la infecci\u00f3n produc\u00eda en el \nh\u00edgado (Deinhardt et al. , 1967). \n  En 1973 se consigui\u00f3 visualizar por microscop\u00eda inmunoelectr\u00f3nica part\u00edculas v\u00edricas de 27nm a partir de heces de pacientes, que reaccionaban con un anticuerpo espec\u00edfico \nprocedente de suero de una pe rsona convaleciente (Feinstone et al. , 1973). Esta part\u00edcula se \nidentific\u00f3 como el virus de la hepatitis A. Nume rosos intentos para cultivar el virus sobre l\u00edneas \ncelulares fracasaron. \u00danicamente los modelos animales permit\u00edan obtener virus purificados para poder iniciar estudios gen\u00e9ticos y realizar  pruebas de estabilidad frente a diferentes \nagentes f\u00edsico-qu\u00edmicos. Al mismo tiempo, se comenzaron a desarrollar ensayos que permit\u00edan diagnosticar la enfermedad y que hicieron po sible iniciar estudios seroepidemiol\u00f3gicos. \n  En 1979 se consigui\u00f3 la multiplicaci\u00f3n in vitro de HAV sobre c\u00e9lulas derivadas de h\u00edgado o de ri\u00f1\u00f3n de mono (Provost y Hilleman, 1979). En los \u00faltimos 30 a\u00f1os se ha avanzado \nde forma espectacular en el conocimiento de la hepatitis A y su agente etiol\u00f3gico. Se ha \nconseguido clonar y secuenciar el genoma de HAV (Ticehurst et al. , 1983; Linemeyer et al. , \n1985; Cohen et al. , 1987b; Paul et al. , 1987; Lemon et al. , 1991; Lemon et al. , 1992), se ha \nestudiado su estructura antig\u00e9nica (Lemon et al. , 1991), el mecanismo de replicaci\u00f3n viral \n(Agn\u00e8s et al. , 1994; Bishop y Anderson, 1997a y b), las mutaciones que permiten la adaptaci\u00f3n \nal cultivo in vitro (Cohen et al. , 1987a; Emerson et al. , 1993; Graff et al. , 1994; Zhang et al. , \n1995), y se han realizado estudios epidemiol\u00f3gicos (Jansen et al. , 1990; Papaevangelou, 1992; \nRobertson et al. , 1991 y 1992; Melnick, 1995). La posibilidad de obtener grandes cantidades de \nvirus en l\u00edneas celulares ha permitido la elabor aci\u00f3n de vacunas basadas en virus inactivados y \nse ha evaluado su utilizaci\u00f3n para prevenir la enfermedad (Koff, 1 998; Rosenthal, 1998). Introducci\u00f3n general \n 35 1.5.2. Caracter\u00edsticas moleculares \n  El virus de la hepatitis A est\u00e1 clasificado dentro de la familia Picornaviridae  con un \ng\u00e9nero propio, el g\u00e9nero Hepatovirus . El genoma est\u00e1 constituido por una mol\u00e9cula de RNA \nmonocatenaria lineal de unas 7,5 Kb, de pola ridad positiva. El extremo 5\u2019 est\u00e1 unido \ncovalentemente a una prote\u00edna VPg, y el extrem o 3\u2019 est\u00e1 poliadenilado. En la organizaci\u00f3n \ngen\u00f3mica de HAV se diferencia n tres regiones (Figura 5): \n \n \n \n \n \ni. Regi\u00f3n no codificante del extremo 5\u2019, que  comprende aproximadamente el 10% del \ngenoma. Es la regi\u00f3n m\u00e1s conservada de l genoma, con m\u00e1s de un 92% de identidad \nentre las diferentes cepas (Hollinger et al. , 2001). Contiene el punto de uni\u00f3n al \nribosoma (IRES). \nii. Contiene una \u00fanica pauta de lectura abierta (O RF) que codifica las prote\u00ednas v\u00edricas: en \nla regi\u00f3n P1 est\u00e1n codificadas las prote\u00ednas de la c\u00e1pside, y en la regi\u00f3n P2 y P3 las prote\u00ednas no estructurales. EL RNA gen\u00f3mico codifica una poliprote\u00edna de 2.227 aa (253 kDa) que es procesada para dar lugar a las prote\u00ednas de la c\u00e1pside (VP4, VP3, VP2 y VP1) y a las prote\u00ednas no estructurales (2A, 2B, 2C; 3A, 3B= VPg, 3C= proteasa, 3D= RNA polimerasa). Figura 5.  Organizaci\u00f3n gen\u00f3mica de HAV. El geno ma est\u00e1 compuesto por una cadena de \nRNA de polaridad positiva que contiene una pa uta de lectura abierta que codifica para una \npoliprote\u00edna potencialmente procesable por la proteasa viral 3Cpro. El lugar de anclaje de la \nproteasa en VP1/2A est\u00e1 indicado con una flecha roja. Las prote\u00ednas estructurales (P1) est\u00e1n indicadas en azul, las prote\u00ednas no estructurales (P2 y P3) est\u00e1n indicadas en amarillo y verde, respectivamente (Cristina y Costa-Mattioli, 2007)  Introducci\u00f3n general \n 36 iii. Regi\u00f3n no codificante del extremo 3\u2019, altame nte estructurada y notablemente variable \nentre cepas. \n  Se postula que, a pesar de la variaci\u00f3n gen\u00e9 tica, existen limitaciones estructurales en \nlas prote\u00ednas de c\u00e1pside de HAV que le permit en mantener su estructura antig\u00e9nica sin \nmodificaciones, presentando un \u00fanico serotipo. Sin embargo, se han encontrado variantes \nvirales con modificaciones vinculadas a sitios antig\u00e9nicos, ya sea como parte de la mezcla de variantes de una poblaci\u00f3n heterog\u00e9nea o como  secuencia predominante de un aislamiento \ncl\u00ednico.  1.5.3. Caracter\u00edsticas f\u00edsico-qu\u00edmicas y estabilidad  \n Los viriones son part\u00edculas de 27 \u2013 32 nm de di\u00e1metro con simetr\u00eda icosa\u00e9drica, sin \nenvuelta lip\u00eddica y sin estructuras superficiales (Feinstone et al. , 1973). Morfol\u00f3gicamente no \nse diferencia de los dem\u00e1s picornavirus. Las part \u00edculas presentan una densidad de flotaci\u00f3n de \n1,21 \u2013 1,34 g/cm\n3 en cloruro de cesio, y un coeficiente de sedimentaci\u00f3n de 150 \u2013 160S en \nsoluciones neutras de sacarosa. A partir de susp ensiones fecales o en cultivos infectados se \nhan podido detectar part\u00edculas no infecci osas que podr\u00edan corresponder a proviriones \ninmaduros con o sin RNA (N\u00fcesch et al. , 1989; Bishop y Anderson, 1997a; Polish et al. , 1999). \n  La capacidad de resistencia de HAV frente a diferentes agentes qu\u00edmicos y en condiciones ambientales se describe en la Tabla 7. Es necesario destacar la gran estabilidad de la part\u00edcula v\u00edrica en el ambiente. \n \nTabla 7.  Estabilidad de HAV en diferentes condiciones. \nAgente  Condiciones  Estabilidad  \nTemperatura a 4 \u00baC  semanas -meses  estable  \nDe -20 a -70 \u00baC  a\u00f1os  estable  \n60 \u00baC  1 h mayor\u00eda estable  \nautoclavado  20 min a 121 \u00baC  inactivado  \npH A pH 3  3 h a 25 \u00baC  estable  \nSolventes \u00c9ter, cloroformo, \ntriclorotrifluoroetano --- resistente \nCloro 10 \u2013 15 ppm  30 min  inactivado  \n3 \u2013 10 mg/L  hipoclorito s\u00f3dico  5 \u2013 15 min  inactivado  \nOtros agentes 3% formalina  5 min a 25  \u00baC inactivado  \n30 mg/L yodo  5 min  inactivado  \nRadiaci\u00f3n ultravioleta  197 \u03bcW/cm2 4 min  inactivado  \nCondiciones \nambientales Aguas naturales y residuales, \nsuelos, bivalvos y alimentos d\u00edas-meses mayor\u00eda estable \nDesecaci\u00f3n  a <20 \u00baC durante a\u00f1os  estable  \nSuperf\u00edcies  d\u00edas-meses  estable  \nDatos extra\u00eddos de Peterson et al. , 1983; Ho llinger et al. , 2001. Introducci\u00f3n general \n 37 1.5.4. Diversi dad gen\u00e9tica \n  Los primeros estudios indicaron que la se cuencia de nucle\u00f3tidos de HAV estaba muy \nconservada entre cepas aisladas de diferentes \u00e1reas geogr\u00e1ficas. Sin embargo, la comparaci\u00f3n de la secuencia de nucle\u00f3tidos de la regi\u00f3n VP 1/2A de aislados de origen humano y animal ha \nconducido a la identificaci\u00f3n de m\u00e1s de un centen ar de cepas que se han clasificado en siete \ngenotipos (I \u2013 VII) que difieren en un 15% \u2013 25% , y en subgenotipos que se diferencian en un \n7,5% (Robertson et al. , 1992). En estudios m\u00e1s recientes, Costa-Mattioli et al.  (2002), han \nestablecido relaciones filogen\u00e9ticos utilizando la secuencia completa de VP1 (900 nucle\u00f3tidos). Las conclusiones del trabajo determinan que HAV se debe clasificar en 6 genotipos diferentes, \n3 aislados a partir de humanos (I \u2013 III) y 3 aislados a partir de primates (IV \u2013 VI).  \n Los distribuci\u00f3n geogr\u00e1fica de los diferent es genotipos de HAV detectados a escala \nmundial se describen en la Figura 6. El Genotipo I es el m\u00e1s prevalente en el mundo, y el subgenotipo IA es m\u00e1s com\u00fan que el IB. Ambos subgenotipos son frecuentemente localizables \nen Norteam\u00e9rica, Sudam\u00e9rica, Europa, China y Jap\u00f3n (Robertson et al. , 1992; Costa-Mattioli et \nal., 2001a, b). \n \n \n Figura 6.  Distribuci\u00f3n geogr\u00e1fica de los genotipos de HAV. Los genotipos aislados a partir de \nhumanos est\u00e1n representados en negro y los ge notipos aislados a partir de monos est\u00e1n \nrepresentados en rojo. El genotipo IIIA asilado  e n  p r i m a t e s  a u t \u00f3 c t o n o s  d e  P a n a m \u00e1  e s t \u00e1  \nrepresentado en verde (Cristina y Costa-Mattioli, 2007)  Introducci\u00f3n general \n 38 5.5. Diversi dad serot\u00edpica \n  A pesar de la existencia de diferentes genotipos, existe \u00fanicamente un serotipo del \nHAV causante de la infecci\u00f3n en humanos, y no se han descrito diferencias en el transcurso \ncl\u00ednico de la enfermedad por las diferentes cepas.  1.5.6. Replicaci\u00f3n del virus   Los cambios gen\u00e9ticos por recombinaci\u00f3n homologa y no homologa son un fen\u00f3meno habitual en los virus RNA, permiti\u00e9ndose as\u00ed la generaci\u00f3n de part\u00edculas v\u00edricas defectivas y de \nh\u00edbridos (Lai, 1992; Nagy et al. , 1997). \n \n Una vez que el HAV ha entrado en contacto con la c\u00e9lula diana mediante un receptor \nde membrana especifico, el RNA es traducido a la poliprote\u00edna P1 \u2013 P2 \u2013 P3. Las prote\u00ednas estructurales, VP1, VP2, VP3 y VP4, provienen todas del precursor P1. As\u00ed mismo, las prote\u00ednas no estructurales, incluyendo la prote\u00ednasa (3C) y polimerasa (3D) v\u00edrica, son liberadas a partir de los dominios P2 y P3 de la poliprote\u00edna,  representando la mayor\u00eda de componentes del \ncomplejo replicativo (RC).   Cuando el RC est\u00e1 formado, el RNA v\u00edrico es utilizado como molde para la replicaci\u00f3n, la cual tiene lugar en direcci\u00f3n opuesta a la traducci\u00f3n (Gamarnik y Andino, 1998). Adem\u00e1s de las prote\u00ednas v\u00edricas, es necesaria la formaci\u00f3n de los elementos de replicaci\u00f3n en cis (CRE). Los componentes del virus y del hu\u00e9sped han sido es tudiados mediante sistemas de traducci\u00f3n y \nreplicaci\u00f3n in vitro  (Molla et al. , 1991). \n \nTras la traducci\u00f3n de las prote\u00ednas v\u00edricas, RC  y del CRE, y de la replicaci\u00f3n del genoma \nde HAV, tiene lugar la encapsidaci\u00f3n, maduraci\u00f3n y liberaci\u00f3n de las part\u00edculas v\u00edricas a trav\u00e9s de la membrana celular sin provoc ar un efecto citop\u00e1tico acusado. \n 1.5.7. Epidemiolog\u00eda  \n\u2022 La transmisi\u00f3n tiene lugar persona a persona a trav\u00e9s de la v\u00eda fecal-oral, tanto de un \nmodo directo como indirecto. \n\u2022 Las v\u00edas de transmisi\u00f3n parenteral y sexual no son demasiado frecuentes. Introducci\u00f3n general \n 39 \u2022 No hay ninguna evidencia que nos confirme una transmisi\u00f3n a trav\u00e9s de la saliva o de \nun modo vertical. \n\u2022 Existen brotes epid\u00e9micos asociados a agua o alimentos contaminada en \u00e1reas con \ncondiciones sanitarias deficientes. \n\u2022 La mayor tasa de incidencia de la enfe rmedad se detecta en ni\u00f1os j\u00f3venes. \n\u2022 Se ha observado una  endemicidad c\u00edclica tras la aplicaci\u00f3n de la vacunaci\u00f3n. \n\u2022 Se siguen manteniendo casos aislados de transmisi\u00f3n en poblaciones con una elevada \ndistribuci\u00f3n de la vacuna. \n 1.5.8. Zonas end\u00e9micas y no end\u00e9micas \n \n El nivel de endemicidad de HAV para una poblaci\u00f3n determinada se define en funcion \nde los resultados obtenidos mediante estudios de seroprevalencia que estiman la proporci\u00f3n \nde cada grupo de edad que ha adquirido in mundad frente a HAV, ya sea debido a una \ninfecci\u00f3n o inmunizaci\u00f3n, como queda demostrado por la presencia de anticuerpos IgG anti-\nHAV en suero (WHO, 2000). La hepatitis A es una enfermedad end\u00e9mica (Figura 7). Existen \n\u00e1reas de alta endemicidad: en el centro y su r de Am\u00e9rica, Medio Oriente, Asia y zonas del \nPac\u00edfico occidental. En estas zonas, el 80% de  los ni\u00f1os menores de 10 a\u00f1os, han padecido la \nenfermedad. Se estima que por un d\u00e9ficit en la notificaci\u00f3n, la cantidad de casos reales es \ncinco veces superior a los declarados (Jacobsen y Wiersma, 2010).  \n \n \n Figura 7.  Distribuci\u00f3n geogr\u00e1fica de la prevalencia estimada de HAV en el a\u00f1 o 2005. Very \nLow: prevalencia muy baja; Low: prevalencia baja; Intermediate: prevalencia intermedia; \nHigh: prevalencia alta (extra\u00eddo de Jacobsen y Wiersma, 2010)  Introducci\u00f3n general \n 40  Cuanto m\u00e1s baja es la propagaci\u00f3n del virus,  mas alta la probabilidad de contraer la \ninfecci\u00f3n a edad avanzada. En Sudam\u00e9rica (d e endemicidad moderada, aunque con distinta \nincidencia seg\u00fan las zonas geogr\u00e1ficas) son afect ados ni\u00f1os, adolescentes y adultos j\u00f3venes. \nNo es una enfermedad mortal, pero hay una inci dencia de casos fulminantes que oscila entre \nun 0,1 y 1% (hasta un 3% en mayores de 50 a\u00f1 os), con alta mortalidad o necesidad de \ntransplante hep\u00e1tico.  \nEl virus de la hepatitis A presenta patrones de aparici\u00f3n c\u00edclica, que oscilan con \nincidencias altas o bajas. \u00c9stas est\u00e1n condicionadas por la acumulaci\u00f3n de personas susceptibles y las condiciones socioecon\u00f3micas y medioambientales.  1.5.9. Seroprevalencia \n \n La hepatitis A es una enfermedad de di stribuci\u00f3n mundial, que puede presentarse en \nforma de casos espor\u00e1dicos o bien en brotes  epid\u00e9micos. La tasa de incidencia est\u00e1 \nestrechamente correlacionada con indicadores socioecon\u00f3micos as\u00ed como con ella acceso a agua de consumo segura, en funci\u00f3n del aument o del nivel econ\u00f3mico y de la disponibilidad \nde agua, la incidencia de HAV decrece (Jacobsen y Koopman, 2004; 2005).   Seg\u00fan la prevalencia registrada se pueden diferenciar cuatro modelos epidemiol\u00f3gicos \n(endemicidad alta, intermedia, baja y muy baja) co rrelacionados con la presencia de IgG anti-\nHAV de una regi\u00f3n. La incidencia m\u00e1s alta de infecci\u00f3n por HAV en el mundo se encuentra en pa\u00edses con un nivel sanitario poco desarrollad o, d\u00f3nde podemos observar una exposici\u00f3n \nuniversal durante la infancia y una seroprevalencia superior al 90%. En pa\u00edses en v\u00edas de desarrollo aparece el segundo modelo epidemiol\u00f3 gico, endemicidad intermedia. La incidencia \nen la poblaci\u00f3n infantil es m\u00e1s baja, sero prevalencia del 20% \u2013 30%, lo que produce un \naumento en los adultos j\u00f3venes expuestos a la infecci\u00f3n con manifestaciones cl\u00ednicas \n(Dom\u00ednguez et al. , 1995; Melnick, 1995; Jacobsen y Wiersma, 2010). En pa\u00edses desarrollados \naparece el modelo de endemicidad baja. En est as zonas la enfermedad ocurre principalmente \nen adolescentes, adultos pertenecientes a grupos de riesgo y personas que han viajado a pa\u00edses de endemicidad media o alta. Ocasional mente aparecen brotes asociados al consumo \nde agua o alimentos contaminados (WHO, 2002). La  prevalencia de anticuerpos es baja en la \npoblaci\u00f3n infantil (<10%) y moderada en la poblaci\u00f3n adulta (30% \u2013 70%) (Dominguez et al. , \n1995; Melnick, 1995). El cuarto modelo es exclusivo de pa\u00edses con un nivel socioecon\u00f3mico muy elevado. En estas regiones las infecciones por HAV est\u00e1n desapareciendo. La Introducci\u00f3n general \n 41 seroprevalencia en adultos j\u00f3venes es inferior al  10% y en la poblaci\u00f3n de edad m\u00e1s avanzada \nse sit\u00faa entre el 30 y 60% (Dominguez et al. , 1995).  \n 1.5.10. Profilaxis  \n  Las buenas pr\u00e1cticas de higiene y la restricci\u00f3n de actividades de las personas enfermas que trabajan en la industria alimentaria son fundamentales. Los viajeros a \u00e1reas end\u00e9micas deben ser aconsejados para evitar  la comida poco cocinada, especialmente \nvegetales y mariscos. Aunque ya no son tan ut ilizadas, las inmunoglobulinas proporcionan \nprotecci\u00f3n contra la hepatitis A a trav\u00e9s de la transferencia pasiva de anticuerpos (inmunizaci\u00f3n pasiva). Se utiliza la preparaci\u00f3n intramuscular cuyas \u00fanicas indicaciones son: inmunoprofilaxis previa a la exposici\u00f3n en  viajeros a \u00e1reas end\u00e9micas (idealmente dos \nsemanas antes del viaje), para personas que han ingerido alimentos manipulados por un \npaciente con hepatitis A aguda o para contactos sexuales de pacientes con hepatitis A. Los \nniveles s\u00e9ricos de anticuerpos neutralizantes persisten durante aproximadamente 18 semanas. \nCuando se utiliza para profilaxis previa a la exposici\u00f3n se administra una dosis de 0.02 mL/Kg intramuscular, confiriendo protecci\u00f3n durante 3 meses. Cuando se administra dentro de las \ndos semanas posteriores a la exposici\u00f3n a hepa titis A, a las dosis se\u00f1aladas, la eficacia \nprotectora es del 85%. La eficacia es mayor cuando la inmunoglobulina es administrada \ntemprano en el per\u00edodo de incubaci\u00f3n. Cuando es administrada m\u00e1s tard\u00edamente, s\u00f3lo aten\u00faa \nlos s\u00edntomas de la hepatitis aguda. No se recomienda su utilizaci\u00f3n en personas que son contactos casuales de los pacientes (colegio o trabajo).   En Febrero de 1995 se licenci\u00f3 en los Estados Unidos una vacuna de virus inactivado (Havrix), para uso en personas de m\u00e1s de dos a\u00f1os de edad (CDCP, 1995). La vacuna no est\u00e1 \naprobada para uso en ni\u00f1os menores de dos a\u00f1 os por la preocupaci\u00f3n de que los ni\u00f1os que \npueden haber adquirido anticuerpos de la ma dre podr\u00edan tener una respuesta menor a la \nvacuna (Fiore et al. , 2003). Se recomienda tambi\u00e9n para viajeros a \u00e1reas end\u00e9micas y otros \ngrupos de riesgo. Cada mL de vacuna para adultos contiene 1.440 Unidades ELISA de ant\u00edgeno viral. La dosis recomendada para adultos es de 1 mL intramuscular en el deltoides, y un \nrefuerzo de 1 mL 6 a 12 meses m\u00e1s tarde (Craig et al. , 2004). Los niveles de protecci\u00f3n se \ndetectan en adultos en un 80 a 98% dos seman as despu\u00e9s de la primera dosis y 96% despu\u00e9s \nde un mes (WHO, 2000). Existen otras presentaciones comerciales de vacuna inactivada de hepatitis A que se encuentran disponibles en el mercado, con eficacia equivalente. Las vacunas \nson altamente inmunog\u00e9nicas en personas adultas.  Tras la segunda dosis, pr\u00e1cticamente todas Introducci\u00f3n general \n 42 las personas tienen niveles protectores de anticuerpos. Sin embargo algunos estudios \nmuestran una menor concentraci\u00f3n de anticuerpos en pacientes con el virus de la Inmunodeficiencia Humana (HIV). Entre los varones HIV positivos, los que respondieron a la vacuna ten\u00edan un mayor recuento de linfocitos CD4 comparado a los que no respondieron. Los \nestimados de la presencia de anticuerpos provenie ntes de estudios de ci n\u00e9tica de anticuerpos \nsugieren que los niveles protectores debe r\u00edan durar por lo menos 20 a\u00f1os (Wiens et al. , 1996). \nLa pol\u00edtica de inmunizaci\u00f3n tiene que ser indivi dualizada tomando en cuenta la prevalencia de \nla infecci\u00f3n en la poblaci\u00f3n del sujeto. Indepe ndientemente de la endemicidad, los siguientes \ngrupos deber\u00edan ser vacunados:  \n\u2022 Pacientes con enfermedades hep\u00e1ticas cr\u00f3nicas. \n\u2022 Manipuladores de alimentos. \n\u2022 Trabajadores de centros de cuidado infantiles o pacientes institucionalizados \n(ancianos, pacientes con retraso mental). \n  La medici\u00f3n de anticuerpos anti-HAV prev ia a la vacunaci\u00f3n podr\u00eda ser una medida \nrentable en zonas de endemicidad alta o interm edia, considerando que el costo de la prueba \nes menor que el de las dos dosis de vacuna \n  En Mayo del 2001, la FDA aprob\u00f3 una vacuna combinada para hepatitis A y B (Twinrix). Los componentes antig\u00e9nicos de dicha vacuna han sido utilizados como vacunas separadas \ndurante muchos a\u00f1os como vac unas de hepatitis A y B respectivamente, y su eficacia como \nproducto combinado es comparable a los productos individuales.   1.6. Virus de la Hepatitis E  1.6.1. Historia  \nDesde mediados de la d\u00e9cada de los 50,  se han descrito numerosas epidemias de \nhepatitis v\u00edricas, principalmente en Asia, que se  hab\u00edan atribuido a HAV ya que la enfermedad \nque causa se desarrolla como una hepatitis aguda  cl\u00ednicamente indistinguible de la causada \npor HEV (Emerson y Purcell, 2001). El virus de la hepatitis E se diferenci\u00f3 de HAV cuando en 1980 se realizaron unos estudios serol\u00f3gicos que demostraban que dos brotes de hepatitis agudas en la India (Delhi y Kashemira) estaban causados por un agente etiol\u00f3gico diferente a Introducci\u00f3n general \n 43 HAV (Viswanathan, 1957; Khuroo, 1980; Wong et al. , 1980). Se defini\u00f3 como una nueva forma \nde hepatitis no-A no-B de tran smisi\u00f3n ent\u00e9rica. \u00c9sta nueva form a hepatitis v\u00edrica presentaba \nalgunas caracter\u00edsticas diferenciales respecto la  causada por HAV, como son una mayor tasa de \nindividuos adultos afectados y una elevada t asa de mortalidad en mujeres embarazadas. \n  El agente causal de la HEV fue descrito por primera vez por Balayan y colaboradores en \nel 1983. Balayan desarroll\u00f3 una hepatitis aguda tras ingerir, voluntariamente, un extracto de heces de un animal infectado de hepatitis no-A no-B. Se  generaron anticuerpos que \nreaccionaron con las part\u00edculas v\u00edricas excretadas por el enfermo durante la fase aguda de su infecci\u00f3n. Posteriormente, Balayan consigui\u00f3 infectar monos con el virus, que tambi\u00e9n \nexcretaron el virus en sus heces (Balayan et al. , 1983). \n \n Inicialmente, HEV se clasific\u00f3 dentro de la familia Caliciviridae  ya que comparte \ncaracter\u00edsticas morfol\u00f3gicas, f\u00edsico-qu\u00edmicas y estructurales con los otros miembros (Bradley y Balagan, 1988). El a\u00f1o 1990 se clon\u00f3 y se caracteriz\u00f3 HEV a partir de b ilis de macacos \ncynomolgus  infectados experimentalmente con heces de enfermos de un brote epid\u00e9mico en \nBirmania (Reyes et al. , 1990). Tam et al.  (1991) secuenciaron el genoma completo de esta cepa \nde Birmania a partir de una muestra de hece s contaminada experiment almente. Una segunda \ncepa fue identificada durante un brote en M\u00e9ji co, la secuencia presentaba una similitud del \n76% con la cepa birmana (Huang et al. , 1992). Las dos cepas descritas representan los 2 \nprimeros genotipos identificados de HEV.   A partir de mediados de los a\u00f1os 90 se han acumulado evidencias de la presencia de \nHEV en poblaciones de regiones consideradas no end\u00e9micas (Bader et al. , 1991; Dawson et al. , \n1992; Pina et al. , 2000). En el a\u00f1o 1998, por su escasa relaci\u00f3n filogen\u00e9tica con el resto de \nmiembros de la familia Caliciviridae  (Koonin et al. , 1992; Berke y Matson, 2000), as\u00ed como por \nlas diferencias en el tipo de enzimas replicativos utilizados por HEV (Koonin y Dolja, 1993), han sido exclu\u00eddos de esta familia y clasificados en el genero \u201c HEV-like viruses \u201d (Pringle, 1998). \nActualmente HEV pertenece a la familia Hepeviridae  y es el \u00fanico miembro del g\u00e9nero \nHepevirus . \n  En los \u00faltimos a\u00f1os se ha estudiado la presencia de HEV en diferentes especies animales, y adem\u00e1s de en cerdos dom\u00e9sticos de diferentes \u00e1reas geogr\u00e1ficas del mundo \n(Huang et al. , 2002; de Deus et al. , 2007; Rutjes et al. , 2009; Sakano et al. , 2009), la presencia \ndel RNA de HEV se ha identificado en mangostas procedentes de Okinawa (Jap\u00f3n), en las que Introducci\u00f3n general \n 44 tambi\u00e9n se encontr\u00f3 serolog\u00eda positiva (Nakamura et al. , 2006), en el 4% de los jabal\u00edes \nanalizados en Holanda (Rutjes et al. , 2009), en el 1,1% de los de Jap\u00f3n (Sakano et al. , 2009), y \nen el 19,6% de los de Espa\u00f1a (de Deus et al. , 2008). Del mismo modo, en Asia se han \nsecuenciado genomas de HEV a partir  de muestras de ciervo (Takahashi et al. , 2004). En el a\u00f1o \n2001 Haqshenas y colaboradores identificaron y caracterizaron gen\u00e9ticamente un nuevo virus relacionado con HEV de humanos a partir de muestras de bilis de gallinas que padec\u00edan el s\u00edndrome de hepatomegalia-esplenomegalia, s\u00edndrome emergente en gallinas de Norte \nAm\u00e9rica del que se desconoc\u00edan hasta entonces las causas (Haqshenas et al. , 2001). \n  Adem\u00e1s, y de modo espor\u00e1dico, se ha repo rtado el aislamiento del RNA del virus en \nroedores del valle de Katmand\u00fa, en Nepal (He et al. , 2006), en caballos en Egipto, donde se \nhall\u00f3 una prevalencia de RNA del 4% (Saad et al. , 2007), y en China (Zhang et al. , 2008). Si bien \nestos datos deben tomarse con precauci\u00f3n ya que  intentos posteriores tratando de infectar \nexperimentalmente a ratas o ratones con HEV mostraron resultados contradictorios (Karetny\u00ef et al. , 1993; Maneerat et al. , 1996; Li et al. , 2008). No ha sido posible profundizar m\u00e1s en este \naspecto hasta que Johne et al.  (2010a) identific\u00f3, en heces de una rata capturada en los \nsistemas de alcantarillado sanitario de Hamburgo (Alemania), dos nuevas secuencias \nrelacionas con HEV, mediante la utilizaci\u00f3n de cebadores degenerados dise\u00f1ados sobre el ORF1 de HEV. Tras la secuenciaci\u00f3n completa del genoma de esta nueva HEV, se ha comprado que las secuencias obtenidas distan significativ amente respecto los genotipos conocidos hasta \nla fecha (Johne et al. , 2010b). \n  \n1.6.2. Caracter\u00edsticas moleculares   El genoma de HEV est\u00e1 formado por una \u00fani ca cadena de RNA de orientaci\u00f3n positiva. \nLa longitud var\u00eda entre 7,2 y 7,5 Kb. La mol\u00e9cula  de RNA est\u00e1 poliadenilada en el extremo 3\u2019 \ncarboxiterminal y presenta una cabeza en  el extremo 5\u2019 aminoterminal con una 7-\nmetilguanosina (Kabrane-Lazizi et al. , 1999). El genoma est\u00e1 organizado en 3 pautas de lectura \nabiertas, diferentes y solapadas entre s\u00ed (Figura 8):  \ni. ORF1: localizada en el extremo 5\u2019, es el ORF de mayor tama\u00f1o. Codifica para prote\u00ednas \nenzim\u00e1ticamente activas implicadas, probablemente, en la replicaci\u00f3n viral y el procesamiento proteico. Se han identificado caracter\u00edsticas propias de una metiltransferasa, una ciste\u00edna papain-like , una RNA helicasa y una RNA polimerasa \nRNA-dependiente. Al mismo tiempo, cont iene 2 dominios (X y Y) de funci\u00f3n Introducci\u00f3n general \n 45 desconocida hasta la fecha y una regi\u00f3n hipervariable rica en prolinas. \u00c9stas regiones \nhipervariables se encuentran habitualmente en prote\u00ednas estructurales de los virus, \nfacilit\u00e1ndose as\u00ed la evasi\u00f3n de la respuesta inmune del hu\u00e9sped (Worm et al. , 2002). \nii. ORF2: se localiza pr\u00f3xima al extremo 3\u2019 del genoma y codifica para una prote\u00edna \nestructural. Esta regi\u00f3n es traducida a un precursor con 3 puntos de glicosilaci\u00f3n que \nposteriormente se procesa y probablemente se glicosila (Worm et al. , 2002). Ensayos \nin vitro  sugieren que la prote\u00edna se transloca a trav\u00e9s del ret\u00edculo enoplasm\u00e1tico y es \nexpresada tanto intracelularmente como en la superficie de la c\u00e9lula (Zafrullah et al. , \n1999). \niii. ORF3: est\u00e1 localizado en el centro del genoma de HEV, se caracteriza por estar \nsolapado en el extremo 5\u2019 con el ORF1 y en el extremo 3\u2019 con el ORF2. Codifica una prote\u00edna de 123aa de funci\u00f3n desconocid a. Diferentes est udios postulan que \ndesempe\u00f1a una funci\u00f3n de elemento de an claje de las part\u00edculas v\u00edricas con el \ncitoesqueleto de las c\u00e9lulas hep\u00e1ticas, actuando como elemento importante en el proceso de ensamblaje de las part\u00edculas v\u00edricas (Zafrullah et al. , 1997). \n \n \n \n \n \n \n \n Figura 8.  Organizaci\u00f3n del genoma de HEV en tres ORF o pautas abiertas de lectura. Los \ndominios identificados en el ORF1 son: un do minio metiltransferasa (MT), un dominio Y (Y), \nun dominio de proteasa papain-like  (Pro), una regi\u00f3n hipervariable rica en prolinas (H), una \ndominio X (X), un dominio helicasa (Hel) y un dominio RNA polimerasa RNA-dependiente (Pol). En el ORF2 podemos observar 3 puntos potenciales de glicosilaci\u00f3n (\n*) y en ORF3 se \nha identificado un punto potencial de fosforilaci\u00f3n ( \u2666) (Purcell y Emerson, 2008)  Introducci\u00f3n general \n 46 1.6.3. Caracter\u00edsticas f\u00edsico-qu\u00edmicas y estabilidad \n  El viri\u00f3n de HEV presenta una estructura  icosa\u00e9drica de 27 \u2013 34 nm de di\u00e1metro. \nForma part\u00edculas v\u00edricas sin envuelta lip\u00eddic a con un coeficiente de sedimentaci\u00f3n de \naproximadamente 183S. Se han detectado part\u00edculas de virus que sedimentan a 165S, pero se piensa que son defectivas. La densidad en gradient e de tartrato de potasio y glicerol es de 1,29 \ng/mL (Purcell y Emerson, 2001).   En condiciones de laboratorio HEV es bastante l\u00e1bil. Se puede observar la \ndesintegraci\u00f3n del virus durante la centrifugaci\u00f3n  para la obtenci\u00f3n de los gradientes de CsCl, \nya que es extremadamente sensible a las altas concentraciones salinas utilizadas (Tam et al. , \n1997). Es necesario el mantenimiento de temper aturas tan bajas como sea posible, aunque se \ndegrada f\u00e1cilmente en procesos de congelaci\u00f3n y descongelaci\u00f3n (Yarbough, 1999). Tambi\u00e9n \nse ha descrito cierta sensibilidad a enzimas proteol\u00edticas (Bradley, 1992; Bradley, 1994; Ticehurst, 1999). Los desinfectantes yodados y el autoclave destruyen los virus (Ticehurst, 1999).   Se ha observado que los viriones se mantie nen inalterables despu\u00e9 s de la exposici\u00f3n a \ntrifluorotricloroetanos (Purcell y Emerson, 2001) . El tipo de transmisi\u00f3n que le caracteriza \n(fecal-oral) sugiere que tambi\u00e9n es relativamente estable en pH \u00e1cidos y b\u00e1sicos medios (Harrison, 1999; Purcell y Emerson, 2001), la presen cia de los virus en agua residual indica que \nes capaz de sobrevivir en el medio ambiente (H arrison, 1999). En experimentos en los que se \nha dopado agua residual con una concentraci\u00f3n conocida de HEV y en los que se ha mantenido la temperatura en 20 \u00baC, se ha observado una T\n90 de 20 d\u00edas y una T 99 de 39 d\u00edas usando RT-\nPCR (Pina et al. , 1998a). En estudios recientes se ha evaluado que una cocci\u00f3n de 56 \u00baC \ndurante 1 hora no es suficiente para inactiva r el virus presente en determinados alimentos \n(Feagins et al. , 2007). \n \n1.6.4. Diversi dad gen\u00e9tica \n  Si no consideramos la regi\u00f3n hipervariable contenida en el ORF1, el genoma de HEV es \nrelativamente estable (Arankalle et al. , 1999). La gran mayor\u00eda de las variaciones que podemos \nobservar a nivel del RNA representan substituciones que no provocan cambios en la secuencia de aa (Yarbough et al. , 1991; Worm et al. , 2002). \n Introducci\u00f3n general \n 47  Se ha observado que la similitud nucleot \u00eddica de las secuencias aisladas durante un \nbrote epid\u00e9mico es elevada, aunque podemos en contrar mutaciones puntuales entre las cepas \npresentes. Debido a que la deriva  gen\u00e9tica no es un factor importante en la evoluci\u00f3n de HEV, \npodemos confirmar que las diferencias no re presentan m\u00e1s que poblaciones concretas del \nvirus (Aggarwal et al. , 1999; Arankalle et al. , 1999). Tambi\u00e9n se han observado diferencias \ngeogr\u00e1ficas donde las diferentes secuencias aisladas presentan, habitualmente, m\u00e1s variaciones entre ellas que entre las secuencias de cepas de una misma zona. Estas diferencias \nrepresentan substituciones silenciosas, \u00fanicamente las localizadas en la regi\u00f3n hipervariable del ORF1 presentan una diversidad  aminoac\u00eddica importante (Worm et al. , 2002). \n  La clasificaci\u00f3n por genotipos m\u00e1s acepta da est\u00e1 basada en estudios de Worm et al.  \n(2002) y se define a un genotipo como un conjunto de virus con una divergencia nucleot\u00eddica \ni n f e r i o r  a l  2 0 %  e n  l a  r e g i \u00f3 n  O R F 2 .  E n  f u n c i \u00f3 n  de este criterio, las diferentes cepas de HEV \nhumanas se clasifican en 4 grandes genotipo s. El genotipo 1 (cepas africanas y asi\u00e1ticas) \npresenta una diversidad muy baja. El genotipo 2 est\u00e1 formado por la cepa Mejicana y algunos \naislados de Nigeria. EL genotipo 3 lo forman  las cepas norteamericanas, europeas, japonesas y \nargentinas. El genotipo 4 est\u00e1 formado por ce pas chinas y japonesas (Figura 9). Adem\u00e1s de los \n4 genotipos mencionados, el genotipo aisl ado en 2001 que infecta a aves (Haqshenas et al. , \n2001) se ha clasificado posteriormente como representante del genotipo 5.  \n \n \n Figura 9.  Distribuci\u00f3n geogr\u00e1fica de cada uno de los genotipos de HEV que i nfecta a \nhumanos (Purcell y Emerson, 2008)  Introducci\u00f3n general \n 48  Las cepas de los virus de HEV de origen animal descritas a partir de los a\u00f1os 90 \nconfirman la hip\u00f3tesis de una posible zoonos is responsable de los casos espor\u00e1dicos de \nhepatitis E en humanos en regiones no end\u00e9mic as. Se ha observado que las secuencias de las \ncepas de origen porcino aislados en una determinada regi\u00f3n son muy similares a las secuencias aisladas a partir de muestras cl\u00ednicas de pacientes humanos con hepatitis agudas (Meng et al. , 1997; Hsieh et al. , 1999; Pina et al. , 2000; Okamoto et al. , 2001). Hasta la fecha, \nse han identificado cepas de HEV de origen porcino pertenecientes a los genotipos 3 y 4.  1.6.5. Diversi dad serot\u00edpica \n  Las diferencias entre cepas de HEV se limitan a la secuencia de nucle\u00f3tidos. Las secuencias aminoac\u00eddicas de las cepas de los diferentes genotipos est\u00e1n altamente \nconservadas, apoyando la teor\u00eda m\u00e1s generaliz ada de la existencia de un \u00fanico serotipo \n(Tsarev et al. , 1999). \u00danicamente se observan ciertas diferencias serol\u00f3gicas al expresar \nantigenos del ORF3 (Yarbough et al. , 1991). \n  Las part\u00edculas v\u00edricas de un genotipo determinado reaccionan con los anticuerpos generados durante la infecci\u00f3n producida por cualquiera de los otros genotipos descritos \n(Yarbough, 1999). Experimentos cruzados con diversas cepas de HEV en primates han \nmostrado protecci\u00f3n cruzada a la infecci\u00f3n (Bradley et al. , 1987; Worm y Wirnsberger, 2004). \n 1.6.6. Replicaci\u00f3n del virus   Debido a que la replicaci\u00f3n de HEV en cultivo celular es poco eficiente y debido a que este pat\u00f3geno no est\u00e1 relacionado con ning\u00fan ot ro virus bien caracterizado, se conoce muy \npoco sobre su estrategia de replicaci\u00f3n. Los mecanismos de adhesi\u00f3n y entrada son \ndesconocidos, aunque se asume que el virus se  une a receptores de los hepatocitos y de \nc\u00e9lulas del tracto biliar y del intestino. \n A pesar de lo poco que se conoce, la propuesta de modelo de replicaci\u00f3n m\u00e1s \naceptada est\u00e1 basada en motivo s conservados de dominios no estructurales y analog\u00edas entre \nHEV y otros virus con genomas formados por RNA de cadena positiva (Reyes et al. , 1993). Los \nhepatocitos son c\u00e9lulas diana por excelencia pa ra HEV, pero estudios con ratas inoculadas \nexperimentalmente con una cepa de HEV de or igen humano han permitido identificar otras \nposibles dianas, como los monocitos de sangre pe rif\u00e9rica, el bazo, los n\u00f3dulos linf\u00e1ticos y las Introducci\u00f3n general \n 49 c\u00e9lulas del intestino delgado (Maneerat et al. , 1996). \n Recientemente se ha desarrollado un sistema de cultivo celular de HEV a partir de una \nsuspensi\u00f3n fecal con una elevada carga v\u00edrica (10\n7 GC/mL). El experimento descrito se ha \nrealizado sobre dos tipos de c\u00e9lulas (PLC y PRF/ 5) y se ha utilizado una cepa del genotipo 3 \n(JE03 \u2013 1760F), (Tanaka et al. , 2007). \n 1.6.7. Epidemiolog\u00eda   Las caracter\u00edsticas epidemiol\u00f3gicas de la infecci\u00f3n por HEV son las descritas a continuaci\u00f3n (Mast y Krawczynski, 1996; Worm et al. , 2002): \n \n\u2022 Transmisi\u00f3n fecal-oral. \n\u2022 Brotes epid\u00e9micos asociados a agua contaminada en \u00e1reas con condiciones sanitarias \ndeficientes. \n\u2022 Mayor tasa de afectados entre j\u00f3venes adultos de entre 15 y 40 a\u00f1os. \n\u2022 Mayor tasa de mortalidad en mujeres emba razadas (especialmente durante el 3r \ntrimestre). \n\u2022 Baja seroprevalencia (IgG anti-HEV) en zo nas con brotes y casos espor\u00e1dicos de \nhepatitis E. \n\u2022 Baja tasa de transmisi\u00f3n por contacto persona-persona. \n\u2022 Ausencia de secuelas o cronicidad. \n 1.6.8. Zonas end\u00e9micas y no end\u00e9micas  \nEl virus de la hepatitis E causa grandes epidemias, principalmente en regiones \ntropicales y subtropicales de \u00c1sia, \u00c1frica y Am\u00e9rica Central (Kumar et al. , 2007) (Figura 10). Es \nel responsable de m\u00e1s del 50% de las hepatitis agudas virales que tienen lugar en pa\u00edses en \ndesarrollo, considerados como end\u00e9micos para  HEV (Yarbough, 1999). En estas regiones \nprovoca casos espor\u00e1dicos de hepa titis y brotes epid\u00e9micos. Los brotes suelen asociarse con el \nconsumo de agua contaminada fecalmente. (Sch lauder y Mushahwar, 2001). La mayor\u00eda de los \nbrotes tienen lugar en zonas rurales y son poco s los individuos que se ven afectados, pero en \notras ocasiones, los brotes se convierten en verdaderas epidemias.   Introducci\u00f3n general \n 50  La enfermedad tiene lugar principalmente en regiones o situaciones donde la \ncontaminaci\u00f3n fecal de las fuentes de suministro de agua es algo habitual. Tambi\u00e9n es t\u00edpico detectar brotes tras desastres naturales o desp lazamientos masivos de refugiados. Adem\u00e1s de \nlos brotes epid\u00e9micos, HEV es tambi\u00e9n responsable  de hepatitis espor\u00e1di cas, incluso en zonas \nque no se consideran propiamente end\u00e9micas (Worm et al. , 2002). \n  Las regiones industrializadas son las cons ideradas habitualmente como regiones no \nend\u00e9micas y donde HEV causa \u00fanicamente casos espor\u00e1dicos. Hasta fechas muy recientes, \nestos casos aislados se atribu\u00edan a cepas impo rtadas de regiones end\u00e9micas (Balyan, 1997; \nAggarwal y Krawczynski, 2000). Con la detecci\u00f3n de cepas de HEV en pa\u00edses desarrollados a partir de muestras cl\u00ednicas de pacientes sin historial de viajes a zonas de riesgo y a partir de muestras ambientales, se ha planteado la posibilidad de la existencia de cepas aut\u00f3ctonas \npropias de regiones donde la prevalencia de l as infecciones por HEV podr\u00eda ser superior a la \nconsiderada tradicionalmente (Pina et al. , 1998a; Jameel, 1999). \n \n \n \n \n1.6.9. Seroprevalencia \n \nPodemos encontrar anticuerpos contra HEV en  casi todas las regiones del planeta. \n\u00c1frica y Asia son regiones consideradas end\u00e9 micas, los valores de seroprevalencia entre \nindividuos sanos son m\u00e1s elevados que los corresp ondientes a individuos sanos de las regiones \nindustrializadas. En general se observa que los valores de seroprevalencia en las zonas Figura 10.  Distribuci\u00f3n geogr\u00e1fica de HEV. Podemos observar las zonas donde se localizan \nepidemias y casos espor\u00e1dicos (Kumar et al. , 2007)  Introducci\u00f3n general \n 51 end\u00e9micas est\u00e1n entre un 3% y un 26%, valores inferiores a lo esperado hipot\u00e9ticamente \n(Purcell y Emerson, 2001). En menores de 10 a\u00f1os la presencia de IgG anti-HEV es poco usual, mientras que los niveles aumentan hasta un 10% \u2013 40% entre adultos mayores de 25 a\u00f1os (Arankalle et al. , 1995). Un patr\u00f3n diferente se ha descrito recientemente en Egipto y la India, \ndonde los niveles de IgG anti-HEV en ni\u00f1os meno res de 5 a\u00f1os son superiores al 60% (Aggarwal \net al. , 1997; Fix, 2001). \n \n En pa\u00edses industrializados de Europa y de  Norteam\u00e9rica, los valores de IgG anti-HEV \noscilan entre un 1 y un 5% (Paul et al. , 1994). En Espa\u00f1a, la seroprevalencia detectada en un \nestudio con 76 individuos sanos fue del 5,5% (Buti et al. , 1995), mientras que en donantes de \nsangre es de un 2,8% (Mateos et al. , 1999). En Catalu\u00f1a, se ha observado una seroprevalencia \ndel 7,3% en un estudio donde se han analizado muestras de 1.280 personas (Buti et al. , 2006). \n \n1.6.10. Profilaxis   Hervir el agua antes de beberla durante las epidemias de hepatitis E ha demostrado \nreducir la transmisi\u00f3n de la enfermedad. Los viajeros a zonas end\u00e9micas, y especialmente las \nmujeres gestantes en el \u00faltimo trimestre, debe n evitar ingerir comida no cocinada y beber \nagua potencialmente contaminada. Las pr eparaciones de inmunoglobulinas no son \nprotectoras, a\u00fan cuando provienen de suer os de personas de \u00e1reas end\u00e9micas (Wald et al. , \n1995).   En Nepal, se est\u00e1 trabajando en un ensayo en fase II con una vacuna recombinante para HEV generada mediante la expresi\u00f3n del OR F2 en baculovirus. Se ha demostrado que la \nvacuna es segura y muy eficaz, no obstante, el ensayo incluye \u00fanicamente individuos adultos \ndel g\u00e9nero masculino, de manera  que no se puede garantizar que sea eficaz para mujeres y \nni\u00f1os (Shrestha et al. , 2007). Recientemente, Zhu et al.  (2010) ha presentado un trabajo donde \nse incluyen m\u00e1s de 110.000 person as, describiendo un ensayo en fase III de otra vacuna \nrecombinante expresada en E. coli . El trabajo presenta una efectividad de m\u00e1s del 99%, \naunque tampoco incluye ni\u00f1os ni mujeres embarazadas. Aunque los ensayos actuales son prometedores, actualmente no se cuenta  con una vacuna para HEV disponible \ncomercialmente.   \n Introducci\u00f3n general \n 52 1.7. Norovirus humanos \n \n1.7.1. Historia \n \nEn 1929, Zahorsky describi\u00f3 la presencia de una enfermedad caracterizada por una \ndiarrea autolimitada acompa\u00f1ada  por n\u00e1useas, v\u00f3mitos y dolor abdominal, t\u00edpica durante los \nmeses de invierno, por lo que se la nombr\u00f3 c\u00f3mo la enfermedad de v\u00f3mitos invernales \n(Zahorsky, 1929). No obstante, no fue hasta el 1972 cuando Kapikian et al.  descubrieron la \netiolog\u00eda de este s\u00edndrome tan ampliamente reportado. Mediante inmuno-microscop\u00eda \nelectr\u00f3nica examinaron las heces de voluntarios inoculados con filtrados fecales procedentes de un grupo de estudiantes de una  escuela de primaria en Norwalk (Ohio, Estados Unidos) que \nhab\u00edan padecido un brote de gastroenteritis en 1968 (Adler y Zickl, 1969; Kapikian et al. , 1972). \nObservaron unas part\u00edculas v\u00edricas peque\u00f1as y de  aspecto redondeado, a las que denominaron \nvirus Norwalk, que actualmente est\u00e1 considerad o como el prototipo del g\u00e9nero Norovirus. \nUno de los avances m\u00e1s importantes se constituy\u00f3 en 1990 mediante la clonaci\u00f3n del genoma del virus Norwalk (Xi et al. , 1990), ya que permiti\u00f3 aplicar t\u00e9cnicas de RT-PCR y de \nsecuenciaci\u00f3n para el estudio de estos virus, reconociendo as\u00ed la magnitud de la enfermedad \nproducida por NoV.  1.7.2. Caracter\u00edsticas moleculares  \nEl g\u00e9nero norovirus pertenece a la familia Caliciviridae  junto con los g\u00e9neros Sapovirus , \nLagovirus  y Vesivirus , recientemente se ha propue sto la inclusi\u00f3n del g\u00e9nero Nebovirus  (Patel \net al. , 2009). Su genoma est\u00e1 constituido por una \u00fanica mol\u00e9cula de RNA de cadena simple y \nsentido positivo, de un tama\u00f1o aproximado de 7,5 kb, que contiene tres pautas abiertas de \nlectura (ORF1 \u2013 ORF3) que codifican los genes no estructurales y estructurales. En el extremo \nterminal 5\u2019 podemos observar una prote\u00edna v\u00ed rica unida covalentemente (VPg), mientras que \nen el extremo 3\u2019 podemos encontrar una cola poliadenilada (polyA). El ORF1 es traducido en una poliprote\u00edna que ser\u00e1 digerida por una proteasa v\u00edrica (PRO) para dar lugar a seis otras prote\u00ednas: p48, nucle\u00f3sido-trifosfatasa (NTPase), VPg, una RNA polimerasa RNA-dependiente (POL) y la propia proteasa v\u00edrica. Dichas prote\u00ednas no estructurales intervienen en los procesos de copia del RNA de polaridad positiva (+) a un RNA de polaridad negativa (-) que ser\u00e1 utilizado \ncomo cadena molde para generar un RNA subgen\u00f3mico (+) de unas 2,8 kb. \u00c9ste RNA \nsubgen\u00f3mico ser\u00e1 traducido para producir la pr ote\u00edna mayoritaria de la c\u00e1pside (VP1) y unas \npocas mol\u00e9culas de la prote\u00edna secundaria de la c\u00e1pside (VP2), que finalmente se Introducci\u00f3n general \n 53 autoensamblar\u00e1n generando las part\u00edculas v\u00edricas (Figura 11). \n \n \n \n \n1.7.3. Caracter\u00edsticas f\u00edsico-qu\u00edmicas y estabilidad  \nLos norovirus son virus peque\u00f1os, con un di\u00e1metro aproximado de 38 nm, no \nenvueltos e icosa\u00e9dricos. La c\u00e1pside contiene 90 d\u00edmeros de VP1, formando una cubierta de la \ncu\u00e1l salen 90 caps\u00f3meros a modo de protubera ncias de forma arqueada. Dichos caps\u00f3meros \nse encuentran dispuestos de tal manera que forman 32 cavida des en la superficie de la \npart\u00edcula viral. La autoordenaci\u00f3n  de la prote\u00edna VP1 en pseudo-part\u00edculas virales (VLP) es un \nproceso eficiente que no requiere ni del RNA ni  de la prote\u00edna menor VP2. La estructura \nat\u00f3mica de NoV se ha determin ado mediante cristalograf\u00eda con rayos X, defini\u00e9ndose dos \ndominios principales en VP1, la cubierta (S) y la  protuberancia (P). El dominio S forma la parte \ninterna de la c\u00e1pside que envuelve al genoma de RNA y el dominio P forma las protuberancias de estructura arqueada que surgen de la cubi erta y que contienen los d\u00edmeros de VP1. El \ndomino S est\u00e1 relativamente bien conservado, mientras que el dominio P, unido al S, se corresponde a la fracci\u00f3n C-terminal de la VP1 y es de naturaleza m\u00e1s variable. El dominio P se \nencuentra dividido en el subdominio P1 y el s ubdominio P2, \u00e9ste \u00faltimo se corresponde a la \nregi\u00f3n VP1 con mayor variabilidad secuencial y confiere especificidad antig\u00e9nica y de uni\u00f3n a \nreceptores (Tan et al. , 2003; Lochridge et al. , 2005) (Figura 12). \n Figura 11.  Organizaci\u00f3n gen\u00f3mica de norovirus. Podemos observar la disp osici\u00f3n de las \npautas abiertas de lectura (ORF1-3), prote\u00ednas no estructurales (p48, NTPase, p22, VPg, \nPRO y POL), prote\u00ednas estructurales (VP1 y VP2), RNA (+) y (-), y RNA subgen\u00f3mico (+), as\u00ed como dos ilustraciones de part\u00edculas v\u00edricas observadas con el microscopia electr\u00f3nico de transmisi\u00f3n. Las part\u00edculas con el interior oscuro carecen del genoma (part\u00edculas \ndefectivas), la coloraci\u00f3n oscura es debida a la  penetraci\u00f3n de la tinc i\u00f3n negativa (extra\u00eddo \nde Glass et al. , 2009)  Introducci\u00f3n general \n 54 \n \n \n \nLos NoV son estables dentro de un amplio rango de temperaturas, sobreviven a la \ncongelaci\u00f3n, la refrigeraci\u00f3n y al calentam iento hasta 60 \u00b0C durante  30 minutos. Se pueden \nencontrar en una gran variedad de superficie s, que si no se desinfectan adecuadamente \nconstituyen un reservorio impo rtante durante los brotes, es pecialmente si hablamos de \nentornos cerrados c\u00f3mo los hospitales, geri\u00e1tricos o cruceros. La infectividad de NoV se mantiene tras estar 3 horas en pH 2,7 o trat\u00e1n dolo con \u00e9ter al 20%, ambos experimentos se \nrealizaron a temperatura ambiente. Adem\u00e1s, re siste el tratamiento con hipoclorito s\u00f3dico \nentre 3,75 \u2013 6,25 g/L (cloro libre  residual 0,5 \u2013 1,0 mg/L) (Dolin et al. , 1972; Barker et al. , 2004; \nDuizer et al. , 2004a). \n 1.7.4. Diversi dad gen\u00e9tica \n \nEl g\u00e9nero NoV presenta una elevada variabilidad gen\u00e9tica que se explica por \nmutaciones puntuales y por recombinaci\u00f3n entr e diferentes fragmentos hom\u00f3logos de RNA \nque, por coinfecci\u00f3n, hayan entrado en una mism a c\u00e9lula. La clonaci\u00f3n del genoma de NoV, \nadem\u00e1s de la ya mencionada aplicaci\u00f3n de las t\u00e9cnicas de PCR, permiti\u00f3 expresar in vitro  \nprote\u00ednas v\u00edricas en sistemas de expresi\u00f3n en procariotas y eucariotas. Bas\u00e1ndose en estas t\u00e9cnicas, se han clasificado los NoV en cinco genogrupos con 29 genotipos o clusters , definidos \npor tener al menos un 80% de iden tidad de los aa sobre la secuencia total de la c\u00e1pside (Ando \net al. , 2000; Zheng et al. , 2006) (Figura 13). Las cepas que infectan a los seres humanos Figura 12.  Estructura de la c\u00e1pside v\u00edrica de norovirus. La figura muestra la estructura \nicosa\u00e9drica constituida por 180 mol\u00e9culas (90 d\u00edmeros) de la prote\u00edna estructural VP1. El \nc\u00f3digo de colores representa los dominios S y P (subdominios P1 y P2). El recuadro \ndelimitado por una l\u00ednea discontinua muestra un lugar de uni\u00f3n receptores (extra\u00eddo de \nGlass et al. , 2009)  Introducci\u00f3n general \n 55 pertenecen a los genogrupos I, II y IV, mientras  que a los genogrupos III y V pertenecen a cepas \nque infectan animales, ganado bovino y ratone s, respectivamente. L as cepas dentro de un \ngenotipo se pueden subdividir en variantes seg \u00fan las secuencias y los an\u00e1lisis filogen\u00e9ticos \n(Zheng et al. , 2006). \n \n \n \n \n1.7.5. Replicaci\u00f3n del virus  \nEn primer lugar, el viri\u00f3n debe interaccionar con la c\u00e9lula hu\u00e9sped mediante \nreceptores espec\u00edficos. Se postula que la part \u00edcula v\u00edrica penetra y seguidamente el RNA es \nliberado al citoplasma. Estas primeras interacciones no se conocen en detalle, pero se sabe que el reconocimiento del receptor es esencial para que se produzca el ciclo vital de NoV. La \ntraducci\u00f3n inicial del genoma introducido est\u00e1 mediado por interacciones entre la prote\u00edna VPg ligada al genoma con los mecanismos de traducci\u00f3n de la c\u00e9lula. Una vez trascrito el ORF1 para producir la poliprote\u00edna no-estructural, la proteasa v\u00edrica la escindir\u00e1 en varios puntos de \nrestricci\u00f3n y se convertir\u00e1 en distintos precursores y productos. Se inicia la s\u00edntesis de una hebra RNA complementaria (-) a partir de la estructura del RNA gen\u00f3mico empezando por el \nextremo 3\u2019 de la hebra de RNA con sentido positivo y con implicaci\u00f3n de prote\u00ednas celulares \n(Gutierrez-Escolano et al. , 2003). Este RNA de sentido negativo servir\u00e1 a su vez como molde Figura 13.  Clasificaci\u00f3n de norovirus en 5 genogrupos (GI  \u2013 GV) y 32 genotipos. El \u00e1rbol \nfilogen\u00e9tico se basa en la secuencia de aminoac\u00eddica completa de VP1 (Glass et al. , 2009)  Introducci\u00f3n general \n 56 para transcribir m\u00e1s RNA gen\u00f3mico y subgen\u00f3mic o de sentido positivo que a su vez servir\u00e1 \npara codificar la s\u00edntesis de las prote\u00ednas estructurales VP1 y VP2.  1.7.6. Epidemiolog\u00eda  \nLa v\u00eda de transmisi\u00f3n m\u00e1s importante es a tr av\u00e9s del contacto fecal-oral y a trav\u00e9s de \nlos v\u00f3mitos, ya sea por contacto directo o mediante aerosoles. Un n\u00famero muy bajo de \npart\u00edculas (10 \u2013 100) son suficientes para que una persona susceptible pueda infectarse (Parashar et al. , 2001; Evans et al. , 2002; Marks et al. , 2003). La susceptibilidad a la \nenfermedad es universal y se da en personas de  cualquier edad. La mayor\u00eda de individuos se \nhan infectado con NoV alguna vez antes de llegar a la edad adulta. Estudios que se han llevado \na cabo en pa\u00edses desarrollados indican que la presencia de anticuerpos, tanto frente al \ngenogrupo I como al genogrupo II, aumenta gr adualmente con la edad, aunque actualmente \nes superior para el genogrupo II (Green et al. , 2002). \n 1.7.7. Sintomatolog\u00eda cl\u00ednica  \nEl per\u00edodo de incubaci\u00f3n m\u00e1s habitual es de 24 a 48 horas y la trasmisi\u00f3n es m\u00e1xima \ndurante este periodo. Los individuos infectados tienen una probabilidad elevada de transmitir la infecci\u00f3n a sus contactos domiciliarios o muy cercanos, por lo que en brotes de exposici\u00f3n \u00fanica son frecuentes los casos secundarios. La en fermedad se caracteriza cl\u00ednicamente por la \naparici\u00f3n brusca de n\u00e1useas (79%), v\u00f3mitos ( 69%), diarrea no sanguinolenta (66%), fiebre \n(37%) y dolor abdominal (30%) (Kaplan et al. , 1982b). Los v\u00f3mitos son muy frecuentes en los \nni\u00f1os mayores de 1 a\u00f1o, mientras que en los lact antes se suele desarrollar s\u00f3lo diarrea (Kaplan \net al. , 1982a). Estos s\u00edntomas pueden persistir en pacientes hospitalizados y en ni\u00f1os menores \nde 11 a\u00f1os, entre 4 y 6 d\u00edas. Se han descrito c asos graves asociados a enterocolitis necrosante \n(Turcios-Ruiz et al. , 2008) y fallecimientos de pacientes de edad avanzada en brotes en \nresidencias de ancianos (Chadwick et al. , 2000). La gravedad de la enfermedad, comparada \ncon la diarrea por rotavirus, parece ser ligera mente menor en estudios basados en pacientes \nextrahospitalarios, mientras que, en ni\u00f1os hospit alizados, posee una gravedad similar (Sakai et \nal., 2001). Se ha descrito la persistencia de infecci\u00f3n con s\u00edntomas durante m\u00e1s de 1 a\u00f1o en \npacientes pedi\u00e1tricos oncol\u00f3gicos (Simon et al. , 2006) y en adultos inmunodeprimidos (Nilsson \net al. , 2003). \n  Introducci\u00f3n general \n 57 1.7.8. Inmunidad \n  Estudios realizados con voluntarios de mostraron que los individuos infectados \ndesarrollan una respuesta inmuni taria despu\u00e9s de la infecci \u00f3n, aunque de corta duraci\u00f3n \n(entre 6 y 14 semanas) (Parrino et al. , 1977; Jonson et al. , 1990). Contrariamente a lo \nesperado, estos estudios tambi\u00e9 n demostraron que los individuos con t\u00edtulos m\u00e1s elevados de \nanticuerpos s\u00e9ricos o de coproanticuerpos ten\u00edan m\u00e1s probabilidad de infectarse con el virus que las personas con concentraciones bajas de anti cuerpos. Este hecho se explica porque las \npersonas sin anticuerpos frente a una cepa determinada de NoV no son gen\u00e9ticamente susceptibles a ella. Tambi\u00e9n se observ\u00f3 que individuos que fueron sintom\u00e1ticos pod\u00edan \nreinfectarse cuando se les volv\u00eda a inocul ar NoV 27 \u2013 42 meses m\u00e1s tarde (Parrino et al. , 1977). \nA pesar de estos resultados, estos mismos est udios con voluntarios y otros trabajos sugieren \nque se desarrolla, al menos, una protecci\u00f3n parcial frente a infecciones posteriores por NoV, \ncomo es el caso de alg\u00fan estudio de cohortes en comunidades (Rockx et al. , 2002). Hay \npersonas que son resistentes a la infecci\u00f3n cuando se exponen por primera vez al virus, pero al \nvolverse a exponer uno o dos a\u00f1 os m\u00e1s tarde, desarrollan manifestaciones cl\u00ednicas. Otros, en \ncambio, no las desarrollan nunca, hecho que sugier e la existencia de una resistencia al virus \ndeterminada gen\u00e9ticamente. Hay estudios que han mostrado una asociaci\u00f3n entre el fenotipo \nsangu\u00edneo ABO y el riesgo de desarrollar infecci\u00f3n sintom\u00e1tica: los voluntarios con el grupo O desarrollan infecci\u00f3n con mayor frecuencia al es tar expuestos, mientras que los que tienen el \ngrupo B se infectan menos y desarrollan la enfermedad con menor frecuencia (Rockx et al. , \n2005).   1.8. Adenovirus humanos \n \n1.8.1. Historia  \nLos primeros adenovirus humanos fueron aislados por Rowe et al.  (1953) a partir de \nlas gl\u00e1ndulas adenoides. En estos tejidos se ob servaban cambios degenerativos resultantes de \nla replicaci\u00f3n de un agente no identificado que se denomin\u00f3 \u201c adenoid degeneration agent \u201d. En \n1954, H illerman y Werner consiguieron aislar un agente infeccioso a partir de secreciones \nrespiratorias, que induc\u00eda cambios citop\u00e1ticos sobre l\u00edneas celulares de origen humano. Los \nadenovirus fueron descritos como agentes etio l\u00f3gicos de enfermedades respiratorias agudas \n(Hilleman y Werner, 1954), infecciones gastrointestinales, urinarias y oculares. Tambi\u00e9n Introducci\u00f3n general \n 58 suponen un problema como pat\u00f3genos opor tunistas en individuos inmunodeprimidos. \nEstudios epidemiol\u00f3gicos confirmaron que los adenovirus provocan una peque\u00f1a proporci\u00f3n \nde las enfermedades respiratorias en la poblac i\u00f3n general y un 5% \u2013 10% en ni\u00f1os. El grupo \n\u201cadenovirus\u201d fue propuesto en 1956 por Enders et al. , y posteriormente aceptado por el \nComit\u00e9 Internacional de Taxonom\u00eda de Virus (Wildy, 1971).  1.8.2. Caracter\u00edsticas moleculares  \nLos adenovirus constituyen una familia de virus DNA (familia Adenoviridae ) que \ninfectan al hombre y a un amplio rango de espe cies animales El genoma esta constituido por \nuna mol\u00e9cula de DNA bicatenario lineal de 36 \u2013 38 Kb (Figura 14), que codifica al menos 10 \npolip\u00e9ptidos estructurales diferentes y 35 pr ote\u00ednas no estructurales (Pettersson, 1984). \nPresenta una prote\u00edna de 55 KDa unida covale ntemente al extremo 5\u2019 de cada una de las \ncadenas (Rekosh et al. , 1977), y repeticiones invertidas redundantes de 103 \u2013 165 pb en los \nextremos (Shinagawa et al. , 1987). Los dos extremos de la mol\u00e9cula pueden funcionar como \norigen de replicaci\u00f3n y las dos cadenas del DNA son transcritas. \n \n \n \n \n  Figura 14.  Mapa de transcripci\u00f3n del genoma de adenovirus. Los mRNA tempranos est\u00e1n \nrepresentados en color verde, los mRNA tard\u00edos est\u00e1n representados en color azul. Las \nflechas indican la direcci\u00f3n de transcripci\u00f3n. La localizaci\u00f3n g\u00e9nica de los VA RNAs est\u00e1 identificada en color marr\u00f3n. MLP, genes tard\u00edos mayoritarios (extra\u00eddo de Russell, 2000)  Introducci\u00f3n general \n 59 1.8.3. Caracter\u00edsticas f\u00edsico-qu\u00edmicas y estabilidad \n \nLas part\u00edculas v\u00edricas presentan una c\u00e1pside desnuda de simetr\u00eda icosa\u00e9drica con un \ndi\u00e1metro entre 70 y 90 nm, con un peso mole cular de 175 \u2013 185 KDa y una densidad de \nflotaci\u00f3n de 1,33 \u2013 1,34 g/cm3 en cloruro de cesio (Li, 1988). El viri\u00f3n contiene un 13% de DNA \ny un 87% de prote\u00edna (Green et al. , 1963). La part\u00edcula completa est\u00e1 formada por al menos 10 \npolip\u00e9ptidos estructurales diferentes. La c\u00e1pside est\u00e1 constituida por 252 caps\u00f3meros, y de la que surgen proyecciones filamentosas con pr opiedades hemoaglutina ntes. Los 240 hexones \nque forman las 20 caras triangulares del icosaedr o, est\u00e1n dispuestos sim\u00e9tricamente de forma \nque cada uno queda rodeado por otros 6 caps\u00f3meros. Los 12 v\u00e9rtices del viri\u00f3n contienen un \ncaps\u00f3mero con una proyecci\u00f3n en forma de ante na (fibra), y que est\u00e1 rodeado por otros 5 \ncaps\u00f3meros formando un pent\u00f3n (Figura 15). \n \nLa part\u00edcula v\u00edrica es resistente a pH \u00e1cido, a la bilis y enzimas proteol\u00edticos, lo que \npermite la multiplicaci\u00f3n en el intestino humano. Asimismo, la ausencia de membranas o estructuras lip\u00eddicas hacen que sean resistentes a disolventes org\u00e1nicos (Green et al. , 1963). \n \n \n  \n \n \n \n1.8.4. Diversi dad gen\u00e9tica \n \nSe ha podido observar una variabilidad gen\u00e9tica que oscila entre un 48% \u2013 99% de \nhomolog\u00eda dentro de cada serotipo y un 4% \u2013 20% entre diferentes serotipos. El m\u00e9todo Figura 15.  Esquema de la estructura de adenovi rus, compuesta por una compleja c\u00e1pside \nproteica que rodea un genoma de DNA y un core prot\u00e9ico, en los v\u00e9rtices podemos \nobservar las proyecciones filamentosas (esp \u00edculas) con propiedades hemoaglutinantes \n(Imagen obtenida de PDB, 2012)  Introducci\u00f3n general \n 60 utilizado com\u00fanmente para identificar diferencias gen\u00f3micas entre adenovirus se basa en el \nan\u00e1lisis mediante enzimas de restricci\u00f3n. Seg\u00fan este an\u00e1lisis se han podido definir m\u00e1s de 200 tipos gen\u00f3micos que se diferencian en el patr\u00f3n de restricci\u00f3n (Li, 1988). La secuenciaci\u00f3n del DNA de representantes de dife rentes serotipos ha demostrado  delecciones e inserciones, y \nmutaciones puntuales (transiciones, transversiones) silenciosas.  1.8.5. Diversi dad serot\u00edpica \n \nExisten 52 serotipos adenovirus inmunitari amente distintos (7 especies: Adenovirus \nhumano A a G) que pueden causar infeccion es en seres humanos desde enfermedad \nrespiratoria (mayormente especies HAdV-B y C) y conjuntivitis (HAdV-B y D) a gastroenteritis (HAdV-F serotipos 40 y 41). La forma m\u00e1s co m\u00fan es una enfermedad respiratoria; sin \nembargo, tambi\u00e9n pueden causar otras enfermed ades como gastroenteritis, conjuntivitis, \ncistitis, y sarpullidos, dependiendo  del serotipo de adenovirus que cause la infecci\u00f3n. La familia \ncontiene los siguientes g\u00e9neros:  \n\u2022 G\u00e9nero Aviadenovirus ; especie tipo: Adenovirus A aviar . \n\u2022 G\u00e9nero Atadenovirus ; especie tipo: Adenovirus D ovino . \n\u2022 G\u00e9nero Mastadenovirus ; especie tipo: Adenovirus C humano . \n\u2022 G\u00e9nero Siadenovirus ; especie tipo: Adenovirus de la rana . \n 1.8.6. Replicaci\u00f3n del virus  \n \nLa infecci\u00f3n se inicia con la uni\u00f3n de las fibras al receptor de la superficie de c\u00e9lulas \npermisivas, y la internalizaci\u00f3n posiblemente por endocitosis. Una vez en el endosoma, una \nbomba proteica dependiente de AT P hace que disminuya el pH, con lo que se altera la carga \nneta de la capside v\u00edrica. La interacci\u00f3n de la c\u00e1pside v\u00edrica con la membrana lip\u00eddica produce la ruptura del endosoma, permitiendo el transp orte del viri\u00f3n hasta el n\u00facleo celular. La \nc\u00e1pside remanente se pierde durante la liberaci\u00f3 n del core dentro del n\u00facleo. La replicaci\u00f3n \ndel DNA, la transcripci\u00f3n y la maduraci\u00f3n de los adenovirus tiene lugar en el n\u00facleo celular (Sharp y Wadell, 1995). Durante el ciclo l\u00edtico lo s genes v\u00edricos se expresan en tres fases (Li, \n1988):  Introducci\u00f3n general \n 61 i. Fase temprana, que ocurre antes de la rep licaci\u00f3n del DNA v\u00edrico. Los genes tempranos \n(E1A, E1B, E2A, E2B, E3 y E4) codifican prote\u00ednas esenciales involucradas en la regulaci\u00f3n de la transcripci\u00f3n viral, replicaci\u00f3n del DNA y responsables de la transformaci\u00f3n celular. El procesamiento post-transcripcional de los mRNA es complejo. Los mRNA maduros migran al citoplasma donde son traducidos a prote\u00edna. \n \nii. Fase intermedia, durante la cual se expresan las prote\u00ednas estructurales pIX y pIVa2 \nque intervienen en la es tabilizaci\u00f3n de la estructura de la c\u00e1pside. \n \niii. Fase tard\u00eda, caracterizada por la inhibici\u00f3n de la replicaci\u00f3n y expresi\u00f3n de prote\u00ednas \ncelulares, y la expresi\u00f3n de los genes v\u00edricos que codifican las prote\u00ednas estructurales (L1, L2, L3, L4 y L5). El procesamiento de los transcritos es complejo, y los mRNA \nmaduros se traducen en el citoplasma. Los polip\u00e9ptidos estructurales son \ntransportados hasta el n\u00facleo d\u00f3nde se inicia el ensamblaje de las part\u00edculas v\u00edricas. Treinta horas despu\u00e9s de la infe cci\u00f3n pueden haberse producido 10\n5 part\u00edculas por \nc\u00e9lula que forman cuerpos de inclusi\u00f3n cristalinos en el n\u00facleo. La proporci\u00f3n de part\u00edculas infectivas var\u00eda entre 1/10 y 1/1.000 seg\u00fan los serotipos. Estas son liberadas de la c\u00e9lula por mecanismos desconocidos.  \n 1.8.7. Epidemiolog\u00eda  \n \nLas infecciones por HAdV est\u00e1n muy extendidas a escala mundial. Entre 1967 y 1976 el \n13% de los 135.702 aislados v\u00edricos asociados a enfermedades respirator ias en todo el mundo \nse identificaron como adenovirus (Schmitz et al. , 1983), ocupando el segundo lugar despu\u00e9s \ndel virus de la gripe que represen t\u00f3 un 28% de los casos descritos. \n \nAproximadamente el 60% de las infecciones por HAdV se producen en ni\u00f1os menores \nde 4 a\u00f1os. El 47% \u2013 55% de las infecciones son asintom\u00e1ticas. Estudios seroepidemiol\u00f3gicos sugieren que la incidencia real de las infecciones por HAdV podr\u00eda ser el doble que las estimaciones hechas a partir de los aislados v\u00edricos (Sharp y Wadell, 1995).   \nLa transmisi\u00f3n de los HAdV puede ocurrir en  forma de casos espor\u00e1dicos o en brotes \nepid\u00e9micos. La v\u00eda de transmisi\u00f3n depende en gr an medida del serotipo y de la enfermedad \nasociada, pudiendo transmitirse a trav\u00e9s de secreciones org\u00e1nicas, transmisi\u00f3n a\u00e9rea (p.e. Introducci\u00f3n general \n 62 aerosoles generados por tos o estornudos), tran smisi\u00f3n h\u00eddrica (p.e. brotes de conjuntivitis \nasociados a piscinas), transmisi\u00f3n fecal-oral (Hunter, 1997).  \nLa elevada prevalencia y estabilidad de los HAdV, as\u00ed como su origen humano, sugieren \nque \u00e9stos pueden ser utilizados como indicadores de la presencia de virus humanos en el ambiente (Pina et al. , 1998b; Puig et al. , 1994). \n 1.8.8. Oncogenicidad  \nLos diferentes serotipos se han dividido en  tres grupos en funci\u00f3n de su capacidad \noncog\u00e9nica observada en animales de experime ntaci\u00f3n (se desconoce la capacidad oncog\u00e9nica \ndel adenovirus humano G) : \n \n\u2022 Altamente oncog\u00e9nicos: especie A, produc en tumores en la mayor\u00eda de animales \ninfectados en un plazo de 4 meses. \n\u2022 D\u00e9bilmente oncog\u00e9nicos: especie B, pro ducen tumores en algunos animales en un \nplazo de 4 \u2013 18 meses. \n\u2022 No oncog\u00e9nicos: especie C, D, E y F. \n \nTodos los HAdV tienen la capacidad de transformar c\u00e9lulas de rat\u00f3n in vitro . Las c\u00e9lulas \ntransformadas est\u00e1n libres de virus infecciosos pero sintetizan  prote\u00ednas v\u00edricas que pueden \ndetectarse mediante ensayos inmunol\u00f3gicos (Li, 1988).   1.9. Poliomavirus  1.9.1. Historia  \n  El g\u00e9nero poliomavirus  sol\u00eda ser uno de los dos g\u00e9neros dentro de la familia ahora \nobsoleta Papovaviridae  (el otro g\u00e9nero, el virus del papiloma, ahora se clasifica en su propia \nfamilia, Papillomaviridae ). Actualmente, los poliomavirus so n el \u00fanico g\u00e9nero dentro de la \nfamilia Polyomaviridae , y su nombre hace referencia a la habilidad de producir m\u00faltiples (poli) \ntumores (oma).  El poliomavirus murino (MPyV), la espe cie tipo del g\u00e9nero, fue el primer \npoliomavirus descubierto, y se aisl\u00f3 en el a\u00f1o 1953 por Ludwig Gross durante investigaciones acerca de la transmisi\u00f3n de la leucemia en ratones (Gross, 1953). MPyV es responsable de un Introducci\u00f3n general \n 63 espectro variado de tumores al inocularse en cr\u00edas de rat\u00f3n. El virus de simio 40 (SV40) se \nidentific\u00f3 en los a\u00f1os 60 en cultivos de c\u00e9lula s de ri\u00f1\u00f3n de monos Rhes us que estaban siendo \nempleados para producir vacunas contra la polio (Sweet y Hilleman, 1960). Tanto la vacuna \noral de Sabin (virus atenuado) como la vacuna in yectable de Salk (virus inactivados) estuvieron \nafectadas; la t\u00e9cnica para inactivar el virus de la polio de la vacuna Salk, por medio del formaldeh\u00eddo, fue in\u00fatil para matar al SV40. Millones de personas fueron inoculadas con las vacunas contaminadas antes de que se identificaran la presencia de SV40 y de que \u00e9stas se retiraran del mercado (revisado en Shah et al. , 2004). \n \nInicialmente, \u00fanicamente se hab\u00edan identi ficado y caracterizado dos poliomavirus \nhumanos; JCPyV y BKPyV. Ambos virus fueron aislados por primera vez en el a\u00f1o 1971 y deben su nombre a las iniciales de los pacientes donde fu eron aislaron. BK fue identificado en la orina \nde un paciente al que hac\u00eda poco tiempo que  se le hab\u00eda transplantado un ri\u00f1\u00f3n (Gardner et \nal., 1971) mientras que JC se aisl\u00f3 en el tejido cerebral de un paciente con Leucoencefalopat\u00eda \nMultifocal Progresiva (PML), una enfermedad neurodegenerativa (Padgett et al. ,1971). Hasta \nlos a\u00f1os 80, cuando empez\u00f3 la epidemia de SI DA, JCPyV y la PML se consideraban \u00edtems de \npoco inter\u00e9s y con poca incidencia. Pero todo cambi\u00f3 cuando se observ\u00f3 que aproximadamente un 4% de los enfermos  de SIDA padecen la PML (Berger et al. , 1987). \nRecientemente, se han descrito diversos po liomavirus que aun no est\u00e1n clasificados: el \npoliomavirus de chimpanc\u00e9 (Johne et al. , 2005), los poliomavirus de cuervo y pinz\u00e1n (Johne et \nal., 2006), el poliomavirus de oca (Guerin et al. , 2000), el poliomavirus de mono ardilla \n(Verschoor et al. , 2008). \n \nActualmente, se han identificado 8 poliomavirus humanos: los ya mencionados BKPyV \ny JCPyV, el poliomavirus KI (Allander et al. , 2007) y el poliomavirus WU (Gaynor et al. , 2007), \nambos aislados a partir del tracto respiratorio , aunque sus caracter\u00edsticas patog\u00e9nicas no est\u00e1n \nbien definidas aun (Norja et al. , 2007; Babakir-Mina et al. , 2011), el poliomavirus de c\u00e9lulas \nMerkel (MCPyV) (Feng et al. , 2008), del que hablaremos m\u00e1s adelante, y los recientemente \ndescritos poliomavirus humanos 6 y 7 (Schmitt et al. , 2011) y el poliomavirus asociado a la \ntricodisplasia espinulosa (van der Meijden et al. , 2012). \n  1.9.2. Caracter\u00edsticas moleculares  \n  La familia Polyomaviridae , constituida \u00fanicamente por el g\u00e9nero poliomavirus , se Introducci\u00f3n general \n 64 caracteriza por poseer un genoma formado por una  mol\u00e9cula de DNA de doble cadena de unas \n5,3 Kb, superenrollado, circular y unido covalent emente. La replicaci\u00f3n tiene lugar en el n\u00facleo \ncelular. EL DNA se encuentra asociado a 4 histon as celulares (H2A, H2B, H3 y H4) formando un \nminicromosoma.  \nCada una de las cadenas de DNA codifica  para aproximadamente el 50% de la \ninformaci\u00f3n gen\u00e9tica. El genoma de poliomavirus se encuentra subdividido en una regi\u00f3n temprana que codifica para los ant\u00edgenos tumora les T y t (AgT y Agt) y una regi\u00f3n tard\u00eda que \ncodifica para la prote\u00ednas estructurales que dan lugar a la c\u00e1pside. Tambi\u00e9n existe una regi\u00f3n \nreguladora (RR), frecuentemente nombrada como regi\u00f3n del control transcripcioal (TCR), con \nun tama\u00f1o de 400 pb donde podemos encontrar promotores de la transcripci\u00f3n y el \u00fanico origen de replicaci\u00f3n (ORI) del virus. El nucle\u00f3tido 1 del genoma de los poliomavirus es el \nnucle\u00f3tido central del pal\u00edndromo que forma part e del ORI. La transcripci\u00f3n se origina de \nmanera bidireccional a partir de la RR y en cadenas diferentes (Figura 16). \n  \n \n \n  \n La regi\u00f3n codificante de VP1 se encuentra solapada con la regi\u00f3n C-terminal com\u00fan a \nVP2 y VP3. La secuencia completa de VP3 se en cuentra incluida en el extremo C-terminal de \nVP2 y presenta 115 aa adicionales en el extremo N-terminal. Los mRNA que codifican para estas prote\u00ednas se originan por splicing alternativo a partir de un \u00fanico pre-mRNA. La Figura 16.  Esquema d e la organizaci\u00f3n gen\u00f3mica de poliomavirus. La transcripci\u00f3n \ntemprana de los ant\u00edgenos T tiene lugar en la direcci\u00f3n en que giran las agujas del reloj, \nmientras que la transcripci\u00f3n de las prote\u00ednas de la c\u00e1pside (VP1, VP2 y VP3) ocurre en sentido contrario. La replicaci\u00f3n y la transcripci\u00f3n est\u00e1n controladas por el \nenhancer/potenciador (ENH) y el origen de replicaci\u00f3n (ORI). Las secuencias codificantes para los ant\u00edgenos T est\u00e1n en diferente color tratando de remarcar las direcciones de las \npautas de lectura (extra\u00eddo de Fluck y Schaffhausen, 2009)  Introducci\u00f3n general \n 65 traducci\u00f3n de VP1 tiene lugar mediante la utiliz aci\u00f3n de una pauta de lectura diferente a la de \nVP2 y VP3. Las tres prote\u00ednas constituyen la re gi\u00f3n tard\u00eda del genoma, expres\u00e1ndose durante y \ndespu\u00e9s de la replicaci\u00f3n.   Los ant\u00edgenos tumorales T y t conforman la regi\u00f3n temprana y son producidos al inicio del ciclo l\u00edtico, son prote\u00ednas no estructurales y se incorporan a los viriones adultos maduros. Su funci\u00f3n es vital en la replicaci\u00f3n y transform aci\u00f3n. Despu\u00e9s de la infecci\u00f3n, los ant\u00edgenos T y \nt son f\u00e1cilmente detectables en el n\u00facleo de l as c\u00e9lulas, donde una vez acumulados, provocan \nla activaci\u00f3n de la regi\u00f3n del genoma que codifica para las prote\u00ednas estructurales. Ambos ant\u00edgenos comparten el extremo N-terminal. Los RNA mensajeros que codifican para estas \nprote\u00ednas son el resultado de un splicing altern ativo de un \u00fanico pre-mRNA. El poliomavirus \nmurino presenta, adem\u00e1s de lo mencionado, un ant\u00edgeno tumoral T medio (AgTm). Los \npoliomavirus humanos y SV40 presentan una sexta prote\u00edna; la agnoprot e\u00edna (LP1), formada \npor 60 \u2013 70 aa y con tendencia a acumularse en la regi\u00f3n perinuclear durante la fase avanzada \nde la infecci\u00f3n. Se sugiere que la funci\u00f3n de la agnoprote\u00edna consiste en regular \nnegativamente la transcripci\u00f3n y replicaci\u00f3n viral, tanto la basal como la inducida por el AgT. Tambi\u00e9n est\u00e1 involucrada en la formaci\u00f3 n de la c\u00e1pside (Sabath y Major, 2002). \n 1.9.3. Caracter\u00edsticas f\u00edsico-qu\u00edmicas y estabilidad  \n  Los poliomavirus presentan virus sin envuel ta lip\u00eddica con un di\u00e1metro aproximado de \n42 \u2013 45 nm (Figura 17). La c\u00e1pside v\u00edrica est\u00e1 formada por tres prote\u00ednas: VP1, VP2 y VP3. El 70% de la masa total del viri\u00f3n (44 KDa) se co rresponde con VP1 (360 copias). La c\u00e1pside est\u00e1 \nconstituida por un n\u00famero de VP2 y VP3 que oscila entre 30 y 60 mol\u00e9culas. Las c\u00e1psides est\u00e1n formadas por un total de 72 caps\u00f3meros pentam\u00e9r icos y presentan una simetr\u00eda icosa\u00e9drica, \n60 caps\u00f3meros se coordinan hexagonalmente mientras que los 12 restante lo hacen \npentagonalmente. Los viriones presentan una dens idad de flotaci\u00f3n de 1,34 g/mL en gradiente \nde cloruro de cesio, mientras que las c\u00e1psidas va c\u00edas presentan una densidad de flotaci\u00f3n algo \nmenor, concretamente 1,29 g/mL. El coeficiente de sedimentaci\u00f3n en gr adiente de sucrosa es \nde 240S. La part\u00edcula v\u00edrica est\u00e1 constituida por un 88% de prote\u00edna y un 12% de DNA (Cole, 1996).  Introducci\u00f3n general \n 66 \n \n \n \n  \nLa ausencia de envuelta lip\u00eddica comporta que las part\u00edculas v\u00edricas sean resistentes al \n\u00e9ter, a los \u00e1cidos y al tratamiento por calor, son capaces de sobrevivir durante una hora en agua a 50 \u00baC, aunque en presencia de MgCl\n2 1M se vuelven vulnerables frente a las mismas \ncondicion es (Virus Taxonomy, 7th report ICTV). La elevada estabilidad y amplia distribuci\u00f3n de \nJCPyV en el ambiente, son detectados en apro ximadamente el 95% de las muestras de agua \nresidual, sugieren su utilidad como indicador de contaminaci\u00f3n fecal y potencial herramienta \npara trazar el origen de dicha contaminaci\u00f3n (Puig et al. , 1994; Pina et al. , 1998b; Bofill-Mas et \nal., 2000). La presencia de estos virus en muestras ambientales ha sido ampliamente reportada \ndurante la \u00faltima d\u00e9cada, mo strando concentraciones de 105 \u2013 108 GC/L en agua residual \ncruda, 100 \u2013 103 GC/L en agua de r\u00edo y 103 \u2013 105 GC/100g de bios\u00f3lidos (revisado en Girones et \nal., 2010). \n 1.9.4. Replicaci\u00f3n del virus  \n  El espectro de hu\u00e9spedes de cada una de  las especies de poliomavirus es bastante \nrestringido y cuando infectan a hu\u00e9spedes de  otras especies producen infecciones no \nproductivas. En hu\u00e9spedes permisivos causan infecciones l\u00edticas mientras que en hu\u00e9spedes no \npermisivos producen un bloqueo de la replicaci\u00f3 n que conlleva a una infecci\u00f3n abortiva o a un \nproceso oncog\u00e9nico. \n \n SV40 y MPyV infectan a una amplia varied ad de c\u00e9lulas de mam\u00edferos en cultivo, \naunque en muchos de los tipos celulares ut ilizados la infecci\u00f3n causada es no productiva. En el \ncaso de JCPyV el espectro de hu\u00e9spedes y el tipo  de c\u00e9lulas a infectar es m\u00e1s limitado (Cole y Figura 17.  Estructura cristalogr\u00e1fica del aspecto que ofrecen las part\u00edculas v\u00edricas de \npoliomavirus. En este caso po demos observar un poliomavirus murino (imagen obtenida de \nVIPERdb, 2012)  Introducci\u00f3n general \n 67 Conzen, 2001). La infecci\u00f3n comienza con la uni\u00f3n de los virus a la c\u00e9lula hu\u00e9sped, aunque \nestos mecanismos de uni\u00f3n no se conocen completamente. Se piensa que VP1 y el \u00e1cido si\u00e1lico juegan un papel importante y, en el caso  de SV40, el ant\u00edgeno MHC de clase I parece \nestar tambi\u00e9n implicado (Norkin, 1999). Los poliomavirus entran en el citoplasma por procesos de pinocitosis ayudados por una interacci\u00f3n previa  de VP2 y VP3 con la superficie celular. Los \nvirus parecen ser transportados desde el citoplasma hasta el n\u00facleo utilizando el citoesqueleto y entran al n\u00facleo por fusi\u00f3n de membranas o mediante los poros nucleares. Una vez en el \nn\u00facleo, los virus se desencapsidan en un proc eso en el que intervienen VP2 y VP3 (Cole y \nConzen, 2001).   La transcripci\u00f3n temprana del genoma v\u00edrico tiene lugar en el n\u00facleo, dando lugar a AgT y Agt y conduciendo as\u00ed a la c\u00e9lula a hu\u00e9sped a la fase S del ciclo celular, donde la \nmaquinaria de replicaci\u00f3n se pone al servicio de l virus. El AgT se une al RR, inhibiendo la \ntranscripci\u00f3n de la regi\u00f3n temprana y activando simult\u00e1neamente la transcripci\u00f3n de la regi\u00f3n tard\u00eda. El mecanismo mediante el cual el AgT in hibe la transcripci\u00f3n temprana no se conoce \ncon detalle.   Una vez que ha comenzado la transcripci\u00f3 n de la regi\u00f3n tard\u00eda, se producen dos \nmol\u00e9culas de mRNA, una se traducir\u00e1 generando VP1 y la otra dar\u00e1 lugar a VP2 y VP3 y, en \nfunci\u00f3n de la especie de poliomavirus, la agnopr ote\u00edna tambi\u00e9n se traducir\u00e1. Las prote\u00ednas se \ntransportan al n\u00facleo donde tendr\u00e1 lugar el ensam blaje de la c\u00e1pside. La liberaci\u00f3n de las \npart\u00edculas v\u00edricas tiene lugar mediante lisis de las c\u00e9lulas hu\u00e9sped o mediante ves\u00edculas citoplam\u00e1ticas (Cole y Conzen, 2001). El ciclo replicativo de poliomavirus dura aproximadamente 36 \u2013 44 horas.  \n1.9.5. Oncogenicidad  \n  Los ant\u00edgenos tumorales reciben este nombre  al ser ant\u00edgenos dominantes en animales \nportadores de tumores que han si do inducidos v\u00edricamente (Black et al. , 1963). El AgT es una \nfosfoprote\u00edna nuclear de 700 aa y el Agt tiene 172 \u2013 174 aa.   Estos ant\u00edgenos son prote\u00ednas multifuncionales. Algunas de las funciones que presentan residen en dominios funcionales discre tos y otras requieren de la interacci\u00f3n entre \ndiferentes dominios y/o la a cci\u00f3n independiente de dos o m\u00e1s dominios (Brodsky y Pipas, \n1998). El AgT (Figura 18) se une a prote\u00ednas de la familia retinoblastoma (pRb) inactiv\u00e1ndolas y Introducci\u00f3n general \n 68 degrad\u00e1ndolas. Para poder realizar esta funci\u00f3 n requiere del motivo LXCXE y un dominio J. La \nuni\u00f3n a pRb provoca el desplazamiento f\u00edsico y la liberaci\u00f3n del factor de transcripci\u00f3n E2F, estimulando as\u00ed la transcripci\u00f3n de genes involucrados con la entrada celular en fase de s\u00edntesis de DNA (fase S). La respuesta celular a dicho fen\u00f3meno suele provocar la activaci\u00f3n de \np53 y en \u00faltima estancia la muerte celular por apoptosis, aunque la uni\u00f3n del AgT a p53 \ninactiva su funci\u00f3n y provoca un aumento en la longevidad de la c\u00e9lula hu\u00e9sped, asegur\u00e1ndose as\u00ed de una generaci\u00f3n elevada de part\u00edculas v\u00edri cas descendientes. El AgT se une a secuencias \nespec\u00edficas del ORI del DNA v\u00edrico y recluta la  maquinaria sint\u00e9tica de la c\u00e9lula hu\u00e9sped \nmediante la uni\u00f3n del complejo DNA polimerasa \u03b1/primasa y la prote\u00edna de replicaci\u00f3n A (RPA). Adem\u00e1s, el Agt presenta actividad helicasa. En cultivo celular el AgT es imprescindible para poder realizar infecciones productivas. Asimismo, aunque no es absolutamente esencial, \ncontribuye a la infecci\u00f3n y transcripci\u00f3n. Si se bloquea la infecci\u00f3n productiva pero continua \nhabiendo expresi\u00f3n del AgT, tendr\u00e1n lugar fen\u00f3menos de transformaci\u00f3n celular. Este \nfen\u00f3meno tiene lugar normalmente en hu\u00e9spedes  no permisivos o hu\u00e9spedes permisivos que \nhan sufrido mutaciones en el ORI. El AgT comparte muchas funciones con las prote\u00ednas E1A y E1B de los adenovirus (Rao et al. , 1992). \n \n \n \n \n Figura 18.  Dominios funcionales de AgT en SV40. Los n\u00fameros representan los residuos \naminoac\u00eddicos. Se han resaltado algunas regiones de inter\u00e9s: \u201csmall t-ag common\u201d es la \nregi\u00f3n de codificaci\u00f3n del AgT y com\u00fan para ambos ant\u00edgenos, AgT y Agt; \u201cpRb/p107/p130 binding\u201d es la regi\u00f3n necesaria para la uni\u00f3n de la prote\u00edna de reti noblastoma supresora de \ntumores y las prote\u00ednas p107 y p130 relacionadas con pRb; \u201cp53 binding\u201d es la regi\u00f3n que requerida para la uni\u00f3n la prote\u00edna supresor a de tumores p53; \u201cvariable domain\u201d es la \nregi\u00f3n que contiene las diferencias de aa entr e cepas v\u00edricas. Los c\u00edrculos que contienen \nuna P indican posiciones de fosforilaci\u00f3n (Stewart et al. , 1996)  Introducci\u00f3n general \n 69 M\u00e1s recientemente, se ha descubierto en SV40 y MPyV un nuevo ant\u00edgeno tumoral al \nque, por su peque\u00f1o tama\u00f1o, se le ha denominado ant\u00edgeno T tiny, ya que comparte los \nprimeros 131 aa del AgT. El papel que juega tiny se desconoce hasta el momento.  \n 1.9.6. V\u00edas de transmisi\u00f3n de poliomavirus humanos  \n  Aunque las v\u00edas de transmisi\u00f3n de los poliomavirus humanos son todav\u00eda desconocidas, la mayor\u00eda de los investigadores coinciden en que la entrada podr\u00eda tener lugar a trav\u00e9s del tracto respiratorio o alimentario (Sundsfjord et al. , 1994). Se sabe que JCPyV y \nBKPyV infectan de manera persistente el tracto u r i n a r i o  y ,  e n  e l  c a s o  d e  J C P y V ,  t a m b i \u00e9 n  e l  \ncerebro. BKPyV fue aislado a partir de cultivo de tejido procedente de las am\u00edgdalas de pacientes con enfermedades respiratorias (Goudsmit et al. , 1982) y de la orina de ni\u00f1os con \namigdalitis aguda (Goudsmit et al. , 1981). Sundsfjord et al.  (1994) aislaron DNA de BKPyV en \nmuestras del tracto nasofar\u00edngeo de ni\u00f1os que presentaban problemas respiratorios agudos, \naunque no fue posible aislar ninguno de los dos vi rus a partir de muestras de saliva procedente \nde individuos adultos inmunosuprimidos o inm unocompetentes, hecho que sugiri\u00f3 al tracto \nalimentario con v\u00eda de entrada de los poliomaviru s al organismo. JCPyV ha sido detectado en \nam\u00edgdalas y linfocitos obtenidos a partir de am\u00edgdalas (Monaco et al. , 1998a; Monaco et al. , \n1998b), as\u00ed como en tejido del tracto gastrointestinal (Ricciardiello et al. , 2000). \n  Debido a que se desconoce el lugar donde se produce la infecci\u00f3n primaria, resulta \ndif\u00edcil conocer la v\u00eda de entrada de los poliomavirus al organismo. Se ha especulado una posible transmisi\u00f3n transplacental de ambos viru s, justificando as\u00ed la reactivaci\u00f3n que tiene \nlugar durante el embarazo (Coleman et al., 1980). No obstante, ya que el reci\u00e9n nacido se encuentra en \u00edntimo contacto con la madre tras el parto, es dif\u00edcil discernir entre la \ntransmisi\u00f3n transplacental y otras v\u00edas de tran smisi\u00f3n. Esta potencial ruta de transmisi\u00f3n a \nedades tempranas no se corresponde con la ed ad de seroconversi\u00f3n descrita, aunque se ha \nespeculado tambi\u00e9n que la seroconversi\u00f3n podr \u00eda deberse a una reactivaci\u00f3n por los cambios \nhormonales caracter\u00edsticos de la pubertad, en lugar de por una infecci\u00f3n primaria.  \n 1.9.7. Poliomavirus de c\u00e9lulas de Merkel  \n  El carcinoma de c\u00e9lulas de Merkel (MCC) fue descrito por Toker en el 1972 como un carcinoma trabecular de la piel (Toker, 1972), es una malignidad cut\u00e1nea agresiva que afecta predominantemente a los cauc\u00e1sicos, de g\u00e9nero  masculino en edad adulta, y en pacientes Introducci\u00f3n general \n 70 inmunosuprimidos, adem\u00e1s de los pacientes trasplantados y con HIV, es propenso a la \nrecurrencia local y a la met\u00e1stasis en n\u00f3dulos linfoides regionales. El riesgo de MCC se incrementa en pacientes con otros tipos de ma lignidades y su incidencia est\u00e1 incrementando \nde manera preocupante (Andea et al. , 2008; Becker, 2010), relacion\u00e1ndose con determinados \nfactores ambientales, mayor poblaci\u00f3n in munosuprimida y con el avance en el \ninmunodiagn\u00f3stico que tambi\u00e9n puede contribuir con un mayor n\u00famero de MCC diagnosticados (Pulitzer et al. , 2009; Wong et al. , 2010). \n  MCPyV fue descrito por primera vez en junio de 2008 (Feng et al. , 2008) y se identific\u00f3 \nsu genoma en m\u00faltiples MCC. Un 80% de MCC ha mostrado la presencia del genoma de MCPyV en comparaci\u00f3n con 8% en tejidos de controles normales y 16% de otros tumores de piel (Tolstov et al. , 2009; Kean et al. , 2009). Se ha descrito en secreciones respiratorias, \nsugiriendo que puede ser transmitido a trav\u00e9s  de la ruta respiratoria (Bialasiewicz et al. , 2009; \nGoh et al. , 2009). No obstante, la mayor\u00eda de MCPyV aislados en tumores de MCC poseen dos \nmutaciones que dificultan su transmisi\u00f3n, los viru s suelen estar integrados en el genoma de la \nc\u00e9lula hu\u00e9sped en un formato monoclonal y el AgT sufre modificaciones que imposibilitan que \u00e9ste favorezca que la c\u00e9lula hu\u00e9sped entre en la  fase S, necesaria para la propagaci\u00f3n del virus \n(Shuda et al. , 2008). Las principales evidencias que relacionan a MCPyV como la causa de los \ntumores de MCC que est\u00e1n infectados con el virus provienen de estudios donde se utiliza part\u00edculas v\u00edricas con oncoprote\u00ednas inhibidas, la baja presencia de estas prote\u00ednas virales causa la muerte celular de tumores de MCC posi tivos para MCPyV, mientras que no se observa \nning\u00fan efecto en las c\u00e9lulas de los tumores negativos para MCPyV (Houben et al. , 2010). \nAcontecimiento indicativo que MCPyV es necesario para el mantenimiento de las c\u00e9lulas tumorales positivas para el virus.  \n1.9.8. Epidemiolog\u00eda  \n  Resulta un hecho m\u00e1s que destacable dentro del marco conceptual de la \nepidemiolog\u00eda de los poliomavirus humanos que numerosos estudios seroepidemiol\u00f3gicos hayan presentado resultados evidenciando que 60% \u2013 80% de la poblaci\u00f3n adulta de \ndiferentes \u00e1reas geogr\u00e1ficas del mundo poseen  anticuerpos frente a JCPyV y BKPyV o ambos \nsimult\u00e1neamente. A pesar de las dificultades existentes a la hora de comparar estudios de esta \u00edndole, se ha constatado una elevada similitud en cuanto a la seroprevalencia presentada por \nzonas distantes dentro del mi smo continente, as\u00ed como la existencia de los m\u00e1ximos \nporcentajes de positivos en grupos heterog\u00e9neos que ronda n los 50 y 60 a\u00f1os de edad. Introducci\u00f3n general \n 71 Reforzando la idea presentada, Brown et al.  (1975) documentaron que existe seropositividad \nfrente a estos virus incluso en muestras po blacionales remotas que han sido expuestas a \nenfermedades v\u00edricas convencionales de transmisi\u00f3n a\u00e9rea. Aunque la presencia de anticuerpos frente a los poliomavirus humanos se incrementa bruscamente durante la infancia, el momento de adquisici\u00f3n de \u00e9stos no  ha sido examinado comparativamente en un \nestudio espec\u00edficamente dise\u00f1ado con tal fin. No  obstante, parece que la infecci\u00f3n por BKPyV \nse adquiere durante una edad temprana pr\u00f3xim a a las 4 a\u00f1os y que la infecci\u00f3n por JCPyV \nentre los 10 \u2013 14 a\u00f1os. Un trabajo reciente realizad o en Italia ha descrito la seroprevalencia de \nMCPyV en una poblaci\u00f3n de estudio formada por cerca de 1.000 individuos, observando un 45% de positivos en ni\u00f1os menores de 10 a\u00f1os  y llegando hasta un 60% en la poblaci\u00f3n \ncomprendida entre 10 \u2013 20 a\u00f1os de edad (Viscidi et al. , 2011). \n \n \n1.10. Otros virus presentes en la contaminaci\u00f3n ambiental  1.10.1. Enterovirus  Los enterovirus pertenecen a la familia Picornaviridae  (\u201cpico\u201d peque\u00f1o; \u201crna\u201d por \u00e1cido \nribonucleico) y est\u00e1 integrada por 10 g\u00e9neros y 28 especies. En estudios serol\u00f3gicos se han \nidentificado 66 serotipos de enterovirus humanos en base a test de neutralizaci\u00f3n de \nanticuerpos (Oberste et al. , 1999). Atendiendo a su patog\u00e9nesis en humanos y animales, los \nenterovirus fueron originalmente clasificados en cuatro grupos: Poliovirus, Coxsackie A virus, \nCoxsackie B virus y Echovirus, pero se observ\u00f3 r\u00e1 pidamente la existencia de solapamientos en \nlas propiedades biol\u00f3gicas de los diferentes grupos. Los Enterovirus afectan a millones de personas en todo el mundo cada a\u00f1o, encont r\u00e1ndose frecuentemente en las secreciones \nrespiratorias (saliva, esputo o moco nasal) y deposiciones de personas infectadas. \nHist\u00f3ricamente, la poliomielitis era la en fermedad m\u00e1s significativa causada por un \nenterovirus. Son virus RNA monocatenarios sin en vuelta lip\u00eddica y estructura icosa\u00e9drica, los \nviriones son muy resistentes a los cambios de pH, aunque son sensibles al cloro y a la radicaci\u00f3n ultravioleta (Racaniello, 2001). Son un grupo de agentes virales que habitan en el intestino de individuos sanos y son responsable s de importantes y frecuentes enfermedades \nhumanas con manifestaciones cl\u00ednicas muy variadas, aunque la mayor\u00eda de infecciones son asintom\u00e1ticas. Los s\u00edntomas var\u00edan desde par\u00e1lisis, meningitis, cardiopat\u00edas o simples constipados acompa\u00f1ados de fiebre. El ag ua residual puede contener enterovirus a \nconcentraciones de hasta 10\n8 GC/L (Schvoerer et al. , 2001), mientras que la vacunaci\u00f3n Introducci\u00f3n general \n 72 mediante virus inactivados (poliovirus 1, 2 y 3) ha reducido dr\u00e1sticamente la presencia de \npoliovirus en el ambiente de regiones donde  se ha aplicado la vacuna con \u00e9xito. Coxsackievirus \nB es frecuentemente identificado en muestras ambientales, especialmente B3, B4 y B5 \n(Hughes et al. , 1992), mientras que los Echovirus se identifican con menos frecuencia (Morris y \nSharp, 1984), aunque algunos estudios siguen describiendo su presencia (Lee y Kim, 2002; \nBorchardt et al. , 2007; Hsu et al. , 2008). \n1.10.2. Astrovirus \nLa familia Astroviridae  se estableci\u00f3 con un solo g\u00e9nero, Astrovirus , que incluye astrovirus \nhumanos y animales (Matsui y Greenberg, 2001; Monroe, 1993). En la actualidad la familia se \ndivide en dos g\u00e9neros seg\u00fan su origen y estructura gen\u00f3mica: Mamastrovirus  que afectan a \nmam\u00edferos incluyendo al hombre y Avastrovirus  aislados de especies aviares. Bajo microscop\u00eda \nelectr\u00f3nica tienen aspecto de estrella de 5 o 6 puntas; son virus icosa\u00e9dricos, sin envoltura y tienen un genoma compuesto por RNA de una sola hebra con polaridad positiva. Se han \nasociado a casos espor\u00e1dicos y peque\u00f1os brotes de diarrea principalmente en ni\u00f1os, aunque \nlos adultos tambi\u00e9n pueden verse afectados (Glass et al. , 1996). Estudios donde se analiza la \npresencia de astrovirus en agua residual cruda de origen urbano describen concentraciones \nque oscilan entre 10\n3 \u2013 105 GC/mL (Le Cann et al. , 2004; Guimar\u00e3es et al. , 2008) y muestran \nuna resistencia en agua de bebida similar a la  de los rotavirus y adenovirus, aunque son m\u00e1s \nsensibles a elevadas temperaturas (Abad et al. , 1997b). \n 1.10.3. Rotavirus \n \nLa primera descripci\u00f3n de rotavirus (del lat\u00edn rota : rueda) se realiz\u00f3 a trav\u00e9s del \nmicroscopio electr\u00f3nico en el 1973, observ\u00e1ndose su apariencia caracter\u00edstica parecida a una rueda (Bishop et al. , 1973). Los rotavirus son virus no envueltos, icosa\u00e9dricos y en su c\u00e1pside \nse observan 3 capas proteicas conc\u00e9ntricas (capa Externa, Media e Interna) (Kapikian et al. , \n2001). El genoma esta compuesto de 11 segmentos de RNA de doble-hebra, que codifican por seis prote\u00ednas estructurales (VP1 \u2013 VP6) y seis no estructurales (NSP1 \u2013 NSP6). Los virus son estables en el medio ambiente y pueden llegar  a medir 76,5 nm de di\u00e1metro. Se clasifican \ndentro de la familia Reoviridae . Seg\u00fan las propiedades antig\u00e9nicas de la prote\u00edna de c\u00e1pside \ninterna VP6, se diferencian siete serogrupos (A \u2013 G) y dos subgrupos (I y II) (Estes y Cohen, \n1989). De estos serogrupos se consideran pat\u00f3genos para el hombre los A, B y C.  Introducci\u00f3n general \n 73 El grupo A (RVA) es el rotavirus humano m\u00e1s com\u00fan y el m\u00e1s esparcido, causando el \n90% de las infecciones y consider\u00e1ndose as\u00ed el principal agente etiol\u00f3gico de gastroenteritis viral en ni\u00f1os. Es responsable de un n\u00famero de muertes significativas en pa\u00edses en desarrollo, \ndonde anualmente mueren 600.000 ni\u00f1os (Parashar et al. , 2006). Entre los pa\u00edses \ndesarrollados, RVA es una causa de morbid idad con un elevado coste socio-econ\u00f3mico \n(Charles et al. , 2006; Parashar et al. , 2006). Viriones de RVA son excretados en \nconcentraciones extremadamente elevadas (superiores a 10\n10 part\u00edculas v\u00edricas por gramo) en \nlas heces de ni\u00f1os infectados que padecen g astroenteritis aguda, y pueden persistir en el \nambiente por largos periodos de tiempo (Carter, 2005; Bosch et al. , 2008). Las caracter\u00edsticas \nde los viriones, incluyendo una elevada estabilidad en ambientes acu\u00e1ticos y resistencia a tratamientos de aguas, facilita su transmisi\u00f3n a trav\u00e9s de agua contaminada (Ansari et al. , \n1991; Espinosa et al. , 2008). Un estudio realizado recientemente en R\u00edo de Janeiro describe la \npresencia de RVA en agua residual cruda entre 10\n4 \u2013 107 GC/L, mientras que en agua residual \ntratada las concentraciones oscilan entre 103 \u2013 105 GC/L (Fumian et al. , 2011). \n \nEn el 2006, dos vacunas contra rotavirus mostraron ser seguras y efectivas en los \nni\u00f1os: Rotarix\u00ae desarrollada por los laboratorios GlaxoSmi thKline y creada a base de virus vivos \natenuados y RotaTeq\u00ae, desarrollada por los laboratorios Merck y creada con virus \nrecombinantes humanos y bovinos. Ambas se ad ministran v\u00eda oral y contienen virus vivos \natenuados. En 2010, Rotarix\u00ae dej\u00f3 de comercializarse en Estados Unidos y Espa\u00f1a debido a que \nse hallaron restos de DNA de un virus denominado circovirus porcino tipo 1 (PCV1), aunque \nhasta la fecha no se ha demost rado ning\u00fan efecto adverso en humanos o cerdos asociado a la \npresencia de PCV1. Baylis et al. , 2011, acaban de publicar un trabajo donde se sugiere que, a \npesar que PCV1 se encuentra encapsid ado dentro de la vacuna Rotarix\u00ae, no ha demostrado \ncapacidad de producir infecci\u00f3n in vitro.  \n   \n  \n \n    \n2. OBJETIVOS  Objetivos \n 77 Los principales objetivos se describen a continuaci\u00f3n: \n \n1) Evaluar la evoluci\u00f3n de la prevalencia de infecciones por HAV y HEV en la poblaci\u00f3n a \ntrav\u00e9s del an\u00e1lisis de las aguas residuales, considerando las mejoras en los sistemas de \nsaneamiento y la implementaci\u00f3n de nue vos programas de vacunaci\u00f3n anti-HAV. \n \n2) Evaluar la prevalencia y diversidad de las cepas de HEV que infectan a la poblaci\u00f3n \nhumana y su reservorio animal. \n \n3) Identificar HEV en muestras cl\u00ednicas (suero) para estudiar la incidencia y caracter\u00edsticas \nde las hepatitis E agudas en la poblaci\u00f3n. \n \n4) Estudiar la presencia de nuevos poliomavirus (KIPyV, WUPyV y MCPyV) en muestras de \nagua residual y r\u00edo para determinar sus patrones de excreci\u00f3n y diseminaci\u00f3n. \n \n5) Evaluar la eficiencia de eliminaci\u00f3n de pat\u00f3genos virales e indicadores microbiol\u00f3gicos \nde contaminaci\u00f3n fecal en plantas de tratamiento de  agua residual. \n \n6) Definir nuevos indicadores microbiol\u00f3gicos de contaminaci\u00f3n fecal para la mejora del \ncontrol de calidad del agua regenerada. \n \n7) Desarrollar un nuevo protocolo para la conc entraci\u00f3n de part\u00edculas v\u00edricas en agua \nresidual que sea eficiente y de reducido co ste, con el objetivo de que pueda ser \nimplementado en laboratorios de rutina y en pa\u00edses con bajo desarrollo econ\u00f3mico. \n \n8) Determinar los niveles de contaminaci\u00f3n de origen v\u00edrico en moluscos bivalvos \nintroducidos en la cadena alimentaria a nivel de mercado. \n \n9) Valorar la eficiencia de eliminaci\u00f3n de virus humanos en plantas depuradoras de \nmoluscos bivalvos. \n \n10) Mejorar los controles microbiol\u00f3gicos de contaminaci\u00f3n fecal en moluscos bivalvos. \n \n11) Desarrollar un modelo matem\u00e1tico que nos pe rmita evaluar el riesgo de infecci\u00f3n y \nenfermedad por NoV asociado al consumo de moluscos bivalvos. \n  Objectives \n 79 The main objectives are described below: \n \n1) To evaluate the evolution of the prevalence  of HAV and HEV in the population through \nthe analysis of sewage, considering the sanitation improvements and the \nimplementation of new programs for anti-HAV vaccination. \n \n2) To evaluate the prevalence and diversity of HEV strains that infects the human \npopulation and its animal reservoir. \n \n3) To identify HEV in clinical samples (serum) to study the incidence and characteristics of \nacute hepatitis E in the population. \n \n4) To study the presence of new polyomaviruses (KIPyV, WUPyV and MCPyV) in sewage \nand river samples to determine their excretion patterns and dissemination. \n \n5) To evaluate the removal efficiency of viral pathogens and microbial indicators of faecal \ncontamination in sewage treatment plants. \n \n6) To define new microbiological indicators of faecal contamination to improve the \nquality control of reclaimed water. \n \n7) To develop a new efficient and low cost protoc ol for the concentration of viral particles \nfrom sewage, with the goal of potentially implement it in routine laboratories and countries with poor economic development. \n \n8) To determine the levels of viral contamination in bivalve molluscan introduced into the \nfood chain at the market level. \n \n9) To evaluate the efficiency in human viru s removal in bivalve molluscan depuration \nplants. \n \n10) To improve microbiological controls of faecal contamination in bivalve molluscan \nshellfish. \n \n11) To develop a mathematical model that allows us to assess the risk of NoV infection and \ndisease associated with consumption of bivalve molluscan.   \n  \n \n    \n3. PUBLICACIONES  Listado de publicaciones \n 83 Esta Tesis Doctoral est\u00e1 basada en las siguientes publicaciones (orden cronol\u00f3gico): \n \n1. Clemente-Casares P, Rodriguez-Manzano J, Girones R. Hepatitis E virus genotype 3 \nand sporadically also genotype 1 circulat e in the population of Catalonia, Spain. J \nWater Health.  2009; 7(4):664-73. \n \n2. Rodriguez-Manzano J, Miagostovich M, Hundesa A, Clemente-Casares P, Carratala A, \nButi M, Jardi R, Girones R.  Analysis of the evolution in the circulation of HAV and HEV \nin eastern Spain by testing urban sewage samples.  J Water Health. 2010; 8(2):346-54. \n \n3. Bofill-Mas S, Rodriguez-Manzano J, Calgua B, Carratala A, Girones R.  Newly described \nhuman polyomaviruses Merkel cell, KI and WU are present in urban sewage and may \nrepresent potential environmental contaminants. Virol J.  2010; 7:141. \n \n4. Rodriguez-Manzano J, Alonso JL, Ferr\u00fas MA, Moreno Y, Amor\u00f3s I, Calgua B, Hundesa \nA, Guerrero-Latorre L, Carratala A, Rusi\u00f1ol M, Girones R.  Standard and new faecal \nindicators and pathogens in sewage treatment plants, microbiological parameters for improving the control of reclaimed water. Water Sci Technol . 2012; In press. \n \n5. Calgua B, Rodriguez-Manzano J, Hundesa A, Su\u00f1en E, Calvo M, Bofill-Mas S, Girones \nR. New methods for the concentration of viruses from urban sewage using \nquantitative PCR. Sometido a J Virol Methods.  2012. \n \n6. Rodriguez-Manzano J, Hundesa A, Calgua B, Carratala A, Maluquer de Motes C,  \nRusi\u00f1ol M, Moresco V,  Ramos AP, Mart\u00ednez-Marca F, Calvo M, Barardi CRM, Bofill-\nMas S, Girones R.  Failure to remove viral contamination in molluscan shellfish applying \ncurrent depuration trea tments. Sometido a Int J Food Microbiol . 2012. \n \n7. Rodriguez-Manzano J, Bouwknegt M, van den Berg HH, Teunis PF, de Roda Husman \nAM. Quantitative risk assessment for human  norovirus infection due to oyster \nconsumption. Manuscrito preparado para su sumisi\u00f3n a Risk Anal . 2012. \n  Informe de participaci\u00f3n \n 85 \n \n \nInforme sobre la participaci\u00f3n del doctorando en los art\u00edculos presentados. \n  Clemente-Casares P, Rodriguez-Manzano J, Girones R (2009). Hepatitis E virus genotype 3 \nand sporadically also genotype 1 circulate in the population of Catalonia, Spain.  \nJournal of Water and Health.  7(4):664-73. \n  El doctorando ha llevado a cabo una gran parte de trabajo experimental en todas las \netapas del estudio. Ha realizado la concentraci\u00f3n de virus en las muestras procesadas, la detecci\u00f3n de part\u00edculas v\u00edricas, clonaci\u00f3n, secuenciaci\u00f3n de una parte de los clones \nobtenidos y ha participaci\u00f3n en el an\u00e1lisis de los datos y en la escritura del art\u00edculo.  \n Rodriguez-Manzano J, Miagostovich M, Hundesa A, Clemente-Casares P, Carratala A, Buti M, \nJardi R, Girones R  (2010). Analysis of the evolution in the circulation of HAV and HEV in \neastern Spain by testing urban sewage samples.  Journal of Water and Health. 8(2):346-\n54. \n  El doctorando ha llevado a cabo la mayor parte del trabajo experimental; tratamiento y \nan\u00e1lisis de las muestras de suero y muestras ambientales para HEV y HAV por t\u00e9cnicas moleculares, as\u00ed como el an\u00e1lisis de las secuencias obtenidas. El doctorando ha participado activamente en la discusi\u00f3n de lo s resultados y ha escrito el manuscrito bajo \nla supervisi\u00f3n de la directora de Tesis. \n \nBofill-Mas S, Rodriguez-Manzano J, Calgua B, Carratala A, Girones R (2010). Newly described \nhuman polyomaviruses Merkel cell, KI and WU are present in urban sewage and may \nrepresent potential environmental contaminants.  Virology Journal.  7:141. \n  El doctorando particip\u00f3 activamente en el dise\u00f1o del estudio y ha  realizado una parte \nimportante del trabajo experimental; tratam iento de las muestras de agua residual y \nagua de r\u00edo, y la detecci\u00f3n y an\u00e1lisis de los poliomavirus estudiados. Los dem\u00e1s \ncoautores han contribuido a la cuantificaci\u00f3n de otros indicadores virales y a la optimizaci\u00f3n de las t\u00e9cnicas de concentraci\u00f3n de virus en agua. Bajo la supervisi\u00f3n de la directora de tesis el doctorando ha contri buido de forma decisiva en el an\u00e1lisis y \ndiscusi\u00f3n de los resultados a la ho ra de redactar el manuscrito.  \n Rodriguez-Manzano J, Alonso JL, Ferr\u00fas MA, Moreno Y, Amor\u00f3s I, Calgua B, Hundesa A, \nGuerrero-Latorre L, Carratala A, Rusi\u00f1ol M, Girones R  (2012). Standard and new faecal \nindicators and pathogens in sewage treatment plants, microbiological parameters for improving the control of reclaimed water.  Water Science and Technology . In press. \n  El doctorando ha llevado a cabo el tratam iento de muestras para los an\u00e1lisis v\u00edricos, \nanalizando los principales virus pat\u00f3genos. Los autores de las otras instituciones han analizado la presencia de bacterias y par\u00e1sitos. El doctorando ha trabajado en la \ninterpretaci\u00f3n de resultados correspondiente  y ha coordinado junto con el resto de \ngrupos de investigaci\u00f3n la toma de muestr a y dise\u00f1o del estudio aqu\u00ed presentado, \ndiscutiendo los resultados y elaborando el manuscrito junto a la directora de Tesis. Informe de participaci\u00f3n \n 86 Calgua B, Rodriguez-Manzano J, Hundesa A, Su\u00f1en E, Calvo M, Bofill-Mas S, Girones R  (2012).  \nNew methods for the concentration of viruses from urban sewage using quantitative \nPCR. Sometido a J Virol Methods. \n  Los dos primeros autores han contribuido de  forma equivalente en este estudio y as\u00ed \nse ha hecho constar en el art\u00edculo enviad o para su publicaci\u00f3n. El doctorando ha \nparticipado en el dise\u00f1o y desarrollo de  los nuevos m\u00e9todos de concentraci\u00f3n de \npart\u00edculas v\u00edricas en agua residual propuestos. Ha realizado la evaluaci\u00f3n estad\u00edstica de los datos con la colaboraci\u00f3n de un bioestad\u00edstico y ha participado activamente en las tareas experimentales. Los otros coautores han contribuido con la preparaci\u00f3n de \nsuspensiones virales, recogida de muestras en otras \u00e1reas geogr\u00e1ficas y an\u00e1lisis de algunos indicadores virales. El doctorando ha  contribuido activamente en el an\u00e1lisis e \ninterpretaci\u00f3n de los resultados, as\u00ed como en la elaboraci\u00f3n del manuscrito.  \n Rodriguez-Manzano J, Hundesa A, Calgua B, Carratala A, Maluquer de Motes C, Rusi\u00f1ol M, \nMoresco V, Ramos AP, Mart\u00ednez-Marca F, Calvo M, Barardi CRM, Bofill-Mas S, Girones R (2012). Failure to remove viral contamination in molluscan shellfish applying current \ndepuration treatments.  Sometido a International Journal of Food Microbiology . \n \n Este es un estudio realiz ado durante mucho tiempo y en el que han participado \nempresas depuradoras de moluscos bivalvos y un veterinario con responsabilidades en \nel control de la calidad de estos productos que son coautores del estudio. El doctorado \nrealiz\u00f3 la gran parte del trabajo experiment al, tratamiento de las muestras de moluscos \nbivalvos y realizando los correspondiente s an\u00e1lisis. Los otros autores de la UB, \ncolaboraron con el doctorando en la optimizaci\u00f3n y comparaci\u00f3n de m\u00e9todos de recuperaci\u00f3n de virus en moluscos bivalvos y en el an\u00e1lisis de virus en algunas de las muestras analizadas. El doctorando ha partic ipado en el dise\u00f1o de los experimentos \nincluidos en el trabajo y ha redactado el ma nuscrito bajo la supervisi\u00f3n de la directora \nde Tesis. \n Rodriguez-Manzano J, Bouwknegt M, van den Berg HH, Teunis PF, de Roda Husman AM \n(2012). Q uantitative risk assessment for human norovirus infection due to oyster \nconsumption.  Manuscrito preparado para su sumisi\u00f3n a Risk Analysis . \n  El doctorando ha dise\u00f1ado la modelizac i\u00f3n matem\u00e1tica e interpretaci\u00f3n de los \nresultados durante la estancia realizada en 2008 en el Instituto Nacional de Salud P\u00fablica y Ambiental (RIVM), Holanda. Ha contri buido de forma decisiva en la redacci\u00f3n \ndel manuscrito bajo la supervisi\u00f3n de la Dra. Ana Maria de Roda Husman. \n \n Ninguno de los coautores de los art\u00edculos ha utilizado los datos descritos en estos art\u00edculos para la elaboraci\u00f3n de su Tesis Doctoral.       Prof. Rosina Giron\u00e9s Llop Barcelona, a 20 de marzo de 2012 Informe factor de impacto \n 87 \n \n \nInforme sobre el factor de impacto de los art\u00edculos presentados en la Tesis Doctoral. \n \nLas publicaciones que forman parte de la Tesi s Doctoral presentada por Jes\u00fas Rodr\u00edguez \nManzano han sido publicadas o se han sometido  para su publicaci\u00f3n en revistas cient\u00edficas \nrelevantes en la l\u00ednea de investigaci\u00f3n en que ha participado, perteneciendo tanto al \u00e1mbito \nb\u00e1sico como aplicado.  \nLos art\u00edculos \u201c Hepatitis E virus genotype 3 and sporadically also genotype 1 circulate in the \npopulation of Catalonia, Spain \u201d y \u201c Analysis of the evolution in the circulation of HAV and HEV \nin eastern Spain by testing urban sewage samples \u201d fueron publicados en Journal of Water \nand Health  en los a\u00f1os 2009 y 2010, en que esta revista present\u00f3 \u00edndices de impacto de 1,469  \ny 1,625 , respectivamente. El art\u00edculo \u201c Newly described human polyomaviruses Merkel cell, KI \nand WU are present in urban sewage and may represent potential environmental contaminants \u201d fue publicado en Virology Journal  en el a\u00f1o 2010, en que esta revista present\u00f3 \nun \u00edndice de impacto de 2,550 . El art\u00edculo \u201c Standard and new faecal indicators and pathogens \nin sewage treatment plants, microbiological parameters for improving the control of \nreclaimed water \u201d ha sido aceptado en la revista Water Science and Technology , que en 2010 \npresent\u00f3 un indice de impacto de 1,056 . El art\u00edculo \u201c New methods for the concentration of \nviruses from urban sewage using quantitative PCR \u201d se ha sometido a Journal of Virological \nMethods , que en 2011 mostr\u00f3 un \u00edndice de impacto de 2,262 . El art\u00edculo \u201c Failure to remove \nviral contamination in molluscan shellfish applying current depuration treatments \u201d se ha \nsometido en International Journal of Food Microbiology , que en el a\u00f1o 2011 present\u00f3 un \u00edndice \nde impacto de 3,143 . El \u00faltimo de los art\u00edculos \u201c Quantitative risk assessment for human \nnorovirus infection due to oyster consumption \u201d est\u00e1 preparado para su sumisi\u00f3n a Risk \nAnalysis , que en el a\u00f1o 2010 mostr\u00f3 un \u00edndice de impacto de 2,096 . \n Firmado:   \n \nProf. Rosina Giron\u00e9s Llop Barcelona, Marzo de 2012\n   \n  \n \n    \n4. RESULTADOS   \n \n \n   \n \n \nCap\u00edtulo I \n \n Infecciones por virus pat\u00f3genos en la \npoblaci\u00f3n, an\u00e1lisis de la prevalencia y \ndiseminaci\u00f3n ambiental  Cap\u00edtulo I: Estudio 1 \n 93  \nINTRODUCCI\u00d3N  \nEuropa y Norteam\u00e9rica se consideran regi ones no end\u00e9micas para HEV debido a que \nlas tasas de seropositividad descritas oscilan entre 1% \u2013 5% y la mayor\u00eda de las infecciones identificadas se asocian con casos importados. No obstante, en los \u00faltimos a\u00f1os se est\u00e1 \nregistrando un incremento de casos espor\u00e1dicos de hepatitis agudas asociados a este \npat\u00f3geno. Al mismo tiempo, Espa\u00f1a se consider a una regi\u00f3n de baja endemicidad para HAV y \ndiversos estudios publicados recientemente confirman la progresiva reducci\u00f3n de la \nprevalencia de anti-HAV, aproxim\u00e1ndose a valo res de pa\u00edses caracterizados como de  \nendemicidad baja. Desde octubre de 1999 en la Comunidad Aut\u00f3noma de Catalu\u00f1a se administra la vacuna combinada frente a los virus de la hepatitis A y B (Twinrix\u00ae) a los ni\u00f1os de 12 a\u00f1os de edad, con una cobertura de vacunaci \u00f3n del 90%. Por otro lado, en la Comunidad \nAut\u00f3noma de Valencia (limitando al norte con Catalu\u00f1a) la vacuna contra HAV se administra \n\u00fanicamente entre grupos de riesgos, principalm ente manipuladores de alimentos. Hasta la \nfecha, no hay una vacuna contra HEV co mercialmente disponible para humanos. \n \nEl objetivo principal de este trabajo consisti\u00f3 en analizar la evoluci\u00f3n de los patrones \nde excreci\u00f3n de HAV y HEV en la poblaci\u00f3n ubicada en el noreste de Espa\u00f1a mediante el an\u00e1lisis de los virus excretados en agua re sidual urbana, con la intenci\u00f3n de evaluar el \npotencial impacto correspondiente a las mejo ras en los sistemas de saneamiento y a la \nimplementaci\u00f3n de programas de vacunaci\u00f3n para HAV. Al mismo tiempo, se evalu\u00f3 la \npresencia de HEV en muestras de suero procedentes de pacientes con hepatitis agudas con el objetivo de confirmar y caracterizar la infecci\u00f3n de cepas aut\u00f3ctonas de este pat\u00f3geno en la poblaci\u00f3n de estudio.  RESUMEN ESTUDIO 1: \n \nAnalysis of the evolution in the circulation of HAV and HEV in Eastern Spain by testing urban sewage samples  Rodriguez-Manzano J, Miagostovich M, Hundesa A, Clemente-Casares P, Carratala A, Buti \nM, Jardi R, Girones R  \nJournal of Water and Health.  2010; 8(2):346-54  Cap\u00edtulo I: Estudio 1 \n 94 RESULTADOS Y DISCUSI\u00d3N \n \nComparando con estudios previos realizados  en nuestro grupo de investigaci\u00f3n, la \nproporci\u00f3n de muestras de agua residual cruda positivas para HEV descritas en Catalu\u00f1a ha \nca\u00eddo de un 43% (1994 \u2013 2002) hasta establecerse en un 30% (2006 \u2013 2008), mostrando una concentraci\u00f3n media de  10\n1 GC/mL. Cuatro muestras de suero de un total de 19 (obtenidas en \npacientes con hepatitis agudas) fueron positivas para el RNA de HEV. Los resultados demuestran que HEV est\u00e1 circulando en la pobl aci\u00f3n del \u00e1rea estudiada y que el agua residual \nsigue representando una potencial fuente de contaminaci\u00f3n para este pat\u00f3geno. Respecto \nHAV, en el periodo 1994 \u2013 2002 se report\u00f3 un 57% de muestras de agua residual positivas procedentes de Catalu\u00f1a, mientras que los muestreos del periodo 2007 \u2013 2008 evidencian \u00fanicamente un 3% de muestras positivas. Tamb i\u00e9n se cuantific\u00f3 la presencia de HAV, \nobservando valores medios de 10\n2 GC/mL de agua residual cruda. No se han observado \ndiferencias en la prevalencia de HEV y HAV en el agua residual de ambas comunidades \naut\u00f3nomas durante el periodo 2006 \u2013 2008, demostr\u00e1ndose que la reducci\u00f3n no est\u00e1 restringida a una zona concreta y que por lo  tanto no se vincula estrictamente con un \nprograma de vacunaci\u00f3n espec\u00edfico. El nivel de  contaminaci\u00f3n fecal de los puntos de muestreo \nfue evaluado mediante la determinaci\u00f3n de la concentraci\u00f3n de HAdV cuantificados por qPCR. \nComo se esperaba, HAdV fue detectado en el 100% de las mues tras de agua residual \nanalizadas y la concentraci\u00f3n registrada fue mayor a 10\n3 GC/mL, valores frecuentemente \nobservados en agua residual cruda de origen  urbano, corroborando un nivel adecuado de \ncontaminaci\u00f3n fecal y descartando este motivo como el responsable de la disminuci\u00f3n de \nHAV. Simult\u00e1neamente, se realizaron an\u00e1lisis de aguas residuales procedentes del norte de \nEgipto, zona end\u00e9mica para HAV, presentando una elevada proporci\u00f3n de muestras positivas. \nLos datos obtenidos sugieren que las mejoras realizadas en saneamiento, la implementaci\u00f3n \nde plantas depuradoras y el desarrollo de nuevo s tratamientos de agua residual es un factor \ndeterminante para la reducci \u00f3n de enfermedades transmitidas oro-fecalmente en una \npoblaci\u00f3n determinada.   \nTodas las secuencias v\u00edricas identificadas en agua residual para HEV mostraron \ngenotipo 3, excepto una muestra que se iden tific\u00f3 como genotipo 1. Las secuencias \nidentificadas entre las muestras de suero most raron el mismo resultado, una \u00fanica muestra \npositiva identificada como genotipo 1 y co rrespondiente con un paciente que hab\u00eda viajado \nrecientemente a India. La variabilidad de secuencias de HEV detectadas en agua residual muestra una gran diversidad entre las secuenci as del genotipo 3 que simult\u00e1neamente circulan Cap\u00edtulo I: Estudio 1 \n 95 en la poblaci\u00f3n estudiada. La detecci\u00f3n espor\u00e1di ca de HEV genotipo 1, considerada t\u00edpica de \nzonas end\u00e9micas y sin reservorio animal asociado,  nos indica que las infe cciones de HEV se han \nestablecido en la poblaci\u00f3n humana de Euro pa y que una peque\u00f1a proporci\u00f3n de este \ngenotipo tambi\u00e9n circula en pa\u00edses industrializados.   CONCLUSIONES  \nLa reciente disponibilidad de una vacuna eficiente para prevenir infecciones por HAV, \nla implementaci\u00f3n de programas de vacunaci\u00f3n de amplia distribuci\u00f3n y las constantes mejoras en las condiciones sanitarias prometen una  reducci\u00f3n en la circulaci\u00f3n de virus en la \npoblaci\u00f3n y en los niveles de excreci\u00f3n de HAV en el agua residual. La dr\u00e1stica reducci\u00f3n observada en la presencia de HAV en agua re sidual procedente del es te de Espa\u00f1a puede \njustificarse con las mejoras generales en lo s sistemas de saneamiento. No obstante, estas \nmejoras parecen no haber tenido un efecto equivalente en la circulaci\u00f3n del genotipo 3 de \nHEV en la misma zona de estudio. La conti nua circulaci\u00f3n de este genotipo puede verse \nestablecida por la presencia de reservorios animales, ya que las infecciones en cerdos \nrepresentan una fuente externa de HEV en la  poblaci\u00f3n humana. Los resultados obtenidos \nsugieren que HEV ha reemplazado a HAV como la hepatitis v\u00edrica potencialmente transmitida a trav\u00e9s de agua y alimentos m\u00e1s frecuentemente detectada en el este de Espa\u00f1a.  Analysis of the evolution in the circulation of HAV and HEV\nin Eastern Spain by testing urban sewage samples\nJesus Rodriguez-Manzano, Marize Miagostovich, Ayalkibet Hundesa,\nPilar Clemente-Casares, Anna Carratala, Maria Buti, Rosend Jardi\nand Rosina Girones\nABSTRACT\nJesus Rodriguez-Manzano\nAyalkibet Hundesa\nAnna Carratala\nPilar Clemente-Casares*\nRosina Girones (corresponding author)\nDepartment of Microbiology, Faculty of Biology,University of Barcelona,\nAvd. Diagonal 645,\n08028 Barcelona,\nSpain\nTel.: 34-93-4021483Fax: 34-93-4039047\nE-mail: rgirones@ub.edu\n*Present address\nCRIB, University of Castilla-La Mancha,\nAvda Almansa 14,\n02006 Albacete,\nSpain\nMarize Miagostovich\nDepartment of Virology,\nInstitute Oswaldo Cruz, Fiocruz,\nAvda Brasil 4365,21045-900, Rio de Janeiro,\nBrazil\nMaria Buti\nRosend JardiHospital General Universitario Valle Hebron\nand Ciber-Ehd,\nPaseo de la Vall d\u2019Hebron, 119-129,\n08035 Barcelona,\nSpainThe aim of the study was to analyse the evolution of the prevalence of HAV and HEV in the\npopulation of eastern Spain by analysing the viruses excreted in urban sewage. Raw urban\nsewage samples were collected and analysed during several years using RT-PCR techniques andsequencing analysis. Two limiting regions were analysed, one of them having implemented HAVvaccination programs. Acute symptomatic HEV cases were also examined. Results were\ncompared with those from previous studies in the area using identical methodology. The\npercentage of positive HAV samples in urban sewage fell from 57.4% to 3.1% in 5\u201310 years in thetwo studied areas in Spain. Around 30% of the urban sewage samples were positive for HEV inthe absence of agricultural sources of contamination. HEV RNA was also detected in four clinical\ncases of acute hepatitis. The dramatic reduction in the presence of HAV in raw urban sewage\nobserved in eastern Spain could be most likely related to the general improvement in sanitation.However, these improvements would not have an equivalent effect on the circulation of HEV andthis observation could be explained by the presence of animal reservoirs for HEV, which act as\nexternal sources of infections.\nKey words |acute hepatitis, HAV, HEV, sanitation, vaccination, wastewater\nABBREVIATIONS\nBLAST Basic Local Alignment Search Tool\nDNA Deoxyribonucleic acid\nEIA Enzyme immunoassayEMEM Eagle\u2019s minimum essential medium\nFDA Food and Drug Administration\nGC Genomic copies\nHAdV Human adenovirus\nHAV Hepatitis A virus\nHBeAg Hepatitis B e-antigenHBsAg Hepatitis B surface antigen\nHCV Hepatitis C virus\nHEV Hepatitis E virusIgG Immunoglobulin G\nIgM Immunoglobulin M\nNAs Nucleic acids\nNCBI National Center for Biotechnology\nNE Northeast\nNJ Neighbour joining\ndoi: 10.2166/wh.2009.042346 QIWA Publishing 2010 Journal of Water and Health |08.2|2010ORF2 Open Reading Frame 2\nPCR Polymerase Chain Reaction\nQPCR Quantitative PCR\nRNA Ribonucleic acidRT\u2013PCR Reverse Transcriptase PCRVP1/2A Viral Protein 1/2A\nINTRODUCTION\nHepatitis A virus (HAV) and hepatitis E virus (HEV) are\nsmall, non-enveloped viruses that contain positive sense,\nsingle-stranded RNA genomes of 7.5 and 7.2 kb, respect-\nively ( Purcell & Emerson 2008 ). HAV has its own genus\n(Hepatovirus ) within the family Picornaviridae whereas\nHEV is the sole member of the genus Hepevirus and family\nHepeviridae (Emerson et al. 2005;Nainan et al. 2006 ). Both\nviruses cause acute, self-limited infections that may vary in\nseverity from asymptomatic to fulminant ( Purcell &\nEmerson 2008 ). The most common route of transmission\nis generally faecal-oral ( Orru`et al. 2004 ) and it causes large-\nscale epidemics.\nHepatitis A affects humans worldwide. HAV infection is\nendemic to developing countries where most individualsare exposed to this virus during childhood ( Jacobsen &\nKoopman 2004 ). Hepatitis E is the major cause of waterborne\noutbreaks and sporadic cases of acute hepatitis in many\ndeveloping countries where sanitation is suboptimal and\nwhere HEV is considered endemic ( Clemente-Casares et al.\n2003;Emerson & Purcell 2004 ). Typically, the disease\ncaused is self-limited but it sometimes has severe compli-cations, particularly in pregnant women, who register a highmortality rate (20%) ( Balayan 1997 ).\nTraditionally, North America and Europe have been\nconsidered non-endemic regions for HEV as they haveseroprevalence rates of 1 to 5% and most HEV infectionsare thought to be imported ( Paul et al. 1994). However, in\nthe last few years several HEV strains associated with\nsporadic acute hepatitis and genetically distinct from the\nendemic ones have been isolated from human serumsamples in North America and in some European countries(Clemente-Casares et al. 2009 ;Legrand-Abravanel et al.\n2009 ). A recent study conducted in the same area, Catalonia(NE Spain), showed a seroprevalence of about 7.3% ( Buti\net al. 2006 ). There is also evidence that some animals,\nparticularly swine, are infected by HEV genotypes 3 and 4.Both genotypes have been recovered from swine principally\nin the same regions that these genotypes were recovered\nfrom humans ( Meng et al. 1997;Purcell & Emerson 2008 ).\nWith few exceptions, genotypes 3 and 4 appear not to\nproduce disease in swine ( Mart\u0131 \u00b4net al. 2007). In certain\nregions, including Spain, swine and human HEV strains are\nnot genetically distinguishable ( Clemente-Casares et al.\n2009 ), thereby supporting the notion that swine are a\nreservoir and that HEV infection is acquired by handling\nthese animals or eating raw pork products.\nSpain is considered an area of low endemicity for HAV\ninfection ( Bell 2002 ) and is characterized by diminishing\nHAV seroprevalence in the population ( Jacobsen &\nKoopman 2004 ), while it is a non-endemic area for HEV\n(Yarbough 1999 ). Previous studies in Spain show that even\nin the absence of signi\ufb01cant numbers of clinical cases of\nacute hepatitis A and E, HAV and HEV are present in more\nthan 50 and 40%, respectively, of urban sewage samples\nanalysed, thereby indicating a high level of subclinical\ninfection in the population ( Pina et al. 2001;Clemente-\nCasares et al. 2003).\nIn 2001, the FDA approved a new combination vaccine\nagainst HAV and the hepatitis B virus. The vaccine, called\nTwinrix, contains the approved vaccine Havrixw(Hepatitis\nA Vaccine, Inactivated) ( US Food and Drug Administration\n2001). Twinrix has been distributed in a pilot program in\nCatalonia for pre-adolescents since 1999. In Valencia, a\nregion immediately south of Catalonia, HAV vaccines are\ndistributed only among groups at risk as a result of handlingfood. No HEV vaccine is currently available for humans.\nBy 2006, 235,170 and 11,826 doses of vaccines\nagainst HAV had been distributed in Catalonia (coveringaround 90% of pre-adolescents) and Valencia (in the\nprofessional food handler group), respectively ( Departa-\nment de Salut, Generalitat de Catalunya 2008 ;Direccio \u00b4\ngeneral de salut pu \u00b4blica, conselleria de sanitat, Generalitat\nValenciana 2008 ).\nThis study analyses changes in the excretion patterns of\nHAV and HEV in eastern Spain by testing the presence of\nthese viruses in urban sewage over several years in order to\nevaluate the potential impact of improvements in sanitation347 J. Rodriguez-Manzano et al. |Excretion patterns of HAV and HEV infections in Eastern Spain Journal of Water and Health |08.2|2010and vaccination programs for HAV. Serum samples from\nacute hepatitis patients were also analysed to con\ufb01rm the\npresence of HEV strains in the population.\nMETHODS\nSewage samples\nSampling areas were selected on the basis of the vaccination\nprograms applied for HAV. Samples were collected inBarcelona and Valencia, the largest cities in Catalonia andValencia respectively, both in Spain. A total of 91 urbansewage samples were collected in Barcelona (50 samples)\nand Valencia (41 samples) from 2000 to 2008. Samples\nwere collected at the entry of two treatment plants inCatalonia receiving sewage from a population of about 1.8million (Barcelona) and three plants from the area ofValencia, with a total population of about 800,000\ninhabitants. Each sample was harvested in a sterile 500-ml\npolyethylene container and kept at 4 8C for less than 8 h\nuntil the virus particles were concentrated.\nClinical samples\nFrom 2004 to 2007, 19 serum samples were collected from\npatients with symptomatic acute hepatitis attending theHospital General Valle Hebron (Barcelona, Spain). All\npatients had elevated aminotransferase levels ( .10 times\nthe upper normal limit) and IgG anti-HEV antibodies.Clinical serum samples were also analysed for other viralinfections. Hepatitis B surface antigen and antibody toHCV (anti-HCV) were detected by commercial enzyme\nimmunoassays (Vitros HBsAg and Vitros anti-HCV;\nJohnson & Johnson, Rochester, NY, USA). IgM anti-HBcand IgM anti-HAV were detected by enzyme immunoassays(Liaison HBeAg/anti-HBe, Liaison HBc IgM and LiaisonHAV IgM, respectively; Diasorin, Vercelly, Italy). IgG anti-HEV was the routine assay in use for HEV infections and\nwas determined by EIA (Bioelisa HEV IgG; Biokit,\nBarcelona, Spain). Serum samples were stored at 2808C\nuntil use for detecting genomic sequences. Other causes ofacute hepatitis such as autoimmune hepatitis or biliarystones were excluded.Viruses\nThe positive controls used for the analysis of HAV consisted\non dilutions of the supernatant of FRhK-4 cell cultures\ninfected with pHM-175 strain. As positive controls for HEV\nanalysis, 10% faecal suspensions obtained from rhesus\nmonkeys experimentally infected with a strain isolated\nfrom a sewage sample collected in Barcelona ( Pina et al.\n1998) were used. HAdV2, isolated from a clinical sample\nand used as positive control for the determinations of\nhuman adenoviruses, was grown on A549 cells propagated\nin Eagle\u2019s minimum essential medium (EMEM) sup-\nplemented with 1% glutamine, 50 mg of gentamicin per ml,\nand 5% (growth medium) or 2% (maintenance medium) of\nheat-inactivated FBS. Viral suspensions were stored at\n2808C until use.\nConcentration of viruses from urban sewage\nThe method used to recover virus particles from sewage\nsamples was chosen on the basis of previous studies ( Puig\net al. 1994;Pina et al. 1998). Brie\ufb02y, 42 ml of sewage was\nultracentrifuged at 110,000 \u00a3gfor 1 h at 4 8C to pellet all\nthe viral particles together with any suspended material.\nThe pellet was eluted by mixing it with 3.5 ml of 0.25 N\nglycine buffer (pH 9.5) on ice for 30 min and, after addition\nof 3.5 ml of 2X phosphate-buffered saline, the suspended\nsolids were separated by centrifugation at 12,000 \u00a3gfor\n20 min. Finally, viruses were concentrated by ultracentrifu-\ngation at 110,000 \u00a3gfor 1 h at 4 8C, resuspended in 100 ml\nof phosphate-buffered saline and stored at 2808C.\nNucleic acid extraction\nThe nucleic acids (NAs) from viral concentrates obtained\nfrom sewage samples were extracted following a highly\nsensitive and ef\ufb01cient procedure ( Puig et al. 1994) described\nby Boom et al. (Boom et al.\n1990). This procedure is based\non the use of guanidinium isothiocyanate and silica\nparticles.\nFor clinical serum samples, QIAamp RNA Blood Mini\nKitw(Qiagen, Valencia, Spain) was used for the viral RNA\nextraction, following the manufacturer\u2019s instructions.348 J. Rodriguez-Manzano et al. |Excretion patterns of HAV and HEV infections in Eastern Spain Journal of Water and Health |08.2|2010Reverse transcription-polymerase chain reaction\nAll samples were analysed with primers designed to amplify\na region within the ORF2 of HEV ( Erker et al. 1999) (semi-\nnested RT-PCR) and a non-codifying region of 50end of\nHAV ( Pina et al. 2001) (nested RT-PCR). The VP1/2A\nregion was used to characterize HAV-positive samples bysequencing ( Pina et al. 2001). Positive and negative controls\nextracted in parallel and inhibition controls were added to\nthe PCR assays. The results of the PCRs using OneStep\nw\nRT-PCR kit from Qiagen, for a typical one-step reaction,\nand the 50- ml reaction mixture containing PCR Gold Buffer,\n1.2 mM MgCl 2and 2 U of AmpliTaqwGold (Applied\nBiosystems, New Jersey, USA), for a second PCR ampli\ufb01ca-tion cycle, were analysed by electrophoresis on agarose gels\nto 3% (w/v), followed by staining with ethidium bromide at\n0.5mg/ml. The amplicons were viewed using an Image\nMaster\nwVDS (Pharmacia Biotech, Uppsala, Sweden).\nAnalysis of sewage samples by QPCR\nHAV- and HEV-positive samples by nested PCR were\nquanti\ufb01ed by real-time PCR ( Jothikumar et al. 2005b, 2006 ).\nFive microlitres of the extracted RNA, corresponding to2.1 ml sewage, was analysed. Five microlitres of ten-folddilutions (from 5 \u00a310\n0to 5\u00a3107GC/5 ml) of a plasmid\nsuspension were used as standard. Ampli\ufb01cation reactionswere performed with the QuantiTect YProbe RT-PCR kit\nreagents (Qiagen).\nHuman adenoviruses (HAdVs) were determined in\neach location. The viral load of HAdV was used to discardnegative HAV and HEV results caused by the absence ofhuman faecal contamination, which could in\ufb02uence theresults of the study ( Bo\ufb01ll-Mas et al. 2006 ).\nQPCR ampli\ufb01cation reactions for HAdV were carried\nout using TaqMan\nwUniversal PCR Master Mix reagents\n(Applied Biosystems), as previously described ( Jothikumar\net al. 2005a;Bo\ufb01ll-Mas et al. 2006 ). The HAdV 41 used\nin the construction of the standards was kindly donatedby Dr Annika Allard at the University of Umea \u02da, Sweden.\nTen microlitres of the NA extractions were analysed,corresponding to 4.2 ml of sewage sample. Dilutions\nfrom 10\n21to 107CG/10 ml of the standard were analysed\nin triplicate.In all PCR assays, standard precautions were taken by\nusing separate areas for the diverse steps of the protocols.\nNegative controls, inhibition controls and positive controlswere added in each assay. Positive results were con\ufb01rmedby sequencing analysis of the ampli\ufb01ed DNA. The QPCRswere conducted in a thermocycler Stratagene\nwMX3000P\n(Stratagene, La Jolla, USA). All the samples and their\nrespective dilutions were analysed in duplicate.\nSequencing and analysis of viral genomes\nAmplicons obtained with the nested PCR were puri\ufb01ed\nusing a QIAquickwpuri\ufb01cation kit (Qiagen), following the\nmanufacturer\u2019s instructions. Both strands of the puri\ufb01edDNA amplicons were sequenced using an ABI Prism 3100\nGenetic Analyzer and Big Dye Terminator Cycle Sequen-\ncing Kit v. 3.1\nw(Applied Biosystems), following the\nmanufacturer\u2019s instructions. Products were checked usingan ABI PRISM 377 analyser (Applied Biosystems) by theScienti\ufb01c and Technical Services of the University ofBarcelona. The sequences were compared with the nucleo-\ntide sequences present in the GenBank using the BLAST\nprogram of the NCBI (National Center for BiotechnologyInformation; www.ncbi.nlm.nih.gov/BLAST ) and aligned\nusing the Clustal X 1.8 program. Phylogenetic tree recon-structions were performed with Mega 3.1 ( www.megasoft-\nware.net ). Evolutionary distances were determined by the\nKimura two-parameter equation, and the tree was con-structed by using the neighbour-joining (NJ) algorithm.The GenBank accession numbers for the sequencesreported in this study are FJ010829-FJ010840 (HAV in\nsewage), FJ010841-FJ010844 (HEV in serum samples) and\nFJ010845-FJ010858 and EU729700 (HEV in sewage).\nRESULTS AND DISCUSSION\nThis study was designed as a comparative analysis for theevaluation of changes in excretion patterns of acute\nhepatitis viruses in eastern Spain. Previous studies con-\nducted in our laboratory between 1994 and 2002 analysedenvironmental and clinical samples using the sameprotocols as in this study and reported a frequent presenceof HAV and HEV in urban sewage ( Pina et al. 2001;349 J. Rodriguez-Manzano et al. |Excretion patterns of HAV and HEV infections in Eastern Spain Journal of Water and Health |08.2|2010Clemente-Casares et al. 2003). The recent availability of an\nef\ufb01cient vaccine against HAV infections, the implemen-tation of vaccination programs for a high proportion of the\nsusceptible population and a general improvement in\nsanitary conditions are expected to decrease the circulationof the virus in the population and the levels of excretion of\nHAV in the urban sewage generated.\nPresence and concentration of HAV and HEV\nAverage viral concentrations in wastewater, as determined\nby the QPCR assays, were 1.6 \u00a310\n2GC/ml for HAV and\n3.2\u00a3101GC/ml for HEV. The results on the prevalence of\npositive HAV and HEV samples using RT-PCR assays wereequivalent in the two regions in NE Spain ( Table 1 ).\nHEV was detected in clinical serum samples using\nnested RT-PCR. Four of the 19 analysed serum samplesanalysed were positive for HEV RNA, with one sample also\nbeing positive for IgM anti-HAV and one positive for anti-\nHCV antibodies without HCV RNA. These results con\ufb01rmthat HEV circulates in the population and that it causes\nsporadic clinical cases of acute hepatitis.\nIn 2001, Pina et al. (Pina et al. 2001), using the same\nmethodology as in the present study, analysed HAV strains\nexcreted in sewage in the area of Barcelona and also the\nHAV strains responsible for acute hepatitis A clinical\ninfections in Barcelona. These authors found that 57.4%\n(31/54) of the sewage samples collected from 1994 to 2000were positive for HAV and identi\ufb01ed clinical HAV infections.\nIn addition, the distribution of HAV was found to be\nequivalent to the strains detected in urban sewage. Thatstudy is considered a reference for the evaluation of changes\nin the epidemiological pattern of HAV in the study area.\nThe results obtained in this study show a marked\nreduction in the prevalence of HAV in the study area,\nthereby suggesting that the higher risk of this population toacquire HAV infection is at present through personal orfood-borne transmission from other areas with a higherlevel of endemicity.\nGeneral immunization in adolescents has a protective\neffect on the population; however, the pattern of HAVexcretion in urban sewage did not differ signi\ufb01cantlybetween the two regions in Spain, one of which has a\ngeneral vaccination program while the other does not.\nHowever, what is unquestionable is that vaccination is theonly measure that guarantees individual protection againstHAV infections in susceptible populations.\nImprovements in sanitation would include not only\nimprovements in water treatment but also improvementsin hygienic and preventive practices that will better protectthe environment, water and food from contamination,\nreducing the overall exposure and the number of infections\nand excreted viruses in the population. HAV is known tobe a very stable virus ( Siegl et al. 1984). The samples\nanalysed in this study were raw urban sewage samplespresenting standard concentrations of human adenovirusesand without any treatment ( Bo\ufb01ll-Mas et al. 2006 ). The\nobserved differences in the presence of HAV in thesamples would be then related with higher probability tothe reduction in the prevalence and excretion of hepatitisA viruses in the population than to signi\ufb01cant changes in\nthe stability of the viruses or in the level of faecal\ncontamination in the sewage.\nConcentration of HAdV in wastewater samples\nThe level of human faecal contamination of the sampling\nsites was evaluated by determining the concentration ofHAdV using QPCR. As expected, HAdV was detected in100% of the analysed samples and the main value ofconcentration was 1.5 \u00a310\n3GC/ml of water tested. These\nvalues are frequently observed in urban sewage and are usedas a marker of faecal contamination in contaminated water(Bo\ufb01ll-Mas et al. 2006 ).Table 1 |Presence of hepatitis A virus (HAV) and hepatitis E virus (HEV) in urban\nwastewater\nHAV HEV\nCountry/Area Year Nested PCR Semi-nested PCR\nSpain/Barcelona 1994\u20132002 31/54 *(57.4%) 20/46 *(43.5%)\nSpain/Barcelona 2000\u20132004 5/18 (27.8%) 7/18 (38.9%)Spain/Barcelona 2006\u20132008 1/32 (3.1%) 9/32 (28.1%)Spain/Valencia 2007\u20132008 1/41 (2.4%) 13/41 (31.7%)\nThe results for nested and semi-nested assays are represented as positive samples/\nsamples analysed (percentage of positives samples).\n*The results shown were obtained from previous studies Pina et al. (2001) and\nClemente-Casares et al. (2003) , respectively.350 J. Rodriguez-Manzano et al. |Excretion patterns of HAV and HEV infections in Eastern Spain Journal of Water and Health |08.2|2010Genetic characterization of the HAV and HEV strains\nThe sequences of HAV and HEV detected were compared\nwith sequences described in previous studies in the same\narea and sequences available in databases. Five out of seven\npositive HAV sequences detected by ampli\ufb01cation of the\nVP1/2A region (290 bp) were genotyped. The strains\ndetected in Spain belonged to genotype IA and IB. Onlytwo urban sewage samples were positive for HAV among\nthe samples collected in Spain between 2006 and 2008,one from Barcelona, genotype IB, and one from Valencia,\ngenotype IA.\nFifteen out of 29 positive samples for HEV were\ngenotyped and the HEV strains detected were analysed bycomparing the 101 bp sequence ampli\ufb01ed in the ORF2region. As expected, most of the HEV strains detected insamples from Barcelona and Valencia corresponded to\ngenotype 3. However, in one sample from Barcelona, a\ngenotype 1 HEV strain was identi\ufb01ed. Three of the HEVstrains identi\ufb01ed from serum samples belonged to genotype\n3, and one to genotype 1, the latter case corresponding to a\nperson that had travelled to India during the previousmonth. Phylogenetic relationships between HEV strainsisolated in Barcelona and Valencia were established bycomparing the representative strains ( Figure 1 ).\nCONCLUSIONS\nA previous study on HEV in the area around Barcelona\n(Clemente-Casares et al. 2003) showed a prevalence of\npositive samples of 43.5% (20/46) in urban sewage samples\ncollected during 1994\u20132002. In the last years the preva-lence appeared to be established at around 30% in the twostudy areas of Spain, with average concentrations of3.2\u00a310\n1GC/ml. These results demonstrate that HEV is\ncirculating in the human population of this area and thaturban sewage may be a source of contamination by this\npathogen. Moreover, the information available on the high\nprevalence of HEV infections in swine ( Meng et al. 1999;\nPina et al. 2000 ) strongly suggests that HEV strains of swine\norigin transmitted through direct or indirect contact withinfected pigs or through contaminated swine products ormanure contribute to the circulation of HEV genotype 3 in\nthe population.\nThe results of the present study show no detectable\ndifferences in the level of excretion of HAV in Barcelona, aplace where all pre-adolescents have been vaccinatedagainst HAV since 1999, compared to Valencia, where\nonly risk groups are vaccinated. This observation strongly\nsuggests that the reduction in HAV circulation does notoccur in a single area of Spain, nor is this decrease relatedto a speci\ufb01c vaccination program. For HAV, 27.8% ofsewage samples collected from 2000 to 2004 were positive.747\n951845\n731\n942\n935\n605\n0.1BCN sewage 031106\nBCN sewage 061106\nBCN sewage 141106\nBCN sewage 280806\nAF110391 Greece1 G3\nVLN sewage 040208\nVLN sewage 191207\nVLN sewage 300108\nVLN sewage 280108\nBCN VH9\nAY626042 France G3\nBCN sewage 180802\nVLN sewage 121207\nVLN sewage 111207\nVLN sewage 060208\nBCN VH10\nBCN sewage 281103\nAF110392 Greece2 G3\nAF060668 USA1 G3\nAF060669 USA2 G3\nAB074918 Japan1 G3\nAB08924 Japan2 G3\nAY115488 Canada G3\nBCN sewage161006\nAF279123 Austria G3\nBCN VH8\nAF110390 Italy G3\nAJ272108 China2 G4\nAF082094 China3 G4\nM73218 Burma G1\nAF058684 BCN G1\nDQ459342 India G1\nBCN sewage 051207\nBCN VH7\nM80581 Pakistan G1\nD11092 China1 G1\nAY230202 Morocco G1\nAY204877 Chad G1\nAF051352 Egypt G1\nM74506 Mexico G2\nAY535004 AvianHEV Genotype 5Genotype 1\nGenotype 2Genotype 3\nGenotype 4\nFigure 1 |Dendogram constructed by alignment of the 101 nucleotide sequences\nwithin the ORF2 region of HEV based on the neighbour-joining method. An\navian HEV strain is included as outgroup. GenBank accession number and\ngenotype (G) are reported. BCN (Barcelona) and VLN (Valencia) are the\nstrains obtained in this study. Strains obtained from human sera areindicated as BCN VH.351 J. Rodriguez-Manzano et al. |Excretion patterns of HAV and HEV infections in Eastern Spain Journal of Water and Health |08.2|2010This period could be considered a transition period and the\nresults could be attributed to the ongoing improvements in\nsanitation. From the samples collected since 2006, HAVwas detected in only one sample (3.1%) from Barcelona and\nin one sample (2.4%) from Valencia. Meanwhile, during this\nstudy, HAV was analysed in faecally contaminated watersamples collected in north Egypt, an endemic area for this\nvirus ( Fixet al. 2006 ), which was present in a very high\nproportion of analysed samples (authors\u2019 unpublishedresults). Implementation of wastewater treatments and\nsewage treatment plants is a determinant factor in reducing\nfaecally transmitted diseases in a population. From 1992 to\n2008, the region of Catalonia experienced a signi\ufb01cant\nincrease in the number of sewage treatment plants (from 91\nto 343) and in the total volume of wastewater depurated\n(from 991,892 to 2,786,871 m\n3/day).\nThe results obtained on the prevalence of HEV showed\na more stable excretion pattern in the population of NESpain, with percentages of 28.1, 38.9 and 31.7% of positive\nurban sewage samples over the years studied after 2000\n(Table 1 ). The concentration of HEV in positive\nurban sewage samples was lower than that of HAV, being\n10\n1CG/ml and 102CG/ml, respectively. The observed\nconcentration of HAdV was much higher, which registeredmore than 10\n3CG/ml in all the samples analysed from\nSpain. This \ufb01nding demonstrates the presence of faecal\ncontamination in the samples studied and supports the\napplicability of human adenoviruses as indicators of\nhuman faecal contamination.\nThe studies of the ampli\ufb01ed viral sequences showed the\nvariability of HAV and HEV strains present in sewage.\nAlthough the sizes of the sequences were small, previouscomparative studies have shown that the sequences\nanalysed can be used for typi\ufb01cation studies. In addition,\nthe phylogenic trees produced in this study show equivalenttopographies to those obtained when longer sequences\nwere analysed ( Pina et al. 2001;Clemente-Casares et al.\n2003;Bo\ufb01ll-Mas et al. 2006 ). All the viral sequences\nobtained differed from the positive controls used in the\nexperiments, thereby demonstrating the absence of cross\ncontamination in the study. All the HEV strains identi\ufb01edwere classi\ufb01ed as genotype 3, except one sample which was\nin genotype 1. Furthermore, the genotyping of the viruses\nidenti\ufb01ed in clinical serum samples revealed the sameresults as for HEV, that is to say, most cases showed the\npresence of genotype 3, while one sample belonged togenotype 1, in this case in a patient who had recentlytravelled to India. The variability of HEV sequencesdetected in urban sewage samples in the studied areashows that diverse genotype 3 strains simultaneouslycirculate in the population. The sporadic detection ofHEV genotype 1, considered typical of endemic regionsand without animal reservoirs identi\ufb01ed to date, indicatesthat HEV infections are well established in the human\npopulation in Europe and that a small proportion of\ngenotype 1 strains also circulate in industrialized countries.\nThe results obtained in this study strongly suggest that\nHEV has replaced HAV as the most frequently detectedhepatitis virus potentially transmitted through local faecally\ncontaminated water or food in eastern Spain.\nIn industrialized countries such as the United States, a\ndecline in the frequency of hepatitis A and in the mortalityrate was observed in the past decade (serologic results andother approach) ( Bell et al. 2005;Vogt et al. 2008 ). The\nstudy of the viruses present in urban sewage provides a\nuseful approach to obtaining global information on theirmolecular epidemiology considering also subclinical infec-tions in the population ( Pina et al. 2001).\nThe dramatic reduction in the presence of HAV in\nsewage observed in eastern Spain could be most likely\nrelated to improvements in sanitation. However, theseimprovements have not had an equivalent effect on thecirculation of HEV genotype 3 in the area. The continuedcirculation of this genotype would be maintained through\nanimal hosts as HEV infections in swine represent an\nexternal source of HEV in the human population.\nACKNOWLEDGEMENTS\nDuring the development of this study, Marize Miagostovichheld a post-doctoral fellowship from the Conselho Nacionalde Desenvolvimento Cient\u0131 \u00b4\ufb01co e Tecnolo \u00b4gico (CNPq\u2014\n210129/2006-9). Jesus Rodriguez-Manzano is a fellow ofthe Spanish Government, MICINN. We thank the Serveis\nCient\u0131 \u00b4\ufb01co-Te `cnics at the University of Barcelona for sequen-\ncing the PCR products. We also thank Hospital Valle Hebronand the INIA laboratory in Valencia for providing serum and352 J. Rodriguez-Manzano et al. |Excretion patterns of HAV and HEV infections in Eastern Spain Journal of Water and Health |08.2|2010raw sewage samples. The research described in the manu-\nscript was supported by a grant of Ministerio de Educacio \u00b4ny\nCiencia of the Spanish Government (project AGL2005-\n07776-C03-02) and the Grup de Recerca Consolidat of theGeneralitat de Catalunya (2005SGR00592).\nREFERENCES\nBalayan, M. S. 1997 Epidemiology of hepatitis E virus infection .\nJ. Viral Hepat. 4(3), 155\u2013165.\nBell, B. P. 2002 Global epidemiology of hepatitis A: implications for\ncontrol strategies. In Tenth International Symposium on Viral\nHepatitis and Liver Disease, Atlanta, GA, USA, 9\u201313 April\n2002, p. 9.\nBell, B. P., Kruszon-Moran, D., Shapiro, C. N., Lambert, S. B.,\nMcQuillan, G. M. & Margolis, H. S. 2005 Hepatitis A virus\ninfection in the United States: Serologic results from the Third\nNational Health and Nutrition Examination Survey .Vaccine\n23(50), 5798\u20135806.\nBo\ufb01ll-Mas, S., Albinana-Gimenez, N., Clemente-Casares, P.,\nHundesa, A., Rodriguez-Manzano, J., Allard, A., Calvo, M. &\nGirones, R. 2006 Quanti\ufb01cation and stability of human\nadenoviruses and polyomavirus JCPyV in wastewater matrices .\nAppl. Environ. Microbiol. 72(12), 7894\u20137896.\nBoom, R., Sol, C. J. A., Salimans, M. M. M., Jansen, C. J.,\nWertheim-van Dillen, P. M. E. & Van der Noordaa, J. 1990\nRapid and simple method for puri\ufb01cation of nucleic acids.\nJ. Clin. Microbiol. 28(3), 495\u2013503.\nButi, M., Dom\u0131 \u00b4nguez, A., Plans, P., Jard\u0131 \u00b4, R., Schaper, M., Espun \u02dces, J.,\nCarden \u02dcosa, N., Rodr\u0131 \u00b4guez-Fr\u0131 \u00b4as, F., Esteban, R., Plase `ncia, A.\n& Salleras, L. 2006 Community-based seroepidemiological\nsurvey of hepatitis E virus infection in Catalonia, Spain .Clin.\nVaccine Immunol. 13(12), 1328\u20131332.\nClemente-Casares, P., Pina, S., Buti, M., Jardi, R., Mart\u0131 \u00b4n, M.,\nBo\ufb01ll-Mas, S. & Girones, R. 2003 Hepatitis E virus\nepidemiology in industrialized countries. Emerg. Infect. Dis.\n9(4), 448\u2013454.\nClemente-Casares, P., Rodriguez-Manzano, J. & Girones, R. 2009\nHepatitis E virus genotype 3 and sporadically also genotype 1circulate in the population in Spain .J. Water Health 7(4),\n664\u2013673.\nDepartament de Salut, Generalitat de Catalunya 2008 (available at\nhttp://www.gencat.cat/salut ).\nDireccio \u00b4general de salut pu \u00b4blica, conselleria de sanitat, Generalitat\nValenciana 2008 (available at http://www.sp.san.gva.es/rvn/ ).\nEmerson, S. U. & Purcell, R. H. 2004 Running like water\u2014the\nomnipresence of hepatitis E .N. Engl. J. Med. 351(23),\n2367\u20132368.\nEmerson, S. U., Anderson, D., Arankalle, A., Meng, X. J., Purdy, M.,\nSchlauder, G. G. & Tsarev, S. A. 2005 Hepevirus. In Virus\nTaxonomy, VIIIth Report of the ICTV (ed. C. M. Fauquet, M. A.\nMayo, J. Maniloff, U. Desselberger & L. A. Ball), pp. 853\u2013857.\nElsevier Academic Press, London.Erker, J. C., Desai, S. M. & Mushahwar, I. K. 1999 Rapid detection\nof Hepatitis E virus RNA by reverse transcription-polymerase\nchain reaction using universal oligonucleotide primers .J. Virol.\nMethods 81(1\u20132), 109\u2013113.\nFix, A. D., Abdel-Hamid, M., Purcell, R. H., Shehata, M. H.,\nAbdel-Aziz, F., Mikhail, N., el Sebai, H., Nafeh, M., Habib, M.,\nArthur, R. R., Emerson, S. U. & Strickland, G. T. 2006\nPrevalence of antibodies to hepatitis E in two\nrural Egyptian communities. Am. J. Trop. Med. Hyg. 62(4),\n519\u2013523.\nJacobsen, K. H. & Koopman, J. S. 2004 Declining hepatitis A\nseroprevalence: a global review and analysis .Epidemiol.\nInfect. 132(6), 1005\u20131022.\nJothikumar, N., Cromeans, T. L., Hill, V. R., Lu, X., Sobsey, M. D.\n& Erdman, D. D. 2005aQuantitative real-time PCR assays for\ndetection of human adenoviruses and identi\ufb01cation of\nserotypes 40 and 41 .Appl. Environ. Microbiol. 71(6),\n3131\u20133136.\nJothikumar, N., Cromeans, T. L., Sobsey, M. D. & Robertson, B. H.\n2005bDevelopment and evaluation of a broadly reactive\nTaqMan assay for rapid detection of hepatitis A virus .Appl.\nEnviron. Microbiol. 71(6), 3359\u20133363.\nJothikumar, N., Cromeans, T. L., Robertson, B. H., Meng, X. J. &\nHill, V. R. 2006 A broadly reactive one-step real-time RT-PCR\nassay for rapid and sensitive detection of hepatitis E virus .\nJ. Virol. Methods 131(1), 65\u201371.\nLegrand-Abravanel, F., Mansuy, J. M., Dubois, M., Kamar, N.,\nPeron, J. M., Rostaing, L. & Izopet, J. 2009 Hepatitis E virus\ngenotype 3 diversity, France .Emerg. Infect. Dis. 15(1),\n110\u2013114.\nMart\u0131 \u00b4n, M., Segale \u00b4s, J., Huang, F. F., Guenette, D. K., Mateu, E.,\nde Deus, N. & Meng, X. J. 2007 Association of hepatitis E\nvirus (HEV) and postweaning multisystemic wasting syndrome\n(PMWS) with lesions of hepatitis in pigs .Vet. Microbiol.\n122(1\u20132), 16\u201324.\nMeng, X. J., Purcell, R. H., Halbur, P. G., Lehman, J. R., Webb,\nD. M., Tsareva, T. S., Haynes, J. S., Thacker, B. J. & Emerson,\nS. U. 1997 A novel virus in swine is closely related to the\nhuman hepatitis E virus .Proc. Natl Acad. Sci. USA 94(18),\n9860\u20139865.\nMeng, X. J., Dea, S., Engle, R. E., Friendship, R., Lyoo, Y. S.,\nSirinarumitr, T., Urairong, K., Wang, D., Wong, D., Yoo, D.,\nZhang, Y., Purcell, R. H. & Emerson, S. U. 1999 Prevalence of\nantibodies to the hepatitis E virus in pigs from countries where\nhepatitis E is common or is rare in the human population .\nJ. Med. Virol. 59(3), 297\u2013302.\nNainan, O. V., Xia, G., Vaughan, G. & Margolis, H. S. 2006\nDiagnosis of hepatitis A virus infection: a molecular approach .\nClin. Microbiol. Rev. 19(1), 63\u201379.\nOrru`, G., Masia, G., Orru `, G., Romano `, L., Piras, V. & Coppola,\nR. C. 2004 Detection and quantitation of hepatitis E virus in\nhuman faeces by real-time quantitative PCR .J. Virol. Methods\n118(2), 77\u201382.\nPaul, D. A., Knigge, M. F., Ritter, A., Gutierrez, R., Pilot-Matias, T.,\nChau, K. H. & Dawson, G. J. 1994 Determination of hepatitis353 J. Rodriguez-Manzano et al. |Excretion patterns of HAV and HEV infections in Eastern Spain Journal of Water and Health |08.2|2010E virus seroprevalence by using recombinant fusion proteins\nand synthetic peptides. Infect. Dis. 169(4), 801\u2013806.\nPina, S., Jofre, J., Emerson, S. U., Purcell, R. H. & Girones, R. 1998\nCharacterization of a strain of infectious hepatitis E virusisolated from sewage in an area where hepatitis E is not\nendemic. Appl. Environ. Microbiol. 64(11), 4485\u20134488.\nPina, S., Buti, M., Cotrina, M., Piella, J. & Girones, R. 2000 HEV\nidenti\ufb01ed in serum from humans with acute hepatitis and in\nsewage of animal origin in Spain .J. Hepatol. 33(5), 826\u2013833.\nPina, S., Buti, M., Jard\u0131 \u00b4, R., Clemente-Casares, P., Jofre, J. &\nGirones, R. 2001 Genetic analysis of the hepatitis A virus\nstrains recovered from the environment and from acute\nhepatitis patients. J. Gen. Virol. 82(12), 2955\u20132963.\nPuig, M., Jofre, J., Lucena, F., Allard, A., Wadell, G. & Girones, R.\n1994 Detection of adenoviruses and enteroviruses in pollutedwaters by nested PCR ampli\ufb01cation. Appl. Environ. Microbiol.\n60(8), 2963\u20132970.\nPurcell, R. H. & Emerson, S. U. 2008 Hepatitis E: an emerging\nawareness of an old disease .J. Hepatol. 48(3), 494\u2013503.\nSiegl, G., Weitz, M. & Kronauer, G. 1984 Stability of hepatitis A\nvirus .Intervirology 22(4), 218\u2013226.\nUS Food and Drug Administration 2001 FDA Talk Paper (available\nathttp://www.fda.gov/bbs/topics/ANSWERS/2001/\nANS01084.html ).\nVogt, T. M., Wise, M. E., Bell, B. P. & Finelli, L. 2008 Declining\nhepatitis A mortality in the United States during the era of\nhepatitis A vaccination .J. Infect. Dis. 197(9), 1282\u20131288.\nYarbough, P. O. 1999 Hepatitis E virus. Advances in HEV biology\nand HEV vaccine approaches .Intervirology 42(2\u20133),\n179\u2013184.\nFirst received 3 March 2009; accepted in revised form 24 July 2009. Available online 9 November 2009354 J. Rodriguez-Manzano et al. |Excretion patterns of HAV and HEV infections in Eastern Spain Journal of Water and Health |08.2|2010 Cap\u00edtulo I: Estudio 2 \n 107 \nINTRODUCCI\u00d3N  \nEn los pa\u00edses en desarrollo es habitual identificar hepatitis agudas espor\u00e1dicas y \nepidemias causadas por HEV, principalmente vinculadas a una transmisi\u00f3n de origen h\u00eddrico. Tradicionalmente, los pa\u00edses indus trializados se han considerado zonas no end\u00e9micas para este \npat\u00f3geno, donde todos los casos espor\u00e1dicos iden tificados se asociaban con cepas importadas. \nEl estudio de la presencia de un pat\u00f3geno determinado en el agua residual generada por una \npoblaci\u00f3n concreta proporciona una visi\u00f3n glob al de su excreci\u00f3n, y por lo tanto de la \nprevalencia de una infecci\u00f3n en esa poblaci\u00f3n. Estudios previos realizados en la Comunidad Aut\u00f3noma de Catalu\u00f1a (Barcelona) muestran  la presencia de HEV en agua residual, \nidentificando m\u00e1s de veinte cepas aut\u00f3ctonas di stintas, principalmente correspondientes al \ngenotipo 3.  \nEl estudio aqu\u00ed descrito tiene como objetivo caracterizar la diversidad de las cepas de \nHEV presentes en muestras de agua residual, bios\u00f3lidos y lodos que potencialmente pueden \ncontaminar el agua y el medio ambiente, as\u00ed como determinar si genotipos distintos al 3 se encuentran circulando de forma habitual a trav \u00e9s del agua residual y los bios\u00f3lidos de zonas \nindustrializadas.  RESULTADOS Y DISCUSI\u00d3N \n \nSeis muestras de agua residual urbana, do s muestras de bios\u00f3lidos urbanos y dos \nmuestras de lodos procedentes de un matadero de ganado bo vino y porcino (80% ganado \nporcino), todas ellas positivas para HEV, han sido estudiadas mediante la clonaci\u00f3n y secuenciaci\u00f3n de 10 \u2013 12 clones/muestra con la in tenci\u00f3n de obtener info rmaci\u00f3n acerca de la \npotencial diversidad de las cepas de HEV excretad as en la poblaci\u00f3n estudiada. Un total de 101 RESUMEN ESTUDIO 2: \n \nHepatitis E virus genotype 3 and sporadically also genotype 1 circulate in the population of Catalonia, Spain  Clemente-Casares P, Rodriguez-Manzano J, Girones R \n \nJournal of Water and Health . 2009; 7(4):664-73 Cap\u00edtulo I: Estudio 2 \n 108clones fueron secuenciados y los resultados mu estran que la mayor\u00eda de cepas identificadas \npertenecen al genotipo 3 (74 clones). Dos mu estras de agua residual y un bios\u00f3lido mostraron \ncepas perteneciente al genotipo 1, mientras que las dos muestras de lodos de matadero \nmostraron estar contaminadas \u00fanicamente con el genotipo 3, tal y como cab\u00eda esperar. Las \nsecuencias obtenidas en las muestras de origen animal mostraron una elevada similaridad con \ncepas de origen humano previamente reportadas en la misma regi\u00f3n de estudio. La similaridad \nde secuencias obtenidas en las diferentes muestras estudiadas (intra-muestra) oscila entre 89% \u2013 99%.  \nLa variabilidad de secuencias de HEV observadas en este estudio sugiere que diversas \ncepas de HEV est\u00e1n circulando de forma habitual entre la poblaci\u00f3n de la zona estudiada. En \nconcordancia con el elevado n\u00famero de mues tras de agua residual positivas para HEV \ndescritas en estudios previos en Barcelona y los valores de seroprevalencia reportados \nrecientemete (7.3%), infecciones por HEV en  humanos (principalmente subcl\u00ednicas) son \nprobablemente m\u00e1s prevalentes de lo esperado.  CONCLUSIONES  \nCepas aut\u00f3ctonas de HEV han sido descri tas como responsables de infecciones \nidentificadas en pa\u00edses industrializados, previa mente considerados como zonas no end\u00e9micas. \nLas cepas de HEV circulantes en una de estas regiones localizada en el sureste de Europa (Barcelona, Espa\u00f1a) han sido estudiadas a trav\u00e9s del an\u00e1lisis de amplicones obtenidos a partir \nde genomas de HEV identificados en muestras de agua residual, bios\u00f3lidos y lodos. Los resultados obtenidos demuestran la presencia de  cepas de HEV pertenecientes al genotipo 3 y \n1, mostrando una circulaci\u00f3n simult\u00e1nea de cepas diversas de HEV entre la poblaci\u00f3n de la \nregi\u00f3n estudiada. En las muestras de lo dos procedentes de mataderos de ganado \nbovino/porcino \u00fanicamente se identific\u00f3 el genotipo 3 y se observ\u00f3 una elevada similaridad con cepas de origen humano identificadas pr eviamente en la misma zona de estudio, \nprobando que las mismas cepas son responsable s de infecciones en humanos y cerdos. La \ncirculaci\u00f3n espor\u00e1dica del genotipo 1 en \u00e1r eas industrializadas representa un problema \npotencial a nivel de salud p\u00fablica desde el momento en que HEV est\u00e1 asociado con \nimportantes epidemias donde se reportan elev adas tasas de mortalidad, especialmente entre \nmujeres embarazadas. La contaminaci\u00f3n de agua  y alimentos a trav\u00e9s del contacto con agua \nresidual tratada incorrectamente y bios\u00f3lidos representa un riesgo significativo para la poblaci\u00f3n humana incluso en pa\u00edses industrializados. Hepatitis E virus genotype 3 and sporadically also\ngenotype 1 circulate in the population of Catalonia, Spain\nPilar Clemente-Casares, Jesus Rodriguez-Manzano and Rosina Girones\nABSTRACT\nPilar Clemente-Casares\nJesus Rodriguez-Manzano\nRosina Girones (corresponding author)\nDepartment of Microbiology,\nFaculty of Biology,\nUniversity of Barcelona,\nAvinguda Diagonal 645,08028 Barcelona,\nSpain\nTel.: +34-93-4021483\nFax: +34-93-4039047\nE-mail: rgirones@ub.edu\nPilar Clemente-Casares\nCRIB, University of Castilla-La Mancha,\nAvenida Almansa 14,\n02006 Albacete,\nSpainAutochthonous hepatitis E virus (HEV) strains have been described infecting populations of\nindustrialized countries, previously considered as non-endemic areas. The HEV strains circulating\nin one of those areas in south-western Europe (Barcelona, Spain) have been studied by analysingamplicons obtained from HEV genomes identi\ufb01ed in wastewater, biosolids and sludge. Six sewageand two biosolid HEV positive samples from urban wastewater treatment plants and two positive\nHEV sludge samples with animal contamination were analysed by cloning and sequencing of\n10\u201312 clones per sample. The results proved the presence of HEV strains belonging to genotype3 and also sporadically to genotype 1 in urban sewage and biosolids, showing the simultaneouscirculation of diverse HEV strains in the human population of the studied area. Only HEV genotype\n3 was identi\ufb01ed in slaughterhouse sludge samples. The circulation of genotype 1 in industrialized\nareas may have further health implications since this genotype has been associated withimportant epidemics in developing areas. Contamination of food and water through their contactwith sewage not properly treated and biosolids presenting HEV may represent a signi\ufb01cant risk\nfor human populations in relation to HEV even in industrialized areas.\nKey words |biosolids, environmental contamination, hepatitis E, Hepevirus , sewage, sludge\nABBREVIATIONS\ncDNA complementary deoxyribonucleic acid\ndNTP deoxyribonucleotide triphosphate\nDTT dithiothreitolORF2 open reading frame 2PBS phosphate buffered salinePCR polymerase chain reaction\nRNA ribonucleic acid\nINTRODUCTION\nHepatitis E virus (HEV) is an RNA virus responsible formore than 50% of acute hepatitis in developing countries\n(Yarbough 1999 ). In these areas, sporadic and epidemic\nacute hepatitis E are frequently identi\ufb01ed, mainly due tofaecally contaminated water ( Emerson & Purcell 2003 ).\nTraditionally, industrialized countries have been considered\nnon-endemic areas for this virus, as only sporadic cases\nrelated to imported strains were diagnosed ( Bader et al.\n1991;Dawson et al. 1992). However, several HEV isolates\nhave recently been identi\ufb01ed from patients with acute\nhepatitis who lived in developed areas and with no history\nof travelling to endemic areas ( Schlauder et al. 1998,1999;\nWorm et al. 1998;Zanetti et al. 1999;Pina et al. 2000 ;\nTakahashi et al. 2001,2002;Mizuo et al. 2002). The HEV\nstrains isolated from these cases, which belong to genotypes\n3 and 4, can be considered autochthonous of these\nindustrialized areas and seem to have a low pathogenic\npro\ufb01le ( Purcell & Emerson 2008 ). However, the arrival\nand circulation of genotypes 1 and 2 in these areas may\nhave further health implications since these genotypes havebeen associated with important epidemics. During these\ndoi: 10.2166/wh.2009.120664 QIWA Publishing 2009 Journal of Water and Health |07.4|2009epidemics, high mortality rates have been observed,\nespecially in pregnant women ( Balayan 1997 ).\nStudying the presence of a pathogen in the sewage\ngenerated by a population provides a global view of\nthe excretion, and therefore the prevalence of infection\nin this population. A previous study carried out inBarcelona revealed the presence of HEV strains in 43.5%\nof the sewage samples collected between 1994 and 2002\n(Clemente-Casares et al. 2003). More than 20 autochtho-\nnous strains have been identi\ufb01ed since then in urban sewage\nin Barcelona (Spain), where the seroprevalence in a\npopulation sample has recently been estimated as 7.3%\n(Buti et al. 2006 ). The sequences detected belonged to\ngenotype 3 ( Clemente-Casares et al. 2003;Bo\ufb01ll-Mas et al.\n2006 ;Albinana-Gimenez et al. 2006 ).\nViruses present in wastewater ef\ufb02uents are discharged\ninto aquatic environments. They also accumulate in the\nbiosolids or sludge generated during the treatment of\nwastewater, which are sometimes applied to \ufb01elds or used\nas fertilizers ( Straub et al. 1993). Accidental contamination of\nfood and water by these viruses represents a risk for human\npopulations. In a study conducted in Barcelona ( Bo\ufb01ll-Mas\net al. 2006 ), HEV was detected in two out of \ufb01ve biosolid\nsamples collected from an urban sewage treatment plant.\nAlthough most of the sequences found were very similar\nto others previously detected in Barcelona (genotype 3),\ngenotype 1 HEV sequences were also identi\ufb01ed.\nHEV has also been detected infecting swine, deer,\nwild boars, mongooses and chickens ( Meng et al. 1997;\nHaqshenas et al. 2001;Matsuda et al. 2003;Teiet al. 2003).\nThe strains isolated from the mammals, which belong to\ngenotypes 3 and 4, are very similar to those infecting\nhumans, especially if they have been detected in the samearea ( Hsieh et al. 1998;Haqshenas et al. 2001). Indeed,\ntransmission of HEV to humans due to the consumption of\nuncooked meat from deer and wild boars has already beenproven ( Matsuda et al. 2003;Teiet al. 2003). Several research\nworks performed in Spain allowed the detection of naturally\nHEV infected pigs and also the presence of the virus insewage and sludge generated in slaughterhouses ( Pina et al.\n2000 ;Clemente-Casares et al.\n2003;Albinana-Gimenez et al.\n2006 ;Seminati et al. 2008 ;Fernandez-Barredo et al. 2007).\nThe arrival of those animal HEV strains in the environment\ncan also represent a risk for human populations.The objective of this study is the further characteriz-\nation of the diversity of HEV strains that may be in onewastewater or sludge/biosolid sample that can potentiallycontaminate water and the environment and to determinewhether genotypes other than genotype 3 are present in thewastewater and sludge generated in an industrialized area.\nMATERIALS AND METHODS\nUrban wastewater treatment plant samples\nUrban sewage samples and biosolids generated during\nsewage treatment were collected from the sewage networkof Barcelona (Spain) during the years 2001, 2003, 2005 and\n2007. Each sample was collected in a sterile container and\nkept at 4 8C for less than 8 hours until the viral particles were\nconcentrated in phosphate buffered saline (PBS pH 7.3).Positive HEV samples identi\ufb01ed by seminested-PCR wereselected (six sewage samples and two biosolid samples).\nA summary of the studied samples is presented in Table 1 .\nThe presence of HEV in sewage from Barcelona has beenestimated in previous studies as 43.5% ( Clemente-Casares\net al. 2003). Six out of 34 HEV-typi\ufb01ed sewage samples\nwere selected for this study. Two HEV positive biosolids\nof four tested samples ( Bo\ufb01ll-Mas et al. 2006 ) were also\nincluded.\nSlaughterhouse samples\nSludge samples with contamination of animal origin were\ncollected in a slaughterhouse located in Catalonia (Spain)\nin 2004 and 2006. This slaughterhouse dealt with bovine\nand, especially, porcine adult animals (more than 80%of the processed animals were pigs). The samples were\ncollected in sterile containers and kept at 4 8C for less than\n8 hours prior to the concentration of the viral particles.Two positive HEV sludge samples (out of \ufb01ve tested by\nAlbinana-Gimenez et al. (2006) andHundesa et al. (2006) )\nwere selected for the study.\nViruses\nFaecal suspensions obtained from monkeys ( Macaca\nmulatta ) infected with the HEV BCN strain (10% in PBS665 P. Clemente-Casares et al. |HEV genotype 3 and sporadically 1 circulate in Spain Journal of Water and Health |07.4|20097.3) were used as positive control for the polymerase chain\nreaction (PCR) analysis. This strain had previously beenisolated from sewage from Barcelona although it isgenetically similar to Indian HEV genotype 1 strains ( Pina\net al. 1998). The viral suspensions were stored at 2808C.\nConcentration of viral particles from sewage samples\nThe recovery and concentration of viral particles were\ncarried out as described in previous studies. The protocolfor processing sewage samples is based on ultracentrifuga-tions and elution in 0.25 N glycine buffer pH 9.5 ( Puig et al.\n1994). Brie\ufb02y, 42 ml of sewage sample were ultracentrifuged\n(110,000 \u00a3gfor 1 hour at 4 8C). The sediment was eluted\nwith 3.5 ml 0.25 N glycine buffer (pH 9.5) and kept on icefor 30 minutes. After the addition of 2 \u00a3PBS, the\nsuspension was centrifuged at 12,000 \u00a3gfor 15 minutes\nto separate any suspended solids. Viruses in the supernatantwere pelleted by ultracentrifugation (110,000 \u00a3gfor 1 h at\n48C), resuspended in 0.1 ml 1 \u00a3PBS and stored at 2808C.\nConcentration of viral particles from biosolid samples\nAs described previously ( Bo\ufb01ll-Mas et al. 2006 ), 40 g of\nthe biosolid samples were eluted in 50 ml glycine buffer pH9.5 and stirred for 1 hour. The pH was neutralized withNaOH 5 M and the sample was centrifuged for 45 minutes\nat 38,400 \u00a3gat 48C. Viral particles contained in thesupernatant were pelleted at 110,000 \u00a3gfor 1 hour at\n48C and \ufb01nally eluted in 200 ml PBS. The viral concentrate\nwas stored at 2808C until nucleic acid extraction.\nConcentration of viral particles from sludge samples\nThe sludge samples from the slaughterhouse were processed\nwith the same protocol used for sewage but starting with the\nelution of 1 g of sludge in 3.5 ml of 0.25 N glycine buffer pH\n9.5 (Albinana-Gimenez et al. 2006 ).\nRNA extraction\nViral nucleic acids from the samples were extracted with a\nprotocol described previously ( Boom et al. 1990) using\nguanidinium isothiocyanate (GuSCN) and adsorption of\nthe nucleic acids to silica particles as described.\nDetection of HEV by seminested RT-PCR\nThe HEV RNA was ampli\ufb01ed by seminested RT-PCR with\ndegenerated primers described by Erker et al. (1999) using a\none-step RT-PCR ( Albinana-Gimenez et al. 2006 ), followed\nby a second-round PCR. Five\nml of the extracted nucleic\nacids and a tenfold dilution, corresponding to 2 and 0.2 ml\nof sewage, 100 mg and 10 mg of dry weight of biosolidand 50 mg and 5 mg of sludge, were analysed for eachsample. Fragments of 198 and 148 bp-long (\ufb01rst-round andTable 1 |Typi\ufb01cation and diversity of the HEV strains identi\ufb01ed by cloning the amplicons obtained from the analysed samples\nSample Type of sample Sampling (year/month) Sequences found % Intra-sample similarity Genotype\nBCN8 Urban sewage 2001/April 3 (BCN8.1 to 3) 90\u201396 G3\nBCN10 Urban sewage 2001/May 1 (BCN10) \u2013 G3\nBCN25 Urban sewage 2003/March 1 (BCN25) \u2013 G3\nBCN26 Urban sewage 2003/May 5 (BCN26.1 to 5) 94\u201399 G3BCN23 Urban sewage 2005/February 1 (BCN23) \u2013 G1BCN27 Urban sewage 2007/December 1 (BCN27) \u2013 G1\nBBCN1 Biosolid * 2005/January 2 (BBCN1.1 & 2) 99 G3\nBBCN2 Biosolid * 2005/February 3 (BBCN2.1 to 3) 98\u201399 G1\nE5 Sludge\n\u20202004/May 4 (E5, E5.2 to 4) 92\u201399 G3\nE6 Sludge\u20202006/February 8 (E6.1 to 8) 89\u201399 G3\n*From an urban sewage treatment plant.\n\u2020From a slaughterhouse (more than 80% of the processed animals in this slaughterhouse were pigs).666 P. Clemente-Casares et al. |HEV genotype 3 and sporadically 1 circulate in Spain Journal of Water and Health |07.4|2009second-round products respectively) were ampli\ufb01ed within\nthe ORF2 of the HEV genome.\nThe RT-PCR assay was performed using the OneStep\nRT-PCR kit from QIAGEN. Five ml of the extracted nucleic\nacids or a tenfold dilution were added to a total volumereaction of 50 ml containing 1 \u00a3OneStep QIAGEN Buffer,\n2ml of QIAGEN OneStep Enzyme Mix, 400 mM of each\ndNTP, 10 units of ribonuclease inhibitor (Applied Biosys-\ntems) and 25 pmol of each outer primer (HEVORF2con-a1\nand HEVORF2con-s1). After 30 minutes at 50 8C, the\nreaction was heated at 95 8C for 15 minutes, followed by\n35 cycles at 94 8C for 20 seconds, annealing at 55 8C for\n30 seconds, and extension at 72 8C for 1 minute. All\nampli\ufb01cations were completed with a 10 minute, 72 8C\nextension period.\nThe second-round PCR was carried out by adding 1 ml\nof the \ufb01rst-round product to a new batch of 50 ml PCR\nreaction mixture containing 1 \u00a3PCR Gold Buffer (Perkin-\nElmer Roche), 1.5 mM MgCl\n2, 10 nmol of each dNTP,\n2 units of Ampli Taq Gold Y(Perkin-Elmer Roche) and\n25 pmol of each nested primer (HEVORF2con-a1 and\nHEVORF2con-s2). The products were analysed by agarose\ngel electrophoresis using ethidium bromide as a stain.\nStandard precautions were applied in all the mani-\npulations in order to reduce the probability of samplecontamination by ampli\ufb01ed DNA molecules. Negative\ncontrols for the RT-PCR reaction and the extraction process\nwere added in every assay and the positive ampli\ufb01cationswere con\ufb01rmed by sequencing analysis. External positivecontrols were used by adding viral particles to viralconcentrates. All samples were also analysed for the\npresence of viral indicators of faecal contamination,\nhuman adenoviruses and porcine adenovirus, and nosigni\ufb01cant inhibition was observed.\nCloning of the amplicons\nThe amplicons obtained were puri\ufb01ed using the QIAquick\nPCR puri\ufb01cation Kit (QIAGEN, Inc.) and ligated into apGEM\nw-T EasyVector (pGEMw-T EasyVector System II,\nPromega Co.) following the manufacturer\u2019s instructions.\nThe ligation product was used to transform Escherichia coli\nJM109 competent cells (Promega Co.) or DH5 a. Trans-\nformed bacterial clones were detected by blue/whitescreening. The insert from presumptive transformed clones\nwas ampli\ufb01ed by inoculation of some growth into a mixcontaining 1 \u00a3Reaction Buffer (160 mM (NH\n4)2SO4,\n670 mM Tris-HCl pH 8.8, Tween-20) (Bioron, GmbH,Germany), 2 mM MgCl\n2, 2 units of Taq DNA polymerase\n(Bioron, GmbH, Germany), 10 nmol of each dNTP and10 pmol of the T7 and SP6 primers (sequences contained inthe vector). Following a denaturing step of 3 minutes at\n948C, 35 cycles at 94 8C for 20 seconds, 55 8C for 30 seconds\nand 72 8C for 30 seconds were carried out. All ampli\ufb01cations\nwere completed with a 10 minute, 72 8C extension period.\nThe products were analysed by agarose gel electrophoresis\nusing ethidium bromide as a stain.\nSequence analysis\nTen to 12 clones per sample were sequenced. The puri\ufb01ed\nDNA was sequenced with the ABI PRISM YDye Termin-\nator Cycle Sequencing Ready Reaction kit version 3.1 withAmpli Taq\nwDNA polymerase FS (Applied Biosystems)\nfollowing the manufacturer\u2019s instructions. The results were\nchecked using the ABI PRISM 377 automated sequencer\n(Perkin-Elmer, Applied Biosystems). A fragment of 101 bpof each amplicon was compared with other HEV sequencespresent in the GenBank and the EMBL (EuropeanMolecular Biology Library) using the basic BLAST programof the NCBI (National Center for Biotechnology\nInformation, http://www.ncbi.nlm.nih.gov/BLAST/ , accessed\n20 March 2009). Alignments of the sequences were carriedout using the ClustalW program of the EBI (EuropeanBioinformatics Institute of the EMBL, http://www.ebi.ac.\nuk/clustalw/ , accessed 20 March 2009). Phylograms\nwere generated by the UPGMA algorithm using the\nNEIGHBOR program. The robustness of the groupingwas determined by bootstrap resampling of the multiplesequence alignments (1,000 sets) with the programsSEQBOOT, DNADIST, NEIGHBOR and CONSENSE.\nThe output graphics of the trees were created with the\nTREEVIEW package, version 1.5 ( Page 1996 ). Sequences\npresent in the databases and used for phylogenetic studiesare shown in Table 2 . The GenBank accession numbers for\nthe sequences reported in this paper are EU450839-EU450866 and EU729700. Accession numbers for\nBCN10, BCN23 and E5, previously reported, are667 P. Clemente-Casares et al. |HEV genotype 3 and sporadically 1 circulate in Spain Journal of Water and Health |07.4|2009AF490991 ( Clemente-Casares et al. 2003), DQ400354 and\nDQ400356 ( Albinana-Gimenez et al. 2006 ), respectively.\nRESULTS\nSix samples of urban sewage, two biosolid samples and two\nsamples of sludge from a slaughterhouse, positive for HEV,were studied by cloning and sequencing of 10\u201312 clonesper sample in order to obtain information on the potentialdiversity of HEV strains excreted in the population and thatmay be accumulated in the generated residues. One\nhundred and six clones were sequenced. The results are\nsummarized in Table 1 .\nAs expected, most of the samples presented HEV\ngenotype 3 strains. Four urban sewage samples (BCN10,\nBCN23, BCN25 and BCN27) showed just one sequenceamong all the analysed clones: BCN23 and BCN27 typi\ufb01edas genotype 1. Three different sequences were found fromsample BCN8 and \ufb01ve from BCN26. The results obtained\nfrom the two biosolid samples collected in the urban sewage\ntreatment plant showed two sequences from BBCN1 andthree from BBCN2, BBCN2.1 to BBCN2.3 belonging togenotype 1. More diversity was identi\ufb01ed in the sludgesamples collected in the slaughterhouse, as four and eight\nsequences were detected from E5 and E6, respectively.\nDifferences among sequences detected from the samesample ranged from 1% to 11% ( Table 1 ). When comparing\ndifferent samples, the biggest differences were observedbetween samples containing sequences belonging to differ-\nent genotypes: that is, differences between sequences from\nBCN8 and BBCN2 ranged from 22.8% to 24.8%, and 19.8%to 25.7% between BBCN2 and E6. In contrast, similaritiesbetween genotype 3 sequences from samples with humanand animal contamination were as high as 98.0% (betweenBCN26.1 and E5.3).\nAs expected, genotype 3 was the most prevalent\ngenotype in the area (74 clones), although genotype 1was also detected. The phylogenetic analysis of thesequences obtained in the study is shown in Figure 1 .\nAll the sequences detected from samples BCN8, BCN10,\nBCN25, BCN26, BBCN1, E5 and E6 belonged to\ngenotype 3. They were very similar or even 100% identicalin the studied fragment to other isolates previouslyTable 2 |Nucleotide sequence accession numbers for hepatitis E virus strains used for\nphylogenetic analysis\nCountry Strain*Accession number\nBarcelona, Spain BCN AF058684\nBCN3 AF490985BCN4 AF491003BCN5 AF490986\nBCN6 AF490987\nBCN7 AF490988BCN12 AF490993BCN16 AF490997VH1 AF491000VH2 AF491001\nVH3 AY540113\nVH4 AY540114VH5 AY540115Por1 AF491002\nFrance France AY626042Greece Greece1 AF110391\nGreece2 AF110392\nItaly Italy AF110390\nAustria Austria AF279123\nThe Netherlands SwNe AF336292\nCanada SwCanada AY115488United States USA1 AF060668\nUSA2 AF060669SwUSA AF082843\nJapan Japan1 AB074918\nJapan2 AB089824Japan3 AB220971\nMexico Mexico M74506\nPakistan Pakistan M80581\nBurma Burma M73218China China1 D11092\nChina2 AJ272108\nChina3 AF082094\nChad Chad AY204877\nEgypt Egypt AF051352Morocco Morocco AY230202\nIndia India DQ459342\n*As named in Figure 1 .668 P. Clemente-Casares et al. |HEV genotype 3 and sporadically 1 circulate in Spain Journal of Water and Health |07.4|2009detected in Barcelona from sewage and clinical serum\nsamples of hepatitis E cases. BCN23, for example, was\n100% identical in the sequenced region to BCN6, detected2 years before.\nThree samples (BCN23, BCN27 and BBCN2) showed\nsequences belonging to genotype 1. When comparing\nsequences from BCN23 and BBCN2, collected in the\nsame wastewater treatment plant and during the same\nmonth, the identity was only about 92.1\u201393.1%. BBCN2.1\nto BBCN2.3 were 98\u2013100% identical to a strain from South\nAfrica (strain RSA-1) and 98\u201399% identical to the BCN\nstrain, detected from sewage in Barcelona and previously\nconsidered as imported as it clustered within genotype 1(Pina et al. 1998). BCN27 was 97% identical in the studied\nfragment to BCN23. They were highly similar to the isolate\nBurmaEpi-1-3 from Myanmar (95.0% and 97%, respect-\nively) and to one from India (DQ459342) (95.0% and\n96.0%, respectively). The nucleotide accession numbers of\nthe HEV strains used for the phylogenetic analysis are\nshown in Table 2 .\nWhile genotypes 3 and 1 were found in sewage and\nbiosolid samples with human faecal contamination, sludge\ncontaining animal faecal contamination only exhibitedsequences belonging to genotype 3 as expected. Those\nanimal HEV sequences were very similar to other European\nisolates, independently of their human or animal origin;Figure 1 |Unrooted phylogenetic tree depicting relationships over 101 nucleotides within ORF2 among representative HEV strains reported in this study and ot hers isolates from\ngenotype 1, genotype 2, genotype 3 and genotype 4. The internal node numbers represent bootstrap values (1,000 replicates) expressed as the percenta ge of all trees.\nOnly values greater than 60 are represented. GenBank accession numbers of the sequences used for phylogenetic analysis can be found in Table 2 .669 P. Clemente-Casares et al. |HEV genotype 3 and sporadically 1 circulate in Spain Journal of Water and Health |07.4|2009E6.1 presented the highest identity (97.0%) with the isolate\nNLSW28 (from swine in the Netherlands) and with BCN12\nand BCN9 (from urban sewage from Barcelona). Similar\ncases are observed with E6.4, E6.8 or E5.2.\nDISCUSSION\nThe variability of HEV sequences observed in this studysuggests that diverse HEV strains are commonly circulatingin the population of the studied area. According to the highnumber of sewage samples containing HEV found over\nprevious studies in Barcelona ( Clemente-Casares et al.\n2003) and the seroprevalence values reported by Buti et al.\n2006 (7.3%), HEV infections in humans (mostly subclinical\ninfections) are probably more prevalent than expected. Thelow number of identi\ufb01ed acute hepatitis E cases in the area\n(Pina et al. 2000 ;Buti et al. 2004 ) and the short excretion\nperiod described for HEV infections would suggest that thefrequent detection of HEV in urban sewage must be relatedto the presence of abundant subclinical infections withexcretion of HEV viral particles by the population. The\nunderestimation of the prevalence of HEV infection may berelated to multiple reasons including the existence of\nsubclinical infections, the reduction of anti-HEV IgG levelsafter several years of initial exposure in the population orthe lack of antibody response (Buti et al. 2004 ,2006 ). The\nseroprevalence found in Catalonia by Buti et al. (2006)\nis an intermediate value compared with other valuesreported among blood donors in recent studies conductedin other industrialized areas. According to Bouwknegt et al.\n(2007) seroprevalence in this group is about 2.0% in The\nNetherlands, while in south-west England or south-west\nFrance the seroprevalence is around 16% ( Dalton et al.\n2008;Mansuy et al. 2008). However, higher values can be\nfound in endemic areas such as China (43%) or Egypt(45.2%) ( Abdelhady et al. 1998;Liet al. 2006 ).\nIt has been con\ufb01rmed in the study that the predominant\ngenotype in Barcelona is genotype 3, as nearly all the\nsequences obtained from samples collected in this areabelonged to this genotype ( Figure 1 ). In fact, about 92% of\nthe HEV typi\ufb01ed samples collected in Barcelona in differentstudies belonged to genotype 3 and 8% to genotype 1\n(Clemente-Casares et al. 2003;Albinana-Gimenez et al.2006 ;Bo\ufb01ll-Mas et al. 2006 ). However, it is signi\ufb01cant that\nHEV genotype 1 was also detected in BCN23 and BBCN2\ncollected in 2005 and BCN27 collected in 2007. Onlygenotype 3 was detected from samples with animal origin.\nThe sequences with animal origin identi\ufb01ed in the study\nwere highly similar to those with human origin in thesame area as previously reported ( Clemente-Casares et al.\n2003). With the exception of BCN26, a higher number of\ndifferent sequences were obtained from samples withanimal contamination than from those with human\ncontamination.\nAlthough the methods applied in this study allow the\ndetection of a diversity of strains present in one speci\ufb01c\nsample, some limitations must be considered. The use of an\nampli\ufb01cation method can potentially lead to the introduc-\ntion of changes related to the error of the polymerase\nactivity. Although this cannot be completely ruled out,\nwhen comparing the obtained sequences with others\npresent in the databases, nucleotide changes were mainly\nobserved in the third position of the codons. In fact, all the\nisolates obtained presented the aa sequence expected for\neach genotype and the sequencing of the HEV strain used as\na positive control produced an identical sequence after\nbeing ampli\ufb01ed and sequenced in the diverse studies. It\nmust also be considered that the sequences analysed by\ncloning amplicons probably represent only some of the\nmost abundant HEV strains of that sample. The diversity\nof HEV strains present in one sample may be still\nunderestimated considering the potential preferential\nampli\ufb01cation of some sequences over others by PCR or\nthe study of a limited number of clones. Some sequences\npresent originally in a sample may not be representedamong the analysed clones. Thus, the presence of more\ngenotype 1 sequences in the tested samples that would be\npresent in lower numbers among other genotype 3 strainscannot be ruled out.\nGenotype 3 infections presumably associated with\nwater have been recently described in Europe. In France,15 patients were identi\ufb01ed having as a risk factor to acquire\nan HEV infection through the consumption of water either\ndirectly from a spring or private well or vegetables from avegetable garden, irrigated with water from a river or a\nprivate well ( Renou et al. 2008 ). A study conducted in the\nNetherlands found one patient whose HEV strain was also670 P. Clemente-Casares et al. |HEV genotype 3 and sporadically 1 circulate in Spain Journal of Water and Health |07.4|2009isolated from a ditch near the house 3 months after the\nonset of illness. This ditch received sewage ef\ufb02uent from a\nleakage in the household septic tank ( Borgen et al. 2008).\nHEV has also been detected contaminating river waters.Genotype 3 sequences were isolated from the river Maas inthe Netherlands ( Borgen et al. 2008) and from two bivalve\nsamples harvested in a Japanese river ( Liet al. 2007).\nAccording to the evidence, environmental isolates in\nindustrialized areas usually correspond to autochthonous\nsequences of HEV genotype 3, which seems to be less\nvirulent than genotypes 1 and 2 ( Purcell & Emerson 2008 ).\nHowever, the identi\ufb01cation of genotype 1 sequences in\nsewage or solid waste in these areas suggests the possibility\nof sporadic environmental contamination by this genotype,responsible for large epidemics of hepatitis E in developingareas ( Emerson & Purcell 2003 ). Although improved\ntreatment of water and sewage has become the best defence\nagainst enterically transmitted diseases, the methods cur-\nrently applied are usually less effective in removing virusesthan enteric bacteria ( Rao & Melnick 1986 ;Bo\ufb01ll-Mas et al.\n2006 ). Moreover, those excreted strains accumulate in\nbiosolid/sludge during waste treatment. Thus, suitable\ndisposal and treatment of the sludge/biosolids generated\nalso seems essential. Special attention must be paid whengenotype 1 infections without history of recent travel aredetected, especially if any association to uncontrolled watersources is pointed out.\nCONCLUSIONS\nThis study provides evidence that diverse HEV strainsare commonly infecting humans and pigs in the studiedarea. Although identi\ufb01ed strains infecting pigs have beentypi\ufb01ed in all samples as genotype 3, sewage and biosolidsfrom urban sewage treatment plants may contain notonly diverse HEV genotype 3 strains but also sporadically\nHEV genotype 1. The circulation of genotype 1 in\nindustrialized areas may have further health implicationssince this genotype has been associated with importantepidemics with high mortality rates, especially in pregnantwomen. Contamination of food and water through their\ncontact with sewage not properly treated and biosolidspresenting HEV may represent a signi\ufb01cant risk for humanpopulations even in industrialized areas. Thus, suitable\ndisposal and treatment of the sewage and sludge/biosolidsgenerated is important whether the source of contaminationis of human or animal origin.\nACKNOWLEDGEMENTS\nThis work was partially supported by the Ministeriode Educacio \u00b4n y Ciencia of the Spanish Government\n(project AGL2005-07776-C03-02), the Xarxa de Refere `ncia\nde Biotecnologia de Catalunya and the Grup deRecerca Consolidat de la Generalitat de Catalunya(2005SGR00592). We thank the Serveis Cient\u0131 \u00b4\ufb01co-\nTe`cnics of the University of Barcelona for their ef\ufb01cient\nsequencing services.\nREFERENCES\nAbdelhady, S. I., Al-Din, M. S. & El-Din, M. E. 1998 A high\nhepatitis E virus seroprevalence among unpaid blood donors\nand haemodialysis patients in Egypt. J. Egypt Public Health\nAssoc. 73, 165\u2013179.\nAlbinana-Gimenez, N., Clemente-Casares, P., Bo\ufb01ll-Mas, S.,\nHundesa, A., Ribas, F. & Girones, R. 2006 Distribution of\nhuman polyomaviruses, adenoviruses, and hepatitis E virus in\nthe environment and in a drinking-water treatment plant .\nEnviron. Sci. Technol. 40, 7416\u20137422.\nBader, T. F., Krawczynski, K., Polish, L. B. & Favorov, M. O. 1991\nHepatitis E in a U.S. traveler to Mexico. N. Engl. J. Med. 325,\n1659.\nBalayan, M. S. 1997 Epidemiology of hepatitis E virus infection .\nJ. Viral Hepat. 4, 155\u2013165.\nBo\ufb01ll-Mas, S., Albinana-Gimenez, N., Clemente-Casares, P.,\nHundesa, A., Rodriguez-Manzano, J., Allard, A., Calvo, M. &\nGirones, R. 2006 Quanti\ufb01cation and stability of human\nadenoviruses and polyomavirus JCPyV in wastewater matrices .\nAppl. Environ. Microbiol. 72, 7894\u20137896.\nBoom, R., Sol, S. J., Salimans, M., Jansen, C. L., Werthein-van Dillen,\nP. M. & van der Noordaa, J. 1990 Rapid and simple method for\npuri\ufb01cation of nucleic acids. J. Clin. Microbiol. 28, 495\u2013503.\nBorgen, K., Herremans, T., Duizer, E., Vennema, H., Rutjes, S.,\nBosman, A., de Roda Husman, A. M. & Koopmans, M. 2008\nNon-travel related hepatitis E virus genotype 3 infections in\nThe Netherlands; a case series 2004\u20132006 .BMC Infect. Dis.\n8(8), 61.\nBouwknegt, M., Engel, B., Herremans, M. M., Widdowson, M. A.,\nWorm, H. C., Koopmans, M. P., Frankena, K., de Roda\nHusman, A. M., De Jong, M. C. & Van Der Poel, W. H. 2007671 P. Clemente-Casares et al. |HEV genotype 3 and sporadically 1 circulate in Spain Journal of Water and Health |07.4|2009Bayesian estimation of hepatitis E virus seroprevalence for\npopulations with different exposure levels to swine in The\nNetherlands .Epidemiol. Infect. 136(4), 567\u2013576.\nButi, M., Clemente-Casares, P., Jardi, R., Formiga-Cruz, M.,\nSchaper, M., Valdes, A., Rodriguez-Frias, F., Esteban, E. &\nGirones, R. 2004 Sporadic cases of acute autochthonous\nhepatitis E in Spain .J. Hepatol. 41, 126\u2013131.\nButi, M., Dom\u0131 \u00b4nguez, A., Plans, P., Jardi, R., Schaper, M.,\nEspunes, J., Cardenosa, N., Rodriguez-Frias, F., Esteban, R.,\nPlasencia, A. & Salleras, L. 2006 Community-based\nseroepidemiological survey of HEV infection in Catalonia,Spain .Clin. Vaccine Immunol. 13(12), 1328\u20131332.\nClemente-Casares, P., Pina, S., Buti, M., Jardi, R. & Girones, R.\n2003 Hepatitis E virus epidemiology in industrialized\ncountries. Emerg. Infect. Dis. 9, 448\u2013455.\nDalton, H. R., Stableforth, W., Thurairajah, P., Hazeldine, S.,\nRemnarace, R., Usama, W., Farrington, L., Hamad, N.,\nSieberhagen, C., Ellis, V., Mitchell, J., Hussaini, S. H., Banks,\nM., Ijaz, S. & Bendall, R. P. 2008 Autochthonous hepatitis E\nin Southwest England: natural history, complications and\nseasonal variation, and hepatitis E virus IgG seroprevalence in\nblood donors, the elderly and patients with chronic liver\ndisease .Eur. J. Gastroenterol. Hepatol. 20(8), 784\u2013790.\nDawson, G. J., Mushahwar, I. K., Chau, K. H. & Gitnick, G. L. 1992\nDetection of long-lasting antibody to hepatitis E virus in a US\ntraveler to Pakistan .Lancet 340, 426\u2013427.\nEmerson, S. U. & Purcell, R. H. 2003 Hepatitis E virus .Rev. Med.\nVirol. 13, 145\u2013154.\nErker, J. C., Desai, S. M. & Mushahwar, I. K. 1999 Rapid detection\nof hepatitis E virus RNA by reverse transcription-polymerase\nchain reaction using universal oligonucleotide primers .J. Virol.\nMethods 81, 109\u2013113.\nFernandez-Barredo, S., Galiana, C., Garcia, A., Gomez-Munoz, M. T.,\nVega, S., Rodr\u0131 \u00b4guez-Iglesias, M. A. & Perez-Gracia, M. T. 2007\nPrevalence and genetic characterization of hepatitis E virus in\npaired samples of feces and serum from naturally infected pigs.\nCan. J. Vet. Res. 71, 236\u2013240.\nHaqshenas, G., Shivaprasad, H. L., Woolcock, P. R., Read, D. H. &\nMeng, X. J. 2001 Genetic identi\ufb01cation and characterization of\na novel virus related to human hepatitis E virus from chickens\nwith hepatitis-splenomegaly syndrome in the United States.\nJ. Gen. Virol. 82, 2449\u20132462.\nHsieh, S. Y., Yang, P. Y., Ho, Y. P., Chu, C. M. & Liaw, Y. F. 1998\nIdenti\ufb01cation of a novel strain of hepatitis E virus responsible\nfor sporadic acute hepatitis in Taiwan .J. Med. Virol.\n55,\n300\u2013304.\nHundesa, A., Maluquer de Motes, C., Bo\ufb01ll-Mas, S.,\nAlbinana-Gimenez, N. & Girones, R. 2006 Identi\ufb01cation of\nhuman and animal adenoviruses and polyomaviruses for\ndetermination of sources of fecal contamination in the\nenvironment .Appl. Environ. Microbiol. 72(12), 7886\u20137893.\nLi, R. C., Ge, S. X., Li, Y. P., Zheng, Y. J., Nong, Y., Guo, Q. S.,\nZhang, J., Ng, M. H. & Xia, N. S. 2006 Seroprevalence of\nhepatitis E virus infection, rural southern People\u2019s Republic of\nChina. Emerg. Infect. Dis. 12(11), 1682\u20131688.Li, T. C., Miyamura, T. & Takeda, N. 2007 Short report: detection\nof hepatitis E virus RNA from the bivalve Yamato-Shijimi\n(Corbicula jponica ) in Japan. Am. J. Trop. Med. Hyg. 76(1),\n170\u2013172.\nMansuy, J. M., Legrand-Abravanel, F., Calot, J. P., Peron, J. M.,\nAlric, L., Agudo, S., Rech, H., Destruel, F. & Izopet, J. 2008\nHigh prevalence of anti-hepatitis E virus antibodies in\nblood donors from South West France .J. Med. Virol. 80,\n289\u2013293.\nMatsuda, H., Okada, K., Takahashi, K. & Mishiro, S. 2003 Severe\nhepatitis E virus infection after ingestion of uncooked liver\nfrom a wild boar .J. Infect. Dis. 188, 944.\nMeng, X. J., Purcell, R. H., Halburg, P. G., Lehman, J. R.,\nWebb, D. M., Tsareva, T. S., Haynes, J. S., Thacker, B. J. &\nEmerson, S. U. 1997 A novel virus in swine is closely related to\nthe human hepatitis E virus .Proc. Natl Acad. Sci. USA 94,\n9860\u20139865.\nMizuo, H., Suzuki, K., Takikawa, Y., Sugai, Y., Tokita, H.,\nAkahane, Y., Itoh, K., Gotanda, Y., Takahashi, M., Nishizawa, T.\n& Okamoto, H. 2002 Polyphyletic strains of hepatitis E virus are\nresponsible for sporadic cases of acute hepatitis in Japan .J. Clin.\nMicrobiol. 40(9), 3209\u20133218.\nPage, R. M. 1996 TREEVIEW: an application to display\nphylogenetic trees on personal computers .Comput. Appl.\nBiosci. 12, 357\u2013358.\nPina, S., Jofre, J., Emerson, S. U., Purcell, R. H. & Girones, R. 1998\nCharacterization of a strain of infectious hepatitis E virus\nisolated from sewage in an area where hepatitis E is notendemic. Appl. Environ. Microbiol. 64, 4485\u20134488.\nPina, S., Buti, M., Cotrina, M., Piella, J. & Girones, R. 2000\nVHE identi\ufb01ed in serum from humans with acute hepatitis\nand in sewage of animal origin in Spain .J. Hepatol. 33,\n826\u2013833.\nPuig, M., Jofre, J., Lucena, F., Allard, A., Wadell, G. & Girones, R.\n1994 Detection of adenoviruses and enteroviruses in polluted\nwaters by nested PCR ampli\ufb01cation. Appl. Environ. Microbiol.\n60, 2963\u20132970.\nPurcell, R. H. & Emerson, S. U. 2008 Hepatitis E: an emerging\nawareness of an old disease .J. Hepatol. 48, 494\u2013503.\nRao, V. C. & Melnick, J. L. 1986 Environmental virology. In\nAspects of Microbiology 13 (eds. J. A. Cole, C. J. Knowles &\nD. Schlessinger). American Society for Microbiology,\nWashington, DC.\nRenou, C., Moreau, X., Pariente, A., Cadranel, J. F., Penaranda, G.,\nHardwigsen, J., Nicand, E., Izopet, J., Maringe, E., Morin, T.,\nArotcarena, R., Bourliere, M., Botreau, Y., Carenco, P.,Causse, X., Conmbet, F., Gerolami, R., Igual, J.P., Halfon, P.,\nImbert, Y., Heluwaert, F., Louvel, D., Martin, T., Muller, P.,\nOules, V., Payen, J. L., Peron, J. M., Picon, M., Poncin, E.,\nRif\ufb02et, H., Rosa, I., Rossi, V., Pavio, N. & L\u2019ANGH 2008\nA national survey of acute hepatitis E in France .Aliment.\nPharmacol. Ther. 27(11), 1086\u20131093.\nSchlauder, G. G., Dawson, G. J., Erker, J. C., Kwo, P. Y., Knigge,\nM. F., Smalley, D. L., Desai, S. M. & Mushahwar, I. K. 1998\nThe sequence and phylogenetic analysis of a novel hepatitis E672 P. Clemente-Casares et al. |HEV genotype 3 and sporadically 1 circulate in Spain Journal of Water and Health |07.4|2009virus isolated from a patient with acute hepatitis reported in\nthe United States. J. Gen. Virol. 79, 447\u2013456.\nSchlauder, G. S., Desai, S. M., Zanetti, A. R., Tassopoolos, N. C. &\nMushahwar, I. K. 1999 Novel hepatitis E virus (VHE) isolates\nfrom Europe: evidence for additional genotypes of VHE .\nJ. Med. Virol. 57, 243\u2013251.\nSeminati, C., Mateu, E., Peralta, B., de Deus, N. & Martin, M.\n2008 Distribution of hepatitis E virus infection and its\nprevalence in pigs on commercial farms in Spain .Vet. J.\n175, 130\u2013132.\nStraub, T. M., Pepper, I. L. & Gerba, C. P. 1993 Hazards from\npathogenic microorganisms in land-disposed sewage sludge.\nRev. Environ. Contam. Toxicol. 132, 55\u201391.\nTakahashi, K., Iwata, K., Watanabe, N., Hatahara, T., Ohta, Y.,\nBaba, K. & Mishiro, S. 2001 Full-genome nucleotide sequence\nof a hepatitis E virus strain that may be indigenous to Japan .\nVirology 287, 9\u201312.Takahashi, M., Nishizawa, T., Yoshikawa, A., Sato, S., Isoda, N.,\nKenichi, I., Sugano, K. & Okamoto, H. 2002 Identi\ufb01cation of\ntwo distinct genotypes of hepatitis E virus in a Japanese\npatient with acute hepatitis who had not travelled abroad.\nJ. Gen. Virol. 83, 1931\u20131940.\nTei, S., Kitajima, N., Takahashi, K. & Mishiro, S. 2003 Zoonotic\ntransmission of hepatitis E virus from deer to human beings .\nLancet 362, 371\u2013373.\nWorm, H. C., Wurzer, H. & Fro \u00a8 sner, G. 1998 Sporadic hepatitis E\nin Austria .N. Engl. J. Med. 339, 1554\u20131555.\nYarbough, P. O. 1999 Hepatitis E virus: advances in HEV\nbiology and HEV vaccine approaches .Intervirology 42,\n179\u2013184.\nZanetti, A. R., Schlauder, G. G., Ramano, L., Tanzi, E., Fabris, P.,\nDawson, G. J. & Mushahwar, I. K. 1999 Hepatitis E virus in\npatients with acute non-A-C hepatitis in Italy .J. Med. Virol.\n57, 356\u2013360.\nFirst received 30 October 2008; accepted in revised form 9 January 2009. Available online July 2009673 P. Clemente-Casares et al. |HEV genotype 3 and sporadically 1 circulate in Spain Journal of Water and Health |07.4|2009Cap\u00edtulo I: Estudio 3 \n 119 \nINTRODUCCI\u00d3N \n \n Los poliomavirus humanos JC y BK son dos miembros de la familia Poliomaviridae  que \npersistentemente infectan humanos y causan enfermed ad en individuos \ninmunocomprometidos. Ambos virus est\u00e1n potencialmente implicados en ciertos tipos de c\u00e1ncer y se postula que la v\u00eda de transmisi\u00f3n es la respiratoria y oral. Se ha descrito una elevada frecuencia de excreci\u00f3n de JCPyV y BKPy V y su presencia persistente en agua residual \nha sido constatada en regiones geogr\u00e1ficas di versas, indicando que pue den ser transmitidos a \ntrav\u00e9s de aguas y alimentos contaminados. En el periodo 2007 \u2013 2008 tres nuevos \npoliomavirus han sido descritos en humanos; KI, WU y el poliomavirus de c\u00e9lulas de Merkel.  KIPyV y WUPyV se han detectado principalmente en  el tracto respiratorio de ni\u00f1os e individuos \ninmunocomprometidos, aunque tambi\u00e9n han sido  detectados en heces de pacientes con \ngastroenteritis. En cuanto a MCPyV, tambi\u00e9n ha  sido descrito en secreciones respiratorias y \nest\u00e1 estrechamente relacionado con MCC, apoy ando un papel fundamental de MCPyV en el \ndesarrollo de este tipo de c\u00e1nc er. Adem\u00e1s, estudios recientes han demostrado la presencia de \nestos tres nuevos virus en poblaciones sanas. An ticuerpos contra el poliomavirus limfotr\u00f3pico \n(LPyV), un virus de simio, han sido detectado en muestras de sangre humanas, as\u00ed como en muestras de sangre perif\u00e9rica de pacien tes con leucoencefalopat\u00edas, individuos \ninmunocomprometido s y sujetos sanos. \n  En este estudio se ha valorado la presencia de KIPyV, WUPyV, MCPyV y LPyV en \nmuestras de agua residual urbana para determinar su prevalencia ambiental, tal y como se ha \ndescrito para JCPyV y BKPyV. Adicionalmente, muestras de agua de r\u00edo utilizadas como fuente de agua potable y muestras de orina proceden te de mujeres embarazadas sanas, han sido \nanalizadas para la presencia de estos nuevos po liomavirus. La presencia de JCPyV y HAdV se \nevalu\u00f3 por qPCR como controles de proceso y como \u00edndices de contaminaci\u00f3n fecal humana. RESUMEN ESTUDIO 3: \n \nNewly described human polyomaviruses Merkel cell, KI and WU are present in urban sewage and may represent potential environmental contaminants  Bofill-Mas S, Rodriguez-Manzano J, Calgua B, Carratala A, Girones R \n \nVirology Journal.  2010; 7:141. Cap\u00edtulo I: Estudio 3 \n 120RESULTADOS Y DISCUSI\u00d3N \n  Todas las muestras analizadas mostraron regi stros habituales de contaminaci\u00f3n fecal \nde origen humano, evaluados mediante la cuantificaci\u00f3n de JCPyV y HAdV. Los poliomavirus KI y WU fueron detectados en 1/8 y 2/8 muestras de agua residual, respectivamente, mientras \nque MCPyV fue detectado en 7/8 muestras y fue el \u00fanico nuevo poliomavirus presente en el \nagua de r\u00edo (2/7) y las muestras de orina (1/4). Aunque la detecci\u00f3n realizada fue cualitativa, diluciones seriadas permitieron estimar una concentraci\u00f3n de 10 \u2013 100 PDU/mL. Las secuencias identificadas mostraron una elevada homolog\u00eda con secuencias descritas en otras \nregiones. Ninguna de las muestras de agua residual ( N = 13), bios\u00f3lidos ( N = 9) analizados fue \npositivo para LPyV.  \n La elevada presencia de DNA de MCPyV respecto KIPyV o WUPyV refleja que MCPyV es \nuna infecci\u00f3n m\u00e1s prevalente en la poblaci\u00f3n estudiada o que este virus se excreta en concentraciones m\u00e1s elevadas que el resto. La presencia de MCPyV en orina, agua residual \nurbana y agua de r\u00edo confirman la hip\u00f3tesis que  este nuevo poliomavirus tiene un patr\u00f3n de \nexcreci\u00f3n similar a JCPyV y BKPyV. La presencia de KI, WU y MC poliomavirus en agua residual revela el potencial riesgo de  que estos virus acaben contaminando agua y alimentos. \n CONCLUSIONES   A nuestro conocimiento, este es el primer trabajo donde se describe la presencia de un \nvirus potencialmente relacionado con c\u00e1ncer human o en agua residual y agua de r\u00edo. Los datos \nobtenidos indican que MCPyV presenta una elev ada prevalencia en la poblaci\u00f3n estudiada y \nque puede diseminarse a trav\u00e9s de la contam inaci\u00f3n fecal/orina del agua. La metodolog\u00eda \ndesarrollada puede representa una  herramienta \u00fatil para el est udio de las cepas excretadas, \nprevalencia y transmisi\u00f3n de estos nuevos poliomavirus descritos.  Bofill-Mas et al.  Virology Journal  2010, 7:141\nhttp://www.virologyj.com/content/7/1/141\nOpen Access SHORT REPORT\n\u00a9 2010 Bofill-Mas et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creativ e Commons\nAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproductio n in\nany medium, provided the original work is properly cited.Short reportNewly described human polyomaviruses Merkel \nCell, KI and WU are present in urban sewage and \nmay represent potential environmental \ncontaminants\nS\u00edlvia Bofill-Mas*, Jesus Rodriguez-Manzano, Byro n Calgua, Anna Carratala and Rosina Girones\nAbstract\nRecently, three new polyomaviruses (KI, WU and Merkel cell polyomavirus) have been reported to infect humans. It has \nalso been suggested that lymphotropic polyomavirus, a virus of simian origin, infects humans. KI and WU polyomaviruses have been detected mainly in specimens from the respiratory tract while Merkel cell polyomavirus has been described in a very high percentage of Merkel cell carcin omas. The distribution, excretion level and transmission \nroutes of these viruses remain unknown.Here we analyzed the presence and characteristics of newly described human polyomaviruses in urban sewage and \nriver water in order to assess the excretion level and the potential role of water as a route of transmission of these viruses. Nested-PCR assays were designed for the sensitive detection of the viruses studied and the amplicons obtained were confirmed by  sequencing analysis. The viruses were concentrated following a methodology previously \ndeveloped for the detection of JC and BK human po lyomaviruses in environmental samples. JC polyomavirus and \nhuman adenoviruses were used as markers of human con tamination in the samples. Merkel cell polyomavirus was \ndetected in 7/8 urban sewage samples collected and in 2/7 river water samples. Also one urine sample from a pregnant woman, out of 4 samples analyzed, was positive for this virus. KI and WU polyomaviruses were identified in 1/8 and 2/8 sewage samples respectively. The viral strains detected were highly homologous with other strains reported from several other geographical areas. Lymphotropic polyomavirus was not detected in any of the 13 sewage neither in 9 biosolid/sludge samples analyzed.This is the first description of a virus isolated from sewage and river wa ter with a strong association with cancer. Our \ndata indicate that the Merkel cell polyomavirus is preval ent in the population and that  it may be disseminated through \nthe fecal/urine contamination of water. The procedure developed may constitute a useful tool for studying the excreted strains, prevalence and transmission of these recently described polyomaviruses.\nFindings\nH uman polyomaviruses JC and BK (JCPy V and BKPy V)\nare two members of the Polyomaviridae family that per-\nsistently infect humans and cause disease in immuno-compromised individuals. These viruses have beenpotentially implicated in certain cancers [1,2]. Both respi-\nratory and oral routes have been postulated for their\ntransmission [3-5]. A high frequency of excretion ofJCPyV and BKPyV has been reported, and both viruseshave been detected in urban sewage from various geo-\ngraphical areas [6,7]. This observation indicates that theycould be transmitted by water or food.\nIn 2007 and 2008, three new polyomaviruses, KI WU\nand Merkel cell polyomavirus (KIPyV, WUPyV andMCPyV), were reported in humans [8-10]. KIPyV and\nW U P y V  h a v e  b e e n  d e t e c t e d  m a i n l y  i n  r e s p i r a t o ry  t r a c t\nspecimens from children and also immunocompromisedindividuals. In 4 continents these viruses showed equiva-lent prevalence and highly conserved nucleotidesequences. KIPyV and WUPyV have also been co-detected with other viruses in patients with respiratory\n* Correspondence: sbofill@ub.edu\n1 Department of Microbiology, Faculty of Biology, Universitat de Barcelona, Av. \nDiagonal 645, 08028 Barcelona, Spain\nFull list of author information is available at the end of the articleBofill-Mas et al.  Virology Journal  2010, 7:141\nhttp://www.virologyj.com/content/7/1/141Page 2 of 5\nand, in some cases, gastrointestinal disorders. Both\nviruses have been detected in feces [11,12] and their rolein the etiology of respiratory infections has recently beenquestioned [13].\nMCPyV, which has also been described in respiratory\nsecretions [14-16], is strongly associated with Merkel cell\ncarcinomas (MCC) [17]. This association strongly sup-\nports an etiological role for MCPyV in the developmento f  M C C  [ 1 8 ] .  R e c e n t  s e r o l o g i c a l  d a t a  s h o w  t h a t  K I P y V ,WUPyV and MCPyV are prevalent in the healthy popula-tion [19].\nAntibodies against lymphotropic polyomavirus (LPyV),\na virus of simian origin, have been found in human bloodsamples [19,20]. Moreover, LPyV has been reported inhuman peripheral blood from patients with leukoenceph-alopathies as well as in immunocompromised and healthysubjects [21,22].\nHere we assessed KIPyV , WUPyV , MCPyV and LPyV in\nurban wastewater to determine whether these viruses areprevalent in the environment, as reported for JCPyV andBKPy V [7]. F or this purpose, we performed nested-PCR(nPCR) assays and compared our results with the nucle-\notide sequences available in data banks. Wastewater sam-\nples collected over the last 6 years from a treatment plantprocessing domestic and industrial wastewater from apopulation of 175,000 inhabitants were tested for thepresence of KIPyV , WUPyV and MCPyV (8 sewage sam-ples) and also for LPyV (13 sewage and 9 biosolid andsludge samples). In addition, 7 samples collected in 2009from river water used to source a drinking water treat-ment plant were also analyzed for the presence of KIPyV,WUPyV and MCPyV. The presence of JCPyV and humanadenoviruses (HAdVs) was evaluated by quantitative PCR(qPCR) as a control of the procedures applied and as anindex of the level of fecal pollution of human origin pres-ent in the samples [6].\nUrine samples collected from 4 healthy pregnant\nwomen were also tested for WUPyV , KIPyV and MCPyV .\nViral particles were concentrated using methods devel-\noped in a previous study using JCPyV as a model. Metodswere based on: ultracentrifugation and elution of sampleswith glycine buffer pH 9.5 for sewage [7] and sludge orbiosolids [6], glass wool columns filtration and glycinebuffer elution for river water [23] and on ultracentrifuga-tion for urine [3]. Negative controls were established foreach batch of samples. Nucleic acids were extracted withthe QIAamp Viral RNA kit (QIAGEN, Inc.). Oligonucle-otide primers (T able 1) were designed based on existingpolyomaviral sequences and their specificity againstother known polyomaviruses (JCPyV, BKPyV, SV40,LPyV) was checked by nPCR. Samples were analyzed bynPCR in final 50-\u03bcL reaction volumes. Briefly, 10 \u03bcL ofthe extracted nucleic acids (corresponding to 2 mL ofsewage, 2.5 mL of sludge, 1 g of biosolids, 13.5 mL of riverwater, and 2 mL of urine) and a 10-fold dilution (to pre-\nvent enzymatic inhibition) of each nucleic acid extractionwere analyzed in a 40-\u03bcL reaction mixture containing1xPCR Buffer, MgCl\n2 at 1.5 mM, 0.025 mM of each dNTP ,\n0.5 \u03bcM of primers and 2 units of TaqGold DNA poly-\nmerase (Applied Biosystems). After a first-round PCR, 1\u03bcL of the product was added to 49 \u03bcL of the nPCR mix-ture containing the same components as the first-roundPCR mixture. The conditions for the first-round andnPCR reaction conditions were as follows: 95\u00b0C for 10min, 30 cycles of 94\u00b0C for 60 sec, 60 sec at the corre-sponding annealing temperature (Table 1) and extensionat 72\u00b0C for 60 sec. Amplification was completed with a 7-min extension step at 72\u00b0C. Amplicons of the expectedsize were purified (QIAquick PCR purification kit, QIA-\nGEN, Inc) and sequenced (BigDye sequencing kit and\nABI Prism 377 genetic analyzer; Applied Biosystems).\nNucleotide sequences were analyzed using the basic\nBLAST program http://www.ncbi.nlm.nih.gov/BLAST/\n.\nSeparate areas were used for the diverse steps of the pro-cedures developed; non-template controls were includedin each nPCR reaction. HAdV and JCPyV were tested as acontrol of the procedures applied as well as of the pres-\nence of enzymatic inhibitors in the samples.\nWe processed the samples as 3 separate batches at 3\nseparate periods of time. The samples showed typical lev-els of human fecal pollution, as shown by JCPyV andHAdV concentrations (Table 2). KIPyV and WUPyV werepresent in 1/8 and 2/8 sewage samples respectively whileMCPyV was present in 7/8 sewage samples and was theunique newly described human polyomavirus found inthe river water (Table 2). MCPyV was also detected in 1/4urine samples. The VP1 and VP1/VP2/VP3 genes of theMCPyV genome were also amplified and sequenced in 3sewage samples to confirm the presence of MCPyVgenome (Table 2).\nAlthough the detection technique used here was not\nquantitative, limiting-dilution nPCR experiments showedapproximately 10-100 PCR units/mL of sewage forKIPyV, WUPyV and MCPyV. Samples showed positive\nresults only after nPCR but not after the first-round PCR.\nDNA cross contamination was ruled out since no viral\nstrains or plasmids with the genomes of the viruses wereavailable, only for LPyV was a plasmid available in thelaboratory as positive control; however, all samples werefound to be negative for this virus.\nW e  f o u n d  t h a t  t h e  v i r u s e s  s h o w e d  a  h i g h  d e g r e e  o f\nsequence stability. All but one sequenced MCPyV ampli-con were identical and also identical to the referencesequence with GenBank accession number: EU375803\n,\ndespite their distinct origins (sewage, river water orurine). This observation confirms the high level of con-servation of the DNA of these viruses. Only one MCPyVVP1 amplicon showed a nucleotide that differed from theBofill-Mas et al.  Virology Journal  2010, 7:141\nhttp://www.virologyj.com/content/7/1/141Page 3 of 5\nTable 1: Oligonucleotide primers used for nPCR amplification of WUPyV, KIPyV, MCPyV and simian polyomavirus LPyV\nPrimer Virus region Position Amplification \nreactionProduct size (bp) Annealing \ntemperature (\u00b0C)Sequence (5'-3')\nWU1 WUPyV (VP1)a 1730-1750 First 505 55 CCCACAAGAGTGCAAAGCCTTC\nWU2 2234-2213 AGGCACAGTACCATTGGTTTTA\nWU3 2044-2063 Nested 164 50 AGTTTTGGTGCTTCCTKTSCWU4 2207-2188 TACAGTATACTGAGCAGGC\nKI1 KIPyV (VP1)b 1684-1704 First 378 59 GCTGCTCAGGATGGGCGTGA\nKI2 2061-2043 CAGKGTTCTAGGGTCTCCTGGT\nKI3 1899-1918 Nested 190 54 GTTGCTTGTTGTACCTCTAGKI4 2088-2067 AATTGTATAGGTAGTTGGGCCT\nMC1 MCPyV (TAg)c 1716-1736 First 477 55 GCCTGTGAATTAGGATGTATTT\nMC2 2210-2198 CATTTCTGTCCTGGTCATTTCCA\nMC3 2010-2033 Nested 183 50 G CCCATTATCTA GACTTTGCAAA\nMC4 2192-2173 TCTAACCTCCTTTTGGCTA\nMC1b MCPyV (VP1)c 3174-3194 First 440 58 GGCTTTCTTTTTGAGAGGCCT\nMC2b 3613-3592 AGTGGGCCCTCTATGCAAAGGA\nMC3b 3276-3297 Nested 240 54 TTGGGTAAACAGTTTTCTCCTGMC4b 3515-3493 TGCCTAGATATTTTAATGTTACT\nMC1c MCPyV (VP1/2/3)c4228-4252 First 265 53 GAATTAACTCCCATTCTTGGATTCA\nMC2c 4492-4472 TTGGCTTCTTCCTCTGGTACT\nMC3c 4264-4286 Nested 198 53 ATTTGGGTAATGCTATCTTCTCCMC4c 4461-4439 GGATATATTTCTCCTGAATTACA\nLN1 LPyV(VP2/VP3)d 1542-1564 First 423 54 GGCACACCAAAGAGTAACTCAAG\nLN2 1965-1943 CAGGTCATGTCTTCATTTAGGAG\nLN3 1617-1639 Nested 232 54 GGAAGTGGAGCTTAATAAATTGGLN4 1863-1849 ATATCCATACAAGTCCTCAGAAG\nVP1, VP2 and VP3 = Virion protein 1, 2 and 3;  TAg = T antigen; K= G +T; S = G + C\na The sequence positions are referred to strain EF444549\nb The sequence positions are referred to strain EF127906\nc The sequence positions are referred to strain EU375803\nd The sequence positions are referred to strain K02562\nothers and from strain EU375803 although it does not\nproduce any change in the derived protein sequence.\nThe WUPyV amplicon sequenced was identical to ref-\nerence strain EF444549 while the KIPyV ampliconsequenced showed one nucleotide of difference with ref-erence strain EF127906.\nThe nucleotide sequences obtained were deposited in\nGenBank [GenBank: GQ376529\n (WUPyV), GQ376528\n(KIPyV), GQ376530  (MCPyV TAg region), GQ452776\n(MCPyV VP1/VP2-VP3 region) and GQ390249/50\n(MCPyV VP1 region)].None of the 22 sewage, sludge and biosolid samples\ntested positive for LPyV although typical concentrationsof JCPyV and HAdV indicated human fecal contamina-tion (data not shown). The nPCR assay showed a sensitiv-ity of 1-10 genomic copies/reaction when the completeLPyV genome [24] cloned in pBR322 and quantifiedspectrophotometrically was analyzed by limiting-dilutionnPCR. Thus, LPyV was not detected in the tested samplesby these methods.\nThe observation that MCPyV DNA was much more\nfrequently detected than that of KIPyV or WUPyV mightBofill-Mas et al.  Virology Journal  2010, 7:141\nhttp://www.virologyj.com/content/7/1/141Page 4 of 5\nreflect that MCPyV is a more prevalent infection or that\nit is a highly excreted virus.\nOur results on MCPyV in urine, urban sewage and river\nwater strongly support the notion that this virus shows anexcretion pattern that resembles that of JCPyV andBKPyV. Human excretion of new polyomaviruses, espe-cially MCPyV, may lead to fecal (urine) contamination ofwater and food.\nIn this study we did not attempt the in vitro culture of\nthe new polyomaviruses because no cell culture systemsfor these viruses are available at present. Furthermore, forother human polyomaviruses, such as JCPyV, the regula-tory regions of strains excreted in urine present an arche-typal structure and are inefficiently cultured.\nTo our knowledge, this is the first report of the pres-\nence of a virus strongly related to human cancer in sew-age and river water samples. We propose that themethodology reported here is suitable to study the preva-lence, excretion pattern and genetic variability of recently\ndiscovered human polyomaviruses in environmentalmatrices.\nCompeting interests\nThe authors declare that they have no competing interests.\nAuthors' contributions\nSBM coordinated the study, concentrated urine samples and nucleic acidextractions of the urine samples, collaborated in PCR assays, typed the ampli-cons detected and drafted the manuscript. JRM concentrated the sewage andbiosolid samples and performed the nucleic acid extractions; he also collabo-rated in the PCR analysis and in the sequencing of the resulting amplicons. BCconcentrated river water samples and pe rformed nucleic acid extraction of the\nsame samples. AC collaborated in the production of standards for the quantifi-cation of HAdV and JCPyV and in the nucleotide sequence comparisons. RGparticipated in the devel opment of the methodology, conception and coordi-\nnation of the study and helped to draft the manu script. All au thors read and\napproved the final manuscript.\nAuthors' information\nSBM is an assistant professor at the Department of Microbiology of the Facultyof Biology, University of Barcelona. Her main research interests are the epidemi-Table 2: Presence of human polyomaviruses and human adenoviruses in sewage and river water samples\nSamples, \ntypeCollection \ndate (month/\nyear)Quantitative PCR (GC/mL of \nsample)Nested-PCR results (presence/absence)\nHAdV JCPyV WUPyV KIPyV MCPyV (Tag)\nBCN1, sewage 02/2004 2.81 \u00d7 103 1.35 \u00d7 103 +- +a\nBCN2, sewage 07/2007 4.29 \u00d7 103 7.94 \u00d7 102 -- +a\nBCN3, sewage 07/2007 1.57 \u00d7 103 NT - - +a\nBCN4, sewage 07/2007 6.10 \u00d7 103 8.65 \u00d7 102 -- +a, b\nBCN5, sewage 05/2008 Non tested 5.48 \u00d7 102 +a +a +b\nBCN6, sewage 09/2006 9.40 \u00d7 101 7.65 \u00d7 102 --+\nBCN7, sewage 11/2006 1.35 \u00d7 102 4.83 \u00d7 102 -- +b\nBCN8, sewage 12/2006 6.00 \u00d7 102 8.33 \u00d7 101 ---\nBCN9, river \nwater03/2009 3.08 \u00d7 100 1.00 \u00d7 100 ---\nBCN10, river \nwater03/2009 7.90 \u00d7 100 9.40 \u00d7 100 -- +a\nBCN11, river \nwater03/2009 1.10 \u00d7 101 1.21 \u00d7 101 -- +a\nBCN12, river \nwater03/2009 1.18 \u00d7 101 1.49 \u00d7 101 ---\nBCN13, river \nwater03/2009 1.99 \u00d7 100 4.40 \u00d7 100 ---\nBCN14, river \nwater03/2009 2.48 \u00d7 100 1.21 \u00d7 101 ---\nBCN15, river \nwater03/2009 3.46 \u00d7 100 9.94 \u00d7 100 ---\nNT = Not tested\na Sequenced amplicons\nb Samples from other regions (VP1 and/or VP1/VP2/VP3) in which MCPyV has been amplified and sequenced (GQ452776, GQ390249-50)Bofill-Mas et al.  Virology Journal  2010, 7:141\nhttp://www.virologyj.com/content/7/1/141Page 5 of 5\nology of human and animal polyomaviruses. She addresses their transmission\nthrough the environment and their  potential as indicators of the presence of\nhuman or/and animal fecal contamination.\nAcknowledgements\nThis work was supported by the \"Ministerio de Ciencia e Innovaci\u00f3n, MICINN\" \nof the Spanish Government (project AGL2008-05275-C03-01/ALI) and by the \n\"Xarxa de Refer\u00e8ncia de Biotecnologia de Catalunya\". We thank Dr. A. Lewis \n(Food and Drug Administration, Maryland, USA) for kindly providing the LPyV plasmid. Jesus Rodriguez-Manzano and Anna Carratala are fellows of the \nMICINN. We thank the \"Serveis Cient\u00edfico T\u00e8cnics\" of the University of Barcelona \nfor sequencing of PCR products.\nAuthor Details\nDepartment of Microbiology, Faculty of Biology, Universitat de Barcelona, Av. Diagonal 645, 08028 Barcelona, Spain\nReferences\n1. Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon \nM: BKvirus, JC virus and Simian Virus 40 infection in humans, and \nassociation with human tumors .  Adv Exp Med Biol  2006, 577: 319-341.\n2. Lee W, Langhoff E: Polyomavirus in human cancer development .  Adv \nExp Med Biol  2006, 577: 310-318.\n3. Bofill-Mas S, Clemente-Casares P, Major EO, Curfman B, Girones R: Analysis \nof the excreted JC virus strains and their potential oral transmission .  J \nNeurovirol  2003, 9:498-507.\n4. Monaco MCG, Jensen PN, Hou J, Durham LC, Major EO: Detection of JC \nvirus DNA in human tonsil tissue: evidence for site of initial viral infection .  J Virol  1998, 72:9918-9923.\n5. Riccardiello L, Laghi L, Ramamirtham P, Chang CL, Chang DK, Randolph \nAE, Boland CR: JC virus DNA sequences are frequently present in human \nupper and lower gastrointestinal tract .  Gastroenterol  2000, \n119: 1228-1235.\n6. Bofill-Mas S, Albinana-Gimenez N, Clemente-Casares P, Hundesa A, \nRodriguez-Manzano J, Allard A, Calvo M, Girones R: Quantification and \nstability of human adenoviruses and polyomavirus JCPyV in wastewater matrices .  Appl Environ Microbiol  2006, 72:7894-7896.\n7. Bofill-Mas S, Pina S, Girones R: Documenting the epidemiologic patterns \nof polyomaviruses in human populations by  studying their presence in \nurban sewage .  Appl Environ Microbiol  2000, 66:238-245.\n8. Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson \nMAA, Dalianis T, Ramqvist T, Andersson B: Identification of a third human \npolyomavirus .  J Virol  2007, 81:4130-4136.\n9. Feng H, Shuda M, Chang Y, Moore PS: Clonal Integration of a \npolyomavirus in human merkel cell carcinoma .  Science  2008, \n319: 1096-1100.\n10. Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB, Wu G, \nBrennan DC, Storch GA, Sloots TP, Wang D: Identification of a novel \npolyomavirus from patients with acute respiratory tract infections .  \nPLoS Pathogens  2007, 3:595-604.\n11. Mourez T, Bergeron A, Ribaud P, Scieux C, de Latour RP, Tazi A, Soci\u00e9 G, \nSimon F, LeGoff J: Polyomaviruses KI and WU in immunocompromised \npatients with respiratory disease .  Emerg Infect Dis  2009, 5:107-109.\n12. Neske F, Blessing K, Pr\u00f6ttel A, Ullrich F, Kreth HW, Weissbrich B: Detection \nof WU polimavirus DNA by real-time PCR in nasopharyngeal aspirates, serum, and stool samples .  J Clin Virol  2009, 44:115-118.\n13. Norja P, Ubillos I, Templeton K, Simmonds P: No evidence for an \nassociation between infections with WU and KI polyomaviruses and respiratory disease .  J Clin Virol  2007, 40:307-311.\n14. Dalianis T, Ramqvist T, Andreasson K, Kean JM, Garcea RL: KI, WU and \nMerkel cell polyomaviruses: A new era for human polyomavirus research .  Sem in cancer biology  2009, 19(4): 270-75.\n15. Goh S, Lindau C, Tiveljung-Lindell A, Allander T: Merkel cell polyomavirus \nin respiratory tract secretions .  Emerg Infec Dis  2009, 15:489-491.\n16. Kantola K, Sadeghi M, Lahtinen A, Koskenvuo M, Aaltonen LM, M\u00f6tt\u00f6nen \nM, Rahiala J, Saarinen-Pihkala U, Riikonen P, Jartti T, Ruuskanen O, S\u00f6derlund-Venermo M, Hedman K: Merkel cell polyomavirus DNA in \ntumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency .  J Clin Virol  2009, \n45(4): 292-295.\n17. Becker JC, Schrama D, Houben R: Visions and reflections (minireview) .  \nCell Mol Life Sci  2009, 66:1-8.\n18. Hodgson NC: Merkel cell carcinoma: changing incidence .  J Surg Oncol  \n2005, 89:1-4.\n19. Kean JM, Rao S, Wang M, Garcea RL: Seroepidemiology of human \npolyomaviruses .  PLoS Pathogens  2009, 5:1-10.\n20. Viscidi RP, Clayman B: Serological cross reactivity between \npolyomavirus capsids .  \nAdv Exp Med Biol  2006, 577: 73-84.\n21. Delbue S, Tremolada S, Branchetti E, Elia F, Gualdo E, Marchioni E, Maserati \nR, Ferrante P: First identification and molecular characterization of \nlymphotropic polyomavirus in peripheral blood from patients with leukoencephalopaties .  J Clin Microbiol  2008, 46:2461-2462.\n22. Delbue S, Tremolada S, Elia F, Carloni C, Amico S, Tavazzi E, Marchioni E, \nNovati S, Maserati R, Ferrante P: Lymphotropic polyomavirus is detected \nin peripheral blood from immunocompromised and healthy subjects .  \nJ Clin Virol  2010, 47(2): 156-160.\n23. Calgua BA, Mengewein A, Grunert A, Bofill-Mas S, Clemente-Casares C, \nHundesa A, Wyn-Jones P, L\u00f3pez-Pila JM, Girones R: Development and \napplication of a one-step low cost procedure to concentrate viruses from seawater samples .  J Virol Methods  2008, 153: 79-83.\n24. Pawlita M, Clad A, zur Hausen H: Complete DNA sequence of \nlymphotropic papovavirus: prototype of a new speci es of the \npolyomavirus genus .  Virology  1985, 143(1): 196-211.\ndoi: 10.1186/1743-422X-7-141\nCite this article as: Bofill-Mas et al. , Newly described human polyomaviruses \nMerkel Cell, KI and WU are present in urban sewage and may represent potential environmental contaminants Virology Journal  2010, 7:141Received: 30 November 2009 Accepted: 28 June 2010 \nPublished: 28 June 2010\nThis article is available from: http://www.virologyj.com/content/7/1/141\u00a9 2010 Bofill-Mas et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons. org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Virology Journal  2010, 7:141  \n \n \n   \n \n \nCap\u00edtulo II \n \n Estudio de la eficiencia de \neliminaci\u00f3n de pat\u00f3genos virales en \nplantas depuradoras de agua residual \ny control microbiol\u00f3gico del \nagua regenerada  Cap\u00edtulo II: Estudio 4 \n 129 \nINTRODUCCI\u00d3N   La mayor\u00eda de pat\u00f3genos ent\u00e9ricos descri tos en muestras ambientales proceden de \nuna contaminaci\u00f3n originada en el agua resi dual o directamente a trav\u00e9s de excreciones \nhumanas y animales. Actualmente, regiones geogr\u00e1ficas diversas se enfrentan a retos constantes para obtener sufi ciente agua de calidad destinada al consumo humano, \nespecialmente en \u00e1reas donde la disponibilidad de este recurso es limitada. La regeneraci\u00f3n \ndel agua residual es un recurso cada vez m\u00e1s ut ilizado e inevitablemente un bien que debemos \nconsiderar. Grupos de microorganismos tales como los coliformes fecales, E. coli  y los \nenterococos son los indicadores de contaminaci\u00f3n fecal m\u00e1s extendidos y m\u00e1s utilizados. No obstante, la utilidad de dichos indicadores para predecir la presencia y concentraci\u00f3n de pat\u00f3genos v\u00edricos y protozoos ha sido amplia mente cuestionada. Comparando con virus y \nprotozoos, los indicadores bacterianos son m\u00e1s se nsibles a tratamientos de inactivaci\u00f3n, a la \nexposici\u00f3n a la luz solar, son menos resistente s en el medio ambiente, carecen de un origen \nexclusivamente fecal, son capaces de multipli carse en el medio ambiente y no permiten \ndiscriminar el origen de la contaminaci\u00f3n fecal. Los adenovirus han emergido como una prometedora herramienta a la hora de mejora r los est\u00e1ndares de calidad del agua, debido \nprincipalmente a la especificidad que presentan frente al hu\u00e9sped, estabilidad en el ambiente \ny su elevada prevalencia en regiones geogr\u00e1ficas diversas.  \n Para el desarrollo de este trabajo se ha realizado una colaboraci\u00f3n entre nuestro grupo \ny otros dos grupos de investigaci\u00f3 n con experiencia constatada en  diferentes \u00e1reas de estudio \ndentro de la microbiolog\u00eda. El objetivo principal consisti\u00f3 en analizar la diseminaci\u00f3n y eficiencia de eliminaci\u00f3n de pat\u00f3genos e indica dores de contaminaci\u00f3n fecal en dos plantas de \ntratamiento de agua residual donde se aplica n tratamientos terciarios, evaluando as\u00ed la RESUMEN ESTUDIO 4: \n \nStandard and new faecal indicators and pathogens in sewage treatment plants, microbiological parameters for improving the control of reclaimed water  Rodriguez-Manzano J, Alonso JL, Ferr\u00fas MA, Mo reno Y, Amor\u00f3s I, Calgua B, Hundesa A, \nGuerrero-Latorre L, Carratala A, Rusi\u00f1ol M, Girones R \n \nWater Science and Technology . 2012; In press. Cap\u00edtulo II: Estudio 4 \n 130presencia de un riesgo microbiol\u00f3gico asociado al agua regenerada y proponiendo indicadores \nde contaminaci\u00f3n alternativos para un cont rol microbiol\u00f3gico m\u00e1s adecuado. El agua \nregenerada producida en ambas estaciones de puradoras es utilizada como agua de riego y \npara mantener el caudal ec ol\u00f3gico de un r\u00edo pr\u00f3ximo. \n RESULTADOS Y DISCUSI\u00d3N   M\u00e9todos moleculares basados en la PCR, qPCR, t\u00e9cnicas de hibridaci\u00f3n in situ y m\u00e9todos de cultivo cl\u00e1sicos han sido utilizados pa ra el an\u00e1lisis de coliformes termotolerantes, \nSalmonella  spp., Vibrio vulnificus , Vibrio parahaemolyticus , Listeria monocytogenes , Arcobacter  \nspp., HAdV, JCPyV, HAV, HEV, NoV GGI, NoV GGII, Giardia  spp. y Cryptosporidium  spp. \nMuestras de agua residual urbana fueron recolectadas en dos estaciones depuradoras \nlocalizadas en el este de Espa\u00f1a (Valencia), se tomaron muestras de agua residual cruda, \ndespu\u00e9s de aplicar el tratamiento primario-s ecundario y tras la aplicaci\u00f3n del tratamiento \nterciario (filtros de arena y UV). Los an\u00e1lisis  mostraron que todos los pat\u00f3genos e indicadores \nde contaminaci\u00f3n fecal analizados fueron detectad os en cada uno de los diferentes puntos de \nmuestreo de ambas plantas de puradoras, exceptuando a HEV, Vibrio vulnificus  y JCPyV, que no \nfueron detectados en las muestras de agua regenerada. Adicionalmente, HAdV y Arcobacter  \nfueron evaluados mediante ensayos de infectivid ad, mostrando resultados positivos incluso en \nmuestras de agua regenerada de l terciario que cumpl\u00edan con la actual legislaci\u00f3n espa\u00f1ola y \nconstatando la presencia de pat\u00f3genos totalmente viables que son vertidos en el medio ambiente.    Tratando de evaluar la efectividad de las estaciones depuradoras a la hora de eliminar \nlos pat\u00f3genos presentes y debido a la elev ada presencia de pat\u00f3genos detectados, se \nestudiaron las eficiencias de eliminaci\u00f3n de HAdV, Cryptosporidium  spp y Giardia  spp. Los \nresultados mostraron que HAdV cuantificados por qPCR fueron detectados en el 100% de las muestras analizadas, mostrando una reducci\u00f3n  media en ambas depuradoras de 1,2 \u2013 1,9 \nlog\n10, mientras que Cryptosporidium  y Giardia  cuantificados por IFA presentaron reducciones \nentre 1,8 \u2013 3,0 log 10. Aproximadamente, un 60-90% de la disminuci\u00f3n observada se \ncorrespond\u00eda con la aplicaci\u00f3n de los tratamie ntos primarios y secundarios, mientras que la \nreducci\u00f3n restante se justificaba por la aplicaci\u00f3n  de UV y filtros de arena. La combinaci\u00f3n de \nlos dos tratamientos terciarios result\u00f3 ser meno s eficiente que la aplicaci\u00f3n convencional del \nprimario y secundario. Mediante regresi\u00f3n log\u00edst ica se estudi\u00f3 la capacidad de predicci\u00f3n que \nHAdV ofrec\u00eda para la presencia de Cryptosporidium  y Giardia , aunque no se observaron buenas Cap\u00edtulo II: Estudio 4 \n 131correlaciones. De todos modos,  a pesar de no poder predecir la presencia de ambos par\u00e1sitos \ndebido a que HAdV estuvo presente en todas l as muestras analizadas, incluso en ausencia de \notros pat\u00f3genos, su elevada prevalencia y co ncentraci\u00f3n sugieren un papel como indicador \nprotector de la contaminaci\u00f3n fecal.   CONCLUSIONES   Los resultados obtenidos en este estudio indican que la presencia y concentraci\u00f3n de \npat\u00f3genos humanos, incluyendo virus, en muestras de agua residual cruda es elevada y que por lo tanto representan un reto constant e para los sistemas de saneamiento. HAdV \ncuantificados mediante qPCR representa una herramienta \u00fatil c\u00f3mo pat\u00f3geno/indicador en \nagua y debe ser utilizado como indicador de la eficiencia de eliminaci\u00f3n de pat\u00f3genos en las \nEDAR. Los tratamiento de depuraci\u00f3n estudiad os reducen la presencia de los pat\u00f3genos \nanalizados en 1,2 \u2013 3 log\n10, aunque el agua regenerada producida contin\u00faa presentando \npat\u00f3genos viables y sigue representando una fuente  de diseminaci\u00f3n en el ambiente de virus y \nbacterias infecciosas. La aplicaci\u00f3n de sistem as de desinfecci\u00f3n por UV y eliminaci\u00f3n de \nmicroorganismos por filtros de arena represen ta un buen sistema para mantener la calidad \nmicrobiol\u00f3gica del agua, reduciendo la necesidad de cloraci\u00f3n. No obstante, los tratamientos \nimplementados en estas EDAR deben ser perfecci onados y la amplia variedad de pat\u00f3genos \ndetectados deber\u00e1n ser evaluados utilizando modelos de an\u00e1lisis de riesgo. Informaci\u00f3n que resultar\u00e1 esencial para el desarrollo de nuevas pautas para la reutilizaci\u00f3n de agua regenerada.  Standard and new faecal indicators and pathogens in\nsewage treatment plants, microbiological parameters\nfor improving the control of reclaimed water\nJ. Rodriguez-Manzano, J. L. Alonso, M. A. Ferr\u00fas, Y. Moreno, I. Amor\u00f3s,\nB. Calgua, A. Hundesa, L. Guerrero-Latorre, A. Carratala, M. Rusi\u00f1ol\nand R. Girones\nABSTRACT\nThis study involved collaboration between three centres with expertise in viruses, bacteria and\nprotozoa. The focus of the research was the study of the dissemination and removal of pathogensand faecal indicators in two sewage treatment plants (STPs) using tertiary treatments. Samples werecollected over a period of 5 months through a sewage treatment processes. Analysis of the samplesrevealed that the plants were not ef \ufb01cient at removing the faecal indicators and pathogens tested\nduring the study. From entry point (raw sewage) to ef \ufb02uent level (tertiary treatment ef \ufb02uent water),\nthe experimental results showed that the reduction ratios of human adenoviruses were 1.2 log\n10in\nSTP1 and 1.9 log 10in STP2. Whereas for Giardia spp. and Cryptosporidium spp. the reduction ratios\nwere 2.3 log 10for both pathogens in STP1, and 3.0 and 1.7 log 10in STP2, respectively. Furthermore,\nthe presence of faecal indicators and pathogens at different sampling points was evaluated revealingthat the tested pathogens were present in reclaimed water. Human adenovirus and Arcobacter spp.\nshowed positive results in infectivity assays for most of the tertiary ef \ufb02uent water samples that\ncomply with current legislation in Spain ( Real Decreto 1620/2007 ). The pathogens detected must be\nevaluated using a risk assessment model, which will be essential for the development of improvedguidelines for the re-use of reclaimed water.J. Rodriguez-Manzano (corresponding author)\nB. CalguaA. Hundesa\nL. Guerrero-Latorre\nA. CarratalaM. Rusi\u00f1olR. GironesDepartment of Microbiology,\nFaculty of Biology,\nUniversity of Barcelona. Av. Diagonal 643,08028 Barcelona,Spain\nE-mail: jesus_rodriguez@ub.edu\nJ. L. Alonso\nI. Amor\u00f3s\nResearch Institute of Water and Environmental\nEngineering,\nUniversidad Polit\u00e9cnica de Valencia,Camino de Vera 14, 46022 Valencia,Spain\nM. A. Ferr\u00fas\nY. MorenoDepartment of Biotechnology,\nUniversidad Polit\u00e9cnica de Valencia,\nCamino de Vera 14, 46022 Valencia,\nSpain\nKey words |ef\ufb01ciency removal, enteric pathogens, faecal indicators, sewage, tertiary treatment,\ntreatment plant\nINTRODUCTION\nNumerous studies have documented the presence of enteric\npathogens in raw and treated sewage and, by using new mol-\necular methods, new pathogens and potential indicators\nhave also been described ( Girones et al.\uf645\uf643\uf644\uf643). Most patho-\ngens found in environmental waters (rivers, lakes,\nseawater and groundwater) originate from contamination\nwith sewage or directly with human or animal excreta.\nAlthough most pathogens can be removed by sewage\ntreatment, many are discharged into the ef \ufb02uent and enter\nreceiving waters, allowing their transmission through\ncontaminated water. Many regions face water supply chal-\nlenges due to water scarcity resulting in an increased need\nfor water re-use and for ways to solve water resource\nissues or create new sources of good quality water supplies.Classic microbiological indicators such as faecal coli-\nforms, Escherichia coli and enterococci are the most\ncommonly analysed indicators used to evaluate the level of\nfaecal contamination. However, whether these bacteria are\nsuitable indicators of the occurrence and concentration of\nhuman viruses and protozoa cysts has been questioned\n(Lipp et al.\uf645\uf643\uf643\uf644;Tree et al.\uf645\uf643\uf643\uf646;W\u00e9ry et al.\uf645\uf643\uf643\uf64b). Compared\nto viral or protozoan pathogens, indicator bacteria are more\nsensitive to inactivation through treatment processes and\nexposure to sunlight ( Hurst et al.\uf645\uf643\uf643\uf645;Sinclair et al.\uf645\uf643\uf643\uf64c).\nOther limitations have been associated with their application:\nshort survival compared to pathogens ( McFeters et al.\uf644\uf64c\uf64a\uf647),\nnon-exclusive faecal source ( Scott et al.\uf645\uf643\uf643\uf645;Simpson et al.\n\uf645\uf643\uf643\uf645), ability to multiply in some environments1 \u00a9 IWA Publishing 2012 Water Science & Technology |in press |2012\ndoi: 10.2166/wst.2012.233Uncorrected Proof(Solo-Gabriele et al.\uf645\uf643\uf643\uf643;Poteet al.\uf645\uf643\uf643\uf64c), inability to identify\nthe source of faecal contamination ( Field et al.\uf645\uf643\uf643\uf646) and low\ncorrelation with the presence of pathogens ( Pina et al.\uf644\uf64c\uf64c\uf64b;\nH\u00f6rman et al.\uf645\uf643\uf643\uf647;Savichtcheva & Okabe \uf645\uf643\uf643\uf649). Enteric\nviruses have emerged as a promising tool in efforts to increase\nwater quality standards, due to their high host-speci \ufb01city,\nstability in different environments, and prevalence in diverse\ngeographical areas. Additionally, the range of methods\navailable for the analysis of pathogens and indicators in\nwater, including the application of molecular techniques, has\nincreased while the associated costs have decreased.\nThree centres with relevant expertise collaborated on\nthis project to assess the dissemination and removal of patho-gens and faecal indicators in sewage treatment plants (STPs)\nusing molecular techniques and infectivity assays. The objec-\ntive of the study was to evaluate ef \ufb01ciencies of pathogen\nremoval and potential risks related to the presence of patho-\ngens in reclaimed water, and to de \ufb01ne suitable indicators for\nthe microbiological control of reclaimed water. The two\nSTPs studied, located in Eastern Spain, use tertiary treat-\nments with UV irradiation. The ef \ufb02uent water from the two\nplants is regenerated for use in agricultural irrigation and\nthe ecological maintenance of a river \ufb02ow.\nMETHODS\nSamples sites\nTwo full-scale STPs with the capacities of 60,000 (STP1) and\n45,000 (STP2) m3/day were studied. The treatments applied\nin these two STPs and the numbers of samples analysed in\nthe study are summarized in Table 1 .\nSamples from both STPs were collected every 2 \u20134 weeks\nover a period of \ufb01ve months, from October 2009 to February2010. A total of 21 sewage samples were collected from\nSTP1, at the entry point (raw sewage), at the exit point fol-\nlowing secondary treatment and at the exit point following\ntertiary treatment (after UV disinfection). A total of 23\nsewage samples were collected from STP2, including one\nsampling point after sand \ufb01ltration (just after secondary\ntreatment). Both STPs received sewage from a populationof around 250,000 inhabitants and included UV disinfection\nas a tertiary treatment with a dose average of 100 mWs/cm\n2.\nThe scheme of the water treatment line and the points of\nwater sample intake are shown on Figure 1 .\nAnalytical methods\nSensitive molecular methods based on polymerase chain\nreaction (PCR), quantitative PCR (qPCR) and quantitative\nreverse transcription PCR (RT-qPCR), in situ hybridization\ntechniques, and classical culture methods such as colony-\nforming units (CFU) and immuno \ufb02uorescence assays (IFA)\nwere used in the analysis of bacteria, viruses and protozoa\n(Moreno et al.\uf645\uf643\uf643\uf646a,b;Bofill-Mas et al.\uf645\uf643\uf643\uf649;Albinana-\nGimenez et al .\uf645\uf643\uf643\uf64c;Amor\u00f3s et al .\uf645\uf643\uf644\uf643;Ca\u00f1igral et al .\n\uf645\uf643\uf644\uf643;Gonz\u00e1lez et al.\uf645\uf643\uf644\uf643;Rodriguez-Manzano et al.\uf645\uf643\uf644\uf643;\nCalgua et al .\uf645\uf643\uf644\uf644). The microorganisms analysed were\nfaecal coliforms and the following groups of viruses:\nhuman adenoviruses (HAdV) and JC polyomaviruses\n(JCPyV) (both proposed as indicators of human faecal/\nurine contamination), hepatitis A virus, hepatitis E virus\nand norovirus GI and GII (NoV GI and GII). The bacterial\npathogens analysed were: Salmonella spp., Vibrio vulni \ufb01-\ncus,Vibrio parahaemolyticus ,Listeria monocytogenes ,\nArcobacter spp. The protozoan pathogens analysed were\nGiardia spp. and Cryptosporidium spp.\nBacteriological and protozoan analyses were performed\non the same day as sample collection at the Department of\nTable 1 |Treatment processes of STPs and sample sites\nSewage treatment plant Treatment process Sample n\nSTP1 Screening and grit removal Untreated sewage (E) 7\nPrimary sedimentationAnaerobic digestionSecondary sedimentation Secondary clari \ufb01er ef\ufb02uent (S) 7\nUV disinfection Reclaimed water after disinfection (T) 7\nSTP2 Screening and grit removal Untreated sewage (E) 6\nPrimary sedimentation\nAnaerobic digestion\nSecondary sedimentation Secondary clari \ufb01er ef\ufb02uent (S) 6\nSand \ufb01ltration Sand \ufb01lter ef \ufb02uent (F) 6\nUV disinfection Reclaimed water after disinfection (T) 52 J. Rodriguez-Manzano et al .|Faecal indicators and pathogens in sewage treatment plants Water Science & Technology |in press |2012Uncorrected ProofBiotechnology and the Research Institute of Water and\nEnvironmental Engineering (Polytechnic University of Valen-\ncia, Valencia, Spain), whereas virological analyses were\nperformed at the Department of Microbiology (University of\nBarcelona, Barcelona, Spain) the day after sample collection\n(located 350 km north of the STPs). All samples were collected\nin sterile containers and kept at 4WC until analysis.\nRecovery of viral particles from sewage was performed\nfollowing a previously described procedure ( Pina et al .\n\uf644\uf64c\uf64c\uf64b) presenting an estimated recovery ef \ufb01ciency ranging\nfrom 30 to 90% for HAdV, JCPyV, NoV GGII and poliovirus\n(Pina et al .\uf644\uf64c\uf64c\uf64b;Bofill-Mas et al .\uf645\uf643\uf643\uf649;Calgua et al .i n\npress ). Detection levels when using qPCR or nested-PCR\ntechniques have been quanti \ufb01ed as 10 genome copies\n(GC) per reaction. Considering viral concentration and\nPCR analysis, the estimated detection limit for viruses is\nabout 60 GC/100 mL of sewage. The presence of faecal coli-\nforms and Salmonella spp. was studied using membrane\n\ufb01ltration procedures according to UNE-EN ISO 9308 \u2013\n1:2001 and ISO 19250:2010, respectively, presenting detec-\ntion limits of 1 CFU/100 mL. The detection limit for\nbacterial qPCR assays (Moreno et al .\uf645\uf643\uf643\uf646a,b;Amor\u00f3s\net al .\uf645\uf643\uf644\uf643;Ca\u00f1igral et al .\uf645\uf643\uf644\uf643;Gonz\u00e1lez et al .\uf645\uf643\uf644\uf643)\nranged from 1 to 100 CFU/mL, whereas the detection\nlimit for Giardia andCryptosporidium has been estimated\nas 1 (oo)cyst per litre, by using Environmental Protection\nAgency Method 1623.\nRESULTS AND DISCUSSION\nPathogens and faecal indicators analysed\nThe presence of pathogens and faecal indicators at each\nsampling point was evaluated in both STPs and the results\nare summarized in Table 2 .All tested pathogens and faecal indicators were detected\nin the samples taken from the different levels of treatment,\nwith the exception of HEV, V. vulni \ufb01cus and JCPyV,\nwhich were not detected in tertiary reclaimed water\nsamples. JCPyV quanti \ufb01ed by qPCR in raw sewage (100%\npositive samples) had an average concentration of 5.44 \u00d7\n104GC/100 mL in STP1 and 9.11 \u00d7104GC/100 mL in\nSTP2. Norovirus GII was quanti \ufb01ed by RT-qPCR at the ef \ufb02u-\nent level (4 out 7 ef \ufb02uent water samples were positive in\nSTP1 and 4 out of 5 were positive in STP2), showing\nmean values of 3.75 \u00d7102GC/100 mL and 3.34 \u00d7102GC/\n100 mL, respectively. Furthermore, HAdV and Arcobacter\nspp. were tested by infectivity assays showing positive results\nat different collection points, including tertiary reclaimed\nwater.\nRemoval ef \ufb01ciencies of human adenoviruses and\nprotozoan pathogens\nRemoval of HAdV, Giardia spp. and Cryptosporidium spp.\nwere studied by calculating the log 10reduction through the\ntreatment processes, the results are summarized in Tables 3\nand4. Primary treatment is mainly used for grit removal and\nthe expected removal of this step is lower than the other pro-\ncesses evaluated ( Fuet al .\uf645\uf643\uf644\uf643), whereas the secondary\ntreatment process plays an important role in reducing patho-\ngens and chemical pollutants since the microorganisms are\nmostly separated from the water through sedimentation,\neither by themselves or attached to activated sludge. For\nthese reasons, the removal ef \ufb01ciencies of primary and sec-\nondary treatments were analysed together.\nThe results show that the \ufb01rst two stages (primary and\nsecondary treatments) are the most important steps in the\nremoval of microorganisms, showing values of 1.03 log 10,\n1.99 log 10and 1.37 log 10in STP1 and 1.51 log 10, 2.56\nlog10and 1.28 log 10in STP2 for HAdV, Giardia andCryp-\ntosporidium , respectively. About 60 \u201389% of total reduction\nFigure 1 |Simpli \ufb01ed scheme of sewage treatment plants.3 J. Rodriguez-Manzano et al .|Faecal indicators and pathogens in sewage treatment plants Water Science & Technology |in press |2012Uncorrected Proofwas quanti \ufb01ed at this sampling point. The application of UV\ndisinfection in STP1 (reducing them by 0.13 log 10, 0.34 log 10\nand 0.90 log 10, respectively) and in STP2 (0.04 log 10, 0.30log10and 0.18 log 10, respectively) was evaluated. UV disin-\nfection should reduce the concentration of pathogens\nnotably, although this process showed relatively poorTable 3 |Log 10removal of microorganisms within the treatment processes of STP1\nParameter Primary and secondary treatments (E \u2013S) UV disinfection (S \u2013T) Whole processes (E \u2013T)\nHuman adenovirusa1.03 (89%) 0.13 (11%) 1.16\nGiardia spp.b1.99 (85%) 0.34 (15%) 2.33\nCryptosporidium spp.b1.37 (60%) 0.90 (40%) 2.27\nE: entry (raw sewage), S: secondary treatment ef \ufb02uent and T: tertiary treatment ef \ufb02uent (after UV disinfection).\naQuanti \ufb01ed by qPCR.\nbQuanti \ufb01ed by IFA. Data in parenthesis show % of log 10removal.Table 2 |Microorganisms analysed in sewage treatment plants STP1 and STP2\nSTP1 STP2\nESTESFT\nHuman adenovirus qPCR 7/7 (100) 7/7 (100) 7/7 (100) 6/6 (100) 6/6 (100) 6/6 (100) 5/5 (100)\nIFA 1/1 (100) NT 5/7 (71.4) 1/1 (100) NT 1/2 (50.0) 5/5 (100)\nJC polyomavirus qPCR 6/6 (100) NT 0/7 (0.0) 5/5 (100) NT NT 0/5 (0.0)Hepatitis A virus RT-nPCR 0/7 (0.0) 1/7 (14.3) 1/7 (14.3) 0/6 (0.0) 0/6 (0.0) 0/6 (0.0) 1/5 (20.0)Hepatitis E virus RT-nPCR 3/7 (42.9) 1/7 (14.3) 0/7 (0.0) 5/6 (83.3) 3/6 (50.0) 1/6 (16.7) 0/5 (0.0)Norovirus GI RT-nPCR 3/6 (50.0) 0/3 (0.0) 0/3 (0.0) 4/5 (80.0) 0/2 (0.0) 1/2 (50.0) 1/2 (50.0)Norovirus GII RT-qPCR 4/6 (66.7) 1/3 (33.3) 4/7 (57.1) 5/5 (100) 1/2 (50.0) 2/3 (66.7) 4/5 (80.0)\nSalmonella spp. SCM 6/7 (85.7) 5/7 (71.4) 1/7 (14.3) 4/6 (66.7) 2/6 (33.3) 3/6 (50.0) 1/5 (20.0)\nFaecal coliforms SCM NT NT 7/7 (100) NT NT 4/6 (66.7) 3/5 (60.0)Vibrio vulni \ufb01cus qPCR 0/7 (0.0) 1/7 (14.3) 0/7 (0.0) 1/6 (16.7) 0/6 (0.0) 0/6 (0.0) 0/5 (0.0)\nVibrio parahaemolyticus qPCR 0/7 (0.0) 1/7 (14.3) 1/7 (14.3) 0/6 (0.0) 2/6 (33.3) 0/6 (0.0) 1/5 (20.0)\nListeria monocytogenes qPCR 1/7 (14.3) 2/7 (28.6) 1/7 (14.3) 4/6 (66.7) 1/6 (16.7) 0/6 (0.0) 1/5 (20.0)\nArcobacter spp. qPCR 7/7 (100) 7/7 (100) 7/7 (100) 6/6 (100) 6/6 (100) 6/6 (100) 5/5 (100)\nGiardia spp. IFA 7/7 (100) 7/7 (100) 5/7 (71.4) 6/6 (100) 6/6 (100) 6/6 (100) 5/5 (100)\nCryptosporidium spp. IFA 7/7 (100) 5/7 (71.4) 4/7 (57.1) 6/6 (100) 6/6 (100) 5/6 (83.3) 4/5 (80.0)\nSTP1 and 2: sewage treatment plant 1 and 2; E: entry (raw sewage); S: secondary treatment ef \ufb02uent; F: after sand \ufb01ltration treatment; T: tertiary treatment ef \ufb02uent (after UV disinfection);\nqPCR: quantitative PCR; RT-nPCR: reverse transcription nested PCR; RT-qPCR: reverse transcription quantitative PCR; SCM: standard culture metho ds; IFA: immuno \ufb02uorescence assay;\nnPCR: nested PCR; NT: not tested. All the data are represented as positive samples/analysed samples (% positive samples).\nTable 4 |Log 10removal of microorganisms within the treatment processes of STP2\nParameter Primary and secondary treatments (E \u2013S) Sand \ufb01ltration (S \u2013F) UV disinfection (F \u2013T) Whole processes (E \u2013T)\nHuman adenovirusa1.51 (81%) 0.31 (17%) 0.04 (2%) 1.86\nGiardia spp.b2.56 (86%) 0.12 (4%) 0.30 (10%) 2.98\nCryptosporidium spp.b1.28 (73%) 0.29 (17%) 0.18 (10%) 1.75\nE: entry (raw sewage), S: secondary treatment ef \ufb02uent, F: after sand \ufb01ltration treatment and T: tertiary treatment ef \ufb02uent (after UV disinfection).\naQuanti \ufb01ed by qPCR.\nbQuanti \ufb01ed by IFA. Data in parenthesis show % of log 10removal.4 J. Rodriguez-Manzano et al .|Faecal indicators and pathogens in sewage treatment plants Water Science & Technology |in press |2012Uncorrected Proofreduction. Furthermore, using a sand \ufb01ltration process\nbefore the UV disinfection in STP2 was also evaluated (redu-\ncing HAdV by 0.31 log 10,Giardia by 0.12 log 10and\nCryptosporidium by 0.29 log 10), and the observed data\nrevealed that the combination of these two processes was\nless effective than the \ufb01rst two stages studied in both STPs.\nThe application of UV disinfection and sand \ufb01ltration is\nrequired to disinfect water and maintain quality, which\nreduces the requirements for chlorination. However, the\ndata obtained reveals that HAdV detected by qPCR was\ndetected in the reclaimed water following the disinfection\nprocesses. It exhibited similar log 10removal behaviour to\nthat of Giardia cysts and Cryptosporidium oocsysts in\nthese plants, which were detected by IFA, showing a\nhigher concentration than other pathogens or faecal indi-\ncators, even in tertiary reclaimed water that complies with\ncurrent regulations in Spain ( Real Decreto 1620/ \uf645\uf643\uf643\uf64a).\nThe presence of HAdV, faecal coliforms, Salmonella ,\nGiardia and Cryptosporidium in tertiary reclaimed\nwater are presented in Table 5 . UV dose (mWs/cm2),\naccumulated precipitation (mm) for a 24 h period and aver-\nage temperature (WC) observed during sampling have also\nbeen included. Climatological data were recorded by the\nSpanish Meteorological Agency (AEMET).\nNo associations between the temperature, precipitation\nand presence of tested microorganisms was observed.\nCorrelations between the concentrations of Giardia ,\nCryptosporidium and the viral faecal indicator evaluated\n(HAdV) were determined by linear regression and the\nmodel adequacy was tested by the Anova Test ( \u03b1\u00bc0.05), cal-\nculated by PASW Statistics 18 (SPSS Inc, Chicago, IL,\nUSA). Values less than the detection limit were considered\nas zero. Taking all samples into account, bad correlations\nwere found between the microorganisms ( r<0.4,P-Value\n<0.05), indicating that HAdV could not predict the concen-\ntration of these pathogens. However, high concentrations of\nHAdV were detected in all samples, even when pathogenic\nprotozoa concentrations were very low or negative, indicat-\ning that human adenoviruses could be a protective indicator\nof faecal contamination considering the diversity of patho-\ngens analysed in both STPs studied.\nCONCLUSIONS\nThe results of this study indicate that the prevalence and\nconcentrations of human pathogens, including viruses, in\nraw sewage in the STPs analysed are elevated and represent\na challenge for the sanitation system. The results obtained\nTable 5 |Presence of faecal bacteria/viral indicators and pathogens in tertiary reclaimed water samples\nSite DayMean\ntemperature (WC)Precipitation\n(mm/day)UV dose\n(mWs/cmb) HAdVa(GC/100 mL) HAdVcFaecal coliformsb\n(CFU/100 mL)Salmonellab(CFU/\n100 mL)Giardiac\n(cysts/L)Cryptosporidiumc\n(oocysts/L)\nSTP1 21/10/2009 19.4 4.1 43 2.61 \u00d7104Presence >1,000 Presence 2.0 0.0\n04/11/2009 20.4 0 49 8.32 \u00d7103Presence >1,000 Absence 0.0 0.0\n18/11/2009 17.2 0 137 6.62 \u00d7102Absence >1,000 Absence 2.0 0.4\n02/12/2009 16.2 1.9 54 5.55 \u00d7102Presence >1,000 Absence 0.0 0.4\n16/12/2009 5.9 0.7 50 1.21 \u00d7104Absence 111 Absence 3.6 0.8\n13/01/2010 12.1 1.8 190 1.10 \u00d7102Presence 35 Absence 1.2 0.0\n04/02/2010 10.5 6.1 161 8.08 \u00d7102Presence 25 Absence 13.2 0.4\nSTP2 05/11/2009 17.2 0 135 7.54 \u00d7102Presence >1,000 Absence 0.4 0.4\n19/11/2009 15.7 0 116 1.97 \u00d7102Presence >1,000 Absence 1.2 0.4\n03/12/2009 14.7 0.2 106 2.42 \u00d7102Presence Absence Absence 0.4 1.6\n17/12/2009 7.6 0 108 4.90 \u00d7103Presence 32 Presence 2.0 3.6\n14/01/2010 12.5 0 96 2.56 \u00d7102Presence Absence Absence 1.2 0.0\nWC: degrees Celsius; mm/day: millimetres per day; mWs/cm2: milliwatt seconds per square centimetre; GC: genomic copies; CFU: Colony-forming unit.\naQuanti \ufb01ed by qPCR.\nbDetected and quanti \ufb01ed by standard culture methods.\ncQuanti \ufb01ed or tested by IFA.5 J. Rodriguez-Manzano et al .|Faecal indicators and pathogens in sewage treatment plants Water Science & Technology |in press |2012Uncorrected Proofindicate that human adenoviruses quanti \ufb01ed by qPCR rep-\nresents a useful tool as pathogen/indicator in water and\nmay be used as an indicator of removal ef \ufb01ciency of patho-\ngens by STPs. The current treatments studied here reduce\nthe numbers of the analysed pathogens by about 1.2 \u20133.0\nlog10; however, the reclaimed water produced contains\nviable pathogens and would be a source of dissemination\nof infectious viruses and bacteria in the environment and\nin food. The application of UV disinfection and sand \ufb01l-\ntration is useful for disinfection and maintaining water\nquality, reducing the requirements for chlorination, how-\never, the depuration treatments applied in many STPs\nshould probably be improved. The pathogens detected\nmust be evaluated using a risk assessment model. Such\ninformation will be essential in developing improved guide-\nlines for the re-use of reclaimed water.\nACKNOWLEDGEMENTS\nThe research reported in the manuscript was supported by\ngrants from the \u2018Ministerio de Educaci\u00f3n y Ciencia \u2019of the\nSpanish Government (projects AGL2008-05275-C03-01\nand AGL2011-30461-C02-01). Anna Carratal\u00e0 and Jes\u00fas\nRodriguez-Manzano were fellows of the Spanish Ministry\nof Science.\nREFERENCES\nAlbinana-Gimenez, N., Clemente-Casares, P., Calgua, B., Huguet,\nJ. M., Courtois, S. & Girones, R. \uf645\uf643\uf643\uf64c Comparison of methods\nfor concentrating human adenoviruses, polyomavirus JC and\nnoroviruses in source waters and drinking water using\nquantitative PCR .J. Virol. Methods 158, 104 \u2013109.\nAmor\u00f3s, I., Alonso, J. L. & Cuesta, G. \uf645\uf643\uf644\uf643 Cryptosporidium\noocysts and giardia cysts on salad products irrigated withcontaminated water. J. Food Prot. 73, 1138 \u20131140.\nBo\ufb01ll-Mas, S., Albi\u00f1ana-Gimenez, N., Clemente-Casares, P.,\nHundesa, A., Rodriguez-Manzano, J., Allard, A., Calvo, M. &Girones, R. \uf645\uf643\uf643\uf649 Quanti \ufb01cation and stability of human\nadenoviruses and polyomavirus JCPyV in wastewater\nmatrices .Appl. Environ. Microbiol. 72, 7894 \u20137896.\nCalgua, B., Barardi, C. R., Bo \ufb01ll-Mas, S., Rodriguez-Manzano, J. &\nGirones, R. \uf645\uf643\uf644\uf644Detection and quantitation of infectious\nhuman adenoviruses and JC polyomaviruses in water by\nimmuno \ufb02uorescence assay .J. Virol. Methods 171,1\u20137.\nCalgua, B., Rodriguez-Manzano, J., Hundesa, A., Su\u00f1en, E., Calvo,\nM. & Girones, R. New methods for the concentration ofviruses in urban sewage using quantitative PCR. In press\nQ1 .\nCa\u00f1igral, I., Moreno, Y., Alonso, J. L., Gonz\u00e1lez, A. & Ferr\u00fas, M.\nA.\uf645\uf643\uf644\uf643 Detection of Vibrio vulni \ufb01cusin seafood, seawaterand wastewater samples from a Mediterranean coastal area .\nMicrobiol. Res. 165, 657 \u2013664.\nField, K. G., Bernhard, A. E. & Brodeur, T. J. \uf645\uf643\uf643\uf646 Molecular\napproaches to microbiological monitoring: fecal source\ndetection .Environ. Monit. Assess. 81, 313 \u2013326.\nFu, C. Y., Xie, X., Huang, J. J., Zhang, T., Wu, Q. Y., Chen, J. N. &\nHu, H. Y. \uf645\uf643\uf644\uf643 Monitoring and evaluation of removal of\npathogens at municipal wastewater treatment plants .Water\nSci. Technol. 61, 1589 \u20131599.\nGirones, R., Ferr\u00fas, M. A., Alonso, J. L., Rodriguez-Manzano, J.,\nCalgua, B., Corr\u00eaa, A. A., Hundesa, A., Carratala, A. & Bo \ufb01ll-\nMas, S. \uf645\uf643\uf644\uf643 Molecular detection of pathogens in water \u2013the\npros and cons of molecular techniques .Water Res. 44,\n4325 \u20134339.\nGonz\u00e1lez, A., Suski, J. & Ferr\u00fas, M. A. \uf645\uf643\uf644\uf643 Rapid and accurate\ndetection of arcobacter contamination in commercialchicken products and wastewater samples by real-time PCR .\nFoodborne Pathog. Dis. 7, 327 \u2013338.\nH\u00f6rman, A., Rimhanen-Finne, R., Maunula, L., von Bonsdorff,\nC. H., Torvela, N., Heikinheimo, A. & H\u00e4nninen, M. L. \uf645\uf643\uf643\uf647\nCampylobacter spp., Giardia spp., Cryptosporidium spp.,\nnoroviruses, and indicator organisms in surface water in\nsouthwestern Finland, 2000 \u20132001 .Appl. Environ. Microbiol.\n70,8 7 \u201395.\nHurst, C. J., Crawford, R. L., Knudsen, G. R., McInerney, M. J. &\nStetzenbach, L. D. \uf645\uf643\uf643\uf645 Manual of Environmental\nMicrobiology . ASM Press, Washington, DC.\nLipp, E. K., Farrah, S. A. & Rose, J. B. \uf645\uf643\uf643\uf644Assessment and impact\nof microbial fecal pollution and human enteric pathogens in\na coastal community .Mar. Pollut. Bull. 42, 286 \u2013\n293.\nMcFeters, G. A., Bissonnette, G. K., Jezeski, J. J., Thomson, C. A.\n& Stuart, D. G. \uf644\uf64c\uf64a\uf647 Comparative survival of indicator\nbacteria and enteric pathogens in well water. Appl.\nMicrobiol. 27, 823 \u2013829.\nMoreno, Y., Botella, S., Alonso, J. L., Ferr\u00fas, M. A., Hern\u00e1ndez, M.\n& Hern\u00e1ndez, J. \uf645\uf643\uf643\uf646aSpeci \ufb01c detection of Arcobacter and\nCampylobacter strains in water and sewage by PCR and\n\ufb02uorescent in situ hybridization .Appl. Environ. Microbiol.\n69, 1181 \u20131186.\nMoreno, Y., Ferr\u00fas, M. A., Alonso, J. L., Jim\u00e9nez, A. & Hern\u00e1ndez,\nJ.\uf645\uf643\uf643\uf646bUse of \ufb02uorescent in situ hybridization to evidence\nthe presence of Helicobacter pylori in water .Water Res. 37,\n2251 \u20132256.\nPina, S., Puig, M., Lucena, F., Jofre, J. & Girones, R. \uf644\uf64c\uf64c\uf64b Viral\npollution in the environment and in shell \ufb01sh: human\nadenovirus detection by PCR as an index of human viruses.Appl. Environ. Microbiol. 64, 3376 \u20133382.\nPote, J., Haller, L., Kottelat, R., Sastre, V., Arpagaus, P. & Wildi,\nW.\uf645\uf643\uf643\uf64c Persistence and growth of faecal culturable bacterial\nindicators in water column and sediments of Vidy Bay, LakeGeneva, Switzerland .J. Environ. Sci. 21,6 2 \u201369.\nReal decreto 1620/2007 \uf645\uf643\uf643\uf64a De 7 de diciembre, por el que se\nestablece el r\u00e9gimen jur\u00eddico de la reutilizaci\u00f3n de las aguas\ndepuradas. B.O.E. 294, 50639 \u201350661.\nRodriguez-Manzano, J., Miagostovich, M., Hundesa, A., Clemente-\nCasares, P., Carratala, A., Buti, M., Jardi, R. & Girones, R.\uf645\uf643\uf644\uf643 Analysis of the evolution in the circulation of HAV6 J. Rodriguez-Manzano et al .|Faecal indicators and pathogens in sewage treatment plants Water Science & Technology |in press |2012Uncorrected Proofand HEV in eastern Spain by testing urban sewage samples .\nJ. Water Health .8, 346 \u2013354.\nSavichtcheva, O. & Okabe, S. \uf645\uf643\uf643\uf649 Alternative indicators of fecal\npollution: relations with pathogens and conventional\nindicators, current methodologies for direct pathogen\nmonitoring and future application perspectives .Water Res.\n40, 2463 \u20132476.\nScott, T. M., Rose, J. B., Jenkins, T. M., Farrah, S. R. & Lukasik, J.\n\uf645\uf643\uf643\uf645 Microbial source tracking: current methodology and\nfuture directions .Appl. Environ. Microbiol. 68, 5796 \u20135803.\nSimpson, J. M., Santo Domingo, J. W. & Reasoner, D. J. \uf645\uf643\uf643\uf645\nMicrobial source tracking: state of the science. Environ. Sci.\nTechnol. 36, 5279 \u20135288 .Sinclair, R. G., Jones, E. L. & Gerba, C. P. \uf645\uf643\uf643\uf64c Viruses in\nrecreational water-borne disease outbreaks: a review .J. Appl.\nMicrobiol. 107, 1769 \u20131780.\nSolo-Gabriele, H. M., Wolfert, M. A., Desmarais, T. R. & Palmer,\nC. J. \uf645\uf643\uf643\uf643 Sources of Escherichia coli in a coastal subtropical\nenvironment .Appl. Environ. Microbiol. 66, 230 \u2013237.\nTree, J. A., Adams, M. R. & Lees, D. N. \uf645\uf643\uf643\uf646 Chlorination of\nindicator bacteria and viruses in primary sewage ef \ufb02uent.\nAppl. Environ. Microbiol. 69, 2038 \u20132043.\nW\u00e9ry, N., Lhoutellier, C., Ducray, F., Delgen\u00e8s, J. P. & Godon, J. J.\n\uf645\uf643\uf643\uf64b Behaviour of pathogenic and indicator bacteria during\nurban wastewater treatment and sludge composting, as\nrevealed by quantitative PCR .Water Res. 42,5 3 \u201362.\nFirst received 25 January 2012; accepted in revised form 20 March 20127 J. Rodriguez-Manzano et al .|Faecal indicators and pathogens in sewage treatment plants Water Science & Technology |in press |2012Uncorrected Proof  \n \n \n   \n \n \nCap\u00edtulo III \n \n Desarrollo de nuevos m\u00e9todos de \nconcentraci\u00f3n de part\u00edculas v\u00edricas en \nagua residual  Cap\u00edtulo III: Estudio 5 \n 143 \nINTRODUCCI\u00d3N   El desarrollo de tecnolog\u00edas moleculares aplicadas a estudios ambientales ha permitido constatar que incluso en pa\u00edses altamente industr ializados existe una alta prevalencia de virus \nen el medio ambiente, lo que causa un importan te impacto en la salud p\u00fablica e importantes \np\u00e9rdidas econ\u00f3micas, principalmente por las infecciones v\u00edricas originadas en agua y alimentos contaminados. Concentraciones significativas de  virus son detectadas en las aguas vertidas en \nel ambiente y en los bios\u00f3lidos generados en pl antas de tratamiento de agua residual. Por lo \ntanto, el agua residual representa un importan te foco de introducci\u00f3n de pat\u00f3genos al \nambiente, especialmente pat\u00f3genos v\u00edricos ya  que estos son estables en condiciones \nambientales. Un reciente estudio de metagen\u00f3mi ca sobre virus en agua residual ha reportado \nla presencia de cerca de 600.000 secuencias potencialmente relacionadas con virus, de las cuales 596.146 podr\u00edan representar nuevos virus.    Debido a actual la necesidad de establecer una metodolog\u00eda para concentrar virus en agua residual que proporcione una buena relaci \u00f3n de coste-efectividad y que sea f\u00e1cilmente \nestandarizable y aplicable en laboratorios de rutina, en este estudi o se han desarrollado y \nevaluado tres nuevos m\u00e9todos de concentraci\u00f3n de part\u00edculas v\u00edricas en agua residual cruda \nprocedente de Barcelona y Pa\u00eds Vasco (Espa\u00f1a)  mediante el estudio de la concentraci\u00f3n y \ncuantificaci\u00f3n por qPCR de virus DNA (HAdV y JCPyV) y RNA (NoV GGII). Adem\u00e1s, los m\u00e9todos \nse han comparado con un protocolo previamente descrito en la literatura y ampliamente \nutilizado en nuestro grupo de investigaci\u00f3n.  RESULTADOS Y DISCUSI\u00d3N   En el estudio aqu\u00ed descrito se ha comp arado y evaluado un m\u00e9todo de concentraci\u00f3n \nde part\u00edculas v\u00edricas en agua residual frecuentemente utilizado en nuestro laboratorio de RESUMEN ESTUDIO 5: \n \nNew methods for the concentration of viruses from urban sewage using quantitative PCR  Calgua B, Rodriguez-Manzano J, Hundesa A, Su\u00f1en E, Calvo M, Bofill-Mas S, Girones R \n \nSometido a Journal of Virological Methods . 2012 Cap\u00edtulo III: Estudio 5 \n 144investigaci\u00f3n (UC) con tres nuevos m\u00e9todos (ESMP, UF y LF). De acuerdo con los estudios \nestad\u00edsticos realizados y con la manipulaci\u00f3n  experimental, el protocolo de concentraci\u00f3n \nbasado en la eluci\u00f3n de las part\u00edculas v\u00edricas mediante la utilizaci\u00f3n de un tamp\u00f3n glicina a pH b\u00e1sico seguido por una floculaci\u00f3n org\u00e1nica (ESMP) se present\u00f3 como el m\u00e1s adecuado para concentrar y cuantificar HAdV, JCPyV y NoV GGII en muestras crudas cuando se lo compar\u00f3 con: (i) ultracentrifugaci\u00f3n-eluci\u00f3n con tamp\u00f3n glicina, pH = 9.5 (UC), (ii) ultrafiltraci\u00f3n-eluci\u00f3n con tamp\u00f3n glicina, pH = 9.5 (UF) y (iii) liofilizaci\u00f3n (LF). Aunque todos los m\u00e9todos aqu\u00ed descritos presentaron rangos de cuantificaci\u00f3n habi tuales para los virus analizados en este tipo \nde muestras, la utilizaci\u00f3n de material y maquinaria espec\u00edfica tales como la ultracentr\u00edfuga (UC), ultrafiltros (UF) o el liofilizador (LF), difi cultan su implementaci\u00f3n debido al elevado coste \necon\u00f3mico asociado.   \n Para evaluar la eficiencia de recuperaci \u00f3n de ESMP y asegurar la repetitividad del \nm\u00e9todo escogido, diez al\u00edcuotas tomadas a partir de una \u00fanica muestra de agua residual cruda \nfueron evaluadas para HAdV, JCPyV y NoV GGII. El CV fue utilizado como estimador de la variabilidad intra-laboratorio y los resultados  obtenidos mostraron un CV de 16% para HAdV, \ndel 12% para JCPyV y del 17 para NoV II. Tambi\u00e9n se realizaron ensayos de recuperaci\u00f3n y se observaron valores que oscilaban entre el 30% \u2013 95% para HAdV, 55% \u2013 90% para JCPyV y 45% \n\u2013 90% para NoV II. Finalmente, ESMP fue valid ado mediante un estudio de campo formado por \nmuestras de agua residual compuestas durante  un per\u00edodo de 24 horas. Tal y como se \nesperaba, el 100% de las muestras fueron positivas y los valores obtenidos se situaron en rangos de detecci \u00f3n habituales. \n CONCLUSIONES  \n Se han descrito un total de cuatro alternativas para concentrar virus DNA y RNA en \nagua residual, tres de las cuales se han desarrollado y presentado por primera vez en el trabajo aqu\u00ed descrito. ESMP se ha definido como el m\u00e9todo m\u00e1s sensible, mostrando una recuperaci\u00f3n \nde part\u00edculas del 50%. Considerando los valores obtenidos para el CV (12 \u2013 17%) este m\u00e9todo \nproduce resultados reproducibles. Dicho m\u00e9 todo puede ser aplicado en programas de \ndetecci\u00f3n de virus a gran escala, es efectivo, econ\u00f3mico y f\u00e1cilmente estandarizable y aplicable \nen laboratorios de rutina relacionados con la  calidad del agua. Los m\u00e9todos moleculares de \nqPCR aplicados son una herramienta \u00fatil para la detecci\u00f3n de virus en agua residual, debido a \nque proporcionan resultados cons istentes y las interferencias por inhibici\u00f3n son muy limitadas.  \n Cap\u00edtulo III: Estudio 5 \n 145El CV se ha propuesto como un elemento para la evaluaci\u00f3n y comparaci\u00f3n de los \nm\u00e9todos desarrollados para concentrar y dete ctar virus en muestras de agua residual, \nproponiendo un CV \u00d7 100 \u2264 50% como valor de re ferencia para considerar a un m\u00e9todo como \nreproducible y eficiente.   Capitulo III: Estudio 5 \n 147NEW METHODS FOR THE CONCENTRATION OF VIRUSES FROM URBAN SEWAGE USING \nQUANTITATIVE PCR  Byron Calgua\na,*, Jesus Rodriguez-Manzano a,*, Ayalkibet Hundesaa, Esther Su\u00f1enb, Miquel \nCalvoc,  S\u00edlvia Bofill-Masa, Rosina Gironesa,1 \n \na Department of Microbiology, Faculty of Biology, University of Barcelona, Av. Diagonal 643, \nBarcelona 08028, Spain  \nbDepartment of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University \nof the Basque Country, Pase o de la Universidad 7, Vitoria-Gasteiz 01006, Spain \n \ncDepartment of Statistics, Faculty of Biology, University of Barcelona, Av. Diagonal 643, \nBarcelona 08028, Spain  *Byron Calgua and Jesus Rodriguez-Manzano contri buted equally to this study and should both \nbe considered first authors.  \n1Author for correspondence: Dr. Rosina Girones,  Departament de Microbiologia, Facultat de \nBiologia, Universitat de Barcelona, Av. Diagonal 643, 08028 Barcelona, Spain. Telephone number: (+34) 93 402 1483. Fax number: (+34) 93 403 9047. E-mail: rgirones@ub.edu  Capitulo III: Estudio 5 \n \n 148ABSTRACT \n Viruses are among the most important pathogens present in water contaminated with feces or \nurine and represent a serious risk to human health. Here we compare four procedures for concentrating viruses from sewage, three of  which were developed in the present study. \nViruses were quantified using PCR techniques. According to statistical analysis and the \nsensitivity to detect human adenoviruses (HAd V), JC polyomaviruses (JCPyV) and noroviruses \ngenogroup II (NoV GGII), (i) a new procedure (ESM P) based on the elution of the viruses with \nglycine-alkaline buffer followed by organic flocculation with skimmed milk was found to be the most efficient method when compared to (ii) ultrafiltration and glycine-alkaline elution, (iii) a \nlyophilization-based method and (iv) ultracentrif ugation and glycine-alkaline elution. Through \nthe analysis of replicate sewage samples, ESMP showed reproducible results with a coefficient of variation (CV) of 16% for HAdV, 12% for JCPyV and 17% for NoV GGII. Using spiked samples, the viral recoveries were estimated at 30%-95% for HAdV, 55%-90% for JCPyV and 45%-50% for NoV GGII. ESMP was validated in a field study using twelve 24-h composite sewage samples collected in a urban sewage treatment plant in the North of (Spain) that reported 100% positive samples with mean values of HAdV, JCPyV and NoV GGII similar to those of other studies. Although all of the methods compared he re consistently yield high values of virus \ndetection and recovery in urban sewage, some require expensive labora tory equipment. ESMP \nis an effective low-cost procedure which allo ws a large number of samples to be processed \nsimultaneously and is easily standardizable for use in a routine laboratory involved in water monitoring. Moreover, in the present study, a CV  was applied and proposed as a parameter to \nevaluate and compare the methods for detecting viruses in sewage samples. \n \nKeywords:  sewage, virus, virus concentration, qPCR, human adenovirus, JC polyomavirus, \nnorovirus, coefficient of variation.  1. INTRODUCTION  Raw sewage is the most important source of pathogens that enter the environment, especially viruses that show a high stability in enviro nmental conditions. Although raw sewage from \nurban areas, hospitals and slaughterhouses is us ually treated before be ing released into the \nenvironment, several studies have documented th e presence of pathogenic viruses in treated \nwater (Bofill-Mas et al ., 2006; Fumian et al ., 2010; Gantzer et al ., 1998; Pusch et al ., 2005; van Capitulo III: Estudio 5 \n 149den Berg et al ., 2005). Untreated and treated sewage may represents a source of \nenvironmental contamination   A recently published metagenomic study of viru ses present in urban sewage reported the \npresence of nearly 600,000 new virus-relate d sequences; 43,381 associated with known \nviruses and 596,146 that may be new viruses unrelated to previously identified ones (Cantalupo et al ., 2011). New vi ruses, such as the picornavirus Klassevirus and the Asfarvirus-\nlike virus, have also recently been  reported in urban sewage (Hotlz et al ., 2009; Loh et al ., \n2009). Moreover, studies of urban sewage have provided valuable information on the prevalence of many viral infections and the dissemination of new viruses in diverse populations; Bofill et al . (2010) described the presence of new polyomaviruses Merkel cell, KI \nand WU; Rodriguez-Manzano et al . (2010) analyzed the evolution in the circulation of the \nhepatitis A and E viruses in the popul ation of Eastern Spain; and Prado et al . (2011) detected \ndifferent enteric viruses in effluent water from two hospitals. All of these data suggest that raw sewage represents a useful matrix to study viruses excreted by human and animal populations.   Classical enteric human viruses, such as ad enoviruses, rotaviruse s, noroviruses and \nenteroviruses, and viruses excreted by urine su ch as the BK and JC polyomaviruses, have been \nwidely detected in sewage from different geographical areas (Bofill-Mas et al ., 2000; Fumian et \nal., 2010; Miagostovich et al ., 2008; Victoria et al ., 2010). Interestingly, various studies have \nreported that the levels of classical bacterial indicators ( E. coli  and enterococci) do not always \ncorrelate with viruses, particularly when bacterial indicator concentrations are low (Brownell et al ., 2007; Calgua et al ., 2008; Colford et al ., 2007; Wyn-Jones et al ., 2011). Improved \nindicators will be useful and human adenoviruses (HAdV) and JC polyomaviruses (JCPyV) have \nbeen proposed as viral indicators of human fe cal contamination in the environment and have \nplayed an important role in recent st udies on water quality (Albinana-Gimenez et al ., 2006; \nBofill-Mas et al ., 2000; McQuaig et al ., 2006, 2009; Miagostovich et al ., 2008; Puig et al. , 1994; \nTong and Lu, 2011; Wyn-Jones et al ., 2011), showing high stab ility in the environmental \nconditions and to disinfection treatments co mmonly applied to sewage and drinking water \n(Bofill et al ., 2006; Ogorzaly et al ., 2010; Wong\n and Xagoraraki, 2011). According to previous \nstudies, HAdV are almost always present in sewage samples from different geographical areas and show a mean concentration of 10\n3 and 102 genomic copies (GC)/mL for HAdV and JCPyV, \nrespectively (Bofill-Mas et al ., 2006; Fong et al . 2009; Rodriguez-Manzano et al. , 2012). \n Capitulo III: Estudio 5 \n \n 150HAdV is grouped in 52 serotypes, which have b een widely reported to cause a broad range of \nclinical manifestations including respiratory tract infection, acute conjunctivitis, cystitis, gastroenteritis, and systemic infections. JCPyV is a human virus in the Polyomaviridae  family \nthat triggers latent and chronic infections that  persist indefinitely in individuals and causes \nhealthy individuals to regularly excrete viral particles in their urine (Shah, 1995). JCPyV is commonly associated with progressive multifocal leukoencephalopathy (PML) in immunocompromised individuals and has attracted new attention due to its reactivation in a \nsmall percentage of patients with multiple sclerosis and other autoimmune diseases treated \nwith immunomodulators (Berger and Major, 1999; Yousry et al ., 2006). The noroviruses are a \nmajor cause of sporadic outbreaks of infectious  gastroenteritis, which occasionally requires \nhospitalization (Glass et al ., 2009). Outbreaks commonly occur in closed populations such as \nchildcare centers and cruise ships (Khan and B ass, 2010), with older children and adults being \ninfected more frequently than infants (Glass et al ., 2009). Based on the phylogenetic analysis \nof the viral capsid (VP1) gene, NoV is classified into five genogroups, which are further subdivided into genotypes. Genogroups I (GGI),  II (GGII) and IV (GGIV) infect humans (Glass et \nal., 2009; Koo et al ., 2010). Despite this diversity, only a few strains, primarily those of \ngenogroup II, genotype 4 (GGII.4), have been re sponsible for the majority of recent cases and \noutbreaks (Barreira et al ., 2010; Bull and White, 2011; Ferreira et al ., 2010; Prado et al ., 2011). \n Methods based on ultracentrifugation and glycin e-alkaline elution, have been described by \nPina et al . (1998) and have been widely used in our laboratory (Bofill-Mas et al. , 2000; \nClemente-Casares et al ., 2003, 2009; Pina et al ., 1998; Rodriguez-Manzano et al. , 2010). In \norder to define concentration methods with high level of cost-efficiency and applicability, new \nprotocols have been developed and evaluated in this study for quantifying viruses present in \nsewage. DNA viruses such as HAdV and JCPyV, and RNA virus as NoV have been selected as representative viruses for the study.  2. MATERIAL AND METHODS  2.1. Sewage samples  Four sets of sewage samples were used in this study. Each sample was harvested\n in a sterile \n1,000-mL polyethylene container and kept at 4 \u00b0C for less than 24 h until the virus particles \nwere concentrated: Capitulo III: Estudio 5 \n 151(i) Comparison of methods: five samples of 200 mL raw urban sewage were collected between \nNovember and December 2010 at the entrance of a sewage treatment plant (STP) located in \nBarcelona (Catalonia, Spain) that receives sewage from a human population of about 1.8 \nmillion inhabitants. Each sample was divided into four aliquots (n=20) a nd each set of aliquots \n(n=5) was processed using one specific concentration method based on flocculation, ultrafiltration, lyophilization and ultracentrifug ation. The volumes of each aliquot and the \nprocedure used are described in Figure 1.  (ii) Repeatability assay for the elution and skimmed-milk flocculation procedure: one sample of \nraw urban sewage was collected at the entrance of STP located in Barcelona (Catalonia, Spain) and divided into te n 50-mL aliquots. \n \n(iii) Recovery assay for the elution and skimmed-m ilk flocculation procedure: one sample of \nraw urban sewage was collected at the\n entrance to a STP located in Barcelona (Catalonia, \nSpain) and divided into ten 50 -mL aliquots. The aliquots were processed using two different \nassays for estimating virus recovery.  (iv) Field study: twelve 24-h composite 50-mL samples were collected between September and \nDecember 2010 at the\n entrance of a STP in Vitoria (Basque Country, Spain) that receives \nsewage from a human population of about 240,000 inhabitants. \n 2.2. Virus-concentration methodology  Figure 1 shows a schematic chart with a description of the protocol used in each of the four virus-concentration methods tested in the pres ent study and a complete description can be \nfound below. According to the virus-concentration method applied and the limitations caused \nby the volume capacity of the filters and ro tors, used sample volumes ranged from 42 to 50 \nmL, depending on the method used. Viral concen trates obtained by applying the different \nprocedures were dissolved with the same pho sphate buffer at pH 7.5 (1:2, v/v of Na\n2HPO 4 0.2 \nM and NaH 2PO 4 0.2 M). When necessary, the final viral concentrates were stored at \u221280 \u00b0C. \n 2.2.1 Elution and skimmed-milk flocculation procedure (ESMP)  The sewage sample (50 mL) was transferred to a 500-mL centrifuge pot and the viruses present were eluted using 100 mL of glycine bu ffer 0.25 N, pH 9.5 (1:2 v/v). The sample was Capitulo III: Estudio 5 \n \n 152stirred rapidly for 30 min on ice and centrifuged at 8,000 x g for a further 30 min at 4 \u00b0C. The \nsupernatant (150 mL) was transferred to a new centrifuge pot, the pH was adjusted to 3.5 with HCl 1N, and 1.5 mL of pre-flocculated skimmed-milk solution (final concentration of skimmed milk 0.01% (w/v)) was added. The pre-flocculated skimmed-milk solution (1% (w/v)) was prepared in advance according to Calgua et al . (2008) by dissolving 1 g of skimmed-milk \npowder (Difco, Detroit, MI, USA) in 100 mL artificial seawater and carefully adjusting the pH to 3.5 with HCl 1 N. The sample was then stirred for 8 h to allow the viruses to be adsorbed into the skimmed-milk flocs at room temperature (RT). Then flocs were sedimented by centrifugation at 8,000 x g for 30 min at 4 \u00b0C. The supern atants were carefully removed \nwithout disturbing the sediment and the pellet was dissolved in 500\u03bcL of phosphate buffer. \n \n2.2.2. Ultrafiltration-based method (UF)  Millipore Ultrafree-15 Centrifugal Filters 100, 000-MW cutoff (Millipore, Milford, MA, USA) \nwere washed with 10 mL of bi-distilled sterile water (four filters per sample), centrifuged at 2,000 x g for 10 min and the filtered water was discarded. A 45-mL sample of sewage was \ntransferred to three pre-washed filters (15 mL each), centrifuged at 2,000 x g for 1 h at RT and \nthe filtered volume was discarded. The viruses wer e eluted from each filter by using 4 mL of \nglycine buffer 0.25 N and pH 9.5. The eluted viruses (approximately 12 mL) were transferred to a sterile 50-mL tube, incubated for 30 min at 4 \u00baC (vortexed every 10 min) and centrifuged at \n3,000 x g for 30 min at 4 \u00baC. The supernatant was then recovered and transferred to a pre-\nwashed filter. The filter was centrifuged at 2,000 x g for 1 h at RT and s ubsequently mixed by \nvortex and centrifuged at 2,000 x g for 2 min at RT. Finally, the volume retained by the filter \nwas collected in 100 \u03bcL. \n 2.2.3. Lyophilization-based method (LF)  A 50-mL sample of sewage was frozen to -80 \u00baC and lyophilized for 24 to 36 h. The lyophilized sample (powder) was then dissolved in 500 \u03bcL of phosphate buffer.  2.2.4. Ultracentrifugation-based method (UC)  This procedure had been described previously  and applied to several studies (Bofill-Mas et al. , \n2000; Clemente-Casares et al ., 2003, 2009; Pina et al ., 1998; Rodriguez-Manzano  et al ., 2010). Capitulo III: Estudio 5 \n 153Briefly, 42 mL of sewage were ultracentrifuged at 100,000 x g for 1 h at 4 \u00b0C to pellet all the \nviral particles together with any suspended material. The viruses present in the pellet were eluted by mixing it with 4 mL of 0.25 N glycine buffer (pH 9.5) on ice for 30 min, and after the addition of 4 mL of phosphate  buffer, the suspended solids were separated by centrifugation \nat 3,000 x g for 20 min. Finally, the viruses were concentrated by ultracentrifugation at 100,000 \nxg for 1 h at 4 \u00b0C and resuspended in 100 \u03bcL of phosphate buffer. \n 2.3. Extraction of nucleic acids from viral concentrates  The extraction of nucleic acids (NA) was performed with QIAamp\n\u00ae Viral RNA Mini Kit (Qiagen, \nValencia, CA, USA) and the automated system QUIACube (Qiagen, Valencia, CA, USA), both according to manufacturer\u2019s instructions. NA extracts were stored at 4 \u00b0C and assayed on the \nsame day using quantitative PCR (qPCR) or quantitative reverse transcription-PCR (qRT-PCR). \n 2.4. Viral enzymatic amplification and quantitation by qPCR  Quantitative PCR was performed in a 25-\u03bcL fina l volume containing 1X Master Mix (Applied \nBiosystems, TaqMan\n\u00ae Environmental Master Mix 2.0, Foster City, CA, USA). The reaction \ncontained 10 \u03bcL of a NA extr action or 10 \u03bcL of a quantified DNA and the corresponding \nprimers and TaqMan probes. HAdV genomes were quantified with 0.9 \u03bcM of the AdF and AdR primers and 0.225 \u03bcM of the AdP1 probe as described by Hernroth et al . (2002). JCPyV \ngenomes were quantified with 0.5 \u03bcM of the JE3F  and JE3R primers and 0.15 \u03bcM of the JE3P \nfluorogenic probe as described in Pal et al . (2006). AmpliTaq Gold was activated for 10 min at \n95 \u00b0C followed by 40 cycles (15 s at 95 \u00b0C and 1 min at 60 \u00b0C) using an MX3000P sequence detector system (Stratagene, La Jolla, CA, USA). The qPCR method used for the quantitation of \nHAdV was tested in previous studies where the qPCR successfully detected human \nadenoviruses from all species, including 40 a nd 41 (data not shown). This assay also showed a \nhigher sensitivity in the quantitation of human viruses from urban sewage compared to other \npreviously described assays (Bofill-Mas et al ., 2006). HAdV and JCPyV qPCR demonstrated high \nspecificity and their sensitivity was estimated as 1\u201310 genome copies.  Quantitative reverse transcription-PCR was also performed in a 25-\u03bcL reaction mixture containing 1X of QuantiTect\nTM Probe RT-PCR kit (Qiagen, Valencia, CA, USA). The reaction \ncontained 5 \u03bcL of NA extraction or 5 \u03bcL of a quantified plasmid cDNA, 1 \u03bcM of the JJV2F and \nCOG2R primers and 0.1 \u03bcM of the RING2- TP probe, as described by Jothikumar et al . (2006). Capitulo III: Estudio 5 \n \n 154Following retrotranscription (30 min at 50 \u00b0C) and activation of the HotStarTaq (15 min at 95 \n\u00b0C), 45 cycles (10 s at 95 \u00b0C, 20 s at 55 \u00b0C, 15 s at 72 \u00b0C) were performed using an MX3000P sequence detection system (Stratagene, La Jolla, CA, USA). The qPCR assay used for noroviruses has been shown to be specific and to present a sensitivity of <10 genome copies \nper reaction (Jothikumar et al ., 2006). \n For the detection and quantitation of specific vi ral genomes, 10 \u03bcL (for HAdV and JCPyV) and 5 \n\u03bcL (for NoV GGII) of neat and 10-fold dilution of every DNA/RNA extraction were tested; these \ndilutions were designed to detect and reduce amp lification inhibition caused by the potential \npresence of inhibitory substances that may interfere with the qPCR. All samples were run in \nquadruplicate (two replicat es per dilution), and positive and negative controls were included. \nKnown quantities of target DNA were added to a parallel amplification reaction containing \nqPCR mix and the plasmid. In every assay, the am plification plots of samples and standard \ndilutions were compared. A sample was considered positive if it produced correct amplification curves and the quantitation data w as within the detection limit. The amount of \nDNA was defined as the average of the duplicate data obtained.  2.5. qPCR standards  For the generation of standards to use in the real-time qPCR assays, three plasmid constructions were employed. The plasmid pJCPyV, which contained the whole JCPyV genome strain Mad-1 in pBR322, was kindly donated by  Andrew M. Lewis at the Office of Vaccine \nResearch and Review, CBER/FDA, MD, USA. The plasmid pAd41, containing the hexon region of \nHAdV 41 in pBR322, was kindly donated by Dr. Annika Allard of the University of Ume\u00e5, \nSweden. For NoV II, the plasmid pNoV, containing the ORF1\u2013ORF2 junction in pTrueBlue, was kindly donated by Dr. Vinj\u00e9 and Dr. Jothikumar at the CDC (Atlanta, GA, USA). Escherichia coli  \nJM109 cells (Promega, Madison, WI, USA) were transformed with the plasmid (pJCPyV, pAdV41 or pNoV). The plasmids were purified from bacteria using the QIAGEN Plasmid Midi Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions and the DNA was quantified with a GeneQuant pro (Amersham Biosciences, Piscataway, NJ, USA). To reduce the possibility of DNA contamination, the plasmids were linearized with EcoRI (pJCPyV and pNoV) or NruI (pAd41) (Promega, Madison, WI, USA), and then purified and quantified again. Suspensions containing 10\n\u22122\u2013107 viral DNA molecules per 10 \u03bcL were made in TE buffer and \nused as standard dilutions, then ali quoted and stored at \u221280 \u00b0C until use. Capitulo III: Estudio 5 \n 1552.6. Statistical analysis \n Data from virus quantification was analyzed using the non-parametric Friedman test for \nrelative efficiency analysis and ranks were allotted by assigning the higher value to the better yield method (Friedman et al ., 1937). A P-value  of <0.05 was considered significant. The \nstatistical analysis was performed using R software version 2.14.1 (R, 2008; Verzani, 2004). 3.  \n 3. RESULTS  3.1. Comparison of methods for conc entrating viruses from raw sewage \n The samples/aliquots evaluated (n = 20) by th e four different viral concentration methods \nwere positive for all viruses test ed and showed high concentration values (Table 1). For HAdV, \nthe different methods differed significantly (Friedman test, P-Value = 0.033) and the \nassociated multiple comparison test showed that UC was significantly different from all the \nother methods tested in terms of the amount of  HAdV detected, being of HAdV significantly \nlower. However, the assigned ranks showed that the higher values were obtained with ESMP (rank = 3.60), followed by LF (rank = 2.60), UF (rank = 2.60) and UC (rank = 1.20). For JCPyV, there were no statistically significant differences (Friedman test, P-Value = 0.948), although \nESMP showed the higher rank value (rank = 2.80), followed by UC (rank = 2.40), LF (rank = \n2.40) and UF (rank = 2.40). For NoV GGII detection, there were no significant differences (Friedman test, P-Value = 0.077) and ESMP (rank = 3.60) showed the higher ranking values, \nfollowed by UC (rank = 2.80), UF (rank = 1.80) and LF (rank = 1.80).   3.2. Repeatability assay for ESMP validation \n \nTo evaluate ESMP efficiency and ensure the repeatability of the procedure, 10 aliquots of raw urban sewage were evaluated for HAdV, JCPyV and NoV GGII as a model for DNA and RNA viruses. The percentage of coefficient of variation (CV) ([standard deviation/mean] \u00d7 100) was used as an estimator of intra-laboratory variabilit y. The results obtained are shown in Figure 2. \nThe estimated CV was 15.9% for HAdV (mean: 6.89 x 10\n2; Min: 5.27 x 102; Max: 8.64 x 102; SD: \n1.09 x 102 GC/mL) and 12.2% for JCPyV (mean: 1.39 x 103; Min: 1.12 x 103; Max: 1.59 x 103; SD: \n1.71 x 102 GC/mL), whereas it was 17.4% for NoV GGII (mean: 3.17 x 103; Min: 2.45 x 103; Max: \n3.81 x 103; SD: 5.52 x 102 GC/mL).  \n Capitulo III: Estudio 5 \n \n 1563.3. Recovery assay for ESMP \n The recovery of ESMP for HAdV, JCPyV and No V GGII was evaluated using two different assays \nfrom one raw-sewage sample collected in Barcelona, Spain.   (i) By analyzing the losses in the viral concentr ation of four aliquots (50 mL) through the \nquantitation of viruses present in the pellet from the first centrifugation (A: Figure 1, step 4) and the supernatant from the last centrifugation (B: Figure 1, step 9), depending on the total \nviruses quantified in the final concentrate (C ) and according to the following equation: \nRecovery (%) = C/(A+B+C) x 100. The viruses present in the A portion were resuspended in 7 \nmL of glycine buffer (0.25 M, pH 9.5) and then ultracentrifuged, whereas the viruses from the \nB portion were directly ultracentrifuged. The vi ruses from both pellete d portions were eluted \nin 100 \u03bcL of phosphate buffe r and the NA directly extracted for the qPCR assay. \n (ii) Six aliquots of 50 mL each were concentrated by ESMP and the titer was determined \namong spiked samples with known amount of viruses (n=4). Non-spik ed samples (n=2) were \nused to determined endogenous viruses. \n For HAdV, JCPyV and NoV GGII, the estimated recoveries were about 30%-95%, 55%-90% and 45%-90%, respectively.  3.4. Field study  \nIn winter 2010 (September to December), 50 mL of twelve 24-h composite samples collected \nat the entrance of a STP located in Vitoria (Basque Country, Spain) were analyzed by applying the ESMP. The NA from viral concentrates were extracted and analyzed using qPCR and qRT-PCR. As expected, all samples were positive for HAdV, JCPyV and NoV GGII, with values (GC/mL) ranging from 4.56 x 10\n2 to 3.41 x 103 (SD: 8.47 x 102), from 1.59 x 102 to 1.61 x 103 \n(SD: 4.07 x 102) and from 1.41 x 100 to 7.98 x 101 (SD: 2.27 x 101), respectively (Table 2). \n 4. DISCUSSION  There is a need for cost-effective easily standard izable virus concentration methods to be used \nin routine laboratories. In the present study, a previously described method that has been Capitulo III: Estudio 5 \n 157successfully applied in many studies (UC) was compared and evaluated using three proposed \nnew protocols. Moreover, the repeatability of the results and the virus recovery of the most sensitive method, i.e. the ESMP protocol, were further evaluated.  The first step of the ESMP is to elute the viruses (50 mL of sewage) from the organic matter using an alkaline-glycine buffer, then the viruse s present in the supernatant are concentrated \nusing organic flocculation under acidic conditions and the addition of a skimmed-milk solution, \na process based on previous methods to concen trate viruses from sea, river and ground water \nwith a viral recovery of about 50% for HAdV, JCPyV, NoV and rotaviruses (Bofill et al ., 2011; \nCalgua et al ., 2008). Although no significant statistical differences were observed in accordance \nwith Friedman\u2019s ranking analysis, this method gave a better yield of HAdV (DNA virus), JCPyV (DNA virus) and NoV GGII (RNA virus) in natura l samples when compared to three alternative \nmethods: (i) Ultracentrifugation a nd glycine-alkaline elution (Pina et al ., 1998), which has been \ndescribed as an efficient method that allows 42 mL of sewage to be concentrated to 100 \u03bcL of PBS, but may be limited by the need for a high-cost ultracentrifugation device, which most routine laboratories involved in water-quality analysis do not have access to. (ii) Ultrafiltration and alkaline-glycine elution, an alternative meth od also described here. This showed the same \nratio of concentration as the ultracentrifugatio n method and although it does not require \nspecial equipment, the cost of the filters re quired for one sample and the potential problems \nassociated with the clogging of high organic matter could limit this method. (iii) The lyophilization-based method is a one-step proc edure also described in the present study as a \nnew method for the concentration of viruses in sewage. This allows 50 mL of sewage to be concentrated to 500 \u03bcL of phosphate buffer with high virus-recovery rates. One advantage of this method is that none of the sample is lost during the concentration process. However, the time required for the method (24-36h) and the lyophilization device it uses mean that this \nmethod is probably unfeasible in most laboratories. Although there are more procedures \ndescribed for the concentration and detection of viruses from sewage, most of them use \nmembranes and/or filters that require pre-trea tments. The use of a pre-filter before virus \nconcentration using membranes or filters to avoid clogging may be associated with the loss of viruses in the organic matter that may be retained in the pre-filter. This represents a significant limitation for the detection of viruses usually present in low concentrations.  The reproducibility of concentration methods for the quantification of viruses in water has been defined as a significant limitation in current protocols (Girones et al ., 2010). The CV of \nthe ESMP, the most sensitive method, was also evaluated by using the values of the viruses Capitulo III: Estudio 5 \n \n 158detected in natural samples together with the virus-recovery test using a spiked sample. The \npercentage of CV (in the present study: CV = standard deviation [SD] /mean-viruses recovered \n[MVR] \u00d7 100) is the ratio between SD and MVR an d, as expected, when a method is developed \nsuccessfully, this value is lower. There is a lack of information in the literature about the CV applied to methods for concentration viruses from water samples. ESMP showed mean recovery values of about 50% for HAdV, JCPyV and NoV GGII, and CVs (n=10) ranging between 12% and 17%. Nupen et al.  (1970) compared two procedures for concentrating viruses from \nsewage and two methods (cell culture-based methods) to detect the virus-recovery rate; the results showed CV values from 40% to 80%, depending on the detection method selected. Lambertini et al . (2008) showed CVs ranging between 21% and 91% with trials of more than \nthree samples for polioviruses, HAdV and NoV detection in different  ground and tap water \nsamples by using the glass-wool based procedure as a virus-concentration method and qPCR as a method for detection and quantification. Moreover, different CVs were reported for poliovirus detection (24-81%) compared to Vilagin\u00e8s et al . (2003) (CV 8-40%). In addition, the \nmolecular protocols for detecting and quantifying viruses using qPCR TaqMan\n\u00ae in the present \nstudy have been applied previously with di fferent environmental samples such as sewage, \nseawater and river water (Albinana-Gimenez et al ., 2009; Bofill-Mass et al ., 2010; Calgua et al ., \n2011; Wyn-Jones et al ., 2011). The variab ility to quantify RNA viruses is expected to be higher \nthan DNA viruses, since an additional RT-PCR step is required. Each qPCR assay included a standard curve (each point per triplicate) that showed significantly lower variability with a \ncorrelation close to 1, meaning that the molecular assays for the detection did not introduce any variation to the results of the processes.  Furthermore, the NA-extraction protocol had \npreviously been compared with other kits and in-house procedures (data not show), and the \nmost sensitive one, which represents a good a pproach for avoiding potential inhibitors that \nmay hamper molecular detection, was selected. According to the data available in the literature, most of the studies to compare methods for viral recovery from water estimated the virus-recovery rate, but sometimes used different means. Due to the importance of the repeatability of the results and the fact that variable data from the viruses detected can also give high recovery rates, the inclusion of the CV showing acceptable ratios that should not be more than 0.5 for these types of meth ods, as previously mentioned (Hill et al ., 1971), provides \na very significant information related to the applicability of the assay.  Finally, the ESMP was validated in a field study to detect HAdV, JCPyV and NoV GGII in sewage samples. The values detected are in concordance with previous data detected in Spanish Capitulo III: Estudio 5 \n 159samples (Bofill-Mas et al ., 2006; Rodriguez-Manzano et al. , 2012). Regarding the quantitative \ndetection assay, each sample and virus were evaluated by quadruplicate; duplicate for the undiluted NA and duplicate for the 10-fold dilution , which led to quantitative data with robust \nvalues (Table 2) and an absence of the inhibition effect on the qPCR.  Therefore, as demonstrated in the present study, the methods recover DNA and RNA viruses and the criteria used to select the method are based on the efficiency, low cost and lack of requirements for expensive equipments.  5. CONCLUSIONS  5.1. A total of four alternative procedures for concentrating RNA or DNA viruses from sewage \nsamples are reported: three new procedures presented here (ESMP,  LF and UF) and one \npreviously reported (UC) with high efficiency values in virus recovery and quantification by \nqPCR.  5.2. ESMP has shown to be the most sensitive procedure and shows about 50% viral recovery (DNA and RNA viruses). Considering the CV values (12%-17%), this procedure produces reproducible results. Moreover, the procedure can be applied to large-scale virus-detection \nprograms since it is effective, inexpensive and easily standardizable for use in a routine laboratory involved in water quality.  5.3 The molecular qPCR protocols applied ar e useful tools for the rapid detection and \nquantification of viruses from sewage samples.   \n5.4. In the present study, the CV measurement is proposed as an essential element in the \nevaluation and comparison of methods that have  been developed to de tect viruses in water \nsamples. In addition, CV \u00d7 100 \u2264 50% is the proposed limit to indicate the reproducibility and efficiency of a method at concentrating and detecting viruses in water samples.   ACKNOWLEDGEMENTS  The research described in the manuscript was supported by a grant from the Ministry of \nEducation and Science of th e Spanish government (projects AGL2008-05275-C03-01 and \nAGL2011-30461-C02-01) and European project VI ROCLIME, Contract 243923, leaded by David Capitulo III: Estudio 5 \n \n 160Kay. We also thank the contribution of the government of Catalonia (2005SGR00592). We \nthank PhD Sara de Mateo for her valuable la nguage revision. Anna Carratal\u00e0 and Jes\u00fas \nRodriguez-Manzano were fe llows of the Spanish Ministry of Science. \n REFERENCES  \nAlbinana-Gimenez, N., Miagostovich, M.P., Calgua, B., Huguet, J.M., Matia, L., Girones, R.,  \n2009. Analysis of adenoviruses and polyomaviruses quantified by qPCR as indicators of water quality in source and drinking-water treatment plants. Water Res. 43, 2011\u20132019. Albinana-Gimenez, N., Clemente-Casares, P., Bofill-Mas, S., Hundesa, A., Ribas, F., Girones, R., 2006. Distribution of human polyomaviruses, adenoviruses, and hepatitis E virus in the \nenvironment and in a drinking-water treatment plant. Environ. Sci. Technol. 40, 7416\u20137422. Barreira, D.M., Ferreira, M.S., Fumian, T.M., Checon. R., de Sadovsky, A.D., Leite, J.P., \nMiagostovich, M.P.,and Spano, L.C.,  2010. Viral load and genotypes of noroviruses in \nsymptomatic and asymptomatic children in Southeastern Brazil. J. Clin. Virol. 47, 60\u201364. Berger, J.R., Major, E.O.,  1999. Progressive multifocal leukoencephalopathy. Semin. Neurol. \n19, 193\u2013200. Bofill-Mas, S.L., Hundesa, A., Calgua, B., Rusi\u00f1ol, M., Maluquer de Motes, C., Girones, R.,  \n2011. Cost-effective Method for Microbial Source  Tracking Using Specific Human and Animal \nViruses. J. Vis. Exp. 3. Bofill-Mas, S., Albinana-Gimenez, N., Clemente-Casares, P., Hundesa, A., Rodriguez-Manzano, J., Allard, A., Calvo, M., Girones, R.,  2006. Quantification and stab ility of human \nadenoviruses and polyomavirus JCPyV in wastewa ter matrices. Appl. Environ. Microbiol. 72, \n7894\u20137896. Bofill-Mas, S., Calgua, B., Clemente-Casares, P., la Rosa, G., Iaconelli, M., Muscillo, M., Rutjes, S., de Roda Husman, A.M., Grunert, A., Gr\u00e4ber, I., Verani, M., Carducci, A., Calvo, M., Wyn-Jones, P., and Girones, R.,  2010. Quantification of human adenoviruses in European \nrecreational waters. Food Environ. Virol. 2, 1001\u20131009. Bofill-Mas, S., Pina, S., Girones, R.,  2000. Documenting the epidemiologic patterns of \npolyomaviruses in human populations by study ing their presence in urban sewage. Appl. \nEnviron. Microbiol. 66, 238\u2013245. Bofill-Mas, S., Rodriguez-Manzano, J., Calgua, B., Carratala, A., Girones, R.,  2010. Newly \ndescribed human polyomaviruses Merkel cell, KI  and WU are present in urban sewage and may \nrepresent potential environmental contaminants. Virol. J. 7, 141. Brownell, M.J., Harwood, V.J., Kurz, R.C., McQuaig, S.M., Lukasik, J., Scott, T.M.,  2007. \nConfirmation of putative stormwater impact on  water quality at a Florida beach by microbial \nsource tracking methods and structure of i ndicator organism populations. Water Res. 41, \n3747\u20133757. Bull, R.A., White, P.A.,  2011. Mechanisms of G II.4 norovirus evolution. Trends Microbiol. 19, \n233\u2013240. Calgua, B., Barardi, C.R., Bofill-Mas, S., Rodriguez-Manzano, J., Girones, R.,  2011. Detection \nand quantitation of infectious human adenovir uses and JC polyomaviruses in water by \nimmunofluoresVirologicalcence assay. J. Virol. Methods. 171, 1\u20137. Calgua, B., Mengewein, A., Grunert, A., Bofill-Mas, S., Clemente-Casares, P., Hundesa, A., Wyn-Jones, A.P., L\u00f3pez-Pila, J.M., Girones, R.,  2008. Development and application of a one-\nstep low cost procedure to concentrate viruses from seawater samples. J. Virol. Methods. 153, 79\u201383. Cantalupo, P.G., Calgua, B., Zhao, G., Hundesa, A., Wier, A.D., Katz, J.P., Grabe, M., Hendrix, R.W., Girones, R., Wang, D., Pipas, J.M.,  2011. Raw sewage harbors diverse viral populations. Capitulo III: Estudio 5 \n 161MBio. 2, 1\u201311. \nClemente-Casares, P., Pina, S., Buti, M., Jardi, R., Martin, M., Bofill-Mas, S., Girones, R.,  2003. \nHepatitis E virus epidemiology in industrialize d countries. Emerg. Infect. Dis. 9, 448\u2013454. \nClemente-Casares, P., Rodriguez-Manzano, J., Girones, R.,  2009. Hepatitis E virus genotype 3 \nand sporadically also genotype 1 circulate in the population of Catalonia, Spain. J. Water Health. 7, 664\u2013673. Colford, J.M., Wade, T.J., Schiff, K.C., Wright, C.C., Griffith, J.F., Sandhu, S.K., Burns, S., Sobsey, M., Lovelace, G., Weisberg, S.B.,  2007. Water quality indicators and the risk of illness \nat beaches with nonpoint sources of feca l contamination. Epidemiology. 18, 27\u201335. \nFerreira, M.S., Victoria, M., Carvalho-Costa, F.A., Vieira, C.B., Xavier, M.P., Fioretti, J.M., Andrade, J., Volot\u00e3o, E.M., Rocha, M., Leite, J.P., Miagostovich, M.P.,  2010. Surve illance of \nnorovirus infections in the state of Rio De Ja neiro, Brazil 2005-2008. J. Med. Virol. 82, 1442\u2013\n1448. Fong, T.T., Phanikumar, M.S., Xagoraraki, I., Rose, J.B.,  2009. Quantitative detection of human \nadenoviruses in wastewater and combined sewer overflows influencing a Michigan river. Appl. Environ. Microbiol. 76, 715\u2013723. Friedman, M.,  1937. The use of ranks to avoid the assumption of normality implicit in the \nanalysis of variance. J. Am. Stat. Assoc. 32, 675\u2013701. \nFumian, T.M., Guimar\u00e3es, F.R., Pereira Vaz, B.J., da Silva, M.T., Muylaert, F.F., Bofill-Mas, S., \nGirones, R., Leite, J.P., Miagostovich, M.P.,  2010. Molecular detection, quantification and \ncharacterization of human polyomav irus JC from waste water in Rio De Janeiro, Brazil. J. Water \nHealth. 8, 438\u2013445. Gantzer, C., Maul, A., Audic, J.M., Schwartzbrod, L.,  1998. Detection of \ninfectiousenteroviruses, entero virus genomes, somatic coliphages, and Bacteroides fragilis \nphages in treated wastewater. Appl. Environ. Microbiol. 64, 4307\u20134312 Girones, R., Ferr\u00fas, M.A., Alonso, J.L., Rodriguez-Manzano, J., Calgua, B., Corr\u00eaa, A.A., Hundesa, A., Carratala, A., Bofill-Mas, S.,  2010. Molecular detection of pathogens in water--\nthe pros and cons of molecular techniques. Water Res. 44, 4325\u20134339. Glass, R.I., Parashar, U.D., Estes, M.K.,  2009. Norovirus gastroenteritis. N. Engl. J. Med. 361, \n1776\u20131785. Hernroth, B.E., Conden-Hansson, A.C., Rehnstam-Holm, A.S., Girones, R., Allard, A.K.,  2002. \nEnvironmental factors influencing human viral pathogens and their potential indicator organisms in the blue mussel, Mytilus edulis: the first Scandinavian report. Appl. Environ. \nMicrobiol. 68, 4523\u20134533. Hill Jr., W.F., Elemer, W.A., Benton, W.H.,  1971. Detection of viruses in water: A review of \nmethods and application. Water Res. 5, 967\u2013995. Holtz, L.R., Finkbeiner, S.R., Zhao, G., Kirkwood, C.D., Girones, R., Pipas, J.M., Wang, D.,  \n2009. Klassevirus 1, a previously undescribed member of the family Picornaviridae, is globally \nwidespread. Virol. J. 6, 86. \nJothikumar, N., Lowther, J.A., Henshilwood, K., Lees, D., Hill V.R., Vinj\u00e9, J.,  2006. Rapid and \nsensitive detection of noroviruses by using TaqMan-Based One-Step Reverse Transcription-PCR assays and application to naturally contaminated shellfish samples. Appl. Environ. Microbiol. \n71, 1870\u20131875. Khan, M.A., Bass, D.M.,  2010. Viral infections: new and emerging. Curr. Opin. Gastroenterol. . \n26, 26\u201330. Koo, H.L., Ajami, N., Atmar, R.L., DuPont, H.L.,  2010. Noroviruses: The leading cause of \ngastroenteritis worldwide. Discov. Med. 10, 61\u201370. Lambertini, E., Spencer, S.K., Bertz, P.D., Loge, F.J., Kieke, B.A., Borchardt, M.A.,  2008. \nConcentration of enteroviruses, adenoviruses, a nd noroviruses from drinking water by use of \nglass wool filters. Appl. Environ. Microbiol. 74, 2990\u20132296. Loh, J., Zhao, G., Presti, R.M., Holtz, L.R., Finkbeiner, S.R., Droit, L., Villas ana, Z., Todd, C., \nPipas, J.M., Calgua, B., Girones, R., Wang, D., Virgin, H.W.,  2009. Detection of novel Capitulo III: Estudio 5 \n \n 162sequences related to african Swine Fever virus in human serum and sewage. J Virol. 83, \n13019\u201313025. McQuaig, S.M., Scott, T.M., Harwood, V.J., Farrah, S.R., Lukasik, J.O.,  2006. Detection of \nhuman-drived fecal pollution in environmen tal waters by use of a PCR-based human \npolyomavirus assay. Appl. Enviro n. Microbiol. 72, 7567\u20137574. \nMcQuaig, S.M., Scott, T.M., Lukasik, J.O., Paul, J.H., Harwood, V.J.,  2009. Quantification of \nhuman polyomaviruses JC Virus and BK Virus by  TaqMan quantitative PCR and comparison to \nother water quality indicators in water and fecal samples. Appl. Environ. Microbiol. 75, 3379\u20133388. Miagostovich, M.P., Ferreira, F.F., Guimar\u00e3es, F.R., Fumian, T.M., Diniz-Mendes, L., Luz, S.L., Silva, L.A., Leite, J.P.,  2008. Molecular detection and characterization of gastroenteritis viruses \noccurring naturally in the stream waters of Ma naus, central Amazonia, Brazil. Appl. Environ. \nMicrobiol. 74, 375\u2013382. Nupen, E.M.,  1970. Virus studies on the windhoek waste-water reclamation plant (south-west \nafrica). Water Res. 4, 661\u2013672.  \nOgorzaly, L., Bertrand, I., Paris, M., Maul, A., Gantzer, C.,  2010. Occurrence, survival, and \npersistence of human adenoviruses and F-sp ecific RNA phages in raw groundwater. Appl. \nEnviron. Microbiol. 76, 8019\u20138025. Pal, A., Sirota, L., Maudru, T., Peden, K., Lewis Jr., A.M.,  2006. Real-time, quantitative PCR \nassays for the detection of virus-specific DNA in samples with mixed populations of polyomaviruses. J. Virol. Methods. 135, 32\u201342. Pina, S., Puig, M., Lucena, F., Jofre, J., Girones, R.,  1998. Viral pollution in the environment \nand shellfish: human adenovirus detection by PC R as an index of human viruses. Appl. Environ. \nMicrobiol. 64, 3376\u20133382. Prado, T., Silva, D.M, Guilayn, W.C., Rose, T.L., Gaspar, A.M., Miagostovich, M.P.,  2011. \nQuantification and molecular characterization of enteric viruses detected in effluents from two hospital wastewater treatment plants. Water Res. 45, 1287\u20131297. Pusch, D., Oh, D.Y., Wolf, S., Dumke, R., Schr\u00f6ter-Bobsin, U., H\u00f6hne, M., R\u00f6ske, I., Schreier, E., 2005. Detection of enteric viruses and bacterial indicators in German environmental \nwaters. Arch. Virol. 150, 929\u2013947. R: A Language and Environment for Statistical Computing, R Development Core Team,  2008. \nISBN 3-900051-07-0, http: //www.R-project.org.  \nRodriguez-Manzano, J., Miagostovich, M., Hundesa, A., Clemente-Casares, P., Carratala, A., Buti, M., Jardi, R., Girones, R.,  2010. Analysis of the evolution in the circulation of HAV and \nHEV in eastern Spain by testing urban sewa ge samples. J. Water Health. 8, 346\u2013354. \nShah, K.V.,  1995. Polyomaviruses, in: Fields, B.N., Knipe, D.M., Howley, P.M., (Eds.), Fields \nVirology, 3rd ed. Raven Publishers, Philadelphia, PA, pp. 1997\u20132005. Tong, H.I., Lu, Y.,  2011. Effective detection of human adenovirus in Hawaiian waters using \nenhanced PCR methods. Virol. J. 8, 57. van den Berg, H., Lodder, W., van der Poel, W., Vennema, H., de Roda Husman, A.M.,  2005. \nGenetic diversity of noroviruses in raw and treated sewage water. Res. Microbiol. 156, 532\u2013540. Verzani, J.,  2004. Using R for Introductory Statistics. Chapman & Hall/CRC. \nVictoria, M., Guimar\u00e3es, F.R., Fumian, T.M., Ferreira, F.F., Vieira, C.B., Shubo, T., Leite ,J.P., and Miagostovich, M.P.,  2010. One year monitoring of norovirus in a sewage treatment plant \nin Rio de Janeiro, Brazil. J. Water Health. 8, 1558\u20131565. Vilagin\u00e8s, P., B. Sarrette, G. Husson, R. Vilagin\u00e8s.,  1993. Glass wool for virus concentration at \nambient water pH level. Water Sci. Technol. 27, 299\u2013306. Wong, K., Xagoraraki, I.,  2011. A perspective on the prevalence of DNA enteric virus genomes \nin anaerobic-digested biological wastes. Environ. Monit. Assess. Wyn-Jones, A.P., Carducci, A., Cook, N., D'Agostino, M., Divizia, M., Fleischer, J., Gantzer, C., Capitulo III: Estudio 5 \n 163Gawler, A., Girones, R., H\u00f6ller, C., de Roda Husm an, A.M., Kay, D., Kozyra, I., L\u00f3pez-Pila, J., \nMuscillo, M., Nascimento, M.S., P apageorgiou, G., Rutjes, S., Sellwood, J., Szewzyk, R., Wyer, \nM., 2011. Surveillance of adenoviruses and noroviruses in European recreational waters. \nWater Res. 45, 1025\u20131038. Yousry, T.A., Major, E.O., Ryschkewitsch, C., Fahle, G., Fischer, S., Hou, J., Curfman, B., Miszkiel, K., Mueller-Lenke, N., Sanchez, E., Barkhof, F., Radue, E.W., Jager H.R., Clifford, D.B.,  2006. Evaluation of patients treated with natalizumab for progressive multifocal. N. Engl. \nJ. Med. 354, 924\u2013933.  1.Transfer 42 mL of sewage into \nultracentrifuge tubes \n2.Centrifuge for 1 h at 100,000xg at 4 \n\u00b0C\n3.Remove the supernatant and elute \nthe viruses in a total of 4 m L of \nglycine buffer 0.25 N, pH 9.5\n4.Place the volum e (4 m L) in a sterile \ncapped tube and incubate on ice for 30 \nmin shaking\n5.Add with 4 mL of cold PBS 2X\n6.Centrifuge at 3,000xg for 20 min\n7.Transfer the supernatant into a \nultracentrifuge tube and centrifuge for \n1 h at 100,000xg at 4 \u00b0C\n8.Discard the supernatant and elute \nthe pellet w ith 100 \u00b5L of phosphate\nbuffer at pH 7.5Ultracentrifugati on (UC)\n(Pina et al., 1998)\n4.Transfer 45 mL of sewage into 3 \npre-w ashed filter units (15 m L/filter)\n5.Centrifuge at 2,000xg for 1 h at RT\n6.Rem ove the filtered volum e\n7.Recover the volum e retained in the \nfilter (100 \u03bcL) with 4 m L of glycinebuffer 0.25 N, pH 9.5\n8.Transfer the eluted to sterile tube \nand incubate at 4 \u00baC for 30 min\n(vortex every 10min)\n9.Centrifuge at 3,000xg for 30 min at \n4 \u00b0C\n10. Recover the supernatant and \ntransfer to a new pre-washed filter \nunit\n11. Centrifuge at 2,000xg for 1 h at \nroom temperature \n12. Vortex the volum e that rem ains in \nthe filter and centrifuge for 2 min at \n2,000xg1.W ash the filter units (100K ) with \n10 m L of bidistilled sterile w ater (4 \nunits by sample)\n2.Centrifuge at 2,000xg for 10 min\n3. Discharge the filtered w ater\n13. Recover the final volum e retained \n(100 \u00b5L )Ultrafiltration (UF)\n1.Transfer 50 mL of sewage into \nsterile glass or plastic capped bottle\n2.Freeze the sample at -80 \u00b0C\n3. Rem ove the water by lyophilization\nfor 24-36 h\n4.D issolved the lyophilized m aterial \nwith 500 \u00b5L of phosphate buffer at \npH 7.5Lyophilization (LF)\n1.Place 50 mL of sewage into 500 \nmL centrifuge pot\n2.Elute viruses using 100 mL of \nglycine buffer 0.25 N, pH 9.5 (1:2 \nv/v)\n3.Incubate on ice for 30 min with \nm agnetic stir\n4.Centrifuge at 8,000xg for 30 min at \n4 \u00b0C\n5.Recover the supernatant (150 m L), \ntransfer to a new centrifuge pot and \ncarefully adjust the pH  to 3.5 with \nHCl 1N\n6.Add 1.5 mL of pre-flocculated \nskim med m ilk solution, final \nconcentration of skimmed milk 0.01% \n(w/v)\n8.Stir from 8 h to O/N at RT to allow \nthe viruses to absorb to the flocs\n10. D issolved the pellet in 500 \u00b5L of \nphosphate buffer at pH 7.5Elution Skimmed M ilk\nProcedure (ESMP)\n9.Centrifuge at 8,000xg for 30 min at \n4 \u00b0C and discard the supernatant\n \nFig. 1.  Protocols developed for virus concentration from raw sewage.  \n \nFig. 2.  Evaluation of four different methods for virus concentration from raw sewage. UC: \nultracentrifugation method; UF: ultrafiltration method; ESMP:  elution skimmed-milk \nprocedure; LF: lyophilization method; GC/mL:  genomic copies/milliliter; HAdV:  human \nadenovirus; JCPyV:  JC polyomavirus; NoV GGII:  norovirus genogroup II. Bars show means of \nquantitation. \n \n   \n \n \nFig. 3.  Repeatab ility assay for ESMP evaluated with HAdV  (DNA), JCPyV (DNA) and NoV GGII \n(RNA). HAdV:  human adenovirus; JCPyV:  JC polyomavirus; NoV GGII:  norovirus genogroup II; \nCV: coefficient of variation percentage; GC/mL:  genomic copies/milliliter. The box plots show \nthe first (bottom of box) and third (top of box) quartiles (equivalent to the 25th and 75th \npercentiles), the median (the ho rizontal line in the box) and the range (excluding outliers and \nextreme scores). \n  Table 1.  \nQuantitation of viruses in raw-sewage samples  by four different concentration methods. \n \nVirus  Method  qPCR (GC/mL)\nMean  SD Minimum  Maximum Ranka P-Value\nHAdV \n      UC 5.3 x 102 3.2 x 1022.3 x 1021.0x 103 1.20 0.033\nUF 1.2 x 103 7.2 x 1023.9 x 1021.9x 103 2.60\nESMP 3.6 x 103 1.8 x 1031.9 x 1036.4x 103 3.60\nLF 1.3 x 103 1.2 x 1034.4 x 1022.9x 103 2.60\nJCPyV  \n      UC 1.2 x 103 6.6 x 1024.2 x 1022.1x 103 2.40 0.948\nUF 1.3 x 103 7.9 x 1024.7 x 1022.4x 103 2.40\nESMP 1.5 x 103 5.7 x 1029.9 x 1022.4x 103 2.80\nLF 1.4 x 103 4.5 x 1027.8 x 1021.9x 103 2.40\nNoV GGI I\n      UC 3.9 x 103 2.0 x 1032.3 x 1037.3x 103 2.80 0.077\nUF 3.5 x 103 4.2 x 1031.1 x 1031.1x 104 1.80\nESMP 7.7 x 103 3.2 x 1032.7 x 1031.2x 104 3.60\nLF 2.3 x 103 1.3 x 1035.4 x 1024.0x 103 1.80\n \nUC: ultracentrifugation method; UF: ultrafiltration method; ESMP:  elution skimmed-milk procedure; LF: \nlyophilization method; HAdV:  human adenovirus; JCPyV:  JC polyomavirus; NoV GGII:  norovirus genogroup \nII; GC/mL:  genomic copies/milliliter; SD: standard deviation. aFriedman\u2019s statistical ranks were assigned \nusing the better yield method. \n  Table 2.  \nDetection of HAdV, JCPyV and NoV GGII in 24-h  composite urban-sewage samples by ESMP. \n \nCollection data \n(day/month/year) qPCR (GC/mL) \nHAdV JCPyV NoV GGII \nVirus titer Mean  \n(SD) Virus titer Mean  \n(SD) Virus titer Mean  \n(SD) \n26/09/2010 1.89 x 103 \n1.62 x 103 \n(8.47 x 102) 3.61 x 102 \n5.70 x 102 \n(4.07 x 102) 2.42 x 101 \n2.84 x 101 \n(2.27 x 101) 27/09/2010 7.66 x 102 6.27 x 102 3.36 x 101 \n13/10/2010 2.83 x 103 8.34 x 102 3.53 x 101 \n14/10/2010 1.12 x 103 2.45 x 102 3.86 x 101 \n03/11/2010 1.57 x 103 8.37 x 102 2.42 x 101 \n04/11/2010 3.41 x 103 7.26 x 102 5.57 x 101 \n16/11/2010 9.86 x 102 2.67 x 102 8.56 x 100 \n17/11/2010 2.05 x 103 5.13 x 102 7.98 x 101 \n30/11/2010 1.72 x 103 1.71 x 102 2.58 x 101 \n01/12/2010 1.50 x 103 1.59 x 102 5.33 x 100 \n15/12/2010 4.56 x 102 1.61 x 103 1.41 x 100 \n16/12/2010 1.15 x 103 4.92 x 102 8.02 x 100 \n \nqPCR: quantitative PCR; HAdV:  human adenovirus; JCPyV:  JC polyomavirus; NoV GGII:  norovirus genogroup II; GC/mL:  genomic \ncopies/milliliter; SD: standard deviation.  \n \n \n   \n \n \nCap\u00edtulo IV \n \n Evaluaci\u00f3n de la contaminaci\u00f3n viral \nen moluscos bivalvos de mercado y \neficiencia de la eliminaci\u00f3n v\u00edrica en \nprocesos de depuraci\u00f3n de moluscos   Cap\u00edtulo IV: Estudio 6 \n 171 \nINTRODUCCI\u00d3N   Diferentes virus pueden ser descritos en el tracto digestivo humano, pero \u00fanicamente \nunos pocos son reconocidos como importantes pat\u00f3genos alimenta rios. Norovirus y el virus  \nde la hepatitis A son los principales pat\u00f3genos v\u00edricos responsables de producir infecciones y \nenfermedades a trav\u00e9s de la ruta de transm isi\u00f3n fecal-oral. Estudios epidemiol\u00f3gicos han \nestimado que NoV es responsable del 60% \u2013 80% de todos los brot es infecciosos de \ngastroenteritis a nivel global, donde el co nsumo de marisco contaminado tiene un papel \nrelevante. HAV tambi\u00e9n est\u00e1 relacionado con el consumo de marisco y es responsable de \nenfermedades graves con una gran morbilidad e incluso la muerte. La principal raz\u00f3n por la que los moluscos est\u00e1n \u00edntimamente relacionados  con la transmisi\u00f3n de NoV y HAV reside en \nel hecho de que son animales filtradore s que crecen en ambientes donde resulta \nextremadamente dif\u00edcil controlar los niveles de contaminaci\u00f3n, adem\u00e1s que habitualmente \nson consumidos crudos o insuficientemente cocinados.   En este trabajo se ha valorado la presen cia de virus ent\u00e9ricos (NoV GGI, NoV GGII y \nHAV) en muestras de moluscos bivalvos (nacionales e importados) recolectadas a nivel de mercado durante los inviernos de 2004 \u2013 2008 a trav\u00e9s del Programa de Vigilancia de la Seguridad de los Alimentos en Catalu\u00f1a (PVSAC). Adem\u00e1s, muestras importadas de coquinas congeladas potencialmente vinculadas a un brote infeccioso de hepatitis A identificado en \nEspa\u00f1a en el 2008 fueron analizadas para describir su probable implicaci\u00f3n. \n \nCon el objetivo de averiguar como muestras de moluscos bivalvos que cumplen con las \nactuales regulaciones europeas son introducidos  en la cadena alimentaria, se evalu\u00f3 la \neficiencia de eliminaci\u00f3n de HAdV como indicador de contaminaci\u00f3n fecal en tres instalaciones RESUMEN ESTUDIO 6: \n \nFailure to remove viral contamination in molluscan shellfish applying current depuration treatments  Rodriguez-Manzano J, Hundesa A, Calgua B, Carra tala A, Maluquer de Motes C,  Rusi\u00f1ol M, \nMoresco V,  Ramos AP, Mart\u00ednez-Marza F, Calvo M, Barardi CRM, Bofill-Mas S, Girones R. \n \nSometido a International Journal of Food Microbiology . 2012 Cap\u00edtulo IV: Estudio 6 \n 172de depuraci\u00f3n de marisco donde se aplican trat amientos espec\u00edficos (ozono, venturi y ozono-\nUV), pertenecientes a empresas productoras.  Por \u00faltimo, un ensayo de inmufluorescencia \nindirecta previamente descrito para muestras ambi entales se adapt\u00f3 para evaluar la presencia \nde HAdV infecciosos en las muestras depuradas,  comprobando as\u00ed la presencia de pat\u00f3genos \nviables en los productos listos para ser consumidos.  RESULTADOS Y DISCUSI\u00d3N   Los resultados globales muestran que un 12% (19/151) de los lotes de moluscos bivalvos recogidos en mercados durante 2004 \u2013 2008 estaban contaminados con NoV GGII, mientras que NoV GGI y HAV no fueron detect ados entre las muestras analizadas. No se \nobservaron diferencias significativas en la pr esencia de NoV GGII entre muestras procedentes \nde zonas de cultivo nacionales e importadas europeas. Con la intenci\u00f3n de evaluar la utilidad \nde HAdV como indicador de contaminaci\u00f3n fecal, se examin\u00f3 su presencia en un grupo de treinta muestras seleccionadas aleatoriamente, observ\u00e1ndose un 43% de muestras positivas e \nidentific\u00e1ndose diferencias significativas respecto las muestras positivas y negativas para NoV GGII. Tras estudiar la correlaci\u00f3n de ambos virus ent\u00e9ricos mediante modelos de regresi\u00f3n log\u00edstica, se observ\u00f3 una sensibilidad del 100% y una especificidad del 74%. De acuerdo con la estad\u00edstica descriptiva, sensibilidad y especifi cidad, HAdV cuantificado por qPCR puede ser \nutilizado como indicador de la contaminaci\u00f3n v\u00edrica en moluscos bivalvos. Respecto el brote de hepatitis A, el 50% (5/10) de las muestras analiz adas fueron positivas para HAV. Los an\u00e1lisis de \nsecuenciaci\u00f3n evidenciaron la presencia de subgenotipos IA y IB, t\u00edpicamente detectados en Europa y Suram\u00e9rica. Las secuencias obtenidas fueron comparadas con una secuencia de HAV \npreviamente descrita en agua residual procedente  de la regi\u00f3n donde tuvo lugar el brote, \nmuestra que fue recogida durante el mismo pe riodo. Las diferencias observadas entre las \nsecuencias estudiadas apoyan la teor\u00eda que la s muestras fueron contaminadas de manera \nprevia a la importaci\u00f3n.  \nLas muestras procedentes de las empresas productoras de marisco cumpl\u00edan con la \nactual legislaci\u00f3n europea, basada en los niveles E. coli , tras la aplicaci\u00f3n de los distintos \ntratamientos de depuraci\u00f3n. Un  60% de las muestras fueron positivas para HAdV, mientras \nque NoV I y II no fueron detectados. Respecto  la presencia de HAdV, no se observaron \ndiferencias significativas antes y despu\u00e9s de aplic ar los tratamientos de depuraci\u00f3n, al igual \nque no se observaron diferencias entre los di ferentes tratamientos aplicados. La elevada \npresencia de HAdV en las muestras pre- y po st-depuradas puede debe rse al hecho que las Cap\u00edtulo IV: Estudio 6 \n 173muestras enviadas a la depuradora proced\u00edan de zo nas de cultivo tipo B, mientras que en el \nmercado se comercializan muestras tipo A y B. Po r el otro lado, se esperaba la ausencia de \nNoV GGI y GGII debido a que las muestras fueron tomadas durante Mayo \u2013 Junio, \u00e9poca en la \nque no se reportan brotes infe cciosos por este pat\u00f3geno. Posteriores ensayos de infectividad \nmostraron la presencia de HAdV infecciosos ta nto en las muestras pre- como post-depuradas. \nAunque est\u00e1 constatado que  la depuraci\u00f3n en mariscos tiene un efecto importante en cuanto \na la capacidad de reducir la presencia de bact erias, los datos obtenidos muestran que esta \nreducci\u00f3n no es equivalente para part\u00edculas v\u00edricas.   CONCLUSIONES   Este trabajo describe la presencia cualitativa y cuantitativa de virus ent\u00e9ricos en \nmoluscos bivalvos recolectados en mercados y supermercados localizados en el noreste de \nEspa\u00f1a, y describe la detecci\u00f3n y el genotipado de cepas de HAV relacionadas con un brote de \nhepatitis causado por coquinas importadas. Los re sultados globales del estudio indican que la \nprevalencia y concentraci\u00f3n de virus ent\u00e9ricos representa un reto para el sistema sanitario. Se sugiere que HAdV cuantificado por qPCR  puede tener un pape l importante como \npat\u00f3geno/indicador, y puede ser utilizado como indicador de la contaminaci\u00f3n de origen fecal. Los actuales sistemas de depuraci\u00f3n de molusc os no reducen la cantidad de HAdV y la \naplicaci\u00f3n de una IFA demuestra la presencia de virus infecciosos en moluscos bivalvos \ndepurados. En definitiva, todos los datos obte nidos corroboran que los indicadores fecales \nbacterianos cl\u00e1sicos no reflejan la presencia de virus ent\u00e9ricos humanos, confirmando que moluscos bivalvos que cumplen con la actu al normativa pueden estar contaminados con \npat\u00f3genos v\u00edricos tales como NoV.  Cap\u00edtulo IV: Estudio 6 \n 175FAILURE TO REMOVE VIRAL CONTAMINATION IN MOLLUSCAN SHELLFISH APPLYING \nCURRENT DEPURATION TREATMENTS \n \nJesus Rodriguez-Manzanoa, Ayalkibet Hundesaa, Byron Calguaa, Anna Carratalaa, Carlos \nMaluquer de Motesa,1,  Marta Rusi\u00f1ola, Vanessa Morescob, Ana Paula Dolores Ramosb, \nFernando Mart\u00ednez-Marcac, Miquel Calvod, Celia Regina Monte Barardib, S\u00edlvia Bofill-Masa, \nRosina Gironesa,* \n \naDepartment of Microbiology, Biology Sc hool, University of Barcelona, Spain \n \nbLaboratorio de Virologia Aplicada, Depart amento de Microbiologia, Imunologia e \nParasitologia, CCB, Universidade Federal de Santa Catarina - UFSC, Brazil \n \ncHealth Protection Agency, Department of Health, Generalitat de Catalunya, Spain \n \ndDepartment of Statistics, Biology School, University of Barcelona, Spain \n \n1Present address: Department of  Virology, Faculty of Medicine, Imperial College London, \nUnited Kingdom.  *Author for correspondenc e: Dr. Rosina Girones, Department  of Microbiology, Biology School, \nUniversity of Barcelona, Diagonal Ave., 643, 08028 Barcelona, Spain. Telephone number: 34-93-4021483. Fax number: 34-93-4039047. E-mail: rgirones@ub.edu  Cap\u00edtulo IV: Estudio 6 \n \n 176ABSTRACT \n Human enteric viruses are frequently detected in shellfish, and constitute a potential source of \nfood-borne diseases such as gastroenteritis and hepatitis. This report describes a large-scale survey of 151 shellfish batches (mussels and clam s) to assess the presence of enteric viruses in \nnational and imported European shellfish samples. The samples were collected in the winter seasons from 2004 to 2008 in a range of regional markets (Spain) through a surveillance system (Food Safety Plan of Catalonia). All ba tches were negative for hepatitis A virus (HAV) \nand norovirus genogroup I (NoV GGI), whereas 13% were positive for norovirus genogroup II \n(NoV GGII). Mussels appeared to be the most contaminated bivalves with 17% of positive \nsamples, whereas only 4% of clams were positive for enteric viruses. Frozen imported coquina \nclams, presumably linked to a hepatitis A outbreak detected in East of Spain in 2008, were tested to analyze the likely implication of these samples resulting in the detection of five out of ten positives by nested PCR. To understand how positive shellfish complying with European \nRegulations were introduced into the market, the levels of viral contamination and the efficiency of decontamination in shellfish depuration plants that use up to 3 different \ntreatments were evaluated. Therefore, human adenoviruses (HAdV) were used as a viral model and were evaluated in pre- and post-de purated samples. There were no statistically \nsignificant differences in the prevalence and quantification of HAdV in the tested samples. \nFurthermore, HAdV were evaluated as a fecal indicator and assessed the predictive values for other pathogens. Finally, a previously describe d indirect immunofluorescence assay developed \nto detect and quantify HAdV in environmental samples was applied in shellfish samples to \ndetect infectious particles, demonstrating the presence of some infectious viruses in \ndepurated mussels. The results indicated that current shellfish depuration systems to reduce \nbacterial indicators do not affect levels of viral contamination or provide any information about the presence of food-borne viral pathogens such as NoV and HAV. Future studies should focus on the evaluation of the risk associated with the consumption of these contaminated shellfish. \n \nKeywords:  food safety, norovirus, hepatitis A virus,  human adenovirus, f ood-borne, shellfish. \n \n1. INTRODUCTION \n Various viruses can be found in the human digestive tract, but only a few are commonly Cap\u00edtulo IV: Estudio 6 \n 177recognized as important food-borne pathogens. Norovirus (NoV) and hepatitis A virus (HAV) \nare the most common causes of illness through the fecal-oral route of transmission (Cliver, \n1997; Craun et al., 2002; Koopmans and Duizer, 2004). Epidemiological studies have estimated NoVs to be responsible for 60\u201380% of all food -borne outbreaks of gastroenteritis worldwide \n(Koopmans et al., 2001; Reuter et al., 2005) and consumption of contaminated shellfish is known to be one of the main transmission routes for NoVs infection (Loisy et al., 2005). Hepatitis A is a worldwide disease that is also linked to shellfish consumption. It can cause \nserious debilitating illness and even death on occasions (Lees, 2000). The infection is endemic in countries with poor sanitation levels, where the majority of the population is exposed to \nHAV during childhood (Jacobsen and Wiersma, 2010). Shellfish consumption can lead to HAV and NoV outbreaks for two main reasons: shellfish can filter and concentrate pathogens; and it is difficult to check that the water in which they grow is free from contamination (U.S. FDA, \n2011). Moreover, shellfish is frequently consumed raw or insufficiently cooked around the \nworld, which increases the risk of viral infection (Murchie et al., 2005).  All European Union (EU) Member States are s ubjected to the requirements of the Shellfish \nHygiene Directive, which sets out the need for purification or treatment before shellfish from Class B or C designated waters are put on the market. These standards rely exclusively on E. \ncoli numbers that are routinely used to test for microbiological quality and to classify shellfish \nharvesting areas into 3 quality levels (A-C). Category A has less than 230 MPN/100g of flesh and intervalvular liquid (FIL); Category B has less than 4,600 MPN/100g FIL; and Category C has less than 46,000 MPN/100g FIL  (EU, 2004a,b, 2008). Depuration is a natural process whereby \nshellfish are placed in clean water and allowed to purge themselves of contaminants. Many of the EU countries with large shellfish production facilities (Italy, Spain and France) have an increased emphasis on end product testing. Shellfish depuration is effective in removing many \nfecal bacterial contaminants from shellfish (Rodrick and Schneider, 2003; Corr\u00eaa et al., 2007). \nHowever, studies focused on enteric viruses,  such as HAV, NoVs and human adenovirus \n(HAdV), have shown that it is difficult to remo ve viruses from contaminated shellfish (Muniain-\nMujika et al., 2000; Formiga et al., 2002; Hernroth and Allard, 2007; Ueki et al., 2007; Corr\u00eaa et al., 2011). Besides, it is recognized that the main bacteriological parameters, such as E. coli , are \nnot good indicators of residual viral levels after depuration, as viruses and bacteria have \ndifferent rates of reduction (Jackson and Ogburn, 1999). Additionally, shellfish depuration methods are not consistently effective, or are ineffective, at removing some contaminants, \nsuch as naturally occurring marine vibrios, ma rine biotoxins or heavy metals and organic \nchemicals (Lee, 2008). Cap\u00edtulo IV: Estudio 6 \n \n 178The high stability of viruses in the environment, the host-specificity and the high prevalence of \nsome viral infections throughout the year in the world population strong ly support the use of \nmolecular techniques to identify and quantify specific viruses that can be used as indicators of fecal contamination and as microbial source tracking tools (Girones et al., 2010). Human adenoviruses are found in nearly 100% of urban sewage samples tested all around the world. HAdVs are also frequently detected in shellfis h, including samples that meet current safety \nstandards based on levels of fecal bacteria (Formiga-Cruz et al., 2002). Officials at the U.S. Environmental Protection Agency recently adde d HAdV to the list of potentially dangerous \ncontaminants, a move that was based on their high prevalence in urban sewage, their ability to cause disease, and their resistance to water purification treatments, particularly those \ninvolving UV irradiation (Girones, 2006). HAdV have been proposed as a viral indicator of fecal \ncontamination in water and shellfish (Pina et al., 1998; Formiga-Cruz et al., 2003).  In this study, a large-scale survey was carried out to assess the presence of enteric viruses in national and imported European shellfish samples. The samples were collected in winter from 2004 to 2008 in markets in Catalonia (NE Spain) through a surveillance system (Food Safety Plan of Catalonia). Frozen imported coquina clam s presumably linked to a hepatitis A outbreak \ndetected in East of Spain in 2008 were tested to analyze the likely implication of these products. To understand how positive shellfis h complying with European Regulations were \nintroduced into consumer markets, we analyzed the levels of viral contamination and the efficiency of decontamination in depuration pl ants that use up to 3 different treatments \n(ozone, the venturi system a nd ozone-UV). Furthermore, HAdV was evaluated as a fecal \nindicator and to assess predictive values for othe r pathogens. Finally, a previously described \nindirect immunofluorescence assay (IFA) developed to detect and quantify HAdV in \nenvironmental samples (river water and raw sewage) was applied in shellfish samples to detect infectious HAdV particles. \n 2. MATERIAL AND METHODS  2.1. Sampling 2.1.1. Samples from markets and grocery stores  A total of 151 molluscan shellfish samples of Mediterranean blue mussels ( Mytilus \ngalloprovincialis ) and clams ( Venus gallina  and Chamelea gallina ) were collected in a range of Cap\u00edtulo IV: Estudio 6 \n 179regional markets and grocery stores from September to February of 2004-2008, via a \nsurveillance system (Food Safety Plan of Catalonia). Among the collected samples, (i) 87 batches of mussels and 30 batche s of clams had been harvested in Spanish shellfish-growing \nareas (Autonomous Community of Galicia and Ca talonia, NW and NE Spain, respectively), \nwhereas (ii) 14 batches of musse ls and 20 batches of clams had been imported and harvested \nin shellfish-growing areas of the EU (Italy, Fran ce and Portugal). Each batch consisted of 500-\n1,000 g of alive or frozen animals.   2.1.2. Samples potentially linked to an HAV outbreak  Ten batches of imported coquina clams ( Donax trunculus ) suspected to be linked to cases of an \nHAV outbreak reported in September 2008 in the East of Spain were analyzed. Each sample \nconsisted of 500 g of frozen coquina clams in plastic packaging. The samples were kept frozen \nat -80\u00baC until analyzed.  2.1.3. Samples collected in shellfish depuration plants  A set of 40 batches of mussels ( Mytilus galloprovincialis ) and 20 seawater samples (10-L each) \nused for shellfish depuration were collected in May-June 2010 from three shellfish depuration companies treating shellfish from an area classified as type B according to European Union Council Regulations (EU, 2004a, b, 2008). Each company used different treatments to disinfect the water used for depuration:  ozone disinfection, a protein skimmer venturi system and \nozone-UV light disinfection, respectively. Shellf ish and seawater samples were collected before \n(N = 20 for shellfish; N = 10 for seawater) and after ( N = 20 for shellfish; N = 10 for seawater) \nthe application of these 24-hour depuration trea tments. Shellfish samples  collected before and \nafter depuration were taken from the same ba tch so as to observe the reduction of \nmicrobiological contamination. The seawater used in the depuration is recircularized along the 24-h treatment. Shellfish and water samples were harvested in sterile polyethylene containers and kept at 4\u00b0C for less than 24 h until the virus particles were concentrated.  2.2. Viruses and cell lines  Fecal suspensions (10-fold dilution in PBS 1X ) obtained from clinical fecal samples from \ngastroenteritis patients were used as positive controls for NoV GGI and GGII. Positive controls for the HAV analysis consisted of dilutions of FRhK-4 cell culture supernatant infected with the Cap\u00edtulo IV: Estudio 6 \n \n 180pHM-175 strain. For the HAdV determination, HAdV2 isolated from a clinical sample was \ngrown on A549 cells. An indirect immunofluore scence assay (IFA) was used to determine HAdV \ninfectivity on 293 cells. All the viral strains had been characterized by sequence analysis and all the viral suspensions were st ored at -80\u00b0C until use. \n 2.3. Concentration of viruses from shellfish samples  Shellfish samples were processed by two virus concentration methods and the viral concentrates were stored at 4\u00b0C for less than 24 h prior to nucleic acid extraction.  \nIn Method A, shellfish processing was performed as described previously by Pina et al. (1998). \nThis method has been used in a range of previous studies (Formiga-Cruz et al., 2002, 2003; Muniain-Mujika et al., 2003). Briefly, the shellfish samples were washed, scrubbed under clean running water and opened with a sterile shucking  knife. Thirty grams of hepatopancreas (HP) \nwere dissected from the samples and collected into a sterile beaker diluted with glycine buffer 0.25 N at pH 10 (1:5, w/v). The mixture was ho mogenized by magnetic stirring. The treated \nhomogenate was clarified by centrifugation at 2,170 x g for 15 min at 4\u00baC and the pH was \nneutralized (7\u00b10.2). The supernatant was centrifuged again at 39,800 x g for 45 min at 4\u00baC. To \npellet all viral particles, the supernatant was ultracentrifuged at 100,000 x g for 1 h at 4\u00baC and \nthe final pellet was resuspended in 200-400 \u03bcL of PBS with a maximum volume of viral concentrate of 500 \u03bcL.  In Method B, viral particles were concentrated from shellfish samples as described by \nJothikumar et al. (2005b). Briefly, a minimum of six shellfish from each sample were aseptically \nopened, and the animals were removed from their shells. The peripheral flesh and organs of each animal were cut away from the HP, which was then finely chopped. To degrade the shellfish tissue and allow the release of virions into solution, an equal volume of a 100 \u03bcg/mL proteinase K solution was added, and the sample was then incubated at 37\u00b0C for 1 h shaking at 320 rpm. Finally, the reaction mixture was incubated at 65\u00b0C for 15 min to inactivate the proteinase and the supernatant was collected by centrifugation at 3,000 \u00d7 g for 5 min.  Method A was used to process shellfish samples  collected from markets and grocery stores, \nwhereas Method B was used to isolate viral particles from mussels collected from commercial shellfish depuration companies. When the samples arrived at the laboratory alive, the HP was Cap\u00edtulo IV: Estudio 6 \n 181excised from the animals and frozen until anal yzed. When samples arrived frozen, the whole \nanimals were kept frozen until analyzed. The recovery efficiencies of both methods were \nsimilar. In shellfish samples spiked with HAdV, recovery values of 20\u201330% were observed (data \nnot shown).  2.4. Concentration of viruses from seawater samples  The protocol used to concentrate viruses has been described by Calgua et al. (2008). Briefly, the viruses were concentrated by the skimmed mi lk flocculation procedure. A volume of 100 \nmL of pre-flocculated skimmed milk solution (1 % [w/v]) was added to each of the previously \nacidified (pH 3.5) 10-L seawater samples used for shellfish depuration. Samples were stirred for 8 h at room temperature and flocs were allowed to sediment by gravity for another 8 h. \nSupernatants were carefully removed and the final volume containing the sediment was \ntransferred to a centrifuge pot and centrifuged at 7000 \u00d7 g for 30 min at 12 \u00b0C. The supernatant was carefully removed and the pelle t resuspended in 10 mL of phosphate buffer. \n 2.5. Bacteriological analysis  The determination of E. coli  was carried out on samples from depuration companies according \nto ISO 16649-3 (ISO, 2005), which uses the most probable number (MPN) procedure (Donovan et al., 1998) in Minerals Modified Glutamate Broth (Oxoid). Considering that samples from markets and grocery stores (from the surveilla nce program and potentially linked to an HAV \noutbreak) had health certificates for their sale in Spanish markets and importation to Spain, bacteriological analyses were not performed on these samples. It was assumed that all samples meet the health and hygiene requirements established in Regulations 853/2004, \n854/2004 and 1021/2008 (EU, 2004a,b, 2008). \n 2.6. Nucleic acid extraction  In order to prevent inhibition in the PCR assays and the generation of false-negative results, \ntwo different nucleic acid (NA) extraction kits were evaluated following the manufacturer's instructions. Nucleic acids from viral concentrates were extracted using a QIAamp\n\u00ae Viral RNA \nMini Kit (QIAGEN, Valencia, CA, USA) and NucliSens\u00ae (Biom\u00e9rieux, Boxtel, The Netherlands). \nBasically, both kits are based on the method of  Boom et al. (1990) and they use guanidinium \nisothiocyanate to denature viral capsids and silica particles or membrane to bind viral nucleic Cap\u00edtulo IV: Estudio 6 \n \n 182acids until their final elution. \n 2.7. Enzymatic amplification  The position, sequences, annealing temperature and length of primers and probes used in this \nstudy are presented in Table 1.  (i) Nested RT-PCR (nRT-PCR) and semi-nested RT-PCR (snRT-PCR).  The amplification \nconditions of the nRT-PCR (HAV) and snRT-PCR (NoV GGI and II) methods used for qualitative detection have been described elsewhere (Pina et al., 1998; Vennema et al., 2002; Boxman et \nal., 2006). In brief, the reverse transcription step was performed on 10 \u03bcL of neat and 10-fold \ndilution of extracted RNA with gene-specific primers, a one-step RT-PCR kit (QIAGEN, Valencia, CA, USA) and 10 U of RNase inhibitor (Invitrogen, Carlsbad, CA, USA) per 50 \u03bcL reaction mixture. The nRT-PCR and snRT-PCR were carried out with AmpliTaq\nTM Gold DNA polymerase \n(Applied Biosystems, Foster City, CA, USA).   (ii) Quantitative PCR (qPCR) and quantitative RT-PCR (RT-qPCR).  For the specific detection \nand quantification of HAdV and HAV genomes,  10 and 5 \u03bcL of neat, 10-fold and 100-fold \ndilutions of every extraction were tested, respectively. These dilutions were made to detect and reduce amplification inhibition due to the potential presence of interfering substances. \nFor HAdV, amplification was performed in a 25 \u03bcL reaction mixture with PCR master mix (Applied Biosystems, Foster City, CA, USA). The reaction contained 10 \u03bcL of a DNA sample or 10 \u03bcL of a quantified plasmid DNA, 1\u00d7 TaqMan master mix, and the corresponding primers \n(900 nM) and probe (250 nM) (Hernroth et al., 2002), following the manufacturer\u2019s \ninstructions and the annealing temperatures desc ribed in Table 1. A one-step RT-qPCR for HAV \ndetection, which combined cDNA synthesis and PCR in a single reaction, was used. The RT-qPCR assays were carried out in 25 \u03bcL of a reac tion mixture composed of 5 \u03bcL of extracted \nRNA and 20 \u03bcL of master mix. This master mix was made with a QIAGEN OneStep RT-PCR kit (QIAGEN, Valencia, CA, USA) and contained 2.5 mM of MgCl\n2, 250 nM of forward and reverse \nprimers and 100 nM of TaqMan probe (Jothikuma r et al., 2005a). The qPCR assays for HAdV \nand HAV were performed in a Stratagene\u00ae MX3000P sequence detector system (Strategene, La \nJolla, CA, USA).  All samples were run in quadruplicate, and positi ve and negative controls were included in all Cap\u00edtulo IV: Estudio 6 \n 183PCR assays. Known quantities of target DNA/RNA were added to a parallel amplification \nreaction containing the qPCR mix and the sampl e. In every assay, the amplification plots of \nsamples and standard dilutions were compared . A sample was considered positive if it \nproduced correct amplification curves and th e quantitation data was within the detection \nlimit. The amount of DNA/RNA was defined as the average of the duplicate data obtained.  2.8. qPCR standards  The pBR322 plasmid containing the complete he xon of HAdV 41 used in the construction of \nthe standards for the HAdV qPCR assay was kindl y donated by Dr. Annika Allard from the \nUniversity of Ume\u00e5, Sweden. Dilutions from 10\n-1 to 107 GC/10 \u03bcL of the standard were \nanalyzed in triplicate.  \n \nFor HAV, standard curves were generated by transforming E. coli  JM109 cells (Promega, \nMadison, WI, USA) with pGEM-T Easy plasmid (Promega, Madison, WI, USA) containing a 412 \nbp sequence of the HAV 5\u2019-untra nslated region (5\u2019UTR). Serial dilutions from 5 x 10-1 to 5 x 107 \nviral DNA molecules per 5 \u03bcL of TE buffer were analyzed in triplicate.  2.9. Sequencing and analysis of viral genomes  Amplicons obtained by nested PCR assays were purified using a QIAquick  purification kit (QIAGEN, Valencia, CA, USA), following the manufacturer's instructions. Both strands of the purified DNA amplicons were sequenced using an ABI Prism 3100 Genetic Analyzer and a Big Dye Terminator Cycle Sequencing Kit v. 3.1\n\u00ae (Applied Biosystems, Foster City, CA, USA), \nfollowing the manufacturer's instructions. Products were checked by the University of \nBarcelona\u2019s Scientific and Technical Services using an ABI PRISM 377 analyzer (Applied \nBiosystems, Foster City, CA, USA). The sequences were compared with the nucleotide sequences present in the GenBank us ing the BLAST program of the NCBI \n(http://blast.ncbi.nlm.nih.gov/Blast.cgi), aligned using the Clustal X 1.8 program. Phylogenetic tree reconstructions for HAV were performed with Mega 3.1 (http://www.megasoftware.net/ ). Evolutionary distances were determined by the Kimura two-\nparameter equation and the tree was constructe d using the neighbor-joining (NJ) algorithm. \n   Cap\u00edtulo IV: Estudio 6 \n \n 1842.10. Nucleotide seque nce accession numbers \n The sequences reported in this paper have been deposited in the GenBank database under \naccession numbers AYXXXXX to AYXXXXX (HAV).  2.11. Indirect immunofluorescence assay  An IFA previously described by Calgua et al. (2011) for the detection of HAdV in environmental samples was applied in the present study to de tect and quantify infectious HAdVs in post-\ndepurated mussels from shellfish companies. For this purpose, 760 \u03bcL of a 293 cell suspension \n(5.00 \u00d7 10\n5 cell/mL, suspension prepared in growth medium) was added to each well of a Lab-\nTek 8-well chamber slide (Nagle Nunc Internationa l, Naperville, IL). Once we had concentrated \nthe viral particles present in the shellfish using Method B (Jothikumar et al., 2005b), the viruses present in 2 mL of the final resuspende d pellet containing approximately 1.3 g of HP \nwere re-concentrated to 500 \u03bcL (PBS 1X) with an ultracentrifugation step (100,000 x g for 1 h \nat 4\u00baC) and clarified with chloroform (1:2 v/v). Then, 140 \u03bcL containing different dilutions were added and mixed in each well. Cells were th en incubated overnight at 37\u00b0C in 5% CO\n2 \natmosphere. Once cells were attached, the medi um was removed carefully and 1 mL of fresh \ngrowth medium was added.  Infected cells were incubated for 8 days at 37\u00b0C in 5% CO\n2. After this period, the medium was \nremoved and the cells washed with cold PBS. Cell s were fixed with ice-cold absolute methanol \nfor 10 min and washed again with PBS for 5 min. Monolayers were incubated for 1 h at 37\u00b0C \nwith blocking solution (BS), which contained PBS with 1% of BSA (w/v) and 0.05% of Tween \n(v/v). They were then stained for 1 h at 37\u00b0 C with their corresponding primary antibody, \npreviously diluted in BS (100 or 240 \u03bcL for 8- or  4-well chambers, respectively). The antibody \nsolution was removed and cells were washed for 15 min at 37\u00b0C with BS. Cells were then \nstained for 15 min at RT with a 1:100 (v/v) dilution of goat anti-mouse IgG-FITC (Sigma\u2013Aldrich, Steinheim, Germany) in BS. Cells were finally w ashed with BS for 15 min at 37\u00b0C and mounted \non chambers to which UltraCruz\u2122 mounting me dium was added (Santa Cruz Biotechnology, \nSanta Cruz, CA, USA). Epifluorescence microscopy with UV light was used for the visualization.    Cap\u00edtulo IV: Estudio 6 \n 1852.12. Comparison of nucleic acid extraction methods \n Two extraction methods were compared using shellfish samples that were naturally contaminated with HAdV. The QIAamp\n\u00ae Viral RNA Mini kit provided a higher number of \npositive samples than the NucliSens\u00ae kit. No significant differences in the quantification of \nHAdV among positives samples were observed  (data not shown). For these reasons, the \nQIAamp\u00ae Viral RNA Mini kit was the method selected for all the NA extractions in this study. \n 2.13. Statistical analysis  The statistical analysis was performed using R software version 2.14.1 (Verzani, 2004; http://www.R-project.org). We used a two-sided Fisher's exact test to study the association \nbetween mussels and clams, national and imported European shellfish, and HAdV detected by \nqPCR and NoV II by snRT-PCR. The potential utility of quantitative HAdV data as a predictor of positive NoV II shellfish samples was evaluated wi th a logistic regression model. The sensitivity \nand specificity of this model in predicting the presence of NoV II was calculated. The nonparametric Kruskal-Wallis test was used to evaluate the statistical significance between pre- and post-depurated shellfish samples an d seawater present during collection time. \nResults were considered to be significant with a P of <0.05 and values less than the detection \nlimit were considered as zero.  3. RESULTS  3.1. Viruses in shellfish from markets and grocery stores, winter seasons of 2004-2008  \nTo determine whether viral food -borne pathogens such as HAV and NoV circulate in shellfish \nsold in Spain, the presence of these viruses in  shellfish collected from Spanish markets during \nthe 2004-2008 winter seasons was studied. The virological analysis performed by RT-PCR amplification of a region of the RNA-dependent RNA polymerase (237 bp) of NoV and the 5' untranslated region (291 bp) of HAV showed that, respectively, NoV GGI and HAV were not detected in any national or imported Euro pean sample analyzed, whereas NoV GGII was \ndetected in 16 out of 117 (13.7%) national samples and in 3 out of 34 (8.8%) imported European samples (Table 2). From the tota l of 101 mussel samples (87 from national \nharvesting areas and 14 from other European harvesting ar eas), 17 samples (16.8%) were \npositive for NoV GGII by snRT-PCR, whereas only 2 out of the 50 (4.0%) clam samples ( Venus Cap\u00edtulo IV: Estudio 6 \n \n 186gallina  and Chamelea gallina ) were positive for NoV GGII. The distribution by year of NoV GGII-\nnegative and -positive shellfish samples is represented in Fig. 1. The statistical analysis showed no significant differences in NoV GGII presence between national and imported European samples (Fisher exact test, P = 0.567). Conversely, the prevalence of NoV GGII in mussels was \nhigher than in clams and statistically significant (Fisher exact test, P = 0.035). Thirteen selected \npositive NoV GGII samples were sequenced, showing similarity percentages ranging from 83% to 100%.  In addition to HAV and NoV, HAdV was analyzed by qPCR in 30 shellfish samples (24 mussel and 6 clam samples) out of the total collected ( N = 151). Ten of the selected samples were \npositive and 20 were negative for NoV GGII. Bo th groups were randomly selected. The overall \nresults show that 13 samples were positive for HAdV (43.3%) by qPCR and the mean \nconcentration was 3.51 x 10\n2 GC/g (SD: 1.23 x 103 GC/g) of the HP tested. Eight (80.0%) of the \n10 NoV GGII-positives samples were positive for HAdV, with a mean value of 9.98 x 102 (SD: \n2.05 x 103) GC/g HP. In contrast, only 5 out of the 20 NoV GGII-negative (25%) samples were \npositive for HAdV, showing a mean concentration of 2.78 x 101 (SD = 6.63 x 101) GC/g HP. \nOverall, the presence of HAdV among NoV GGII-positive samples determined by qPCR showed a significant association (Fisher exact test, P = 0.007). To ensure at least 80% sensitivity, a \npredicted probability cutpoint of 0.5 was required (if the predicted probability of HAdV presence was \u2265 0.5, the shellfish was classified as NoV II positive, but if the predicted probability was < 0.5, the shellfish was classified as negative). This cutpoint resulted in a sensitivity of 100% and a specificity of 74%.  \n3.2. Analysis of shellfish potentially linked to an HAV outbreak in September 2008 \n HAV RNA was detected by nested RT-PCR with primers of 5\u2019UTR in 50% (5 out of 10) of the frozen coquina clam samples potentially linked to hepatitis A cases. One of the HAV-positive coquina samples was also positive by qPCR, with an estimated concentration of 4.6 x 10\n2 GC/g \nHP. Three out of five positive HAV samples detected by amplification of 5\u2019UTR (291 bp) were sequenced. The sequences of th e detected HAV were compared with sequences described in \nprevious studies (Pina et al., 2001; Rodriguez-Manzano et al., 2010) and those available in databases. The strains detected from clams belonged to subgenotype IA (clams B and C) and IB (clam A). The identified sequences are represented in Fig. 2. The HAV sequence from clam A was most closely related to Clam C with an identity of 99.6%, and was 96.0% similar to clam B. Cap\u00edtulo IV: Estudio 6 \n 187HAV from clam B shared 95.1% nucleotide identity with clam C. We had previously identified \none HAV-positive sample out of 41 sewage samples collected from the same area during 2007-2008 (Rodriguez-Manzano et al., 2010). A pairwi se comparison between the three sequences \nand this sewage sequence revealed that there were differences among the 226 bp of 5\u2019UTR. HAV from the sewage sample was most closely related to clam C (98.2%), followed by clam A (96.5%) and clam B (96.0%). This diversity su ggests that HAV sequences from the shellfish \noutbreak had different origins to the HAV strains detected in the sewage.  3.3. Study of the effectiven ess of shellfish depuration \n Shellfish marketed in the EU needs to comp ly with strict European regulations on \nmicrobiological safety. This is usually achieved in shellfish classified as B category by using \nshellfish depuration treatments. To understand ho w depuration treatments affect viral load in \nshellfish, a study on the effectiveness of sh ellfish depuration in samples collected from 3 \ndifferent depuration plants fr om May to June 2010 was perf ormed. HAdV was used as the \nmodel for this study. The presence and concentr ation of HAdV was evaluated in a) mussels \nbefore the depuration treatmen t (non-depurated mussels); b) mussels from the same batch \nthat were already depurated (depurated mussels) ; c) seawater used for shellfish depuration, \nand d) seawater after shellfish depuration. The presence and quantitation of HAdV in mussels \nand seawater (pre- and post-depur ation) detected by qPCR are reported in Table 3. HAdV was \ndetected by qPCR in 14 (70%) non-depurat ed samples and 12 (60%) depurated shellfish \nbatches, showing mean concentration values of 1.07 x 10\n2 (SD = 1.22 x 102) GC/g HP and 1.14 x \n102 (SD = 2.35 x 102) GC/g HP, respectively. Five out of 12 (42%) seawater samples used for \ndepuration and 6 out of 12 (50%) after depuration were positive for HAdV, with mean values \nof 6.45 x 102 (SD = 1.80 x 103) GC/L and 5.99 x 102 (SD = 1.10 x 103) GC/L, respectively. Taken \ntogether, the results indicated no reduction in  HAdV levels due to depuration treatments. \nOverall, no statistically significant differences in the pre- and post-treatment application (Kruskal-Wallis test, P = 0.849) were found, either between pre- and post-depurated seawater \n(Kruskal-Wallis test, P = 0.580) or mussels (Kruskal-Wallis test, P = 0.821). The samples were \nnegative for NoV GGI and GGII in all pre- and post-depurated samples.  3.4. Indirect immunofluorescence assay (IFA)  Although the qPCR analysis provided clear quantitative data, it gave no indication of the infectivity of the contaminating virus. To address this, a previously developed Cap\u00edtulo IV: Estudio 6 \n \n 188immunofluorescence protocol (Calgua et al., 2011) was adapted. Two depurated shellfish \nsamples from each depuration treatment were selected. The concentrates were cleared with chloroform and dilutions (1:10, 1:2 and undiluted) were used to infect 293 cells, followed by staining with an HAdV-specific antibody (Fig. 3). Three out of 6 (50%) analyzed samples were HAdV-positive by IFA and this was quantified as 2.10 x 10\n0 (SD = 1.00 x 100) FFU/g HP. The 6 \nselected samples had been previously evaluated by HAdV qPCR and contained a mean of 3.18 \nx 102 GC/g HP (SD = 3.63 x 102 GC/g HP). As described previously in water matrixes (Calgua et \nal., 2011), we observed a 2 log 10 reduction in the numbers of infectious viruses (FFU/g HP) \ncompared with the number of genome copies detected by qPCR (GC/g HP) (Table 4). Despite the low concentration level of HAdV detected in the IFA assay, an inhibition effect was not \nobserved. \n 3.5. E. coli  determination in shellfish \n The presence of E. coli  in shellfish from depuration plants was quantified among post-\ndepurated samples from the three applied treatments. The results demonstrate that all batches had E. coli  counts below the upper limit, ranging from <20 MPN/g to 220 MPN/g and \ncomplying with EU regulations (EU, 2004a,b, 2008).  4. DISCUSSION  Enteric viral disease outbreaks linked to the co nsumption of contaminated bivalve shellfish \nhave been reported in the scientific literat ure from many countries and the presence of \npathogens combined with an absence of fecal indicators is currently a major concern (Cliver, \n1997; Lees, 2000). This study describes the dispersal of viral contaminants in shellfish in the Spanish markets, defining the abundance of NoVs as contaminants in mussels and clams, the absence of HAV in the common market and the presence in imported samples from endemic areas with contamination of HAV. The results support the previously described limitations in some shellfish depuration systems for the removal of viruses, using HAdV as an indicator of \nfecal contamination.  No statistically significant differences amon g national and imported European samples \ncollected in winter from Spanish mark ets have been found in this study ( P > 0.05). Conversely, \nthe prevalence of NoV GGII was significantly hi gher in the analyzed mussel samples (16.8%) Cap\u00edtulo IV: Estudio 6 \n 189than in the tested clams (4.0%) ( P < 0.05). Although global epidemiological data suggests that \noysters, followed by clams and mussels, are th e most common route of infectious outbreaks \nassociated with bivalve molluscan shellfish (Pot asman et al., 2002), mussels appear to be the \nmost contaminated bivalves in this study. This  is in agreement with another study performed \nin Europe (Gabrieli et al., 2007). The overall results show that 19 out of 151 (12.6%) shellfish samples were positive for NoV GGII, whereas NoV GGI and HAV were not detected in any sample. The absence of HAV and NoV GGI was expected, as most developed countries in \nEurope are non-endemic areas for HAV (Beth, 2002) and GGII strains predominate worldwide in fecal samples (Myrmel et al., 2004). The reduction of HAV in Spanish urban sewage in recent years was described in Rodriguez-Manzano et al. (2010) and was related to the improvement of sanitation systems. However, sporadic outbreak s are detected in relation to imported food \nfrom endemic countries. \n \nIn September 2008, the Health Department of the Autonomous Community of Valencia (NE \nSpain) reported the occurrence of a hepatitis A outbreak and its possible association with \nimported frozen cockles from Peru (www.aesan.m sc.es). A rapid alert system for food-borne \noutbreaks (www.gencat.cat), together with the National Epidemiological Surveillance Network (BOE, 1996), quickly reported the existence of the outbreak. In this outbreak, 25 people developed hepatitis A after the consumption of raw cockles ( Donax  spp .). A similar hepatitis A \noutbreak associated with the same vector had been  previously reported (S\u00e1nchez et al., 2002). \nThis suggests that imported shellfish are a source of hepatitis A outbreaks in developed countries. The samples complied with required health controls and were suitable for human \nconsumption.  Five out of 10 analyzed clam samples likely to be  linked to HAV infected people were positive \nwhen analyzed by nRT-PCR. The analysis of  the 5\u2019UTR demonstrated the presence of \nsubgenotypes IA and IB, which are typically dete cted in Europe and South America (Cristina \nand Costa-Mattioli, 2007). However, because of the low concentration of viruses, only 3 out of 5 positive samples could be sequenced. Genetic characterization of es tablished HAV genotypes \nhas focused traditionally on the VP1 amino terminus or the VP1/P2A junction region, for which a reference database of sequences is available (Ching et al., 2002). In this study, it was not possible to obtain a complete sequence from these genomic regions, probably because the \nconcentration of viruses present in the samples was bordering the detection limit of the applied techniques. The phylogenetic analysis wa s performed on the basis of 5\u2019UTR, a region \nthat proved useful for HAV characterization in a previous study (Pina et al., 2001). The Cap\u00edtulo IV: Estudio 6 \n \n 190comparison of the three identified sequence s from HAV-contaminated clams, with the \nsequence previously obtained from sewage in the area where the outbreak was detected, reveals differences in the 5\u2019UTR region. These data support the fact that the clams might have been contaminated prior to importation. The endemic origin of the samples (Beth, 2002) confirms that HAV strains are circulating wo rldwide and both IA and IB are related with \nsewage and shellfish in endemic areas (Pina et al., 2001). This is in agreement with dramatic reduction of HAV in Spain reported in recent years (Rodriguez-Manzano et al., 2010).  The prevalence of HAdVs was generally associated with the presence of faecal contamination and risk of contamination by NoV and HAV (Pina et al., 1998, Muniain-Mujika et al., 2000). In \nthe present study, in 30 shellfish samples collected at market level in winter from 2004 to 2008 \n(20 negative and 10 positive for NoV GGII), the estimated sensitivity and specificity of HAdV to predict the presence of NoV GGII was 100% and 74%, respectively. The percentage of positive samples for HAdV (43%) was similar to those obtained in previous studies employing molecular detection procedures (Muniain-Mujika et al., 2002; Formiga et al., 2003). HAdV concentration in the HP of shellfish samples ranged from 2.83 x 10\n0 to 6.49 x 103 GC/g HP, with means of 2.78 \nx 101 and 9.98 x 102 GC/g HP for negative- and positive-NoV GGII samples, respectively. The \nresults showed significant differences in the presence and concentration of HAdV between \nnegative- and positive-NoV GGII samples. According to descriptive statistics, sensitivity and specificity, HAdV quantified by qPCR may have a role as a pathogen/indicator, and may be used as an indicator of viral pollution in shellfish during the studied season.  Samples analyzed from commercial shellfish depuration companies comply with European \nUnion Council Regulations after the application of three shellfish depuration treatments. The \ngreater presence of HAdV in po st-depurated shellfish (60%) than in samples from market and \ngrocery stores (43%) may be due to the fact that depurated samples were collected in type B areas and samples from the market could also come from type A areas. However, the absence of NoV GGI and GGII was expected as samples were collected from May to June and many \nnorovirus-associated outbre aks reported in the EU occur durin g the winter (Bue sa et al., 2002; \nPotasman et al., 2002; Nyg\u00e5rd et al., 2003; Siebenga et al., 2009). When the data were analyzed, no significant differences ( P > 0.05) were observed in HAdV quantification between \npre- and post-depuration processes at shellfis h and seawater level. This indicates that \ndepuration protocols do not reduce viral load . Conversely, depuration is known to affect \nbacterial levels in shellfish (Love et al., 2010). All depurated samples analyzed in this work Cap\u00edtulo IV: Estudio 6 \n 191complied with EU microbiological safety legislation (based on E. coli levels) and thus were \nconsidered safe for consumption. The results indicate that current shellfish depuration \nsystems to reduce bacterial indicators do not affect levels of viral contamination and are \nunable to inform about the presence of food-borne viral pathogens such as HAV and NoV. It also confirms previous studies showing that shellfish complying with EU regulations may be contaminated by viral pathogens such as NoVs (Lees, 2000; Formiga et al., 2002; Romalde et al., 2002; Muniain-Mujika et al., 2003). This study also proved the infectivity of viral pathogens detected in shellfish after three depuration treatments. Collectively, the presence of NoVs in mussels and clams, and the presence of HAV in  clams associated with a hepatitis outbreak, \nreaffirm that classical bacterial indicators do no t reveal viral contamination in shellfish and \ncannot be used alone for the evaluation of bivalve safety.  \nAs demonstrated here and in previous studies (Bofill-Mas et al., 2006; Hundesa et al., 2009; \nHundesa et al., 2010), qPCR is a useful tool to detect and quantify viruses in the environment as it provides sensitive and accurate results in a considerably short period of time. However, in some conditions, qPCR data may not correlate to the presence of infectious viral particles and \nthus infectivity assays are required. The results of  the present study indicate that the described \nIFA is a suitable tool for obtaining infectivity data from environmental HAdVs. In this study, infectious HAdVs have been detected in depurat ed mussels. No direct quantitative correlation \nis expected between the concentration of HAdV and NoVs, since the excretion and infection patterns of both viruses are different. However, absence or a very low level of HAdV is an indication of low fecal contamination and it may be expected that the risk for pathogens such as HAV or NoV will also be very low.  In conclusion, this study reports qualitative a nd quantitative data on the presence of human \nenteric viruses in bivalve molluscan shellfish from markets and grocery stores located in the \nNorth East of Spain, and describes the detect ion and genotyping of HAV strains that are \npotentially linked to a hepatiti s A outbreak caused by frozen imported coquina clams. The \noverall results of the study indicate that the prevalence and concentrations of enteric human \npathogens in molluscan bivalve shellfish repres ents a challenge for the sanitation system. It \nsuggests that HAdVs, quantified by qPCR, may ha ve a role as a pathogen/indicator and may be \nused as an indicator of fecal pollution. The cu rrent depuration treatments do not reduce the \namount of HAdV and the application of IFA demons trates the presence of infectious viruses in \ndepurated shellfish. The risk associated with th e consumption of these contaminated shellfish \nmust be evaluated using a risk assessment model,  and this information will be essential to Cap\u00edtulo IV: Estudio 6 \n \n 192develop improved guidelines for the microbiological quality of shellfish products. \n ACKNOWLEDGEMENTS  We thank the University of Barcelona\u2019s Scientific and Technical Services for sequencing the PCR products. The research described in the manuscript was supported by grants from the \n\u201cMinisterio de Educaci\u00f3n y Ciencia\u201d of the Spanish Government (project AGL2008-05275-C03-01, AGL2011-30461-C02-01 and A/017172/08) and the European Commission Framework Program 7 project \u201cIntegrated monitoring and co ntrol of foodborne viruses in European food \nsupply chains (VITAL)\u201d (Grant No. KBBE 213178) le d by the coordination team of Nigel Cook \n(FERA, UK), Martin D\u2019Agostino (FERA, UK) and Franco M. Ruggeri (ISS, Italy). The work was also \npossible for the support and coop eration of the Health Protection Agency, Health Department, \nGeneralitat de Catalunya. Anna Carratal\u00e0 was a fellow of the Spanish Ministry of Science. We \nare grateful to Dr. D. Furones from the Centre d\u2019Aquicultura, Institut de Recerca i Tecnologies \nAgroalimentaries (IRTA), San Carles de la R\u00e0pita, Spain, for assistance during the sampling in the Ebro River Delta area. C.R.M. Barardi has a fellowship from CNPq, V. Moresco and A.P. D.Ramos received support from AECID, Spain.  REFERENCES  \nBeth, P. B.,  2002. Global epidemiology of hepatitis A: implications for control strategies. 10th \nInternational Symposium on Viral Hepatitis and Liver Disease. Bofill-Mas, S., Albinana-Gimenez, N., Clemente-Casares, P., Hundesa, A., Rodriguez-Manzano, J., Allard, A., Calvo, M., Girones, R.,  2006. Quantification and stab ility of human \nadenoviruses and polyomavirus JCPyV in w astewater matrices. Applied and Environmental \nMicrobiology 72, 7894\u20137896. \nBolet\u00edn Oficial del Estado,  1996. Por la que se crea la Red Nacional de Vigilancia  \nEpidemiol\u00f3gica, Madrid, Spain, Real Decreto 2210/1995, BOE 21, pp. 2153\u20132158. Boom, R., Sol, C. J., Salimans, M. M., Jansen, C. L., Wertheim-van Dillen, P. M., van der Noordaa, J.,  1990. Rapid and simple method for purification of nucleic acids. Journal of Clinical \nMicrobiology 28, 495\u2013503. Boxman, I. L., Tilburg, J. J., Te Loeke, N. A., Vennema, H., Jonker, K., de Boer, E., Koopmans, M., 2006. Detection of noroviruses in shellfish in the Netherlands. International Journal of \nFood Microbiology 108, 391\u2013396. Buesa, J., Collado, B., L\u00f3pez-And\u00fajar, P., Abu-Mallouh, R., Rodr\u00edguez D\u00edaz, J., Garc\u00eda D\u00edaz, A., Prat, J., Guix, S., Llovet, T., Prats, G., Bosch, A.,  2002. Molecular epidemiology of caliciviruses \ncausing outbreaks and sporadic cases of acute gastroenteritis in Spain. Journal of Clinical Microbiology 40, 2854\u20132859. Calgua, B., Barardi, C. R., Bofill-Mas, S., Rodriguez-Manzano, J., Girones, R.,  2011. Detection \nand quantitation of infectious human adenovir uses and JC polyomaviruses in water by \nimmunofluorescence assay. Journal of Virological Methods 171, 1\u20137. Calgua, B., Mengewein, A., Grunert, A., Bofill-Mas, S., Clemente-Casares, P., Hundesa, A., Cap\u00edtulo IV: Estudio 6 \n 193Wyn-Jones, A. P., L\u00f3pez-Pila, J. M., Girones, R.,  2008. Development and application of a one-\nstep low cost procedure to concentrate viruses from seawater samples. Journal of Virological Methods 153, 79\u201383. Ching, K. Z., Nakano, T., Chapman, L. E., Demby, A., Robertson, B. H.,  2002. Genetic \ncharacterization of wild-type geno type VII hepatitis A virus. Jour nal of General Virology 83, 53\u2013\n60. Cliver, D. O.,  1997. Virus transmission via food. World Health Statistics Quarterly 50, 90\u2013101. \nCorr\u00eaa, A. A., Albarnaz, J. D., Moresco, V., Poli, C. R., Teixeira, A. L., Sim\u00f5es, C. M. O., Barardi, C. R. M.,  2007. Depuration dynamics of oysters (Crassostrea gigas) artificially contaminated by \nSalmonella enterica serovar Typhimurium. Marine Environmental Research 63, 479\u2013489. Corr\u00eaa, A. A., Rigotto, C., Moresco, V. Kleeman, C. R.,Teixeira, A. L., Poli, C. R., Sim\u00f5es, C. M. O., Barardi, C. R. M.,  2011. The depuration dynamics of oysters (Crassostrea gigas) artificially \ncontaminated with hepatitis A virus and human adenovirus.  Mem\u00f3rias do Instituto Oswaldo \nCruz 106, in press. Craun, G. F., Nwachuku, N., Calderon, R. L., Craun, M. F.,  2002. Outbreaks in drinking-water \nsystems, 1991-1998. Journal of Environmental Health 65, 16\u201323. Cristina, J., Costa-Mattioli, M.,  2007. Genetic variab ility and molecular evolution of hepatitis A \nvirus. Virus Research 127, 151\u2013157. \nDonovan, T.J., Gallacher, S., Andrews, N.J., Greenwood, M.H., Graham, J., Russell, J.E., \nRoberts, D., Lee, R.,  1998. Modification of the standard method used in the United Kingdom \nfor counting Escherichia coli in live bivalve molluscs. Communicable Disease and Public Health 1, 188\u2013196. EU, 2004a. Commission regulation (EC) No 853/2004 of 29 April 2004 laying down specific \nhygiene rules for food of animal origin. Official Journal of the European Communities L 139, 22\u201382. EU, 2004b. Commission regulation (EC) No 854/2004 of 29 April 2004 laying down specific \nrules for the organization of official controls on products of animal origin intended for human \nconsumption. Official Journal of the European Communities L 139, 83\u2013127. EU, 2008. Commission regulation (EC) No 1021/2008 of 17 October 2008 amending Annexes I, \nII and III to Regulation (EC) No 854/2004 laying down specific rules for the organization of official controls on products of animal orig in intended for human consumption and Regulation \n(EC) No 2076/2005 as regards live bivalve molluscs , certain fishery pro ducts and staff assisting \nwith official controls in slaughterhouses. Official Journal L 277, 15\u201317. Formiga-Cruz, M., Tofi\u00f1o-Quesada, G., Bofill-Mas, S., Lees, D. N., Henshilwood, K., Allard, A. K., Conden-Hansson, A. C., Hernroth, B. E., Vant arakis, A., Tsibouxi, A., Papapetropoulou, M., \nFurones, M. D., Girones, R.,  2002. Distribution of human virus contamination in shellfish from \ndifferent growing areas in Greece, Spain, S weden, and the United Kingdom. Applied and \nEnvironmental Microbiology 68, 5990\u20135998. \nFormiga-Cruz, M., Allard, A. K., Conden-Hansson, A. C., Henshilwood, K., Hernroth, B. E., \nJofre, J., Lees, D. N., Lucena, F., Papapetropoulou, M., Rangdale, R. E., Tsibouxi, A., Vantarakis, A., Girones, R.,  2003. Evaluation of potential indicators of viral contamination in \nshellfish and their applicability to diverse geographical areas. Applied and Environmental Microbiology 69, 1556\u20131563. Gabrieli, R., Macaluso, A., Lanni, L., Saccares, S., Di Giamberardino, F., Cencioni, B., Petrinca, A. R., Divizia, M.,  2007. Enteric viruses in molluscan shellfish. New Microbiologica 30, 471\u2013\n475. Girones, R.,  2006. Tracking viruses that contaminate environment. Journal of Environmental \nEngineering and Science 1, 19\u201325. Girones, R., Ferr\u00fas, M.A., Alonso, J.L., Rodriguez-Manzano, J., Calgua, B., Corr\u00eaa A.A., Hundesa, A., Carratala, A., Bofill-Mas, S.,  2010. Molecular detection of pathogens in water--\nthe pros and cons of molecular techniques. Water Research 44, 4325\u20134339. Cap\u00edtulo IV: Estudio 6 \n \n 194Hernroth, B., Allard, A.,  2007. The persistence of infectious adenovirus (type 35) in mussels \n(Mytilus edulis) and oysters (Ostrea edulis). International Journal of Food Microbiology 113, 296\u2013302. Hernroth, B. E., Conden-Hansson, A. C., Rehnstam-Holm, A. S., Girones, R., Allard, A. K ., \n2002. Environmental factors influencing human viral pathogens and their potential indicator organisms in the blue mussel, Mytilus edulis: the first Scandinavian report. Applied and Environmental Microbiology 68, 4523\u20134533. Hundesa, A., Bofill-Mas, S., Maluquer de Motes, C., Rodriguez-Manzano, J., Bach, A., Casas, M., Girones, R.,  2010. Development of a quantitative PC R assay for the quantitation of bovine \npolyomavirus as a microbial source-tracking tool . Journal of Virological Methods 163, 385\u2013389. \nHundesa, A., Maluquer de Motes, C., Albinana-Gimenez, N., Rodriguez-Manzano, J., Bofill-Mas, S., Su\u00f1en, E., Girones, R.,  2009. Development of a qPCR assay for the quantification of \nporcine adenoviruses as an MST tool for swin e fecal contamination in the environment. \nJournal of Virological Methods 158, 130\u2013135. ISO, 2005. Microbiology of food and animal feeding stuffs. Horizontal method for the \nenumeration of beta-glucuronidase-positive Esch erichia coli - Part 3: most probable number \ntechnique using 5-bromo-4-chloro-3-indolyl-beta-D-glucuronide. ISO 16649:2005. International Organisation fo r Standardisation, London. \nJacobsen, K. H., Wiersma, S. T.,  2010. Hepatitis A virus seroprevalence by age and world \nregion, 1990 and 2005. Vaccine. 41, 6653\u20136657. Jackson, K. L., Ogburn, D. M.,  1999. Review of depuration and its role in shellfish quality \nassurance. NSW Fisheries Final Report Series  No. 13. FRDC Project No. 96/355, pp. 77. \nJothikumar, N., Cromeans, T. L., Sobsey, M. D., Robertson, B. H., 2005a. Development and \nevaluation of a broadly reactive TaqMan assay fo r rapid detection of hepatitis A virus. Applied \nand Environmental Microbiology 71, 3359\u20133363. Jothikumar, N., Lowther, J. A., Henshilwood, K., Lees, D. N., Hill, V. R., Vinj\u00e9. J.,  2005b. Rapid \nand sensitive detection of noroviruses by usin g TaqMan-based one-step reverse transcription-\nPCR assays and application to naturally contaminated shellfish samples. Applied and Environmental Microbiology 71, 1870\u20131875. Koopmans, M., Vinj\u00e9, J., Duizer, E., de Wit, M., van Duijnhoven, Y.,  2001. Molecular \nepidemiology of human enteritc caliciviruses in The Netherlands. Novartis Foundation symposium 238, 197\u2013214. Koopmans, M., Duizer, E.,  2004. Foodborne viruses: an emerging problem. International \nJournal of Food Microbiology 90, 23\u201341. Lee, R.,  2008. Bivalve depuration: fundamental and pr actical aspects. FAO Fischeries Technical \nPaper No. 511. FAO, Rome, Italy.  \nLees, D.,  2000. Viruses and bivalve shellfish. International Journal of Food Microbiology 59, 81\u2013\n116. Loisy, F., Atmar, R. L., Guillon, P., Le C ann, P., Pommepuy, M., Le Guyader, F. S.,  2005. Real-\ntime RT-PCR for norovirus screening in shellfish. Journal of Virological Methods 123, 1\u20137. Love, D.C., Lovelace, G.L., Sobsey, M.D.,  2010. Removal of Escherichia coli, Enterococcus \nfecalis, coliphage MS2, poliovirus, and hepatitis A virus from oysters (Crassostrea virginica) and hard shell clams (Mercinaria mercinaria) by depuration. Internatio nal Journal of Food \nMicrobiology, 143, 211\u2013217. Muniain-Mujika, I., Calvo, M., Lucena, F., Girones, R.,  2003. Comparative analysis of viral \npathogens and potential indicators in shellfish. International Journal of Food Microbiology 83, 75\u201385. Muniain-Mujika, I., Girones, R., Lucena, F.,  2000. Viral contamination of shellfish: evaluation \nof methods and analysis of bacteriophages and human viruses. Journal of Virological Methods \n89, 109\u2013118. Murchie, L. W., Cruz-Romero, M., Kerry, J. P., Linton, M., Patterson, M. F., Smiddy, M., Kelly, Cap\u00edtulo IV: Estudio 6 \n 195A. L.,  2005. High pressure processing of shellfish: a review of microbiological and other quality \naspects. Innovative Food Science and Emerging Technologies 6, 257\u2013270. Myrmel, M., Berg, E. M., Rimstad, E., Grinde, B., 2004 . Detection of enteric viruses in shellfish \nfrom the Norwegian coast. Applied and Envi ronmental Microbiology 70, 2678\u20132684. \nNyg\u00e5rd, K., Torv\u00e9n, M., Ancker, C., Knauth, S. B., Hedlund, K. O., Giesecke, J., Ande rsson, Y., \nSvensson, L.,  2003. Emerging genotype (GGIIb) of norovirus in drinking water, Sweden. \nEmerging Infectious Diseases 9, 1548\u20131552. Pina, S., Buti, M., Jard\u00ed, R., Clemente-Casares, P., Jofre, J., Girones, R.,  2001. Genetic analysis \nof hepatitis A virus strains recovered from th e environment and from patients with acute \nhepatitis. Journal of General Virology 82, 2955\u20132963. Pina, S., Puig, M., Lucena, F., Cofre, J., Girones, R.,  1998. Viral pollution in the environment \nand in shellfish: human adenovir us detection by PCR as an index of human viruses. Applied and \nEnvironmental Microbiology 64, 3376\u20133382. Potasman, I., Paz, A., Odeh, M.,  2002. Infectious outbreaks associ ated with bivalve shellfish \nconsumption: a worldwide perspective. Clinical Infectious Diseases 35, 921\u2013928. Reuter, G., Krisztalovics, K., Vennema, H., Koopmans, M., Szucs, G.,  2005. Evidence of the \netiological predominance of norovirus in gast roenteritis outbreaks--emerging new-variant and \nrecombinant noroviruses in Hungary. Journal of Medical Virology 76, 598\u2013607. \nRodrick, G. E., Schneider, K. R.,  2003. Molluscan shellfish depuration. In: V illaboa, A., Reguera, \nB., Romalde, J., Reis, R., Proceedings of the 4th International Conference on Molluscan Shellfish Safety, Santiago de Compostela, Spain, 2002. Rodriguez-Manzano, J., Miagostovich, M., Hundesa, A., Clemente-Casares, P., Carratala, A., Buti, M., Jardi, R., Girones, R ., 2010. Analysis of the evolution in the circulation of HAV and \nHEV in eastern Spain by testing urban sewage samples. Journal of Water and Health 8, 346\u2013\n354. Romalde, J. L., Area, E., S\u00e1nchez, G., Ribao, C., Torrado, I., Abad, X., Pint\u00f3, R. M., Barja, J. L., Bosch, A.,  2002. Prevalence of enterovirus and hepatitis A virus in bivalve molluscs from \nGalicia (NW Spain): inadequacy of the EU standards of microbiological quality. International Journal of Food Microbiology 74, 119\u2013130. S\u00e1nchez, G., Pint\u00f3, R. M., Vanaclocha, H., Bosch, A.,  2002. Molecular characterization of \nhepatitis a virus isolates from a transcontinental shellfish-borne outbreak. Journal of Clinical Microbiology 40, 4148\u20134155. Siebenga, J.J., Vennema, H., Zheng, D.P., Vinj\u00e9, J., Lee, B.E., Pang, X.L., Ho, E.C., Lim, W., Choudekar, A., Broor, S., Halperin, T., Rasool, N.B., Hewitt, J., Greening, G.E., Jin, M., Duan, Z.J., Lucero, Y., O'Ryan, M., Hoehne, M., Schreier, E., Ratcliff, R.M., White, P.A., Iritani, N., Reuter, G., Koopmans, M.,  2009. Norovirus illness is a global problem: emergence and spread \nof norovirus GII.4 variants, 2001-2007. Journal of Infectious Diseases. 200, 802\u2013812. \nUeki, Y., Shoji, M., Suto, A., Tanabe, T., Okimura, Y., Kikuchi, Y., Saito, N., Sano, D., Amura, \nT., 2007. Persistence of caliciviruses in artificially contaminated oysters during depuration. \nApplied and Environmental Microbiology 73, 5698\u20135701. U.S. Food and Drug Administration,  2011. Pathogens from the harvest area, Chapter 4, In: Fish \nand Fishery Products Hazards and Controls Guidance, pp. 75\u201390. Vennema, H., de Bruin, E., Koopmans, M.,  2002. Rational optimization of generic primers used \nfor Norwalk-like virus detection by reverse transcriptase polymerase chain reaction. Journal of Clinical Virology 25, 233\u2013235. Verzani, J.,  2004. Using R for Introductory Statistics. Chapman & Hall/CRC. \n  WEB REFERENCES  Health Department in the Autonomous Community of Valencia  \nhttp://www.aesan.msc.es/AESAN/web/notas_pren sa/retirada_coquinas.shtml (last accessed Cap\u00edtulo IV: Estudio 6 \n \n 196February 20th 2012). \nMolecular Evolutionary Genetics Analysis (MEGA)  http://www.megasoftware.net/ (last \naccessed February 20th 2012). National Center for Biotechnology Information (NCBI)  http://blast.ncbi.nlm.nih.gov/Blast.cgi \n(last accessed February 20th 2012). R: A Language and Environment for Statistical Computing, R Development Core Team,  2008. \nISBN 3-900051-07-0, http ://www.R-project.org (last accessed February 20th 2012).  \nRapid alert system for food-borne outbreaks http://www.gencat.cat/salut/ac sa/html/es/dir3505/index.html \n(last accessed February 20th 2012).  024681012141618202224262830\n2003 2004 2005 2006 2007 2008Analyzed mussels by year\nNoV  G G II positi ve sam ples NoV  GG II negative samples \n024681012141618202224262830\n2003 2004 2005 2006 2007 2008Analyzed clams by year\nNo V GGII p o s it iv e s a mp le s No V GGII n eg at iv e s amp le s \n \nFig. 1.  Presence and absence of NoV GGII in mussel (A) and clam (B) batches collected in winter \nfrom markets and grocery stores (by ye ar) detected by semi-nested RT-PCR. \n A \nB   \nD00924 V  \nRussia \nAJ299464 IIIA  \nNorway \nAY644337 IIIA  \nGermany 999 \nAB258387 IIIB J apan \nAB279735 IIIB J apan 1000  779\nM20273 IB G ermany\nAF268396 IB Bra zil \nM14707 IB \nAustralia \nA 781 980 664\nAY644676 IIA  \nFrance \nAY644670 IIB \nUSA  994 \nB \nC 988 \nk0299 0 IA \nUSA  \nX75215 IA  \nGermany 861 \nAF357222 IA  \nChina \nAB020565 IA  \nJapan 875 \nX83302 IA  \nItaly 347 642 489 712800 \n \n \nFig. 2.  Constructed phylogenetic tree based on 247 bp of 5\u2019UTR (HAV) by the neighbour-joining \nmethod using D00924 (genotype V) as outgroup. A: positive clam subgenotype IB; B: positive \nclam subgenotype IA; C: positive clam subgenotype IA.   \n \nFig. 3.  Infected 293 cells with HadV isolated from the mussel HP by IFA. (A) 8th day of \ninfection, individual infected cells are detected, (B) Negative control. Cells stained with anti-mouse-IgG/FITC and with mountain medium DAPI.  \nA B  Table 1 \nOligonucleotide primer sequences and additional inform ation for enteric virus detection in shellfish samples \n \nPrimers*  Polarity  Position**  Sequence (5\u2019 \u20133\u2019) Annealing temperature  Length  \n \nHAV (5\u2019UTR) by nested RT-PCR \nHAV1  + 332\u2013352 TTGGAACGTCACCTTGCAGTG  55 \u00b0C  369 bp  \nHAV2  \u2013 680\u2013700 CTGAGTACCTCAGAGGCAAAC  \nneHAV1  + 371\u2013391 ATCTCTTTGATCTTCCACAAG  55 \u00b0C  291 bp  \nneHAV2  \u2013 641\u2013661 GAACAGTCCAGCTGTCAATGG  \n \nNoV GGI (RdRp) by semi-nested RT-PCR \nJV13I  \u2013 4858 \u20134878  TCATCATCACCATAGAAIGAG  37 \u00b0C  \n 327 bp  \nJV12Y  + 4552 \u20134572  ATACCACTATGATGCAGAYTA  \nG1 + 4691 \u20134707  TCNGAAATGGATGTTGG  37 \u00b0C 188 bp  \n \nNoV GGII (RdRp) by semi-nested RT-PCR \nJV13I  \u2013 4585 \u20134605  TCATCATCACCATAGAAIGAG  37 \u00b0C  \n 327 bp  \nJV12Y  + 4279 \u20134299  ATACCACTATGATGCAGAYTA  \nNoroII -R \u2013 4495 \u20134515  AGCCAGTGGGCGATGGAATTC  37 \u00b0C  237 bp  \n \nHAdV (Hexon) by qPCR \nADF + 18869 \u201318887  CWTACATGCA CATCKCSGG  60 \u00b0C  69 bp  \nADR  \u2013 18919 \u201318937  CRCGGGCRAAYTGCACCAG  \nADP + 18890 \u201318917  6-FAM -CCGGGCTCAGGTACTCCGAGGCGTCCT -BHQ1  \n \nHAV (5\u2019UTR) by qRT-PCR \nQHAVF  + 392\u2013410 GGTAGGCTACGGGTGAAAC  55 \u00b0C  89 bp  \nQHAVR  \u2013 461\u2013480 GCGGATATTGGTGAGTTGTT  \nQHAVP  + 413\u2013441 6-FAM -CTTAGGCTAATACTTCTATGAAGAGATGC -BHQ1  \n *HAV (nested RT-PCR) primer sets were earlier published by Pina et al. (1998), NoV GI and GII by Boxman et al. (2006), HAdV by H ernroth et al. (2002) and HAV \n(qRT-PCR) by Jothikumar et al. (2005a). **Primer positions ar e based on GenBank accession numbers: HAV (M14707), NoV GGI (M8766 1), NoV GGII (X86557) \nand HAdV (L19443). 5\u2019UTR:  5\u2019untranslated region; RdRp:  RNA-dependent RNA polymerase; 6-FAM:  6-carboxyfluorescein; BHQ1:  black hole quencher 1; Mixed \nbases in the primers:  Y=C/T, N=A/T/C/G, R=A/G, W= A/T, K= G/T, S= C/G, I=inosine.  Table 2 \nNorovirus GGII distribution in molluscan shellfish collected in winter from markets and grocery stores (2004-2008) detected by semi-nested RT-PCR  \nShellfish species National Imported \nMytilus galloprovincialis 15/87 (17.2%) 2/14 (14.3%) \nVenus gallina 0/27 (0.0%) 0/8 (0.0%) \nChamelea gallina 1/3 (33.3%) 1/12 (8.3%) \nTotal 16/117 (13.7%) 3/34 (8.8%) \n \nThe results are expressed as positive samples/analyzed samples (percentage of positive samples).   Table 3 \nPresence and quantitation of HAdV in mussels and seawater from commercial shellfish companies as analyzed by qPCR \n \nSample Treatment Pre-depuration Post-depuration \nP/A (%) Mean (SD) P/A (%) Mean (SD) \nMussels \n(GC/g HP) T1 5/8 (62.5) 1.64 x 102 (1.65 x 102) 5/8 (62.5) 1.93 x 102 (3.52 x 102) \nT2 6/8 (75.0) 7.05 x 101 (7.24 x 101) 5/8 (62.5) 3.01 x 101 (3.56 x 101) \nT3 3/4 (75.0) 6.80 x 101 (6.33 x 101) 2/4 (50.0) 1.23 x 102 (1.48 x 102) \nSeawater \n(GC/L) T1 2/4 (50.0) 1.50 x 103 (2.92 x 103) 3/4 (75.0) 1.98 x 102 (2.32 x 102) \nT2 3/4 (75.0) 1.16 x 102 (1.27 x 102) 3/4 (75.0) 1.30 x 103 (1.58 x 103) \nT3 0/4 (0.0) \u2013 0/4 (0.0) \u2013 \n \nT1: Ozone disinfection; T2: Protein skimmer venturi system; T3: Ozone-UV light disinfection; GC/g HP:  Genomic \ncopies/gram of hepatopancreas; GC/L:  Genomic copies/liter; P/A (%):  Positive samples/analyzed samples (percentage of \npositive samples); SD: Standard deviation.  Table 4 \nApplication of IFA and qPCR for the detection of HAdV in post-depurated shellfish samples. \n \nTreatment qPCR HAdV (GC/g HP) IFA HAdV (FFU/g HP) \nT1 2.10 x 102 3.25 x 100 \n7.60 x 101 ND \nT2 1.04 x 103 1.40 x 100 \n8.90 x 101 ND \nT3 2.99 x 102 1.65 x 100 \n1.94 x 102 ND \n \nGC/g HP:  Genomic copies/gram of hepatopancreas; FFU/g HP: Focus-forming \nunits/gram of he patopancreas; T1: Ozone disinfection; T2: Protein skimmer venturi \nsystem; T3: Ozone-UV light disinfection; ND: not detected. \n  \n \n    \n \n \n   \n \n \nCap\u00edtulo V \n \n Desarrollo de un modelo matem\u00e1tico \npara la valoraci\u00f3n cuantitativa del \nriesgo de infecci\u00f3n y enfermedad por \nnorovirus asociado al consumo \nde marisco  Cap\u00edtulo V: Estudio 7 \n 207 \nINTRODUCCI\u00d3N   Infecciones producidas por NoV humanos se han atribuido recurrentemente al \nconsumo de moluscos bivalvos. Las ostras son co ntaminadas por part\u00edculas v\u00edricas a causa de la \nfiltraci\u00f3n de agua contaminada, de manera que  retienen dichas part\u00edculas incluso despu\u00e9s de \nla aplicaci\u00f3n de procesos de depuraci\u00f3n. Apro ximadamente un 5% de las ostras cultivadas en \nHolanda presentan contaminaci\u00f3n por NoV humanos, incluso aquellas que cumplen con la \nvigente legislaci\u00f3n europea. Actualmente se desconoce la magnitud del impacto que estas \ninfecciones por NoV tienen a nivel de salud p\u00fablica, dificult\u00e1ndose as\u00ed la interpretaci\u00f3n de los datos obtenidos a partir de los programas establ ecidos para la detecci\u00f3n de NoV en moluscos \nbivalvos, y m\u00e1s concretamente, en ostras.   Los an\u00e1lisis de riesgo microbiol\u00f3gico so n un componente emergente dentro del \u00e1mbito \nde la microbiolog\u00eda y la seguridad alimentaria, y r\u00e1pidamente est\u00e1n acumulando reconocimiento como la metodolog\u00eda m\u00e1s pr\u00e1ctica para valorar el riesgo microbiol\u00f3gico asociado con productos alimenticios. Actualmente, los an\u00e1lisis de riesgo cuantitativo est\u00e1n siendo utilizados para establecer est\u00e1ndares, gu\u00edas y recomendaciones acerca de la seguridad alimentaria y la salud del consumidor. La evalua ci\u00f3n de riesgos es una herramienta \u00fatil para \nobtener informaci\u00f3n acerca de las probabilidades de infecci\u00f3n, enfermedad y los potenciales puntos de intervenci\u00f3n para su prevenci\u00f3n. El obje tivo del estudio aqu\u00ed de scrito consiste en la \nmodelizaci\u00f3n matem\u00e1tica y aplicaci\u00f3n del modelo desarrollado para evaluar el riesgo de \ninfecci\u00f3n y enfermedad por NoV asociado al cons umo de ostras. Para lograr dicho objetivo y \ncomo modelo de estudio, se ha evaluado cu antitativamente la presencia de NoV en dos \nescenarios diferentes: (i) ostras cultivadas en  \u00e1reas de producci\u00f3n tipo A localizadas en \nHolanda (2008) y (ii) un brote de gastroenteritis que tuvo lugar en un peque\u00f1o n\u00facleo familiar holand\u00e9s (2004).  RESUMEN ESTUDIO 7: \n \nQuantitative risk assessment for human norovirus infection due to oyster consumption  Rodriguez-Manzano J, Bouwkneg t M, van den Berg HH, Teunis PF, de Roda Husman AM \n \nManuscrito preparado para su sumisi\u00f3n a Risk Analysis . 2012 Cap\u00edtulo V: Estudio 7 \n 208RESULTADOS Y DISCUSI\u00d3N \n  La exposici\u00f3n a NoV debido al consumo de ostras ( D) depende de (i) n\u00famero de NoV \ninfecciosos en las ostras en el momento del consumo ( C\ncons) y (ii) n\u00famero de ostras consumidas \npor persona ( N) de acuerdo con la siguiente ecuaci\u00f3n: \n \nD = C cons x N \n  Al mismo tiempo, C\ncons depende de (i) n\u00famero de NoV infecciosos por ostra en el \nmomento de la recolecci\u00f3n ( Charv), (ii) eliminaci\u00f3n de NoV durante los procesos de depuraci\u00f3n \n(sdep), (iii) la tasa de inactivaci\u00f3n decimal de NoV por d\u00eda ( \u03b4), (iv) tiempo transcurrido entre la \nrecolecci\u00f3n y el consumo ( t), (v) eficiencia de recuperaci\u00f3n para NoV ( R), (vi) l\u00edmite de \ndetecci\u00f3n de la RT-qPCR ( \u03bb), y (vii) fracci\u00f3n de NoV infeccios os por ostra (\u03c6) de acuerdo con la \necuaci\u00f3n que sigue a continuaci\u00f3n:  \nC\ncons =  C harv x s dep x 10\u03b4xt x (1/R) x \u03bb x \u03c6 \n  La estimaci\u00f3n de C\ncons se obtuvo mediante una simu laci\u00f3n de Monte Carlo (10.000 \nr\u00e9plicas) a partir de una distribuci\u00f3n gama aplicada al modelo matem\u00e1tico desarrollado. \n  Norovirus GGII fue detectado en un 6,3% (4/63) de las ostras recolectadas en el estuario de Oosterchelde (norte de Holanda), con una concentraci\u00f3n estimada de 7 PDU/ostra, \nmientras que 33% (3/9) de las ostras procedentes del brote infeccioso fueron positivas, mostrando una concentraci\u00f3n de 17 PDU/ostra. El  tama\u00f1o promedio de ostras servidas en 25 \nrestaurantes fue de 6 ostras por comensal, oscilando entre 5 y 12 ostras. El riesgo de infecci\u00f3n \nasociado fue del 33%, variando entre un 8,4 \u2013 49%  en funci\u00f3n del n\u00famero de ostras consumida \n(1 \u2013 20 unidades). La probabilidad de encontrar una ostra contaminada al consumir 6 ostras es del 29%. Para el escenario del br ote infeccioso, el riesgo de infecci\u00f3n tras ingerir 6 ostras se \nestim\u00f3 en un 51%, oscilando entre un 47 \u2013 54% en relaci\u00f3n a una ingesti\u00f3n de 1 \u2013 20 ostras, \nrespectivamente. Las probabilidades de enfe rmedad asociadas a estas probabilidades de \ninfecci\u00f3n fueron calculadas a partir de la funci\u00f3n de dosis-respuesta. Para las muestras del estuario, la probabilidad de enfermar tras se r infectado fue de un 11% , oscilando entre 0,7 \u2013 \n27%. Para el brote, la probabilidad de enfermar se estim\u00f3 en un 31%, oscilando entre 21 \u2013 36%. Se realizaron an\u00e1lisis de sensibilidad para estimar el efecto que la recuperaci\u00f3n de part\u00edculas v\u00edricas tiene sobre las probabilidad es de infecci\u00f3n y enfermedad calculadas. Cap\u00edtulo V: Estudio 7 \n 209CONCLUSIONES \n  El riesgo estimado de infecci\u00f3n por NoV GGII al consumir seis ostras, el n\u00famero promedio de unidades servidas en los restaurant es holandeses, es de un 33% para las ostras \nconsumidas en el estuario de Oosterchelde y de  un 51% para el escenario del brote que tuvo \nlugar dentro del n\u00facleo familiar, mientras que el riesgo estimado de enfermedad tras ser infectado es de un 11% y 33%, respectivamente. A la  hora de realizar el modelo de an\u00e1lisis de \nriesgo se han identificado importantes lagunas, tales como la eficiencia de recuperaci\u00f3n, el \nl\u00edmite de detenci\u00f3n de la RT-qPCR y la variaci\u00f3n en la concentraci\u00f3n de NoV entre las diferentes \u00e1reas de producci\u00f3n de marisco (A \u2013 C). Disponer de dicha informaci\u00f3n resultar\u00e1 \nesencial para la realizaci\u00f3n de futuros an\u00e1lisis. Nuevos datos de la presencia de NoV obtenidos a partir de an\u00e1lisis de RT-qPCR pueden ser f\u00e1cilmente implementados en el modelo aqu\u00ed \ndesarrollado, estimando as\u00ed el riesgo asociado para salud p\u00fablica en otros pa\u00edses/regiones.  Cap\u00edtulo V: Estudio 7 \n 211QUANTITATIVE RISK ASSESSMENT FOR HUMAN NOROVIRUS INFECTION DUE TO OYSTER \nCONSUMPTION  Jesus Rodriguez-Manzano,\n1,2 Martijn Bouwknegt,2* Harold H. J. L. van den Berg,2 Peter \nTeunis,3,4 and Ana Maria de Roda Husman2 \n \n1Department of Microbiology, Faculty of Biology, University of Barcelona, Barcelona, Spain; \n2Laboratory for Zoonoses and Environmental Mi crobiology, Centre for Infectious Disease \nControl Netherlands, National Institute for Public  Health and the Environment, Bilthoven, The \nNetherlands; 3Epidemiology and Surveillance Unit, Centre for Infectious Disease Control \nNetherlands, National Institute for Public Health and the Environment, Bilthoven, The Netherlands;\n 4Hubert Department of Global Health, Rollins School of Public Health, Emory \nUniversity, Atlanta, Georgia, United States of America. \n \n*Corresponding author.  Mailing address: Laboratory for Zoonoses and Environmental \nMicrobiology, Centre for Infectious Disease Control, National Institute of Public Health and the Environment, P.O. Box 1, NL-3720 BA Bilthoven, The Netherlands. Phone: +31 302743272. Fax: +31 302744434. E-mail address: martijn.bouwknegt@rivm.nl  (Martijn Bouwknegt).  Key words:  norovirus, oysters, risk assessment, infe ction, illness \nRunning title:  QMRA of noroviruses in oyster fr om harvesting area and outbreak Cap\u00edtulo V: Estudio 7 \n \n 212ABSTRACT \n Human noroviruses (HuNoVs) currently belong  to the most important human foodborne \npathogens and HuNoV illness has been attributed to oyster consumption, but inference on public health risks is missing. A quantitative ri sk assessment model was developed to estimate \nthe risks of infections and illness due to consum ption of oysters. The model was fed with data \non HuNoVs in oysters collected from harvesting  areas and a family outbreak. Four out of 63 \noysters (6%) were positive for HuNoV by re al-time quantitative RT-PCR (RT-qPCR) and a \ndistribution of the HuNoV-concentration was cons tructed with a mean of 7 (95% interval: 0-\n77) PCR-detectable units (PDU) per oyster. Assuming the efficiency of recovery of HuNoV from \noysters is 100%, and a negligible inactivation rate between the moment of harvest and \nconsumption, the estimated probability of HuNoV infection and illness ranged from 0.08 to 0.50 and 0.01 to 0.27, respectively, for consuming 1 to 20 oysters. Additionally, nine oysters associated with a family outbreak were examined for HuNoVs, and four were positive (44%). A \ndistribution of the HuNoV-concentration was cons tructed with a mean of 17 (95% interval: 4-\n45) PDU. The estimated probability of HuNoV infection and illness using these RT-qPCR data ranged from 0.47 to 0.54 and 0.21 to 0.36 per consumption event (1 to 20 oysters), respectively. The developed model could be used  to set health targets for the contamination \nof shellfish with HuNoVs. Furthermore, RT-qPC R data from other batc hes of oysters can be \nimplemented in the model to estimate the associated public health risks.  INTRODUCTION  \nNoroviruses (NoVs) are members of the Norwalk-like virus genera within the Caliciviridae  \nfamily. The virus is 27 nm in diameter, non-enve loped and contains a positive sense, single-\nstranded RNA genome of 7.8 Kb to 8.3 Kb in length, excluding the polyA tract (16). Five \ngenogroups (GI-GV) and 29 genotypes are distin guished, and human NoV (HuNoV) infections \nare known to be caused by ge nogroups GI, GII and GIV (41). \n Human NoV, together with hepatitis A virus, are currently considered as two of the most important human foodborne pathogens with rega rd to the number of outbreaks and people \naffected in the Western world (7, 23). In the US, HuNoVs have been estimated to cause 23 million of human cases and 50,000 hospitalizatio ns annually (32). In The Netherlands, HuNoVs \nwere found to be the causative ag ent for 78% of 941 investigated  gastroenteritis outbreaks in Cap\u00edtulo V: Estudio 7 \n 213the period 1994 - 2005 (42). \n Human NoV infections have been attributed re currently to the consumption of raw molluscan \nshellfish (2, 36). Oysters become virally contaminated by filtering faecally contaminated ( e.g. \nby sewage discharge) water and thereby concentrating viruses (45). Oysters can retain those viruses throughout the depuratio n process (29). About 5% of oy sters harvested in Japan and \nThe Netherlands, and 10.5% of oysters imported into Hong Kong from 11 countries were found to contain HuNoVs (4, 6, 35). Furthermore, oysters that are considered safe to consume due to compliance with the European microbiological safety legislation (based on Escherichia coli  \nlevels) can be contaminated by HuNoVs and ma y cause infection in humans after consumption \n(27). The magnitude of adverse public health e ffects caused by the presence of HuNoVs in \noysters is currently unknown. This ignorance hamp ers the meaningful interpretation of results \nfrom screening programs focused on the detection of HuNoVs in oysters. \n Quantitative microbial risk analysis is an emerging component of the field of microbial food safety and it is rapidly accumulating recognition as the most practical method for assessing the risks associated with microbial contamination of  foodstuffs (48). Quantitative risk assessment \ntoday is applied for establishing standards, guidelines and other recommendations regarding \nfood safety and consumer health. Risk assessment is a valuable tool for yielding information \nabout probabilities of infection and illness, and possible reduction thereof by intervention. Thus quantitative risk assessment models can support the health protection of shellfish consumers. The aim of the current study was to  develop and apply such a model for norovirus \ninfection and illness due to oyster consumption. To this end, oysters that were harvested in The Netherlands in 2008 were examined quantitatively for HuNoV and the data were used to predict the associated risk of infect ion and illness due to consumption. \n \nMATERIAL AND METHODS  Oysters from Oosterschelde Estuary (screening).  In 2008, a total of 63 Japanese oysters \n(Crassostea gigas ) were collected by monthly sampling from a commercial harvesting area in \nthe Oosterschelde Estuary, located in the southwest of The Netherlands. The oysters were tested individually for the presence of HuNoVs by real-time reverse transcription polymerase \nchain reaction (RT-qPCR).  Oysters from household outbreak (outbreak case). Nine oysters from the same batch of Cap\u00edtulo V: Estudio 7 \n \n 214oysters that was associated with a small household outbreak of HuNoV in The Netherlands, in \nDecember 2004, were obtained at the same local store as a household member did. The oysters were tested individually by RT-qPCR. Tw o persons in a household of three became ill \nafter consumption of six oysters. After an inc ubation period of 24 h, the woman experienced \nmostly nausea and vomiting, whereas the male  patient had abdominal cramps and diarrhea. \nThe child had not eaten any oysters and did not get ill (10).  Oyster processing. Oyster shells were opened manually us ing a sterile oyster knife. After \nopening, the oyster was transferred to a Petri dish. The digestive glands were chopped with a razor blade and transferred into a centrifuge t ube. An equivalent volume of Proteinase K \nsolution (30u/mg) (Roche Diagnostics Neth erlands, Almere, The Netherlands) was added \nfollowed by incubation at 37\u00b0C for 60 min. A second Proteinase K incubation was carried out at 65\u00b0C for 15 min prior to centrifugation at 3,000 g for 5 min as described previously (21). From \nthe supernatant, 500 \u03bcL was subjected to magnetic RNA extraction.  RNA extraction and HuNoV (GI and GII) RT-qPCR.  RNA was extracted using NucliSens \nmagnetic silica particles (bioM\u00e9rieux, Boxtel, The Netherlands) according to the instructions of the manufacturer. Nucleic acids were recovered from the particles during a 5 minute incubation period at 60\u00b0C, using 50\u03bcL elution buffer (37). HuNoV GI RNA was tested using a RT-qPCR with the primers QNIF4 and NV1LCR, and probe NVGG1p (9, 42) and HuNoV GII RNA was detected using the primerset QNIF2/COG2R and probe QNIFS (22, 28). The detection of RNA \nwas performed on neat RNA samples and 10-fold serially diluted RNA samples. \n \nVirus.  As a positive extraction control 100 \u03bcL of HuNoV G II.4, obtained from a fecal sample, \nwas used. RNA was extracted from a 10% fecal suspension that tested positive up to the 10\n5 \ntenfold dilution using RT-qPCR.  Risk Assessment The risks of infection (invasion by and multiplication of pathogenic microorganisms in a bodily part or tissue) and risk  of illness (the condition of being sick) were assessed for two scenarios, \nthe first being based on the HuNoV-concentration from the cross-sectional screening of oysters, and the second on data from a small fam ily outbreak with two cases that occurred in \n2004 in The Netherlands.   Cap\u00edtulo V: Estudio 7 \n 215Exposure assessment.  Exposure to HuNoV due to oy ster consumption depends on ( i) the \nnumber of infectious HuNoVs in the oy sters at the time of consumption ( Ccons) and ( ii) the \nnumber of oysters cons umed per person ( N) according to equation (1):  \n N C Dcons\u00d7=  (1) \nThe Ccons depends on ( i) the number of infectious HuNoVs pe r oyster at the moment of harvest \n(Charv), (ii) the removal of HuNoVs during depuration (s dep), (iii) the decimal inactivation rate of \nHuNoVs per day ( \u03b4), (iv) the time period between harvest and consumption ( t), (v) the \nefficiency of the recovery procedures for HuNoV ( R), (vi) the detection limit of the RT-qPCR ( \u03bb), \nand ( vii) the fraction of infectious HuNoVs per oyster ( \u03c6) as described by equation (2): \n Rs C\nCt\ndep harv\ncons\u03d5\u00d7\u03bb\u00d7\u00d7\u00d7\n=\u00d7\u03b4\u221210\n (2) \nEstimates of Ccons were obtained by taking 10,000 Monte Carlo samples from a gamma \ndistribution in the model using Mathematica 6 (Wolfram Inc.). \n Estimation of HuNoV genome concentration at harvest ( C\nharv). The dichotomous outcome of \nthe RT-qPCR (positive/negative) of each sample (neat and 10-fold diluted) was used to estimated by means of maximum likelihood the shape and scale parameter of a gamma distribution. This gamma distri bubtion described the estimated concentration of HuNoVs in \noysters. This approach uses the fundamental  concepts of Most Probable Number (MPN) \nestimation, as described (49). One distribution was created for all oysters, meaning that each oyster was considered to be contaminated albeit the majority at very low levels. This assumption was valid to the authors, because each oyster is exposed to sewage discharge and therefore all the oysters are potentially contaminated in a similar manner. As HuNoV detection in oysters was done on only a small portion of the oyster, low-level contamination may be missed by chance (i.e., virus is present in the oyster, but by chance not in the examined \nportion). \n Efficiency of the recovery methods ( R). The recovery values for HuNoV detection in oysters \nare unknown. These values may be highly variable between oysters from the same location and between oysters from different locations and time periods. Therefore, the recovery value used in the baseline risk assessment was as sumed to be 100%, and the effect of lower \nrecoveries was evaluated as part of the sensitivity analysis.  Detection limit ( \u03bb). The sensitivity for the RT-qPCR used  in the current study is unknown. \nReported sensitivities for HuNoV detection in shellfish ranged from 1 up to 10\n2 genomes per Cap\u00edtulo V: Estudio 7 \n \n 216gram of sample applying different protocols ( 24, 34, 47). To estimate the risk for HuNoV \ninfection due to oyster consumption a detection limit of 1 PCR detectable unit (PDU) was used \nin the current study.  Removal by depuration ( S\ndep). All the oysters used in this study originated from an A-classified \narea according to European legislation (less than 230 Escherichia coli  per 100 g of oyster meat \nand intravalvular liquid, and absence of Salmonella in 25 g of mollusc flesh). These oysters can be harvested and marketed directly for huma n consumption (1). Thus , depuration would not \nhave been applied to the oysters obtained in the screening in the current study and therefore \nvirus reduction by depuration was not considered further. \n \nInactivation rate of HuNoV ( \u03b4). The inability to grow NoV in cultured cells has hampered \nstudies on the inactivation rate (12, 13). However, related caliciviruses, including murine norovirus (MNoV) and feline calicivirus (FCV ) can be cultured (5, 50). Studies show an \ninactivation rate of FCV lower than 1 log\n10 in two weeks in cell culture medium (12) and <1 \nlog 10 reduction for MNoVs after 40 days of incubation in a stool suspension (25), both assays at \n4\u00b0C. Assuming these rates also apply to HuNoVs, and considering oysters are stored at temperatures of 4\u00b0C to 7\u00b0C (as advised by Shellfish Control Authorities for a few days because of rapid marketing of harvested oysters), in activation was assumed not to affect the HuNoV \nconcentration between harvest and consumption.  Fraction of infectious HuNoV per oyster ( \u03c6). RT-qPCR detects both in fectious and defective \nvirus particles, with the infectious viruses being a fraction of all genomes detected. This \nfraction, however, is undetermined due to the inab ility to grow NoV in cell cultures and \nhampers translation of the number of detected genomes into the number of infectious NoV. \nHowever, the dose-response relation that was used to determine the infection risk is also based on RT-qPCR detected genomes (43). Accepting that the fraction of infectious HuNoVs among the HuNoVs PDU are compar able between the studies, which is likely considering the \nsame detection procedure was used, the parameter \u03c6 was given the value of unity. \n Consumption.  The average number of oysters consumed  per person in this study was assessed \nby doing a web survey of 25 menus from differe nt restaurants in The Netherlands regarding \nthe size of oyster servings. The web sites of  the restaurants were fo und via Google. Moreover, \nprevious studies have recorded average numbers  of oysters consumed per serving or used Cap\u00edtulo V: Estudio 7 \n 217nominal serving sizes of 13.8 oysters, 110 g, 196 g and 240 g (approximately 8 to 10 oysters) \n(30). As part of the sensitivity analysis, the risk  of infection was estimated for consumption of 1 \nto 20 oysters. Each oyster within a serving was randomly attributed a HuNoV-concentration from the distribution of C\nharv. \n Dose-response relation. Teunis et al. (43) desc ribed a dose response relation to estimate the \nprobability of infection and the conditional probability of illness given infection. Both models were applied to the doses estimated in the current study.   The probability of infection per infectious HuNoV particle as a function of the dose can be written as (43):  \n f ( D; \u03b1, \u03b2) = 1 \u2013 \n1F1(\u03b1, \u03b1 + \u03b2; \u2212D) \nwhere D represents the number of viruses ingested  during oyster consumption, parameters \u03b1 \nand \u03b2 characterize the infectivity and 1F1 represents a confluent hype rgeometric function (43). \n The dose response relation for the conditional probability of illness in an infected subject was calculating using the next formula (43). \nh (D\u2502\u03b7, r) = 1 \u2013 (1 + \u03b7 D) \u2013r  \nwhere \u03b7 and r were described in a previous study (44). \n RESULTS  HuNoVs in oysters.  Human NoV GII RNA was detected in fo ur of the 63 oyster samples (6.3%) \nfrom the Oosterschelde Estuary by RT-qPCR. Three samples tested positive in the neat RNA solution and negative in the 10-fold dilution. One sample tested positive in the neat and 10-\nfold diluted RNA solution. These data yielded an estimated average HuNoV concentration in \noysters of 7 PDU per oyster (Median = 0; 95% interval: 0 \u2013 77) (Figure 1).  Three out of the nine samples collected retrospectively after a household outbreak was observed tested positive for HuNoV GII RNA. All three oysters tested positive in the neat RNA \nonly. These data yielded an estimated HuNoV co ncentration in oysters of 17 PDU per oyster \n(Median = 14; 95% interval: 4 \u2013 45) (Figure 2).  Human NoV GI RNA was not detected in any an alyzed oyster, from Oosterschelde Estuary \nneither household outbreak. Cap\u00edtulo V: Estudio 7 \n \n 218Public health implications.  The public health risk estimates are summarized in Table 1. The \naverage size of a serving in the 25 Dutch restaurants was six (range: 5 - 12). The average number of ingested HuNoV PDU for a serving of six oysters was 37 (median: 7, 95% interval: 0 \n\u2013 252). The associated probab ility of infection was estimated to be 33% (95% interval: 0 \u2013 74), \nranging from 8.4% to 49% for the consumption of 1 - 20 oysters, respectively. The probability of eating a HuNoV-contaminated oyster in a serving of six equalled 29%. The probability of infection conditional on the presence of at least one HuNoV-contaminated oyster within the serving was estimated to be 45% (95% interval: 7 \u2013 75).  For the outbreak scenario, the risk of infect ion due to the consumption of six oysters was \nestimated to be 51% (95% interval: 25 \u2013 76). The risk of infection ranged from 47% to 54% for \nthe consumption of either a single or 20 oysters from the batch, respectively. The risk of the \ntwo household members becoming infected after  consuming six oysters from the respective \nbatch was estimated to be 28%.  The probability of illness given infection was calculated from the estimated HuNoV dose using an illness dose response function (43). For the monitoring data, the probability of becoming ill when individuals are infected after consuming six oysters was 11% (95% interval: 0 \u2013 50), ranging from 0.7% to 27% for the consumption of 1 - 20 oysters. For the outbreak data, the probability of illness upon infection was 31% (95% interval: 23 \u2013 56), ranging from 21% to 36% for the consumption of 1 - 20 oysters (Figure 3 and 4). Comparison of the probabilities of infection between both scenarios is represented in Figure 5.  \nSensitivity analysis.  The effect of HuNoV recovery for the RNA extraction and HuNoV \ndetection on the probability of infection due to oyster consumption was assessed by \nconsidering the ingestion of 6 oysters. The probability of infection varied from 37% (40% of recovery) to 33% (100% of recovery) for the monitoring data, and from 54% (40% of recovery) to 51% (100% of recovery) for the outbreak data.  DISCUSSION  \n Oysters can be contaminated by  HuNoV and thereby pose a foodborne health risk to humans \n(6). Quantitative Microbial Risk Assessment can be a useful tool to estimate the infection risk from for instance HuNoV counts in oysters (17, 18). In the current study a quantitative risk Cap\u00edtulo V: Estudio 7 \n 219assessment model was developed. Cr oss sectional data on HuNoVs in oysters was obtained, as \nwell as HuNoV counts in shellfish from the same ba tch of shellfish that was associated with a \nsmall ( n=2) household outbreak. \n The risk of infection due to the consumption of  six oysters was estimated to be 33% based on \nthe data from oysters harvested in the Oosterschelde Estuary. In the Netherlands, with 16.5 million inhabitants (40), Dutch food consumpt ion survey showed that one individual among \n6,270 individuals had consumed oysters on one of the two days of the survey (14). Assuming these two days are representative for an entire year, this finding would indicate a total of about 500,000 consumption events per year. Based on  the risk of infection presented in this \npaper, about 150,000 HuNoV infections per year would be caused by oyster consumption. Of \nthese, about 50,000 are estimated to become ill due to oyster consumption. Data from \nliterature for 1996 to 1999 showed an incidenc e of around 128.000 gastroenteritis cases per \nyear in the Netherlands (11). Considering that 5% of the total gastroenteritis are originated by HuNoVs (11), 12-17% are foodborne (8) and 12% of these cases are linked to oyster consumption (8), there would be around 90-130 case s of gastroenteritis per year due to oyster \nconsumption in The Netherlands. The difference in outcomes between the two studies may be explained by failure of infected persons to seek  medical attention, leading to an underestimate \nof number of ill persons.  Here, the infection risk was estimated from the ingested HuNoV dose. Heterogeneity among hosts with respect to susceptibility to HuNoV infections was taken into account, because of the probability of individual organism to achieve an infection was modeled as a beta distribution (43). However, genetic susceptibility and acquired immunity for HuNoV infection and illness were not taken into account. Although HuNoV is  highly infectious, volunteer studies have \nshown that some subjects remain uninfected ev en after challenge with high doses (20, 31). \nHuman ABH histo-blood group antigens a nd the secretor phenotype may influence \nsusceptibility to HuNoV, although it is not clear whether these volunteers remain disease-free because of innate resistance or  because of pre-existing immunity (26). The individuals that \nexperienced a HuNoV-infection acquire short te rm immunity (51). Previous studies have \nshown that most raw oyster consumers were ma le, young or middle-aged adults, persons of \nhigh socioeconomic status, and persons from spec ific ethnic groups are more likely to eat raw \noysters than others (3, 38). These considerations may affect the immune response against HuNoV infections of the consumers and therefore, the final risk estimation. If more data become available with respect to distribution of  immunities in the population these could be Cap\u00edtulo V: Estudio 7 \n \n 220fed into the risk assessment. \n The currently estimated risks based on the envi ronmental survey used data from 63 oysters \ncollected in the Oosterschelde. The HuNoV-findings for these oysters were assumed to represent the level of HuNoV-contamination of all oysters consumed in The Netherlands. However, different harvesting areas exist, likely with different influxes of sewage discharge \n(46) and thus with different probabilities of  HuNoV contamination. Furthermore, oysters \nconsumed by the Dutch population are partly im ported and imported oy sters were not part of \nthe 63 oysters examined (10). If the variation between harvesting areas is greater than the variation within a single harvesting area, then  the distribution of HuNoV concentrations is \nexpected to show more variation. This would have increased the 95% uncertainty intervals of \nthe infection and illness risks thus resulting in more uncertainty in the risk outcomes.  The assessed risks could be underestimated due to the assumption of a 100% recovery. In \npractice, such a recovery is unlikely to be achieved because viral contamination levels in shellfish are often relatively low and because sh ellfish contain compounds that interfere with \nRT-qPCR (33, 39).  In addition, it was assumed that 1 PDU represents one infectious unit. \nHowever, because of cell culture methods are not available for quantifying infectious HuNoV, one PDU represents an unknown quantity of infectious units. These aspects likely resulted in underestimation of the HuNoV-cont amination level of oysters reflected by the relatively low \nprobability of 28% that both individuals in the outbreak setting were infected by HuNoV, and an even lower probability of both individuals becoming ill. Improved diagnostic methods and proper estimates for the recovery and detectio n limits for HuNoV from oysters could improve \nthe accuracy and decrease the uncertainty of the estimated risks. \n The total number of people infected as a result of consuming HuNoV contaminated oysters will \nlikely be increased through seco ndary person to person transmission (19). When an initial \ninfection occurs in a person eating oysters, secondary and tertiary waves of infection may \noccur due to interperson transmission. Hence, the total number of infected persons due to \nconsumption of oysters may be larger than es timated in the current study. Such secondary \ntransmission depends strongly on prevaili ng (hygiene) condition s (19). Consequently, \ndecreasing the HuNoV contamination levels of oysters might have an impact also on individuals that do not consume oysters.  Cap\u00edtulo V: Estudio 7 \n 221In a recent study (30), the corre lation between the extent of HuNoV contamination in oysters \nand the consequential risk to  human health was evaluated by comparing self-reported \ncustomer illness with counts of HuNoVs in consumed oysters. The presence of HuNoV PDU showed a statistically significant association wi th self-reported illness complaints, suggesting \nthat absence of HuNoV RNA in oyster batches can be considered a reliable indicator of low \nhealth risk (30). Nevertheless, the current study showed that also when HuNoV PDU is \ndetected, the infection risks will  depend on the count of HuNoV and on the number of oysters \nconsumed. Hence, doing quantitative risk estimati on after HuNoV detection will give valuable \ninformation for the public health risks.  In conclusion, the estimated risk for HuNoV in fection when consuming six oysters, the number \nserved in Dutch restaurants was estimated to be 33% for oysters from Oosterschelde Estuary \nand 51% for oysters from the household outbreak . The associated risks of illness were 11% and \n31% for each scenario, respectively. Important data gaps that were identified include the efficiency of recovery of HuNoVs, the detection limit of the RT-qPCR, and the variation in HuNoV concentration between different (nationa l and international) harvesting areas and \ndifferently classified harvesting areas (A-C). Fil ling these data gaps would improve future risk \nassessments regarding HuNoV. The developed mode l could be used for setting health targets \nfor contamination levels of shellfish with Hu NoVs. Furthermore, RT-qPCR data from other \nbatches of oysters can be easily implemented in the model to estimate the associated public health risks for other countries than The Netherlands.  ACKNOWLEDGMENTS  This research was supported by the Ministry  of Education and Science of the Spanish \nGovernment (project AGL2005-07776-C03-02) and the \u201cGrup de Recerca Consolidat de la \nGeneralitat de Catalunya\u201d (2005SGR00592). During the development of this study, Jes\u00fas Rodr\u00edguez Manzano received a pr e-doctoral fellowship of Ministry of Education and Science. \n REFERENCES  1. Anonymous. 1991. Council directive laying down the health conditions for the production \nand the placing on the market of live bivalve molluscs. 91/492/EEC. Offic. J. Eur. Communities L268: 1\u201314.  \n2. Ahmed, F. E. 1992. Review: assessing and managing ri sk due to consumption of seafood \ncontaminated with micro-organisms parasites and natural toxins in the US. International Cap\u00edtulo V: Estudio 7 \n \n 222Journal of Food Science Technology 27:243\u2013260. \n3. Altekruse, S. F., S. Yang, B. B. Timbo, and F. J.  Angulo. 1999. A multi-state survey of \nconsumer food-handling and food-consump tion practices. Am. J. Prev. Med. 16:216\u2013221. \n4. Boxman, I. L., J. J. Tilburg, N. A. Te Loeke, H. Vennema, K. Jonker, E. de Boer, and M. \nKoopmans. 2006. Detection of noroviruses in shellfish in the Netherlands. Int. J. Food \nMicrobiol. 108: 391\u2013396. \n5. Buckow, R., S. Isbarn, D. Knorr, V. Heinz, and A.  Lehmacher. 2008. Predictive model for \ninactivation of feline calicivirus, a noroviru s surrogate, by heat and high hydrostatic \npressure. Appl. Environ. Microbiol. 74:1030\u20131038. \n6. Cheng, P. K., D. K. Wong, T. W. Chung, and W. W.  Lim. 2005. Norovirus contamination \nfound in oysters worldwide. J. Med. Virol. 76:593\u2013597. \n7. Cliver, D.O.  1997. Virus transmission via food. World Health Stat. Q. 50:90-101. \n8. Codex Alimentarius Commission.  2005. Discussion paper on the viruses in food. In Codex \nCommittee on Food Hygiene, 37st session, Buenos Aires, Argentina. \n9. da Silva, A. K., J. C. Le Saux, S. Parnaudeau, M. Pommepuy, M. Elimelech, and F. S.  Le \nGuyader. 2007. Evaluation of removal of noroviruses during wastewater treatment, using \nreal-time reverse transcription-PCR: different  behaviors of genogroups I and II. Appl. \nEnviron. Microbiol. 73:7891\u20137897. \n10. de Roda Husman, A. M., F. Lodder-Verschoor, H. H. van den Berg, F. S. Le Guyader, H. van \nPelt, W. H. van der Poel, and S. A.  Rutjes. 2007. Rapid virus detection procedure for \nmolecular tracing of shellfish associated with disease outbreaks. J. Food Prot. 70:967\u2013974. \n11. de Wit, M. A., M. P. Koopmans, L. M. Kortbeek, N. J. van Leeuwen, A. I. Bartelds, and Y. T.  \nvan Duynhoven. 2001. Gastroenteritis in sentinel general practices, The Netherlands. \nEmerg Infect Dis. 7:82\u201391. \n12. Duizer, E., P. Bijkerk, B. Rockx, A. De Groot, F. Twisk, and M.  Koopmans. 2004. \nInactivation of caliciviruses. Appl. Environ. Microbiol. 70:4538\u20134543. \n13. Duizer, E., K. J. Schwab, F. H. Neill, R. L. Atmar, M. P. Koopmans, and M. K. Estes. 2004. \nLaboratory efforts to cultivate noroviruses. J. Gen. Virol. 85:79\u201387.  \n14. Hulshof, K. F. A. M., C. Kistemaker, and M. Bouman. 1998. [De consumptie van \nafzonderlijke producten door Nederlandse bevolkingsgroepen: Voedselconsumptiepeiling 1997\u20131998] in Dutch. Rep. V 98.812. TNO Voeding, Zeist, The Netherlands.  \n15. Fazil, A. M.  2005. A primer on risk assessment modelling: focus on seafood products. Food \nand Agriculture Organization of the United Nations. FAO Fish. Tech. Pap. 462: 1\u201355.  \n16. Green, K., R. C hanock, and A.  Kapikian. 2001. Human caliciviruses, p. 841-874. In D.M. \nKnipe & M.M. Howeley (ed.), Fields virology. 4th ed., vol.1. Lippincott-Raven, Philadelphia, \nPa. \n17. Haas, C. N.  1983. Estimation of risk due to low doses of microorganisms: a comparison of \nalternative methodologies. Am. J. Epidemiol. 118: 573\u2013582. \n18. Haas, C. N., J. B. Rose, C. Gerba, and S. Regli.  1993. Risk assessment of virus in drinking \nwater. Risk Anal. 13:545\u2013552. \n19. Heijne, J. C., P. Teunis, G. Morroy, C. Wijkmans, S. Oostveen, E. Duizer, M. Kretzschmar, \nand J.  Wallinga. 2009. Enhanced hygiene measures and norovirus transmission during an \noutbreak. Emerg. Infect. Dis. 15:24\u201330. \n20. Johnson, P. C., J. J. Mathewson, H. L. DuPont, and H. B.  Greenberg. 1990. Multiple-\nchallenge study of host susceptibility to Norwalk gastroenteritis in US adults. J. Infect. Dis. 161: 18\u201321. \n21. Jothikumar, N., J. A. Lowther, K. Henshilwood, D. N. Lees, V. R. Hill, and J.  Vinj\u00e9. 2005. \nRapid and sensitive detection of noroviruse s by using TaqMan-based one-step reverse \ntranscription-PCR assays and application to naturally contaminated shellfish samples. Appl. Environ. Microbiol. 71:1870\u20131875. Cap\u00edtulo V: Estudio 7 \n 22322. Kageyama, T., S. Kojima, M. Shinohara, K. Uchida, S. Fukushi, F. B. Hoshino, N. Takeda, \nand K.  Katayama. 2003. Broadly reactive and highly sensitive assay for Norwalk-like viruses \nbased on real-time quantitative reverse transcription-PCR. J. Clin. Microbiol. 41:1548\u2013\n1557. \n23. Koopmans, M., and E.  Duizer. 2004. Foodborne viruses: an emerging problem. Int. J. Food \nMicrobiol. 90:23\u201341.  \n24. Kou, X., Q. Wu, J. Zhang, and H.  Fan. 2006. Rapid detection of noroviruses in fecal samples \nand shellfish by nucleic acid sequence-based amplification. J. Microbiol. 44:403\u2013408. \n25. Lee, J., K. Zoh, and G. Ko. 2008. Inactivation and UV disinfection of murine norovirus with \nTiO 2 under various environmental conditions. Appl. Environ. Microbiol. 74:2111\u20132117.  \n26. Lindesmith, L., C. Moe, S. Marionneau, N. Ruvoen, X. Jiang, L. Li ndblad, P. Stewart, J. \nLePendu, and R.  Baric. 2003. Human susceptibility and resistance to Norwalk virus \ninfection. Nat. Med. 9:548\u2013553. \n27. Lodder-Verschoor, F., A. M. de Roda Husman, H. H. van den Berg, A. Stein, H. M. van Pelt-\nHeerschap, and W. H. van der Poel. 2005. Year-round screening of noncommercial and \ncommercial oysters for the presence of human pathogenic viruses. J. Food Prot. 68:1853\u2013\n1859. \n28. Loisy, F., R. L. Atmar, P. Guillon, P. Le Cann, M. Pommepuy, and F. S. Le Guyader. 2005. \nReal-time RT-PCR for norovirus screenin g in shellfish. J. Virol. Methods 123: 1\u20137. \n29. Loisy, F., R. L. Atmar, J. C. Le Saux, J. Cohen, M. P. Caprais, M. Pommepuy, and F. S. Le \nGuyader.  2005. Use of rotavirus virus-like particles as surrogates to evaluate virus \npersistence in shellfish. Appl. Environ. Microbiol. 71:6049\u20136053. \n30. Lowther, J. A., J. M. Avant, K. Gizynski, R. E. Rangdale, and D. N.  Lees. 2010. Comparison \nbetween quantitative real-time reverse transcription PCR results for norovirus in oysters and self-reported gastroenteric illness in restaurant customers. J. Food Prot. 73:305\u2013311. \n31. Matsui, S. M., and H. B. Greenberg. 2000.  Immunity to calicivirus infection. J. Infect. Dis. \n2:331\u2013335. \n32. Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. S hapiro, P. M. Griffin, and R. \nV. Tauxe. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. \n5:607\u2013625.  \n33. Mullendore, J. L., M. D. Sobsey, and Y. C.  Shieh. 2001. Improved method for the recovery \nof hepatitis A virus from oysters. J. Virol. Methods 94:25\u201335. \n34. Muniain-Mujika, I., M. Calvo, F. Lucena, and R. Girones. 2003. Comparative analysis of \nviral pathogens and potential indicators in shellfish. Int. J. Food Microbiol. 83:75\u201385. \n35. Nishida, T., O. Nishio, M. Kato, T. Chuma, H. Kato, H. Iwata, and H. Kimura. 2007. \nGenotyping and quantitation of noroviruses in oy sters from two distinct sea areas in Japan. \nMicrobiol. Immunol. 51:177\u2013184. \n36. Potasman, I., A. Paz, and M. Odeh. 2002. Infectious outbreaks associated with bivalve \nshellfish consumption: a worldwide perspective. Clin. Infect. Dis. 35:921\u2013928.  \n37. Rutjes, S. A., R. Itali aander, H. H. van den Berg, W. J. Lodder, and A. M. de Roda Husman.  \n2005. Isolation and detection of enterovirus RNA from large-volume water samples by using the NucliSens miniMAG system and real-time nucleic acid sequence-based amplification. Appl. Environ. Microbiol. 71:3734\u20133740. \n38. S hapiro, R. L., S. Altekruse, L. Hutwagner, R. Bishop, R. Hammond, S. Wilson, B. Ray, S. \nThompson, R. V. Tauxe, and P. M.  Griffin. 1998. The role of Gulf Coast oysters harvested in \nwarmer months in Vibrio vulnificus infections in the United States, 1988-1996. J. Infect. Dis. 178: 752\u2013759. \n39. Shieh, Y., S. S. Monroe, R. L. Fankhauser, G. W. Langlois, W. Burkhardt, and R. S. Baric. \n2000.  Detection of norwalk-like virus in shellfish implicated in illness. J. Infect. Dis. 2:\n360\u2013\n366. \n40. Statistics Netherl ands.  2009. http://www.cbs.nl/nl-NL/menu/home/default.htm \n41. Str aub, T. M., K. H\u00f6ner zu Bentrup, P. Orosz-Coghlan, A. Dohnalkova, B. K. Mayer, R. A. Cap\u00edtulo V: Estudio 7 \n \n 224Bartholomew, C. O. Valdez, C. J. Bruckner-Lea, C. P. Gerba, M. Abbaszadegan and C. A. \nNickerson. 2007. In vitro cell culture infectivity assay for human noroviruses. Emerg. Infect. \nDis. 13:396\u2013403. \n42. Svraka, S., E. Duizer, H. Vennema, E. de Bruin, B. van der Veer, B. Dorresteijn, and M.  \nKoopmans. 2007. Etiological role of viruses in outbreaks of acute gastroenteritis in The \nNetherlands from 1994 through 2005. J. Clin. Microbiol. 45:1389\u20131394. \n43. Teunis, P. F., C. L. Moe, P. Liu, S. E. Miller, L. Lindesmith, R. S. Baric, J. Le Pe ndu, and R. L.  \nCalderon. 2008. Norwalk virus: how infectious is it? J. Med. Virol. 8:1468\u20131476.  \n44. Teunis, P. F., N. J. Nagelkerke, and C. N.  Haas. 1999. Dose response models for infectious \ngastroenteritis. Risk. Anal. 19:1251\u20131260. \n45. U.S. Food and Drug Administration.  2001. Pathogens from the harvest area. In Fish and \nfisheries products hazards and controls guidance, 3rd ed. Food and Drug Administration \nCenter for Food Safety & Applied Nutrition, Washington, D.C. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/Seafood/FishandFisheriesProductsHazardsandControlsGuide/ucm091606.htm \n46. van den Berg, H., W. Lodder, W. van der Poel, H. Vennema, and A. M.  de Roda Husman. \n2005. Genetic diversity of noroviruses in raw and treated sewage water. Res. Microbiol. 156: 532\u2013540.  \n47. Vinj\u00e9, J., H. Vennema, L. Maunula, C. H. von Bonsdorff, M. Hoehne, E. Schreier, A. \nRichards, J. Green, D. Brown, S. S. Beard, S. S. Monroe, E. de Bruin, L. Svensson, and M. P.  \nKoopmans. 2003. International collaborative study to compare reverse transcriptase PCR \nassays for detection and genotyping of noroviruses. J. Clin. Microbiol. 41:1423\u20131433. \n48. Vose, D. J.  1998. The application of quantitative risk  assessment to microbial food safety. J. \nFood. Prot. 61:640\u2013648. \n49. Westrell, T., P. Teunis, H. van den Berg, W. Lodder, H. Ketelaars, T. A. Stenstr\u00f6m, and A. \nM. de Roda Husman. 2006. Short- and long-term variations of norovirus concentrations in \nthe Meuse river during a 2-year study period. Water Res. 40:2613\u20132620. \n50. Wobus, C. E., S. M. Karst, L. B. Thackray, K. O. Chang, S. V. Sosnovtsev, G. Belliot, A. Krug, \nJ. M. Mackenzie, K. Y. Green, and H. W.  Virgin. 2004. Replication of Norovirus in cell \nculture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2:432.  \n51. Wyatt, R. G., R. Dolin, N. R. Blacklow, H. L. DuPont, R. F. Buscho, T. S. Thornhill, A. Z. \nKapikian, and R. M. Chanock. 1974. Comparison of three agents of acute infectious \nnonbacterial gastroenteritis by cross-challenge in volunteers. J. Infect. Dis. 129: 709\u2013714. \n TABLE 1.  Daily risk of human norovirus infection and illness per number of oysters ingested.  \n  Number of ingested oysters  \n    1 6 10 20 \nScenario 1 \n  Pinfection  8.4%  33%  42%  49%  \n (0 - 67) (0 - 74) (0 - 75) (13 - 75) \nPillness 0.7%  11%  18%  27%  \n  (0 - 36) (0 - 50) (0 - 53) (1 - 56) \nScenario 2 \n  Pinfection  47%  51%  53%  54%  \n (12 - 75) (25 - 76) (27 - 76) (30 - 76) \nPillness 21%  31%  33%  36%  \n  (14 - 46) (23 - 56) (26 - 58) (29 - 61) \nScenario 1: screening data; Scenario 2: outbreak data. Pinfection : Probability of infection; Pillness: \nProbability of illness. Ninety-five per cent confidence intervals are in parentheses.  \n FIG 1.  Distribution of human norovirus PDU concen tration per oyster in screening data.   \n \nGamma distribution was assumed for human norovirus concentration in oysters from \nOosterschelde Estuary, The Netherlands.  \n FIG 2.  Distribution of human norovirus PDU concen tration per oyster in household outbreak \ncase.  \n \nLog-normal distribution was assumed for human norovirus concentration in oysters from \nhousehold outbreak, The Netherlands.  \n FIG 3.  Risk of human norovirus infection and risk of  illness per number of oysters consumed for \nscreening data. \n5 10 15 200.00.20.40.60.81.0\nNumber of ingested oystersProb .ofinfection\u0001Prob .ofillness\n \nProbability of infection/day (uppe r line) and Probability of illn ess/day (downer line). For these \nestimations was assumed an efficiency of viral particles recuperation of one-hundred per cent.  \n FIG 4.  Risk of human norovirus infection and risk of  illness per number of oysters consumed for \nthe household outbreak case in The Netherlands. \n5 10 15 200.00.20.40.60.81.0\nNumber of ingested oystersProb .ofinfection\u0001Prob .ofillness\n \nProbability of infection/day (uppe r line) and Probability of illn ess/day (downer line). For these \nestimations was assumed an efficiency of viral particles recuperation of one-hundred per cent.  \n FIG 5. Boxplots of the probability of human norovirus infection based on screening data of \noysters from Oosterschelde Estuary and household outbreak.  \n \n \n  \n  \n \n    \n5. RESUMEN GENERAL  Resumen general \n 233RESUMEN GENERAL \n \n El impacto de la poblaci\u00f3n sobre los sistem as ecol\u00f3gicos del planeta se ha ido haciendo \nm\u00e1s aparente en los \u00faltimos a\u00f1os , poniendo de manifiesto la es trecha relaci\u00f3n existente entre \nlos niveles de contaminaci\u00f3n ambiental y la salud de la poblaci\u00f3n. Las enfermedades \ninfecciosas representan un gran riesgo y son la principal causa de muerte en ni\u00f1os y adultos \nj\u00f3venes. Seg\u00fan informaci\u00f3n facilitada por la Orga nizaci\u00f3n Mundial de la Salud, considerando \n\u00fanicamente las enfermedades diarreicas frecuentemente asociadas al consumo de agua o \nalimentos contaminados, aproximadamente 2 millones de personas mueren cada a\u00f1o, \nmayoritariamente ni\u00f1os menores de 5 a\u00f1os (WHO, 2009). Dentro de las enfermedades \ninfecciosas, los virus son los principales causantes de brotes relacionados con la contaminaci\u00f3n del agua y los alimentos en los pa\u00edses m\u00e1s desa rrollados, donde la mejora de los tratamientos \nde depuraci\u00f3n de las aguas residuales ha reducid o la transmisi\u00f3n de la mayor parte de los \npat\u00f3genos bacterianos (Craun, 1991; revisado en Godfree y Farrell, 2005).  \nLa contaminaci\u00f3n del medio ambiente a part ir de aguas residuales se confirma al \nanalizar la presencia de virus en aguas superficiales de r\u00edos y lagos en los que se destacan altos porcentajes de muestras posi tivas (revisado en Girones et al. , 2010), y en los frecuentes casos \nde infecciones virales asociados al consumo de mo luscos bivalvos que se observan cada a\u00f1o en \npa\u00edses industrializados (Lees, 2000). Los virus ent\u00e9ricos en agua pueden permanecer estables durante meses o incluso m\u00e1s tiempo si est\u00e1n asociados a s\u00f3lidos, y pueden acumularse en \nsedimentos que posteriormente  se resuspender\u00e1n en la co lumna de agua por procesos \nnaturales y artificiales, facilitando la diseminaci\u00f3n viral (Melnick, 1984; Rao et al. , 1984; \nRzezutka y Cook, 2004). Se ha observado en algunos casos que los est\u00e1ndares de calidad microbiol\u00f3gica actuales no garantizan la ausenc ia de virus y se han aislado virus en agua de \nbebida, aguas superficiales, agua de mar o moluscos bivalvos que cumplen los est\u00e1ndares \nactuales de \u00edndices bacterianos (Vivier et al. , 2004; Formiga-Cruz et al. , 2002; 2003). \n \nLa primera parte de la Tesis (Cap\u00edtulo I) se  dise\u00f1\u00f3 con el objetivo de estudiar la \nprevalencia de virus emergentes, principalmente el  virus de la hepatitis E, mediante un an\u00e1lisis \ncomparativo que nos permitiera evaluar cambios en los patrones de excreci\u00f3n de hepatitis \nagudas en el este de Espa\u00f1a y valorar simult \u00e1neamente la presencia de nuevos poliomavirus \n(Estudios 1, 2 y 3). Estudios previos elaborad os en nuestro grupo de investigaci\u00f3n hab\u00edan \ndescrito la presencia de HAV y HEV en agua residual recolectada en el periodo 1994 \u2013 2002 \n(Pina et al. , 2001; Clemente-Casares et al. , 2003), de manera que la continuaci\u00f3n de estos Resumen general \n 234trabajos nos permitir\u00eda evaluar las din\u00e1micas de ambos pat\u00f3genos. Al mismo tiempo, la \ncaracterizaci\u00f3n y prevalencia de las distintas cepas circulantes en la poblaci\u00f3n estudiada nos aportar\u00edan la informaci\u00f3n necesaria para di lucidar si HEV contin\u00faa siendo un pat\u00f3geno \nemergente, y si la disponibilidad de vacuna para HAV y aplicaci\u00f3n de planes de vacunaci\u00f3n universal est\u00e1n teniendo el efecto esperado  frente a las mejoras generales a nivel de \nsaneamiento, implementaci\u00f3n de nuevos tratam ientos de depuraci\u00f3n y a la apertura de \nnuevas EDAR. Actualmente, HEV se considera la causa m\u00e1s importante de hepatitis cl\u00ednicas \nagudas entre adultos en el cent ro y sudeste asi\u00e1tico, y la segunda causa m\u00e1s importante, \ndetr\u00e1s de la HBV, en el medioeste y norte de \u00c1frica (Das et al. , 2000; Ghabrah et al. , 1995; \nGomatos et al. , 1996). Por otro lado, se considera que HEV es responsable de un n\u00famero \nmenor de casos de hepatitis en los Estado s Unidos y otros pa\u00edses industrializados, \nrecientemente se ha descrito que HAV es el principal agente responsable de estas infecciones \n(Purcell y Emerson, 2008). \n \nLos datos obtenidos en el Estudio 1 nos mu estran que la presencia de HEV en agua \nresidual del noreste espa\u00f1ol se ha mantenido estable durante la \u00faltima d\u00e9cada (30%), \nmientras que la presencia de HAV ha ca\u00eddo considerablemente, de un 57% (1994 \u2013 2002) a un 3% (2006 \u2013 2008). Esta observaci\u00f3n nos podr\u00eda hacer concluir que la disminuci\u00f3n de la presencia de HAV en el agua residual podr\u00eda just ificarse exclusivamente con la implementaci\u00f3n \nde un plan de vacunaci\u00f3n universal obligatori o a menores de 12 a\u00f1os que tiene lugar en la \nComundiad Aut\u00f3noma de Catalu\u00f1a desde 1999 (Oviedo et al. , 2009). Para contrastar esta \nhip\u00f3tesis se recolectaron muestras de agua re sidual de dos regiones geogr\u00e1ficas pr\u00f3ximas al \n\u00e1rea estudiada. Se escogi\u00f3 la Comunidad Aut\u00f3 noma Valenciana y dos regiones del norte de \nEgipto, debido a la ausencia de planes de vac unaci\u00f3n de gran cobertura y a la caracterizaci\u00f3n \ncomo \u00e1rea de elevada endemicidad para HA V, respectivamente. Los datos observados \nmostraron que en ausencia de un plan de vacunaci \u00f3n y frente a la disponibilidad de un sistema \nde saneamiento adecuado (Valencia), la pr esencia de HAV en agua residual mostraba \nporcentajes similares a los descritos en Catalu\u00f1a, mientras que las muestras procedentes de Egipto, tal y como se esperaba , presentaban un elevado \u00edndice de positividad para HAV. De \nmanera que, la dr\u00e1stica reducci\u00f3n observada para HAV no puede justificarse \u00fanicamente \ndebido a la disponibilidad y aplicaci\u00f3n de una  vacuna eficiente, debemos considerar que la \nreducci\u00f3n puede deberse tambi\u00e9n a las mejoras en las condiciones de saneamiento de la \nregi\u00f3n. En el periodo comprendido entre 1992 \u2013 2008, Catalu\u00f1a ha experimentado un incremento significativo en el n\u00famero de es taciones depuradoras de agua residual (de 91 a \n343) y del volumen total de agua residual depurada (de 991.892 a 2.786.871 m\n3/d\u00eda). Todas las Resumen general \n 235muestras analizadas presentaron valores elevados de HAdV (103 GC/mL), lo cual nos indica que \nlos niveles de contaminaci\u00f3n fecal son los habituales para este tipo de muestras. El efecto que han tenido las EDAR respecto a la circulaci\u00f3n de HAV no se observa de manera equivalente \npara HEV, probablemente debido a la presencia de un reservorio animal asociado, los cerdos. \nLas secuencias de HEV descritas nos muestran una elevada similitud entre las cepas identificadas en el agua residual y en las he ces de origen porcino, estudiadas mediante \nmuestras procedentes de matade ro, hecho que nos demuestra la circulaci\u00f3n de los mismos \nagentes infecciosos entre animales y humanos que habitan zonas pr\u00f3ximas. Adem\u00e1s de analizar muestras de agua residual, se analizaron 19 muestras de suero procedentes de pacientes con hepatitis agudas nega tivas para hepatitis B y C (muestras cedidas por el Hospital \nUniversitari Vall d'Hebron de Barcelona), dete ct\u00e1ndose 4 muestras positivas para HEV. La \ndetecci\u00f3n de pacientes positivos para HEV nos confirma la presencia de estos virus no solo en \nel ambiente sino tambi\u00e9n en la poblaci\u00f3n est udiada. Para todas las matrices estudiadas la \nsecuenciaci\u00f3n mostr\u00f3 la presencia del genotipo  3 y, espor\u00e1dicamente, el genotipo 1 (una \nmuestra de agua residual y un suero).  \nA ra\u00edz de la detecci\u00f3n espor\u00e1di ca del genotipo 1 no end\u00e9mico en la regi\u00f3n evaluada, se \ndecidi\u00f3 profundizar acerca de su circulaci\u00f3n ambi ental en el noreste espa\u00f1ol (Estudio 2). Seis \nmuestras de agua residual urbana, dos muestr as de bios\u00f3lidos urbanos y dos muestras de \nlodos procedentes de un matadero  de ganado bovino y porcino (80% ganado porcino), todas \nellas positivas para HEV, fueron analizadas  mediante clonaci\u00f3n y secuenciaci\u00f3n con la \nintenci\u00f3n de obtener informaci\u00f3n acerca de la potencial diversidad de las cepas de HEV excretadas por la poblaci\u00f3n. Un total de 101 clones fueron secuenciados y los resultados mostraron que la mayor\u00eda de cepas identificadas pertenecen al genotipo 3 (74 clones), aunque \nel genotipo 1 tambi\u00e9n fue detectado. Dos mues tras de agua residual y un bios\u00f3lido mostraron \ncepas pertenecientes al genotipo 1, mientr as que las dos muestras de lodos de matadero \nmostraron estar contaminadas \u00fanica mente con el genotipo 3, tal y como era de esperar. Las \nsecuencias obtenidas en las muestras de origen animal mostraron una elevada similaridad con \ncepas de origen humano previamente reportadas en la misma regi\u00f3n de estudio. La similaridad \nde secuencias obtenidas en las diferentes muestras estudiadas (intra-muestra) oscila entre 89% \u2013 99%. La circulaci\u00f3n espor\u00e1di ca de este genotipo en \u00e1reas industrializadas representa un \nproblema a nivel de salud p\u00fablica ya que se ha  asociado a importantes brotes infecciosos con \nelevadas tasas de mortalidad. La contaminaci\u00f3n de agua y alimentos a trav\u00e9s del contacto con agua residual o regenerada, as\u00ed como bios\u00f3lidos , representa un riesgo significativo para la \npoblaci\u00f3n. En definitiva, Los resultados obteni dos demuestran una circulaci\u00f3n simultanea de Resumen general \n 236cepas diversas de HEV entre la poblaci\u00f3n de la regi\u00f3n estudiada. \n \nEn modo de breve introducci\u00f3n al Estudio 3, debemos considerar que hasta el a\u00f1o \n2007 \u00fanicamente se conoc\u00edan dos poliomavirus que fueran capaces de infectar humanos; BKPyV y JCPyV. El poliomavirus BK fue identifi cado en la orina de pacientes con transplante \nrenal (Gardner et al. , 1971), mientras que JCPyV fue encontrado en el cerebro de un paciente \ncon PML (Padgett et al. , 1971). Recientemente, tres nuevos poliomavirus han sido \ndescubiertos; los poliomavirus KI y WU fueron iden tificados en el tracto respiratorio de ni\u00f1os \ncon afecciones en \u00e9ste (Allander et al. , 2007; Gaynor et al. , 2007) y MCPyV fue encontrado \nasociado a un extra\u00f1o tipo de c\u00e1ncer nomb rado carcinoma de c\u00e9lulas Merkel (Feng et al. , \n2008). Adem\u00e1s, dos distintos poliomavirus de simio, LPyV y SV40 se han relacionado con humanos. SV40 ha sido introducido en humanos a tr av\u00e9s de la vacuna infectada de poliovirus, \ny su papel en el desarrollo de tumores en human os ha sido ampliamente estudiado. Estudios \nprevios no han detectado la presencia de SV40 en  agua residual urbana, lo que nos indica que \nsi SV40 est\u00e1 infectando a los humanos, no es t\u00e1 siendo excretado en el medio ambiente a \nconcentraciones detectables (Bofill-Mas et al. , 2000). Por el contrario, anticuerpos contra LPyV \nhan sido detectados en muestras de sangre human a, sugiri\u00e9ndose que LPyV tambi\u00e9n infecta a \nhumanos (Viscidi y Clayman, 2006). Adem\u00e1s, recientemente se ha descrito la presencia de part\u00edculas v\u00edricas de LPyV en la sangre perif\u00e9rica de pacien tes con PML (Delbue et al. , 2008). \n \nDebido a que se ha descrito una elevad a prevalencia de JCPyV y BKPyV en agua \nresidual procedente de diferentes \u00e1reas geogr\u00e1fi cas y se sugiere que el agua residual tiene un \npapel importante en la transmisi\u00f3 n de ambos pat\u00f3genos (Bofill-Mas et al. , 2000, 2006), se \ndecidi\u00f3 evaluar los patrones de excreci\u00f3n de KIPyV, WUPyV, MCPyV y LPyV en muestras de agua residual urbana para determinar su preval encia ambiental y determinar el papel de estos \nvirus como contaminantes ambientales (Estudio 3). Tambi\u00e9n se ha estudiado la presencia de \ndichos pat\u00f3genos en muestras de agua de r\u00ed o y en orinas de mujeres embarazadas sanas. \n \nTodas las muestras analizadas mostraron regi stros habituales de contaminaci\u00f3n fecal \nde origen humano evaluados mediante la cuantificaci\u00f3n de JCPyV (10\n2 GC/mL) y HAdV (103 \nGC/mL). Los poliomavirus KI y WU fueron detect ados en 1/8 y 2/8 muestras de agua residual, \nrespectivamente, mientras que MCPyV fue detect ado en 7/8 muestras de agua residual y fue \nel \u00fanico nuevo poliomavirus presente en el agua de r\u00edo (2/7) y orina (1/4). Aunque la detecci\u00f3n \nrealizada fue cualitativa, diluciones seriadas permitieron estimar una concentraci\u00f3n de 10 \u2013 \n100 PDU/mL. Ninguna de las muestras de agua residual ( n = 13) y bios\u00f3lidos ( n = 9) analizadas Resumen general \n 237fue positiva para LPyV. Los datos obtenidos repr esentan la primera descripci\u00f3n de la presencia \nde los nuevos poliomavirus KiPyV, WUPyV y MCPyV en el ambiente y confirman que est\u00e1n ampliamente diseminados entre la poblaci\u00f3n humana. La elevada prevalencia de MCPyV sugiere que su patr\u00f3n de excreci\u00f3n es similar al  de JCPyV y BKPyV. La presencia de estos virus \nen el agua residual representa una potencial v\u00eda de infecci\u00f3n para humanos y, a nuestro \nconocimiento, este trabajo representa la pr imera descripci\u00f3n de un virus relacionado con \nc\u00e1ncer presente en el medio ambiente.  \nLas aguas residuales son la principal fuen te de microorganismos pat\u00f3genos que se \ntransmiten a trav\u00e9s del ambiente y que llegan a la poblaci\u00f3n especialmente a causa de la \ncontaminaci\u00f3n del agua de consumo, agua utilizada en cultivos de vegetales o en cultivos de moluscos bivalvos, en la preparaci\u00f3n de comida, para lavar, en el ba\u00f1o o en los diversos usos \nrecreativos (Cliver, 1984). El tratamiento actualmente aplicado a las aguas residuales \nprocesadas por m\u00e9todos biol\u00f3gicos y f\u00edsico-qu\u00edmicos ha reducido significativamente la incidencia de enfermedades entre la poblaci\u00f3n,  especialmente las de etiolog\u00eda bacteriana, sin \nembargo los protozoos y los virus son m\u00e1s resistentes que las bacterias a muchos de estos tratamientos. Concentraciones significativas de virus son detectadas en las aguas vertidas al ambiente y en los bios\u00f3lidos generados en plan tas de tratamiento de agua residual (Girones et \nal., 2010). Por este motivo, junto con la elevada presencia de pat\u00f3genos observados en los tres \nestudios iniciales, en el Cap\u00edtulo II (Estudio 4) de esta Tesis se analiz\u00f3 la diseminaci\u00f3n y eficiencia de eliminaci\u00f3n de pat\u00f3genos e indica dores de contaminaci\u00f3n fecal en dos plantas de \ntratamiento de agua residual donde se  aplican tratamientos terciarios. \n \nLos resultados obtenidos nos muestran como  existe una elevada presencia de virus, \nbacterias y protozoos en cada uno de los puntos  analizados en las dos EDAR estudiadas. Se \nanalizaron muestras recolectadas quincenal mente durante un periodo de cinco meses \n(octubre 2009 \u2013 febrero 2010) en tres puntos del tratamiento de depuraci\u00f3n: a la entrada de la \nestaci\u00f3n depuradora, tras aplicar el tratamie nto secundario y tras aplicar el tratamiento \nterciario (agua regenerada). Ambas plantas depuradoras tienen capacidad para depurar \n60.000 y 45.000 m\n3/d\u00eda, respectivamente, y reciben aguas fecales de poblaciones pr\u00f3ximas a \nlos 250.000 habitantes (situadas en la Comunidad Aut\u00f3noma de Valencia). Los tratamientos terciarios inclu\u00edan desinfecci\u00f3n por ultravioleta con una dosis media de 100 mWs/cm\n2 y una de \nlas dos plantas, adem\u00e1s, combinaba los UV con desinfecci\u00f3n por filtro de arena. \n  Resumen general \n 238Mediante la colaboraci\u00f3n entre nuestro gr upo de investigaci\u00f3n y otros dos grupos con \nexperiencia en bacterias y protozoos, ubicados en Universidad Polit\u00e9cnica de Valencia, se \nanalizaron los siguientes microorganismos: coliformes fecales, HAdV y JCPyV (como indicadores de contaminaci\u00f3n fecal), HAV, HEV, NoV GGI, NoV GGII, Salmonella  spp., Vibrio \nvulnificus , Vibrio parahaemolyticus , Listeria monocytogenes , Arcobacter  spp., Giardia  spp. y \nCryptosporidium  spp. Todos los pat\u00f3genos e indicadores de contaminaci\u00f3n fecal analizados \nfueron detectados en cada uno de lo s puntos analizados, exceptuando a HEV, Vibrio vulnificus  \ny JCPyV, los cuales no fueron detectados en agua regenerada. JCPyV y NoV GGII fueron \ncuantificados por qPCR, mostrando concentraciones medias de 10\n4 y 102 GC/mL de agua \nresidual cruda, respectivamente. HAdV y Arcobacter  spp. tambi\u00e9n fueron evaluados por \nensayos de infectividad, mostrando resultados positivos en los diferentes puntos analizados, \nincluyendo agua regenerada. \n \nLa eficiencia de eliminaci\u00f3n de HAdV, Giardia  spp. y Cryptosporidium  spp. fue \nestudiada calculando la reducci\u00f3n logar\u00edtmica a trav\u00e9s de los tratamientos aplicados en las plantas depuradoras. El tratamiento primario se aplica principalmente para la eliminaci\u00f3n de materia de gran tama\u00f1o que pue da representar un problema para la maquinaria implicada en \nel resto de la depuraci\u00f3n, de  manera que la eliminaci\u00f3n es perada para este proceso es \ndespreciable (Fu et al.,  2010). Al contrario, el tratam iento secundario juega un papel \nimportante en la reducci\u00f3n de microorganism os y contaminantes qu\u00edmicos. Por las razones \naqu\u00ed expuestas, los tratamientos primarios y secundarios se evaluaron conjuntamente. Tal y \ncomo cabr\u00eda esperar, las muestras recolectadas tras la combinaci\u00f3n de los dos primeros tratamientos muestran la reducci\u00f3n m\u00e1s acusad a en la concentraci\u00f3n de los microorganismos \nanalizados, observ\u00e1ndose una reducci\u00f3n de 1,03 \u2013 1,51 log\n10 para HAdV, 1,99 \u2013 2,56 log 10 para \nGiardia  spp. y 1,28 \u2013 1,37 log 10 para Cryptosporidium  spp., reducci\u00f3n equivalente al 60% \u2013 89% \ndel total estimado. La aplicaci\u00f3 n de desinfecci\u00f3n por UV most r\u00f3 unos valores menores a los \nesperados, concretame nte de 0,04 \u2013 0,13 log 10, 0,30 \u2013 0,34 log 10 y 0,18 \u2013 0,34 log 10, para HAdV, \nGiardia  spp. y Cryptosporidium  spp., respectivamente, equivalente a un 2 \u2013 17% del total. \nExcepcionalmente, una de las plantas depurad oras mostr\u00f3 una reducci\u00f3n del 40% (0,90 log 10) \npara Cryptosporidium  spp. La utilizaci\u00f3n de filtros de arena represent\u00f3 una reducci\u00f3n del 4 \u2013 \n17%. Adenovirus humanos cuantificados por qPCR fueron detectados en un 100% de las muestras, pasando de 10\n3 GC/mL en el agua residual cruda a 101 GC/mL en el agua \nregenerada. La aplicaci\u00f3n de de sinfecci\u00f3n por UV y filtros de arena es necesaria para la \ndesinfecci\u00f3n y mantenimiento de la calidad del agua, reduciendo la necesidad de cloraci\u00f3n. No \nobstante, los datos obtenidos revelan que debido al elevado coste asociado y al limitado Resumen general \n 239efecto sobre la reducci\u00f3n de los pat\u00f3genos evaluados, los tratamientos actualmente \nempleados deber\u00edan perfeccionarse.  \nLos resultados obtenidos en este estudio indican que la elevada prevalencia y \nconcentraci\u00f3n en agua residual y regenerada de un amplio rango de pat\u00f3genos evaluados \nrepresenta un riesgo sanitario considerable y un reto actual para el desarrollo de nuevos \nsistemas de saneamiento. Los tratamientos estudiados reducen la presencia de HAdV, Giardia  \nspp. y Cryptosporidium  spp., pat\u00f3genos/indicadores de elev ada resistencia ambiental y frente \na tratamientos, entre 1,2 \u2013 3,0 log\n10, siendo estos valores insuficientes para garantizar un agua \nregenerada terciaria con una calidad microbio l\u00f3gica adecuada. La presencia de pat\u00f3genos \nviables en agua regenerada que cumple la actual normativa espa\u00f1ola (An\u00f3nimo, 2007) corrobora el riesgo para la salud p\u00fablica y la necesidad de implementar nuevos indicadores \nmicrobiol\u00f3gicos que sean m\u00e1s restrictivos. Por otro lado, mediante regresi\u00f3n log\u00edstica se \nestudi\u00f3 la capacidad de predicci\u00f3n que  HAdV ofrec\u00eda para la presencia de Cryptosporidium  y \nGiardia , aunque no se observaron bue nas correlaciones. De todos mo dos, a pesar de no poder \npredecir la presencia de ambos par\u00e1sitos debi do a que HAdV estuvo presente en todas las \nmuestras analizadas, incluso en ausencia de otros pat\u00f3genos, su elevada prevalencia y \nconcentraci\u00f3n sugieren un papel como indica dor protector de la contaminaci\u00f3n fecal. \n \nLlegados a este punto de la Tesis hemos po dido comprobar la elevada presencia de \npat\u00f3genos v\u00edricos, bacterianos y protozoos en el  agua residual y agua regenerada (secundaria y \nterciaria), evidenciando que representan la fuente m\u00e1s importante de introducci\u00f3n de \npat\u00f3genos en el medio ambiente, especialmente pat\u00f3genos v\u00edricos. Debido a la laboriosidad \ny/o elevado coste econ\u00f3mico asociado a los actu ales m\u00e9todos de concentraci\u00f3n de part\u00edculas \nv\u00edricas en agua residual, en el Estudio 5 descrito  dentro del Cap\u00edtulo III , se desarroll\u00f3 una nueva \nmetodolog\u00eda eficiente y de bajo coste para concentrar part\u00edculas v\u00edricas. Con el objetivo de \nencontrar un protocolo que fuera f\u00e1cilmente estandarizable, econ\u00f3mico y eficiente, se abordaron tres estrategias diferentes para concentrar HAdV, JCPyV y NoV GGII (como virus \nmodelo de DNA y RNA) en agua residual.  \nEl primer m\u00e9todo descrito (ESMP) consiste en una eluci\u00f3n inicial utilizando un tamp\u00f3n \nglicina 0,25N, pH 9,5 (1:2 v/v). La muestra (50 mL) se homogeniza durante 30 min en hielo y posteriormente se centrifuga a 8.000x g durante otros 30 min a 4 \u00baC. El sobrenadante obtenido \n(150 mL) se transfiere a un nuevo recipiente, se ajusta el pH a 3,5 ut ilizando HCl 1N y se le \na\u00f1ade 1,5 mL de una soluci\u00f3n prefloculada de leche descremada (concentraci\u00f3n final de 0,01% Resumen general \n 240(w/v)). La soluci\u00f3n de leche descremada pref loculada se prepara de acuerdo con Calgua et al.  \n2008. Despu\u00e9s, la muestra se mantiene en agitaci\u00f3n durante 8 h a RT para permitir que los virus se adhieran a los fl\u00f3culos de leche. Posteriormente, los fl\u00f3culos son precipitados mediante una centrifugaci\u00f3n a 8.000x g durante 30 min a 4 \u00baC. El sobrenadante es eliminado \ncuidadosamente y el precipitado se resuspende  en 500 \u03bcL de un tamp\u00f3n fosfato a pH 7,5. \n \nEl segundo m\u00e9todo desarrollado (UF) utiliza la ultrafiltraci\u00f3n como principio b\u00e1sico \npara la concentraci\u00f3n. En primer lugar se lavan 4 filtros (Millipore Ultrafree\n\u00ae-15 filter, 100.000 \nMW) con agua bi-destilada por muestra a analizar, se centrifugan a 2.000x g durante 10 min y \nse descarta el filtrado de cada uno de ello s. Para una muestra analizada, 45 mL de agua \nresidual se transfieren a 3 filtros pre-lavados (15 mL por filtro), se centrifugan a 2.000x g \ndurante 1 h a RT y se descarta el filtrado. Los viru s se eluyen de cada filtro utilizando 4 mL de \ntamp\u00f3n glicina 0,25N y pH 9,5. El eluido v\u00edrico se traspasa a un tubo est\u00e9ril, se incuba 30 min a \n4 \u00baC (homogenizando cada 10 min) y se centrifuga a 3.000x g durante 30 min a 4 \u00baC. El \nsobrenadante se recupera y se a\u00f1ade a un nuevo filtro pre-lavado, se centrifuga a 2.000x g \ndurante 1 h a RT y se recupera el l\u00edquido retenido en el filtro (100 \u03bcL) que contiene las part\u00edculas v\u00edricas.  \nEn el \u00faltimo de los m\u00e9todos desarrollados (LF), 50 mL de agua residual se congelan a \nuna temperatura de -80 \u00baC y se liofilizan durante 24 \u2013 36 h. Una vez se ha liofilizado la muestra, las part\u00edculas restantes se resuspende n en 500 \u03bcL de tamp\u00f3n fosfato a pH 7,5.  \n \nLos nuevos m\u00e9todos descritos se compararon con un protocolo basado en la \nultracentrifugaci\u00f3n (UC) para concentrar las part\u00edculas v\u00edricas presenten en el agua residual. Dicho m\u00e9todo ha sido previamente de scrito en nuestro laboratorio (Pina et al. , 1998a) y se ha \nutilizado para la detecci\u00f3n de part\u00edculas v\u00edricas en los estudios englobados dentro de los dos \nprimeros cap\u00edtulos de esta Tesis.  \nEstos cuatro m\u00e9todos se utilizaron para cuantificar la presencia de HAdV, JCPyV y NoV \nGGII en cinco muestras de agua residual urbana recolectada en Barcelona. Los resultados mostraron que para HAdV, el m\u00e9todo m\u00e1s efic iente fue ESMP, seguido por LF, UF y UC. Para \nJCPyV los mejores resultados se obtuvieron co n ESMP, seguido por UC, LF y UF. Por \u00faltimo, \npara NoV GGII las cuantificaciones m\u00e1s elevad as fueron obtenidas mediante ESMP, seguido \npor UC, LF y UF.  Resumen general \n 241Aunque los cuatro m\u00e9todos estudiados mo straron un buen comportamiento a la hora \nde recuperar est\u00e1s tres especies v\u00edricas, incluy endo virus DNA y RNA, en  el trabajo presentado \nnos inclinamos a profundizar en el estudio de ES MP debido a que es el m\u00e9todo propuesto que \nrequiere menos equipamiento y presenta una menor inversi\u00f3n econ\u00f3mica. El CV ([desviaci\u00f3n est\u00e1ndar/media] x 100) se ut iliz\u00f3 como estimador de la variabilidad intra-laboratorio y los \nresultados observados fueron 15,9% para HAdV, 12,2% para JCPyV y 17,4% para NoV GGII. Respecto a la recuperaci\u00f3n, ESMP present\u00f3 valores entre 30% \u2013 95%, 55% \u2013 90% y 45% \u2013 90% \npara HAdV, JCPyV y NoV GGII, respectivamente. Finalmente, el m\u00e9todo escogido se valid\u00f3 mediante un estudio de campo donde se eval uaron 12 muestras de agua residual compuesta \ndurante 24h. Los resultados obtenidos para los vi rus estudiados se enco ntraron dentro de los \nrangos habituales de detecci\u00f3n, tanto en los estudios previos de esta Tesis como en otros \ntrabajos llevados a cabo en nue stro laboratorio (Bofill-Mas et al. , 2006). Los resultados \nobtenidos muestran que ESMP puede ser aplicado en estudios a gran escala, es una \nmetodolog\u00eda r\u00e1pida, econ\u00f3mica y f\u00e1cilmente estanda rizable para ser aplicada en laboratorios \nde rutina y pa\u00edses con poco desarrollo econ\u00f3mic o. De todos modos, en disposici\u00f3n del equipo \nnecesario (ultracentrifuga y/o liofilizador) y de los recursos econ\u00f3micos suficientes \n(principalmente para comprar los filtros), el resto de alternativas pr opuestas pueden suponer \nventajas en situaciones determinadas, ya que pue den ofrecer una concentraci\u00f3n m\u00e1s r\u00e1pida o \nun espectro de virus m\u00e1s generalizado.  \nEl segundo gran bloque de esta Tesis (Cap\u00edtul os IV y V) est\u00e1 centrado en el estudio de \nlos moluscos bivalvos como potenciales respon sables de brotes infecciosos. Tras comprobar la \nelevada presencia de pat\u00f3genos en el agua re sidual y agua regenerada, cabe esperar que los \nmoluscos bivalvos que crecen en estuarios donde son vertidas dichas aguas presenten pat\u00f3genos humanos. \n \nEn el Cap\u00edtulo IV se ha llevado a cabo un es tudio a gran escala donde se ha evaluado la \npresencia de virus ent\u00e9ricos en muestras de molu scos bivalvos recolectados durante los meses \nde invierno (2004 \u2013 2008) en mercados de la Comunidad Aut\u00f3noma de Catalu\u00f1a a trav\u00e9s de un programa de vigilancia gubernamental (Progr ama de Vigilancia de la Seguridad de los \nAlimentos). Entre las muestras analizadas podemos diferenciar un total de 151 lotes de moluscos bivalvos de los cuales; (i) 87 lotes de mejillones ( Mytilus galloprovinciales ) y 30 de \nalmejas ( Venus gallina  y Chamelea gallina ) fueron cultivados en \u00e1reas de producci\u00f3n de \nmarisco espa\u00f1olas (comunidades aut\u00f3nomas de Galic ia y Catalu\u00f1a) y (ii) 14 lotes de mejillones \ny 20 de almejas fueron importados de Italia, Fran cia y Portugal. La evaluaci\u00f3n mediante RT-PCR Resumen general \n 242muestra la ausencia de NoV GGI y HAV entre las muestras analizadas, mientras que NoV GGII \nfue detectado en un 13,7% (16/117) de las muestras nacionales y en un 8,8% (3/34) de las muestras importadas de Europa. Durante el pe riodo de estudio, un 16,8% (17/101) de los \nmejillones y un 4% (2/50) de las almejas fueron positivos para NoV GGII. An\u00e1lisis estad\u00edsticos posteriores mostraron que no se observan di ferencias significativas entre los positivos \ndetectados en funci\u00f3n del origen de las mu estras, aunque si se observan diferencias \nsignificativas respecto la especie animal analizada, siendo los mejillones los m\u00e1s contaminados por NoV GGII.  \n Paralelamente al estudio de mercado, diez lotes de tellinas ( Donax trunculus ) \ncongeladas importadas de Per\u00fa fueron analizadas para comprobar su potencial vinculaci\u00f3n con \nun brote infeccioso de hepatitis A que tuvo lugar en el este de Espa\u00f1a en 2008. Los an\u00e1lisis por \nRT-PCR mostraron que un 50% (5/10) de las mu estras analizadas presentaban contaminaci\u00f3n \npor HAV y se estim\u00f3 mediante RT-qPCR una concentraci\u00f3n media de 10\n2 GC/g HP. Los an\u00e1lisis \nde secuenciaci\u00f3n describieron la presencia de lo s subgenotipos IA y IB, genotipos habituales en \nEuropa y Sudam\u00e9rica. Estudios comparativos posteriores, donde se utiliz\u00f3 una muestra de agua residual positiva para HAV, previamente ai slada en la misma zona que el brote durante y \nel mismo periodo de tiempo (incluida en el Est udio 1), mostraron una similaridad respecto esta \nsecuencia del 96% \u2013 98,2%. Las diferencias detectadas entre las secuencias presentes en las tellinas y el agua residual sugieren que ambas contaminaciones tienen diferente origen.  \nAdicionalmente a los an\u00e1lisis de NoV y HAV, adenovirus humanos fueron cuantificados \npor qPCR en un grupo de 30 mues tras (24 mej illones y 6 alme jas), de las cuales diez resultaron \nser positivas y veinte negativas para NoV GGII. Los resultados globales muestran que un 43,3% \n(13/30) fueron positivas para HAdV. Entre las muestras positivas para NoV GGII, un 80% (8/10) \nfueron HAdV-positivas con una concentraci\u00f3n media de 10\n3 GC/g HP, mientras que \u00fanicamente \nun 25% (5/20) de las negativas para NoV GGII  result\u00f3 serlo tambi\u00e9n para HAdV, con una \nconcentraci\u00f3n media de 101 GC/g HP. En funci\u00f3n de los resu ltados obtenidos, se estudi\u00f3 una \npotencial correlaci\u00f3n entre HAdV y NoV GGII, con el  objetivo de poder predecir la presencia de \nNoV GGII mediante la detecci\u00f3n cuantitativa  de HAdV, y se dete rminaron diferencias \nsignificativas entre los dos grupos evaluados. La  asociaci\u00f3n entre HAdV y NoV GGII refleja una \nsensibilidad del 100% y una especificidad del 74%.  \nPara dilucidar porqu\u00e9 muestras de moluscos bivalvos que cumplen con la actual \nlegislaci\u00f3n europea presentan pat\u00f3genos de or igen v\u00edrico y tratar de entender como los Resumen general \n 243tratamientos afectan a la carga v\u00edrica, se estudi\u00f3 la eficiencia de eliminaci\u00f3n de \nmicroorganismos que tiene lugar en actuales trat amientos de depuraci\u00f3n.  Un total de 40 lotes \nde mejillones y 20 muestras de agua de mar ut ilizada en el proceso de depuraci\u00f3n, ambas \nmatrices recogidas durante Mayo-Junio de 2010, fueron recolectadas en tres empresas \nproductoras de marisco que utilizan sistemas distintos para depurar el marisco cultivado en una \u00e1rea clasificada como tipo B, de acuerdo con la regulaci\u00f3n europea. Los tratamientos \nutilizados para depurar el marisco fueron: (i) ozono, (ii) sistema venturi y (iii) ozono combinado con UV. Se analizaron muestras procedentes de los mismos lotes de moluscos antes y despu\u00e9s \nde aplicar los diferentes tratam ientos de depuraci\u00f3n (24h) para observar la reducci\u00f3n en la \ncontaminaci\u00f3n microbiol\u00f3gica. Se cuantific\u00f3 la presencia de HAdV entre las muestras seleccionadas, observ\u00e1ndose un 70%  (14/20) de positivos entre las muestras de mejillones sin \ndepurar y un 60% (12/20)  de positivos entre las muestras depuradas, con concentraciones \nmedias de 10\n2 GC/g HP para ambos tipos de muestras. Un 42% (5/12) de las muestras de agua \nde mar utilizada para la depuraci\u00f3n y un 50% (6 /12) de las muestras de agua de mar tras la \ndepuraci\u00f3n, fueron positivas para HAdV, co n valores medios de concentraci\u00f3n de 102 GC/L. \nAn\u00e1lisis estad\u00edsticos muestran que no hay diferencias significativas entre las muestras pre- y post-depuradas, de manera que no podemos co nsiderar que los diferentes tratamientos \naplicados tengan efecto alguno en la presencia y concentraci\u00f3n de HAdV en las muestras evaluadas. Todas las muestras fueron negativas para NoV, presumiblemente debido al periodo \nde muestro. NoV es una infecci\u00f3n asociada a lo s meses fr\u00edos, de manera que durante Mayo-\nJunio su incidencia es m\u00ednima.  \nAunque los an\u00e1lisis por qPCR proporcionan una informaci\u00f3n cuantitativa precisa, no \nexiste ninguna indicaci\u00f3n acerca de la presencia de part\u00edculas v\u00edricas infecciosas entre los virus contaminantes. Para dilucidar este aspecto se  adapt\u00f3 un ensayo de inmunoflorescencia (IFA) \npara HAdV bas\u00e1ndonos en trabajos previos de nue stro grupo de investigaci\u00f3n. Concretamente, \nse utiliz\u00f3 el protocolo descrito por Calgua et al.  (2011). Dos muestras positivas para HAdV \nprocedentes de cada uno de los tratamientos de depuraci\u00f3n utilizados fueron seleccionadas, observ\u00e1ndose un 50% (3/6) de muestr as infecciosas para dicho pat\u00f3geno. \n \nLos resultados indican que los actuales sistemas de depuraci\u00f3n destinados a reducir el \nn\u00famero de bacterias no tienen un efecto equivalente para los niveles de contaminaci\u00f3n v\u00edrica. Estudios previos confirman los resultados aqu\u00ed  obtenidos, indicando que moluscos bivalvos \nque cumplen con la normativa europea respec to las concentraciones de indicadores de \ncontaminaci\u00f3n fecal de origen bacteriano so n incapaces de determinar la presencia de Resumen general \n 244pat\u00f3genos v\u00edricos tales como NoVs (Lees, 2000; Formiga et al. , 2002; Romalde et al. , 2002; \nMuniain-Mujika et al. , 2003). \n \nEn conclusi\u00f3n, el Cap\u00edtulo IV de esta Tesis describe la presencia cualitativa y \ncuantitativa de virus ent\u00e9ricos humanos presen tes en moluscos bivalvos recolectados en \nmercados localizados en el noreste de Espa\u00f1a,  definiendo la abundancia de NoVs como \ncontaminantes en mejill\u00f3n y almejas. Aunque no  se han detectado muestras positivas para \nHAV entre las muestras de mercado, s\u00ed se ha de scrito la presencia en muestras potencialmente \nvinculadas a un brote de hepatitis originado a partir del consumo de tellinas congeladas \nimportadas de una regi\u00f3n end\u00e9mica. Los result ados generales indican que la presencia y \nconcentraciones de pat\u00f3genos humanos en molu scos bivalvos representan un reto para los \nsistemas de saneamiento. Simult\u00e1neamente, se sugiere que los HAdV cuantificados por qPCR \npueden jugar un papel de indi cadores de contaminaci\u00f3n fe cal, ofreciendo una nueva \nherramienta para determinar la calidad microbiol\u00f3gica. \n  \nEn el \u00faltimo estudio incluido en esta Tesis y descrito en el Cap\u00edtulo V (Estudio 7) se ha \nrealizado la modelizaci\u00f3n matem\u00e1tica del riesgo de infecci\u00f3n (colonizaci\u00f3n/invasi\u00f3n de un microorganismo pat\u00f3geno en una parte determ inada del cuerpo o tejido) y enfermedad \n(estatus consecuent e de afecci\u00f3n de un ser vivo, caracteriz ado por una alteraci\u00f3n de su estado \nde salud) asociado al consumo de ostras contam inadas por NoV. Este trabajo se realiz\u00f3 en \ncolaboraci\u00f3n con el Departamento de Zoonosis  y Microbiolog\u00eda Ambiental (LZO) del Instituto \nNacional de Salud P\u00fablica y Ambiental (RIVM)  holand\u00e9s, durante una estancia de 6 meses \nrealizada en 2008. Frecuentemente se describen infecciones por NoV asociadas al consumo de moluscos bivalvos (Ahmed, 1992; Altekruse, et al. , 1999). Las ostras se contaminan a trav\u00e9s del \nfiltrado de agua de mar que contiene part\u00edc ulas v\u00edricas (USFDA, 2001), reteniendo los virus \nincluso despu\u00e9s de aplicar los tr atamientos de depuraci\u00f3n. Tal y como se ha descrito para \nmejillones y almejas en el Cap\u00edtulo IV, las ostras que pueden considerarse seguras para el consumo humano ya que cumplen con la actual legislaci\u00f3n europea (basada en E. coli ), \npresentan concentraciones elevadas de NoV (Cheng et al. , 2005; Boxman, et al. , 2006; Nishida \net al. , 2007) y representan un riesgo real para la salud del consumidor (Lodder-Verschoor et \nal., 2005). En la actualidad, la magnitud del efecto adverso originado por dichas infecciones a \nnivel de salud p\u00fablica se desconoce por comple to, especialmente si queremos considerar las \ninfecciones secundarias que tienen  lugar a partir de \u00e9stas. \n \nLa evaluaci\u00f3n cuantitativa de riesgo micr obiol\u00f3gico es un nuevo componente dentro Resumen general \n 245del campo de la seguridad microbiol\u00f3gica en alimentos y est\u00e1 ganando terreno r\u00e1pidamente \ndebido a su f\u00e1cil implementaci\u00f3n a la hora de estimar el riesgos asociado a la contaminaci\u00f3n \nmicrobiana de los alimentos (Vose, 1998). Actualmente, ECRM est\u00e1 siendo aplicada para establecer nuevos est\u00e1ndares, gu\u00edas y otras recomendaciones respecto la seguridad alimentaria y la salud del consumidor. La evalua ci\u00f3n de riesgo es una herramienta de gran \nutilidad para calcular de forma precisa las probabilidades de infecci\u00f3n y enfermedad, y lo que es m\u00e1s importante, establecer los puntos cr\u00edticos  de control para una posterior intervenci\u00f3n.  \n \nEl riesgo de infecci\u00f3n fue evaluado en dos escenarios distintos; (i) en el escenario 1 se \nestudio la concentraci\u00f3n de NoV presente en las ostras procedentes del estuario de \nOosterchelde (Holanda), zona de producci\u00f3n de moluscos bivalvos clase A seg\u00fan las actuales regulaciones europeas, mientras que en el (ii) escenario 2 se utilizaron datos procedentes de \nun peque\u00f1o brote familiar de gastroenteritis identificado en el 2004, tambi\u00e9n localizado en \nHolanda.  \nLa exposici\u00f3n a NoV, o dosis ( D) debido al consumo de os tras depende de (i) n\u00famero \nde NoV infecciosos en las ostr as en el momento del consumo ( C\ncons) y (ii) n\u00famero de ostras \nconsumidas por persona ( N) de acuerdo con la siguiente ecuaci\u00f3n: \n \nD = C cons x N \n Al mismo tiempo, C\ncons depende de (i) n\u00famero de NoV infecciosos por ostra en el \nmomento de la recolecci\u00f3n ( Charv), (ii) eliminaci\u00f3n de NoV durante los procesos de depuraci\u00f3n \n(sdep), (iii) la tasa de inactivaci\u00f3n decimal de NoV por d\u00eda ( \u03b4), (iv) tiempo transcurrido entre la \nrecolecci\u00f3n y el consumo ( t), (v) eficiencia de recuperaci\u00f3n para NoV ( R), (vi) l\u00edmite de \ndetecci\u00f3n de la RT-qPCR ( \u03bb), y (vii) fracci\u00f3n de No V infecciosos por ostra ( \u03c6) de acuerdo con la \necuaci\u00f3n que sigue a continuaci\u00f3n: \n \nCcons = C harv x s dep x 10\u03b4xt x (1/R) x \u03bb x \u03c6 \n \nPara poder llevar a cabo el modelo desarro llado y obtener result ados que nos hablen \nde las probabilidades de infecci\u00f3n y enfermed ad, se tuvo que recopilar informaci\u00f3n para \ncomplementar cada uno de los par\u00e1metros de scritos. En todo momento, se trat\u00f3 de \nimplementar el modelo de manera equilibrada , pensando en la potencial aplicaci\u00f3n para \nfuturos trabajos. Resumen general \n 246La estimaci\u00f3n de Ccons se obtuvo mediante una simu laci\u00f3n de Monte Carlo (10.000 \nr\u00e9plicas) a partir de una distribuci\u00f3n gama ap licada al modelo matem\u00e1tico desarrollado. Los \nresultados obtenidos a partir de la RT-qPCR fueron utilizados para establecer los l\u00edmites y escalar los par\u00e1metros de la distribuci\u00f3 n gama. Los valores de recuperaci\u00f3n ( R) de los m\u00e9todos \nutilizados se desconoc\u00edan, de manera que se asumi\u00f3 que la eficiencia fue del 100%, y los \nefectos sobre las probabilidades finales de infecci\u00f3n/enfermedad debido a recuperaciones menos eficientes se evaluaron mediante un an\u00e1lisis de sensibilidad. Por otro lado, el l\u00edmite de detecci\u00f3n ( \u03bb) de la RT-qPCR utilizada pa ra el estudio aqu\u00ed presenta do tambi\u00e9n se desconoc\u00eda, \naunque estudios realizados sobr e la detecci\u00f3n de NoV en mari sco describen concentraciones \nque oscilan entre 1 \u2013 100 GC/gramo, utilizando diferentes protocolos (Muniain-Mujika et al. , \n2003; Vinj\u00e9 et al. , 2003; Kou et al. , 2006). Para estimar el riesgo de infecci\u00f3n asociado a NoV se \nutiliz\u00f3 un l\u00edmite de detecci\u00f3n de 1 PDU. \n \nTodas las ostras utilizadas en el estudio provienen de \u00e1reas de cultivo clase A de \nacuerdo con la legislaci\u00f3n europea, de manera que  no existe la aplicaci\u00f3n de tratamientos de \ndepuraci\u00f3n para tratar de disminuir la carga micr obiana antes de introducirse al mercado. Por \nlo tanto, la eliminaci\u00f3n de NoV debida a la ut ilizaci\u00f3n de tratamientos de depuraci\u00f3n no se \nconsider\u00f3 ( s\ndep). \n \nLa tasa de inactivaci\u00f3n de NoV ( \u03b4) es un par\u00e1metro extremadamente complicado de \nestimar en ausencia de cultivo celular, tal y como ocurre con NoV (Duizer et al. , 2004a; 2004b). \nNo obstante, existen virus de la misma familia, MNoV y FCV, que s\u00ed pueden ser cultivados (Wobus et al. , 2004; Buckow et al. , 2008). Diversos trabajos describen una elevada estabilidad \nde estos virus en cultivo celular y en suspension es fecales, evidenciando una inactivaci\u00f3n de \nmenos de un logaritmo tras estar 14 y 40 d\u00edas en dichas matrices, respectivamente, a 4 \u00baC \n(Duizer et al. , 2004a; Lee et al. , 2008a). Considerando que las regulaciones europeas \nrecomiendan un transporte y almacenaje en te mperaturas comprendidas entre los 4 y 7 \u00baC, y \nque las ostras son un producto con elevado reca mbio una vez han llegado al punto de venta, \nen la implementaci\u00f3n de este modelo se asumi\u00f3 que no ocurr\u00eda inactivaci\u00f3n para NoV entre el \ntiempo de recolecci\u00f3n y consumo. Respecto la  fracci\u00f3n de part\u00edculas v\u00edricas infecciosas ( \u03c6) \ndetectadas mediante la RT-qPCR, se le asign\u00f3 el valor 1.  \nEl n\u00famero promedio de ostras consumidas po r persona en este estudio fue evaluado \nmediante la b\u00fasqueda a trav\u00e9s de internet de 25 men\u00fas de restaurantes localizados en \nHolanda, as\u00ed como la utilizaci\u00f3n de material bibliogr\u00e1fico (Lowther et al. , 2010). Como parte de Resumen general \n 247los an\u00e1lisis de sensibilidad, se estim\u00f3 el riesgo de infecci\u00f3n a partir de la ingesti\u00f3n de 1 \u2013 20 \nostras. Para cada ostra incluida en el an\u00e1lisis se le asign\u00f3 aleatoriamente una concentraci\u00f3n de NoV procedente de la distribuci\u00f3n de C\nharv. \n \nTeunis et al.  (2008) describi\u00f3 una relaci\u00f3n de dosis respuesta para estimar la \nprobabilidad de infecci\u00f3n y la probabilidad condicional de enfermar tras ser infectado. Ambos modelos fueron aplicados en el estudio. La prob abilidad de infecci\u00f3n por part\u00edculas infecciosas \nde NoV como resultado de la dosis puede se r descrita de la siguiente manera (Teunis et al. , \n2008):  \n f ( D; \u03b1, \u03b2) = 1 \u2013 \n1F1(\u03b1, \u03b1 + \u03b2; \u2212D) \n \nDonde la D representa el n\u00famero de virus ingeridos durante un evento de consumo de \nostras, los par\u00e1metros \u03b1 y \u03b2 caracterizan la infectividad y 1F1 representa una funci\u00f3n \nhipergeom\u00e9trica confluente (Teunis et al. , 2008). La relaci\u00f3n dosis respuesta para la \nprobabilidad condicional de enfermedad tras que un individuo sea infectado se describe en funci\u00f3n de la siguiente f\u00f3rmula (Teunis et al. , 2008). Donde \u03b7 y r fueron descritos en un \nestudio previo (Teunis et al. , 1999). \n \nh (D\u2502\u03b7, r) = 1 \u2013 (1 + \u03b7 D) \u2013 r \n \nLos resultados obtenidos muestran que NoV GGII fue detectado en un 6,3% (4/63) de \nlas ostras recolectadas en el estuario de Oosterchelde, con una concentraci\u00f3n estimada de 7 PDU/ostra, mientras que 33% (3/9) de las ostras procedentes del brote infeccioso fueron positivas, mostrando una concentraci\u00f3n de 17 PD U/ostra. El riesgo de infecci\u00f3n asociado al \nconsumo de ostras procedentes del escenario 1 fue del 33%, variando entre un 8,4 \u2013 49% en \nfunci\u00f3n del n\u00famero de ostras consumida (1 \u2013 20 unidades). La probabilidad de encontrar una \nostra contaminada al consumir 6 ostras es del 29%. Para el escenario 2, el riesgo de infecci\u00f3n tras ingerir 6 ostras se estim\u00f3 en un 51%, os cilando entre un 47 \u2013 54% en relaci\u00f3n a una \ningesti\u00f3n de 1 \u2013 20 ostras. Para las muestras del estuario, la probabilidad de enfermar tras ser infectado fue de un 11%, oscilando entre 0,7 \u2013 27%, mientras que para el escenario 2, la \nprobabilidad de enfermar se estim\u00f3 en un 31%, oscilando entre 21 \u2013 36%.  \nEl efecto producido sobre la probabilidad de  infecci\u00f3n debido a la variabilidad en los \nprocesos de recuperaci\u00f3n de part\u00edculas v\u00edricas, extracci\u00f3n de AN y detecci\u00f3n de NoV fue Resumen general \n 248evaluado mediante an\u00e1lisis de sensibilidad y considerando una ingesti\u00f3n de 6 ostras. Los \nc\u00e1lculos muestran que la probabilidad de infecci\u00f3n var\u00eda de un 37% (40% de recuperaci\u00f3n) a un 33% (100% de recuperaci\u00f3n) para el escenario 1, y de un 54% (40% de recuperaci\u00f3n) a un 51% (100% de recuperaci\u00f3n) para el escenario 2.  \nEn conclusi\u00f3n, en el Estudio 7 se ha evaluado el riesgo de infecci\u00f3n y enfermedad \nasociado al consumo de ostras ( n = 6) contaminadas con NoV. El riesgo de infecci\u00f3n para el \nescenario 1 es del 33% y para el escenario 2 es del 51%. El riesgo de enfermedad asociado a estas infecciones es del 11% y 31% para cada  escenario, respectivamente. Durante la \nelaboraci\u00f3n del trabajo se han identificado puntos donde se carece de la informaci\u00f3n \nnecesaria para poder realizar una evaluaci\u00f3n del riesgo precisa, incluyendo la eficiencia de \nrecuperaci\u00f3n, el l\u00edmite de detecci \u00f3n de la RT-qPCR y la variaci\u00f3n en la concentraci\u00f3n de NoV \nentre zonas productoras de marisco clasificadas en diferentes clases (A \u2013 C). La obtenci\u00f3n de \ndicha informaci\u00f3n mejorar\u00e1 futuras evaluaciones  de riesgo para NoV. El presente modelo \ndesarrollado puede utilizarse en otros escenarios donde se quiera estimar los riesgos \nasociados al consumo de moluscos bivalvos contaminados por NoV, adem\u00e1s, informaci\u00f3n \ncuantitativa obtenida en otros lotes de marisco puede implementarse f\u00e1cilmente.  \nComo conclusi\u00f3n general de esta Tesi s podemos decir que existe una elevada \nprevalencia de virus en el medio ambiente, lo  que causa un importante impacto en la salud \np\u00fablica e importantes p\u00e9rdidas econ\u00f3micas principa lmente a trav\u00e9s de la transmisi\u00f3n de virus \npor agua y alimentos. El contro l de la contaminaci\u00f3n viral del medio ambiente requiere la \nestandarizaci\u00f3n de t\u00e9cnicas de concentraci\u00f3n y detecci\u00f3n y el desarrollo de un programa de \nvigilancia que permita valorar par\u00e1metros v\u00edricos y reducir la diseminaci\u00f3n de las enfermedades establecidas, as\u00ed como de las infecciones v\u00edricas emergentes. Con todo esto, \npodemos considerar que la presente Tesis ha contribuido al estudio de diferentes virus \npat\u00f3genos humanos que pueden ser transmitidos a la poblaci\u00f3n a trav\u00e9s del agua o alimentos \ncontaminados, aportando datos sobre la eficienc ia de eliminaci\u00f3n de virus en plantas de \ntratamiento de agua residual que producen ag ua regenerada (secundaria y terciaria) y en \nplantas depuradoras de moluscos bivalvos. Se  han propuesto mejores metodolog\u00edas y un \nnuevo m\u00e9todo de concentraci\u00f3n de virus en ag ua residual. Finalmente, se ha desarrollado un \nmodelo matem\u00e1tico para la evaluaci\u00f3n del ries go de infecci\u00f3n/enfermedad v\u00edrica por consumo \nde moluscos bivalvos contaminados. Overview \n 249OVERVIEW \n \nThe population impact on the planet's ecol ogical systems has been becoming more \napparent in recent years, highlighting the close relationship between environmental pollution levels and population health. Infectious diseases pose a great risk and are the leading cause of \ndeath in children and young adults. According to information provided by the World Health Organization, considering only diarrheal diseases often associated with consumption of contaminated food or water, about 2 million people die each year, mostly children under 5 \nyears (WHO, 2009). Among infectious diseases, viruses are the main cause of outbreaks \nrelated to contaminated water and food in the majority of developed countries where the improvement of sewage treatments has reduced the transmission of most of bacterial pathogens (Craun, 1991; reviewed in Godfree and Farrell, 2005). \n Environmental pollution from sewage is confirmed by analyzing the presence of \nviruses in surface waters (rivers and lakes), in which high percentages of positive samples are \nnoted (reviewed in Girones et al. , 2010), and in the frequent cases of viral infections \nassociated with consumption of molluscan sh ellfish that are observed every year in \nindustrialized countries (Lees, 2000). Enteric viruses in water can remain stable for months or even longer if they are associated with solids , and can accumulate in sediments subsequently \nresuspended in the water column by natural and artificial processes, facilitating viral spread (Melnick, 1984; Rao et al. , 1984; Rzezutka and Cook, 2004). It has been observed in some cases \nthat the current microbiological quality standards do not guarantee the absence of viruses, \nbeing isolated in drinking water, surface water, seawater or bivalve molluscan which meet the current bacteriological standards (Vivier et al. , 2004; Formiga-Cruz et al. , 2002, 2003). \n The first part of this Thesis (Chapter I) was designed to aim the study of the prevalence \nof emerging viruses, mainly hepatitis E virus, th rough a comparative analysis that allowed us to \nevaluate changes in excretion patterns of acute hepatitis in eastern Spain and simultaneously assess the presence of new polyomaviruses (Studies 1, 2 and 3). Previous studies developed in our research group had reported the presence of HAV and HEV in sewage collected in the period 1994 \u2013 2002 (Pina et al. , 2001; Clemente-Casares et al. , 2003), thus, the continuation of \nthese studies would let us determine the dynami cs of both pathogens. At the same time, the \ncharacterization and prevalence of different circulating strains in the studied population would \nprovide us with the information needed to determine whether HEV is still an emerging \npathogen, and if the availability of HAV vaccine  and implementation of universal vaccination Overview \n 250programs are having the expected effect compared  to the overall improvements at the level of \nsanitation, implementation of new depuration treatments and sewage treatment plants (STPs). Currently, HEV is considered the most important cause of acute clinical hepatitis among adults in central and south-east  Asia, and the second leading cause, behind the HBV, in the \nmiddle-west and north Africa (Das et al ., 2000; Ghabrah et al ., 1995; Gomatos et al ., 1996). On \nthe other hand, it is considered that HEV is responsible for fewer number of cases of hepatitis in the United States an d other industrialized countries, however , it has recently  been reported \nthat HAV is the main agent responsible for these infections (Purcell and Emerson, 2008). \n Data from Study 1 show that the presence of HEV in sewage from north-eastern Spain \nhas remained stable over the last decade ( 30%), while the presence of HAV has dropped \nconsiderably, from 57% (1994 \u2013 2002) to 3% (2006 \u2013 2008). This observation would lead to \nprompt that the decrease in the presence of HA V in sewage could be justified solely for the \nimplementation of an universal vaccination program for children under 12 years, which takes \nplace in Catalonia since 1999 (Oviedo et al. , 2009). To test this hypothesis, sewage samples \nfrom two geographic regions near the area of study were collected. The Autonomous Community of Valencia and two regions of northern Egypt were selected due to the absence of vaccination programs with high coverage a nd the characterization as an area of high \nendemicity for HAV, respectively. The observ ed data showed that in the absence of a \nvaccination plan and with the availability of a sanitation system (Valencia), the presence of HAV in sewage showed rates similar to those described in Catalonia, while samples from Egypt showed a high rate of positivity for HAV. T hus, the drastic reduction observed for HAV cannot \nbe justified solely because of the availability and implementation of an effective vaccine, we must consider that the reduction may also be  due to improved sanitary conditions in the \nregion. In the period 1992 \u2013 2008, Catalonia experienced a significant increase in the number \nof sewage treatment plants (91 to 343) and in the total volume of treated raw sewage (from \n991,892 to 2,786,871 m\n3/day). All samples showed high levels of HAdV (103 GC/mL), values \nfrequently observed in urban se wage. The observed HAV reduction have not had an equivalent \neffect on the circulation of HEV genotype 3 in  the area. The continued circulation of this \ngenotype would be maintained through animal hosts since HEV infections in swine represent \nan external source of HEV in the human popul ation. Described HEV sequences show a high \nsimilarity between the strains identified in sewage and faeces of pigs in the studied area by using samples from slaughterhouse, fact that de monstrate the circulation of such infectious \nagents between animals and humans living in surrounding areas. In addition, 19 sera samples from patients with acute hepatitis, negative for hepatitis B and C (samples provided by the Overview \n 251Hospital Universitari Vall d'Hebron in Barcelona ), were analyzed. Four of them were detected \npositive for HEV. The identification of positive HEV patients confirms the presence of these viruses not only in the environm ent but also in the human popul ation studied. Most of the HEV \nstrains identified were classified as genotype 3,  except for two samples (one sewage and one \nserum) which fell in the genotype 1 group. \n \n Following with the sporadic detection of the non-endemic genotype 1 in the evaluated \nregion, it was decided to deepen about this environmental prevalence in the north-eastern \nSpain (Study 2). Six urban sewage samples, two samples of urban biosolids and two samples of \nsludge from a slaughterhouse for cattle and pigs (80% pigs), all positive for HEV, were studied \nby cloning and sequencing with the purpose of  obtaining information about the potential \ndiversity of HEV strains excreted by the population. A total of 101 clones were sequenced and \nthe results showed that most st rains identified belong to genotype 3 (74 clones), although \ngenotype 1 was also detected. Two samples of sewage and one biosolid showed strains belonged to genotype 1, while the two slau ghterhouse samples resulted to be solely \ncontaminated with genotype 3, as expected. The sequences obtained in samples of animal origin showed a high similarity with strains of human origin previously reported in this study region. The similarity of sequences obtained in  the different samples studied (intra-sample) \nranges between 89% \u2013 99%. The sporadic circulation of this genotype in industrialized areas is a problem at the level of public health since it  has been associated with large outbreaks with \nhigh mortality rates. Contamination of food and water through contact with sewage, reclaimed water and biosolids, represents a significant risk to the population. In short, the results obtained show a simultaneous circulation of several strains of HEV in the population of the studied area.  \nAs a brief introduction to Study 3, we ha ve to consider that until 2007 only two \npolyomaviruses able to infect humans were known; BKPyV and JCPyV. BK polyomavirus was identified in the urine of renal transplant patients (Gardner et al. , 1971), while JCPyV was \nfound in the brain of a patient with PML (Padgett et al. , 1971). Recently, three new \npolyomaviruses have been discovered; the KI and WU polyomaviruses were identified in the respiratory tract of children (Allander et al. , 2007, Gaynor et al. , 2007) and MCPyV was found \nassociated with a rare type of cancer named Merkel cell carcinoma (Feng et al. , 2008). \nInterestingly, two different simian polyomaviruses (LPyV and SV40) have been associated with humans. SV40 has been introduced to humans through infected vaccine with poliovirus, and its role in cancer development in humans has b een extensively studied. Previous studies have Overview \n 252not detected the presence of SV40 in urban sewage indicating that, if SV40 is infecting \nhumans, is not being excreted into the enviro nment at detectable concentrations (Bofill-Mas \net al. , 2000). By contrast, antibodies against LPyV have been detected in human blood \nsamples, suggesting that LPyV also infects humans (Viscidi and Clayman, 2006). It has been also recently described the presence of LPyV vi ral particles in the peripheral blood of patients \nwith PML (Delbue et al. , 2008). \n Due to the fact that it has been described a high prevalence of JCPyV and BKPyV in \nurban sewage from different geographical areas and that it has been suggested that sewage has an important role in the transmi ssion of both pathogens (Bofill-Mas et al. , 2000, 2006), it \nwas decided to evaluate the ex cretion patterns of KIPyV, WUPyV, MCPyV and LPyV in urban \nsewage samples to determine their environmenta l prevalence and the role of these viruses as \nenvironmental pollutants (Study 3). It was also studied the presence of these pathogens in \nriver water and urine samples from healthy pregnant women. \n All analyzed samples showed frequently  detected records of human faecal \ncontamination evaluated by quantifying JCPyV (10\n2 GC/mL) and HAdV (103 GC/mL). The KI and \nWU polyomaviruses were detected in 1/8 and 2/8 sewage samples, respectively, while MCPyV was detected in 7/8 sewage samples and was the only new polyomavirus present in river water (2/7) and urine (1/4). Although qualitat ive detection was performed, serial dilutions \nallowed estimating a concentration of 10 to 100 PDU/mL. None of the sewage samples ( n = 13) \nand biosolids ( n = 9) was tested positive for LPyV. These data represent the first description of \nthe presence of new polyomaviruses KiPyV, WUPyV and MCPyV in the environment and confirm that these new polyomaviruses are fo und widespread among human populations. The \nhigh prevalence of MCPyV suggests that their pattern of excretion is similar to JCPyV and \nBKPyV. The presence of these viruses in sewage represents a potential route of infection for \nhumans and, to our knowledge, this work is th e first description of a virus isolated from \nsewage and river water with a strong association with cancer. \n Sewage is the main source of pathogenic microorganisms that are transmitted through \nthe environment and reach the population by the contamination of the water used in \nagricultural, industrial, household, recreational  and environmental activities (Cliver, 1984). The \ntreatment currently applied to the processed s ewage through biological and physicochemical \nmethods has reduced the incidence of disease among the population, especially those from \nbacterial etiology, but the protozoa and viruses are more resistant than bacteria to many of Overview \n 253these treatments. Significant concentrations of  viruses are frequently detected in sewage \ndischarged into the environment and in biosolids generated in STPs (Girones et al. , 2010). For \nthis reason, together with the high presence of pathogens observed in the three initial studies, in the Chapter II (Study 4) of this Thesis it was analyzed the spread a nd efficiency removal of \npathogens and faecal indicators in two tertiary sewage treatment plants. \n The obtained results show that viruses, bact eria and protozoa were highly detected in \neach sampling point from the studied STPs. Wate r samples were fortnightly collected over a \nperiod of five months (October 2009 \u2013 February  2010) at three different collection points: at \nthe entry point (raw sewage), at the exit point following secondary treatment and at the exit point following tertiary treatment (tertiary reclaimed water). Both STPs are able to depurate 60,000 (STP1) and 45,000 (STP2) m\n3/day respectively, and receive sewage from a population of \naround 250,000 inhabitants (located in the Autono mous Community of Valencia). The tertiary \ntreatments included UV disinfection as a tertiary treatment with a dose average of 100 mWs/cm\n2 and in one of them, combined the UV treatment with sand filtration disinfection as \nwell. \n \n Through collaboration between our research group and two other groups with expertise in bacteria and protozoa, located at Polytechnic University of Valencia, the microorganisms analyzed were faecal coliforms a nd the following groups of viruses: HAdV and \nJCPyV (both proposed as indicators of human fae cal/urine contamination), HAV, HEV, NoV GGI \nand NoV GGII. The bacterial pathogens analyzed were: Salmonella  spp., Vibrio vulnificus , Vibrio \nparahaemolyticus , Listeria monocytogenes , Arcobacter  spp. The protozoan pathogens analyzed \nwere Giardia  spp. and Cryptosporidium  spp. All analyzed pathogens and faecal indicators were \ndetected in each sampling point, except for HEV, JCPyV and Vibrio vulnificus  that were not \ndetected in tertiary reclaimed water. NoV GG II and JCPyV were quantified by qPCR, showing \naverage concentrations of 10\n4 and 102 GC/mL of raw sewage, respectively. HAdV and \nArcobacter  spp. were evaluated by infectivity assays, showing positive results in the different \nsampling points, including tertiary reclaimed water.  \nThe removal efficiency of HAdV, Giardia  spp. and Cryptosporidium  spp. was studied by \ncalculating the log reduction through the treatments applied in STPs. The primary treatment is applied mainly to eliminate large material that may pose a problem for the machinery involved in the rest of the cleaning, so that the removal expected for this process is negligible (Fu et al. , \n2010). On the contrary, the secondary treatment plays an important role in reducing Overview \n 254microorganisms and chemical contaminants. For the above reasons, the primary and \nsecondary treatments were evaluated together. As expected, the samples collected after the combination of the first two treatments showed the biggest drop in the concentration of microorganisms analyzed, showing a reduction from 1,03 to 1,51 log\n10 for HAdV, 1,99 to 2,56 \nlog 10 for Giardia  spp. and from 1,28 to 1,37 log 10 for Cryptosporidium  spp., reduction equal to \n60% \u2013 89% of the estimated total reduction. The application of UV disinfection showed values lower than expected, particularly from 0,04 to 0,13 log\n10, 0,30 to 0,34 log 10 and 0,18 to 0,34 \nlog 10 for HAdV, Giardia  spp. and Cryptosporidium  spp., respectively, equivalent to 2 \u2013 17% of \nthe total. Exceptionally, one of the treatment plants showed a reduction of 40% (0,90 log 10) for \nCryptosporidium  spp. The use of sand filters repres ented a reduction of 4 \u2013 17%. Human \nadenoviruses quantified by qPCR were detected in 100% of the samples, from 103 GC/mL in \nthe raw sewage to 101 GC/mL in the tertiary reclaimed water. The application of UV and sand \nfilters is required for disinfection and main tenance of water quality, reducing the need for \nchlorination. However, the data show that due to the high cost associated and the limited effect on reducing the pathogens tested, the treatments currently used should be improved. \n The results obtained in this study indicate that the high prevalence and concentration \nin sewage and reclaimed water of a wide range of pathogens evaluated represents a significant \nhealth risk and a current challenge for the development of new sanitation systems. The \ntreatments reduce the presence of HAdV, Giardia  spp. and Cryptosporidium  spp., \npathogens/indicators with high environmental resistance and against treatments, between 1,2 \nto 3,0 log\n10, being not enough to ensure an adequate microbiological quality of reclaimed \nwater. The presence of viable pathogens in tertiary reclaimed water that meets the current Spanish regulations (Anonymous, 2007) corroborates the risk to public health and the need to implement new microbiological indicators that wo uld be more restrictive. Furthermore, using \nlogistic regression it was examined the ability of  prediction that HAdV offered for the presence \nof Cryptosporidium  and Giardia , although there were no good correlations. Nevertheless, \ndespite not being able to predict the presence of both parasites because HAdV was present in \nall samples analyzed, even in the absence of  other pathogens, its high prevalence and \nconcentration suggest a role as protective indicator of faecal contamination. \n At this point of the Thesis we have demonstr ated the high prevalence of viral, bacterial \nand protozoa in sewage and reclaimed water, sh owing that they represent the largest source \nfor the introduction of pathogens in the environment, particularly viral pathogens. Due to the laboriousness and/or high cost associated wi th current methodology for viral particles Overview \n 255concentration in sewage, in the Study 5 described in Chapter III, we developed a new cost \nefficient methodology to concentrate virus particles. In order to find a protocol that was easily standardizable, economical and efficient, three different strategies to concentrate HAdV, JCPyV and NoV GGII (as DNA and RNA model viruses) in sewage were addressed. \n The first method described (ESMP) consists of an initial elution using a 0,25 N glycine \nbuffer, pH 9,5 (1:2 v/v). The sample (50 mL) is homogenized for 30 min on ice and then centrifuged at 8.000x g for another 30 min at 4 \u00baC. The obtained supernatant (150 mL) is \ntransferred to a new vessel, the pH adjusted to 3,5 using 1N HCl and 1,5 mL of a pre-flocculated skim milk solution is added (final concentration 0,01% (w/v)). The pre-flocculated skim milk solution is prepared according to Calgua et al.  2008. Following, the sample is kept \nunder stirring for 8 h at RT to a llow the viruses to adhere to th e milk flocs. Subsequently, the \nflocs are precipitated by centrifugation at 8.000x g for 30 min at 4 \u00baC. The supernatant is \ncarefully removed and the pellet is resuspended in 500 \u03bcL of a phosphate buffer at pH 7,5. \n The second method developed (UF) uses the ultrafiltration as the basic principle for \nconcentration. First, four filters per sample ar e washed (Millipore Ultrafree\u00ae-15 filter, 100,000 \nMW) with bi-distilled water, centrifuged at 2.000x g for 10 min and the filtrate is discarded \nfrom each one of them. For a tested sample, 45 mL of sewage are transferred to 3 pre-washed \nfilters (15 mL per filter), centrifuged at 2.000x g for 1 h at RT and the filtrate is discarded. The \nviruses are eluted from each filter using 4 mL of 0,25 N glycine buffer at pH 9,5. The viral eluate is transferred to a sterile tube, incuba ted 30 min at 4 \u00baC (homogenizing every 10 min) \nand centrifuged at 3.000x g for 30 min at 4 \u00baC. The supernat ant is recovered and added to a \nnew pre-washed filter, centrifuged at 2.000x g for 1 h at RT and the liquid retained in the filter \n(100 \u03bcL) containing the viral particles is recovered. \n \nIn the last of the developed methods (LF), 50 mL of sewage are frozen at -80 \u00baC and \nlyophilized for 24 to 36 h. Once the sample is lyophilized, the remaining particles are resuspended in 500 \u03bcL of phosphate buffer at pH 7,5. \n The new described methods were compared with a protocol based on \nultracentrifugation (UC) to concentrate the viral particles present in the sewage. This method has been previously described in our laboratory (Pina et al., 1998a) and has been used for the \ndetection of viral particles in the studies included within the first two chapters of this Thesis. \n Overview \n 256These four methods were used to evaluate the presence of HAdV, JCPyV and NoV GGII \nin five urban sewage samples collected in Barcelona. The results showed that the most \nefficient method for HAdV was ESMP, followed  by LF, UF and UC. For JCPyV the higher \nquantified values were obtained  in ESMP, followed by UC, LF and UF. Finally, for NoV GGII the method with highest obtained quantification was ESMP, followed by UC, LF and UF. \n Although the four methods studied showed a good performance for the recovery of \nthese three viral species, including DNA and RNA viruses, in the present work we tend to deepen the study of ESMP because this is the proposed method that requires less equipment \nand presents a fewer economic investment. The CV ([standard deviation/mean] x 100) was used as an estimator of the intra-laboratory variability and the results observed were 15,9% \nfor HAdV, 12,2% for JCPyV and 17,4% for NoV GGII. Concerning recovery, ESMP presented \nvalues between 30% \u2013 95%, 55% \u2013 90% and 45% \u2013 90% for HAdV, JCPyV and NoV GGII, \nrespectively. Finally, the chosen method was validated by a field study in which 12 composite 24 h-sewage samples were evaluated. The results obtained for the viruses studied were found to be within normal ranges of detection, both in previous studies of this Thesis and in other \nstudies performed previously in our laboratory (Bofill-Mas et al., 2006). The results show that \nESMP can be applied in large-scale studies and is a quick methodology, inexpensive and readily \nstandardizable to be applied in routine labo ratories and countries with poor economic \ndevelopment. However, if equipment (ultracent rifuge and/or lyophilizator) and sufficient \nfinancial resources (mainly to buy the filters) ar e available, the other proposed alternatives can \noffer advantages in certain situations because they can provide a faster concentration procedure or a more generalized viral spectrum. \n The second main section of this Thesis (Cha pters IV and V) focuses on the study of \nmolluscan shellfish as responsible for outbre aks. After verifying the high presence of \npathogens in sewage and reclaimed water, it is expected that the bivalve molluscan growing in estuaries, where such water is discharged, present human pathogens. \n In the Chapter IV it has performed a large study for the evaluation of the presence of \nenteric viruses in molluscan shellfish samples collected in a range of regional markets and \ngrocery stores from September to February of 2004 \u2013 2008, via a surveillance system (Food Safety Plan of Catalonia). Among the collected samples, (i) 87 batches of mussels and 30 batches of clams had been harvested in Sp anish shellfish-growing areas (Autonomous \nCommunity of Galicia and Catalonia, NW and NE Spain, respectively), whereas (ii) 14 batches Overview \n 257of mussels and 20 batches of clams had been imported and harvested in shellfish-growing \nareas of the EU (Italy, France and Portugal). The evaluation by RT-PCR shows the absence of \nNoV GGI and HAV among the analyzed samples, while NoV GGII was detected in 13,7% (16/117) of national samples and in 8,8% (3/34)  of the samples imported from Europe. During \nthe study period, 16,8% (17/101) of the mussels and 4% (2/50) of clams were positive for NoV GGII. Subsequent statistical analysis showed no significant differences between positives \ndetected according to the origin of the samples , although significant differences regarding the \nanimal species tested were found , being mussels the most contaminated samples by NoV GGII. \n Parallel to the market study, ten ba tches of imported coquina clams ( Donax trunculus ), \nsuspected to be linked to the cases of an HAV outbreak reported in eastern Spain in 2008, were collected from Spanish markets and groceries. The RT-PCR showed that 50% (5/10) of the \nsamples were contaminated with HAV. One of the HAV-positive coquina samples was also \npositive by qPCR, with an estimated concentration of 10\n2 GC/g HP. Sequencing analyses \nidentified the presence of subgenotypes IA a nd IB, genotypes usually de tected in Europe and \nsouth America. Subsequent co mparative studies, using a positive sewage sample for HAV \npreviously isolated in the same area during the outbreak and in the same period of time (included in Study 1), showed a similarity over 96% \u2013 98,2%. The differences detected between the sequences isolated from the coquina clams and the sewage suggest that both contaminants have different origins. \n In addition to the analysis of NoV and HAV, human adenoviruses were quantified by \nqPCR in a group of 30 samples (24 mussels a nd 6 clams), ten of which were positive and \ntwenty negative for NoV GGII. The overall resu lts show that 43,3% (13/30) were positive for \nHAdV. Among the positive samples for NoV GG II, 80% (8/10) were HAdV-positive with an \naverage concentration of 10\n3 GC/g HP, while only 25% (5/20) of negative NoV GGII resulted to \nbe also negative for HAdV, with an average concentration of 101 GC/g HP. According to the \nobtained results, a potential correlation between HAdV and NoV GGII was analyzed in order to predict the presence of NoV II by quantitative detection of HAdV, and significant differences \nbetween the two groups evaluated were also assessed. The association between HAdV and NoV GGII reflects a sensitivity of 100% and a specificity of 74%. \n To elucidate why samples of molluscan shellfish which meet the current European \nlegislation have viral pathogens and to understand how treatments affect the viral load, it was studied the efficiency of microorganism\u2019s removal that takes place in current purification Overview \n 258treatments. A total of 40 batches of mussels and 20 samples of seawater used in the \npurification process, both matrices collected during May-June 2010, were collected from three \nseafood companies that perform different systems for the purification of shellfish grown in an \narea classified as type B, according to the Europe an regulations. The treatments used to purify \nshellfish were: (i) ozone, (ii) venturi system and (iii) ozone combined with UV. Shellfish samples collected before and after depuration were take n from the same batch (24 h) to observe the \nreduction of microbiological contamination. The presence HAdV was quantified between the \nselected samples, showing a 70% (14/20) of po sitives among samples fr om untreated mussels \nand 60% (12/20) of positives among the purified ones, with average levels of 10\n2 GC/g HP for \nboth types of samples. A 42% (5/12) of sample s of seawater used for purification and 50% \n(6/12) of seawater samples after purificat ion were positive for HAdV, with average \nconcentration values of 102 GC/L. Statistical analyses showed no significant differences \nbetween samples pre- and post- purified, suggesting th at we cannot consider that the different \ntreatments applied have any effect on the presence and concentration of HAdV in the \nevaluated samples. All samples were negative for NoV, presumably due to the sampling \nperiod. NoV infection is associated with the colder months, having a minimal impact during May \u2013 June. \n Although the analyses by qPCR provide accu rate quantitative information, there is no \nindication about the presence of infectious vira l particles among the contaminating viruses. To \nelucidate this aspect an immunofluorescence assay  (IFA) for HAdV based on previous work by \nour research group was adapted. Specifically , it was performed following the protocol \ndescribed by Calgua et al.  (2011). Two HAdV-positive samples from each developed \npurification treatments were selected, showing a 50% (3/6) of positive samples for this pathogen. \n \nThe results indicate that current shellf ish depuration systems applied to reduce \nbacterial indicators do not affect levels of viral contamination and are unable to inform about the presence of food-borne viral pathogens such as HAV and NoV. It also confirms previous studies showing that shellfish complying with EU regulations may be contaminated by viral pathogens such as NoVs (Lees, 2000; Formiga et al. , 2002; Romalde et al. , 2002; Muniain-\nMujika et al. , 2003). \n In conclusion, the Chapter IV of this Thes is describes the quantitative and qualitative \npresence of viral contaminants in shellfish fr om north-east Spanish markets, defining the Overview \n 259abundance of NoVs as contaminants in mussels and clams, as well as the absence of HAV in \nthe common market and the presence in samples potentially related to an outbreak originated from the consumption of frozen clams import ed from endemic areas The overall results \nindicate that the presence and concentrations of human pathogens in bivalve molluscan represent a challenge for sanitation systems. Simultaneously, it is suggested that HAdV \nquantified by qPCR may play a role as indicators of faecal contamination, providing a new tool \nfor determining the microbiological quality. \n In the latest study included in this Thesis and described in Chapter V (Study 7) it was \nperformed mathematical modeling of the risk of infection (colonization/invasion of a pathogen \nin a particular body part or tissue) and disease  (consequent status of a condition in a living \nbeing, characterized by impaired health stat us) associated with the consumption of oysters \ncontaminated with NoV. This work was done in collaboration with the Department of \nZoonoses and Environmental Microbiology (LZO), National Institute of public health and Environment (RIVM), Netherlands, during a 6 mo nth stay in 2008. NoV infections associated \nwith consumption of bivalve molluscan are often described (Ahmed, 1992; Altekruse, et al. , \n1999). The oysters are contaminated through the filtration of seawater containing viral particles (USFDA, 2001), retaining the virus even after applying the purification treatments. As described for mussels and clams in Chapter IV, oysters that can be considered safe for human \nconsumption as they comply with curre nt European legislation (based on E. coli ), have high \nconcentrations of NoV (Cheng et al. , 2005; Boxman et al. , 2006, Nishida et al. , 2007) and \nrepresent a health risk for th e consumer (Lodder-Verschoor et al. , 2005). At present, the \nmagnitude of the adverse effect caused by these infections at the level of public health is completely unknown, especially if we consider the secondary infections that occur consequently. \n \nQuantitative microbiological risk assessme nt (QMRA) is a new component within the \nfield of food microbiological safety and is quickly increasing interest because of its easy implementation at estimating the risks associated with food microbial contamination (Vose, 1998). Today, QMRA is being applied to set new standards, guidelines and other recommendations for food safety and consumer he alth. Risk assessment is a useful tool to \naccurately calculate the probability of infection and disease, and most importantly, establish critical check points for further intervention. \n The risk of infection was evaluated in two di fferent scenarios: (i) in the scenario 1 it Overview \n 260was studied the NoV concentration present in oysters from the Oosterchelde estuary \n(Netherlands), area of production of bivalve molluscan under the current Class A European regulations, while in the (ii) scenario 2 it w as used data from a small family outbreak of \ngastroenteritis identified in 2004, also located in the Netherlands. \n The exposure to NoV, or dose ( D) due to consumption of oysters depends on (i) the \nnumber of infectious NoV in oysters at the time of consumption ( C\ncons) and (ii) the number of \noysters consumed per person ( N) according with the following equation: \n \nD = C cons x N \n \nAt the same time, the Ccons depends on (i) the number of in fectious NoVs per oyster at \nthe moment of harvest ( Charv), (ii) the removal of NoVs during depuration (s dep), (iii) the decimal \ninactivation rate of NoVs per day ( \u03b4), (iv) the time period between harvest and consumption \n(t), (v)  the efficiency of the recovery procedures for NoV ( R), (vi) the detection limit of the RT-\nqPCR ( \u03bb), and (vii) the fraction of infectious NoVs per oyster ( \u03c6) as described by following \nequation: \n \nCcons = C harv x s dep x 10\u03b4xt x (1/R) x \u03bb x \u03c6  \n \nTo carry out the developed model and obtain results that tell us about the probabilities \nof infection and disease, it was needed to collect data to fill the identified gaps. At all times, we tried to implement the model in a balanced manner, considering the potential application for future works. \n \nEstimates of C\ncons were obtained by taking 10,000 Monte Carlo samples from a gamma \ndistribution applied to the deve loped mathematical model. The obtained results from RT-qPCR \nwere used to establish the limits and scale the parameters of the gamma distribution. The recovery values ( R) of the methods used were unknown, thus it was assumed that the \nefficiency was 100%, and the effects on final probab ilities of infection/illness due to less \nefficient recoveries were evaluated by a sensitiv ity analysis. Furthermore, the detection limit \n(\u03bb) of the RT-qPCR used for the study presented here was also unknown, although studies on \nthe detection of NoV in shellfish describe concentrations ranging 1 \u2013 100 GC/gram, using different protocols (Muniain-Mujika et al. , 2003; Vinje et al. , 2003; Kou et al. , 2006). To \nestimate the risk of infection associated with NoV it was used a detection limit of 1 PDU. Overview \n 261All oysters used in the study come from class A growing areas according to European \nlegislation, hence, there is no application of  purification treatments to try to reduce the \nmicrobial load before entering the market. Therefore, the elimination of NoV due to the use of purification treatments is not considered ( s\ndep). \n The inactivation rate of NoV ( \u03b4) is an extremely difficult parameter to estimate in the \nabsence of cell culture, as it occurs with NoV (Duizer et al. , 2004a, 2004b). However, there are \nviruses of the same family, MNoV and FCV, which can be cultured (Wobus et al. , 2004; Buckow \net al. , 2008). Several studies describe a high stability of these viruses in cell culture and in \nfaecal suspensions, showing inactivation of less than one log after being 14 and 40 days in these matrices at 4 \u00baC, respectively (Duizer et al. , 2004a; Lee et al. , 2008a). Considering that \nthe European regulations recommend a transport and storage temperatures from 4 to 7 \u00baC \nand that oysters are a product with high turnover  once they have reached the point of sale, for \nthe implementation of this model it was assumed that inactivation did not happen for NoV between the time of collection and consumption. Regarding the fraction of infectious viral particles ( \u03c6) detected by RT-qPCR, this was assigned with the value 1. \n The average number of oysters consumed pe r person in this study was assessed by \ndoing a web survey of 25 menus from different restaurants in The Netherlands regarding the size of oyster servings, as well as the use of bibliographic material (Lowther et al. , 2010). As \npart of sensitivity analysis, we estimated the risk of infection from the ingestion of 1 to 20 oysters. For each oyster included in the analysis it was randomly assigned a concentration of NoV from the C\nharv distribution. \n Teunis et al.  (2008) described a dose-response relationship to estimate the probab ility \nof infection and the conditional probability of becoming ill after being infected. Both models \nwere applied in the study. The likelihood of infection by infectious particles of NoV as a result of the dose can be desc ribed as follows (Teunis et al. , 2008): \n \nf ( D; \u03b1, \u03b2) = 1 \u2013 \n1F1(\u03b1, \u03b1 + \u03b2; \u2212D) \n \nWhere D represents the number of viruses in gested during an event of oyster \nconsumption, \u03b1 and \u03b2 parameters characterize the infectivity and 1F1 is a confluent \nhypergeometric function (Teunis et al. , 2008). The dose-response relationship for the \nconditional probability of disease when an indivi dual is infected is described in terms of the Overview \n 262following formula (Teunis et al. , 2008). Where \u03b7 and r were described in a previous study \n(Teunis et al. , 1999). \n \nh (D\u2502\u03b7, r) = 1 \u2013 (1 + \u03b7 D) \u2013 r \n \nThe results obtained show that NoV GGII was detected in 6,3% (4/63) of the oysters \nharvested in the Oosterchelde estuary, with an estimated concentration of 7 PDU/oyster, while 33% (3/9) of the oysters from the disease outbreak were positive, showing a concentration of 17 PDU/oyster. The risk of infection associated with consumption of oysters from the scenario 1 was 33%, ranging from 8,4 to 49% depending on the number of oysters \nconsumed (1 \u2013 20 units). The probability of finding one contaminated oyster after eating 6 oysters is a 29%. For scenario 2, the risk of infection after the ingestion of 6 oysters was \nestimated at 51%, ranging from 47 to 54% in relation to an intake of 1 to 20 oysters. For \nestuary samples, the likelihood of becoming ill after being infected was 11%, ranging from 0,7 to 27%, while for scenario 2, the probability of illness was estimated at 31%, ranging between 21 \u2013 36%. \n The effect caused on the probability of infection due to variability in the recovery \nprocesses of viral particles, nucleic acids extr action and detection of NoV was evaluated by a \nsensitivity analysis and considering an intake of 6 oysters. The calculations show that the probability of infection varies from 37% (40% recovery) to a 33% (100% recovery) for the scenario 1, and 54% (40% recovery) to a 51% (100% recovery) for scenario 2. \n In conclusion, in the Study 7 it was evaluated the risk of infection and disease \nassociated with the consumption of oysters ( n = 6) contaminated with NoV. The risk of \ninfection for scenario 1 is 33% and for scenario  2 is 51%. The risk of illness associated with \nthese infections is 11% and 31% for each scenario, respectively. During the elaboration of this study it has been identified points that lack necessary information to make an accurate risk \nassessment, including the recovery efficiency, the detection limit of RT-qPCR and the variation in the concentration of NoV among seafood produc er zones classified in different classes (A \u2013 \nC). Obtaining such information will improve future risk assessments for NoV. The present developed model can be used in other scenar ios that are willing to estimate the risks \nassociated with consumption of bivalve molluscan contaminated with NoV, besides, quantitative information obtained  from other batches of seafood  can be easily implemented. \n Overview \n 263As a general conclusion of this Thesis we can say that there is a high prevalence of \nvirus in the environment, causing a major public health impact and economic losses mainly through the transmission of viruses by water and food. The control of environmental viral \ncontamination requires the standa rdization of concentration a nd detection techniques and the \ndevelopment of a monitoring program designed to assess viral parameters and reduce the spread of established diseases and emergent vi ral infections. With all this, we can consider \nthat the present Thesis has contributed to th e study of different human pathogenic viruses \nthat can be transmitted to population through contaminated food or water, providing data on the efficiency of virus removal in sewage trea tment plants that produce reclaimed water and \nin bivalve molluscan treatment plants. Improv ed methodologies and a new method for viral \nconcentration from sewage have been proposed. Finally, we have developed a mathematical model to predict the associated risk of infe ction and illness due to  consumption of NoV-\ncontaminated bivalve molluscan shellfish.   \n  \n \n    \n6. CONCLUSIONES  Conclusiones \n 267Los objetivos desarrollados en esta Tesis han dado lugar a una serie de resultados publicados \no en fase de publicaci\u00f3n, concluyendo los siguientes puntos: \n \n1) La prevalencia de HEV en muestras de agua residual se ha establecido en un 30% (22/73) en los \n\u00faltimos a\u00f1os, demostrando que HEV est\u00e1 circulando entre la poblaci\u00f3n de Espa\u00f1a y que el agua \nresidual representa un foco de infecci\u00f3n para este pat\u00f3geno. \n \n2) La presencia espor\u00e1dica del genotipo 1 de HEV, no end\u00e9mico y pat\u00f3geno humano exclusivo, \nreafirman la hip\u00f3tesis de la amplia distribuci\u00f3n de los genotipos de HEV. Este genotipo \nrepresenta un riesgo importante para salud p\u00fablica ya que es responsable de brotes \nepid\u00e9micos con tasas de mortalidad elevadas, especialmente para mujeres embarazadas.  \n \n3) No se observan diferencias significativas en el patr\u00f3n de excreci\u00f3n de HAV al comparar las \naguas residuales de dos \u00e1reas geogr\u00e1ficas lim\u00edtrofes d\u00f3nde existen planes de vacunaci\u00f3n \ndistintos y niveles de saneamiento equivalentes, de manera que se presume que la reducci\u00f3n \ndr\u00e1stica en los niveles de HAV observada durante la \u00faltima d\u00e9cada no se debe a la aplicaci\u00f3n de \nun programa de vacunaci\u00f3n de amplia cobertura sino a la implementaci\u00f3n de tratamientos de \nagua residual y estaciones depuradoras, as\u00ed como a las mejoras en sanidad. \n \n4) Los resultados obtenidos sugieren que HEV ha reemplazado a HAV como la hepatitis v\u00edrica \ntransmitida a trav\u00e9s agua contaminada m\u00e1s abundante en nuestra \u00e1rea. \n \n5) Los nuevos poliomavirus KI (1/8), WU (2/8) y MC (7/8) han sido detectados en agua residual, \nMCPyV (2/7) tambi\u00e9n en agua de r\u00edo, indicando que pueden ser diseminados a trav\u00e9s de la \ncontaminaci\u00f3n por heces/orina del agua y potencialmente transmitidos por la ruta fecal-oral. A \nnuestro conocimiento, este trabajo representa la primera descripci\u00f3n de virus en agua residual \ny agua de r\u00edo asociado con c\u00e1ncer. \n \n6) A pesar de la actual implementaci\u00f3n de normativa espec\u00edfica que regula a la calidad \nmicrobiol\u00f3gica del agua regenerada y sus potenciales usos, la prevalencia y concentraciones de \npat\u00f3genos humanos (virus, bacterias y protozoos) en agua regenerada es elevada y representa \nun reto para los sistemas de saneamiento. \n \n7) Las estaciones depuradoras de agua residual estudiadas reducen significativamente la \npresencia de HAdV (1,03 \u2013 1,51 log 10), Cryptosporidium  (1,99 \u2013 2,56 log 10) y Giardia  (1,28 \u2013 1,37 \nlog 10), evaluados como indicadores de contaminaci\u00f3n fecal de elevada resistencia. No obstante, \nel hecho que la reducci\u00f3n debida exclusivamente a los tratamientos terciarios sea poco \nsignificativa y que se hayan detectado pat\u00f3genos viables en el agua regenerada, sugiere \nconsistentemente que los tratamientos aplicados deben perfeccionarse. \n \n8) Mediante diferentes aproximaciones t\u00e9cnicas (ultrafiltraci\u00f3n, floculaci\u00f3n org\u00e1nica y \nliofilizaci\u00f3n), se han desarrollado tres nuevos m\u00e9todos para concentrar part\u00edculas v\u00edricas en \nagua residual. El m\u00e9todo seleccionado presenta un reducido coste econ\u00f3mico, buena \nrepetitividad (CV = 12 \u2013 16%) y alta eficiencia de  recuperaci\u00f3n (30 \u2013 95%). El m\u00e9todo propuesto \nse basa en la floculaci\u00f3n org\u00e1nica y es f\u00e1cilmente estandarizable en laboratorios de rutina y \npa\u00edses de reducido desarrollo econ\u00f3mico. \n \n \n Conclusiones \n 2689) Se ha descrito la presencia cualitativa y cuantitativa de NoV GGII (19/151) y HAV (5/10) en \nmuestras de moluscos bivalvos de mercado recolectados a trav\u00e9s de un programa de vigilancia \nepidemiol\u00f3gica y muestras vinculadas a un brote de hepatitis A, respectivamente. Reafirmando \nla presencia de pat\u00f3genos v\u00edricos en muestras que cumplen las normativas vigentes. \n \n10) Se ha evaluado la eficiencia de tres tratamientos de depuraci\u00f3n de moluscos bivalvos (UV, \nventuri y Ozono-UV) utilizando a HAdV como indicador de la contaminaci\u00f3n fecal, y se ha \ncomprobado que son ineficientes a la hora de reducir la presencia de part\u00edculas v\u00edricas. Se ha \ndetectado la presencia de HAdV infecciosos (3/6 ) en muestras depuradas mediante los distintos \ntratamientos evaluados, evidenciando el potencial riesgo asociado al consumo de moluscos \nbivalvos crudos o poco cocinados. \n \n11) Se ha descrito una correlaci\u00f3n estad\u00edsticamente significativa entre la identificaci\u00f3n de muestras \nde moluscos bivalvos positivos para HAdV y para NoV GGII, mostr\u00e1ndose valores elevados de \nsensibilidad (100%) y especificidad (74%) de HAdV respecto la presencia de NoV GGII. \n \n12) Los adenovirus humanos cuantificados por qPCR representan una herramienta r\u00e1pida y efectiva \npara identificar la presencia de contaminaci\u00f3n fecal de origen humano en muestras de agua y \nalimentos (moluscos bivalvos). Los datos obtenidos muestran que los indicadores bacterianos \ncl\u00e1sicos no reflejan la presencia de virus ent\u00e9ricos humanos. \n \n13) Utilizando modelos de dosis-respuesta se ha modelizado matem\u00e1ticamente el riesgo de \ninfecci\u00f3n y enfermedad por NoV asociado al consumo de ostras crudas. El modelo se evalu\u00f3 \ncon datos obtenidos a partir de muestras procedentes de \u00e1reas de cultivo holandesas (4/63) y \nvinculadas a un peque\u00f1o brote de gastroenteritis (4/9) que tuvo lugar tambi\u00e9n en Holanda. Los \nresultados muestran elevadas probabilidades de infecci\u00f3n (8 \u2013 54%) y enfermedad (1 \u2013 36%) en \nfunci\u00f3n del n\u00famero de ostras ingeridas (1 \u2013 20), aunque se desconoce el impacto que puedan \nllegar a tener a nivel de salud p\u00fablica debido a las infecciones secundarias producidas a partir \nde aqu\u00ed. El modelo elaborado puede ser implementado f\u00e1cilmente con otros pat\u00f3genos o \nespecies de moluscos bivalvos. Conclusions \n 269The objectives developed in this Thesis have led to obtain results already published or under \npublication, concluding the following points: \n \n1) The prevalence of HEV in sewage samples has been established by 30% (22/73) in recent years, \ndemonstrating that HEV is circulating among the population of Spain and that sewage is a \nsource of infection for this pathogen. \n \n2) The occasional presence of HEV genotype 1, non-endemic and exclusive human pathogen, \nconfirm the hypothesis about the wide distributi on of the HEV genotypes. This genotype \nrepresents a significant risk to public health and is responsible for outbreaks with high mortality \nrates, especially for pregnant women. \n \n3) No significant differences in the excretion patterns of HAV by comparing sewage from two \nareas with different vaccination programs and equivalent levels of sanitation were observed, \nthus, the drastic reduction observed in the levels of HAV during the last decade is suggested \nnot to be due to the implementation of a universal vaccination program but due to the \nimplementation of sewage treatment and sewage treatment plants, such as to improvements \nin healthcare. \n \n4) The obtained results suggest that HEV has replaced HAV as the viral hepatitis transmitted \nthrough contaminated water more frequently detected in our area. \n \n5) The new polyomaviruses KI (1/8), WU (2/8) a nd MC (7/8) have been detected in sewage, \nMCPyV (2/7) also in river water, indicating that they can be potentially spread through \nfaecal/urine contaminated water and through the faecal-oral route. To our knowledge, this \nwork represents the first description of a virus isolated from sewage and river water strongly \nassociated with cancer. \n \n6) Despite the current implementation of specific regulations governing the microbiological \nquality of regenerated water and its potential uses, the prevalence and concentrations of \nhuman pathogens (viruses, bacteria and protozoa) in reclaimed water is high and represents a \nchallenge for sanitation. \n \n7) The studied sewage treatment plants significantly reduced the presence of HAdV (1,03 \u2013 1,51 \nlog 10), Cryptosporidium  (1,99 \u2013 2,56 log 10) and Giardia  (1,28 \u2013 1,37 log 10), evaluated as \nindicators of faecal contamination of high resistance. However, the exclusively observed \nreduction due to the tertiary treatment is not significant and viable pathogens were detected in \nthe tertiary reclaimed water, strongly suggesting that treatments should be improved. \n \n8) By different technical approaches (ultrafiltration, lyophilization and organic flocculation), three \nnew methods for concentrating virus particles from sewage have been developed. The selected \nmethod is a low-cost procedure and shows reproducible results (CV = 12 \u2013 16%) and efficient \nrecovery values (30 - 95%). The selected method is based on organic flocculation and is easily \nstandardizable in routine laboratories and countries with poor economic development. \n \n9) The qualitative and quantitative presence of NoV GGII (19/151) and HAV (5/10) have been \ndescribed in market bivalve molluscan shellfish samples through an epidemiological \nsurveillance program and linked to an outbreak of hepatitis A, respectively. Reaffirming the \npresence of viral pathogens in samples that meet the current regulations. Conclusions \n 27010) The effectiveness of three depuration treatments of bivalve molluscs were evaluated using a \nHAdV as an indicator of faecal contamination and were proven to be inefficient in reducing the \npresence of virus particles. It has been detected the presence of infectious HAdV particles (3/6) \nin depurated samples applying the different evaluated treatments, demonstrating the potential \nrisk associated with consumption of raw molluscan shellfish or undercooked. \n \n11) It has been described a statistically significant correlation between the identification of bivalve \nshellfish samples positive for HAdV and NoV GGII, showing high levels of sensitivity (100%) and \nspecificity (74%) of HAdV respect to the presence of NoV GGII. \n \n12) Human adenoviruses quantified by qPCR are a quick and effective tool to identify the presence \nof faecal pollution of human origin in samples of water and food (bivalve molluscan). The data \nobtained show that the classical bacterial indicators do not reflect the presence of human \nenteric viruses. \n \n13) Using dose-response models, the risk of NoV infection and disease associated with \nconsumption of raw oysters has been modeled mathematically. The model was evaluated with \ndata obtained from samples from Dutch farming areas (4/63) and linked to a small outbreak of \ngastroenteritis (4/9) that occurred also in the Netherlands. The results show high probabilities \nof infection (8 \u2013 54%) and disease (1 \u2013 36%) depending on the number of ingested oysters (1 \u2013 \n20), although it is unknown at what extent they  may have reached the level of public health \ndue to secondary infections produced from here. The model developed can be implemented \neasily with other pathogens or species of bivalve molluscan.  \n  \n \n    \n7. REFERENCIAS  Referencias \n 273REFERENCIAS \n \n-A- \n Abad FX, Pinto RM, Gajardo R, Bosch A. Viruses in mussels: public health implications and \ndepuration. J. Food Prot.  1997a; 60(6):677-81. \n Abad FX, Pint\u00f3 RM, Villena C, Gajardo R, Bosch A. Astrovirus survival in drinking water. Appl \nEnviron Microbiol.  1997b; 63(8):3119-22. \n Adam RD. Biology of Giardia lamblia. Clin Microbiol Rev.  2001; 14(3):447-75. \n \nAdler JL, Zickl R. Winter vomiting disease. J Infect Dis . 1969; 119(6):668-73. \n AESAN [Agencia Espa\u00f1ola de Seguridad Alimentaria y Nutrici\u00f3n].  Retirada de \ncoquinas/tellinas procedentes de Per\u00fa. 2008. Disponible en: http://www.aesan.msc.es/AESAN/web/not as_prensa/retirada_coquinas.shtml \n Aggarwal R, Krawczynski K. Hepatitis E: an overview and recent advances in clinical and \nlaboratory research. J Gastroenterol Hepat ol. 2000; 15:9-20. \n Aggarwal R, McCaustland KA, Dilawari JB, Sinha SD, Robertson BH. Genetic variability of \nhepatitis E virus within and between three epidemics in India. Virus Res . 1999; 59(1):35-48. \n Agn\u00e8s F, Crance JM, L\u00e9v\u00eaque F. Separate detection of the two complementary RNA strands of \nhepatitis A virus. J Virol Methods. 1994; 49(3):323-30. \n Ahmed, F.E.  Review: assessing and managing risk  due to consumption of seafood \ncontaminated with micro-organisms parasites and natural toxins in the US. Food Sci Technol \nInt. 1992; 27:243\u2013260. \n \nAlbinana-Gimenez N, Clemente-Casares P, Bofill-Mas S, Hundesa A, Ribas F, Girones R.  \nDistribution of human polyomaviruses, adenovirus es, and hepatitis E virus in the environment \nand in a drinking-water treatment plant. Environ Sci Technol.  2006; 40(23):7416-22. \n Albinana-Gimenez N, Miagostovich MP, Calgua B, Huguet JM, Matia L, Girones R. Analysis of \nadenoviruses and polyomaviruses quantified by qPCR as indicators of water quality in source \nand drinking-water treatment plants.  Water Res.  2009; 43(7):2011-9. \n Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Pe rsson MA, Dalianis T, \nRamqvist T, Andersson B.  Identification of a third human polyomavirus. J Virol.  2007; \n81(8):4130-6.  Altekruse SF, Yang S, Timbo BB, Angulo FJ.  A multi-state survey of consumer food-handling \nand food-consumption practices. Am J Prev Med.  1999; 16(3):216-21. \n Andea AA, Coit DG, Amin B, Busam KJ.  Merkel cell carcinoma: histologic features and \nprognosis. Cancer.  2008; 113(9):2549-58. \n Ando T, Noel JS, Fankhauser RL. Genetic classification of \"Norwalk-like viruses. J Infect Dis.  \n2000; 181(2):336-48. Referencias \n 274An\u00f3nimo, 1991. Council directive of 22nd July 1991 laying down the health conditions for the \nproduction and placing on the market of live bivalve mollusks (91/492/EEC). Off. J. Eur. \nCommunities L , 268:1-13. \n An\u00f3nimo, 1992.  B.O.E. 288/1992: Real Decreto 1315/1992, de 30 de octubre por el que se \nmodifica parcialmente el Reglamento del Dominio P\u00fablico Hidr\u00e1ulico, que desarrolla los T\u00edtulos Preliminar, I, IV, V, VI y VII de la Ley 29/1985, de 2 de agosto, de Aguas, aprobado por el Real Decreto 849/1986, de 11 de abril. Pp. 40563-40565.  An\u00f3nimo, 1993.  Real Decreto 308/1993, de 27 de marzo, por el que se aprueba la \nReglamentaci\u00f3n T\u00e9cnico-Sanitaria que fija las normas aplicables a la producci\u00f3n y comercializaci\u00f3n de moluscos bivalvos vivos. B.O.E. n\u00ba 74:9386- 9394.  An\u00f3nimo, 1999. Real Decreto 571/1999, de 9 de abril, por el que se aprueba la \nReglamentaci\u00f3n T\u00e9cnico-Sanitaria que fija las normas aplicables a la producci\u00f3n y comercializaci\u00f3n de moluscos bivalvos vivos. B.O.E. N\u00ba 86:13522-1353. An\u00f3nimo, 2000.  Directiva 2000/60/CE del Parlamento Europeo y del Consejo, de 23 de octubre \nde 2000, por la que se establece un marco comunitario de actuaci\u00f3n en el \u00e1mbito de la pol\u00edtica \nde agues. \n An\u00f3nimo, 2003.  Decisi\u00f3n de la Comisi\u00f3n de 30 de octubre de 2003 por la que se aprueban \nalgunos tratamientos para inhibir la profil eraci\u00f3n de microorganismos pat\u00f3genos en los \nmoluscos bivalvos y los gaster\u00f3podos marinos. DO L283:78-80.  An\u00f3nimo, 2004a.  Regulation (EC) 852/2004 of the European Parliament and of the Council of \n29 April 2004 laying down specific hygiene rules for food of animal origin. Off. J. Eur. \nCommunities L , 226:22-82. \n An\u00f3nimo, 2004b. Regulation (EC) 853/2004 of the European Parliament and of the Council of \n29 April 2004 laying down specific hygiene rules for food of animal origin. Off. J. Eur. \nCommunities L , 226:22-82. \n An\u00f3nimo, 2004c.  Regulation (EC) 854/2004 of the European Parliament and of the Council of \n29 April 2004 laying down specific rules for the organisation of official controls on products of animal origin intended for human consumption. Off. J. Eur. Communities  L, 226:83-127. \n An\u00f3nimo, 2005. Ley 11/2005 de 22 de junio publicada en el BOE n\u00famero 149 de 23/06/2005 \nen la que se exponen las deficiencias ambienta les y econ\u00f3micas del proyecto y mediante la \ncual se modifica la ley 10/2001 de 5 de julio del Plan Hidrol\u00f3gico Nacional \n An\u00f3nimo, 2006.  Commission Regulation (EC) n\u00ba 1666/2006 amending Regulation (EC) n\u00ba \n2076/2005 laying down transitional arrangements for the implementation of Regulations (EC) n\u00ba 853/2004, (EC) n\u00ba 854/2004 and (EC) n\u00ba 882/2004 of the European Parliament and of the Council. Off. J. Eur. Communities L , 320:47-49 18.11.06. \n An\u00f3nimo, 2007.  B.O.E. 294/2007: Real Decreto 1620/2007, de 7 de diciembre, por el que se \nestablece el r\u00e9gimen jur\u00eddico de la reutilizaci\u00f3n de las aguas depuradas. Pp. 50639-50661. \n An\u00f3nimo, 2008.  Commission regulation (EC) n\u00ba 1021/2008 of 17 October 2008 amending \nAnnexes I, II and III to Regulation (EC) n\u00ba 854/2004 laying down specific rules for the \norganization of official controls on products of animal origin intended for human consumption \nand Regulation (EC) No 2076/2005 as regards live bivalve molluscs, certain fishery products Referencias \n 275and staff assisting with official controls in slaughterhouses. Off. J. Eur. Communities L , 277: 15-\n17.  Ansari SA, Springthorpe VS, Sattar SA. Survival and vehicular spread of human rotaviruses: \npossible relation to seasonality of outbreaks. Rev Infect Dis.  1991; 13(3):448-61. \n Arankalle VA, Chobe LP.  Hepatitis E virus: can it be transmitted parenterally? J Viral Hepat . \n1999; 6(2):161-4.   \n-B- \n Babakir-Mina M, Ciccozzi M, Perno CF, Ciotti M.  The novel KI, WU, MC polyomaviruses: \npossible human pathogens? New Microbiol . 2011; 34(1):1-8. \n Bader TF, Krawczynski K, Polish LB, Favorov MO. Hepatitis E in a U.S. traveler to Mexico. N \nEngl J Med. 1991; 325(23):1659. \n \nBalayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, \nPoleschuk VF.  Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral \nroute. Intervirology . 1983; 20(1)23-31. \n Balayan MS. Epidemiology of hepatitis E virus infection. J Viral Hepat. 1997; 4:155-65. \n Barbuddhe SB, Chakraborty T. Listeria as an enteroinvasive gastrointestinal pathogen. Curr \nTop Microbiol Immunol. 2009; 337:173-95.  Barker J, Vipond IB, Bloomfield SF. Effects of cleaning and disinfection in reducing the spread \nof Norovirus contamination via environmental surfaces. Hosp Infect.  2004; 58(1):42-9.  \n Bavaro MF. Escherichia coli O157: what every internist and gastroenterologist should know. \nCurr Gastroenterol Rep.  2009; 11(4):301-6. \n Baylis SA, Finsterbusch T, Bannert N, Bl\u00fcmel J, Manker tz A. Analysis of porcine circovirus type \n1 detected in Rotarix vaccine. Vaccine.  2011; 29(4):690-7. \n Becker JC. Merkel cell carcinoma. Ann Oncol.  2010; 21(7):81-5. \n \nBerger JR, Kaszovitz B, Post MJ, Dickinson G.  Progressive multifocal leukoencephalopathy \nassociated with human immunodefi ciency virus infection. A review of the literature with a \nreport of sixteen cases. Ann Intern Med. 1987; 107(1):78-87. \n Berke T, Matson DO. Reclassification of the Caliciviridae into distinct genera and exclusion of \nhepatitis E virus from the family on the basis of comparative phylogenetic analysis. Arch Virol.  \n2000; 145:1421-36.  Beutin L, Martin A.  Outbreak of Shiga Toxin-Producing Escherichia coli (STEC) O104:H4 \nInfection in Germany Causes a Paradigm Shift with Regard to Human Pathogenicity of STEC Strains. J Food Prot.  2012; 75(2):408-18. \n Bialasiewicz S, Lambert SB, Whiley DM, Nissen MD, Sloots TP. Merkel cell polyomavirus DNA \nin respiratory specimens from children and adults. Emerg Infect Dis.  2009; 15(3):492-4. Referencias \n 276Bishop NE, Anderson DA.  Early interactions of hepatitis A virus with cultured cells: viral elution \nand the effect of pH and calcium ions. Arch Virol.  1997b; 142(11):2161-78. \n Bishop NE, Anderson DA. Hepatitis A virus subviral particles: purification, accumulation, and \nrelative infectivity of virions, provirions and procapsids. Arch Virol.  1997a; 142(11):2147-60.  \n Bishop RF, Davidson GP, Holmes IH, Ruck BJ. Virus particles in epithelial cells of duodenal \nmucosa from children with acute non-bacterial gastroenteritis. Lancet.  1973; 2(7841):1281-3. \n Black PH, Rowe WP, Turner HC, Huebner RJ. A specific complement-fixing antigen present in \nsv40 tumor and transformed cells. Proc Natl Acad Sci USA.  1963; 50:1148-56. \n Bofill-Mas S, Albinana-Gimenez N, Clemente-Casares P, Hundesa A, Rodriguez-Manzano J, Allard A, Calvo M, Girones R. Quantification and stability of human adenoviruses and \npolyomavirus JCPyV in wastewater matrices . Appl Environ Microbiol.  2006; 72(12):7894-6. \n Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, Calafell F, Girones R. Potential \ntransmission of human polyomaviruses through the gastrointestinal tract after exposure to \nvirions or viral DNA. J Virol.  2001; 75(21):10290-9. \n Bofill-Mas S, Hundesa A, Calgua B, Rusi\u00f1ol M, de Motes CM, Girones R. Cost-effective \nmethod for microbial source tracking using specific human and animal viruses. J Vis Exp.  2011; \n(58):2820  Bofill-Mas S, Pina S, Girones R. Documenting the epidemiologic patterns of polyomaviruses in \nhuman populations by studying their presence in urban sewage. Appl Environ Microbiol.  2000; \n66(1):238-45.  Boher S, Piclet G, Beril-Stien S, Masson D, Delonce R, Biziagos E, Schwartzbrod L. Viral \ncontamination and depuration of oysters under field conditions. Conference Internationale sur \nla Purification des Coquillages, Rennes (France), 6-8 Apr. 1992. Disponible en: http://archimer.ifremer.fr/doc/00000/1615/  Borchardt MA, Bradbury KR, Gotkowitz MB, Cherry JA, Parker BL.  Human enteric viruses in \ngroundwater from a conf ined bedrock aquifer. Environ Sci Technol.  2007; 41:6606-12. \n Bosch A, Guix S, Sano D, Pint\u00f3 RM. New tools for the study and direct surveillance of viral \npathogens in water. Curr Opin Biotechnol.  2008; 19(3):295-301. \n \nBosch A, S\u00e1nchez G, Le Guyader F, Vanaclocha H, Haugarreau L, Pint\u00f3 RM. Human enteric \nviruses in Coquina clams associated with a large hepatitis A outbreak. Water Sci Technol.  2001; \n43(12):61-5.  Bouwknegt M, Rutjes SA, Reusken CB, Stockhofe-Zurwieden N, Frankena K, de Jong MC, de Roda Husman AM, Poel WH. The course of hepatitis E virus infection in pigs after contact-\ninfection and intravenous inoculation. BMC Vet Res . 2009; 4:5-7. \n Boxman IL, Tilburg JJ, Te Loeke NA, Vennema H, Jonker K, de Boer E, Koopmans M.  Detection \nof noroviruses in shellfish in the Netherlands. Int J Food Microbiol.  2006; 108(3):391-6. \n Bradley DW, Balagan MS. Virus of enterically transmitted non-A, non-B hepatitis . Lancet.  \n1988; 1(8589):819. Referencias \n 277Bradley DW, Krawczynski K, Cook EH, McCaustland KA, Humphrey CD, Spelbring JE, Myint H, \nMaynard JE.  Enterically transmitted non-A, non-B hepatitis: serial passage of disease in \ncynomolgus macaques and tamarins and recovery of diseasea ssociated 27 to 34 nm virus like \nparticles. Proc Natl Acad Sci USA.  1987; 84(17):6277-81. \n Bradley DW.  Hepatitis E: epidemiology, aetiology and molecular biology. Rev Med Virol.  1992; \n2(1):19-28.  Breitenmoser A, Fretz R, Schmid J, Besl A, Etter R.  Outbreak of acute gastroenteritis due to a \nwashwater-contaminated water supply, Switzerland, 2008. J Water Health.  2011; 9(3):569-76. \n Brodsky JL, Pipas JM. Polyomavirus T antigens: molecular chaperones for multiprotein \ncomplexes. J Virol.  1998; 72(7):5329-34. \n Brown P, Tsai T, Gajdusek DC. Seroepidemiology of human papovaviruses. Discovery of virgin \npopulations and some unusual patterns of antibo dy prevalence among remote peoples of the \nworld. Am J Epidemiol.  1975; 102(4):331-40. \n \nBrownell MJ, Harwood VJ, Kurz RC, McQuaig SM, Lukasik J, Scott TM.  Confirmation of \nputative stormwater impact on water quality at a Florida beach by microbial source tracking methods and structure of indicator organism populations. Water Res.  2007; 41(16):3747-57. \n Brugha R, Vipond IB, Evans MR, Sandifer QD, Roberts RJ, Salmon RL, Caul EO, Mukerjee AK.  A \ncommunity outbreak of food-borne small round-s tructured virus gastroenteritis caused by a \ncontaminated water supply. Epidemiol Infect.  1999; 122(1):145-54. \n Buckow R, Isbarn S, Knorr D, Heinz V, Lehmacher A.  Predictive model for inactivation of feline \ncalicivirus, a norovirus surrogate, by heat and high hydr ostatic pressure. Appl Environ \nMicrobiol.  2008; 74(4):1030-8. \n Buti M, Dom\u00ednguez A, Plans P, Jard\u00ed R, Schaper M, Espu\u00f1es J, Carde\u00f1osa N, Rodr\u00edguez-Fr\u00edas F, Esteban R, Plas\u00e8ncia A, Salleras L. Community-based seroepidemiological survey of hepatitis E \nvirus infection in Catalonia, Spain. Clin Vaccine Immunol.  2006; 13(12):1328-32. \n Buti M, Jard\u00ed R, Cotrina M, Rodr\u00edguez-Frias F, Troonen H, Viladomiu L, Esteban JI, Esteban R, Guardia J.  Hepatitis E virus infection in acute hepatitis in Spain. J Virol Methods.  1995; 55:49-\n54.  \n \n-C- \n Cacci\u00f2 SM. Molecular techniques to detect and id entify protozoan parasites in the \nenvironment. Acta Microbiol Pol. 2003; 52:23-34. \n Calci KR, Meade GK, Tezloff RC, Kingsley DH. High-pressure inactivation of hepatitis A virus \nwithin oysters. Appl Environ Microbiol.  2005; 71(1):339-43. \n Calgua B, Barardi CR, Bofill-Mas S, Rodriguez-Manzano J, Girones R.  Detection and \nquantitation of infectious human adenovirus es and JC polyomaviruses in water by \nimmunofluorescence assay. J Virol Methods.  2011; 171(1):1-7. \n Calgua B, Mengewein A, Grunert A, Bofill-Mas S, Clemente-Casares P, Hundesa A, Wyn-Jones Referencias \n 278AP, L\u00f3pez-Pila JM, Girones R.  Development and application of a one-step low cost procedure \nto concentrate viruses from seawater samples. J Virol Methods.  2008; 153(2):79-83. \n Candela L, Fabregat S, Josa A, Suriol J, Vigu\u00e9s N, Mas J. Assessment of soil  and groundwater \nimpacts by treated urban wastewater reuse. A case  study: application in a golf course (Girona, \nSpain). Sci Total Environ.  2007; 374(1):26-35. \n Cantalupo PG, Calgua B, Zhao G, Hundesa A, Wier AD, Katz JP, Grabe M, Hendrix RW, Girones R, Wang D, Pipas JM.  Raw sewage harbors diverse viral populations. MBio.  2011, 4:2(5). \n Carter MJ.  Enterically infecting viruses: pathogenicity, transmission and significance for food \nand waterborne infection. Appl  Microbiol.  2005; 98(6):1354-80. \n CCA [Comisi\u00f3n del Codex Alimentarius].  Principios y Directrices para la Aplicaci\u00f3n de la \nEvaluaci\u00f3n de Riesgos Microbiol\u00f3gicos. Documento CAC/GL-30. 1999. Disponible en: \nwww.codexalimentarius.net/download/standards/357/CXG_030e.pdf  CDCP [Center for Disease Control and Prevention].  Licensure of inactiva ted hepatitis A vaccine \nand recommendations for international travelers' use. JAMA.  1995; 274(8):603. \n Chadwick PR, Beards G, Brown D, Caul EO, Cheesbrough J, Clarke I, Curry A, O'Brien S, Quigley K, Sellwood J, Westmoreland D. Management of hospital outbreaks of gastro-\nenteritis due to small roundstructured viruses. J Hosp Infect . 2000; 45(1):1-10. \n Charles MD, Holman RC, Curns AT, Parashar UD, Glass RI, Bresee JS. Hospitalizations \nassociated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J.  \n2006; 25(6):489-93.  Cheng PK, Wong DK, Chung TW, Lim WW.  Norovirus contamination found in oysters \nworldwide. J Med Virol.  2005; 76(4):593-7. \n Christensen BF, Lees D, Wood KH, Bergskow T, Green J. Human enteric viruses in oysters \ncausing a large outbreak of human food borne infection in 19996/97. J Shellfish Res.  1998; \n17(5):1633-35.  Clemente-Casares P, Pina S, Buti M, Jardi R, MartIn M, Bofill-Mas S, Girones R. Hepatitis E \nvirus epidemiology in industrialized countries. Emerg Infect Dis.  2003; 9(4):448-54. \n \nCliver DO.  Significance of water and the environment in the transmission of virus disease. En: \nMelnick JL, eds. Monographs in Virology , 15. Nueva York: Karger Basel, 1984:30-42. \n Cohen JI, Rosenblum B, Ticehurst JR, Daemer RJ, Feinstone SM, Purcell RH. Complete \nnucleotide sequence of an attenua ted hepatitis A virus: comparison with wild-type virus. Proc \nNatl Acad Sci USA.  1987a; 84(8):2497-501.  \n Cohen JI, Ticehurst JR, Purcell RH, Buckler-White A, Baroudy BM.  Complete nucleotide \nsequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus \nand other picornaviruses. J Virol.  1987b; 61(1):50-9. \n Cole CN, Conzen SD. Polyomaviridae: the viruses and their replication. En: Knipe DM, Howley \nPM, eds. Fields virology. 4th ed. Philadelphia: Lippincott, Williams, and Wilkins, 2001; 2141-74. \n Referencias \n 279Coleman DV, Wolfendale MR, Daniel RA, Dhanjal NK, Gardner SD, Gibson PE, Field AM.  A \nprospective study of human polyomavirus infection in pregnancy. J Infect Dis.  1980; 142(1):1-8. \n Colford JM Jr, Wade TJ, Schiff KC, Wright CC, Griffith JF, Sandhu SK, Burns S, Sobsey M, Lovelace G, Weisberg SB. Water quality indicators and the risk of illness at beaches with \nnonpoint sources of fecal contamination. Epidemiology.  2007; 18(1):27-35. \n Collins MV, Flick GJ, Smith SA, Fayer R, Croonenberghs R, O'Keefe S, Lindsay DS.  The effect of \nhigh-pressure processing on infectivity of Cr yptosporidium parvum oocysts recovered from \nexperimentally exposed Eastern oysters (Crassostrea virginica). J Eukaryot Microbiol.  2005; \n52(6):500-4.  Cooper PF.  Historical aspects of wastewater treatment. En: Decentralized sanitation and reuse \nconcepts, systems and Implementation. Lens P, Zeeman G, Lettinga G, eds. IWA Publishing. London (UK). 2001;11-38.  Corbo MR, Bevilacqua A, Campaniello D, D\u2019Amato D, Speranza B, Sinigaglia M. Prolonging \nmicrobial shelf life of foods through the use of natural compounds and non-thermal \napproaches - a review. Int J Food Sci Technol. 2009; 44(2):223-41. \n Costa-Mattioli M, Cristina J, Romero H, Perez-Bercof R, Casane D, Colina R, Garcia L, Vega I, Glikman G, Romanowsky V, Castello A, Nic and E, Gassin M, B illaudel S, Ferr\u00e9 V.  Molecular \nevolution of hepatitis A virus: a new classification based on the complete VP1 protein. J Virol.  \n2002; 76(18):9516-25.   Costa-Mattioli M, Ferre V, Monpoeho S, Garcia L, Colina R, Billaudel S, Vega I, Perez-Bercoff R, Cristina J.  Genetic variability of hepatitis A virus in South America reveals heterogeneity and \nco-circulation during epidemic outbreaks. J Gen Virol.  2001a; 82(11):2647-52.  \n Costa-Mattioli M, Monpoeho S, Schvoerer C, Besse B, Aleman MH, Billaudel S, Cristina J, Ferr\u00e9 V. Genetic analysis of hepatitis A virus outbreak in France confirms the co-circulation of \nsubgenotypes Ia, Ib and reveals a new genetic lineage. J Med Virol.  2001b; 65(2):233-40.  \n Craig AS, Schaffner W.  Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med.  \n2004; 350(5):476-81.  Craun GF.  Waterborne disease outbreaks in the United States of America: causes and \nprevention. World Health Stat Q.  1992; 45(2-3):192-9. \n \nCristina J, Costa-Mattioli M.  Genetic variability and molecular evolution of hepatitis A virus. \nVirus Res.  2007; 127(2):151-7. \n Croci L, De Medici D, Scalfaro C, Fiore A, Divizia M, Donia D, Cosentino AM, Moretti P, Costantini G.  Determination of enteroviruses, hepatitis A virus, bacteriophages and \nEscherichia coli in Adriatic Sea mussels. J Appl Microbiol.  2000; 88(2):293-8. \n Croci L, De Medici D, Franco E, Gabrielli R, Dipas quale S, Toti L. Viral depuration of Mytilus \ngalloprovincialis in ozone treated water. 2. Conference Internationale sur la Purification des Coquillages, Rennes (France), 6-8 Apr 1992. Disponibe en: http://archimer.ifremer.fr/doc/00000/1610/   Referencias \n 280-D- \n Das K, Agarwal A, Andrew R, Fr\u00f6sner GG, Kar P.  Role of hepatitis E and other hepatotropic \nvirus in aetiology of sporadic acute viral hepati tis: a hospital based study from urban Delhi. Eur \nJ Epidemiol.  2000; 16(10):937-40. \n David ST, McIntyre L, MacDougall L, Kelly D, Liem S, Schalli\u00e9 K, McNabb A, Houde A, Mueller P, Ward P, Trottier YL, Brassard J. An outbreak of norovirus caused by consumption of oysters \nfrom geographically dispersed harvest sites, British Columbia, Canada, 2004. Foodborne \nPathog Dis.  2007; 4(3):349-58. \n Dawson GJ, Mushahwar IK, Chau KH, Gitnick GL. Detection of long-lasting antibody to \nhepatitis E virus in a US traveler to Pakistan. Lancet.  1992; 340 426-27. \n de Deus N, Peralta B, Pina S, Allepuz A, Mateu E, Vidal D, Ruiz-Fons F, Mart\u00edn M, Gort\u00e1zar C, Segal\u00e9s J.  Epidemiological study of hepatitis E virus infection in European wild boars (Sus \nscrofa) in Spain. Vet Microbiol.  2008; 129(1-2):163-70. \n \nde Deus N, Seminati C, Pina S, Mateu E, Mart\u00edn M, Segal\u00e9s J.  Detection of hepatitis E virus in \nliver, mesenteric lymph node, serum, bile and fa eces of naturally infected pigs affected by \ndifferent pathological conditions. Vet Microbiol.  2007; 119(2-4):105-14. \n Deinhardt F, Holmes AW, Capps RB, Popper H. Studies on the transmission of human viral \nhepatitis to marmoset monkeys. Transmission of  disease, serial passages, and description of \nliver lesions. J Exp Med.  1967; 125(4):673-88. \n Delbue S, Tremolada S, Branchetti E, Elia F, Gualco E, Marchioni E, Maserati R, Ferrante P.  \nFirst identification and molecular characterizati on of lymphotropic polyomavirus in peripheral \nblood from patients with  leukoencephalopathies. J Clin Microbiol.  2008; 46(7):2461-2. \n Di Girolamo R, Liston J, Matches J. Ionic bonding, the mechanism of viral uptake by shellfish \nmucus.  Appl Environ Microbiol. 1977; 33(1):19-25. \n Dolin R, Blacklow NR, DuPont H, Buscho RF, Wyatt RG, Kasel JA, Hornick R, Chanock RM. Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc \nSoc Exp Biol Med.  1972; 140(2):578-83.  \n Dominguez A, Vidal J, Bruguera M, Salleras Ll.  Epidemiolog\u00eda de las hepatitis virales. Enferm \nInfecc Microbiol Clin.  1995; 13 (Supl. 1):50-61.  \n Doorn MRJ, Towprayoon S, Maria S, Vieira M, Irving W, Palmer C, Pipatti, R, Wang C.  \nWastewater treatment and discharge. En: IPCC Guidelines for National Greenhouse Gas Inventories volume 5. (Waste). WMO, UNEP. 2006; 1-6, 28.  Doultree JC, Druce JD, Birch CJ, Bowden DS, Marshall JA.  Inactivation of feline calicivirus, a \nNorwalk virus surrogate. J Hosp Infect.  1999;41 (1):51-7. \n Duizer E, Bijkerk P, Rockx B, De Groot A, Twisk F, Koopmans M.  Inactivation of caliciviruses. \nAppl Environ Microbiol. 2004a; 70(8):4538-43. \n Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK.  Laboratory efforts to \ncultivate noroviruses. J Gen Virol.  2004b; 85(1):79-87. Referencias \n 281-E- \n EFSA [European Food Safety Authority].  Scientific Opinion on an update on the present \nknowledge on the occurrence and control of foodborne viruses.  EFSA Journal.  2011; 9(7):2190-\n96. Disponible en: http://www.efsa.europa.eu/en/efsajournal/pub/2190.htm  Elimelech M. The global challenge for adequate and safe water. J. Water. Supp.: Res. Technol.-\nAQUA. 2006; 55:3-10. Disponible en: http://www.yale.edu/env/elimelech/Research_Pag e/sanitation/Sanitation_Presentation_1.pdf \n Emerson SU, Huang YK, Purcell RH.  2B and 2C mutations are essential but mutations \nthroughout the genome of HAV contribute to adaptation to cell culture. Virology.  1993; \n194(2):475-80.   Emerson SU, Purcell RH.  Recombinant vaccines for hepatitis E. Trends Mol Med.  2001; \n7(10):462-6.  Enders JE, Bell JA, Dingle JH, Francia T, Hillem ann RJ, Huebner RJ, Payne AMM.  \n\"Adenoviruses\": group name proposed for new respiratory-tract viruses. Science.  1956; \n124(3212):119-20.  Espinosa AC, Mazari-Hiriart M, Espinosa R, Maruri-Avidal L, M\u00e9ndez E, Arias CF.  Infectivity \nand genome persistence of rotavirus and ast rovirus in groundwater and surface water. Water \nRes. 2008; 42(10-11):2618-28. \n Estes MK, Cohen J.  Rotavirus gene structure and function. Microbiol Rev.  1989; 53(4):410-49. \n Evans MR, Meldrum R, Lane W, Gardner D, Ribeiro CD, Gallimore CI, Westmorel and D.  An \noutbreak of viral gastroenteritis following en vironmental contamination at a concert hall. \nEpidemiol Infect.  2002; 129(2):355-60. \n \n \n-F- \n FAO/OMS [Food and Agriculture Organization/Organizaci\u00f3n Mundial de la Salud].  \nCaracterizaci\u00f3n de peligros de pat\u00f3genos en los alimentos y el agua: directrices. 2003. Disponible en: http://www.who.int/foodsafety/publications/micro/en/spanish.pdf  \nFayer R, Morgan U, Upton SJ.  Epidemiology of Cryptosporidium: transmission, detection and \nidentification. Int J Parasitol.  2000; 30(12-13):1305-22. \n Fayer R.  Cryptosporidium: a water-borne zoonotic parasite. Vet Parasitol.  2004; 126(1-2):37-\n56.  Feagins AR, Opriessnig T, Guenette DK, Halbur PG, Meng XJ.  Inactivation of infectious \nhepatitis E virus present in commercial pig livers sold in local grocery stores in the United States. Int J Food Microbiol.  2008; 123(1-2):32-7. \n Feinstone SM, Kapikian AZ, Purceli RH.  Hepatitis A: detection by immune electron microscopy \nof a viruslik e antigen associated with acut e illness. Science.  1973; 182(116):1026-8. \n Feng H, Shuda M, Chang Y, Moore PS.  Clonal integration of a polyomavirus in human Merkel Referencias \n 282cell carcinoma. Science.  2008; 319(5866):1096-100. \n Fiore AE, Shapiro CN, Sabin K, Labonte K, Darling K, Culver D, Bell BP, Margolis HS.  Hepatitis \nA vaccination of infants: effect of maternal antibody status on antibody persistence and \nresponse to a booster dose. Pediatr Infect Dis J.  2003; 22(4):354-9.  \n Fix AD.  Prevalence of antibodies to hepatitis e virus in rural Egyptian communities. Am J Trop \nMed Hyg.  2001; 62:519-523. \n Fluck MM, Schaffhausen BS.  Lessons in signaling and tumorigenesis from polyomavirus middle \nT antigen. Microbiol Mol Biol Rev . 2009; 73(3):542-63 \n Formiga-Cruz M, Allard AK, Conden-Hansson AC, Henshilwood K, Hernroth BE, Jofre J, Lees DN, Lucena F, Papapetropoulou M, Rangdale RE, Tsibouxi A, Vantarakis A, Girones R.  \nEvaluation of potential indicators of viral contamination in shellfish and their applicability to diverse geographical areas. Appl Environ Microbiol.  2003; 69(3):1556-63. \n Formiga-Cruz M, Tofi\u00f1o-Quesada G, Bofill-Mas S, Lees DN, Henshilwood K, Allard AK, \nConden-Hansson AC, Hernroth BE, Vantarakis A, Tsibouxi A, Papapetropoulou M, Furones \nMD, Girones R.  Distribuion of human virus contaminatio n in shellfish from different growing \nareas in Greece, Spain, Sweeden and the United Kingdom. Appl. Environ. Microbiol . 2002; \n68(12):5990-5998.  Fu CY, Xie X, Huang JJ, Zhang T, Wu QY, Chen JN, Hu HY.  Monitoring and evaluation of \nremoval of pathogens at municipal wastewater treatment plants. Water Sci Technol.  2010; \n61(6):1589-99.  Fumian TM, Guimar\u00e3es FR, Pereira Vaz BJ, da Silva MT, Muylaert FF, Bofill-Mas S, Giron\u00e9s R, Leite JP, Miagostovich MP.  Molecular detection, quantificatio n and characterization of human \npolyomavirus JC from waste water in Rio De Janeiro, Brazil. J Water Health.  2010; 8(3):438-45. \n Fumian TM, Leite JP, Rose TL, Prado T, Miagostovich MP.  One year environmental \nsurveillance of rotavirus specie A (RVA) genotype s in circulation after the introduction of the \nRotarix\u00ae vaccine in Rio de Janeiro, Brazil. Water Res.  2011; 45(17):5755-63. \n  \n-G- \n \nGalm\u00e9s Truyols A, Duran JG, Riutort AN, Cerd\u00e1 GA, Isabel CB, Arbona MP, Berga JV.  \nNorovirus outbreak in Majorca (Spain) associated with oyster consumption. Gac Sanit.  2011; \n25(2):173-5.  Gamarnik AV, Andino R.  Switch from translation to RNA replication in a positive-stranded RNA \nvirus. Genes Dev. 1998; 12(15):2293-304.  \n Gantzer C, Maul A, Audic JM, Schwartzbrod L.  Detection of infectious enteroviruses, \nenterovirus genomes, somatic coliphages, and Bacteroides fragilis phages in treated wastewater. Appl Environ Microbiol.  1998; 64(11):4307-12. \n Gard S. Method for detecting poliomyelitic virus in sewage and stools. J Exp Med.  1940; \n71(6):779-85.  Referencias \n 283Gardner SD, Field AM, Coleman DV, Hulme B.  New human papovavirus (B.K.) isolated from \nurine after renal transplantation. Lancet.  1971; 1(7712):1253-7. \n Gauss-M\u00fcller V, Kusov YY.  Replication of a hepatitis A viru s replicon detected by genetic \nrecombination in vivo. J Gen Virol.  2002; 83(9):2183-92.  \n Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB, Wu G, Brennan DC, Storch GA, Sloots TP, Wang D.  Identification of a novel polyomavirus from patients with acute respiratory \ntract infections. PLoS Pathog. 2007; 3(5):64. \n Gerba CP, Farrah SR, Goyal SM, Wallis C, Melnick JL.  Concentration of enteroviruses from \nlarge volumes of tap water, treated sewage, and seawater. Appl Environ Microbiol.  1978; \n35(3):540-8.  Gerba CP, Haas CN.  Assessment of Risks Associated with Enteric Viruses in Contaminated \nDrinking Water 976. ASTM Special Technical Publication, 1988; 489-94.  Ghabrah TM, Stickland GT, Tsarev S, Yarbough P, Farci P, Engle R, Emerson S, Purcell R.  Acute \nviral hepatitis in Saudi Arabia: seroepidemiological analysis, risk factors, clinical manifestations, \nand evidence for a sixth hepatitis agent. Clin Infect Dis.  1995; 21(3):621-7. \n Gibson CJ, Haas CN, Rose JB.  Risk assessment of waterborne protozoa: current status and \nfuture trends. Parasitology.  1999; 117:205-12. \n Girones R, Ferr\u00fas MA, Alonso JL, Rodriguez-Manzano J, Calgua B, Corr\u00eaa Ade A, Hundesa A, Carratala A, Bofill-Mas S.  Molecular detection of pathogens in water--the pr os and cons of \nmolecular techniques. Water Res.  2010; 44(15):4325-39. \n Glass RI, Noel J, Mitchell D, Herrmann JD, Blacklow NR, Pickering LK, Dennehy P, Ruiz-Palacios G, de Guerrero ML, Monroe SS.  The changing epidemiology of astrovirus-associated \ngastroenteritis: a review. Arch Virol Suppl. 1996; 12:287-300. \n Glass RI, Parashar UD, Estes MK.  Norovirus gastroenteritis. N Engl J Med.  2009; 361(18):1776-\n85.  Goh S, Lindau C, Tiveljung-Lindell A, Allander T.  Merkel cell polyomavirus in respiratory tract \nsecretions. Emerg Infect Dis.  2009; 15(3):489-91. \n \nGoldstein ST, Alter MJ, Williams IT, Moyer LA, Judson FN, Mottram K, Fleenor M, Ryder PL, \nMargolis HS.  Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: \nimplications for vaccination programs. J Infect Dis.  2002; 185(6):713-9. \n Godfree A, Farrell J . Processes for managing pathogens. J Environ Qual.  2005; 34(1):105-13. \n Gomatos PJ, Monier MK, Arthur RR, Rodier GR, el-Zimaity D, Hassan NF, Quinti I, el-Sahly AD, Sultan Y, Hyams KC.  Sporadic acute hepatitis caused by hepatitis E virus in Egyptian adults. Clin \nInfect Dis.  1996; 23(1):195-6. \n Gonz\u00e1lez A, Botella S, Montes RM, Moreno Y, Ferr\u00fas MA.  Direct detection and identification \nof Arcobacter species by multiplex PCR in chicken and wastewater samples from Spain. J Food \nProt.  2007; 70(2):341-7. \n Referencias \n 284Goudsmit J, Baak ML, Sleterus KW, Van der Noordaa J.  Human papovavirus isolated from \nurine of a child with acute tonsillitis. Br Med J (Clin Res Ed). 1981; 283(6303):1363-4. \n Goudsmit J, Wertheim-van Dillen P, van Strien A, van der Noor daa J.  The role of BK virus in \nacute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol.  1982; \n10(2):91-9.  Graff J, Normann A, Feinstone SM, Flehmig B.  Nucleotide sequence of  wild-type hepatitis A \nvirus GBM in comparison with two cell culture-adapted variants. J Virol.  1994; 68(1):548-54.  \n Grassi T, Bagordo F, Idolo A, Lugoli F, Gabutti G, De Donno A.  Rotavirus detection in \nenvironmental water samples by tangential flow ultrafiltration and RT-nested PCR. Environ \nMonit Assess.  2010; 164(1-4):199-205. \n Green KY, Belliot G, Taylor JL, Valdesuso J, Lew JF, Kapikian AZ, Lin FY.  A predominant role for \nNorwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. J Infect Dis.  2002; 185(2):133-46. \n \nGreen M, Pina M.  Biochemical studies on adenovirus multiplication, IV. Isolation, purification \nand chemical analysis of adenovirus. Virology.  1963; 20:199-207. \n Gross L.  A filterable agent, recovered from Ak leukemic extracts, causing salivary gland \ncarcinomas in C3H mice. Proc Soc Exp Biol Med . 1953; 83(2):414-21. \n Guerin JL, Gelfi J, Dubois L, Vuillaume A, Boucraut-Baralon C, Pingret JL.  A novel polyomavirus \n(goose hemorrhagic polyomavirus) is the agent of  hemorrhagic nephritis enteritis of geese. J \nVirol.  2000; 74(10):4523-9. \n Guillois-B\u00e9cel Y, Couturier E, Le Saux JC, Roque- Afonso AM, Le Guyader FS, Le Goas A, Pern\u00e8s \nJ, Le Bechec S, Briand A, Robert C, Dussaix E, Pommepuy M, Vaillant V.  An oyster-associated \nhepatitis A outbreak in France in 2007. Euro Surveill.  2009; 14(10). pii:19144. \n Guimar\u00e3es FR, Ferreira FF, Vieira CB, Fumian TM, Shubo T, Leite JP, Miagostovich MP. Molecular detection of human astrovirus in an ur ban sewage treatment plant in Rio de Janeiro, \nBrazil. Mem Inst Oswaldo Cruz.  2008; 103(8):819-23. \n Gutierrez-Escolano AL, Vazquez-Ochoa M, Escobar-Herrera J, Hernandez-Acosta J.  La, PTB, \nand PAB proteins bind to the 3(\u2018) untransla ted region of Norwalk virus genomic RNA. Biochem \nBiophys Res Commun.  2003; 311(3):759-66. \n  \n-H- \n Haas CN.  Estimation of risk due to low doses of microorganisms: a comparison of alternative \nmethodologies . Am J Epidemiol.  1983; 118:573-82. \n Haas CN, Rose JB, Gerba CP.  Quantitative microbial risk assessment. Nueva York, NY: John \nWiley and Sons. 1999  H\u00e4fliger D, H\u00fcbner P, L\u00fcthy J.  Outbreak of viral gastroenteritis due to sewage-contaminated \ndrinking water. Int J Food Microbiol.  2000; 54(1-2):123-6. \n Referencias \n 285Halliday ML, Kang LY, Zhou TK, Hu MD, Pan QC, Fu TY, Huang YS, Hu SL.  An epidemic of \nhepatitis A attributable to the ingestion of raw clams in Shanghai, China. J Infect Dis.  1991; \n164(5):852-9.  Hamilton AJ, Stagnitti F, Premier R, Boland AM, Hale G.  Quantitative microbial risk \nassessment models for consumption of raw vege tables irrigated with reclaimed water. Appl \nEnviron Microbiol.  2006; 72(5):3284-90. \n Haqshenas G, Shivaprasad HL, Woolcock PR, Read DH, Meng XJ.  Genetic identification and \ncharacterization of a novel virus related to human hepatitis E virus from chickens with \nhepatitis-splenomegaly syndrome in the United States. J Gen Virol.  2001; 82(10):2449-62. \n Harrison TJ.  Hepatitis E virus- an update. Liver.  1999; 19(3):171-6. \n Hart CA, Cunliffe NA, Nakagomi O.  Diarrhoea caused by viruses. En; Cook GC, Zumla AI, eds. \nManson\u2019s tropical diseases,Saunders Elsevier, Philadelphia, USA. 2009; 815\u201324.   Harwood VJ, Gandhi JP, Wright AC.  Methods for isolation and confirmation of Vibrio vulnificus \nfrom oysters and environmental sources: a review. J Microbiol Methods.  2004; 59(3):301-16. \n Havelaar AH, Hogeboom WH.  A method for the enumeration of male-specific bacteriophages \nin sewage. J Appl Bacteriol. 1984; 56(3):439-47. \n Havelaar AH, Hogeboom WH.  F-specific RNA bacteriophages as model viruses in water \nhygiene: ecological aspects. Water Sci Technol.  1988; 20(11-12):399-407. \n Havelaar AH. A bacteriophage standard for bathing wa ters. Final report, Commission of the \nEuropean Communities. 1993; B4:3040/92/012609.  He J, Innis BL, Shrestha MP, Clayson ET, Scott RM, Linthicum KJ, Musser GG, Gigliotti SC, Binn LN, Kuschner RA, Vaughn DW.  Evidence that rodents are a reservoir of hepatitis E virus for \nhumans in Nepal. J Clin Microbiol. 2006; 44(3):1208. \n Hedberg CW, Osterholm MT.  Outbreaks of food-borne and waterborne viral gastroenteritis. \nClin Microbiol Rev. 1993; 6(3):199-210. \n Hijnen WA, Beerendonk EF, Medema GJ.  Inactivation credit of UV radiation for viruses, \nbacteria and protozoan (oo) cysts in water: a review. Water Res.  2006; 40(1):3-22. \n \nHillerman MR, Werner JH.  Recovery of new agent from patients with acute respiratory illness. \nProc Soc Exp Biol Med.  1954; 85(1):183-8. \n Ho HT, Lipman LJ, Gaastra W.  Arcobacter, what is known and unknown about a potential \nfoodborne zoonotic agent! Vet Microbiol.  2006; 115(1-3):1-13. \n Hochstrat R, Wintgens T, Melin T, Jeffrey P.  Wastewater reclamation and reuse in Europe: a \nmodel-based potential estimation. Water Supply.  2005; 5(1):67-75. \n Hollinger FB, Emerson SU.  Hepatitis A virus. En: Knipe DM, Howley PM, eds. Fields virology. \n4th ed. Philadelphia: Lippincott, Williams, and Wilkins, 2001; 799-840. \n Homma A, Sobsey MD, Wallis C, Melnick JL.  Virus concentration from sewage. Volume 7, Referencias \n 286Issue 7. 1973; 945-8. \n Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, Moore PS, Becker JC.  Merkel \ncell polyomavirus-infected Merkel cell carcinoma cells require expression  of viral T antigens. J \nVirol.  2010; 84(14):7064-72. \n Hsieh S, Meng X, Wu Y, Liu S, Tam A, Lin D, Liaw Y.  Identity of a novel swine hepatitis E virus in \nTaiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus. J Clin \nMicrobiol.  1999; 37(12):3828-34. \n Hsu BM, Chen CH, Wan MT.  Prevalence of enteroviruses in hot spring recreation areas of \nTaiwan. FEMS Immunol Med Microbiol.  2008; 52(2):253-9. \n Huang CC, Nguyen D, Fernandez J, Yun KY , Fry KE, Bradley DW, Tam AW, Reyes GR.  \nMolecular cloning and sequencing of the Mexi co isolate of hepatitis E virus (HEV). Virology.  \n1992; 191(2):550-8.  Huang FF, Haqshenas G, Guenette DK, Halbur PG, Schommer SK, Pierson FW, Toth TE, Meng \nXJ. Detection by reverse transcription-PCR and genetic characterization of field isolates of \nswine hepatitis E virus from pigs in differe nt geographic regions of the United States. J Clin \nMicrobiol.  2002; 40(4):1326-32. \n Hughes MS, Hoey EM, Coyle PV.  Enteroviruses in recreational waters of Northern Ireland. \nEpidemiol Infect.  1992; 108(3):529-36. \n Hunter PR.  Waterborne Disease. Epidemiology and Ecology. Ed.: J. Wiley & Sons. 1997. \n  \n-I- \n \nIAWPRC [International Association on Water Pollution Research and Control]. Bacteriophages as model viruses in water quality control. Wat Res . 1991; 25:529-545. \n Igbinosa EO, Obi LC, Okoh AI.  Occurrence of potentially pathogenic vibrios in final effluents of \na wastewater treatment facility in a rural community of the Eastern Cape Province of South Africa. Res Microbiol.  2009; 160(8):531-7. \n ISO [International Organization for Standardization].  Water Quality-Detection and \nEnumeration of Bacteriophages. Part 2: Enum eration of Somatic Coliphages. ISO 1075-2, \nGeneva, Switzerland. 2000.   \n-J- \n Jacobsen KH, Koopman JS.  The effects of socioeconomic de velopment on worldwide hepatitis \nA virus seroprevalence patterns. Int J Epidemiol.  2005; 34(3):600-9. \n Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. \nEpidemiol Infect.  2004; 132(6):1005-22. \n Jacobsen KH, Wiersma ST.  Hepatitis A virus seroprevalence by age and world region, 1990 and \n2005. Vaccine. 2010; 28(41):6653-7. Referencias \n 287Jameel S.  Molecular biology and pathogenesis of hepatitis E virus. Expert Rev Mol Med. 1999; \n1-16.  Jansen RW, Siegl G, Lemon SM.  Molecular epidemiology of human hepatitis A virus defined by \nan antigen-capture polymerase chain reaction method . Proc Natl Acad Sci USA.  1990; \n87(8):2867-71.  Jofre J, Blasi M, Bosch A, Lucena F.  Ocurrence of bacteriophages infecting Bacteriodes fragilis \nand other viruses in pollu ted marine sediments. Water Sci Techno.  1989; 21(3):15-19. \n Johne R, Enderlein D, Nieper H, M\u00fcller H.  Novel polyomavirus detected in the feces of a \nchimpanzee by nested broad-spectrum PCR. J Virol . 2005; 79(6):3883-7. \n Johne R, Wittig W, Fern\u00e1ndez-de-Luco D, H\u00f6fle U, M\u00fcller H.  Characterization of two novel \npolyomaviruses of birds by using multiply primed rolling-circle amplification of their genomes. J Virol.  2006; 80(7):3523-31. \n Johnson PC, Mathewson JJ, DuPont HL, Greenberg HB.  Multiple-challenge study of host \nsusceptibility to Norwalk gastroenteritis in US adults. J Infect Dis.  1990; 161(1):18-21. \n Jyoti A, Ram S, Vajpayee P, Singh G, Dwivedi PD, Jain SK, Shanker R.  Contamination of surface \nand potable water in South Asia by Salmone llae: culture-independent  quantification with \nmolecular beacon real-time PCR. Sci Total Environ . 2010; 408(6):1256-63. \n  \n-K- \n Kabrane-Lazizi Y, Meng XJ, Purcell RH, Emerson SU.  Evidence that the genomic RNA of \nhepatitis E virus is capped. J Virol.  1999; 73(10):8848-50. \n Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR, Chanock RM.  Visualization by \nimmune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol.  1972; 10(5):1075-81. \n Kaplan JE, Gary GW, Baron RC, Singh N, Schonberger LB, Feldman R, Greenberg HB.  \nEpidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med. 1982a; 96(6 Pt 1):756-61. \n \nKapikian AZ, Hoshino Y, Chanock RM. Rotaviruses.  En: Knipe DM, Howley PM, eds. Fields \nvirology. 4th ed. Philadelphia: Lippincott, Williams, and Wilkins, 2001; 1787-1833. \n Kaplan JE, Schonberger LB, Varano G, Jackman N, Bied J, Gary GW.  An outbreak of acute \nnonbacterial gastroenteritis in a nursing home. Demonstration of personto-person \ntransmission by temporal clustering of cases. Am J Epidemiol.  1982b; 116(6):940-8. \n Karaganis JV, Larkin EP, Melnick JL, Sarpino PV, Schaub SA, Sorber CA, Su llivan R, Wellings \nFM. Research priorities for monitoring viruses in the environment. EPA-600/9-83-010. U.S. \nEnvironment Protection Agency, Office of Research and Development, Environmental Monitoring and Support Laboratory, Cincinnatti. 1983.  Kean JM, Rao S, Wang M, Garcea RL.  Seroepidemiology of human polyomaviruses. PLoS \nPathog.  2009; 5(3):e1000363. Referencias \n 288Khuroo MS.  Study of an epidemic non-A, non-B hepa titis: possibility of another human virus \ndistinct from post-transfusion non-A, non-B type. Am J Med.  1980; 68(6):818-24. \n Kingsley DH, Calci K, Holliman S, Dancho B, Flick GJ.  High pressure inactivation of HAV within \noysters: comparison of shucked oysters with whole-in-shell meats. Food Environ Virol.  2009; \n1(3-4):137 -40. \n Kingsley DH, Holliman DR, Calci KR, Chen H, Flick GJ.  Inactivation of a norovirus by high-\npressure processing. Appl Environ Microbiol.  2007; 73(2):581-5. \n Koff RS.  Hepatitis A. Lancet.  1998; 351(9116):1643-9. \n Koonin EV, Dolja VV.  Evolution and taxonomy of positive -strand RNA viruses: implication of \ncomparative analysis of amino acid sequences. Crit Rev Biochem Mol Biol.  1993; 28(5):375-430. \n Koonin EV, Gorbalenya AE, Purdy MA, Rozanov M. Reyer GR, Bradley DW.  Computer-assisted \nassignment of functional domains in the non-structural polyprotein of hepatitis E virus: delineation of an additional group of posi tive-strand RNA plant and animal viruses. Proc  Natl \nAcad Sci USA.  1992; 89(17):8259-63. \n Koopmans M, von Bonsdorff CH, Vinj\u00e9 J, de Medici D, Monroe S.  Foodborne viruses. FEMS \nMicrobiol Rev.  2002; 26(2):187-205. \n Kott Y, Roze N, Sperber S, Betzer N.  Bacteriophages as viral pollution indicators. Wat Res.  \n1974; 8(3):165-77.  Kou X, Wu Q, Zhang J, Fan H.  Rapid detection of noroviruses in fecal samples and shellfish by \nnucleic acid sequence-based amplification. J Microbiol.  2006; 44(4):403-8. \n Kukkula M, Arstila P, Klossner ML, Maunula L, Bonsdorff CH, Jaatinen P.  Waterborne \noutbreak of viral gastroenteritis. Scand J Infect Dis.  1997; 29(4):415-8. \n Kumar M, Sharma BC, Sarin SK.  Hepatitis E virus as an etiology of acute exacerbation of \npreviously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver \ndisease. J Gastroenterol Hepatol.  2008; 23(6):883-7. \n Kural AG, Shearer AE, Kingsley DH, Chen H.  Conditions for high pressure inactivation of Vibrio \nparahaemolyticus in oysters. Int J Food Microbiol.  2008; 127(1-2):1-5. \n \n \n-L- \n Lai MM.  Genetic recombination in RNA viruses. Curr Top Microbiol Immunol . 1992; 176:21-32.  \n Landry EF, Vaughn JM, Thomas MZ, Vicale TJ.  Efficiency of beef extract for the recovery of \npoliovirus from wastewater effluents. Appl Environ Microbiol.  1978; 36(4):544-8. \n Langford, M.  The United Nations Concept of Water as a Human Right: A New Paradigm for Old \nProblems? Water Resources Development . 2005; 21 (2):273\u2013282. \n Larsdotter K, Jansen JC, Dalhammar G.  Phosphorus removal from wastewater by microalgae \nin Sweden--a year-round perspective. Environ Technol.  2010; 31(2):117-23. Referencias \n 289Le Cann P, Ranarijaona S, Monpoeho S, Le Guyader F, Ferr\u00e9 V.  Quantification of human \nastroviruses in sewage using real-time RT-PCR. Res Microbiol.  2004; 155(1):11-5. \n Le Guyader F, Neill FH, Estes MK , Monroe SS, Ando T, Atmar RL.  Detection and analysis of a \nsmall round-structured virus strain in oysters implicated in an outbreak of acute gastroenteritis. Appl Environ Microbiol.  1996; 62(11):4268-72. \n Le Guyader FS, Bon F, DeMedici D, Parnaudeau S, Bertone A, Crudeli S, Doyle A, Zidane M, Suffredini E, Kohli E, Maddalo F, Monini M, Gallay A, Pommepuy M, Pothier P, Ruggeri FM.  \nDetection of multiple noroviruses associated wi th an international gastroenteritis outbreak \nlinked to oyster consumption. J Clin Microbiol. 2006; 44(11):3878-82. \n Lee J, Zoh K, Ko G.  Inactivation and UV disinfection of murine norovirus with TiO2 under \nvarious environmental conditions. Appl Environ Microbiol . 2008a; 74(7):2111-7. \n Lee R, LovatelliA, Ababouch L.  Bivalve depuration: fundamental and practical aspects. FAO \nFisheries Technical Paper. No. 511. Rome, FAO, 2008b; 139. Disponible en: http://www.fao.org/docre p/011/i0201e/i0201e00.html \n \nLee SH, Kim SJ.  Detection of infectious enteroviruses and adenoviruses in tap water in urban \nareas in Korea. Water res.  2002; 36(1):248-56. \n Lees D.  Viruses and bivalve shellfish. Int J Food Microbiol.  2000; 59(1-2):81-116. \n Lemon SM, Jansen RW, Brown EA.  Genetic, antigenic and biological differences between \nstrains of hepatitis A virus. Vaccine.  1992; 10(1):40-4.  \n Lemon SM, Murphy PC, Shields PA, Ping LH, Feinstone SM, Cromeans T, Jansen RW.  Antigenic \nand genetic variation in cytopathic  hepatitis A virus variants aris ing during persistent infection: \nevidence for genetic recombination. J Virol.  1991; 65(4):2056-65.  \n Levine AD, Asano T.  Recovering sustainable water from wastewater. Environ Sci Technol.  2004; \n38(11):201A-208A.  Li Q.-G . Molecular epidemiology and genetic variability of certain human adenoviruses. Tesis \nDoctoral. 1988.  Li R, Mannon RB, Kleiner D, Tsokos M, Bynum M, Kirk AD, Kopp JB.  BK virus and SV40 co-\ninfection in polyomavirus nephropathy. Transplantation . 2002; 74(11):1497-504. \n Linemeyer DL, Menke JG, Martin-Gallardo A, Hughes JV, Young A, Mitra SW.  Molecular \ncloning and partial sequencing of hepatitis A viral cDNA. J Virol.  1985; 54(2):247-55. \n Lipp EK, Rose JB.  The role of seafood in foodborne diseases in the United States of America. \nRev Sci Tech.  1997; 16(2):620-40. \n Lochridge VP, Jutila KL, Graff JW, Hardy ME.  Epitopes in the P2 domain of norovirus VP1 \nrecognized by monoclonal antibodies that block cell interactions. J Gen Virol.  2005; \n86(10):2799-806.  Lodder-Verschoor F, de Roda Husman AM, van den Berg HH, Stein A, van Pelt-Heerschap HM, van der Poel WH.  Year-round screening of noncommercial and commercial oysters for Referencias \n 290the presence of human pathogenic viruses. J Food Prot.  2005; 68(9):1853-9. \n L\u00f3pez-Caballero ME, P\u00e9rez-Mateos M, Montero P, Border\u00edas AJ.  Oyster preservation by high-\npressure treatment. J Food Prot.  2000; 63(2):196-201. \n Lowther JA, Avant JM, Gizynski K, Rangdale RE, Lees DN.  Comparison between quantitative \nreal-time reverse transcription PCR results for norovirus in oysters and self-reported gastroenteric illness in restaurant customers. J Food Prot.  2010; 73(2):305-11. \n Lucena F, Lasobras J, McIntosh D, Forcadell M, Jofre J.  Effect of distance from the polluting \nfocus on relative concentrations of Bacteroides fragilis phages and coliphages in mussels. Appl \nEnviron Microbiol. 1994; 60(7):2272-7. \n  \n-M- \n Ma L, Su YC.  Validation of high pressure processing fo r inactivating Vibrio parahaemolyticus in \nPacific oysters (Crassostrea gigas). Int J Food Microbiol.  2011; 144(3):469-74. \n \nManeerat Y, Clayson ET, Myint KS, Young GD, Innis BL.  Experimental infection of the \nlaboratory rat with the hepatitis E virus. J Med Virol . 1996; 48(2):121-8. \n Marks PJ, Vipond IB, Regan FM, Wedgwood K, Fey RE, Caul EO.  A school outbreak of Norwalk-\nlike virus: evidence for airborne transmission. Epidemiol Infect.  2003; 131(1):727-36. \n Mast EE, Krawczynski K.  Hepatitis E: an overview. Annu Rev Med.  1996; 47:257-66. \n Matsui SM, Greenberg HB.  Astroviruses. En: Knipe DM, Howley PM, eds. Fields virology. 4th \ned. Philadelphia: Lippincott, Williams, Wilkins, 2001; 875-93. \n Mateos ML, Camarero C, Lasa E, Teruel JL, Mir N, Baquero F.  Hepatitis E virus: relevance in \nblood donors and risk groups. Vox Sang.  1999; 76(2):78-80. \n McDade JE, Shepard CC, Fraser DW, Tsai TR, Redus MA, Dowdle WR.  Legionnaires' disease: \nisolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J \nMed.  1977; 297(22):1197-203. \n Melnick JL, Gerba CP, Wallis C.  Viruses in water. Bull World Health Organ.  1978; 56(4):499-\n508. \n Melnick JL.  History and epidemiology of hepatitis A virus . J Infect Dis . 1995; 171(1):2-8. \n Meng XJ, Purcell RH, Halburg PG, Lehman JR, Webb DM, Tsareva TS, Haynes JS, Thacker BJ, Emerson SU.  A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl \nAcad Sci USA.  1997; 94(18):9860-5. \n Miagostovich MP, Ferreira FF, Guimar\u00e3es FR, Fumian TM, Diniz-Mendes L, Luz SL, Silva LA, Leite JP.  Molecular detection and characterization of gastroenteritis viruses occurring naturally \nin the stream waters of Manaus, central Amazonia, Brazil. Appl Environ Microbiol.  2008; \n74(2):375-82.  Mokhtari A, Jaykus LA.  Quantitative exposure model for the transmission of norovirus in retail Referencias \n 291food preparation. Int J Food Microbiol.  2009; 133(1-2):38-47. \n Molla A, Paul AV, Wimmer E.  Cell-free, de novo synthesis of poliovirus. Science.  1991; \n254(5038):1647-51.   Monaco MC, Jensen PN, Hou J, Durham LC, Major EO.  Detection of JC virus DNA in human \ntonsil tissue: evidence for site of initial viral infection. J Virol. 1998a; 72(12):9918-23. \n Monaco MC, Shin J, Major EO.  JC virus infection in cells from lymphoid tissue. Dev Biol Stand.  \n1998b; 94:115-22.  Monroe SS, Jiang B, Stine SE, Koopmans M, Glass RI.  Subgenomic RNA sequence of human \nastrovirus supports classification of Astroviridae as a new family of RNA viruses. J Virol.  1993; \n67(6):3611-4.  Morris R, Sharp DN.  Enteric viruses levels in wastewater effluents and surface waters in the \nSevern Trent Water Authority 1979-1981. Water Res.  1984; 18(8):935-9. \n \nMPM [Minist\u00e8re de l\u2019Agriculture, et de la P\u00eache Maritime]. Bonne Pratiques D\u2019Hygiene Vol. 9 \n\u2013 La Purification et L\u2019Expedition de Coquillages Vivants. Ministere de la Peche Maritime. 2003; 9. Disponible en: http://www.mpm.gov.ma/documentation/pdf/coquillage_hygie.pdf  Muniain-Mujika I, Calvo M, Lucena F, Girones R.  Comparative analysis of viral pathogens and \npotential indicators in shellfish. Int J Food Microbiol.  2003; 83(1):75-85. \n Muniain-Mujika I, Girones R, Tofi\u00f1o-Quesada G, Calvo M, Lucena F.  Depuration dynamics of \nviruses in shellfish. Int J Food Microbiol . 2002; 77(1-2):125-33. \n Munoz I, Tomas N, Mas J, Garcia-Reyes JF, Molina-Diaz A, Fernandez-Alba AR.  Potential \nchemical and microbiological risks on human  health from urban wastewater reuse in \nagriculture. Case study of wastewater effluents in Spain. J Environ Sci Health B.  2010; \n45(4):300-9.  Murchie LW, Cruz-Romero M, Kerry JP, Linton M, Patterson MF, Smiddy M, Kelly AL.  High \npressure processing of shellfish: A review of microbiological and other quality aspects. Innovat \nFood Sci Emerg Tech.  2005; 6(3):257-70 \n  \n-N- \n Nagy PD, Simon AE.  New insights into the mechanisms of RNA recombination. Virology.  1997; \n235(1):1-9.  Nakamura M, Takahashi K, Taira K, Taira M, Ohno A, Sakugawa H, Arai M, Mishiro S.  \nHepatitis E virus infection in wild mongooses of Okinawa, Japan: Demonstration of anti-HEV antibodies and a full-genome nucleotide sequence. Hepatol Res.  2006; 34(3):137-40. \n NAS [National Academy of Sciences]. Risk Assessment in the Federal Government: Managing \nthe Process National Academy Press, Washington DC. 1983. Disponible en: http://www.nap.edu/ope nbook.php?isbn=0309033497. \n Nenonen NP, Hannoun C, Olsson MB, Bergstr\u00f6m T.  Molecular analysis of an oyster-related Referencias \n 292norovirus outbreak. J Clin Virol.  2009; 45(2):105-8. \n Niemczynowicz J.  The water profession a nd Agenda 21. Water Quality International. Volume \n1997, Issue 3-4, 1997; 9-11.   Nilsson M, Hedlund KO, Thorhagen M, Larson G, Johansen K, Ekspong A, Svensson L.  \nEvolution of human calicivirus RNA in vivo: accu mulation of mutations in the protruding P2 \ndomain of the capsid leads to structur al changes and possibly a new phenotype. J Virol.  2003; \n77(24):13117-24.  Nishida T, Nishio O, Kato M, Chuma T, Kato H, Iwata H, Kimura H.  Genotyping and \nquantitation of noroviruses in oysters fr om two distinct sea areas in Japan. Microbiol Immunol.  \n2007; 51(2):177-84.  Norja P, Ubillos I, Templeton K, Simmonds P.  No evidence for an association between \ninfections with WU and KI polyomaviruses and respiratory disease. Clin Virol.  2007; 40(4):307-\n11.  \nNorkin LC.  Simian virus 40 infection via MHC class I molecules and caveolae. Immunol Rev.  \n1999; 168:13-22.  N\u00fcesch JP, de Chastonay J, Siegl G.  Detection of defective ge nomes in hepatitis A virus \nparticles present in clinical specimens. J Gen Virol . 1989; 70 (12):3475-80.  \n  \n-O- \n Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA, Pallansch MA.  Typing of \nhuman enteroviruses by pa rtial sequencing of VP1. J Clin Microbiol.  1999; 37(5):1288-93. \n Ogorzaly L, Bertrand I, Paris M, Maul A, Gantzer C.  Occurrence, survival, and persistence of \nhuman adenoviruses and F-specific RNA phages in raw groundwater. Appl Environ Microbiol.  \n2010; 76(24):8019-25.  Okamoto H, Takahashi M, Nishizawa T, Fukai K, Muramatsu U, Yoshikawa A.  Analysis of the \ncomplete genome of indigenous swine hepatitis E virus isolated in Japan. Biochem Biophys Res \nCommun.  2001; 289(5):929-36. \n \nOkoh AI, Sibanda T, Gusha SS.  Inadequately treated wastewater as a source of human enteric \nviruses in the environment. Int J Environ Res Public Health . 2010; 7(6):2620-37. \n Oviedo M, Mu\u00f1oz P, Dom\u00ednguez A, Carmona G, Batalla J, Borras E, Jans\u00e0 JM.  Evaluation of \nmass vaccination programmes: the experience of Hepatitis A in Catalonia. Rev Esp Salud \nPublica.  2009; 83(5):697-709. \n  \n-P- \n Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH . Cultivation of papova-like virus \nfrom human brain with progressive multifocal leucoencephalopathy. Lancet.  1971; \n1(7712):1257-60.  Referencias \n 293PAHO [Pan American Health Organization].  Cholera: Number of Cases and Deaths in the \nAmericas (1991\u20132001). 2001. Disponible en: http://www.paho.org/English/HCP/HCT/EER/cholera-cases-deaths-91-01.htm  Papaevangelou G.  Epidemiology of hepatitis A in Mediterranean countries. Vaccine.  1992; \n10(1):63-6.   Papapetropoulou M, Vantarakis AC.  Detection of adenovirus outbreak at a municipal \nswimming pool by nested PCR amplification. J Infect.  1998; 36(1):101-3. \n Parashar U, Quiroz ES, Mounts AW, Monroe SS, Fankhauser RL, Ando T, Noel JS, Bulens SN, Beard SR, Li JF, Bresee JS, Glass RI.  \"Norwalk-like viruses\". Public health consequences and \noutbreak management. MMWR Recomm Rep.  2001; 50(RR-9):1-17. \n Parashar UD, Gibson CJ, Bresse JS, Glass RI.  Rotavirus and severe childhood diarrhea. Emerg \nInfect Dis.  2006; 12(2):304-6. \n Park SR, Mackay WG, Reid DC.  Helicobacter sp. recovered from drinking water biofilm \nsampled from a water distribution system. Water Res.  2001; 35(6):1624-6. \n Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR.  Clinical immunity in acute \ngastroenteritis caused by Norwalk agent. N Engl J Med.  1977; 297(2):86-9. \n Patel MM, Hall AJ, Vinje J, Parashar UD.  Noroviruses: a comprehensive review. J Clin Virol.  \n2009; 44(1):1-8.  Paul DA, Knigge MF, Ritter A, Gutierrez R, Pilot-Matias T, Chau KH, Dawson GJ.  \nDetermination of hepatitis E virus seroprevalen ce by using recombinant fusion proteins and \nsynthetic peptides. J Infect Dis.  1994; 169(4):801-6. \n Payment P, Berte A, Pr\u00e9vost M, M\u00e9nard B, Barbeau B.  Occurrence of pathogenic \nmicroorganisms in the Saint Lawrence River (Canada) and comparison of health risks for populations using it as their source of drinking water. Can J Microbiol.  2000; 46(6):565-76. \n Percival SL, Thomas JG.  Transmission of Helicobacter pylori and the role of water and biofilms. \nJ Water Health.  2009; 7(3):469-77. \n Pereira LS, Cordery I, Iacovides I.  Coping with water scarcity: Addressing the challenges. \nBerlin, Germany: Springer. 2009. \n Peterson DA, Hurley TR, Hoff JC, Wolfe LG.  Effect of chlorine treatment on infectivity of \nhepatitis A virus. Appl Environ Microbiol.  1983; 45(1):223-7.  \n Petterson SR, Ashbolt NJ.  Viral risks associated with wastewater reuse: modeling virus \npersistence on wastewater irrigated salad crops. Water Sci Technol.  2001; 43(12):23-6. \n Petterson SR, Ashbolt NJ, Sharma A.  Microbial risks from wastewater irrigation of salad crops: \na screening-level risk assessment. Water Environ Res.  2001; 73(6):667-72. \n Pettersson U.  Structural and nonstructural adenovirus proteins. En: The Adenovirus. H.S. \nGinsberg, eds. Plenum Press, New York and London. 1984.  Referencias \n 294PDB, [Protein data bank] , 2012. An Educational Resource for Exploring a Structural View of \nBiology. 2012. Disponible en: http:// www.rcsb.org/pdb/101/motm.do?momID=132 \n Pina S, Buti M, Cotrina M, Piella J, Girones R.  HEV identified in serum from humans with acute \nhepatitis and in sewage of animal origin in Spain. J Hepatol.  2000; 33(5):826-33. \n Pina S, Buti M, Jard\u00ed R, Clemente -Casares P, Jofre J, Girones R.  Genetic analysis of hepatitis A \nvirus strains recovered from the environment and from patients with acute hepatitis. J Gen \nVirol.  2001; 82(12):2955-63. \n Pina S, Jofre J, Emerson SU, Purcell RH, Girones R.  Characterization of a strain of infectious \nhepatitis E virus isolated from sewage in an area where hepatitis E is not endemic. Appl \nEnviron Microbiol.  1998a; 64(11):4485-8. \n Pina S, Puig M, Lucena F, Jofre J, Girones R.  Viral pollution in the environment and in shellfish: \nhuman adenovirus detection by PCR as an index of human viruses. Appl Environ Microbiol.  \n1998b; 64(9):3376-82.  \nPinto RM, Costafreda MI, Bosch A.  Risk assessment in shellfish-bo rne outbreaks of hepatitis A. \nAppl Environ Microbiol . 2009; 75(23):7350-5. \n Polish LB, Robertson BH, Khanna B, Krawczynski K, Spelbring J, Olson F, Shapiro CN.  Excretion \nof hepatitis A virus (HAV) in adults: compar ison of immunologic and molecular detection \nmethods and relationship between HAV positivity and infectivity in tamarins. J Clin Microbiol.  \n1999; 37(11):3615-7.  Potasman I, Paz A, Odeh M.  Infectious outbreaks associated with bivalve shellfish \nconsumption: a worldwide perspective. Clin Infect Dis.  2002; 35(8):921-8. \n Pringle CR.  Virus Taxonomy - San Diego 1998. Arch Virol.  1998; 143(7):1449-59. \n Provost PJ, H illeman MR.  Propagation of human hepatitis A virus in cell culture in vitro. Proc \nSoc Exp Biol Med.  1979; 160(2):213-21. \n Puig M, Jofre J, Lucena F, Allard A, Wadell G, Girones R.  Detection of adenovirus and \nenterovirus in polluted waters by nested PCR amplification. Appl Environ Microbiol.  1994; \n60(8):2963-70.  \nPuig M, Queralt N, Jofre J, Araujo R.  Diversity of Bacteroides fragilis and their capacity to \nrecover phages from human and animal wast es and from fecally polluted wastewater. Appl \nEnviron Microbiol.  1999; 65(4):1772-6. \n Pulitzer MP, Amin BD, Busam KJ.  Merkel cell carcinoma: review. Adv Anat Pathol.  2009; \n16(3):135-44.  Purcell RH, Emerson SU.  Hepatitis E: An emerging awareness of an old disease. J Hepatol.  \n2008; 48(3):494-503.   Purcell RH, Emerson SU.  Hepatitis E virus. En: Knipe DM, Howley PM, eds. Fields virology. 4th \ned. Philadelphia: Lippincott, Williams, and Wilkins, 2001: 3051-61. \n Purdy MA, Khudyakov YE.  The molecular epidemiology of hepatitis E virus infection. Virus Res.  Referencias \n 2952011; 161(1):31-9. \n Pusch D, Oh DY, Wolf S, Dumke R, Schr\u00f6ter-Bobsin U, H\u00f6hne M, R\u00f6ske I, Schreier E.  \nDetection of enteric viruses and bacterial indicators in German environmental waters. Arch \nVirol.  2005; 150(5):929-47.  \n  \n-Q- \n Queralt N, Bartolom\u00e9 R, Araujo R.  Detection of Helicobacter pylori DNA in human faeces and \nwater with different levels of faecal pollution in the north-east of Spain. J Appl Microbiol.  2005; \n98(4):889-95.   \n-R- \n Racaniello VR.  Picornaviridae: the viruses and their replication. En: Knipe DM, Howley PM, eds. \nFields virology. 4th ed. Philadelphia: Lippincott, Williams, and Wilkins, 2001; 685-722. \n \nRao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E.  The adenovirus E1A \nproteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl \nAcad Sci USA . 1992; 89(16):7742-6. \n Rao VC, Melnick JC.  Aspects of microbiology. En: Environmental virology, American Society for \nMicrobiology, Washington, DC. 1986; 5:18-40.   Rao VC, Seidel KM, Goyal SM, Metcalf TG, Melnick JL.  Isolation of enteroviruses from water, \nsuspended solids, and sediments from Galvesto n Bay: survival of poliovirus and rotavirus \nadsorbed to sediments. Appl Environ Microbiol.  1984; 48(2):404-9. \n Regli S, Rose JB, Haas CN, Gerba CP.  Modeling the risk from Giardia and viruses in drinking \nwater. J Am Water Works Assoc . 1991; 83(11):76-84. \n Rekosh DMK, Rusell WC, Bellet AJD, Robinson AJ.  Identification of a protein linked to the ends \nof adenovirus DNA. Cell.  1977; 11(2):283-95. \n Reyes GR, Huang CC, Tam AW, Purdy MA.  Molecular organization a nd replication of hepatitis \nE virus (HEV). Arch Virol Suppl.  1993; 7:15-25. \n \nReyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE, Bradley DW.  Isolation of cDNA from \nthe virus responsible for enterica lly transmitted non-A, non-B. Science.  1990; 247(4948):1335-\n9.  Reynolds KA, Mena KD, Gerba CP.  Risk of waterborne illness via drinking water in the United \nStates. Rev Environ Contam Toxicol . 2008; 192:117-58. \n Ricciardiello L, Laghi L, Ramamirtham P, Chang CL, Chang DK, Randolph AE, Boland CR.  JC \nvirus DNA sequences are frequently present in  the human upper and lower gastrointestinal \ntract. Gastroenterology.  2000; 119(5):1228-35. \n Rigotto C, Victoria M, Moresco V, Kolesnikovas CK, Corr\u00eaa AA, Souza DS, Miagostovich MP, Sim\u00f5es CM, Barardi CR.  Assessment of adenovirus, hepatitis A virus and rotavirus presence in Referencias \n 296environmental samples in Florianopolis, South Brazil. J Appl Microbiol.  2010; 109(6):1979-87. \n Robertson BH, Jansen RW, Khanna B, Totsuka A, Nainan OV, Siegl G, Widell A, Margolis HS, Isomura S, Ito K, et al.  Genetic relatedness of he patitis A virus strains recovered from different \ngeographical regions. J Gen Virol. 1992; 73(6):1365-77.  \n Robertson BH, Khanna B, Nainan OV, Margolis HS.  Epidemiologic patterns of wild-type \nhepatitis A virus determined  by genetic variation. J Infect Dis.  1991; 163(2):286-92.  \n Rockx B, De Wit M, Vennema H, Vinj\u00e9 J, De Bruin E, Van Duynhoven Y, Koopmans M.  Natural \nhistory of human calicivirus infection: a prospective cohort study. Clin Infect Dis.  2002; \n35(3):246-53.  Rockx BH, Vennema H, Hoebe CJ, Duizer E, Koopmans MP.  Association of histo-blood group \nantigens and susceptibility to norovirus infections. J Infect Dis.  2005; 191(5):749-54. \n Romalde JL, Area E, S\u00e1nchez G, Ribao C, Torrado I, Abad X, Pint\u00f3 RM, Barja JL, Bosch A.  \nPrevalence of enterovirus and hepatitis A viru s in bivalve molluscs from Galicia (NW Spain): \ninadequacy of the EU standards of microbiological quality. Int J Food Microbiol.  2002; 74(1-\n2):119-30.  Rose JB, Singh SN, Gerba CP, Kelley LM.  Comparison of microporous filters for concentration \nof viruses from wastewater. Appl Environ Microbiol.  1984; 47(5):989-92. \n Rose JB, Haas CN, Regli S.  Risk assessment and the control of waterborne Giardiasis. Am J \nPublic Health.  1991; 81(6):709-13. \n Rosenthal P.  Hepatitis A vaccine: current indications. J Pediatr Gastroenterol Nutr.  1998; \n27(1):111-3.  Rowe WP, Huebner RJ, Gilmore RK, Parrott RH, Ward TG.  Isolation of a cytopathogenic agent \nfrom human adenoids undergoing spontane ous degeneration in tissue culture. Proc Soc Exp \nBiol Med.  1953; 84(3):570-3. \n Russell WC. Update on adenovirus and its vectors. J Gen Virol.  2000; 81(11):2573-604. \n Rutjes SA, Lodder WJ, Lodder-Verschoor F, van den Berg HH, Vennema H, Duizer E, Koopmans M, de Roda Husman AM.  Sources of hepatitis E virus genotype 3 in The \nNetherlands. Emerg Infect Dis.  2009; 15(3):381-7. \n Rzezutka A, Cook N.  Survival of human enteric viruses in the environment and food. FEMS \nMicrobiol Rev.  2004; 28(4):441-53. \n  \n-S- \n Saad MD, Hussein HA, Bashandy MM, Kamel HH, Earhart KC, Fryauff DJ, Younan M, Mohamed AH. Hepatitis E virus infection in work horses in Egypt. Infect Genet Evol.  2007; \n7(3):368-73.  Sabath BF, Major EO.  Traffic of JC virus from sites of initial infection to the brain: the path to \nprogressive multifocal leukoencephalopathy. J Infect Dis.  2002; 186(2):180-6. Referencias \n 297Sahlstr\u00f6m L, Aspan A, Bagge E, Danielsson-Tham ML, Albihn A.  Bacterial pathogen incidences \nin sludge from Swedish sewage treatment plants. Water Res.  2004; 38(8):1989-94. \n Sakai Y, Nakata S, Honma S, Tatsumi M, Numata-Kinoshita K, Chiba S.  Clinical severity of \nNorwalk virus and Sapporo virus gastroente ritis in children in Hokkaido, Japan. Pediatr Infect \nDis J.  2001; 20(9):849-53. \n Sakano C, Morita Y, Shiono M, Yokota Y, Mokudai T, Sato-Motoi Y, Noda A, Nobusawa T, Sakaniwa H, Nagai A, Kabeya H, Maruyama S, Yamamoto S, Sato H, Kimura H.  Prevalence of \nhepatitis E virus (HEV) infection in wild boar s (Sus scrofa leucomystax) and pigs in Gunma \nPrefecture, Japan. J Vet Med Sci. 2009; 71(1):21-5. \n S\u00e1nchez Tapias JM.  Virus de la hepatitis. Enferm Infecc Microbiol Clin.  1995; 13(1):3-15. \n SARF [Scottish Aquaculture Research Forum].  Review and cost-benefit analysis for industry of \nreduced depuration times for the mussel Mytilus edulis. 2010. Disponible en: http://www.sarf.org.uk/c ms-assets/documents/29383-342050.sarf066.pdf \n \nSchlauder GG, Mushahwar IK.  Genetic hetero geneity of hepatitis E virus. J Med Virol . 2001; \n65(2):282-92.  Schmitt M, H\u00f6fler D, Koleganova N, Pawlita M. Human polyomaviruses and other human \nviruses in neuroendocrine tumors. Cancer Epidemiol Biomarkers Prev . 2011 Jul;20(7):1558-61. \n Schmitz H, Wigand R, Heinrich W.  Worlwide epidemiology of human adenovirus infections. \nAm J Epidemiol. 1983; 117(4):455-66. \n Schvoerer E, Ventura M, Dubos O, Cazaux G, Serceau R, Gournier N, Dubois V, Caminade P, Fleury HJ, Lafon ME.  Qualitative and quantitative molecular detection of enteroviruses in \nwater from bathing areas and from a sewage treatment plant. Res Microbiol.  2001; \n152(2):179-86.  Shah KV, Galloway DA, Knowles WA, Viscidi RP.  Simian virus 40 (SV40) and human cancer: a \nreview of the serological data. Rev Med Virol . 2004; 14(4):231-9. \n Sharma S, Sachdeva P, Virdi JS.  Emerging water-borne pathogens. Appl Microbiol Biotechnol.  \n2003; 61(5-6):424-8.  \nSharp IR, Wadell G.  Adenoviruses. En: Principles and Practice of Clinical Virology. Zuckerman \nAJ, Banatvala JE, Pattison JR, eds. J. Wiley & Sons. 1995; 7:287-308.  Shieh YC, Khudyakov YE, Xia G, Ganova-Raeva LM, Khambaty FM, Woods JW, Veazey JE, Motes ML, Glatzer MB, Bialek SR, Fiore AE.  Molecular confirmation of oysters as the vector \nfor hepatitis A in a 2005 multistate outbreak. J Food Prot . 2007; 70(1):145-50. \n Shinagawa M, Lida Y, Matsuda A, Tsukiyama T, Sato G.  Phylogenetic relationships between \nadenoviruses as inferred from nucleotide se quences of inverted terminal repeats. Gene.  1987; \n55(1):85-93.  Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr, Thapa GB, Thapa N, Myint KS, Fourneau M, Kuschner RA, Shrestha SK, David MP, Seriwatana J, Vaughn DW, Safary A, Endy TP, Innis BL. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med . 2007; 356(9):895-Referencias \n 298903. \n Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y.  T antigen mutations are \na human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA . 2008; \n105(42):16272-7.  Sidhu JP, Toze SG.  Human pathogens and their indicators in biosolids: a literature review. \nEnviron Int.  2009; 35(1):187-201. \n Simon A, Schildgen O, Maria Eis-H\u00fcbinger A, Hasan C, Bode U, Buderus S, Engelhart S, Fleischhack G.  Norovirus outbreak in a pediatric oncology unit. Scand J Gastroenterol.  2006; \n41(6):693-9.  Sinclair RG, Jones EL, Gerba CP.  Viruses in recreational water-borne disease outbreaks: a \nreview. J Appl Microbiol.  2009; 107(6):1769-80. \n Slomka MJ, Appleton H.  Feline calicivirus as a model system for heat inactivation studies of \nsmall round structured viruses in shellfish. Epidemiol Infect.  1998; 121(2):401-7. \n \nSmith EM, Gerba CP.  Development of a method for detect ion of human rotavirus in water and \nsewage. Appl Environ Microbiol.  1982; 43(6):1440-50. \n Smith HV, Cacci\u00f2 SM, Cook N, Nichols RA, Tait A.  Cryptosporidium and Giardia as foodborne \nzoonoses. Vet Parasitol . 2007; 149(1-2):29-40. \n Smith JJ, Gunasekera TS, Barardi CR, Veal D, Vesey G.  Determination of Cryptosporidium \nparvum oocyst viability by fluorescence in situ hybridization using a ribosomal RNA-directed probe. J Appl Microbiol. 2004; 96(2):409-17. \n Steinert M, Hentschel U, Hacker J.  Legionella pneumophila: an aquatic microbe goes astray. \nFEMS Microbiol Rev. 2002; 26(2):149-62. \n Stewart AR, Lednicky JA, Benzick US, Tevethia MJ, Butel JS.  Identification of a variable region \nat the carboxy terminus of SV40 large T-antigen. Virology. 1996; 221(2):355-61. \n Stine SW, Song I, Choi CY, Gerba CP.  Application of microbial risk assessment to the \ndevelopment of standards for enteric pathogens in water used to irrigate fresh produce. J Food \nProt.  2005; 68(5):913-8. \n \nSundsfjord A, Spein AR, Lucht E, Flaegstad T, Seternes OM, Traavik T.  Detection of BK virus \nDNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and imm unocompetent adult patients. J Clin Microbiol. 1994; \n32(5):1390-4.  Sweet BH, Hilleman MR.  The vacuolating virus, S.V. 40. Proc Soc Exp Biol Med.  1960; 105:420-\n7.    \n-T- \n \nTakahashi K, Kitajima N, Abe N, Mishiro S.  Complete or near-complete nucleotide sequences Referencias \n 299of hepatitis E virus genome recovered from a w ild boar, a deer, and four patients who ate the \ndeer. Virology.  2004; 330(2):501-5. \n Tam AW, Smith MM, Guerra ME, Huang C, Bradley DW, Fry KE, Reyes GR.  Hepatitis E virus \n(HEV): Molecular cloning and sequencing of the full-length viral genome. Virology.  1991; \n185(1):120-31.  Tam AW, White R, Yarbough PO, Murphy BJ, McAtee CP, Lanford RE, Fuerst TR.  In vitro \ninfection and replication of he patitis E virus in primary cyno molgus macaque hepatocytes. \nVirology.  1997; 238(1):94-102. \n Tan M, Huang P, Meller J, Zhong W, Farkas T, Jiang X.  Mutations within the P2 domain of \nnorovirus capsid affect binding to human histo- blood group antigens: evidence for a binding \npocket. J Virol.  2003; 77(23):12562-71. \n Tanaka T, Takahashi M, Kusano E, Okamoto H.  Development and evaluation of an efficient \ncell-culture system for Hepatitis E virus. J Gen Virol. 2007; 88(3):903-11.  \n \nTartera C, Jofre J, Lucena F.  Relationship between numbers of enteroviruses and \nbacteriophages infecting Bacteroides fragilis in different environmental samples. Environ \nTechnol Lett.  1988; 9(5):407-10. \n Terio V, Tantillo G, Martella V, Di Pinto P, Buonavoglia C, Kingsley DH.  High pressure \ninactivation of HAV within mussels. Food Environ Virol.  2010; 2:83-8. \n Teunis PF, Havelaar AH, Medema GJ.  A Literature Survey on the Assessment ofMicrobial Risk \nfor DrinkingWater. RIVM Report 734301006, RIVM Bilthoven, The Netherlands. 1994. Disponible en: http://rivm.openrepository.com/rivm/bitstream/10029/10480/1/734301006.pdf  Teunis PF, Moe CL, Liu P, Miller SE, Lindesmit h L, Baric RS, Le Pendu J, Calderon RL.  Norwalk \nvirus: how infectious is it? J Med Virol.  2008; 80(8):1468-76. \n Teunis PF, Nagelkerke NJ, Haas CN.  Dose response models for infectious gastroenteritis. Risk \nAnal.  1999; 19(6):1251-60. \n Ticehurst JR, Racaniello VR, Baroudy BM, Baltimore D, Purcell RH, Feinstone SM.  Molecular \ncloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci USA.  1983; \n80(19):5885-9. \n Ticehurst JR.  Hepatitis E virus. En: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, \neds. Manual of Clinical Microbiology, 7th edition. American Society for Microbiology Press, Washington DC. 1999; 1053-69.  Tickner J, Gouveia-Vigeant T.  The 1991 cholera epidemic in Peru: not a case of precaution \ngone awry. Risk Anal.  2005; 25(3):495-502. \n Toker C.  Trabecular carcinoma of the skin. Arch Dermatol.  1972; 105(1):107-10. \n Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, Chang Y, Buck CB, Moore PS. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can \nbe detected by conformational capsid epitope immunoassays. Int J Cancer.  2009; 125(6):1250-Referencias \n 3006. \n Toze S.  Microbial pathogens in wastewater. CSIR O Land and Water Tec hnical report 1/97. \n1997. Disponible en: http: //www.clw.csiro.au/publications/technical97/tr1-97.pdf \n Tsai YL, Sobsey MD, Sangermano LR, Palmer CJ.  Simple method of concentrating \nenteroviruses and hepatitis A virus from sewa ge and ocean water for rapid detection by \nreverse transcriptase-polymerase chain reaction. Appl Environ Microbiol.  1993; 59(10):3488-\n91.  Tsarev SA, Binn LN, Gomatos PJ, Arthur RR, Monier MK, van Cuyck-Gandre H, Longer CF, Innis BL.  Phylogenetic analysis of hepatitis E virus isolates from Egypt. J Med Virol.  1999; \n57(1):68-74.  Turcios-Ruiz RM, Axelrod P, St John K, Bullitt E, Donahue J, Robinson N, Friss HE.  Outbreak of \nnecrotizing enterocolitis caused by norovirus in a neonatal intensive care unit. J Pediatr.  2008; \n153(3):339-44.  \n \n-U- \n UNCSD [United Nations Commission on Sustainable Development].  Comprehensive \nassessment of the fresh water resources of the wo rld: A report of the Secretary-General. 1997. \nDisponible en: http://www.feem-web.it/nostrum/db_doc/SEI_1997.pdf  UNEP [United Nations Environment Programme].  Global environment outlook. Water \navailability by sub-region in 2000 (1 000 m\n3 per capita/year). 2002. Disponible en: \nhttp://www.unep.org/geo/geo3/english/fig152a.htm  USEPA [United States Environmental Protection Agency].  Primer for Municipal Wastewater \ntreatment systems. U.S. EPA, Washington DC. 2004.  USFDA [U.S. Food and Drug Administration].  Pathogens From The Harvest Area (A Biological \nHazard). Pathogens from the harvest area. 2001.Disponible en: http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/Seafood/FishandFisheriesProductsHazardsandControlsGuide/ucm091606.html  Upadhyay AR, Mishra VK, Pandey SK, Tripathi BD.  Biofiltration of seco ndary treated municipal \nwastewater in tropical city. Ecol Eng.  2007; 30(1)9-15.  \n  \n-V- \n van den Berg H, Lodder W, van der Poel W, Vennema H, de Roda Husman AM.  Genetic \ndiversity of noroviruses in raw and treated sewage water. Res Microbiol.  2005; 156(4):532-40. \n van der Giessen JW, de Vries A, Roos M, Wielinga P, Kortbeek LM, Mank TG.  Genotyping of \nGiardia in Dutch patients and animals: a phylogenetic analysis of human and animal isolates. Int J Parasitol.  2006; 36(7):849-58. \n van der Meijden E, Janssens RW, Lauber C, Bouwes Bavinck JN, Gorbalenya AE, Feltkamp MC. Discovery of a new human polyomavirus associ ated with trichodysplasia spinulosa in an Referencias \n 301immunocompromized patient. PLoS Pathog . 2010;6(7). \n van Heerden J, Ehlers MM, Grabow WO.  Detection and risk assessment of adenoviruses in \nswimming pool water. J Appl Microbiol.  2005a; 99(5):1256-64. \n van Heerden J, Ehlers MM, Heim A, Grabow WOK.  Prevalence, quantification and typing of \nadenoviruses detected in river and tr eated drinking water in South Africa. J Appl Microbiol.  \n2005b; 99(2):234-42.  V e r s c h o o r  E J ,  G r o e n e w o u d  M J ,  F a g r o u c h  Z ,  K e w a l a p a t  A ,  v a n  G e s s e l  S ,  K i k  M J ,  H e e n e y  J L .  \nMolecular characterization of the first polyomavirus from a New World primate: squirrel monkey polyomavirus. J Gen Virol. 2008; 89(1):130-7. \n Victoria M, Guimar\u00e3es FR, Fumian TM, Ferreira FF, Vieira CB, Shubo T, Leite JP, Miagostovich MP. One year monitoring of norovirus in a sewage  treatment plant in Rio de Janeiro, Brazil. J \nWater Health . 2010; 8(1):158-65. \n VIPERdb [Virus Particle Explorer\n2]. Database for icosahedral virus capsid structures. 2012. \nDisponible en: http://viperdb.scripps.edu \n Virus Taxonomy, seventh report of the International Commitee on Taxonomy of Viruses.  van \nRegenmortel MHS, et al., eds. Virology Division, International Union of Microbiological Societies. Academic press. 241-246.  Vinj\u00e9 J, Vennema H, Maunula L, von Bonsdorff CH, Hoehne M, Schreier E, Richards A, Green J, Brown D, Beard SS, Monroe SS, de Bruin E, Svensson L, Koopmans MP.  International \ncollaborative study to compare reverse transc riptase PCR assays for detection and genotyping \nof noroviruses. J Clin Microbiol.  2003; 41(4):1423-33. \n Viscidi RP, Clayman B.  Serological cross reactivity between polyomavirus capsids. Adv Exp Med \nBiol.  2006; 577:73-84. \n Viscidi RP, Rollison DE, Sondak VK, Silver B, Messina JL, Giuliano AR, Fulp W, Ajidahun A, Rivanera D.  Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. \nClin Vaccine Immunol.  2011; 18(10):1737-43. \n Viswanathan R.  Infectious hepatitis in Delhi (1955-56): A critical study: Epidemiology. Indian J \nMed Res . 1957; 45:1-30. \n \nVivier JC, Ehlers MM, Grabow WO.  Detection of enteroviruses in treated drinking water. \nWater Res.  2004; 38(11):2699-705. \n Vose DJ.  The application of quantitative risk assessment to microbial food safety. J Food Prot.  \n1998; 61(5):640-8.   \n-W- \n Wald A.  Hepatitis E. Adv Pediatr Infect Dis.  1995; 10:157-66. \n Wallace BJ, Guzewich JJ, Cambridge M, Altekruse S, Morse DL.  Seafood-associated disease \noutbreaks in New York, 1980-1994. Am J Prev Med.  1999; 17(1):48-54. Referencias \n 302Wallis C, Melnick JL.  Concentration of viruses from sewage by adsorption on millipore \nmembranes. Bull World Health Organ. 1967; 36(2):219-25. \n Wallis PM, Erl andsen SL, Isaac-Renton JL, Olson ME, Robertson WJ, van Keulen H.  Prevalence \nof Giardia cysts and Cryptosporidium oocysts and characterization of Giardia spp. isolated from drinking water in Canada. Appl Environ Microbiol. 1996; 62(8):2789-97. \n WHO [World Health Organzation].  WHO Position Paper Hepatitis A vaccines. 2000. Disponible \nen: http://www.who.int/immunization/Refs_Hepatitis%20A_4_Oct_2000.pdf  WHO [World Health Organzation].  WHO Report on Diarrhoeal disease. 2009. Disponible en: \nhttp://www.who.int/mediacentre/factsheets/fs330/en/index.html   WHO [World Health Organization].  Guidelines for Drinking Water Quality; Addendum-\nMicrobial Agents in Drinking Water, second ed. Switzerland, Geneva. 2002.   Westrell T, Ciampa N, Boelaert F, Helwigh B, Korsgaard H, Chr\u00edel M, Ammon A, M\u00e4kel\u00e4 P.  \nZoonotic infections in Europe in 2007: a summary of the EFSA -ECDC annual report. Euro \nSurveill.  2009; 14(3):19100. \n Wiens BL, Bohidar NR, Pigeon JG, Egan J, Hurni W, Brown L, Kuter BJ, Nalin DR.  Duration of \nprotection from clinical hepatitis A disease after vaccination with VAQTA. J Med Virol.  1996; \n49(3):235-41.   Wildy P. Classification and nomenclature of viruses. First report of International Commitee on \nNomenclature of Viruses. Monogr Virol, 1971; 5.  Wilkes G, Edge T, Gannon V, Jokinen C, Lyautey E, Medeiros D, Neumann N, Ruecker N, Topp E, Lapen DR.  Seasonal relationships among indicator bacteria, pathogenic bacteria, \nCryptosporidium oocysts, Giardia cysts, and hydrological indices for surface waters within an agricultural landscape. Water Res.  2009; 43(8):2209-23. \n Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV, Belliot G, Krug A, Mackenzie JM, Green KY, Virgin HW.  Replication of Norovirus in cell culture reveals a tropism for \ndendritic cells and macrophages. PLoS Biol.  2004; 2(12):432. \n Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, Pavri KM.  Epidemic and endemic hepatitis \nin India: evidence for non-A/non-B hepatitis virus etiology. Lancet.  1980; 2(8200):876-8. \n \nWong HH, Wang J.  Merkel cell carcinoma. Arch Pathol Lab Med.  2010; 134(11):1711-6. \n Worm HC, van der Poel WH, Brandst\u00e4tter G.  Hepatitis E: an overview. Microbes Infect.  2002; \n4(6):657-66.  Worm HC, Wirnsberger G.  Hepatitis e vaccines: progress and prospects. Drugs.  2004; \n64(14):1517-31.  Wyn-Jones AP, Carducci A, Cook N, D'Agostino M, Divizia M, Fleischer J, Gantzer C, Gawler A, Girones R, H\u00f6ller C, de Roda Husman AM, Kay D, Kozyra I, L\u00f3pez-Pila J, Muscillo M, Nascimento MS, Papageorgiou G, Rutjes S, Sellwood J, Szewzyk R, Wyer M.  Surveillance of \nadenoviruses and noroviruses in European recreational waters. Water Res.  2011; 45(3):1025-\n38. Referencias \n 303Wyn-Jones AP, Sellwood J.  Enteric viruses in the aquatic environment. J Appl Microbiol.  2001; \n91(6):945-62.   \n-X- \n Xi JN, Graham DY, Wang KN, Estes MK.  Norwalk virus genome cloning and characterization. \nScience.  1990; 250(4987):1580-3. \n X i a o  L ,  R y a n  U M .  Molecular Epidemiology. En: Fayer R, Xiao L, eds. Cryptosporidium and \ncryptosporidiosis, CRC Press, Boca Raton, Florida, USA. 2008; 120-171.   \n-Y- \n Yarbough PO, Tam AW, Fry KE, Krawczynski K, McCaustland KA, Bradley DW, Reyes GR.  \nHepatitis E virus: identification of type-common epitopes. J Virol.  1991; 65(11):5790-7. \n \nYarbough PO.  Hepatitis E virus: Advances in HE V biology and HEV vaccine approaches. \nIntervirology.  1999; 42(2-3):179-84. \n  \n-Z- \n Zafrullah M, Ozdener MH, Kumar R, Panda SK, Jameel S.  Mutation analysis of glycosylation, \nmembrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein. J \nVirol.  1999; 73(5):4074-82. \n Zafrullah M, Ozdener MH, Panda SK, Jameel, S.  The ORF3 protein of hepatitis E is a \nphosphoprotein that associate s with the cytoskeleton. J Virol . 1997; 71(12):9045-53. \n Zahorsky J.  Hyperemesis hemis or the winter vomiting disease. Arch Pediatr. 1929; 46:391-5. \n Zhang H, Chao SF, Ping LH, Grace K, Clarke B, Lemon SM.  An infectious cDNA clone of a \ncytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect. Virology.  1995; 212(2):686-97. \n Zhang W, Shen Q, Mou J, Gong G, Yang Z, Cui L, Zhu J, Ju G, Hua X.  Hepatitis E virus infection \namong domestic animals in eastern China. Zoonoses Public Health. 200; 55(6):291-8. \n Zheng D-P, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe S.  Norovirus classification and \nproposed strain nomenclature. Virology.  2006; 346:312-23. \n Zhou H, Smith DW.  Advanced technologies in water and wastewater treatment. J Environ Eng \nSci. 2001; 28(1):49-66. \n Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, Wang YJ, Ai X, Hu YM, Tang Q, Yao X, Yan Q, Xian YL, Wu T, Li YM, Miao J, Ng MH, Shih JW, Xia NS.  Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, \nrandomised, double-blind placebo-controlled, phase 3 trial. Lancet . 2010;376(9744):895-902. \n \n   \n  \n \n    \n8. ANEXOS  Otras publicaciones \n 307Otras publicaciones no incluidas en esta Tesis (orden cronol\u00f3gico): \n \n1. Bofill-Mas S, Albinana-Gimenez N, Clemente-Casares P, Hundesa A, Rodriguez-\nManzano J, Allard A, Calvo M, Girones R.  Quantification and stability of human \nadenoviruses and polyomavirus JCPyV in wastewater matrices. Appl Environ Microbiol.  \n2006; 72(12):7894-6. \n \n2. Hundesa A, Maluquer de Motes C, Albinana-Gimenez N, Rodriguez-Manzano J, Bofill-\nMas S, Su\u00f1en E, Rosina Girones R. Development of a qPCR assay for the quantification \nof porcine adenoviruses as an MST tool for swine fecal contamination in the environment. J Virol Methods.  2009; 158(1-2):130-5. \n \n3. Hundesa A, Bofill-Mas S, Maluquer de Motes C, Rodriguez-Manzano J, Bach A, Casas \nM, Girones R.  Development of a quantitative PCR assay for the quantitation of bovine \npolyomavirus as a microbial source-tracking tool. J Virol Methods.  2010; 163(2):385-9. \n \n4. Girones R, Ferr\u00fas MA, Alonso JL, Rodriguez-Manzano J, Calgua B, Corr\u00eaa AA, \nHundesa A, Carratala A, Bofill-Mas S.  Molecular detection of pathogens in water--the \npros and cons of mo lecular techniques. Water Res.  2010; 44(15):4325-39. \n \n5. Navarro JT, Hern\u00e1ndez A, Rodriguez-Manzano J, Mate JL, Grau J, Morgades M, \nMartr\u00f3 E, Tural C, Ribera JM, Matas L.  Plasma Epstein-Barr viral load measurement as \na diagnostic marker of lymphoma in HIV-infected patients. Med Clin (Barc).  2010; \n135(11):485-90. \n \n6. Calgua B, Barardi CR, Bofill-Mas S, Rodriguez-Manzano J, Girones R.  Detection and \nquantitation of infectious human adenovirus es and JC polyomaviruses in water by \nimmunofluorescence assay. J Virol Methods.  2011; 171(1):1-7. \n \n7. Guerrero-Latorre L, Carratala A, Rodriguez-Manzano J, Calgua B, Hundesa A, Girones \nR. Occurrence of water-borne enteric viruses in two settlements based in Eastern \nChad: analysis of hepatitis E virus, hepati tis A virus and human adenovirus in water \nsources. J Water Health.  2011; 9(3):515-24. \n \n8. Jardi R, Crespo M, Homs M, Van den Eyden E, Girones R, Rodriguez-Manzano J, \nCaballero A, Buti M, Esteban R, Rodriguez-Frias F.  HIV, HEV and cirrhosis: evidence of \na possible link from eastern Spain. HIV Med.  2012 [Epub ahead of print]. \n  APPLIED AND ENVIRONMENTAL MICROBIOLOGY , Dec. 2006, p. 7894\u20137896 Vol. 72, No. 12\n0099-2240/06/$08.00 /H110010 doi:10.1128/AEM.00965-06\nCopyright \u00a9 2006, American Society for Microbiology. All Rights Reserved.\nQuanti\ufb01cation and Stability of Human Adenoviruses and Polyomavirus\nJCPyV in Wastewater Matrices/H17188\nSilvia Bo\ufb01ll-Mas,1Nestor Albinana-Gimenez,1Pilar Clemente-Casares,1Ayalkibet Hundesa,1\nJesus Rodriguez-Manzano,1Annika Allard,3Miquel Calvo,2and Rosina Girones1*\nDepartment of Microbiology1and Department of Statistics,2Faculty of Biology, University of Barcelona, Av. Diagonal 645,\nBarcelona 08028, Spain, and Department of Clinical Virology, Ume\u00e5 University Hospital, S-901 85 Ume\u00e5, Sweden3\nReceived 24 April 2006/Accepted 2 October 2006\nHuman adenoviruses (HAdV) and human polyomavirus JCPyV have been previously proposed as indicators\nof fecal viral contamination in the environment. Dif ferent wastewater matrices have been analyzed by applying\nreal-time quantitative PCR procedures for the presence, quantity, and stability of a wide diversity of excretedHAdV and JCPyV. High quantities of HAdV and JCPyV were detected in sewage, ef \ufb02uent wastewater, sludge,and biosolid samples. Both viruses showed high stability in urban sewage. These results con\ufb01rm the suitabilityof both viruses as indicators of human fecal viral pollution.\nTwo groups of DNA viruses have been proposed as indica-\ntors of the presence of human viral pathogens in the environ-ment: human adenoviruses (HAdV) and human polyomavi-ruses (2, 13, 14). PCR-based procedures have been describedfor the detection of these viruses in environmental samples (2,\n13). The aim of this study was to analyze the presence, quan-\ntity, and stability of HAdV and human polyomavirus JCPyV indifferent wastewater matrices. The applied real-time quantita-tive PCR (QPCR) procedures showed enough sensitivity to\ndetect not only speci\ufb01c serotypes but also a wide diversity of\nexcreted strains. The presence of hepatitis E virus (HEV),considered an emergent pathogen in developed countries, wasalso evaluated in this study by conventional nested-PCR tech-niques (5).\nA total of 28 samples were obtained from a wastewater\ntreatment plant located in the south of Barcelona (Spain)which treats the domestic and industrial wastewater from apopulation equivalent of 400,000 with a capability of 72,000 m\n3\nper day. The treatment includes primary sedimentation andaerobic activated sludge digestion. The samples analyzed con-sisted of six raw sewage samples, seven treated wastewatersamples, eight sludge samples (dry weight, 3.6% to 4%) and,\ufb01nally, seven biosolid samples (dry weight, 25%).\nRecovery of viral particles from sewage was carried out\nfollowing a previously described procedure (13) presenting anestimated recovery ef\ufb01ciency of 34% for JCPyV. Recoveryof viral particles from ef\ufb02uent wastewater was carried outfollowing EPA procedure 600/4-84/013 (N14) (www.epa.gov\n/microbes/ chapt14.pdf) combined with a second concentration\nprocedure (13). The recovery ef\ufb01ciencies observed for thiscombined procedure were 0.15 to 0.16% for JCPyV and 2 to25% for HAdV. Recovery of viral particles from sludge andbiosolid samples was carried out by applying a method based\non EPA 600/4-84/013 (R7) (www.epa.gov/nerlcwww/chap7.pdf)with minor modi\ufb01cations. Viral nucleic acids were extracted by\na procedure described by Boom et al. (3) which have been\npreviously detailed (7).\nTwo QPCR procedures based on the use of TaqMan probes\n(8, 9) were evaluated for their suitability in the analysis andquanti\ufb01cation of HAdV present in different wastewater matri-\nces (Table 1). After comparing the two QPCR methods by\nstatistically analyzing the results obtained by applying two dif-ferent analysis of variation (ANOVA) tests, we concluded thatassay 1 (9) was signi\ufb01cantly different from assay 2 (8) in that itdetected a higher number of HAdV ( P/H110050.012 in the repeated\nmeasures ANOVA for sewage and ef\ufb02uent wastewater; P/H11005\n0.004 in the repeated measures ANOVA for sludge and bio-solids; P/H110210.001 for both sewage and ef\ufb02uent wastewater and\nfor sludge and biosolids in the nested hierarchical ANOVA).The speci\ufb01city of assay 1 for detecting the diverse HAdV\nserotypes had been previously evaluated, and adenoviruses\nbelonging to all six human species have been detected. How-ever, some strains of animal adenoviruses excreted by farmanimals may also be detected with the described protocol (data\nnot shown).\nHAdV assay 1 had been performed using probe AdP1. A\nsecond probe, AdP2, originally designed to better detect someadenovirus serotype B strains, did not improve the resultswhen added to AdP1 in the analysis of environmental samples\n(data not shown).\nThe quanti\ufb01cation of JCPyV has been evaluated using a\nQPCR assay (11) that showed to be speci\ufb01c and highly sensi-tive for JCPyV, which is a very stable DNA virus presenting alow level of genetic variability. To the best of our knowledge,\nthis is the \ufb01rst attempt to detect JCPyV in treated urban\nsewage and in the sludge and/or biosolids generated in waste-water treatment plants (Table 1).\nThe sensitivities of both QPCR assays applied in this study\nwere estimated to be of 1 to 10 genome copies (GC).\nHigh concentrations of HAdV and JCPyV were found in\nsludge and biosolid samples (Tables 1 and 2). HEV RNA wasalso detected in 6/12 analyzed samples by seminested reversetranscription-PCR (RT-PCR) with degenerated primers (6) aspreviously described (5) by use of a one-step RT-PCR proce-\nCorresponding author. Mailing address: Department of Microbiol-\nogy, Faculty of Biology, University of Barcelona, Av. Diagonal 645,Barcelona 08028, Spain. Phone: 34 93 402 14 83. Fax: 34 93 4039047.E-mail: rgirones@ub.edu.\n/H17188Published ahead of print on 6 October 2006.\n7894Journal of Virological Methods 158 (2009) 130\u2013135\nContents lists available at ScienceDirect\nJournal of Virological Methods\njournal homepage: www.elsevier.com/locate/jviromet\nDevelopment of a qPCR assay for the quanti\ufb01cation of porcine adenoviruses\nas an MST tool for swine fecal contamination in the environment\nA. Hundesaa, C. Maluquer de Motesa, N. Albinana-Gimeneza, J. Rodriguez-Manzanoa,\nS. Bo\ufb01ll-Masa,E .S u \u02dcnenb, R. Rosina Gironesa,\u2217\naDepartment of Microbiology, Faculty of Biology, University of Barcelona, Av. Diagonal 645, Barcelona 08028, Spain\nbDepartment of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country, Paseo de la Universidad 7, Vitoria -Gasteiz 01006, Spain\nArticle history:\nReceived 7 November 2008\nReceived in revised form 2 February 2009Accepted 5 February 2009Available online 17 March 2009\nKeywords:PAdVsqPCR\nAdenovirus\nFecal contaminationEnvironmentWaterMicrobial source trackingabstract\nThe Adenoviridae family comprises a wide diversity of viruses that may be excreted for long periods in\nfeces or urine. Previous studies have suggested that the detection of human and animal adenoviruses\nas well as human and animal polyomaviruses by PCR could be used as an index of fecal contaminationof human and animal origin. In this study, quantitative PCR assays targeting speci\ufb01cally porcine aden-oviruses have been developed and applied to fecal and environmental samples, including pig slurries,urban sewage, slaughterhouse sewage and river water samples. To develop real-time quantitative PCR forthe detection and quantitation of porcine adenoviruses, primers and a TaqMan probe targeting a 68-bpregion of the porcine adenovirus hexon gene were designed to amplify speci\ufb01cally porcine adenovirus,and the conditions of the reaction were optimized. The assay detected 1\u201310 genome copies per test tubeand was speci\ufb01c in showing no positive results when samples containing human or bovine adenoviruseswere analyzed. Fecal samples contained mean concentrations of porcine adenoviruses of 10\n5GC/g while\nslaughterhouse wastewater samples showed mean values of 103GC/ml. The assay detected porcine fecal\npollution in samples that were highly diluted and had been collected at a considerable distance from the\ninput source, such as river water. In general, the data presented here provide a quantitative tool for theanalysis of porcine adenoviruses as indicators of the presence of porcine contamination in the environ-ment, and support the detection of porcine adenoviruses by real-time quantitative PCR as a promisingand valuable tool for source-tracking studies.\n\u00a9 2009 Elsevier B.V. All rights reserved.\n1. Introduction\nMicrobial contamination of the environment poses a signi\ufb01cant\nrisk to human health through recreational exposure or consump-tion of water or contaminated food. According to the requirementsof the Water Framework Directive and the United States Clean\nWater Act there has been a major shift from traditional point-source\nef\ufb02uent quality regulations towards a catchment-wide approach(Stapleton et al., 2007 ). Given this new approach there is a need\nfor new information on the microbial dynamics of catchments for\nthe effective control of water quality at the point of use. Bacterial\nindicators including Escherichia coli and fecal coliform bacteria have\nbeen used historically to monitor water quality and safety. However,their major shortcoming is that they are often not correlated with\nviral pathogens or protozoan parasites ( Gerba et al., 1979; Grif\ufb01n\net al., 2003; Pina et al., 1998 ). Fecal contamination may originate\nfrom point or nonpoint sources. Generally, point sources of fecal\n\u2217Corresponding author. Tel.: +34 934021483; fax: +34 934039047.\nE-mail address: rgirones@ub.edu (R. Rosina Girones).contamination include discrete sources such as discharges from\nlarge animal feeding operations, wastewater treatment outfalls and\nstorms and combined sewers. The nonpoint sources are diffuse andinclude agricultural sources and livestock waste applied to agri-cultural land. Identifying the sources of microbial contamination\nplays a very important role in enabling effective management and\nremediation strategies and is known as microbial source tracking(MST). MST includes a group of methodologies that aim to iden-tify, and in some cases quantify, the dominant sources of fecal\ncontamination in the environment and, more speci\ufb01cally, in water\nresources ( Field, 2004; Stoeckel and Harwood, 2007 ). Environmen-\ntal and water contamination by the waste produced in pig farms isa source of microbiological and chemical contamination. The hep-\natitis E virus is a human viral pathogen that causes acute hepatitis\nand is highly prevalent in young pigs and present frequently in fecalsamples, as well as in waste water and sludge produced in slaugh-terhouses dealing with pigs ( Clemente-Casares et al., 2003; Pina et\nal., 1998 ). The identi\ufb01cation of fecal contamination of porcine origin\nis important to pinpoint the source of contamination for remedia-tion purposes and to evaluate the potential public health impact offecal contamination in water.\n0166-0934/$ \u2013 see front matter \u00a9 2009 Elsevier B.V. All rights reserved.\ndoi:10.1016/j.jviromet.2009.02.006Journal of Virological Methods 163 (2010) 385\u2013389\nContents lists available at ScienceDirect\nJournal of Virological Methods\njournal homepage: www.elsevier.com/locate/jviromet\nDevelopment of a quantitative PCR assay for the quantitation of bovine\npolyomavirus as a microbial source-tracking tool\nAyalkibet Hundesaa, Silvia Bo\ufb01ll-Masa, Carlos Maluquer de Motesa, Jesus Rodriguez-Manzanoa,\nAlex Bachb,c, Maribel Casasd, Rosina Gironesa,\u2217\naDepartment of Microbiology, University of Barcelona, Avda Diagonal 645, 08028 Barcelona, Spain\nbICREA, Instituci\u00f3 Catalana de Recerca i Estudis Avanc \u00b8 ats, Pg. Lluis Companys 23, 08010 Barcelona, Spain\ncGrup de Recerca en Nutrici\u00f3, Maneig, i Benestar Animal, Unitat de Remugants, IRTA (Institut de Recerca i Tecnologia Agroaliment\u00e0ries), Torre Marimo n, 08140 Caldes de Montbui,\nBarcelona, Spain\ndCentre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Campus de la Universitat Aut\u00f2noma de Barcelona, Edi\ufb01cio CReSA, 08193 Bellaterra, Barcelona, Spain\nArticle history:\nReceived 24 July 2009\nReceived in revised form 26 October 2009\nAccepted 27 October 2009Available online 1 November 2009\nKeywords:BovinePolyomavirusSewage\nWater\nMicrobial source trackingabstract\nAdenoviruses and polyomaviruses are two distinct DNA viral families that are excreted in high concentra-\ntions and distributed in human and animal populations. Targeting speci\ufb01c virus included in these familieshas proved to be a promising and useful tool for tracing speci\ufb01cally sources of environmental contami-nation. In this study, a quantitative PCR assay that is speci\ufb01c for bovine polyomaviruses was developedand used to determine the excretion level and concentration of bovine polyomaviruses in urine and envi-ronmental samples, including urban sewage, slaughterhouse sewage, and river water. A set of primersand a TaqMan probe were designed to target a 77-bp region of the bovine polyomavirus VP1 gene, andthe conditions of the reaction were optimized. A detection limit was established at 1\u201310 genome copiesper test tube. The assay was speci\ufb01c and produced negative results when samples containing humanor porcine fecal contamination were analyzed. This is, to our knowledge, the \ufb01rst description of bovine\npolyomaviruses excreted in bovine urine samples (mean values of 10\n4GC/l). Bovine polyomaviruses were\nalso detected and quanti\ufb01ed in slaughterhouse wastewater and river waters, which shows the spreadof these viruses in many environmental samples containing contamination of bovine origin. The pro-cedure described in this paper provides a quantitative source-tracking tool for the analysis of bovinepolyomaviruses as indicators of the presence of bovine contamination in environmental samples.\n\u00a9 2009 Elsevier B.V. All rights reserved.\n1. Introduction\nFecal contamination of water systems may represent a high risk\nto human health, due to recreational exposure or consumption offecally polluted water and/or food. Such contamination involves\nusually signi\ufb01cant economic losses and serious disturbances of\nnatural and ecological environments. The origin of fecal contam-ination must be identi\ufb01ed and tracked to monitor water quality,assess potential health risks, and determine optimal remediation\nstrategies. Methods for detecting and identifying the source of fecal\npollution in the environment are known as microbial source track-ing ( Field, 2004; Stapleton et al., 2007; Stoeckel and Harwood,\n2007 ). These methods focus mainly on detecting a microorgan-\nism that is related intrinsically to fecal contents and stools, which\nindicates the presence of contamination and, thus, of potentialpathogens, such as bacteria, viruses, and parasites.\n\u2217Corresponding author. Tel.: +34 93 4021483; fax: +34 93 4039047.\nE-mail address: rgirones@ub.edu (R. Girones).A large body of work has been developed in the microbial\nsource-tracking \ufb01eld over the past few years. This research has\nprovided new and valuable information on microbial dynamics andimproved considerably the maintenance of water quality and safety(Field, 2004 ).\nEnteric viruses have emerged as a promising tool in efforts to\nincrease water quality standards, due to their high host-speci\ufb01city,stability in different environments, and prevalence in diverse geo-graphical areas. Polymerase chain reaction (PCR)-based techniques\nhave been used conventionally to monitor the presence or absence\nof genomic copies of targeted viral indicators. However, the recentdevelopment of real-time quantitative PCR (qPCR) techniquesallows the speci\ufb01c, sensitive detection and reliable quantitation\nof small amounts of target molecules. Assessment of health risk\nassociated with fecal pollution requires a reliable fecal indicatorand a rapid quantitation method. The development of a quantita-tive assay for the evaluation of the concentration of a host speci\ufb01c,\nwidely excreted DNA virus, the bovine polyomavirus, provides a\nquick reliable protocol. The availability of a quantitative assay willalso expand the use of PCR indicators for fecal source tracking into a\n0166-0934/$ \u2013 see front matter \u00a9 2009 Elsevier B.V. All rights reserved.\ndoi: 10.1016/j.jviromet.2009.10.029Molecular detection of pathogens in water eThe pros and\ncons of molecular techniques\nRosina Gironesa,*, Maria Antonia Ferru \u00b4sb, Jose \u00b4Luis Alonsoc, Jesus Rodriguez-Manzanoa,\nByron Calguaa, Adriana de Abreu Corre \u02c6aa,d, Ayalkibet Hundesaa, Anna Carratalaa,\nS\u0131\u00b4lvia Bo\ufb01ll-Masa\naDepartment of Microbiology, Faculty of Biology, University of Barcelona. Av. Diagonal 645, 08028 Barcelona, Spain\nbDepartment of Biotechnology, Polytechnic University of Valencia, Camino de Vera 14, 46022 Valencia, Spain\ncInstitute of Water Engineering and Environment, Polytechnic University of Valencia, Camino de Vera 14, 46022 Valencia, Spain\ndDepartment of Microbiology and Parasitology, Laboratory of Applied Virology, Federal University of Santa Catarina, 88040-900\nFloriano \u00b4polis, Santa Catarina, Brazil\narticle info\nArticle history:\nReceived 1 February 2010\nReceived in revised form\n10 June 2010\nAccepted 14 June 2010\nAvailable online 19 June 2010\nKeywords:\nPathogen\nWaterVirus\nProtozoa\nBacteriaPCRabstract\nPollution of water by sewage and run-off from farms produces a serious public health problemin many countries. Viruses, along with bacteria and protozoa in the intestine or in urine are\nshed and transported through the sewer system. Even in highly industrialized countries,\npathogens, including viruses, are prevalent throughout the environment. Molecular methodsare used to monitor viral, bacterial, and protozoan pathogens, and to track pathogen- andsource-speci\ufb01c markers in the environment. Molecular techniques, speci\ufb01cally polymerase\nchain reaction-based methods, provide sensitive, rapid, and quantitative analytical tools with\nwhich to study such pathogens, including new or emerging strains. These techniques are usedto evaluate the microbiological quality of food and water, and to assess the ef\ufb01ciency of virusremoval in drinking and wastewater treatment plants. The range of methods available for the\napplication of molecular techniques has increased, and the costs involved have fallen. These\ndevelopments have allowed the potential standardization and automation of certain tech-niques. In some cases they facilitate the identi\ufb01cation, genotyping, enumeration, viability\nassessment, and source-tracking of human and animal contamination. Additionally, recent\nimprovements in detection technologies have allowed the simultaneous detection of multipletargets in a single assay. However, the molecular techniques available today and those underdevelopment require further re\ufb01nement in order to be standardized and applicable to\na diversity of matrices. Water disinfection treatments may have an effect on the viability of\npathogens and the numbers obtained by molecular techniques may overestimate the quan-ti\ufb01cation of infectious microorganisms. The pros and cons of molecular techniques for the\ndetection and quanti\ufb01cation of pathogens in water are discussed.\n\u00aa2010 Elsevier Ltd. All rights reserved.\nAbbreviations: MST, microbial source-tracking; HAdV, human adenoviruses; HAV, hepatitis A virus; HEV, hepatitis E virus; JCPyV,\nhuman polyomavirus JC; BKPyV, human polyomavirus BK; PCR, polymerase chain reaction; qPCR, quantitative PCR; qRT-PCR, quanti-\ntative reverse transcriptase PCR; NASBA, acid sequence-based ampli\ufb01cation; CFU, colony-forming units; mPCR, multiplex PCR; IFAs,immuno\ufb02uorescent assays; IMS, immunomagnetic separation; RT-PCR, reverse transcriptase PCR; mRNA, messenger RNA; PAdV,porcine adenoviruses; BPyV, bovine polyomaviruses; EMA, ethidium monoazide; PMA, propidium monoazide; VBNC, viable non-cul-\nturable; PBS, phosphate buffered saline; nPCR, nested-PCR.\n*Corresponding author . Tel.: \u00fe34 93 402 1483; fax: \u00fe34 93 403 9047.\nE-mail address: rgirones@ub.edu (R. Girones).\nAvailable at www.sciencedirect.com\njournal homepage: www.elsevier.com/locate/watreswater research 44 (2010) 4325 e4339\n0043-1354/$ esee front matter \u00aa2010 Elsevier Ltd. All rights reserved.\ndoi:10.1016/j.watres.2010.06.030Original\nPlasma Epstein-Barr viral load measurement as a diagnostic marker\nof lymphoma in HIV-infected patients\nJose\u00b4-Toma \u00b4s Navarroa,/C3,~,A\u00b4gueda Herna \u00b4ndezb,~, Jesu \u00b4s Rodr\u0131 \u00b4guez-Manzanob, Jose \u00b4-Luis Matec,\nJavier Graua, Mireia Morgadesa, Elisa Martro \u00b4b, Cristina Turald, Josep-Maria Riberaaand Lurdes Matasb\naDepartment of Hematology, Institut Catal /C18a d\u2019Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Universitat Aut /C18onoma de Barcelona, Spain\nbDepartment of Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, Universitat Aut /C18onoma de Barcelona, Spain\ncDepartment of Pathology, Hospital Universitari Germans Trias i Pujol, Badalona, Universitat Aut /C18onoma de Barcelona, Spain\ndHIV Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Universitat Aut /C18onoma de Barcelona, Spain\nARTICLE INFO\nArticle history:\nReceived 2 December 2009\nAccepted 9 February 2010\nAvailable online 31 July 2010\nKeywords:\nHIV\nEpstein-Barr virus\nViral load\nNon-Hodgkin\u2019s lymphoma\nHodgkin\u2019s lymphomaABSTRACT\nBackground and objectives: To assess the use of the Epstein-Barr virus (EBV) viral load as a marker for\nlymphoma diagnosis in HIV-infected patients. We also aimed to identify the relationship between EBV\nviral load in plasma and the presence of EBV in lymphoma cells.\nPatients and methods: Retrospective observational study of two HIV-infected populations: one of patients\ndiagnosed with lymphoma and a control group. Thirty-nine patients with AIDS-related lymphoma (ARL)\n(32 non-Hodgkin\u2019s and 7 Hodgkin\u2019s lymphomas) and 134 HIV-positive individuals without neoplasia or\nopportunistic infections were studied. Blood samples were collected before lymphoma treatment in\nARL patients. EBV viral load was measured in plasma by real-time quantitative PCR and the presence of\nEBV-EBER mRNA in lymphoma tumor was investigated by in situ hybridization.\nResults: Patients with ARL had higher EBV viral loads than those without lymphoma: 24,180.5\n(773,387.6) copies/mL versus 2.6 ( 721.6) copies/mL ( po0.001). HIV-infected patients without lympho-\nma had negative or very low EBV load values. Among ARL patients, no correlation was found between EBV\nviral loads and CD4+ lymphocyte counts or between EBV and HIV RNA loads, or any other clinical or\nbiological parameter. Cases with an EBV-EBER-positive lymphoma had higher EBV viral loads than thosewith EBER-negative tumors.\nConclusions: EBV viral load is a useful marker of lymphoma in HIV-infected patients, and may be a useful\ntool for early diagnosis and treatment.\n&2009 Elsevier Espan \u02dca, S.L. All rights reserved.\nCarga viral del virus de Epstein-Barr como marcador diagno \u00b4stico de linfoma en\npacientes infectados por el VIH\nPalabras clave:\nVIH\nVirus de Epstein-Barr\nCarga viral\nLinfoma no hodgkiniano\nLinfoma de HodgkinRESUMEN\nFundamento y objetivo: Evaluar el uso de la carga viral del virus de Epstein-Barr (VEB) como marcador\npara el diagno \u00b4stico de linfomas en pacientes infectados por el VIH. Identi\ufb01car la relacio \u00b4n entre la carga viral\nde VEB en plasma y la presencia del virus en las ce \u00b4lulas del linfoma.\nPacientes y me \u00b4todo: Estudio observacional retrospectivo de dos poblaciones de pacientes VIH: una de\npacientes diagnosticados de linfoma y un grupo control. Se estudiaron 39 pacientes con linfoma asociado a\ninfeccio \u00b4n por el VIH (32 linfomas no hodgkinianos y 7 de Hodgkin) y 134 individuos con infeccio \u00b4n por el\nVIH sin neoplasia ni infecciones oportunistas. Las muestras de plasma de los pacientes con linfoma fueronobtenidas en el momento del diagno \u00b4stico. La carga viral en plasma del VEB fue realizada mediante una PCR\ncuantitativa en tiempo real y la presencia de RNAm VEB-EBER en los tumores fue investigada por\nhibridacio \u00b4nin situ .\nResultados: Los pacientes con linfoma asociado a infeccio \u00b4n por el VIH ten\u0131 \u00b4an cargas virales de VEB ma \u00b4s\nelevadas que los pacientes sin linfoma: 24.180,5 ( 773.387,6) copias/ml frente a 26 ( 721,6) copias/ml\n(po0,001). Los pacientes con infeccio \u00b4n por el VIH sin linfoma presentaron carga viral muy baja o negativa.\nEn los pacientes con linfoma no se hallo \u00b4correlacio \u00b4n entre la carga viral del VEB y el recuento de linfocitoswww.elsevier.es/medicinaclinica\n0025-7753/$ - see front matter &2009 Elsevier Espan \u02dca, S.L. All rights reserved.\ndoi:10.1016/j.medcli.2010.02.041/C3Corresponding author.\nE-mail address: jnavarro@iconcologia.net (J.-T. Navarro).\n~Both authors contributed equally to this study.Med Clin (Barc). 2010; 135(11) :485\u2013490Journal of Virological Methods 171 (2011) 1\u20137\nContents lists available at ScienceDirect\nJournal of Virological Methods\njournal homepage: www.elsevier.com/locate/jviromet\nProtocols\nDetection and quantitation of infectious human adenoviruses and JC\npolyomaviruses in water by immuno\ufb02uorescence assay\nByron Calguaa, Celia Regina Monte Barardib, Silvia Bo\ufb01ll-Masa, Jesus Rodriguez-Manzanoa,\nRosina Gironesa,\u2217\naDepartment of Microbiology, Faculty of Biology, University of Barcelona, Diagonal 645, 08028 Barcelona, Spain\nbDepartment of Microbiology, Immunology and Parasitology, Center of Biological Sciences, Universidade Federal de Santa Catarina, 88040-900 Flori an\u00f3polis, Santa Catarina, Brazil\nArticle history:\nReceived 26 April 2010Received in revised form 3 September 2010Accepted 13 September 2010\nAvailable online 21 September 2010\nKeywords:\nImmuno\ufb02uorescence assayPlaque assayTCID50qPCR\nCell culture\nAdenovirusesJC polyomavirusabstract\nHuman adenoviruses (HAdV) and JC polyomaviruses (JCPyV) have been proposed as markers of fecal/urine\ncontamination of human origin. An indirect immuno\ufb02uorescence assay has been developed to quantifyinfectious human adenoviruses types 2 and 41 and JC polyomaviruses strain Mad-4 in water samples.The immuno\ufb02uorescence assay was compared with other quantitative techniques used commonly suchas plaque assay, tissue culture infectious dose-50 and quantitative PCR (qPCR). The immuno\ufb02uorescenceassays showed to be speci\ufb01c for the detection of infectious viruses, obtaining negative results whenUV or heat-inactivated viruses were analyzed. The assays required less time and showed higher sen-\nsitivity for the detection of infectious viral particles than other cell culture techniques (1 log\n10more)\nevaluated. River water samples spiked previously with human adenoviruses and raw sewage sampleswere also analyzed using the proposed immuno\ufb02uorescence assay as well as by qPCR. The results showquantitations with 2 log\n10reduction in the numbers of infectious viruses compared with the number of\ngenome copies detected by qPCR. The immuno\ufb02uorescence assay developed is fast, sensitive, speci\ufb01c,and a standardizable technique for the quantitation and detection of infectious viruses in water samples.\n\u00a9 2010 Elsevier B.V. All rights reserved.\n1. Introduction\nWater quality is impaired by the presence of pathogenic\nmicroorganisms derived from treated ef\ufb02uent or untreated sewagethat is released into the environment. These pathogens includemany types of viruses that infect humans and that are excreted\nin high concentration in the feces of patients with gastroen-\nteritis ( Carter, 2005; IAWPRC, 1983 ). Some viruses, such as\npolyomaviruses and some strains of human adenoviruses (HAdV),establish persistent infections, and viral particles may be excreted\nin feces and/or urine for months and even years ( Carter, 2005;\nCrabtree et al., 1997; Imperiale and Major, 2007; Wadell et al.,1988 ). HAdV and JC polyomavirus (JCPyV) have been reported\nin high concentrations in sewage ( Bo\ufb01ll-Mas et al., 2000, 2006;\nKatayama et al., 2004; Pina et al., 1998 ), river and lake water\n(Albinana-Gimenez et al., 2009a; Wong et al., 2009 ), seawater\n(Calgua et al., 2008; McQuaig et al., 2009 ) and even drinking water\n(Albinana-Gimenez et al., 2009b; Hamza et al., 2009; Lambertini\net al., 2008 ). Both DNA viruses are highly stable to environmental\n\u2217Corresponding author. Tel.: +34 93 4021483; fax: +34 93 4039047.\nE-mail address: rgirones@ub.edu (R. Girones).conditions ( Bo\ufb01ll-Mas et al., 2006; Fong and Lipp, 2005 ). Several\nstudies have questioned the use of bacterial indicators to predict\nthe occurrence of viruses and have proposed HAdV and JCPyV\nas indicators of fecal contamination of human origin ( Bo\ufb01ll-Mas\net al., 2000; Calgua et al., 2008; Formiga-Cruz et al., 2003; Lippet al., 2001; Pina et al., 1998; Sinclair et al., 2009; Wong et al.,\n2009 ).\nHAdVs have linear double-stranded DNA and are included in\nthe Mastadenovirus genera, in the Adenoviridae family ( Stewart et\nal., 1993 ). HAdVs are grouped in 52 serotypes, which have been\ndivided in 7 species (A\u2013G). Most of the serotypes (main serotypes:\n1\u20137, 14 and 21) cause respiratory diseases, particularly in children.HAdV 40 and 41 are the most important serotypes responsible forgastroenteritis in children ( Wold and Horwitz, 2007 ).\nJC polyomavirus is a human virus classi\ufb01ed in the Polyomaviridae\nfamily. This virus produce latent and chronic infections that persistinde\ufb01nitely in individuals and viral particles are excreted regu-larly in urine of healthy individuals ( Imperiale and Major, 2007 ).\nThe virus affects a large proportion of the population worldwide;\nconsequently, its presence in water may not represent a signif-icant health risk for most of the population. The pathogenicityof the virus is commonly associated with progressive multifocal\nleukoencephalopathy (PML) in immunocompromised states and\n0166-0934/$ \u2013 see front matter \u00a9 2010 Elsevier B.V. All rights reserved.\ndoi: 10.1016/j.jviromet.2010.09.013Occurrence of water-borne enteric viruses in two\nsettlements based in Eastern Chad: analysis of hepatitis Evirus, hepatitis A virus and human adenovirus in watersources\nLaura Guerrero-Latorre, Anna Carratala, Jesus Rodriguez-Manzano,\nByron Calgua, Ayalkibet Hundesa and Rosina Girones\nABSTRACT\nHepatitis E virus (HEV) is a common cause of water-borne acute hepatitis in areas with poor\nsanitation. In 2004 an outbreak of HEV infection affected around 2,000 people in Eastern Chad (DarSila). This paper describes the decrease in the incidence of acute jaundice syndrome (AJS) from 2004until 2009 when a mean incidence of 0.48 cases/1,000 people/year was recorded in the region.Outbreaks of AJS were identi \ufb01ed in some of the camps in 2007 and 2008. Moreover, water samples\nfrom drinking water sources were screened for human adenoviruses considered as viral indicatorsand for hepatitis A virus and HEV. Screening of faecal samples from donkeys for HEV gave negativeresults. Some of the samples were also analysed for faecal coliforms showing values beforedisinfection treatment between 3 and >50 colony forming units per 100 mL. All water samples tested\nwere negative for HEV and HAV; however, the presence of low levels of human adenoviruses in 4 outof 16 samples analysed indicates possible human faecal contamination of groundwater.Consequently, breakdowns in the treatment of drinking water and/or increased excretion of hepatitis\nviruses, which could be related to the arrival of a new population, could spread future outbreaks\nthrough drinking water.Laura Guerrero-Latorre\nIntermon Oxfam Humanitarian Action Program,C/Roger de Ll\u00faria, 15,\n08010 Barcelona,\nSpain\nLaura Guerrero-Latorre\nAnna CarratalaJesus Rodriguez-ManzanoByron CalguaAyalkibet Hundesa\nRosina Girones (corresponding author)\nDepartment of Microbiology,Faculty of Biology,University of Barcelona,\nAvd. Diagonal 645,\n08028 Barcelona,SpainE-mail: rgirones@ub.edu\nKey words |acute jaundice syndrome, drinking-water, Eastern Chad, HEV, HAdV, humanitarian\naction\nABBREVIATIONS\nAJS acute jaundice syndrome\nEWARS Early Warning Alert and Response SystemGC genomic copiesHAdV human adenoviruses\nHAV hepatitis A Virus\nHEV hepatitis E VirusIDPs internally displaced personsNCBI National Center for Biotechnology InformationnPCR nested PCRORF1 open reading frame 1ORF2 open reading frame 2\nPBS phosphate-buffered salinePCR polymerase chain reaction\nqPCR quantitative polymerase chain reactionRT-PCR reverse transcription-PCRSD standard deviation\nUV ultraviolet\nWaSH water, sanitation and hygiene\nINTRODUCTION\nHepatitis E virus (HEV) and hepatitis A virus (HAV) aresmall, non-enveloped viruses that contain positive sense515 \u00a9 IWA Publishing 2011 Journal of Water and Health |09.3|2011\ndoi: 10.2166/wh.2011.126HIV, HEV and cirrhosis: evidence of a possible link from\neastern Spain\nR Jardi,1,2M Crespo,3M Homs,1,2E Van den Eyden,3R Girones,4J Rodriguez-Manzano,4A Caballero,1M Buti,2,5\nR Esteban2,5and F Rodriguez-Frias2\n1Department of Biochemistry, Vall d\u2019Hebron Hospital, University \u201cAutonoma\u201d of Barcelona, Barcelona, Spain,2Centro\nde Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Biomedical Research Network\nCenter, Hepatic and Gastrointestinal Diseases, Carlos III Institut, Spanish Ministry of Health, Barcelona, Spain,\n3Department of Infectious Diseases, Vall d\u2019Hebron Hospital, University \u201cAutonoma\u201d of Barcelona, Barcelona, Spain,\n4Microbiology, Faculty of Biology, University of Barcelona, Barcelona, Spain and5Department of Hepatology, Vall\nd\u2019Hebron Hospital, University \u201cAutonoma\u201d of Barcelona, Barcelona, Spain\nObjectives\nThe aim of the study was to assess the seroprevalence of hepatitis E virus (HEV) infection in an\nHIV-infected population, as determined by HEV immunoglobulin G (IgG) antibodies (anti-HEV).\nMethods\nThe design of the study was cross-sectional. Serum anti-HEV IgG was determined by enzymeimmunoassay in 238 HIV-infected patients consecutively attending our out-patient clinicbetween April and May 201 1. In HEV-seropositive patients, HEV RNA was analysed by nestedreverse transcriptase\u2013polymerase chain reaction (RT-PCR). Associations between anti-HEV andliver cirrhosis, route of HIV infection, hepatitis B virus (HBV) and hepatitis C virus (HCV)serological markers, age, sex and alanine aminotransferase (ALT) levels were examined byunivariate and multivariate analysis.\nResults\nOne hundred and forty patients (59%) had chronic liver disease (99% were HBV- and/orHCV-coinfected). Liver cirrhosis was detected in 44 individuals (19%). Two hundred and twelvepatients (89%) were on antiretroviral treatment; the median CD4 T-cell count was 483 cells/ mL\n[interquartile range (IQR) 313\u2013662 cells/ mL] and the HIV viral load was <25 HIV-1 RNA\ncopies/mL. Overall, 22 patients (9%) were anti-HEV positive. Liver cirrhosis was the only factorindependently associated with the presence of anti-HEV, which was documented in 23% ofpatients with cirrhosis and 6% of patients without cirrhosis ( P=0.002; odds ratio 5.77). HEV\nRNA was detected in three seropositive patients (14%), two of whom had liver cirrhosis.\nConclusions\nOur \ufb01ndings show a high prevalence of anti-HEV in HIV-infected patients, strongly associatedwith liver cirrhosis. Chronic HEV infection was detected in a signi\ufb01cant number ofHEV-seropositive patients. Further research is needed to ascertain whether cirrhosis is apredisposing factor for HEV infection and to assess the role of chronic HEV infection in thepathogeneses of cirrhosis in this population.\nKeywords: hepatitis E virus, HIV infection, immunosuppression, liver cirrhosis, prevalence\nAccepted 8 November 201 1\nIntroduction\nHepatitis E virus (HEV) is an enterically transmitted RNA\nvirus. It is a major cause of acute hepatitis outbreaks in\nendemic areas and acute sporadic cases in industrializedCorrespondence: Dr Francisco Rodriguez-Frias, Servicio de Bioquimica,\nHospital General Vall d\u2019Hebr\u00f3n, Paseo Valle Hebr\u00f3n s/n, Barcelona 08035,Spain. Tel: 34 (93) 2746100; fax: 34 (93) 2746831; e-mail:frarodri@vhebron.netDOI: 10. 1 1 1 1/j.1468-1293.201 1.00985.x\n\u00a92012 British HIV Association HIV Medicine (2012)\nSHORT COMMUNICATION\n1", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}